TW487559B - A83543 compounds, their preparation process and their uses - Google Patents

A83543 compounds, their preparation process and their uses Download PDF

Info

Publication number
TW487559B
TW487559B TW83102553A01A TW487559B TW 487559 B TW487559 B TW 487559B TW 83102553A01 A TW83102553A01 A TW 83102553A01A TW 487559 B TW487559 B TW 487559B
Authority
TW
Taiwan
Prior art keywords
spinoxin
dihydro
mmol
propyl
compound
Prior art date
Application number
Other languages
Chinese (zh)
Inventor
Carl Vincent Deamicis
Peter Biagio Anzeveno
Jacek G Martynow
Kevin L Mclaren
Frederick Richard Green Iii
Original Assignee
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc filed Critical Dow Agrosciences Llc
Application granted granted Critical
Publication of TW487559B publication Critical patent/TW487559B/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The compounds of the present invention are prepared directly or indirectly by modifying the compounds that are naturally produced from Saccharopolyspora spinosa. The compounds of the invention have been shown to have activity against insects and mites. The compounds are prepared by modifying the rhamnose sugar, modification of the forosamine sugar, or starting with pseuodoaglycone and then replacement with a nonsugar derivative or different sugar, modification of the 5,6,5-tricyclic and 12-membered macrocyclic lactone part of the compounds naturally produced or of the pseudoaglycone of the natural compounds.

Description

487559 A7 __B7 五、發明説明(1 ) 發明領Μ 本發明傜關於使由史賓多泡酵母菌(^^nnharopoly-a.j>.Q-r,a. s.&jnosa)生産之史賓多辛(SP IH0SYN)化合物藉由化 學修飾産生之化合物。此等化合物具有殺昆蟲活性。 薛明背暑 美國專利第5,362,634號確認發酵産物A83543為史賓 多泡酵母菌所生産之一族相關化合物,該專利文獻併入本 文中以供參考。此等化合物已被稱為A、B、C、D、E、F、 經濟部中夬標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) G、H、J、K、L、M、H、0、P、Q、U、S、T、U、V、W、Y 等因子或成分(亦可參見PCT WO 93/09126及PCT WO 94/ 20518)及在後文中傺稱為史賓諾辛A、B等。此等史賓諾辛 化合物可用於蜘蛛類、線蟲類及昆蟲的控制。天然産生之 史賓諾辛化合物是由稠合至12員大璟内酯之5,6,5 -三環糸 、中性糖(鼠李糖)及胺醏(f ο r 〇 s a m i n e)(參見κ i r s t等人, (1991) , Tetrahedron Letters 32 · 4839)戸斤組成0 如果 化合物中不含胺醣則稱為A , D等之反假糖苷配基化合物。 用於指稱假糖苷配基合物之較佳命名為史賓諾辛A 9-Psa 、史賓諾辛D 9-Psa等。史賓諾辛化合物一般具有下述結 構: R3’、 .〇487559 A7 __B7 V. Description of the invention (1) Invention invention The present invention relates to the use of spinaldoxin (SP) produced by Spinaldo yeast (^^ nnharopoly-a.j > .Qr, as & jnosa). IHOSYN) Compounds produced by chemical modification. These compounds have insecticidal activity. Xue Mingbeishu U.S. Patent No. 5,362,634 confirms that the fermentation product A83543 is a family of related compounds produced by S. spp., Which is incorporated herein by reference. These compounds have been called A, B, C, D, E, F, printed by the Consumers' Cooperatives of the China Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) G, H, J, K , L, M, H, 0, P, Q, U, S, T, U, V, W, Y and other factors or components (see also PCT WO 93/09126 and PCT WO 94/20518) and later傺 is called Spinozin A, B and so on. These Spinozin compounds are useful for the control of spiders, nematodes and insects. Spinocinol compounds that are naturally occurring are 5,6,5-tricyclic hydrazones, neutral sugars (rhamnose), and amines (f ο r 〇samine) fused to 12-membered gallide κ irst et al. (1991), Tetrahedron Letters 32 · 4839) If the compound does not contain amine sugar, it is called A, D and other pseudo-aglycone compounds. The preferred names for referring to pseudoglycoside ligands are Spinoxin A 9-Psa, Spinoxin D 9-Psa, and the like. Spinozin compounds generally have the following structure: R3 ’, .〇

本紙張尺度適用中國鹵家標準(CNS ) A4規格(210 X 297公釐) 4^7559 五、發明説明(2 ) 經濟部中央標準局員工消費合作社印製 因子 R1, R2, R3, R4, Rs, R6, R7/ 史賓諾辛A Η CHg C2H5 CH3 CH3 CHa 史賓諾辛B Η CH3 C2Hs CH3 CH3 CH3 史賓諾辛C Η CH3 CH3 ^ Η5Ν"^λ_ C2Hs CH3 CHa CHa 史賓諾辛D ch3 CHa C2Hs CH3 CHa CHa 史賓諾辛E Η ch3 CH3 CHa ch3 CH3 史賓諾辛F Η Η (CH3)2N-^^l^-^ C2H5 CH3 ch3 CHa 史賓諾辛G Η CH3 ch3 C2Hs CH3 CHo CH3 史賓諾辛Η Η CH〇 CHn C2Hs H CH3 CH3 史賓諾辛J Η ch3 C 2 H 5 CH3 H CH3 史賓諾辛Κ Η CHa CsHs CHg CHa H 史賓諾辛L CHa CH3 (CH3)2N--^^x^^ C2Hs CHg H CHa 史賓諾辛Μ Η CH3 (CH3)NH-^^^ C 2 H 3 CHg H CH3 裝— (請先閲讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 487559 五、發明説明(3 ) 經濟部中央標準局員工消費合作杜印製This paper size applies to the Chinese Standard (CNS) A4 (210 X 297 mm) 4 ^ 7559 V. Description of the invention (2) Printing factors R1, R2, R3, R4, Rs of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs , R6, R7 / Spinozin A Η CHg C2H5 CH3 CH3 CHa Spinozin B Η CH3 C2Hs CH3 CH3 CH3 Spinozin C Η CH3 CH3 ^ Η5Ν " ^ λ_ C2Hs CH3 CHa CHa Spinozin D ch3 CHa C2Hs CH3 CHa CHa Spinoxin E Η ch3 CH3 CHa ch3 CH3 Spinoxin F Η CH (CH3) 2N-^^ l ^-^ C2H5 CH3 ch3 CHa Spinoxin G Η CH3 ch3 C2Hs CH3 CHo CH3 Spinozin Η Η CH〇CHn C2Hs H CH3 CH3 Spinozin J Η ch3 C 2 H 5 CH3 H CH3 Spinozin KK Η CHa CsHs CHg CHa H Spinozin L CHa CH3 (CH3) 2N- -^^ x ^^ C2Hs CHg H CHa Spinozin M Η CH3 (CH3) NH-^^^ C 2 H 3 CHg H CH3 Pack — (Please read the notes on the back before filling this page) Standards are applicable to China National Standard (CNS) A4 (210 X 297 mm) 487559 V. Description of invention (3) Printed by the staff of the Central Standards Bureau of the Ministry of Economic Affairs for consumer cooperation

因子 R1, R2, R3, R4, R5, Re, R7, 史賓諾辛N CHa CHa (ch3)nh-^^^ C 2 H 5 CHa H CHa 史賓諾辛0 CHa CHg (CH3)2N--^^X^^ C2H5 CH3 CH3 H 史賓諾辛P Η ch3 CaHs CHg H H 史賓諾辛Q CH3 CHa CaHs H CHa CH3 史賓諾辛R Η CHa C2H5 H CHa CH3 史賓諾辛S Η CH3 CH3 H CHg CHg 史賓諾辛T Η CHg C2H5 H H CH3 史賓諾辛U Η CH3 C 2 H 5 H ch3 H 史賓諾辛V CHg CHa C 2 H 5 H CHa H 史賓諾辛W CHa CH3 (C H3)2 N — C 2 H 5 CH3 H H 史賓諾辛Y Η ch3 (CH3)2N-^^^^ C2H5 CH3 CH3 H 裝— (請先閱讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 487559 A7 B7 五、發明説明(斗) 經濟部中央標準局員工消費合作社印製 因子 R1, R2' # R3, R5; RB, R7; 史賓諾辛A 17-Psa Η CH3 Η C2Hs ch3 ch3 CH3 史賓諾辛A 17-Psa Η CH3 Η C 2 Η 5 ch3 ch3 CH3 史賓諾辛B 17-Psa CH3 CH3 Η C2Hs ch3 CHa CH3 史賓諾辛E 17-Psa Η CH3 Η CHa CHa CH3 ch3 史賓諾辛F 17-Psa Η Η Η CsHs CH3 CHa CHa 史賓諾辛Η 17-Psa Η CHa Η C 2 H 5 H CHa CHa 史賓諾辛J 17-Psa Η CHa Η C2Hs CH3 H CH3 史賓諾辛L 17-Psa CHo CHa Η C2Hs CHa H CH3 (請先閱讀背面之注意事項再填寫本頁) -裝- 訂 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 487559— A7 B7 五、發明説明(左)R3’、。Factors R1, R2, R3, R4, R5, Re, R7, Spinozin N CHa CHa (ch3) nh-^^^ C 2 H 5 CHa H CHa Spinozin 0 CHa CHg (CH3) 2N-- ^^ X ^^ C2H5 CH3 CH3 H Spinoxin P Η ch3 CaHs CHg HH Spinoxin Q Q3 CHa CaHs H CHa CH3 Spinoxin R Η CHa C2H5 H CHa CH3 Spinoxin S Η CH3 CH3 H CHg CHg Spinoxin T Η CHg C2H5 HH CH3 Spinoxin U Η CH3 C 2 H 5 H ch3 H Spinoxin V CHg CHa C 2 H 5 H CHa H Spinoxin W CHa CH3 (C H3 ) 2 N — C 2 H 5 CH3 HH Spinozin Y Η ch3 (CH3) 2N-^^^^ C2H5 CH3 CH3 H Pack — (Please read the precautions on the back before filling this page) The size of the paper is applicable China National Standard (CNS) A4 specification (210X 297 mm) 487559 A7 B7 V. Description of the invention (bucket) Printing factors R1, R2 '# R3, R5; RB, R7; Shi Bin Northyn A 17-Psa Η CH3 Η C2Hs ch3 ch3 CH3 Spinnock A 17-Psa Η CH3 Η C 2 Η 5 ch3 ch3 CH3 Spinnock B E 17-Psa Η CH3 Η CHa CHa CH3 ch3 Spinozin F 17-Psa Η Η Η CsHs CH3 CHa CHa Spinozin Η 17-Psa Η CHa Η C 2 H 5 H CHa CHa Spinozin J 17-Psa Η CHa Η C2Hs CH3 H CH3 Spino Xin L 17-Psa CHo CHa Η C2Hs CHa H CH3 (Please read the precautions on the back before filling out this page) -Packing-The size of the paper is applicable to the Chinese National Standard (CNS) A4 (210X 297 mm) 487559— A7 B7 V. Description of the invention (left) R3 '.

因子 R1 ; R2, R3, R4/ Rs, 史賓諾辛A 9~Psa Η CHa (CH3)jN C 2 H 5 史賓諾辛D 9-Psa CH3 CHg (CH3)NH〇 CsHs H 史賓諾辛A 配_基 Η CHa H CaHs H 史賓諾辛D 配_基 CH3 CH3 H CaHs H (請先閱讀背面之注意事項再填寫本頁) 裝.Factor R1; R2, R3, R4 / Rs, Spinozin A 9 ~ Psa Η CHa (CH3) jN C 2 H 5 Spinozin D 9-Psa CH3 CHg (CH3) NH〇CsHs H Spinozin A with base CHa H CaHs H Spinozin D with base CH3 CH3 H CaHs H (Please read the precautions on the back before filling this page).

、1T 經濟部中央標準局員工消費合作社印製 天然産生之史賓諾辛化合物可藉由菌種NRRL 13719、 18 537、18533、18539、1843及 18823的發酵作用以生産 ° 此等菌種已被寄存及製成美國農業部農業研究所之種菌保 存收集的一部分·· -S - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 487559 A7 * B7 五、發明説明(6 ) 如上所述,史賓諾¥化合物特別有效於對抗鱗翅目及 雙翅目種類之昆蟲。史賓諾辛化合物相當環保及具有引人 興趣之毒理學圖形。然而,在某些應用中,最理想的是能 比習知專利案及公開案所揭露之史賓諾辛具有更長的殘餘 效果。具有更長之殘餘效果的史賓諾辛類似物可用於控制 水果及堅果類上的蟎或控制影響梨果果實的蠢蛾。 發明摘要 本文中所揭露之本發明為由史賓多泡酵母菌( Saccharopolv-spora soinosa)生產之產物的合成修飾, 藉此生產用於農業及動物保健市場之中間產物及/或殺昆 蟲產物。許多合成修飾係對鼠李糖、胺醣(forosamine)進 行,經由氫化作用、環氧化作用、遨原作用、鹵化作用、 氧化作用、加成烷基、加成氮基對及巨環內酯上之取代基 的加成及脫去Μ對分子進行。 發明之詳细說明 本發明之化合物係直接或間接藉由修飾化合物Κ製備 ,該化合物係由史賓多泡酵母菌天然生產,參見頒發給 0〇;^1心(:〇之美國專利第5,362,634號,該專利併入本文中 Μ供參考。本發明之化合物已顯示出具有抗昆蟲、蜘蛛類 及線蟲類之活性。因此,本發明之化合物可用於製造其他 化合物或本發明之化合物本身可用作抑制毘蟲或蟎或使其 去活化。使抑制或去活化量之化合物與毘蟲或蟎之出沒地 點接觸。昆蟲之“出沒地點”係指毘蟲或蟎居住的環培或 其卵出現的地方,毘蟲或邊周圍之空氣,毘蟲或蟎吃的食 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) -裝-- (請先閱讀背面之注意事項再填寫本頁) 訂 4 487559 A7 __.____ B7 ,五、發明説明(7 ) 物,或與其接觸之物體/一般這些化合物係施用至植物之 葉子,其為毘蟲或蟎賴Μ為生的食物。除非本文中特別說 明,下述詞語及術語之意義如下:“鹵烷基”一詞意指具 有1至4個碳原子的烷基,其中至少一鹵素结合至碳原子。 “鹵素”一詞意指C 1、F、Br,或I。“烷醇基”一詞意指 具有1至4個碳原子的烷基,其中至少一羰基連接至烷基。 “烷基羥基胺” 一詞意指具有下述化學式之取代基 -裝-- (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作杜印製 其中R1*1及R11各自獨立為具有1至4個碳原子的烷基,或具 有1至5個碳原子的烷醇基。“被保護的羥基”一詞意指被 甲基酯取代,例如但不限定為甲氧甲基、四氫吡喃,被乙 基酯取代,例如但不限定為1-乙氧乙基,被苯甲醯醚取代 *例如但不限定為對甲氧苄基、被甲矽烷基醚取代,例 如但不限定為具有1至2個碳原子的甲矽烷基醚,一般為具 有1至2個碳原子的醚類,一般為具有1至2個碳原子的酯類 ,更特別為甲酸酯或乙酸酯,碳酸酯一般為具有1至2個碳 原子的碳酸酯,更特別為碳酸甲酯,及一般為具有1至2涸 硫原子的磺酸酯,更特別為磺酸甲酯。這些保護基在 Green, T. W· Wuts, P. Q. M* 有機合成 ^ 保譜某( Organic戈Groups in Organic Syntheses, John Wiley and Sons,紐約,1991,第17-18頁)中說明地更詳细,該 文獻全文併入本文中以供_考。“被保護的胺基”一詞意 10 訂 4 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29*7公釐) 487559 經濟部中央標準局員工消費合作社印製 A7 B7____五、發明説明(8 ) 指具有1至2個碳原子的Μ基甲酸酯,具有1至4個碳原子的 醯胺,一般為η-甲醯基及η-乙醯基,及例如η-亞苄基之亞 胺。這些保護基係進一步敘述於Greene有機合成之保護基 (Organic Groups in Organic Syntheses)。抑制昆蟲 或蟎”一詞意指活著之毘蟲或蟎的數目降低’或其卵數目 降低。“去活化量”係意指用Μ造成被處理之毘蟲或蟎的 族群可計數地降低的化合物量。一般所使用之化合物約1 至約 1,000 ppm(或 0.01 至 1 Kg/畝)。 這些化合物一般可有效地對抗紫菀葉蟬(Hacroste les fascifrons· aster leafhopper)、甜菜夜蛾(Spodoptera ex i gua · beet armyworm)、花生根節線结蟲類( Meloidogyne a r q n a r i a . peanutroot knot nematode)、 棉呀(.Aphis g o s 5; Y p i i . cotton aphids)、棉葉騎(Tetra-anychus ur t i ca^. two spotted spider mite)、十一星 爪葉甲(Diabrotioa undecimounctata howardi· Southern corn rootworm)、美洲棉玲蟲(He 1 i oth i s · cotton bollworm)、菲島玉米蠘禪(Per egr i nus ma i d i s . corn p 1 an t hopper)、美洲 葉蛾(He 1 i oth i s virescfin^, T o b b a c c o b u d w o r m)、德國蟑螂(B 1 a 11 e 11 a g e r m a n i c u s, German cockroach)、歐洲玉米螺(Gstrinia nubilalis. European cornborer)、黑尾葉蟬(Neohotett i x c Ljlc i t i c e p s i green rice leafhopper)、裼褐飛風( Ni lapar ya ta__Lu g e n s . brown planthopper) » 及二化虫冥( Chilo suppressalis, rice stem borer)等0 ____-11 -_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事 4 •項再填· :寫本頁) 裝., 1T printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, the naturally produced Spinozin compounds can be produced by fermentation of strains NRRL 13719, 18 537, 18533, 18539, 1843 and 18823 ° These strains have been Deposited and made part of the collection of germ fungi of the USDA Agricultural Research Institute--S-This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 * B7 V. Description of the invention (6) As mentioned above, Spino ¥ compounds are particularly effective against insects of the order Lepidoptera and Diptera. Spinozin compounds are quite environmentally friendly and have interesting toxicology graphics. However, in some applications, it is desirable to have a longer residual effect than the spinosinoxin disclosed in conventional patents and publications. Spinozin analogues with longer residual effects can be used to control mites on fruits and nuts or to control moths that affect pear fruit. Summary of the Invention The invention disclosed herein is a synthetic modification of a product produced by Saccharopolv-spora soinosa, thereby producing intermediate products and / or insecticidal products for the agricultural and animal health markets. Many synthetic modifications are performed on rhamnose and forosamine, through hydrogenation, epoxidation, primogenization, halogenation, oxidation, addition of alkyl groups, addition of nitrogen groups and macrolides. The addition and removal of the substituents are performed on the molecule. DETAILED DESCRIPTION OF THE INVENTION The compounds of the present invention are prepared directly or indirectly by modifying compound K, which is produced naturally by Spindowella yeast, see US Patent No. 5,362,634 issued to 0〇; ^ 1 心 (: 〇 No., the patent is incorporated herein by reference. The compounds of the present invention have been shown to have activity against insects, spiders and nematodes. Therefore, the compounds of the present invention can be used to make other compounds or the compounds of the present invention can be used by themselves Inhibits or deactivates phobias or mites. Contacts the inhibited or deactivated amount of compounds with the habitat of worms or mites. The "infestation" of insects refers to the presence of ring culture or their eggs inhabited by phobias or mites Place, the adjacent air or the air around it, the paper size of the food to be eaten by the worm or the mite applies the Chinese National Standard (CNS) A4 specification (210X 297 mm)-Packing-(Please read the precautions on the back before filling This page) Order 4 487559 A7 __.____ B7, V. Description of the invention (7), or objects in contact with it / Generally these compounds are applied to the leaves of plants, which are born of pygma or mites Food. Unless specifically stated herein, the following words and terms have the following meanings: The term "haloalkyl" means an alkyl group having 1 to 4 carbon atoms, of which at least one halogen is bonded to a carbon atom. The word means C 1, F, Br, or I. The term "alkanolyl" means an alkyl group having 1 to 4 carbon atoms, of which at least one carbonyl group is attached to the alkyl group. The term "alkylhydroxylamine" Means the substituents with the following chemical formulas-equipment-(Please read the precautions on the back before filling out this page) Printed by the Consumer Cooperation Department of the Central Standards Bureau of the Ministry of Economic Affairs where R1 * 1 and R11 are each independently 1 to 4 Alkyl groups having 1 to 5 carbon atoms, or alkanol groups having 1 to 5 carbon atoms. The term "protected hydroxyl" means substituted with a methyl ester, such as, but not limited to, methoxymethyl, tetrahydropyran , Substituted by ethyl ester, such as but not limited to 1-ethoxyethyl, substituted by anisole * such as but not limited to p-methoxybenzyl, substituted by silyl ether, such as but not limited to having Silyl ethers of 1 to 2 carbon atoms are generally ethers having 1 to 2 carbon atoms, generally Esters having 1 to 2 carbon atoms, more particularly formate or acetate, carbonates are generally carbonates having 1 to 2 carbon atoms, more specifically methyl carbonate, and generally having 1 to 2 2 sulfonate sulfonate, more specifically methyl sulfonate. These protecting groups are in Green, T.W · Wuts, PQ M * Organic Synthesis ^ Organic Groups in Organic Syntheses, John Wiley and Sons , New York, 1991, pp. 17-18) in more detail, the entire text of which is incorporated herein for reference. The term “protected amine group” means 10 and 4 (CNS) A4 specification (210X29 * 7 mm) 487559 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7____ 5. Description of the invention (8) Refers to M-formate with 1 to 2 carbon atoms, with 1 The fluorene amines having 4 to 4 carbon atoms are generally η-methylamino and η-ethylfluorenyl, and imines such as η-benzylidene. These protective groups are further described in Greene's Organic Groups in Organic Syntheses. The term "inhibiting insects or mites" means a decrease in the number of living worms or mites' or a decrease in the number of eggs. "Deactivation amount" means the use of M to cause a countable decrease in the population of worms or mites being treated The amount of the compound. Generally, the compound used is about 1 to about 1,000 ppm (or 0.01 to 1 Kg / mu). These compounds are generally effective against Haploste les fascifrons aster leafhopper, Spodoptera ex i gua · beet armyworm), Meloidogyne arqnaria. peanutroot knot nematode), cotton (.Aphis gos 5; Y pii. cotton aphids), cotton leaf ride (Tetra-anychus ur ti ca ^. two spotted spider mite), eleven star claw leaf beetle (Diabrotioa undecimounctata howardi Southern corn rootworm), American cotton worm (He 1 i oth is cotton bollworm), Peregr i nus ma idis. corn p 1 an t hopper), American leaf moth (He 1 i oth is virescfin ^, T obbaccobudworm), German cockroach (B 1 a 11 e 11 agermanicus, German cockroach), Europe Gstrinia nubilalis. European cornborer, Neohotett ixc Ljlc iticepsi green rice leafhopper, Ni lapar ya ta__Lu gens. Brown planthopper »and Chilo suppressalis, rice stem borer) etc. 0 ____- 11 -_ This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the notes on the back 4 • Items and then fill in:: Write this page).

、1T 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(9 ·) 合成化合物一般係藉ΐ修飾鼠李糖、修飾胺糖、或以 9-或17-假糖苷配基化合物為起點及接著Μ鼠李糖或胺糖 取代非糖物或不同的糖類。合成化合物亦藉由修飾如本文 中實施例所描述之天然產生的化合物的5,6,5-三環及/或 12-員大環假糖苷配基化合物。本文中所請求之化合物包 含該化合物之所有異構物及任何酸加成鹽類及其異構物。 在本文中所請求之化合物存在有數種非鏡像異構物。 因為具有多數立體性中心,可預期非鏡像異構物有殺毘蟲 劑的活性。雖然有一些非鏡像異構物可能比其他非鏡像異 構物有效,但本發明將所有非鏡像異構物一視同仁。 在實施例17之Α部份中,鼠李糖在化學式I之R5’、 R6’及R7’位置係藉由加成長鏈烷基、芳基及/或具有鹵素 取代基之長鏈烷基、芳基的加成修飾。酯類亦可形成在 R5’、R6’及R7’位置。額外的糖類亦可取代在這些位置。 另一修飾方式為在這些位置加成含有如氮、硫、磷及矽等 原子的取代基。除了鼠李糖上之修飾外,化學式I中C5及C 6位置間的雙鍵係藉由環氧化作用或氫化作用修飾。 在實施例17之B部份中,胺糖係由非糖物取代基經由 酯鐽结取代。酯類一般具有氮雜環基、鹵素、或胺基。在 實施例17之C部份中,胺糖係藉由改變氮上之取代基,由 Η或甲基改變為長鏈烷基、泠基、四级銨鹽或N-氧化物。 在實施例17之D部份中,係在C13及C14之雙鍵位置藉由氫 化作用、環氧化作用、遨原作用及加成例如羥基胺及氟化 合物之烷基及氮基修飾分子‘。在實施例17之Ε部份中,脫 本纸張尺度適用中國國家標準(CNS ) Α4規格(21〇'乂 297公釐) ---------^^裝-- (請先閱讀背面之注意事項再填寫本頁) 、1Τ Φ 經濟部中央標準局員工消費合作社印製 487559 A7 B7 · 五、發明説明(1〇 ) 去大環內酯之C17取代基K獲得雙鐽及/或以鹵素、環氧 化物及烷氧化物修飾C5及C6位置。在實施例17之F部份中 ,在C5及C6在位置,藉由氫化作用、環氧化作用、鹵化作 用、氧化作用及雜原子取代基及酯類之加成修飾。 在實施例17之G部份中,係Μ如鼠李糖衍生物之其他 糖類取代胺糖。在實施例17之Η部份中,使史賓諾辛起始 物質烷基化或L去甲基化。所得物質最好用作製造其他化 合物之起始物質。在實施例17之I部份中,製備去氧化鼠 李糖類似物及進一步Μ酯類或雜原子取代修飾。在實施例 17之J部份中,鼠李糖係Κ其他糖類及例如酯類及醚類之 非糖物取代。在實施例17之Κ部分中,分子中5,6,5-三環 部分之C9位置係藉由將羥基氧化成酮及接著將烷基加成至 C-0雙鍵上修飾。再者,使C9位置之羥基去氧化或Μ含氮 基取代。 本文中所揭露之化合物不僅可用於生產農業用產品, 這些化合物之酸加成鹽類亦為理想的產品。酸加成鹽類可 由化學式I、E、IV、VI、VI、及XV所揭露之化合物製 備。化合物之鹽類使用製備鹽類之標準技術,其為熟習是 項技術者所熟知者。鹽類可被中和Μ形成酸加成鹽類。特 別有用之酸加成鹽類包含,但不限制於由有機酸及無機酸 之標準反應所形成者,例如硫酸、氫氯酸、磷酸、乙酸、 t 琥珀酸、擰檬酸、乳酸、順丁烯二酸、反丁烯二酸、膽酸 、雙羥萘酸、半乳糖二酸、麩胺酸、樟腦酸、戊二酸、羥 基乙酸、鄰苯二甲酸、酒石‘酸、甲酸、月桂酸、硬脂酸、 -13 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公漦) Γ 裝 訂 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 B7___ 五、發明説明(1 1 ) 水楊酸、甲磺酸、苯磺酸'山梨酸、苦味酸、苯甲酸、内 桂酸等。 製備組合物所根據之步驟及配方係屬習知農業或害蟲 控制技術領域之傳統技術。該組合物可被濃縮或分散於水 中,或可Μ粉末、食餌或顆粒配方使用。分散液一般為由 化合物之濃縮配方製得之水性懸浮液或乳化液。水溶性或 水分散性或可乳化性配方為固體、可濕潤粉末、或液體, 已知為可乳化之濃縮物或水性分散液。可濕潤粉末可凝结 或壓研Μ形成水可分散之顆粒。這些顆粒包含化合物、惰 性載體及界面活性劑之混合物。化合物之濃度一般為介於 約0.1重量%至約90重量%之間。惰性載體一般為矽鎂土 、蒙脫土及矽藻土或純化之矽酸鹽。 界面活性劑包含約0.5%至約10%可濕潤粉末,其中 界面活性劑一般為磺酸化木質素、濃縮禁磺酸鹽、萘磺酸 鹽、苯磺酸烷基酯、磺酸烷基酯、或非離子性界定活性劑 ,例如烷基酚之環氧乙烷加成物或其混合物。 本發明化合物之可乳化的濃縮物一般為每升液體含約 50至約500克化合物,等於約10至約50%溶於惰性載體, 該載體為與水不能相混合之溶劑或乳化劑的混合物。有機 溶劑包含有機物,例如二甲苯及石油餾分,例如石油之高 沸點萘及烯烴部分,包含箄石腦油及芳族石腦油。其他可 利用之有機物例如萜烯溶劑松脂衍生物、例如環己酮及複 雜之脂族嗣及複雜的醇類。可乳化濃縮物所有之乳化劑一 般為混合之離子性或非離子性界面活性劑,洌如本文中前 _______— 14 ~___ 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) I-----Ν--^^抑衣一.-----1Τ------ (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 _____ B7___ 五、發明説明(12 ) 述者及其等效物。 ‘ 可製備含有水不溶性物質之水性懸浮液,其中化合物 係Μ —般為約5重量%至約50重量%之濃度分散於水性媒 介物中。懸浮液較佳係藉由精细研磨化合物及剌烈地將其 與本文中所述之水、界面活性劑及分散劑等媒介物混合。 惰性成份,例如無機鹽類及合成或天然膠類,亦可適需要 地應用於增加水性媒介物之密度及/或黏度。 經沈澱之可流動物質可藉由溶解活性分子於可與水相 混合之溶劑及界面活性劑或界面活性聚合物而製備。當這 些配方與水混合時,活性化合物沈澱物與界面活性劑控制 所得微结晶沈澱之尺寸大小。晶體的大小可經由選擇特定 之聚合物及界面活性劑混合物而控制。 本發明之化合物亦可Μ施用於土壤之顆粒狀組合物方 式應用。顆粒組合物一般含有約0.5重量%至約10重量% 化合物。化合物係分散於惰性載體中,該載體一般為黏土 或一等效物質。一般而言,顆粒狀組合物係藉由將化合物 溶解於適當之溶劑中及將其應用至已預形成理想顆粒大小 之顆粒載體。顆粒大小一般為約0.5 mm至3 mm。顆粒性組 合物亦可藉由形成糰狀或糊狀之載體及化合物,乾燥組合 化合物,及粉碎此糰狀或糊狀物Μ形成所欲的顆粒大小。 化合物亦可與適當有機溶劑組合。有機溶劑一般為廣 泛地使用於農業上之溫和的石油潤滑油。這些組合物一般 係Κ噴霧劑之方式應用。更特別地,此化合物係Μ液體載 體之分散液方式應用,該液體載體為水。化合物亦可以氣 __- 15 _ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) -裝-- (請先閲讀背面之注意事項再填寫本頁) 、11 487559 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(13 溶膠組合物之形式應用。化合物係溶於惰性載體中,其為 產生壓力之推進劑混合物。氣溶膠組合物係Μ容器方式包 裝,其中混合物係經由霧化閥而分散。推進劑混合物包含 低沸點之鹵烴,其可與有機溶劑或Μ惰性氣體或氣態鹵烴 加壓之水性分散液混合。 施用於昆蟲及蟎出沒處之化合物量並不重要且可容易 地由熟習是項技術者決定。一般提供理想控制之濃度為約 10 ppm至約5,000 ppm。對大豆及棉花等作物而言,施用 速率約0.01至約11^/}^,其中化合物係以5至5〇83 1/八噴 霧劑配方應用。化合物亦可施用至任何昆蟲或蟎居住的地 點。這些地點一般為棉花、大豆或蔬菜作物,水果及榛樹 、葡萄樹、屋子或裝飾植物。本發明之化合物亦可應用於 處理動物Μ控制節肢動物,即昆蟲及蜘蛛類,其為動物身 上之害蟲。這些蜘蛛類害蟲一般係侵害寄主的體外(“ect 〇”)表面;用於控制此類害蟲之藥劑最好為“外用殺寄生 蟲藥”。 所有動物皆易於被此類害蟲侵害,雖然脊椎動物寄主 的問題最嚴重。人類為許多寄生蟲的潛伏寄主,及在熱帶 地區及在衛生設備缺乏的地區,寄生蟲侵害為醫療上的普 遍問題。另外,高度易於被寄生蟲侵害者為許多家畜*例 如牛、綿羊、豬、山羊、水牛、鹿、兔子、雞、火雞、鴨 ( 、鵝、駝鳥等。馬及其他娛樂用動物易遭寄生蟲侵害,貂 及其他Μ毛皮為飼養目的之動物亦同,及大白鼠、鼠及其 他實驗及研究用動物亦然。作伴型的動物,例如狗及貓, 16 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 丨 _ 裝 . 訂 (請先閲讀背面之注意事項再填寫本頁) 487559 A7 B7 五、發明説明(14 ) 係高度易遭寄生蟲侵害者,且因為其與人類之親密關係’ 此種寄生蟲病亦會在與該等動物结伴之人類身上產生。魚 、甲殻類及其他水生種類亦容易遭受寄生蟲侵害。簡言之 ,寄生蟲病涉及主要為整個動物範圍的寄主。 由體外寄生蟲蔓延產生之經濟代價相當大。在家畜飼 養領域中,動物遭到飼料效率及生長速率降低等問題。牛 乳及羊毛生產受害及危害到羊毛、獸皮及毛皮的生產。動 物變得易遭二次微生物感染及寄生蟲侵害。即使當體外寄 生蟲不會危害到健康及生產時,亦可造成不可忽視的不舒 服。 雖然已有許多殺寄生蟲劑可供使用,其等遭遇到各種 不同的問題,包含有限之作用種類、環境毒性、重複處理 之需求,及在許多例子中,體外寄生蟲的抗性。因此,仍 存在有對新外用殺寄生蟲劑的需求。 本發明之化合物提供一種用於控制體外寄生蟲之醫療 設備上的新工具。在本發明之具體例中,本發明係著重於 抑制或殺死寄主動物體上節肢動物寄生蟲的方法,其包含 使寄生蟲與有效量之本發明化合物接觸。 經濟部中央榡準局員工消費合作社印製 本發明之化合物可用於控制廣泛不同之節肢動物寄生 蟲。可被本發明化合物控制之代表性寄生蟲如下: 美洲花蜱、斑點鈍眼蜱、波斯壁虱、微小牛蜱、牛尾· 癢蟎、牛蟠形蟎、狗蟠形蟎、安氏短頭蜱、美洲大蜱、雞 皮剌蟎、羊硬蜱、雞羽蟎、膝疥蟎、耳殘喙蜱、馬癢蟎、Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, 1T 487559 A7 B7 V. Description of the invention (9 ·) Synthetic compounds are generally modified by rhamnose, amine sugar, or 9- or 17-pseudoglycoside compounds Is the starting point and then M rhamnose or amine sugar replaces non-sugars or different carbohydrates. Synthetic compounds are also prepared by modifying the 5,6,5-tricyclic and / or 12-membered macrocyclic pseudoglycoside compounds of naturally occurring compounds as described in the examples herein. The compounds requested herein include all isomers of the compound and any acid addition salts and isomers thereof. There are several non-mirromeric isomers of the compounds claimed herein. Because of the majority of stereogenic centers, non-mirromeric isomers can be expected to be active against the insecticide. Although some non-image isomers may be more effective than others, the present invention treats all non-image isomers equally. In the A portion of Example 17, the rhamnose at positions R5 ′, R6 ′, and R7 ′ of Chemical Formula I is obtained by adding a long-chain alkyl group, an aryl group, and / or a long-chain alkyl group having a halogen substituent, Addition modification of aryl. Esters can also be formed at R5 ', R6', and R7 'positions. Additional sugars can also be substituted at these positions. Another modification is to add substituents containing atoms such as nitrogen, sulfur, phosphorus, and silicon at these positions. In addition to the modification on rhamnose, the double bond between the C5 and C6 positions in Chemical Formula I is modified by epoxidation or hydrogenation. In Part B of Example 17, the amine sugar was substituted with a non-sugar substituent via an ester coupling. Esters generally have a nitrogen heterocyclic group, a halogen, or an amine group. In part C of Example 17, the amine sugar was changed from arsine or methyl to a long-chain alkyl group, a phenyl group, a quaternary ammonium salt, or an N-oxide by changing a substituent on the nitrogen. In the part D of Example 17, the molecule is modified by alkylation and nitrogen group at the double bond positions of C13 and C14 by hydrogenation, epoxidation, primogenization, and addition such as hydroxylamine and fluoride. In the part E of Example 17, the paper size of the paper is applicable to the Chinese National Standard (CNS) A4 specification (21〇 '乂 297mm) --------- ^^ install-(please first Read the notes on the back and fill in this page), 1T Φ Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, printed 487559 A7 B7 · V. Description of the invention (1) C17 substituent K removed from the macrolide was obtained with dihydrazone and / Or modify the C5 and C6 positions with halogen, epoxide and alkoxide. In part F of Example 17, at positions C5 and C6, they were modified by hydrogenation, epoxidation, halogenation, oxidation, and addition of heteroatom substituents and esters. In part G of Example 17, the other saccharides such as rhamnose derivatives are substituted amine sugars. In the part VII of Example 17, the Spinoxin starting material was alkylated or demethylated. The resulting material is preferably used as a starting material for the manufacture of other compounds. In Part I of Example 17, a deoxidized rhamnose analog and further M ester or heteroatom substitution modifications were prepared. In Part J of Example 17, the rhamnose is replaced with other sugars and non-sugars such as esters and ethers. In the K part of Example 17, the C9 position of the 5,6,5-tricyclic part in the molecule was modified by oxidizing a hydroxyl group to a ketone and then adding an alkyl group to a C-0 double bond. Furthermore, the hydroxyl group at the C9 position is deoxidized or substituted with an M nitrogen-containing group. The compounds disclosed herein are not only useful in the production of agricultural products, but acid addition salts of these compounds are also ideal products. Acid addition salts can be prepared from compounds disclosed by Chemical Formulae I, E, IV, VI, VI, and XV. The salts of the compounds use standard techniques for preparing salts, which are well known to those skilled in the art. Salts can be neutralized to form acid addition salts. Particularly useful acid addition salts include, but are not limited to, those formed by standard reactions of organic and inorganic acids, such as sulfuric acid, hydrochloric acid, phosphoric acid, acetic acid, t succinic acid, citric acid, lactic acid, cisbutane Glycolic acid, fumaric acid, cholic acid, paranaphthoic acid, galactic acid, glutamic acid, camphoric acid, glutaric acid, glycolic acid, phthalic acid, tartaric acid, formic acid, laurel Acid, stearic acid, -13-This paper size applies Chinese National Standard (CNS) A4 (210X 297 cm) Γ Binding (please read the notes on the back before filling this page) Staff Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs Printed 487559 A7 B7___ V. Description of the invention (1 1) Salicylic acid, methanesulfonic acid, benzenesulfonic acid 'sorbic acid, picric acid, benzoic acid, lauric acid, etc. The steps and formulations on which the composition is prepared are conventional techniques in the field of conventional agricultural or pest control technology. The composition can be concentrated or dispersed in water, or it can be used in the form of a powder, bait or granule. Dispersions are generally aqueous suspensions or emulsions prepared from concentrated formulations of the compounds. Water-soluble or water-dispersible or emulsifiable formulations are solid, wettable powders, or liquids and are known as emulsifiable concentrates or aqueous dispersions. The wettable powder can be coagulated or crushed to form water-dispersible particles. These particles include a mixture of a compound, an inert carrier, and a surfactant. The concentration of the compound is generally between about 0.1% and about 90% by weight. Inert carriers are generally diatomite, montmorillonite and diatomaceous earth or purified silicate. The surfactant comprises about 0.5% to about 10% of a wettable powder, wherein the surfactant is generally a sulfonated lignin, a concentrated sulfonate, a naphthalenesulfonate, an alkyl benzenesulfonate, an alkylsulfonate, Or non-ionic defined active agents, such as ethylene oxide adducts of alkylphenols or mixtures thereof. Emulsifiable concentrates of the compounds of this invention generally contain from about 50 to about 500 grams of compound per liter of liquid, equal to about 10 to about 50% dissolved in an inert carrier, which is a mixture of solvents or emulsifiers that are immiscible with water. . Organic solvents include organics such as xylene and petroleum distillates, such as the high boiling naphthalene and olefin fractions of petroleum, including vermiculite and aromatic naphtha. Other available organics such as terpene solvent turpentine derivatives, such as cyclohexanone and complex aliphatic amidines and complex alcohols. All emulsifiers of emulsifiable concentrates are generally mixed ionic or non-ionic surfactants, as described in this article _______— 14 ~ ___ This paper size is applicable to the Chinese National Standard (CNS) Λ4 specification (210X297 mm) ) I ----- N-^^ 依 衣 一 .----- 1Τ ------ (Please read the precautions on the back before filling out this page) Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs System 487559 A7 _____ B7___ V. Description of the invention (12) The author and its equivalent. ‘An aqueous suspension containing a water-insoluble substance may be prepared, in which the compound is generally dispersed at a concentration of about 5% to about 50% by weight in an aqueous medium. The suspension is preferably finely ground and vigorously mixed with a vehicle such as water, a surfactant, and a dispersant as described herein. Inert ingredients, such as inorganic salts and synthetic or natural gums, can also be used as needed to increase the density and / or viscosity of aqueous vehicles. The precipitated flowable material can be prepared by dissolving the active molecule in a solvent and a surfactant or a polymer that can be mixed with water. When these formulations are mixed with water, the active compound precipitate and the surfactant control the size of the resulting microcrystalline precipitate. The size of the crystals can be controlled by selecting a specific polymer and surfactant mixture. The compounds of the present invention can also be applied as granular compositions to soils. Granular compositions typically contain from about 0.5% to about 10% by weight of the compound. The compounds are dispersed in an inert carrier, which is generally clay or an equivalent. Generally, granular compositions are obtained by dissolving the compound in a suitable solvent and applying it to a particulate carrier that has been preformed into the desired particle size. The particle size is generally about 0.5 mm to 3 mm. The granular composition can also be formed into a pellet or paste-like carrier and compound, dried to combine the compounds, and pulverize the pellet or paste M to form a desired particle size. The compound may also be combined with a suitable organic solvent. Organic solvents are generally mild petroleum lubricants that are widely used in agriculture. These compositions are generally applied as a K spray. More particularly, the compound is applied as a dispersion of a M liquid carrier, which is water. Compounds can also be __- 15 _ This paper size is applicable to Chinese National Standard (CNS) A4 specifications (210 × 297 mm)-Packing-(Please read the precautions on the back before filling this page), 11 487559 A7 B7 Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards V. Invention Description (13 Application in the form of a sol composition. The compound is dissolved in an inert carrier, which is a propellant mixture that generates pressure. The aerosol composition is packaged in a M container, where the mixture It is dispersed through an atomizing valve. The propellant mixture contains a low-boiling halocarbon which can be mixed with an organic solvent or an inert gas or a gaseous halocarbon pressurized aqueous dispersion. The amount of compound applied to insects and mites It is not important and can be easily determined by those skilled in the art. Generally, the concentration that provides ideal control is about 10 ppm to about 5,000 ppm. For crops such as soybeans and cotton, the application rate is about 0.01 to about 11 ^ /} ^, The compound is applied in a spray formulation of 5 to 5083 / eight. The compound can also be applied to any place where insects or mites live. These places are generally cotton, soybean or Vegetable crops, fruits and hazels, grape vines, houses or decorative plants. The compounds of the present invention can also be used to treat animals M control arthropods, namely insects and spiders, which are pests on animals. These spider pests are generally Injures the host's external ("ect 0") surface; the agent used to control such pests is preferably an "external parasite killer." All animals are susceptible to such pests, although vertebrate hosts have the most serious problems. Humans are latent hosts for many parasites, and parasite infestation is a common medical problem in tropical regions and in areas where sanitary facilities are inadequate. In addition, those who are highly susceptible to parasite infestation are many livestock * such as cattle, sheep, pigs , Goat, buffalo, deer, rabbit, chicken, turkey, duck (, goose, ostrich, etc. Horses and other recreational animals are susceptible to parasites. Mink and other animals with fur for breeding purposes are also the same, and rats The same is true for rats, rats, and other experimental and research animals. For companion animals, such as dogs and cats, 16 paper standards are applicable to the Chinese National Standard (CNS) A4 specification (210X 297mm) 丨 _ Pack. Order (please read the precautions on the back before filling this page) 487559 A7 B7 V. Description of the invention (14) It is highly susceptible to parasite infestation, and because it is related to humans Intimacy 'This parasitic disease can also occur in humans who accompany these animals. Fish, crustaceans and other aquatic species are also vulnerable to parasites. In short, parasitic diseases involve mainly the entire animal range The economic cost caused by the spread of ectoparasites is considerable. In the field of livestock breeding, animals suffer from problems such as reduced feed efficiency and growth rates. The production of milk and wool is harmed and the production of wool, animal skins and fur is endangered. Animals become vulnerable to secondary microbial infections and parasites. Even when in vitro parasites do not endanger health and production, they can cause discomfort that cannot be ignored. Although many parasiticides are available, they have encountered various problems, including limited types of action, environmental toxicity, the need for repeated treatments, and in many cases resistance to ectoparasites. Therefore, there is still a need for new topical parasiticides. The compounds of the present invention provide a new tool for medical devices for controlling ectoparasites. In a specific example of the present invention, the present invention is directed to a method for inhibiting or killing an arthropod parasite on an active object, which comprises contacting the parasite with an effective amount of a compound of the present invention. Printed by the Consumer Cooperatives of the Central Associated Bureau of the Ministry of Economic Affairs The compounds of this invention can be used to control a wide variety of arthropod parasites. Representative parasites that can be controlled by the compounds of the present invention are the following: American flower ticks, stippled spotted ticks, Persian ticks, small bovine ticks, oxtail, itch mites, burdock mites, maggot dogs, and shortheaded tick , American tick, Goose skin mite, Ixodes sibiricus, Feather mite, Kestrel mite, Beak-eared tick, Horse tick,

本紙張尺度顧巾關家縣(⑽( 2lQx 297公慶 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(15 ) 羊痒蟎、血紅扇頭蜱、疥铜、伊蚊、瘧蚊、庫蚊、 普通蚊、羽虱、螺旋錐蠅、斑蚊、溫帶臭蟲、螺旋錐蠅 、狗櫛頭蚤、貓櫛頭蚤、庫蠓、毛蠓、蠓、羊羽虱、皮蠅 、赤尾胃蠅、大馬賈蠅、馬鼻胃蠅、舌蠅、騷擾角蠅、越 盲虱、牛盲虱、體盲頭I、猪盲虱、Hydrota^a irritans、 牛皮蠅、紋皮蠅、長顎虱、Li nognathus Pedalis、膜長 顎虱、絲光綠蠅、綿羊虱蠅、家蠅、羊輿蠅、虱、毛蠓、 黑花蠅、壞血蚊、陰虱、獵、墨蚊、管虱、水牛盲虱、 蠅、虻、粉蟲、錐獵 。 本發明之化合物之體外殺寄生蟲活性可於與寄生蟲接 觸時達到。該接觸可為卵、幼蟲、成蟲或其他生命階段。 “接觸”包含寄生蟲攝食本發明之化合物。 外用殺寄生蟲劑之傳送技術是热習是項技術者皆熟知 者。一般而言,本發明之化合物係施用至動物體表,藉此 本發明之化合物在有效期間内可與已在寄主身上寄生蟲及 將會侵害寄主之寄生蟲接觸。一般而言,化合物係配製成 液體配方,其可噴覆至動物體表或倒在動物體表。另一種 傳統的治療方法為“沈浸”,其中被治療的牛係大致沈凟 於殺蟲劑之稀釋液中。對某些寄主及寄生蟲而言,配方可 為可散佈在寄主身上的粉末,或動物洗澡所用洗髮精或乳 液。貓或狗的項圈亦可應用為一種傳送外用殺寄生蟲劑的 方式,藉此外用殺寄生蟲劑可直接傳送至動物體表。 在其他技術中,外用殺寄生蟲劑係施用至動物常出沒 的地方,因此,如同直接廠用至寄主一般可使化合物與寄 _______ - 18 _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) _裝-- (請先閱讀背面之注意事項再填寫本頁) 、訂 d ^7559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(16 ) 生蟲接觸。就家畜而言,撒粉袋亦屬習知,其係採定位方 式,其中牛無法避免地會與袋摩擦而使化合物可與寄生蟲 接觸。 於另一實施例中,本發明之化合物可用於控制昆蟲及 蜘蛛類,其屬牛及其他動物排泄物中之寄生蟲。在本發明 之實施例中,本發明之化合物可經由口服投藥而通過腸道 並包埋於排泄物中。排泄物中寄生蟲之控制可間接地保護 動物免受寄生蟲侵害。 本發明之化合物係配製成可Μ熟習此項技藝者所知曉 之方法使用的殺寄生蟲劑。一般而言,配方中可包含本發 明之化合物及一或多種生理上可接受的佐劑。配方包含濃 縮劑,其中本發明之活性藥劑係Κ0.001至98,0百分比之 濃度存在,其他内容物可為生理上可接受的載劑。此種配 方中,特別是該等本發明化合物之含量低於50百分比者, 有時候可直接使用,但這些配方亦可Μ其他生理上可接受 的載劑稀釋Μ形成較稀的治療配方。後者配方可包含 0,001至0.1百分比之較低濃度的活性劑。 在另一實施例中,本發明之化合物可有效地與其他殺 寄生蟲藥劑或驅蟲劑組合,後者為習知之内用殺寄生蟲劑 (“endo” =內部,控制內部寄生蟲者,該類寄生蟲一般為 扁蠕蟲及線蟲類)。代表性之內用殺寄生蟲藥劑包含如下Gujia County, Guanjia County (⑽ (2lQx 297 printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs of the People's Republic of China, printed 487559 A7 B7) V. Description of the invention (15) Sheep itch mite, Sanguine red tick, cymbal copper, Aedes mosquito, Malaria mosquitoes, Culex mosquitoes, common mosquitoes, feather lice, spiral cone flies, spotted mosquitoes, temperate bed bugs, spiral cone flies, dog head flea, cat head flea, caterpillars, hairy pupae, pupae, sheep flea, skin flies , Red-tailed gastronomy flies, Gastrodia magna, Equine nose gastroflies, Tongue flies, Disturbing horn flies, Blind lice, Cattle blind lice, Body blind head I, Pig blind lice, Hydrota ^ a irritans, Bovine fly, Striated skin fly , Long-nosed lice, Li nognathus Pedalis, Membrane long-nosed mosquitoes, Cercospora melanogaster, Sheep lice fly, Housefly, Sheep fly, Lice, Hairy maggot, Black flower fly, Blood mosquito, Pubic lice, Hunting, Mosquito, Tube lice, buffalo blind lice, flies, pupae, mealworms, cone hunting. The in vitro parasiticidal activity of the compounds of the present invention can be achieved upon contact with parasites. The contact can be eggs, larvae, adults or other life stages. "Contact" involves the parasite ingesting a compound of the present invention. The delivery technology of a topical parasite killer is a hot habit. Those skilled in the art are well-known. In general, the compound of the present invention is applied to the surface of an animal, whereby the compound of the present invention can be contacted with the parasite already on the host and the parasite that will invade the host during the effective period. In general, compounds are formulated into liquid formulations that can be sprayed onto or poured onto the animal's body surface. Another traditional treatment is "immersion", in which the treated cattle are generally intoxicated. In the diluent of insecticide. For some hosts and parasites, the formula can be powder that can be spread on the host, or shampoo or lotion for animal bathing. Collars for cats or dogs can also be used as a topical delivery A parasiticidal method whereby topical parasiticides can be delivered directly to the surface of the animal. In other technologies, topical parasiticides are applied to places where animals often infest, so they are treated as if they were directly applied to the host. Can make compounds and send _______-18 _ This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) _ installed-(Please read the precautions on the back before filling this page) Order d 7559 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (16) Insect contact. As far as domestic animals are concerned, dusting bags are also known, and they are located in a way that cattle cannot avoid. The ground will rub against the bag to allow the compound to contact the parasites. In another embodiment, the compounds of the present invention can be used to control insects and spiders, which are parasites in cattle and other animal waste. In the present invention, In the embodiment, the compound of the present invention can be passed through the intestine through the oral administration and embedded in the feces. The control of parasites in the feces can indirectly protect animals from parasites. The compounds of the present invention are formulated Parasites can be used by methods known to those skilled in the art. In general, the formulations may include a compound of the invention and one or more physiologically acceptable adjuvants. The formulation contains a concentration agent, in which the active agent of the present invention is present at a concentration of K 0.001 to 98.0%, and the other contents may be physiologically acceptable carriers. Such formulations, especially those containing less than 50% of the compounds of the present invention, can sometimes be used directly, but these formulations can also be diluted with other physiologically acceptable carriers to form thinner therapeutic formulations. The latter formulations may contain the active agent at a lower concentration of from 0.001 to 0.1 percent. In another embodiment, the compound of the present invention can be effectively combined with other parasiticides or insect repellents, the latter being a conventional internal parasiticide ("endo" = internal, who controls internal parasites, the Parasites are generally flat worms and nematodes). Representative parasiticides for internal use include the following

Abamectin、内硫蹄唑、Avermectin、丁萘脒、蠅毒、 敵敵畏、Doramectin、Epsiprantel、Febantel、苯硫 _____- 19-_ ^紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ------:—^^辦衣------、訂------0, (請先閱讀背面之注意事項再填寫本頁) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(π ) 嗅唑、氟苯_啤、Ivermectin、左旋四畔啤、甲笨畔啤 、M i t r 〇 s c a n a t e、_ 婦氫喃 _、Μ ο X i d e c t i η、Abamectin, thiotetrazol, avermectin, butylene naphtha, fly venom, dichlorvos, Doramectin, Epsiprantel, Febantel, benzenesulfur _____- 19-_ ^ Paper size applies to Chinese National Standard (CNS) A4 specification (210X 297 mm) ------ : — ^^ 办 衣 ------ 、 Order ------ 0, (Please read the notes on the back before filling this page) 487559 Employee Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs Printed A7 B7 V. Description of the invention (π) Olfactory azole, fluorobenzene_beer, Ivermectin, L-four-side beer, methylbenside beer, Mitr 〇scanate, _ hydrogen __, Μ ο X idecti η,

Netobimin、氯硝柳胺、硝異硫氰二苯醚、磺唑胺酯、 氧苯噠睡、六氣呢0井、嗣、Clorsulon、Closantel 、雙醋氨苯氧乙醚、硝羥碘苄腈、羥氧柳_胺、氯苯磺 柳胺、三氯苯咪唑。 代表性之內用殺寄生蟲藥劑包含:Netobimin, niclosamide, nitroisothiocyandiphenyl ether, sulfazolamide, oxybenzidine, six gas wells 0, 嗣, Clorsulon, Closantel, diacetaminophenoxy ether, nitroiodobenzonitrile Hydroxysalamine, mesylamine, triclosan. Representative parasite killers include:

Abamectin、 Alphmethrin、 Amitraz、 Avermectin、蠅 毒 Λ Cycloprothrin ^ Cyfluthrin ^ Cyhalothrin ^ Cype r m e t h r i n、C y r o m a z i n e、D e 11 a m e t h r i n 、地亞農、D i f lubenzuron、二嗎硫鱗、Doramectin、氧黃碟、位硫鱗 、Fenvalerate Λ F 1 ucythrinate、Flumethrin、 Hexaflumuron、Ivermectin、六氯化苯、Lufenuron、 馬拉硫鱗、Methoprene、Metriphonate、Moxidectin、 ¥ 氯菊酯、P h o s m e、P ί r i m i p h o s、P r o p e r a m p h o s、殘殺 威、魚藤二酮、硫甲雙硫、殺蟲威、敵百蟲、 Z e t a c y p e r m e t h r i η、B · t ·生物毒素及硼酸。 管例 一船啻驗郤份 除非另外說明,所使用之試劑及溶劑皆直接購自市售 商品供應商及所有反應皆利用定速磁攪拌在室溫(20-22°C )下進行。所有涉及有機金屬試劑、濕度敏感性試劑、或 金靥氫化物試劑之反應皆在市面上可取得之無水溶劑中及 乾燥氮氣環境下進行。利用NaCl、NaHC〇3、NfUCl及其他 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) : 裝 訂 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 B7____ 五、發明説明(18 ) 鹽類以分配、萃取、或洗_係指這些鹽類的飽和水溶液。 反應一般藉由利用一上述之鹽類溶液萃取產物的有機溶液 Μ “逐漸完成”;利用K2C〇3、Na2S〇4、或MgS〇4乾燥有機 層,過漶及減壓蒸發。在玻璃底板並結合十八烷基矽烷之 板(0.2 mm,取自Whatman)上進行逆相薄層層析法(RPTLC) 。層析係指閃蒸層析法以及係在E. Merck矽膠60 (20-400 篩目)上進行。逆相高效液相層析法(RPHPLC)係在结合C18 之砂膠(Rain Dynamax 60 A, 8wm)上進行。所有熔點皆 在開口毛细管中測定及未校正。分別在300至400 MHz及75 或101MHz下測定iHNMR及13C NMR光譜。藉由電噴霧離子化 (ESI)測量質譜數據。元素分析係由Dowlanco或Midwest Micro labs之分析實驗室提供。 窨)例1 Φ客諾辛A配_基夕合成 將史賓諾辛A樣品(8,50 g,11·61 mmol)溶於EtOH( 100 inL)。加入水(100 mL),及在搜拌時,同時將4N Η 2 SO 4(aq)溶液(200 mL)加入溶液中。在氮氣環境下,加 熱所得之混合物至迴流溫度4.5小時。冷卻至室溫,以甲 苯(250 mL)及乙酸乙酯(300 mL)稀釋,及加入鹽水(300 mL)。於萃取後,分離各相。利用乙酸乙酯(1〇〇 mL)再次 萃取水層。連續地利用稀釋之鹽水(3X)及5%NaHC〇3(2X) 洗滌合併的有機層及接著Μ無水MgS〇4乾燥,及減壓濃縮。 使殘餘物在閃蒸Si〇2管柱中純化(250 g ;乙酸乙酯)。將 層析法上純化部分濃縮至乾燥後,可得到玻璃狀固體( 4.08 g» 87%) » [a] 5 8 9 =-145.6 ° (MeOH) · [a]5B9 = ____- 21 __ 本纸乐尺度適用中國國家標準(CNS ) A4規格( 210X 297公釐) -------7--裝------訂---------- (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A 7 • B7 · 五、發明説明(19 ) -131.7。(CHC13) 〇 、 啻麻例2 中窨諾辛A17-Psa夕合成Abamectin, Alphmethrin, Amitraz, Avermectin, fly poison Λ Cycloprothrin ^ Cyfluthrin ^ Cyhalothrin ^ Cype rmethrin, Cymazine, De 11 amethrin, Diaron, D if lubenzuron, dimorphine scale, Doramectin, oxygen yellow plate, metasulfide scale , Fenvalerate Λ F 1 ucythrinate, Flumethrin, Hexaflumuron, Ivermectin, hexachlorobenzene, Lufenuron, malathion, Methoprene, Metriphonate, Moxidectin, ¥ permethrin, Phosme, P rimiphos, Promramphos, fish Glycoledione, thiomethanil, fendicarb, trichlorfon, Z etacypermethri η, B · t · biotoxin and boric acid. Pipeline regulations Except for one shipment, unless otherwise stated, all reagents and solvents used were purchased directly from commercial suppliers and all reactions were performed at room temperature (20-22 ° C) using constant speed magnetic stirring. All reactions involving organometallic reagents, humidity sensitive reagents, or gold hydride reagents are performed in commercially available anhydrous solvents and under a dry nitrogen environment. Use of NaCl, NaHC〇3, NfUCl and other paper standards Applicable to Chinese National Standard (CNS) A4 specifications (210X 297 mm): Binding (Please read the precautions on the back before filling this page) Employees of the Central Bureau of Standards, Ministry of Economic Affairs Cooperative printed 487559 A7 B7____ V. Description of the invention (18) Salts for distribution, extraction, or washing_ means saturated aqueous solutions of these salts. The reaction is generally "gradually completed" by extracting the organic solution M of the product with a salt solution as described above; the organic layer is dried with K2CO3, Na2S04, or MgS04, evaporated and evaporated under reduced pressure. Reverse-phase thin-layer chromatography (RPTLC) was performed on a glass substrate combined with an octadecylsilane plate (0.2 mm from Whatman). Chromatography refers to flash chromatography and is performed on E. Merck Silicone 60 (20-400 mesh). Reverse-phase high-performance liquid chromatography (RPHPLC) was performed on a C18-bound sand gum (Rain Dynamax 60 A, 8wm). All melting points are measured in open capillaries and are uncorrected. The iHNMR and 13C NMR spectra were measured at 300 to 400 MHz and 75 or 101 MHz, respectively. Mass spectrometry data was measured by electrospray ionization (ESI). Elemental analysis was provided by Dowlanco or Midwest Micro labs' analytical laboratories. Ii) Example 1 Φ Kerosin A with _ Kiyoshi Synthesis A sample of Spinozin A (8,50 g, 11.61 mmol) was dissolved in EtOH (100 inL). Water (100 mL) was added, and a 4N Η 2 SO 4 (aq) solution (200 mL) was added to the solution while searching. The resulting mixture was heated to a reflux temperature under a nitrogen atmosphere for 4.5 hours. Cool to room temperature, dilute with toluene (250 mL) and ethyl acetate (300 mL), and add brine (300 mL). After extraction, the phases were separated. The aqueous layer was extracted again with ethyl acetate (100 mL). The combined organic layers were washed successively with diluted brine (3X) and 5% NaHC03 (2X) and then dried over anhydrous MgS04 and concentrated under reduced pressure. The residue was purified on a flash SiO 2 column (250 g; ethyl acetate). After concentrating the purified part on the chromatography to dryness, a glassy solid (4.08 g »87%) can be obtained» [a] 5 8 9 = -145.6 ° (MeOH) · [a] 5B9 = ____- 21 __ Paper Music scale is applicable to China National Standard (CNS) A4 specification (210X 297 mm) ------- 7--install ------ order ---------- (Please read the back first Please note this page, please fill in this page) Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A 7 • B7 · V. Description of Invention (19) -131.7. (CHC13) 〇, Ramie Example 2 Indoxin A17-Psa synthesis

將史賓諾辛A樣品(20.0 gms,27.4 mmol)溶於300mL II H2S〇4中並利用磁搜拌加熱至80t: 2小時。接著使反應 物冷卻至室溫。利用吸力過滹沈澱物,及利用新鲜配製之 III H2S〇4洗滌。接著使固體產物溶於二氯甲烷中,以鹽水 洗澉,利用K2C〇3乾燥,及在減壓下蒸發。利用70%Et0Ac 之己烷溶液藉由矽膠層析法純化Μ獲得無色玻璃狀之史賓 諾辛 17-Psa(14.46 gms ; 89%)。 啻倫例3 中窨諾辛A 9-Psa之合成 N-氯丁二醯亞胺(1.20 gm,9.00 mmol)於二氯甲烷( 45 ml)中之懸浮液在氮氣下冷卻至-78C。將純二乙基硫( 1.07ml,9.90 mmol)加入懸浮液,歷時5分鐘,及混合物 在-781C下攪拌0.5小時。將溶於8 mL二氯甲烷之史賓諾辛 J(2,15 gm,3.00 mmol)媛緩地加至混合物中,歷時15分 鐘並保持低於-601:之反應溫度。當添加已完成後,在_78 它下攪拌溶液6小時。接著逐滴加入三乙胺(1.25 inL, 9.00 mmol)及使溶液回溫至室溫。利用40 mL二氯甲烷稀 釋反應物並倒入20 mL 1N硫酸氫鈉及30 mL水。分層並利 用30 mL飽和碳酸氫納萃取有機層及Μ硫酸納乾燥。於減 壓下蒸發溶劑,及將殘餘物溶於Me0H(100 ml)中。加入無 水K2C0 3 (4.15 gm,30· 00 mmol)及在室溫下攪拌懸浮液。 在攪拌2小時後,將反應物冷卻至〇°C及在旋轉式蒸發器中 蒸發水份至1/5反應物體積。加入二氯甲烷(100 mL)及水( 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) =裝 訂 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 ^_ B7__·— 五、發明説明(2〇 ) 100 inL)並分層。利用3^50 inL二氯甲烷萃取水層並與有 機萃取物合併Μ及先以水再K鹽水溶液洗滌。以硫酸納乾 燥溶液,過滤及在旋轉式蒸發器中濃縮Μ獲得粘性黃色油 。藉由閃蒸層析法(250 gm矽膠,含0.5%濃硫酸之5%甲 醇的二氯甲烷溶液)純化產物,Μ獲得白色發泡體狀之史 賓諾辛 A 9-Psa(1.52 gra; 93%”H NMR(CDCl3)378(br s,l, Η-13),4·63(ιη,1, Η-21),4.43(m, 2, H-l”,Η-9 ),2.23(s, 6, N(CH3)2) 〇 實施例4 利用中窨冬泡醆昼爾(Sacnh aropo1yspota spinc^a) NRRL 1 8395培秦物製備中窨諾辛 A部分•振潘忒憤瓶發醏 將冷凍乾燥九粒或保持在液態氮中之懸浮液形式的史 賓多泡酵母菌NRRL 18395培養物接種至含有組成物A及組 成物B(培養基B較適用於大規模生產)之營養性培養基, 其中營養性培養基A包含(含量Μ %表示)胰胳大豆培養 基 Μ3·0%、酵母萃取物0.3%、MgS〇4 · 7Η2〇 0.2%、葡萄 糖0.5%、麥芽糖0.4%、去離子水q.s.l升,未調整ρΗ(” 購自巴爾的摩生物實驗室)及營養性培養基Β包含經酵素 水解之賂蛋白〃3.〇%、酵母萃取物0.3%、MgS〇4 · 7Η2〇 〇·2%、葡萄糖1.0%、去離子水q.s.l升,利用氫氧化納 將 pH 由 6·2 調整至 6.5,(”購自 NZ Amine A,Sheffield Products,Ρ·0· Box638,Norwich,NY 13815J。藉由添 加2.5%洋菜至營養性種菌培養基A或B中製備斜面培養 基或平板培養基。將經接種之斜面培養基培養在30 °C下約 本纸張尺度適用中國國家標準(CNS〉A4規格(210X 297公釐) ------:—------訂----- (請先閲讀背面之注意事項再填寫本頁) 487559 經濟部中央標準局員工消費合作社印製 A7 ___ B7___ 五、發明説明(21 ) 10至14天。成熟之斜面培濬基培養物Μ無菌器具刮取使孢 子鬆落及去除並浸乾菌絲體叢。所得到鬆開之孢子及培養 物生長取約1/4接種至第一階段營養性種菌培養基。另外 ,可由液態氮安瓿接種至第一階段培養基。當培養物保持 在液態氮中時,安瓿係利用等體積之營養性培養物(培養 48-72小時,30Ό)及懸浮培養基製備。懸浮培養基包含乳 糖(100 g)、甘油(200 mL)及去離子水(q.s.至1升)。將液 態氮安瓿接種至含有100 mL營養性培養基之500-mL三角瓶 中(或含有50 inL培養基之250-inL三角瓶)。將培養物30Ό ’ 下,在振盪器上M 250 γριπ之速率環繞2吋(5.08 cm)之圓 周,培養48小時。將經接種之培養物(5% v/v接種體)接種 至100 inL具有下述組成之生產性培養基中:(含量表 示)蔔萄糖4.0%、部分酵素水解”之植物性蛋白質1.5-3.0 %、棉籽粉*Kl.〇%、CaC〇3(試藥级或工業级)0.3%、大 豆油1.0%、自來水q.s.l升(預滅菌及利用NaOH調整pH至 7.0) » HSheftone H J Sheffield Products » ^'•Proflo » Traders Protein » P.0. BOX 8407 » Memphis» TN 38108 。經接種之生產性培養基在500-mL三角瓶中,在28-301C 下,在振盪器上M 250 ΓΡίη之速率環繞2吋之圓周,培養 6至8天。 B ·揋榉忒Φ物反膜器發酵 為了提供大量的接種體,將10 mL如A部分所述方法 製備之第一階段培養基接種至400 mL之與第一階段培養基 具有相同組成的第二階段培‘養基。將此第二階段培養基在 _____- 24 - 本纸浪尺度適用中國國家標準(CNS ) Μ規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 一裝· 、1Τ Φ 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(22 ) 2 - L廣口三角瓶中,在30t:下,在振盪器上M 250 rpro之速 率環繞2吋之圓周,培養48小時。將所製得之第二階段營 養培養基接種至80-115升之如A ·部分所述方法製備之無 菌生產性培養基中。若有需要的話,可額外添加大豆油K 控制發泡。 使經接種之生產性培養基在165-L之攪拌式生物反應 器中,在28Ϊ:之溫度下發酵5至8天。攪拌槽中之氣流及攪 拌器速率係由電腦控制以保持溶氧量為空氣飽和度之50% 或更高。A sample of Spinozin A (20.0 gms, 27.4 mmol) was dissolved in 300 mL II H2SO4 and heated to 80 t using a magnetic stirrer: 2 hours. The reaction was then allowed to cool to room temperature. The precipitate was filtered through suction and washed with freshly prepared III H2SO4. The solid product was then dissolved in dichloromethane, washed with brine, dried over K2CO3, and evaporated under reduced pressure. Purification of M by silica gel chromatography using 70% EtOAc in hexanes gave spinoline 17-Psa (14.46 gms; 89%) as a colorless glass. Synthesis of Phenyloxin A 9-Psa in Example 3 A suspension of N-chlorobutanediimide (1.20 gm, 9.00 mmol) in dichloromethane (45 ml) was cooled to -78C under nitrogen. Pure diethylsulfur (1.07 ml, 9.90 mmol) was added to the suspension over 5 minutes, and the mixture was stirred at -781C for 0.5 hour. Spinoloxin J (2,15 gm, 3.00 mmol) dissolved in 8 mL of dichloromethane was slowly added to the mixture for 15 minutes and kept below -601: reaction temperature. When the addition is complete, stir the solution at _78 for 6 hours. Triethylamine (1.25 inL, 9.00 mmol) was then added dropwise and the solution was allowed to warm to room temperature. The reaction was diluted with 40 mL of dichloromethane and poured into 20 mL of 1N sodium bisulfate and 30 mL of water. The layers were separated and the organic layer was extracted with 30 mL of saturated sodium bicarbonate and dried over sodium sulfate. The solvent was evaporated under reduced pressure, and the residue was dissolved in MeOH (100 ml). Anhydrous K2C0 3 (4.15 gm, 30.00 mmol) was added and the suspension was stirred at room temperature. After stirring for 2 hours, the reaction was cooled to 0 ° C and the water was evaporated to 1/5 of the reaction volume in a rotary evaporator. Add dichloromethane (100 mL) and water (This paper size applies to Chinese National Standard (CNS) A4 specification (210X 297 mm) = binding (please read the precautions on the back before filling this page)) Staff of the Central Bureau of Standards, Ministry of Economic Affairs Consumption cooperatives print 487559 A7 ^ _ B7__ · — V. Description of the invention (20) 100 inL) and layered. The aqueous layer was extracted with 3 ^ 50 inL dichloromethane and combined with the organic extracts and washed with water followed by K saline solution. The solution was dried over sodium sulfate, filtered and concentrated in a rotary evaporator to obtain a viscous yellow oil. The product was purified by flash chromatography (250 gm silica gel, 0.5% concentrated sulfuric acid in 5% methanol in dichloromethane) to obtain Spinoxin A 9-Psa (1.52 gra; 93% "H NMR (CDCl3) 378 (br s, l, Η-13), 4.63 (ιη, 1, Η-21), 4.43 (m, 2, Hl", Η-9), 2.23 (s , 6, N (CH3) 2) 〇 Example 4 Preparation of A part of Zhong Nuoxin by using Sacnh aropo1yspota spinc ^ a) NRRL 1 8395 culture material Nine grains of freeze-dried or a suspension of S. polyspora yeast NRRL 18395 in the form of a suspension in liquid nitrogen is inoculated into a nutrient medium containing composition A and composition B (medium B is more suitable for large-scale production) The nutrient medium A contains (indicated by the content M%) pancreatic soybean medium M3. 0%, yeast extract 0.3%, MgS04.7.20.2%, glucose 0.5%, maltose 0.4%, deionized water qsl liter, Unadjusted pH ("purchased from Baltimore Biolabs") and nutrient medium B contains 3.0% of proteolytic enzyme peptone hydrolyzed by yeast, 0.3% of yeast extract, MgS04.7.20.2%, Glucose 1.0%, qsl liter of deionized water, pH was adjusted from 6.2 to 6.5 with sodium hydroxide ("purchased from NZ Amine A, Sheffield Products, P. Box 638, Norwich, NY 13815J. By adding 2.5 % Amaranth to nutrient seed fungus culture medium A or B to prepare slanted medium or plate medium. The inoculated slanted medium is cultured at 30 ° C. This paper size is applicable to Chinese national standards (CNS> A4 size (210X 297 mm) ) ------: ------- Order ----- (Please read the notes on the back before filling out this page) 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 ___ B7___ V. Description of the invention (21) 10 to 14 days. Scrape the mature slant culture medium M aseptically scrape the spores to loosen and remove and drench the mycelium plexus. The resulting loose spores and culture growth take about 1 / 4 Inoculation to the first-stage nutrient culture medium. In addition, it can be inoculated to the first-stage medium from liquid nitrogen ampoules. When the culture is maintained in liquid nitrogen, the ampoules use an equal volume of nutrient culture (cultivation 48-72) Hours, 30Ό) and suspension medium preparation Suspension medium contains lactose (100 g), glycerol (200 mL), and deionized water (qs to 1 liter). Inoculate liquid ampoule into a 500-mL Erlenmeyer flask containing 100 mL of nutrient medium (or 50 inL medium) 250-inL triangle bottle). The culture was placed on a shaker at a rate of M 250 γρππ around a circle of 2 inches (5.08 cm) at 30Ό 'for 48 hours. The inoculated culture (5% v / v inoculum) was inoculated into 100 inL of a productive medium having the following composition: (content indication) 4.0% glucose, partial enzyme hydrolysis "of plant protein 1.5-3.0 %, Cottonseed meal * Kl.〇%, CaC03 (test grade or industrial grade) 0.3%, soybean oil 1.0%, tap water lsl (pre-sterilized and pH adjusted to 7.0 with NaOH) »HSheftone HJ Sheffield Products» ^ 'Proflo »Traders Protein» P.0. BOX 8407 »Memphis» TN 38108. The inoculated production medium was placed in a 500-mL Erlenmeyer flask at 28-301C on a shaker at a rate of M 250 ΓΡίη at a rate of 2 Incubate for 6 to 8 days. B. 揋 zel 忒 Φ substance reverse membrane fermentation To provide a large amount of inoculum, inoculate 10 mL of the first stage culture medium prepared as described in Part A to 400 mL and the first The first stage culture medium has the same composition as the second stage culture medium. This second stage culture medium is _____- 24-This paper is in accordance with the Chinese National Standard (CNS) M specifications (210X 297 mm) (Please read first Note on the back, please fill out this page) 487559 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the Invention (22) 2-L wide mouth triangle flask, at 30t :, the rate of M 250 rpro on the oscillator is around a 2-inch circle, training 48 hours. Inoculate the prepared second-stage nutrient medium into 80-115 liters of sterile productive medium prepared as described in section A. If necessary, additional soybean oil K can be added to control foaming. Ferment the inoculated productive medium in a 165-L stirred bioreactor at a temperature of 28 ° C for 5 to 8 days. The air flow in the stirring tank and the speed of the agitator are controlled by a computer to maintain the dissolved oxygen content as 50% or more of air saturation.

奮施例5 分雛中窨諾辛A、B、C及D 利用助滤劑(l%Hyflo)過濾如實施例4所述方法製備 之發酵培養基(225升),及Μ水(〜50 L)洗滌分離之生物 質。接著將生物質與甲醇(〜100 L)—起攪動約1小時並過 滤。將甲醇漶液濃縮至體積約1升。Κ乙醚(每次1 L)萃取 濃縮物3次。將組合之乙醚萃取物濃縮至體積約200 niL。 將濃縮物(8 mL)部分在矽膠管柱(RP-8 Lobar,尺寸B,E. M· Science,E.M. Industries分部,30 Inc,)中層析。 將此步驟重覆總共12次(循環)。進行製備型層析之儀器設 定及實施步驟係以如下述之“Autoprep”模式: —完整的“Autoprep” HPLX系統包含三個Rainin Rabbit HPX 泵,一壓力組仵,一 Gilson Model 20 1B HPLC分部收集器,一 IsC〇-v4吸光度偵測器及一蘋果牌麥 金塔(AppleMacintosh)Plus電腦。完整系統係依據得自 Rainiri儀器公司之Dynaraax HPLC方法管理者手冊配置。“ -25 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -------Γ — ‘批衣------、訂-------0 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 __B7 _ , 五、發明説明(23 )Fenshi Example 5 Dioxin A, B, C, and D in the broiler were filtered with a filter aid (1% Hyflo), the fermentation medium (225 liters) prepared as described in Example 4, and M water (~ 50 L ) Wash the separated biomass. The biomass was then stirred with methanol (~ 100 L) for about 1 hour and filtered. The methanol solution was concentrated to a volume of about 1 liter. The concentrate was extracted 3 times with K ether (1 L each). The combined ether extracts were concentrated to a volume of about 200 niL. A portion of the concentrate (8 mL) was chromatographed on a silica gel column (RP-8 Lobar, size B, E.M. Science, E.M. Industries Division, 30 Inc,). Repeat this step a total of 12 times (cycles). The instrument setup and implementation steps for preparative chromatography are performed in the "Autoprep" mode as follows:-The complete "Autoprep" HPLX system contains three Rainin Rabbit HPX pumps, a pressure group, and a Gilson Model 20 1B HPLC section. Collector, an IsC0-v4 absorbance detector and an Apple Macintosh Plus computer. The complete system was configured according to the Dynaraax HPLC Method Administrator Manual from Rainiri Instruments. "-25-This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) ------- Γ-'batch clothes ------, order ------- 0 (Please read the notes on the back before filling out this page) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 __B7 _, V. Description of the Invention (23)

Autoprep” HPLC结構具有>、統自動化的優點,以容許在實 際上完全相同的條件下重覆進行製備分離可具有實際上完 全相同的结果。收集及合併由多次操作所獲得之對應部分 可提供層析可分析量而無需大型管柱。Μ權力平等模式( ISOCRATIC)及流速0.8 mL/miri使用二溶劑混合物(Α )及( B )。溶劑系統 A 包含 95 inL CH3〇H、95 mL CHaCN、10 raL H2〇,及溶劑糸統 B 包含 100 mL CH3〇H、100 mL CHaCN、 0 mL H2〇。所使用之權力平等混合物包含60%溶劑B。 每次溶析循環之進行時間為28.0分鐘。丟棄每次循 環之前16分鐘的析出液。接下來之析出物以6個時間溶析 份,每管2分鐘(每管16 mL)。由每一次循環(共12次)自動 合併之溶析份所得之6管最終部分(層析溶析份)。藉由分 析每個最終溶析份對蚊蟲幼蟲之活性及亦藉由分析型HPLC 測定活性史賓諾辛化合物之存在。接著根據活性及HPLC圖 譜合併活性溶析份並進一步純化,純化係利用相同之“ Autoprep” HPLC及溶劑系統,但是具有高解析度,及預填 充018逆相矽膠之21.4imX25-Cm製備型管柱( Rainin Dynamax),Μ獲得史賓諾辛A、B、C及D。史 賓諾辛A及D可自CH3〇H/H2〇結晶出來。 實施例6 Φ客諾辛純化 依實施例4之A部分所述方法製備發酵培養基(10 L) ,但是1)在1-L燒瓶中使用200 mL生產性培養基;2)自生 產培養基中去掉大豆油;及3)在30它下培養4-6天。過滤 培養基。丟棄含有4 meg史食諾辛A /inL及非可偵測量之史 ________- 26 _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) I ; 裝 訂 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 B7 _,一 五、發明説明(24 ) 賓諾辛B、C,或D /mL之'濾液。以水清洗生物量及Μ甲 醇萃取1小時。萃取液(7 L)包含72 meg史賓諾辛A/mL及 7 meg史賓諾辛D /mL。使甲醇萃取液濃縮至5 L之體積, 及加至置於水(2 L)中之HP-20樹脂(150 mL,Mitsubishi 化學工業有限公司.,日本)。攪拌混合物1小時。接著將 HP-20樹脂混合物置於玻璃管柱中。使用甲醇:水(1 : 1, 1L)之最初流出液及析出液不具活性。使用甲醇:水(7 : 3 ,1 L)之第二析出液包含微量史賓諾辛A。使用甲醇(1 L )之後續析出液包含史賓諾辛A及史賓諾辛D活性。將甲 醇析出液濃縮及與由其他溶析操作所得之2類似溶析份合 併並濃縮至乾。將殘餘物溶於75 mL甲醇:THF(4 : 1)並藉 由添加至10倍體積之乙睛中Μ沈澱。過滤混合物,並使滤 液濃縮至乾。將殘餘物溶於甲醇¢25 mL)並置入LH-2(/ Sephadex(Pharmacia LKB 生物技術公司,U,S,A·)之 5.5X 90-cin管柱,該管柱係Μ甲醇製備,利用實施例1所述之 HPLC方法收集及分析125份25-mL之溶析份。 合併含有所欲化合物之溶析份並濃縮。將殘餘物溶於 甲醇(10 mL)並置入以C-18逆相矽膠(Rainin Dynamax )填充之41.1-mm x 25-cin的製備型管柱。管柱係調整於甲 醇:乙睛:水(37.5 : 37,5 : 25)之條件下。於置入樣品後 ,利用下述溶劑之180-mi η線性梯度展開樣品,該等溶劑 為:溶劑系統 Α 為 37.5 mL CH3〇H、37.5 mL CH3N、25 mL H2〇,及溶劑系統 B 為 45 mL CH3OH、45 mL CH3CN、0 mL H2〇。合併含有史賓諾辛Ai溶析份,乾燥,溶於t-Bu0H(5 ______- 27 ~ 本纸張尺度適用中國國家標準(CNS ) A4規格(21 OX 2W公釐) 1 裝 訂 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 B7 . 五、發明説明(25 ) mL)並冷凍乾燥K獲得77, rag純史賓諾辛A。含有史賓諾 辛D之溶析份與6類似之分離操作的D溶析份合併及濃縮 及如上文所述般層析,利用相同的管柱,但是溶劑不同。 管柱係調整於甲醇··乙請··水(40 ·· 40 ·· 20)之條件下。管 柱中M 180-m i η線性梯度操作之用於展開樣品的溶劑系統 為:溶劑糸統 A 包含 40 mL CH3〇H、40 niL CHaH、20 mL H2〇,及溶劑糸統 B 包含 95 mL CHaOH、95 mL CH3CN、 10 mL H2〇。合併及濃縮含有D之溶析份。將殘餘物溶於 t-BuOH(5 mL)並冷凍乾燥Μ獲得212 mg史賓諾辛D。 啻廝例7 成分中窨諾辛F:、F、G、Η及J及中窨諾宰 A 17-Psa之分雜 _ 依實施例4所述方法處理利用類似於實施例4所述步 驟製備之發酵培養基(8 L)。將由LH-20 Sephadex管柱所 得之含有所欲化合物的溶析份與由其他類似發酵作用所得 之對應溶析份合併。因為成分E、F、G、Η、J及A之 假糖苷配基化合物之產生量非常少,必須以多次發酵作用 Μ提供足供進一步純化之量。 將Μ此方式製備及包含接近1.6 g固體15物質之次要 因子收集部分置入如實施例4所述之M8微米C-18逆相矽 膠(0DS)預填充之HPLC管柱(Rainin Dynamx)。管柱係Μ CH3〇H : CH3CN : Η2〇(75 : 75 : 50)調整,及梯度係Μ 下述 溶劑系統由100%溶劑(Α )至50% (Β ):溶劑系統A 75% CHaOH、75%CH3CN、50%H2〇及溶劑系統 B95%CH3〇H、75 %CH3CN、50%H2〇,M25-ml溶析份之方式收集。收集下 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X 297公釐) — ^ 裝 訂 (請先閱讀背面之注意事項再填寫本頁) A7"Autoprep" HPLC structure has the advantages of > automation, to allow repeated preparative separations under virtually identical conditions to have virtually identical results. Collecting and combining the corresponding portions obtained from multiple operations can be Provides chromatographic analytical quantities without the need for large columns. M-equivalent mode (ISOCRATIC) and flow rates of 0.8 mL / miri use two-solvent mixtures (A) and (B). Solvent system A contains 95 inL CH3OH, 95 mL CHaCN , 10 raL H2〇, and solvent system B contains 100 mL of CH3OH, 100 mL of CHaCN, and 0 mL of H2. The power equal mixture used contains 60% of solvent B. The duration of each dissolution cycle is 28.0 minutes The discarded solution was discarded 16 minutes before each cycle. The next precipitate was dissolved in 6 times, 2 minutes per tube (16 mL per tube). The lysis was automatically combined by each cycle (12 times in total). The final portion (chromatographic lysate) of 6 tubes was obtained by analyzing the activity of each final lysate on mosquito larvae and also the presence of active spinoxin compounds by analytical HPLC. Then based on the activity and HPL Figure C combines active eluates and further purification. The purification uses the same "Autoprep" HPLC and solvent system, but with high resolution and pre-packed 21.4imX25-Cm preparative column (Rain Dynamax) , M obtained Spinoxin A, B, C and D. Spinoxin A and D can be crystallized from CH3OH / H2O. Example 6 Φ Chernosin purification as described in part A of Example 4 Method To prepare a fermentation medium (10 L), but 1) use 200 mL of production medium in a 1-L flask; 2) remove soybean oil from the production medium; and 3) incubate at 30 for 4-6 days. Filter the medium .Discard the history containing 4 meg of historical Nosin A / inL and non-detectable amount ________- 26 _ This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) I Binding (please read first Note on the back, please fill in this page again.) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A7 B7 _, one or five, description of the invention (24) Binoxin B, C, or D / mL of the filtrate. Wash with water Biomass and M methanol extraction for 1 hour. The extract (7 L) contains 72 meg Spinoloxin A / mL And 7 meg spinosinol D / mL. The methanol extract was concentrated to a volume of 5 L, and added to HP-20 resin (150 mL, Mitsubishi Chemical Industry Co., Ltd.) in water (2 L), Japan. ). The mixture was stirred for 1 hour. The HP-20 resin mixture was then placed in a glass column. The initial effluent and precipitation using methanol: water (1: 1, 1L) are not active. The second precipitate using methanol: water (7: 3, 1 L) contained a small amount of Spinoxin A. Subsequent precipitations using methanol (1 L) included spinoxin A and spinoxin D activity. The methanol eluate was concentrated and combined with 2 similar eluate fractions obtained from other dissolution operations and concentrated to dryness. The residue was dissolved in 75 mL of methanol: THF (4: 1) and precipitated by addition to 10 volumes of acetonitrile. The mixture was filtered and the filtrate was concentrated to dryness. The residue was dissolved in methanol (25 mL) and placed in a 5.5X 90-cin column of LH-2 (/ Sephadex (Pharmacia LKB Biotechnology Company, U, S, A ·), which was prepared by M methanol. 125 HPLC fractions were collected and analyzed using the HPLC method described in Example 1. The fractions containing the desired compound were combined and concentrated. The residue was dissolved in methanol (10 mL) and placed in C- Preparative 41.1-mm x 25-cin prefilled tubing column filled with 18 reverse-phase silicone (Rainin Dynamax). The tubing system was adjusted under the conditions of methanol: acetonitrile: water (37.5: 37, 5: 25). After the sample, the sample was developed using a 180-mi η linear gradient of the following solvents: solvent system A: 37.5 mL CH3OH, 37.5 mL CH3N, 25 mL H2O, and solvent system B: 45 mL CH3OH, 45 mL CH3CN, 0 mL H2〇. Combined with Spinoxin Ai dissolving fraction, dry, soluble in t-Bu0H (5 ______- 27 ~ This paper size applies Chinese National Standard (CNS) A4 specification (21 OX 2W (Mm) 1 Binding (Please read the notes on the back before filling out this page) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7. V. (25) mL) and freeze-dried K to obtain 77, rag pure Spinoxin A. The spines containing Spinozin D and 6 similar separation operations were combined and concentrated and as described above. For general chromatography, the same column is used, but the solvents are different. The column system is adjusted under the conditions of methanol, acetol, water (40, 40, 20). The linear gradient of M 180-mi η in the column The solvent system used to develop the sample was: solvent system A contains 40 mL CH3OH, 40 niL CHaH, 20 mL H2O, and solvent system B contains 95 mL CHaOH, 95 mL CH3CN, 10 mL H2O. The fractions containing D were combined and concentrated. The residue was dissolved in t-BuOH (5 mL) and freeze-dried to obtain 212 mg of spinosinol D. 7 Example 7 indoxin F :, F, G Miscellaneous Miscellaneous of Η, Η and J and 中 窨 诺扎 A 17-Psa_ Treated according to the method described in Example 4 using a fermentation medium (8 L) prepared in a similar manner to that described in Example 4. The LH-20 Sephadex column will be used. The obtained lysate containing the desired compound is combined with the corresponding lysate obtained by other similar fermentations. Because the components E, F, G, Η, J, and A The amount of pseudoglycoside compound produced is very small and must be provided in sufficient quantities for further purification by multiple fermentations. A secondary factor collection portion prepared in this manner and containing approximately 1.6 g of solid 15 substance was placed in a M8 micron C-18 reverse phase silica (0DS) pre-packed HPLC column (Rainin Dynamx) as described in Example 4. The column system M CH3〇H: CH3CN: Η20 (75: 75: 50) adjustment, and the gradient system M The following solvent system from 100% solvent (A) to 50% (B): solvent system A 75% CHaOH, 75% CH3CN, 50% H2O and solvent system B95% CH3OH, 75% CH3CN, 50% H2O, M25-ml eluate were collected. Collected This paper size is applicable to China National Standard (CNS) A4 (210X 297mm) — Binding (please read the precautions on the back before filling this page) A7

五、發明説明(26 ) 述之溶析份30: 收集郤分 溶析份 1 31-44 2 45-63 3 64-69 4 70-80 5 81-130 6 131-160 將收集部分5 (100 mL)之部分濃縮成殘餘物,溶於甲醇(1 mL)及如實施例5所述方法置入21,4imX 250-nnn HPLC管 柱(Rainin Dynamx)。利用下述溶劑糸統(A )調整管柱: 溶劑系統 A 30: 30: 40 CH3〇H/CH3CN/H2〇(lN NfUOAc, pH 5),及溶劑 B 95 : 95 : 10 CH3〇H/CH3CN/H2〇(lN NH4〇Ac,pH 5),利用由100%溶劑(A )至50%溶劑(B )之 120-分鐘線形梯度展開,M7.5 mL/roin收集15-mL溶析份 。在50% (B)下額外繼續收集析出液60分鐘。收集下述之 溶分: _收集部分 溶枳份 成分V. Description of the invention (26) The lysate described in 30: The lysate is collected but separated 1 31-44 2 45-63 3 64-69 4 70-80 5 81-130 6 131-160 The collected part 5 (100 mL) was concentrated to a residue, dissolved in methanol (1 mL) and placed in a 21,4imX 250-nnn HPLC column (Rainin Dynamx) as described in Example 5. The column was adjusted using the following solvent system (A): Solvent system A 30: 30: 40 CH3〇H / CH3CN / H2〇 (1N NfUOAc, pH 5), and solvent B 95: 95: 10 CH3〇H / CH3CN / H2O (1N NH4OAc, pH 5), developed with a 120-minute linear gradient from 100% solvent (A) to 50% solvent (B), 15-mL eluate was collected at M7.5 mL / roin. Collection of the precipitate was continued for an additional 60 minutes at 50% (B). Collect the following solvents: _Collect part Dissolve ingredients

1 37 F 2 38-48 Ε 3 52-63 Β ’ -G 4 65-70 Η , 丨J 將這些收集部分與由其他使用類以起始物質之層析過程所 得的收集部分合併。如本文中所描述之方法,利用管柱層 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) I----J-1衣------、玎----- (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 收羞部分 溶析份 成分 E 249 717 F 4 717 G 104 731 Η,J 87 717 假A 288 590 487559 A7 _ B7 · 五、發明説明(27 ) 析進一步純化合併所得之^集部分;利用標準技術在HP-20樹脂内 脫鹽; 並濃縮及冷 凍乾燥K 獲得下述成分 : ”藉由質譜 啻施例8 利用培寨物NRRL 1 8743製備中窨諾辛K、中客 曹諾辛Ο及Φ窨諾辛Y_ A部分•振潘忒憤Μ搿醆 將冷凍乾燥九粒或保持在液態氮中之懸浮液形式的史 賓多泡酵母菌NRRL 18743培養物接種至具有下述組成之營 養性培養基中: 營寨件培寨基 組成分 β (ζ) 胰胳大豆培養基” 30 酵母萃取物 3 MgS〇4一 Η20ο 2 葡萄糖 《 5 麥芽糖 4 去離子水 q . S . 120TC下高壓殺菌30分鐘 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210:,&lt; 297公釐) ^ 裝 訂 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 經濟部中央標準局員工消費合作社印製 487559 A7 B7 , 五、發明説明(28 )1 37 F 2 38-48 Ε 3 52-63 B′-G 4 65-70 ,, 丨 J Combine these collection portions with those obtained by other chromatography processes using starting materials. As described in this article, the paper size is applied to the Chinese National Standard (CNS) A4 specification (210X 297 mm) using the column layer. I ---- J-1 clothing ------, 玎 --- -(Please read the precautions on the back before filling out this page) Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs, the content of the dissolved fractions E 249 717 F 4 717 G 104 731, J 87 717 Fake A 288 590 487559 A7 _ B7 · V. Description of the invention (27) Analyze and further purify the combined part; demineralize in HP-20 resin using standard techniques; and concentrate and freeze-dry K to obtain the following components: ”Applied by mass spectrometry Example 8 Preparation of Zhongluoxin K, Zhongke Caoxinoxo 0, and Φ 窨 nuoxin Y_A using Peizhai NRRL 1 8743 The culture of Sporola multiflora NRRL 18743 in the form of a suspension was inoculated into a nutrient medium having the following composition: Peizhai base composition β (ζ) Pancreatic soybean medium "30 Yeast extract 3 MgS04 1Η20ο 2 glucose <5 maltose 4 deionized water q. S. 12 Autoclave for 30 minutes at 0TC. This paper size applies the Chinese National Standard (CNS) Λ4 specification (210 :, &lt; 297 mm) ^ Binding (please read the precautions on the back before filling this page) Staff of the Central Bureau of Standards, Ministry of Economic Affairs Cooperatives Printed by the Central Standards Bureau of the Ministry of Economic Affairs Printed by the Consumer Cooperatives 487559 A7 B7, V. Description of Inventions (28)

•巴爾的摩生物實驗室,tockeysville,MD 可藉由添加2.5%洋菜至營養性培養基製備斜面培養 基或平板培養基。將經接種之斜面培養基培養在30°C下約 10至約14天。成热之斜面培養基培養物Μ無菌器具刮取使 孢子鬆落及去除並浸軟菌絲體叢。將約1/4由此所獲得之 鬆落孢子及培養物生長接種至50 mL第一階段營養性種菌 培養基。另外,可由液態氮安瓿接種至第一階段培養基。 藉由均質營養性培養基、以甘油:乳糖:水(2 : 1 : 7 )之無菌懸浮劑Μ 1 : 1 (體積:體積)稀釋,及分配至無菌 管(1.5 ml/管)中Μ製備液態-氮-原接種體。接著將稀釋 之培養物儲存於液態氮下及適當之儲存容器中並作為振盪 -燒瓶培養物及發酵槽菌種培養物之培養所用的原接種體 Ο 快速解凍液態氮安瓿及取0.5 mL接種至含有50mL營養 性培養基之250-raL廣口三角瓶中。將培養物在32t!下,在 振盪器中K 250rpm之速率環繞2-吋圓周,培養48小時。 將經培養之培養物(5% v/v接種體)接種至25 mL具有 下述組成之生產性培養基中: 牛產袢培寨某 細成分_ g (g) 葡萄糖 , 80 腺化牛乳” 20 棉籽粉11 30 玉米浸液 10 H - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ------ΓΙ-^批衣------1T------Φ (請先閱讀背面之注意事項再填寫本頁) 487559 經濟部中央標率局員工消費合作社印製• Baltimore Biolabs, tockeysville, MD can be used to prepare slanted or flat media by adding 2.5% agar to nutrient media. The inoculated slant medium is cultured at 30 ° C for about 10 to about 14 days. The heat-producing slant culture medium M is scraped off with a sterile instrument to loosen and remove the spores and soak the mycelium clumps. About 1/4 of the thus obtained pine spores and cultures were inoculated into 50 mL of the first-stage nutrient seed culture medium. Alternatively, the first stage culture medium can be inoculated from a liquid nitrogen ampoule. Liquid was prepared by homogenizing a nutrient medium, diluting with a sterile suspension M 1: 1 (volume: volume) of glycerol: lactose: water (2: 1: 7), and dispensing into a sterile tube (1.5 ml / tube). -Nitrogen-protozoa. The diluted culture is then stored under liquid nitrogen and in a suitable storage container as the original inoculum used for the culture of the shake-flask culture and the fermenter strain culture. Quickly thaw the liquid nitrogen ampoule and inoculate 0.5 mL In a 250-raL wide mouth Erlenmeyer flask containing 50 mL of nutrient medium. The culture was cultured at 32t! Around a 2-inch circle in a shaker at K 250 rpm for 48 hours. The cultured culture (5% v / v inoculum) was inoculated into 25 mL of a productive medium having the following composition: a fine ingredient of boiled pei village _ g (g) glucose, 80 adenized milk ”20 Cottonseed meal 11 30 Corn infusion 10 H-This paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) ------ ΓΙ- ^ 批 衣 ------ 1T ---- --Φ (Please read the notes on the back before filling out this page) 487559 Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

A7 B7 五、發明説明(29) CaC〇3 (工業级)· 5 油酸甲酯 30 自來水 q·S·至1-L ”腺化牛乳營養素,Sheffield Products » Norwich » HY ^^Proflo» graders Protein, Memphis TH 將經接種之生產性培養基培養在250-mL廣口三角瓶中,於 301C下,Μ 250ΓΡΙΠ之速率環繞2-吋圓周,培養7天。 R·揋拌式Φ物反應器發酵 為了提供大量的接種體,將10 mL如上述方法製備之 10 mL第一階段營養性培養基接種至400 mL之與第一階段 營養培養基具有相同組成的第二階段營養性培養基。第二 階段營養性培養基之純度&gt;98%。由第一製備型HPLC分離 之含有史賓諾辛K之收集部分及再純化之史賓諾辛0合併 ,濃縮至200 ml,及Μ與史賓諾辛0相同之方式脫鹽。收 集含有純度&gt;98%成分Κ之溶析份,濃縮至乾,及由t -BuOH冷凍乾燥Μ獲得史賓諾辛K (11.1 g ; &gt;99%純度)。 管)fe例9 由Μ秩NRRL 1 8743分雛中窨諾辛K、史賓諾辛 Π及中客諾辛Υ_ 大致Μ上述實施例Β部分所述方法製備發酵培養基(2 (30-L)。Μ5Ν HC1調整pH至3.0後,將丙酮(260-L)添加至 整個培養基中。所得混合物經由陶瓷過S器過濾Μ獲得滤 液(480-L),將滤液於冷藏下保持隔週。利用25% HaOH將 培養基/丙嗣滤液調整至pH 12及在填料至流速為0.5 L/ 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) ~裝------訂-----參 (請先閱讀背面之注意事項再填寫本頁) 487559 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(3〇 )A7 B7 V. Description of the invention (29) CaC〇3 (industrial grade) · 5 methyl oleate 30 tap water q · S · to 1-L "adenized milk nutrient, Sheffield Products» Norwich »HY ^^ Proflo» graders Protein Memphis TH cultured the inoculated productive medium in a 250-mL wide-mouthed triangle flask at 301C at a rate of M 250 ΓΡΠΠ around a 2-inch circle and cultured for 7 days. Provide a large amount of inoculum, inoculate 10 mL of the first-stage nutritional medium prepared as described above to 400 mL of the second-stage nutritional medium having the same composition as the first-stage nutritional medium. The second-stage nutritional medium Purity> 98%. The collected fraction containing Spinoxin K separated by the first preparative HPLC and the repurified Spinoxin 0 were combined and concentrated to 200 ml, and M was the same as Spinoxin 0 Desalting method. Collect the eluate containing purity> 98% of component K, concentrate to dryness, and obtain spinosinol K (11.1 g; &gt; 99% purity) from t-BuOH freeze-drying. Tube) 9 by M rank NRRL 1 8743 points Nosin Π and Zhongke Nosin Υ _ Approximately M. The fermentation medium (2 (30-L)) was prepared as described in Example B above. After adjusting the pH of M5N HC1 to 3.0, acetone (260-L) was added to the entire medium The obtained mixture was filtered through a ceramic filter to obtain a filtrate (480-L), and the filtrate was kept under refrigeration for another week. The medium / propionate filtrate was adjusted to pH 12 with 25% HaOH and the filler was flowed to a flow rate of 0.5 L per sample. Paper size applies Chinese National Standard (CNS) Λ4 specification (210X 297 mm) ~ installed ------ order ----- see (please read the precautions on the back before filling this page) 487559 A7 B7 Economy Printed by the Consumers' Cooperatives of the Ministry of Standards of the People's Republic of China. 5. Description of Inventions (30)

分鐘之含有 HP-20ss樹脂(Mi tsubishi Chemical Industries, Ltd·,日本)之鋼管柱(l〇-L,10 cmX 122cm )之前經過陶瓷過濾器再過滤2次。MCH3CN-CH3〇H-〇.l%a q. NhOAc (利用 NH4〇H調整至 pH8.1) (25 ·· 25 : 50 ; 20-L) 。利用 CH3CH-CH3〇H-〇. 1% aq.NH4〇Ac (利用 NFUOH調整至 pH 8.1) (95 : 95 : 10 ; 30-L)在流速1-L/分鐘析出史賓諾辛K 、◦及Y。濃縮析出液(30-L)復溶於CHaOH中,再濃縮至 乾,復溶於CH30H(100 ml),接著於CH3CS(2-L)中沈澱。 藉由過滹去除所得之沈澱,KCH3CN清洗沈澱,及丟棄沈 層:將合併之滤液及清洗液(3-L)濃縮至乾。將所得殘餘 物復溶於二氯甲烷(50 ml)中及置入平衡於乙腈之矽膠(EM 级62·60-200篩目)管柱(7·5croX50cm)。管柱係KCH3CN 為溶析液,接著為(:[13^(:[13〇1^(9:1:2〇-[),接著為 CH3CN-CH3〇H(8 ··_ 2 : 10-L),收集1-L溶析份。收集溶析份 11-30及濃縮至乾。將所得殘餘物溶於CH3〇H(50 mL)及置 入(溶析操作1〇次)製備型逆相HPLC 60A,8厚 C18,41.4 mm IDX25 cm 與 41·4 mmX5 cm 防護 組件),該管柱係平衡於H2〇-CH3〇H-CH3CN ; (50 : 175 : 175,包含0.1%閜4(^〇:)。管柱係以4〇1111/分鐘之速率及 60 分鐘之由 H2〇 CH3〇H-CH3CH 至(50: 175: 175;含有(K1 ;NfUOAc)至 H2〇-CH3〇H CH3CN(10 : 45 : 45 ;含有 0·1 ; / NH4〇Ac)之線形梯度析出。利用調整至250 nra之可變波長 UV偵測器監測分離過程。收集對應於少量史賓諾辛Y ( 收集部分1,hL)、史賓諾‘辛K (收集部分2,8-L)及史賓 -33 - 本,·氏張尺度適用中國國家標準(CNS ) A4規格(210X29?公釐) 一裝-- (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 487559 A7 __B7_ , 五、發明説明(31 ) 諾辛〇(收集部分3,4-L)乏溶析液的前3個波峰(收集溶 析操作10次所得者)。將史賓諾辛K濃縮至小體積,接著 在相同的管柱中藉由再層析脫鹽,不含媛衝液之溶析。將 對應吸收波峰之流出液濃縮至乾,溶於t-BU〇H,及冷凍乾 燥至獲得純史賓諾辛K(7.3 g)。^類似方式使史賓諾辛 Ο脫鹽及冷凍乾燥K獲得史賓諾辛〇(1.4 g)。藉由相似 之層析法使史賓諾辛丫脫鹽(Rainin Dynamax-60A 8 pm C18 管柱,21.4 mmIDX25 cm,具有 21.4 fflinX5 cm 之防護 組件)及M類似方式冷凍乾燥M獲得純史賓諾辛Y (46 mg) Ο 管)例10 利用NRRL 18719製備中窨諾辛J、中窨諾辛L 、中害諾辛Μ,及中W諾辛N 利用史賓多泡酵母菌(Saccharopolyspora soinosa) NRRL 18719培養物Μ獲得史賓諾辛J、史賓諾辛L、史賓諾辛 Μ,及史賓諾辛N。 Α郤分·振湿式煊瓶發睹 將冷凍乾燥九粒或保持在液態氮中之懸浮液形式的史 賓多泡酵母菌NRRL 18743培養物接種至具有下述組成之營 養培養基中: 螢羞件培蕃基 組成分 a (R) 胰賂大豆培養基11 30 酵母萃取物 3 MgS〇4_H2〇° 2 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) I .. 裝 訂 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 ____._ B7___ 五、發明説明(32 ) 葡萄糖 ' 5 麥芽糖 4A steel pipe column (10-L, 10 cmX 122 cm) containing HP-20ss resin (Mi tsubishi Chemical Industries, Ltd., Japan) was filtered twice before passing through a ceramic filter. MCH3CN-CH3OH-0.1% a q. NhOAc (adjusted to pH 8.1 with NH4OH) (25 ·· 25: 50; 20-L). Spinolsin K, CH3CH-CH3〇H-0.1% (adjusted to pH 8.1 with NFUOH) (95: 95: 10; 30-L) at a flow rate of 1-L / min. And Y. The concentrated precipitate (30-L) was redissolved in CHaOH, then concentrated to dryness, redissolved in CH30H (100 ml), and then precipitated in CH3CS (2-L). The resulting precipitate was removed by centrifugation, the precipitate was washed with KCH3CN, and the precipitate was discarded: the combined filtrate and washing solution (3-L) were concentrated to dryness. The obtained residue was re-dissolved in dichloromethane (50 ml) and placed in a column of silica gel (EM grade 62 · 60-200 mesh) equilibrated in acetonitrile (7.5crox50cm). The column system KCH3CN is the eluent, followed by (: [13 ^ (: [13〇1 ^ (9: 1: 2〇- [), followed by CH3CN-CH3〇H (8 ·· _ 2: 10- L), collect 1-L fractions. Collect fractions 11-30 and concentrate to dryness. Dissolve the resulting residue in CH3OH (50 mL) and place (10 times of dissolution operation) Phase HPLC 60A, 8 thick C18, 41.4 mm IDX25 cm and 41.4 mmX5 cm protective assembly), the column system is balanced with H2〇-CH3〇H-CH3CN; (50: 175: 175, containing 0.1% 閜 4 ( ^ 〇 :). The column system was changed from H2〇CH3〇H-CH3CH to (50: 175: 175; containing (K1; NfUOAc) to H2〇-CH3〇H CH3CN at a rate of 40111 / min and 60 minutes. (10:45:45; containing 0 · 1; / NH4〇Ac) linear gradient precipitation. The variable wavelength UV detector adjusted to 250 nra was used to monitor the separation process. The collection corresponds to a small amount of Spinozin Y (collect Part 1, hL), Spinoluo 'Sin K (collection Part 2, 8-L) and Spinn-33-this, · Zhang's scales are applicable to China National Standard (CNS) A4 specifications (210X29? Mm) one pack -(Please read the precautions on the back before filling out this page) Order the consumer cooperation of the Central Standards Bureau of the Ministry of Economic Affairs The company printed 487559 A7 __B7_, V. Description of the invention (31) Nosin 0 (collection part 3, 4-L) The first 3 peaks of the depleted lysate (collection of 10 leaching operations) Sin K was concentrated to a small volume, and then desalted by re-chromatography in the same column, without the dissolution of Yuanyuan solution. The effluent corresponding to the absorption peak was concentrated to dryness, dissolved in t-BUOH, and frozen. Dry to obtain pure Spinoxin K (7.3 g). ^ Desalting Spinoxin 0 in a similar manner and freeze-drying K to obtain Spinoxin 0 (1.4 g). Spinoxin is obtained by similar chromatography. Ya desalting (Rainin Dynamax-60A 8 pm C18 column, 21.4 mm IDX25 cm, with 21.4 fflinX 5 cm protective components) and M similarly freeze-drying M to obtain pure Spinoxin Y (46 mg) Ο tube) Example 10 NRRL 18719 Preparation of Sinopinoxin J, Zhongpinoxin L, Zhongoxinoxin M, and Zhongwanoxin N. Spinacin polyspora soinosa NRRL 18719 culture M was used to obtain spinoxin J, spinn Nosin L, Spinozin M, and Spinnozin N. Α Buttering · Vibrating Wet Bottle A culture of Spinaldella yeast NRRL 18743 in suspension in liquid nitrogen was inoculated into a nutrient medium having the following composition: fluorescein-based component a (R) pancreatic soybean medium 11 30 yeast extraction Object 3 MgS〇4_H2〇 ° 2 This paper size applies to Chinese National Standard (CNS) Λ4 specification (210X 297 mm) I .. Binding (please read the notes on the back before filling this page) Staff of the Central Bureau of Standards, Ministry of Economic Affairs Printed by the Consumer Cooperative 487559 A7 ____._ B7___ V. Description of the Invention (32) Glucose '5 Maltose 4

去離子水 q.S.l-LDeionized water q.S.l-L

120°C下高壓殺菌30分鐘 #巴爾的摩生物實驗室,Cockeysville,MD 可藉由添加2.5%洋菜至營養性培養基製備斜面培養 基或平板培養基。將經接種之斜面培養基培養在301C下約 10至約14天。成熟之斜面培養基培養物K無菌器具刮取使 孢子鬆落及去除並浸軟菌絲體叢。將約1/4由此所獲得之 鬆落孢子及培養物生長接種至50 mL第一階段營養性種菌 培養基。另外,可由液態氮安瓿接種至第一階段培養基。 當培養物保持在液態氮中時,利用均質一營養性培養 基(在301C下培養48-72小時),利用無菌懸浮劑Ml : 1(體 積:體積)稀釋,及分配至無菌管(1.5 ml/管)製備安瓿。 懸浮劑包含乳糖(100 g),甘油(200 ml),及去離子水( q · S ·至 1升)。 將\液態氮安瓿接種至含有100 mlmL營養性培養基之 500-inL三角瓶(或含有50 ml培養基之250-ml燒瓶)中。將 培養物在301C下,在振盪器中M 260 rpia之速率環繞2-时( 5.08 cm)圓周,培養48小時。 將經培養之培養物(10% v/v接種體)液態氮安瓿,依 燒瓶之大小而定,接種至含有50 ml或100 ml具有下述組 成之生產性培養基: 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) :裝 訂 (請先閱讀背面之注意事項再填寫本頁) 487559 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(33 ) φ產疮培蕃基Autoclave at 120 ° C for 30 minutes. #Baltimore Biolabs, Cockeysville, MD Can be used to prepare slanted or flat media by adding 2.5% agar to nutrient media. The inoculated slant medium was cultured at 301C for about 10 to about 14 days. The mature slant medium culture K was scraped with sterile equipment to loosen and remove the spores and soak the mycelium clumps. About 1/4 of the thus obtained pine spores and cultures were inoculated into 50 mL of the first-stage nutrient seed culture medium. Alternatively, the first stage culture medium can be inoculated from a liquid nitrogen ampoule. When the culture is maintained in liquid nitrogen, use a homogeneous nutrient medium (cultivated at 301C for 48-72 hours), dilute with sterile suspension M1: 1 (volume: volume), and distribute into sterile tubes (1.5 ml / Tube) to prepare ampoules. The suspension contains lactose (100 g), glycerin (200 ml), and deionized water (q · S · to 1 liter). Inoculate the \ liquid nitrogen ampoule into a 500-inL Erlenmeyer flask (or a 250-ml flask containing 50 ml medium) containing 100 ml mL of nutrient medium. The culture was cultured at 301C in a shaker at a rate of M 260 rpia around a 2-hour (5.08 cm) circle for 48 hours. The cultured culture (10% v / v inoculum) of liquid nitrogen ampoule, depending on the size of the flask, is inoculated to a production medium containing 50 ml or 100 ml of the following composition: This paper size applies Chinese national standards (CNS) A4 specification (210X297 mm): Binding (please read the notes on the back before filling out this page) 487559 A7 B7 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of invention base

畺 葡萄糖 80 腺化牛乳* 20 棉籽粉h 30 玉米浸液 10 CaC〇3 (工業级) 5 油酸甲酯 30… 自來水 q·s·至 1-L MIN NaOH 調整 pH 至 ρΗ7·0,在 120Ό 下殺菌 40 min。 * 腺化牛乳營養素,Sheffield Products,Norwich,HY 13815畺 glucose 80 adenized milk * 20 cottonseed meal h 30 corn infusion 10 CaC〇3 (industrial grade) 5 methyl oleate 30… tap water q · s · to 1-L MIN NaOH adjust pH to ρΗ7 · 0, at 120Ό Sterilize for 40 min. * Adrenalized milk nutrients, Sheffield Products, Norwich, HY 13815

MifProflo» graders Protein, Memphis TN 38018 油酸甲酯的量為30 rol。 將經接種之生產性培養基培養於250-ml或500-ml燒瓶 中,在371C下,在振盪器中M 260 rpm之速率環繞2-吋( 5.08cm)圓周,培養7至10天。 B ·揋榉忒反腱恶搿醆 為了提供大量的接種體,將如上述A部分所述方法製 備之10 ml第一階段培養基接種至400 ml與第一階段培養 基具有相同組成之第二階段營養性培養基。將此第二階段 培養基培養在2-L廣口燒瓶中,在30°C下,在振盪器中Μ 260 rpm之速率環繞2-吋圓周,培養48小時。經培養之第 二階段營養性培養基(2 L)舍種至80至115升如上述A部分 -36 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) — r 裝 訂 (請先閲讀背面之注意事項再填寫本頁) 487559 Α7 Β7 五、發明説明(34 ) 所述方法製備之無菌生產性培養基。 使經接種之生產性培養基在165-L攪拌式生物反應器 中,在溫度301C下發酵7天至10天。攬拌槽中空氣流及攬 拌器速率係由電腦控制以維持溶氧濃度在或高於60%至約 80%空氣飽和度。 下表說明藉由NRRL 18719培養物製備之史賓諾辛J、 史賓諾辛L、史賓諾辛Μ及史賓諾辛Μ,及史賓諾辛N之 量° 第I表 利用NRRL 18719培養物藉由振盪式燒瓶發酵生產之史 賓諾辛化合物的量。 i衣-- (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 因子 量(mg/m 1) 史賓諾辛J 661 史賓諾辛L 133 史賓諾辛Μ NDH 史賓諾辛Ν, ND*1 **藉由HPLC分析無法測得。 37 本紙張尺度適用中國國家標準(CNS ) Α4規格(:M0X 297公趁) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 1、發明説明(35 ) 第互表MifProflo »graders Protein, Memphis TN 38018 The amount of methyl oleate is 30 rol. The inoculated productive medium was cultured in a 250-ml or 500-ml flask at a speed of M 260 rpm in a shaker at 2-371 (5.08 cm) circumference at 371C for 7 to 10 days. B. Zygophyllum inverse tendinosa: In order to provide a large amount of inoculum, inoculate 10 ml of the first-stage medium prepared as described in Part A above to 400 ml of second-stage nutrition that has the same composition as the first-stage medium Sex medium. This second-stage culture medium was cultured in a 2-L wide-mouthed flask, and was cultured for 48 hours at 30 ° C in a shaker at a rate of 260 rpm around a 2-inch circle. The cultured second-stage nutrient medium (2 L) is seeded to 80 to 115 liters as described in Part A-36 above.-This paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) — r binding ( (Please read the precautions on the back before filling this page) 487559 Α7 Β7 V. Sterile production medium prepared by the method described in the description of the invention (34). The inoculated production medium was fermented in a 165-L stirred bioreactor at a temperature of 301C for 7 to 10 days. The air flow and the mixer speed in the mixing tank are controlled by a computer to maintain the dissolved oxygen concentration at or above 60% to about 80% air saturation. The following table illustrates the amount of Spinoxin J, Spinoxin L, Spinoxin M, and Spinoxin M, and Spinoxin N prepared from a culture of NRRL 18719. Table I Use NRRL 18719 The amount of spinosin compound produced by the culture by fermentation in a shake flask. i clothing-(Please read the precautions on the back before filling out this page) The amount of printing factors (mg / m 1) printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Spinoxin J 661 Spinoxin L 133 Spinox Sin M NDH Spinozin N, ND * 1 ** Not detectable by HPLC analysis. 37 This paper size applies to Chinese National Standard (CNS) A4 specifications (M0X 297) 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 1. Description of the invention (35) Section mutual table

I 利用NRRL 18719培養物藉由攬拌式反應器發酵生產之 史賓諾辛化合物的量。 因子 量(mg/ra 1) 史賓諾辛J 5,282 史賓諾辛L 2,487 史賓諾辛Μ 136 史賓諾辛Ν 71 管脓例11 利用培秦物NRRL 18719製備中窨諾辛J、中客 諾辛K、中窨諾宰Μ,及中窨諾宰N_ Μ上述方法製備發酵培養基(105-L),藉由添加5Ν心 0Η調整pH至10(最初為pH 6.8)。將所得混合物經由陶瓷過 滤器過滤。丟棄濾液,將丙酮及水(1 : 1,50 L)之混合物 添加至菌絲固體,及過滤所得混合物。將丙酮及水(1 : 1 ,50 L)之第2混合物添加至菌絲固體,及將所得混合物以 25%硫酸調整至pH 3.0。過濾所得之混合物,及將丙酮及 水(1 : 1 50 L)之第3混合物添加至菌絲固體。過滤所得混 合物及合併酸性滤液。 . 本紙張尺度適用中國國家標準(CNS ) A‘4規格(210X 297公釐)I Amount of spinosin compound produced by NRRL 18719 culture fermentation by a stirred reactor. Amount of factor (mg / ra 1) Spinoxin J 5,282 Spinoxin L 2,487 Spinoxin M 136 Spinoxin N 71 Tube pus example 11 Preparation of Sinopinoxin J, Medium Chernosin K, Zhongluo Nuozai M, and Zhongluo Nuozai N_M prepared the fermentation medium (105-L) as described above, and the pH was adjusted to 10 by adding 5N Xin 0Η (initial pH 6.8). The resulting mixture was filtered through a ceramic filter. The filtrate was discarded, a mixture of acetone and water (1: 1, 50 L) was added to the mycelium solid, and the resulting mixture was filtered. A second mixture of acetone and water (1: 1, 50 L) was added to the mycelium solid, and the resulting mixture was adjusted to pH 3.0 with 25% sulfuric acid. The resulting mixture was filtered, and a third mixture of acetone and water (1: 150 L) was added to the hypha solid. The resulting mixture was filtered and the acidic filtrate was combined. . This paper size applies Chinese National Standard (CNS) A’4 size (210X 297mm)

Hi' mu IK f ^Jn ml mi ·ϋϋ ·ϋϋ —ϋ ϋ_ϋ ϋϋ V J, —^ϋ —ϋ 1_ιϋ ml 1— ^^^1 tin— I f (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 B7 ^ 五、發明説明(36 ) 將合併之滤液Μ己^(10 L)萃取。使相分離及於水相 中添加第2份的己烷(10 L)。利用5Ν NaOH將所得混合物 之pH調整至pH 10。M50 L水稀釋所得之乳化液。使相分 離及利用第3份己烷(10 L)萃取己烷。使相分離及合併第2 份及第3份己烷萃取物及濃縮至體積約4升。在靜置時,澹 縮物分成三相,水相、乳化液相、及有機相。使有機相冷 凍乾燥可獲得15.29 g粗產物。 將粗產物溶於甲醇(500 mL),過漶,及在減壓下濃縮 至乾。將殘餘物溶於第2部份的甲醇(20 ml)及置入LH-20 SEPHADEX (Pharraacia LKB Biotechnology, Inc. Piscata way, NJ, 7.5 cmX46 cm),M甲醇進行溶析及收集25 ml 溶析份。使用HPLC糸統,分析溶析份M測定含有史賓諾辛 化合物之溶析份。合併溶析份18-50及濃縮至乾。 將殘餘物溶於甲醇、乙睛及水(5 : 5 : 1)之混合物中 以及取1 ml部份在製備型逆相HPLC管柱(Rainin Dynamax -60A,C18,41·4 πιιηΧ 300 mm, 8 mm顆粒,60A孔洞, Woburn, MA)中層析。管柱M添加乙酸銨至最終濃度為0.1 % (pH 7.6)之甲醇、乙睛及水(87.5 : 87.5 : 25)的混合物 溶析。利用HPLC系統分析溶析份,合併類似的溶析份及濃 縮Μ獲得3種半純之濃縮物A、B、及C。 在前文段落中所描述之系統上使半純濃縮物C再層析 ,進行10次再層析,每次再層析操作充填200 ml。合併每 次操作之溶析並濃縮Μ獲得製物C 1及C2。製備物C2 再進行第3次層析;但是/利用水取代0,1%乙酸铵(脫鹽 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) _ 裝 訂 (請先閲讀背面之注意事項再填寫本頁) 487559 A7 B7 ’ 五、發明説明(37 ) 步驟)。合併}1卩1^純度至&gt;為99.5%之含有史賓諾辛1^的 溶析份並濃縮。使殘餘物由乙醇/水(1 : 1)中結晶K獲得 2.4g史賓諾辛L。Hi 'mu IK f ^ Jn ml mi · ϋϋ · ϋϋ —ϋ ϋ_ϋ ϋϋ VJ, — ^ ϋ —ϋ 1_ιϋ ml 1— ^^^ 1 tin— I f (Please read the notes on the back before filling this page) Economy Printed by the Consumer Standards Cooperative of the Ministry of Standards of the People's Republic of China 487559 A7 B7 ^ V. Description of the invention (36) The combined filtrate M has been extracted (10 L). The phases were separated and a second portion of hexane (10 L) was added to the aqueous phase. The pH of the resulting mixture was adjusted to pH 10 using 5N NaOH. The emulsion was diluted with M50 L water. The phases were separated and hexane was extracted with a third portion of hexane (10 L). The phases were separated and the 2 and 3 hexane extracts were combined and concentrated to a volume of about 4 liters. When standing, the condensate is divided into three phases, an aqueous phase, an emulsified liquid phase, and an organic phase. The organic phase was freeze-dried to obtain 15.29 g of a crude product. The crude product was dissolved in methanol (500 mL), filtered, and concentrated to dryness under reduced pressure. Dissolve the residue in Part 2 of methanol (20 ml) and place in LH-20 SEPHADEX (Pharraacia LKB Biotechnology, Inc. Piscata way, NJ, 7.5 cmX46 cm), and dissolve in M methanol and collect 25 ml. Serving. The HPLC system was used to analyze the eluate M to determine the eluate containing the spinoxin compound. Fractions 18-50 were combined and concentrated to dryness. The residue was dissolved in a mixture of methanol, acetonitrile, and water (5: 5: 1) and a 1 ml portion was taken in a preparative reverse-phase HPLC column (Rainin Dynamax -60A, C18, 41.4 μm 300 ×, 8 mm particles, 60A holes, Woburn, MA). Column M was added with ammonium acetate to a final concentration of 0.1% (pH 7.6) in a mixture of methanol, acetonitrile, and water (87.5: 87.5: 25) to elute. The eluate fractions were analyzed using an HPLC system, and similar eluate fractions and concentrated M were combined to obtain three semi-pure concentrates A, B, and C. The semi-pure concentrate C was rechromatographed on the system described in the previous paragraph, and rechromatography was performed 10 times, with each rechromatography operation being filled with 200 ml. The elutions from each operation were combined and concentrated to obtain Preparations C1 and C2. Preparation C2 was subjected to the third chromatography; however, 0,1% ammonium acetate was replaced with water (desalted. The paper size is in accordance with Chinese National Standard (CNS) A4 size (210X 297 mm). Binding (please read the back first (Notes on this page, please fill out this page) 487559 A7 B7 'V. Description of the invention (37) Step). The fractions containing Spinoloxine 1 ^ with a purity of 1 卩 1 ^ to &gt; 99.5% were combined and concentrated. The residue was crystallized from K in ethanol / water (1: 1) to obtain 2.4 g of spinosinol L.

將製備物C2及半純的濃縮物B合併及如前文段落中 所述方法脫鹽(12 X 200 inL操作);但是,所欲化合物係利 用甲醇、乙腈及水(11 : 11 : 3)之混合物溶析。合併HPLC .純度至少為99.5%之含有史賓諾辛J的溶析份並濃縮。使 殘餘物溶於熱t-丁醇並冷凍乾煉Μ獲得4.3 g史賓諾辛J Ο 依上述方法層析半純濃縮物A,但是所欲化合物係利 用添加乙酸銨至最終濃度為0.1%之甲醇、乙睛及水(37.5 :37.5 : 25)的混合物溶析。合併每次操作(共4次)之溶 析份並濃縮Μ獲得製備物A 1、A 2及A 3。 利用前述管柱層析製餚物A 1 ;但是,管柱係K甲醇 、乙請及水(2 : 2 ·· 1)的混合物溶析。合併HPLC純度至少 為99.5%之含有史賓諾辛Μ的溶析份並濃縮。使殘餘物溶 於熱t-丁醇並冷凍乾燥Μ獲得136 mg史賓諾辛Μ。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 製備物Α2係依前述段落所述方法層析及處理,以獲 得71 mg史賓諾辛Ν。 啻嫌例12 利用培羞物NRRL 18823郸備中客諾幸Q A部分•振潘式:愤瓶發酵‘ 將冷凍乾燥九粒或保持在液態氮中之懸浮液形式的史 賓多泡酵母菌NRRL 18823培養物接種至具有下述組成之營 養性培養基中: ___-40 -_ 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(38 ) 螢蕃件培_蕃某1 _組成分_ 最(g ) 胰賂大豆培養基” 30 0酵母萃取物 3The preparation C2 and the semi-pure concentrate B are combined and desalted as described in the previous paragraph (12 X 200 inL operation); however, the desired compound is a mixture of methanol, acetonitrile and water (11: 11: 3) Dissolution. HPLC. Spinesin J-containing fractions with a purity of at least 99.5% were combined and concentrated. The residue was dissolved in hot t-butanol and freeze-dried to obtain 4.3 g of Spinoxin J 0. The semi-pure concentrate A was chromatographed as described above, but the desired compound was added with ammonium acetate to a final concentration of 0.1%. A mixture of methanol, acetonitrile and water (37.5: 37.5: 25) was eluted. The fractions from each operation (4 times in total) were combined and concentrated to obtain Preparations A1, A2 and A3. The above-mentioned column chromatography was used to prepare the food A 1; however, the column system was a mixture of K methanol, Ethan and water (2: 2 ·· 1) was eluted. Spinelin M-containing eluates containing at least 99.5% HPLC purity were combined and concentrated. The residue was dissolved in hot t-butanol and lyophilized to obtain 136 mg of spinosinol M. Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the notes on the back before filling this page) Preparation A2 was chromatographed and processed according to the method described in the previous paragraph to obtain 71 mg Spinoloxin N.啻 Scenario 12: Utilization of NRRL 18823, Part of QA's Nuoxing QA • Zhenpan Style: Anger Bottle Fermentation ': Spinolae sp. Yeast NRRL 18823, freeze-dried 9 capsules or kept in liquid nitrogen The culture is inoculated into a nutrient medium with the following composition: ___- 40 -_ This paper size applies to the Chinese National Standard (CNS) A4 (210X 297 mm) 487559 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (38) Firefly pieces _ Fanmou 1 _ composition _ most (g) pancreatic soybean culture medium "30 0 yeast extract 3

MgS〇47H2〇 2 葡萄糖 5MgS〇47H2〇 2 glucose 5

去離子水 q.S.l-LDeionized water q.S.l-L

120TC下高壓殺菌30分鐘 &quot;巴爾的摩生物實驗室,Cockeysville,MD 可由液態氮安瓿接種至第一階段培養基。這種安瓿係 藉由均質一營性培養物(48-72小時培養,301!),利用無 菌懸浮劑以1 : 1(體積:體積)稀釋,並分配至無菌管(1,5 ml/管)中。懸浮液包含孔糖(100 g)、甘油(200 ml),及 去離子水U.s·至1 L)。將液態氮安瓿接種至含有50 ml營 養性培養基之250-ml廣口三角瓶。培養物係在32°C下,在 振盪器中M 250rpm之速率環繞2-时(5.08 cm)圓周,培養 48小時。 將經培養之培養物(5% v/v接種體)接種至含有具有 下述組成之生產性培養基的50 mL三角瓶中: 4:茬袢培寨基 組成分_ , S (g) 葡萄糖 80 腺化牛乳” 20 棉籽粉U • 30 -41 - 本纸浪尺度適用中國國家標準(CNS ) A4規格(210X29?公釐) I-----J-I----------- (請先閲讀背面之注意事項再填寫本頁) 487559 A7Autoclave for 30 minutes at 120TC &quot; Baltimore Biological Laboratories, Cockeysville, MD can be inoculated to the first stage medium from liquid nitrogen ampoules. This ampoule is a homogeneous one-pot culture (48-72 hours incubation, 301!), Diluted 1: 1 (volume: volume) with sterile suspension, and distributed into sterile tubes (1,5 ml / tube) )in. The suspension contains pore sugar (100 g), glycerol (200 ml), and deionized water (U.s. to 1 L). Liquid nitrogen ampoules were inoculated into a 250-ml wide-mouthed triangle flask containing 50 ml of nutrient medium. The culture was cultured at 32 ° C for 2 hours (5.08 cm) in a shaker at a rate of 250 rpm in a shaker, and cultured for 48 hours. The cultured culture (5% v / v inoculum) was inoculated into a 50-mL Erlenmeyer flask containing a productive medium having the following composition: 4: peizhai base composition, S (g) glucose 80 Adenized milk ”20 Cottonseed meal U • 30 -41-The paper scale is applicable to China National Standard (CNS) A4 (210X29? Mm) I ----- JI ----------- (Please read the notes on the back before filling this page) 487559 A7

五、發明説明(39 ) 玉米浸液 ' 10 CaCOa (工業级) 5 油酸甲酯 30 自來水 q · M1.N NaOH 調整 pH 至 ρΗ7·0,在 120t!下殺菌 40 min。 M腺化牛乳營養素,Sheffield Products,Norwich,HY HHProflo» graders Protein, Memphis, TH 油酸甲酯的量為30 ml。 將經接種之生產性培養基培養在250-mL三角瓶中,於30°C 下,Μ25〇ΓΡΐα之速率環繞2-吋圓周,培養7天。 R·摴榉忒半物反腱器發醆 為了提供大量的接種體,將10 inL如上述Α部份製備 之10 mL第一階段營養性培養基接種至400 mL之與第一階 段營養培養基具有相同組成的第二階段營養性培養基。第 二階段營養性培養基係培養於2 L廣口三角瓶中,於321: 下在,M 260rpm之速率環繞2-时圓周,培養48小時。所 製得經培養之第二階段營養性培養基(2 L)係用Μ接種Π5 升如上述Α部分所述之無菌生產性培養基。 使經接種之生產性培養基在165-L攪拌式生物反應器 中,在溫度301:下發酵7天。攬拌槽中空氣流及攪拌器速 率係由電腦挖制K維持溶氧濃度在或高於60%至約80%空 氣飽和度。 啻嫵例13 潯自培蕃物NRRL 18823之史賓諾辛Q、史賓_諾 辛R、中窨謀去S及史賓諾辛T之分雛_ -42 - 本纸張尺度適用中國國家標隼(CNS ) A4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁}5. Description of the invention (39) Corn infusion '10 CaCOa (industrial grade) 5 methyl oleate 30 tap water q · M1.N NaOH adjust the pH to ρΗ7 · 0 and sterilize at 120t! For 40 min. M glandularized milk nutrient, Sheffield Products, Norwich, HY HHProflo »graders Protein, Memphis, TH The amount of methyl oleate is 30 ml. The inoculated productive culture medium was cultured in a 250-mL Erlenmeyer flask at 30 ° C at a rate of M25〇ΓΡΐα around a 2-inch circle and cultured for 7 days. In order to provide a large amount of inoculum, 10 mL of the first-stage nutrient medium prepared as described in Part A above was inoculated to 400 mL, which is the same as the first-stage nutrient medium. Composition of the second phase of nutrient medium. The second-stage nutrient medium was cultured in a 2 L wide-mouthed Erlenmeyer flask, at 321: below, at a rate of 260 rpm around a 2-hour circle, and cultured for 48 hours. The cultured second-stage nutrient medium (2 L) was prepared by inoculating 5 L of sterile production medium as described in Section A above. The inoculated production medium was fermented in a 165-L stirred bioreactor at a temperature of 301 ° C for 7 days. The air flow and agitator speed in the mixing tank are dug by the computer to maintain the dissolved oxygen concentration at or above 60% to about 80% air saturation. Example 13: Spinozin Q, Spinn_Nosin R, Zhongxun Mou S, and Spinnoxin T from self-cultivation NRRL 18823_ -42-This paper is for Chinese country Standard (CNS) A4 (210X 297mm) (Please read the precautions on the back before filling this page}

經濟部中央標準局員工消費合作社印製 經濟部中央標準局員工消費合作社印製 487559 A7 _____ B7 , 五、發明説明(40 ) 依上述實施例所述方法製備發酵培養基(100 L ;獲得 之史賓諾辛Η的效價為303pg/ml,史賓諾Q的效價為50pg /ml),並於處理前冷藏2天。在利用5N HC1將pH調整至 3.0後,將丙酮(100 L)添加至整涸培養基中。使所得混合 物經由陶瓷過滤器過濾Μ獲得滹液(170 L),將其在冷藏 下保持至隔週。將培養基/丙酮滤液調整至pH 13並在填 充至鋼質管質(10 L; 10X122 cm)前經由陶瓷過滤器再過 滹,該管柱含有 HP-20SS樹脂(Mitsubishi Chemical Industries, Ltd·,日本)及流速為1 L /分鐘。此管柱係 於流速1 L/分鐘下,利用由溶劑“A”(0.1%aq.NH4〇Ac ,利用 NH4OH調整至pH8.1)與溶劑 “ B ”(CH3CH CH3〇H 1 : 1)混合之梯度,收集4 L溶析份。泵系統被程序控制Μ 於1分鐘內產生由0至50% Β之梯度,接著在90分鐘內產生 由50至100% Β之梯度,接著再將100% Β權力平等輸送15 分鐘。HPLC分析指出溶析份17(4 L)所含大部份為史賓諾 辛R及另外之較極性物質及少量的史賓諾辛Τ及Η;溶析 份18-22所含大部分為史賓諾辛Η與較少量的史賓諾辛R 及Q及少量的史賓諾辛S及較極性物質;溶析份23-24含 有史賓諾辛Η及Q。收集部分的HPLC分析建議下述之總量 :史賓諾辛Η 23.0 g;史賓諾辛Q 3.4 g;史賓諾辛R 2.0g;史賓諾辛S 0.2?;史賓諾辛T 0,2g。 啻)fe例14 由中客諾辛半紊蘭秩冋收中客諾辛Q、中窨諾 奈R、中W諾垒S,及中窨諾辛T_ 由Q生產菌株製備之發酵培養基(85 L ;獲得之史賓 -43 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) ---- 訂 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(41 ) 諾辛Η的效價為302 pg/iil,史賓諾Q的效價為44ps/io1) ,並於處理前冷藏隔夜。在利用5N HC1將pH調整至3.0後 ,將丙酮(90 L)添加至整個培養基中。使所得混合物經由 陶瓷過濾器過濾Μ獲得漶液(176 L),將其在冷藏下保持 至隔週。將培養基/丙酮滤液Κ 50% NaOH調整至pH 13並在 填充至鋼質管質(10 L ; 10 X 122 cm)前經由陶瓷過滹器( 140L濾液)再過據,該管柱含有HP-20SS樹脂(Mitsubishi C h e m i c a 1 I n d u s t r i e s,L t d ·,日本)及流速為 1 L / 分鐘。 此管柱係於流速1 L/分鐘下,利用由溶劑“A”(0.1% aq • NfUOAc,利用 NH4OH調整至 pH 8.1)與溶劑 “ B ”(CHaCN CH3〇H 1 : 1)混合之梯度,收集4 L(近似值)溶析份。泵糸 統被程序控制Μ於1分鐘內產生由0至50% B之梯度,接著 在90分鐘內產生由50至100%Β之梯度,接著再將100%Β 權力平等輸送15分鐘。HPLC分析指出收集部份1 (溶析份 16-21 ; 24.5 L)含有史賓諾辛 H (12.32g)及 Q (0.34g); 收集部份2 (溶析份22-25 ; 16 L)含有史賓諾辛Η (4.66 g )、Q (2·06 g)、R、S 及 T。 A ·純成分0夕分雜 將收集部份2濃縮至乾,復溶於二氯甲烷(50 ml), 並填充至含有矽膠(EM級62,60-200篩目)及平、衡於二氯甲 烷中之玻璃管柱(5,5 cm X, 30 cm)。Μ二氯甲烷(2 L)清洗 管柱,接著Μ二氯甲烷-甲醇(95: 5)展開溶析,收集250 ml溶析份。合併經由15次操作所得之溶析份3並濃縮成殘 餘物,接著溶於乙醇/水(400 ml)及容許在室溫下維持隔 ___ - 44 -___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本貢)Printed by the Consumers 'Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs printed 487559 A7 _____ B7, V. Description of the Invention (40) Prepare a fermentation medium (100 L according to the method described in the above example); The potency of nosinol was 303 pg / ml, and the potency of Spinolol Q was 50 pg / ml), and it was refrigerated for 2 days before processing. After the pH was adjusted to 3.0 with 5N HC1, acetone (100 L) was added to the whole culture medium. The resulting mixture was filtered through a ceramic filter to obtain mash (170 L), which was kept under refrigeration until every other week. The medium / acetone filtrate was adjusted to pH 13 and passed through a ceramic filter before filling to steel tubing (10 L; 10X122 cm). The column contained HP-20SS resin (Mitsubishi Chemical Industries, Ltd., Japan) ) And the flow rate is 1 L / min. This column was mixed at a flow rate of 1 L / min using a solvent "A" (0.1% aq. NH4〇Ac, adjusted to pH 8.1 with NH4OH) and a solvent "B" (CH3CH CH3〇H 1: 1). Gradient, 4 L of eluate was collected. The pump system is programmed to generate a gradient from 0 to 50% Β within 1 minute, then a gradient from 50 to 100% Β within 90 minutes, and then 100% Β power is equally transmitted for 15 minutes. HPLC analysis indicated that the majority of the eluate 17 (4 L) was Spinoxin R and other more polar substances and a small amount of Spinoxin T and Y; the majority of the eluates 18-22 were Spinozinol and smaller amounts of Spinozin R and Q and a small amount of Spinozin S and more polar substances; eluates 23-24 contain Spinoxin and Q. The HPLC analysis of the collected part suggested the following total amount: Spinozin® 23.0 g; Spinozin® Q 3.4 g; Spinozin® R 2.0g; Spinozin® S 0.2 ?; Spinozin® T 0 , 2g. Iv) fe Example 14: Zhongke Nuoxin semi-blue orchid rank 冋 received Zhongke Nuoxin Q, Zhong Nu Nuo R, Zhong W Nuo Nu S, and Zhong Nuoxin T_ fermentation medium (85 L; Obtained Shibin-43-This paper size applies to Chinese National Standard (CNS) Α4 specification (210X297 mm) (Please read the precautions on the back before filling this page) ---- Order the staff of the Central Standards Bureau of the Ministry of Economic Affairs Printed by the Consumer Cooperative 487559 A7 B7 V. Description of the Invention (41) The potency of Nuoxin is 302 pg / iil, and the potency of Spinol Q is 44ps / io1), and it is refrigerated overnight before processing. After the pH was adjusted to 3.0 with 5N HC1, acetone (90 L) was added to the entire medium. The resulting mixture was filtered through a ceramic filter to obtain mash (176 L), which was kept under refrigeration until every other week. Adjust the medium / acetone filtrate K 50% NaOH to pH 13 and pass through a ceramic filter (140L filtrate) before filling the steel tube (10 L; 10 X 122 cm). The column contains HP- 20SS resin (Mitsubishi Chemica 1 Industries, L td ·, Japan) and a flow rate of 1 L / min. This column was mixed at a flow rate of 1 L / min using a gradient of solvent "A" (0.1% aq • NfUOAc, adjusted to pH 8.1 with NH4OH) and solvent "B" (CHaCN CH3〇H 1: 1). Collect 4 L (approximate) eluate. The pump system is controlled by the program. M generates a gradient from 0 to 50% B within 1 minute, then generates a gradient from 50 to 100% B within 90 minutes, and then transmits 100% B power equally for 15 minutes. HPLC analysis indicated that fraction 1 (fractions 16-21; 24.5 L) contained spinoxin H (12.32g) and Q (0.34g); fraction 2 (fractions 22-25; 16 L) Contains Spinozinol (4.66 g), Q (2.06 g), R, S and T. A · The pure ingredients are mixed in a concentrated manner. The collected part 2 is concentrated to dryness, redissolved in dichloromethane (50 ml), and filled with silica gel (EM grade 62, 60-200 mesh), and the balance is equal to two. Glass columns in methyl chloride (5,5 cm X, 30 cm). The column was washed with M dichloromethane (2 L), followed by lysis with M dichloromethane-methanol (95: 5), and 250 ml of the eluate was collected. The fraction 3 obtained after 15 operations was combined and concentrated to a residue, and then dissolved in ethanol / water (400 ml) and allowed to be maintained at room temperature. ___-44 -___ This paper size applies Chinese national standards (CNS ) A4 size (210X 297mm) (Please read the precautions on the back before filling in this tribute)

# 經濟部中央榡準局員工消費合作社印製 487559 A7 _ B7 / 五、發明説明(42 ) 週。所得结晶Μ冷乙醇/氷清洗(1 ·· 1)並乾燥Μ獲得6 .lg 乾燥结晶,該结晶藉由HPLC分析可知含有68.7%史賓諾辛 Η及31.2%史賓諾辛Q。將乾燥结晶物質2溶於四氫呋喃 /甲醇(1 : 1)及Μ 12次操作置入製備型逆相HPLC管柱( R a i n i n D y n a m a X 6 0 A 8 p m C18 , 41 · 4 m in ID X 2 5 c m,具有 41.4roinx 5 cm防護組件)。管柱在50 ml/分鐘之流速下溶 , 析,利用由溶劑 “ A ”(H2〇-CH3CN-CH3〇H ; 30 : 35 : 35, 含有 0.1%NH4〇Ac)與溶劑 “B”(H2〇-CH3CN-CH3〇H 10: 45 : 45,含有0,1% NH4〇 Ac)混合之梯度。泵系統被程序控 制Μ於60分鐘內產生由50至100% B之梯度。分離過程係 Μ調整在250 ηπι之可變波長UV偵測器監測。 波峰1,含有首先析出之史賓諾辛Η (99% ; 6 L), 接著是史賓諾辛Q。合併所有操作(12次)之波峰2 (含有 史賓諾辛Η 20%,成分Q 80% ; 8 L)並濃縮至500 ml, 再置入相同的管柱中,並在相同的移動相條件下操作5次 。收集部份2 (2 L),藉由置入平衡於H2〇-CH3〇H-CH3CH( 20 : 40 : 40)之相同管柱Μ使含有99%純史賓諾辛Q脫鹽 。管柱係以112〇-(:113〇[1-(^3〇[&lt;(10:45:45)溶析,收集10 溶析份(每3分鐘一份)。合併溶析份2至7,濃縮成殘餘物 ,及溶於熱乙醇(80 ml)。加入等量Η2〇及使溶液冷卻隔夜 。在過滹器收集所得结晶,,Μ冷EtOH-H2〇(l : 1)清洗,及 乾燥Μ獲得1.5 g純史賓諾辛Q。 管脓例1 5 殺匡蟲姐仝物 A ·氷忡_浮液 . -—____ - 45 - 本紙張尺度適用中國國家鮮(CNS ) Λ4規格(21GX 297公慶)— (請先閱讀背面之注意事項再填寫本頁)# Printed by the Consumers' Cooperatives of the Central Prospective Bureau of the Ministry of Economic Affairs 487559 A7 _ B7 / V. Description of Invention (42) weeks. The obtained crystals were washed with cold ethanol / ice (1 ·· 1) and dried to obtain 6.1 g of dry crystals. The crystals were analyzed by HPLC and found that they contained 68.7% Spinoxin IX and 31.2% Spinoxin Q. The dry crystalline material 2 was dissolved in tetrahydrofuran / methanol (1: 1) and placed in a preparative reverse-phase HPLC column (Rainin D ynama X 6 0 A 8 pm C18, 41 · 4 m in ID X 2 in 12 operations). 5 cm with 41.4roinx 5 cm protective assembly). The column was dissolved and eluted at a flow rate of 50 ml / min, using a solvent "A" (H2O-CH3CN-CH3〇H; 30:35:35, containing 0.1% NH4OAc) and a solvent "B" (H2 〇-CH3CN-CH3〇H 10: 45: 45, containing a gradient of 0.1% NH4 (Ac). The pump system is programmed to produce a gradient from 50 to 100% B in 60 minutes. The separation process was monitored by a variable wavelength UV detector adjusted at 250 nm. Peak 1, containing Spinozin (Η) (99%; 6 L), followed by Spinozin Q. Combine all the operations (12 times) of peak 2 (containing 20% spinoxin Η, component Q 80%; 8 L) and concentrate to 500 ml, then put into the same column and under the same mobile phase conditions Operate 5 times. Part 2 (2 L) was collected and desalted by placing it in the same column M equilibrated in H2O-CH3OH-CH3CH (20:40:40) containing 99% pure Spinozin Q. The column system was eluted with 112-(: 113〇 [1-(^ 3〇 [&lt; (10:45:45)), and 10 lysates were collected (one every 3 minutes). The lysates were combined to 2 to 7. Concentrate to a residue and dissolve in hot ethanol (80 ml). Add an equal amount of Η20 and allow the solution to cool overnight. Collect the resulting crystals in a decanter and wash with cold EtOH-H2O (1: 1). And dried M to obtain 1.5 g of pure spinosinoxin Q. Tube pus example 1 5 killing Kuang insect sister A · Bing _ floating liquid. -—____-45-This paper size applies to China National Fresh (CNS) Λ4 specifications ( 21GX 297 public holiday)-(Please read the notes on the back before filling this page)

經濟部中央標準局員工消費合作社印製 A7 __B7_ , 五、發明説明(43 ) 史賓諾辛化合物 ' 12.5¾ TERGITOL TMN-6(非離子性界面活性劑) 1.0% ZI0SYL 200 (氧化矽) 1.0% AF-100 (聚矽氧為主的消泡劑) 0.2% 三仙膠溶液(3%) 10.096 ΜΑΚ0Ν 10(10莫耳環氧乙烷壬基酚界面活性劑) 9.0% 自來水 66.3% R·可乳化漕物 史賓諾辛化合物 12.4% EXXON (萘溶劑) 83.6% T0XIMUL Η(非離子性/陰離子性界面活性劑摻合物) 2.0% TOXIMUL D(非離子性/陰離子性界面活性劑摻合物) 2.0% 管淪例1ft 本發明夕配方 A ·餵料箱溫物 史賓諾辛化合物 1〇% 米粗糠 85% 輕礦物油 5% R ·餵料葙混物 史賓諾辛化合物 , 25% 苜蓿粉 60% 粉化粘土 5% 廢糖蜜 1〇% -46 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)A7 __B7_ printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs, V. Description of the Invention (43) Spinozin compound '12 .5¾ TERGITOL TMN-6 (non-ionic surfactant) 1.0% ZI0SYL 200 (silica) 1.0% AF-100 (Polysilicone-based defoamer) 0.2% Sanxan gum solution (3%) 10.096 ΜΑΚΝ 10 (10 mol ethylene oxide nonylphenol surfactant) 9.0% tap water 66.3% R · Emulsifiable Spinocin compound 12.4% EXXON (naphthalene solvent) 83.6% T0XIMUL Η (nonionic / anionic surfactant blend) 2.0% TOXIMUL D (nonionic / anionic surfactant blend) 2.0% Pipeline Example 1ft Inventive Formula A of the invention • Feed box warming substance Spinoxin compound 10% rice coarse bran 85% light mineral oil 5% R • Feeding mixture of Spinoxin compound, 25% Alfalfa flour 60% Powdered clay 5% Waste molasses 10% -46-This paper size is applicable to China National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page)

,1T 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明钪明(44 ) C·懸浮液 · 史賓諾辛化合物 30% 萘磺酸鹽 5% 非離子性界面活性劑 5% 燻製氧化矽 1% 水 59% D ·滴液溶液 史賓諾辛化合物 20% 非離子性界面活性劑 0.8% 丙二醇 15% 水 64,2% E ·滴液懸浮液 史賓諾辛化合物 1096 非離子性界面活性劑 1% 輕礦物油 8996 F ·可沣射溶液 史賓諾辛化合物 15% 丙二醇 85% G ·可沣射縣浮液 史賓諾辛化合物 25% 丙二醇 , 1596 水 60% Η ♦可泮射懸浑液 史賓諾辛化合物 . 30% -47 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X29*7公釐) (請先閱讀背面之注意事項再填寫本頁), 1T 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 Fifth, invention Ming (44) C · suspension · Spinoxin compound 30% naphthalenesulfonate 5% non-ionic surfactant 5% smoke Silica 1% Water 59% D · Drop solution Spinoxin compound 20% Nonionic surfactant 0.8% Propylene glycol 15% Water 64,2% E · Drop suspension Spinoxin compound 1096 Nonionic Surfactant 1% Light mineral oil 8996 F · Sprayable solution Spinoxin compound 15% Propylene glycol 85% G · Sprayable county liquid suspension Spinoxin compound 25% Propylene glycol, 1596 Water 60% Η ♦ 可 泮Spinococcus Spinocinus Compound. 30% -47-This paper size applies to China National Standard (CNS) Α4 size (210X29 * 7 mm) (Please read the precautions on the back before filling this page)

487559 A7 B7 五、發明説明(45 ) 聚乙烯吡咯烷酮 ' 1% 水 68% 當油Γ例17 合成倐飾作用 A部份 鼠李煻-修飾衍半物 經濟部中央標準局員工消費合作社印製 裝— (請先閱讀背面之注意事項再填寫本頁) _線 啻敝例八1-(化合物9邛-(2.3.4-三-0-乙基-(14-鼠李糖 基之5.6-二氣衍半物)Φ窨諾辛A 9-Psa 將化合物9-0-(2,3,4-三-0-乙基-oc -L-鼠李糖基)史 賓諾辛 A 9-Psa(106 mg,0,137 mmol)溶於 5 mL 甲苯。將 參-三苯基滕錯(I )気化物(11.9 mg,0.0128 mmol)。將 燒瓶之頭部空間抽真空並導入氮氣3次。抽真空並導入氫 氣3次。利用球形瓶將燒瓶維持在氫氣中並加熱至110-120 °C。於3.5小時後,使燒瓶冷卻至室溫並油空氫氣以氮氣 取代。使甲苯溶劑蒸發及M20 inL乙醚取代。M3X 10 mL IN HC1萃取乙醚溶液。合併酸萃取物及M10 ml 4H NaOH 中和。M3x 10 mL乙醚萃取中和之懸浮液,合併乙醚萃取 物,M20 mL鹽水清洗,MK2C〇3乾燥,及在減壓下蒸發。 可得化合物9-0-(2,3,4-三-0-乙基-a 鼠李糖基之5,6-二氫衍生物)史賓諾辛A 9-Psa之化合物5,6-二氫衍生物 ,39♦4Ing,36·8%部份1H-NMRδ6.84(lH,bs),l·01( 1H , m) , 0.68(1H , m) 〇487559 A7 B7 V. Description of the invention (45) Polyvinylpyrrolidone '1% water 68% when oil Γ Example 17 Synthetic decoration effect Part A rhamnolide-modified derivative Printed by employee consumer cooperative of Central Standard Bureau of Ministry of Economic Affairs — (Please read the notes on the back before filling this page) _ 线 啻 敝 例 八 1- (Compound 9 邛-(2.3.4-Tri-0-ethyl- (14-rhamnosyl 5.6-II Gas-derived halves) Φ 窨 oxin A 9-Psa The compound 9-0- (2,3,4-tri-0-ethyl-oc-L-rhamnosyl) Spinoxin A 9-Psa (106 mg, 0,137 mmol) was dissolved in 5 mL of toluene. Phenyl-triphenyl temco (I) halide (11.9 mg, 0.0128 mmol) was evacuated. The head space of the flask was evacuated and nitrogen was introduced 3 times. Hydrogen was introduced 3 times. The flask was maintained in hydrogen using a spherical bottle and heated to 110-120 ° C. After 3.5 hours, the flask was cooled to room temperature and the oil-air hydrogen was replaced with nitrogen. The toluene solvent was evaporated and M20 inL Replace with ether. M3X 10 mL IN HC1 extract the ether solution. Combine the acid extract and M10 ml 4H NaOH to neutralize. M3x 10 mL ether extract the neutralized suspension, combine the ether extracts, and wash with M20 mL brine. MK2C03 was dried and evaporated under reduced pressure. Compound 9-0- (2,3,4-tri-0-ethyl-a rhamnosyl 5,6-dihydro derivative) was obtained. Nosin A 9-Psa compound 5,6-dihydro derivative, 39 ♦ 4Ing, 36.8% 1H-NMR δ6.84 (lH, bs), l01 (1H, m), 0.68 (1H , M) 〇

當腧例A 2 -2 二氡Z _某中窨諾辛Q 將化合物史賓諾辛Q (302 rog,0.412 ππηοΐ)溶於乾 CH2C12(8 ml)。在氮氣下攬拌溶液及加入DMAP(二異戊基 甲基膦酸鹽,269 mg,2.“ mmol)。接著導入二氯乙酸酐 -48 ~ 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印家 487559 A7 —___B7___,一 五、發明説明(46 ) (492 mg,315/i 1,2.05 mmol)。於 45 分鐘後,加入 Ptt 陡( 1.5ml),接著加入Et0Ac(50 ral)及甲苯(50 ml)。M5% aq.NaHC〇3(3X )萃取溶液。Manh· Ha2S〇4乾燥有機相並 減壓乾燥。殘餘物在閃蒸Si〇2管柱(30 g/EtOAc接著為5% EtOH之EtOAc溶液)中純化。純溶析份所得之化合物2’-0-二氯乙醯基史賓諾辛Q ; 310 mg,89% Cl MS ro/z 844 ( M + 3),842 (M + 1) ; IR v 1772 cm” ; 4 NMR (CDC13) δ 6.7Q(1H,bs),6·00(1Η,s),5·43(1Η,bs),5·19(1Η ,dd: 3·1,1·8 Hz),1·67(3Η,CHa,bs)ppm° 例A 3 ~2’-0-三氤乙醯基史賓諾辛_Q 將化合物史賓諾辛Cl(330 mg,0.451 mmol)溶於乾 CH2C12 (10 ml)。在氮氣下攬拌溶液及加入DMAP(二異戊基 甲基滕酸鹽,306 mg,2.50 mmol)。接著導入三氟乙酸酐 (473 rag,320 // 1,2.25 mmol)。於 14小時後,加入吡啶( 1.5ml),接著加入 Et0Ac(50 ml)及甲苯(50 ml)。K5% aq.NaHCOa (3X )萃取溶液。Manh· Na2S〇4乾燥有機相並 減壓乾燥。殘餘物在閃蒸Si〇2管柱(100 g/EtOAc接著為5 %Et0H之EtOAc溶液)中純化。純溶析份所得之化合物2’-0 -三氟乙醯基史賓諾辛Q ; 199 mg,54904 NMR (CDC13) δ 6·69(1Η,bs),5·43(1Η,bs),5·26(1Η,dd : 2』, 1.6 Hz),1·66(3Η,CH3 'bs) ; 13C-HMR (CDC13) δ 156.7( d : 32·5 Hz),114.0(q : 286 Hz)ppro 〇 當油?例Α4-2’-Π-(對三氣甲某)笼甲醢某中客諾辛Q 將化合物史賓諾辛Q(i30 mg,0.587 mmol)溶於乾 -49 -In the case of A 2 -2 Dioxin Z _ some intermediate Nuoxin Q, the compound Spinoxin Q (302 rog, 0.412 ππηοΐ) was dissolved in dry CH2C12 (8 ml). Stir the solution under nitrogen and add DMAP (diisoamylmethyl phosphonate, 269 mg, 2. "mmol). Then introduce dichloroacetic anhydride -48 ~ This paper applies the Chinese National Standard (CNS) Λ4 Specifications (210X 297mm) Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economy, Yinjia 487559 A7 — ___B7___, one or five, invention description (46) (492 mg, 315 / i 1, 2.05 mmol). After 45 minutes, add Ptt Stir (1.5 ml), then add Et0Ac (50 ral) and toluene (50 ml). M5% aq. NaHC03 (3X) extraction solution. Manh · Ha2SO4 dried the organic phase and dried under reduced pressure. The residue was flashed Purify in a SiO2 column (30 g / EtOAc followed by 5% EtOH in EtOAc). Purely eluate the compound 2'-0-dichloroacetamispino Spinoxin Q; 310 mg, 89% Cl MS ro / z 844 (M + 3), 842 (M + 1); IR v 1772 cm "; 4 NMR (CDC13) δ 6.7Q (1H, bs), 6.0 (1Η, s), 5. · 43 (1Η, bs), 5.19 (1Η, dd: 3.1, 1.8 Hz), 1.67 (3Η, CHa, bs) ppm ° Example A 3 ~ 2'-0-Trimethylacetate Gibbs Spinoxin_Q The compound Spinoxin Cl (330 mg, 0.451 mmol) was dissolved in dry CH2C12 (10 ml). The solution was stirred under nitrogen and DMAP (diisoamylmethyl pentanoate, 306 mg, 2.50 mmol) was added. Then trifluoroacetic anhydride (473 rag, 320 // 1, 2.25 mmol) was introduced. After 14 hours, pyridine (1.5 ml) was added, followed by Et0Ac (50 ml) and toluene (50 ml). K5% aq. NaHCOa (3X) extraction solution. The organic phase was dried with Manh. Na2S04 and dried under reduced pressure. The residue was purified in a flashed SiO 2 column (100 g / EtOAc followed by 5% EtOH in EtOAc). Compound 2'-0-trifluoroacetamido-spinnockin Q obtained by pure dissolution; 199 mg, 54904 NMR (CDC13) δ 6.69 (1Η, bs), 5.43 (1Η, bs), 5 · 26 (1Η, dd: 2 ′, 1.6 Hz), 1.66 (3Η, CH3 'bs); 13C-HMR (CDC13) δ 156.7 (d: 32 · 5 Hz), 114.0 (q: 286 Hz) ppro 〇 When oil? Example A4-2’-Π- (to Sanqijia Mou) Cangjia Mou Zhongke Nuoxin Q Dissolve Spinoxin Q (i30 mg, 0.587 mmol) in dry -49-

Awl IT (請先閱讀背面之注意事項再填寫本頁) 氏張尺度適用中國國家橾準(CNS ) A4規格1 210X297公釐) &quot; 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(47 ) CH2C12 (10 ml)。加入DmAp (二異戊基甲基膦酸鹽,367 mg ,3.0 mmol),接著加入三氟甲基苯甲醢基氯化物(613 mg ,440 ml,2.94 mmol)。於室溫下攪拌2小時後,M EtOA c (100 u 1)及甲苯(30 ml)稀釋反應混合物,將溶液連績Μ 鹽水及5%aq,NaHC〇3(3x )清洗。Manh. Na2S〇4乾燥有機 層並減壓乾燥。殘餘物在閃蒸Si〇2管柱(100 g/E t0 Ac接著 為5%EtOH之EtOAc溶液)中分離Μ獲得化合物2’-0-對三氟 甲基)苯甲醯基史賓諾辛Q ; 473 mg,89%iH NMR (CDC13 )58,13(1H,bd: 8.1 Hz),7.68(1H,bd: 8·2 Hz), 6·73(1Η,bs),5·45(1Η,bs),5.42UH,dd : 3·3,1.8 Hz) ’ 1·69(3Η’ CH3 ’ bs);兀素分析:對C43H68MO11F3 之 估計值:C 65.10,Η 7.58,N 1.55 ;實際值:C 64.89, Η 7.55,N 1.56。Awl IT (Please read the notes on the back before filling out this page) The scales are applicable to China National Standard (CNS) A4 size 1 210X297 mm) &quot; 487559 Printed by A7 B7, Cooperative of Employees of the Central Standards Bureau of the Ministry of Economic Affairs Description of the invention (47) CH2C12 (10 ml). DmAp (diisoamylmethylphosphonate, 367 mg, 3.0 mmol) was added, followed by trifluoromethylbenzyl chloro (613 mg, 440 ml, 2.94 mmol). After stirring at room temperature for 2 hours, M EtOA c (100 u 1) and toluene (30 ml) were used to dilute the reaction mixture, and the solution was washed successively with M saline and 5% aq, NaHC0 3 (3 ×). The organic layer was dried with Manh. Na2S04 and dried under reduced pressure. The residue was separated in a flashed Si02 column (100 g / E t0 Ac followed by 5% EtOH in EtOAc) to obtain the compound 2′-0-p-trifluoromethyl) benzylspinoxin Q ; 473 mg, 89% iH NMR (CDC13) 58,13 (1H, bd: 8.1 Hz), 7.68 (1H, bd: 8 · 2 Hz), 6.73 (1Η, bs), 5.45 (1Η, bs), 5.42UH, dd: 3.3, 1.8 Hz) '1.69 (3Η'CH3'bs); Element analysis: Estimated value of C43H68MO11F3: C 65.10, Η 7.58, N 1.55; Actual value: C 64.89, Η 7.55, N 1.56.

窖施例A 5 化S,6R)-環氬(對三氟甲基)笼甲臨基 Φ窨諾垒Q 將化合物(5S,6R)-環氧-史賓諾辛Q (406 mg,0.543 mrool)溶於乾CH2Cl2(10ml)。加入DMAP(二異戊基甲基膦 酸鹽,369 mg,3.0 mmol),接著加入三氟甲基苯甲醯基 氯化物(623 mg,445 w 1,2.98 mmol)。於室溫下攪拌14 小時後,加入三乙胺(2 ml)並持續授拌30分鐘。MEt0Ac( 100 ml)及甲苯(30 ml)稀釋反應混合物,將溶液連缜以鹽 水、5%aq.NaHC〇3(2x )及水(IX )清洗。在減壓下濃縮有 機層。殘餘物在閃蒸Si〇2管柱(80 g/Et0Ac)中純化Μ提供 化合物(5S,6R)-環氧-2 ’-0Μ對三氟甲基)苯甲醯基史賓諾 -50 - 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X 297公釐) ------*—裝— (请先閲讀背面之注意事項再填寫本頁) ,ιτ •Ay 487559 A7 ____ _ ’ B7 , 五、發明説明(48 ) 辛 Q ; 391 mg , 78% IR / 1728 , 1664 , 1324 , 1272cm-1 ;4 隱(CDCla) δ 8·12(1Η , bd : 8·2 Hz) , 7·67(1Η , bd : 8·2 Hz) , 6·54(1Η , bs) , 5·42(1Η , dd : 3·2 , 1·8 Hz),131 (3Η,CH3,bs) 〇 g脓例A R -2’-(1-二氡乙蹢某中窨諾辛Η 將化合物史賓諾辛Η (170 mg,0.237 ππποί)溶於乾吡 啶(3 ml)。加入DMAP(二異戊基甲基膦酸鹽,30 mg,2.46 mmol)。在室溫下攪拌並加入二氯乙酸酐(0.077 ml,120 mg,0.50 mmol)。於30分鐘後,加入甲苯(50 ml)及EtOAc (50 ml)。接著Μ水清洗溶液,接著以5%aq.NaHC〇3 (3X ) 清洗。MNa2C〇3乾燥有機層並減壓濃縮。殘餘物在閃蒸 Si〇2管柱(15 g/Et0Ac)中纯化以提供化合物2’-0-二氯乙 醯基史賓諾辛 Η ; 155 mg,79% Cl MSm/z 830 (M + 3), 828(M+1) ; 4 NMR (CDC13) δ 6.70(1H , bs) , 5·99(1Η , s ),5.18(1H, s) , 5.18(1H, dd: 3·0, 2.0 Hz)。Example A 5 (S, 6R) -Cyclo (p-trifluoromethyl) cylamine 临 窨 窨 NuoQi Q Compound (5S, 6R) -epoxy-spinoxin Q (406 mg, 0.543 mrool) was dissolved in dry CH2Cl2 (10 ml). DMAP (diisoamylmethylphosphonate, 369 mg, 3.0 mmol) was added, followed by trifluoromethyl benzamidine chloride (623 mg, 445 w 1, 2.98 mmol). After stirring at room temperature for 14 hours, triethylamine (2 ml) was added and stirring was continued for 30 minutes. MEt0Ac (100 ml) and toluene (30 ml) were used to dilute the reaction mixture, and the solution was successively washed with brine, 5% aq. NaHC03 (2x) and water (IX). The organic layer was concentrated under reduced pressure. The residue was purified in a flashed Si02 column (80 g / Et0Ac) to provide the compound (5S, 6R) -epoxy-2'-0M-p-trifluoromethyl) benzyl spinol-50-Ben Paper size is applicable to China National Standard (CNS) A4 (210X 297mm) ------ * — packing— (Please read the precautions on the back before filling this page), ιτ • Ay 487559 A7 ____ _ ' B7, V. Description of the invention (48) Xin Q; 391 mg, 78% IR / 1728, 1664, 1324, 1272cm-1; 4 Hidden (CDCla) δ 8 · 12 (1Η, bd: 8 · 2 Hz), 7 · 67 (1Η, bd: 8.2 Hz), 6.54 (1Η, bs), 5.42 (1Η, dd: 3.2, 1.8 Hz), 131 (3Η, CH3, bs) 〇g Pus AR -2 '-(1-dioxoacetamidine, a certain intermediate, nosine) The compound spinoxin (170 mg, 0.237 ππποί) was dissolved in dry pyridine (3 ml). DMAP (diisoamyl) was added Methyl phosphonate, 30 mg, 2.46 mmol). Stir at room temperature and add dichloroacetic anhydride (0.077 ml, 120 mg, 0.50 mmol). After 30 minutes, add toluene (50 ml) and EtOAc (50 ml). The solution was washed with M water, and then washed with 5% aq. NaHC03 (3X). The organic was dried with MNa2CO3. And concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (15 g / Et0Ac) to provide the compound 2'-0-dichloroethenylspinoxine; 155 mg, 79% Cl MSm / z 830 (M + 3), 828 (M + 1); 4 NMR (CDC13) δ 6.70 (1H, bs), 5.99 (1Η, s), 5.18 (1H, s), 5.18 (1H, dd: 3 0, 2.0 Hz).

管餱例A 7 - (二Z基)亞磷酿_中窨諾辛H 經濟部中央標準局員工消費合作社印製 a、----- (請先閱讀背面之注意事項再填寫本頁) 將化合物史賓諾辛Η (351 mg,0.489 mmol)溶於乾吡 啶(5 ml)。加入DMAP (二異戊基甲基膦酸鹽,62 mg,0·51 mmol)並在室溫及氮氣下持纊攪拌5分鐘。加入二乙基氯亞 磷酸酯(157 mg,0,145 ml,1·0 mraol)。於 30分鐘後,加 入甲苯(50 ml)及Et0Ac(50 ml)。連纊Μ鹽水(2X)及5% t β aq.NaHC〇3清洗溶液並濃縮。殘餘物在閃蒸Si〇2管柱(100 s/EtOAc)中分離Μ獲得化合物2’R-(二乙基)亞磷酸酯史賓 諾辛 Η ; 306 mg,75%CI MS m/z 838 (M + 1) ; 4 NMR ( 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210Χ 297公釐) 487559 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(49 ) CDC13) δ 6·69(1Η,bs),ί·40(1Η,ιη),3·83(4Η,2X CH2 ,m),1·18(6Η,2X CH3,m);元素分析:對CuH72N〇12P 之估計值:C 63.06,Η 8·66,N 1·67 ;實際值:C 62.94 ,Η 8·88 , N 1·71 。 g倫例A 8 - (2 ’ R)-(二7」基)硫磷g楚酯史窨諾辛ΗCase A 7-(Two-Z-based) Phosphorous Beverage _Zhongluo Nuoxin H Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs a, ----- (Please read the precautions on the back before filling this page) The compound spinoxin IX (351 mg, 0.489 mmol) was dissolved in dry pyridine (5 ml). Add DMAP (diisoamylmethylphosphonate, 62 mg, 0.51 mmol) and stir at room temperature under nitrogen for 5 minutes. Diethyl chlorophosphite (157 mg, 0,145 ml, 1.0 mraol) was added. After 30 minutes, toluene (50 ml) and Et0Ac (50 ml) were added. Flammy brine (2X) and 5% t β aq. NaHC0 3 were used to wash the solution and concentrated. The residue was separated in a flashed Si02 column (100 s / EtOAc) to obtain the compound 2'R- (diethyl) phosphite spinoxin; 306 mg, 75% CI MS m / z 838 (M + 1); 4 NMR (This paper size applies to the Chinese National Standard (CNS) Λ4 specification (210 × 297 mm) 487559 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 Β7 V. Description of the invention (49) CDC13) δ 6.69 (1Η, bs), · 40 (1Η, ιη), 3.83 (4Η, 2X CH2, m), 1.18 (6Η, 2X CH3, m); Elemental analysis: For CuH72N〇12P The estimated value: C 63.06, Η 8.66, N 1.67; the actual value: C 62.94, Η 8.88, N 1.71. Example 1 A 8-(2 ′ R)-(di 7 ″) thionyl phosphorium

將化合物史賓諾辛Η (261 mg,0.364 mmol)溶於乾吡 啶(3 ml)。加入DMAP(二異戊基甲基膦酸鹽,60 rag),接 著加入二乙基氯硫磷酸酯(152 mg,125αζ 1,0.80 rarool) 。在室溫及氮氣下攪拌反應混合物。於12小時後,加入甲 苯(5^ ml)及 Et0Ac(50 ml)。先Μ鹽水再M5%aq.NaHC〇3 萃取溶液。MNa2SO4乾燥有機層並於減壓下濃縮。殘餘物 在閃蒸Si〇2管柱(30g/Et0Ac)中純化以獲得化合物2’R-(二 乙基)硫磷酸酯史賓諾辛Η ; 84 mg,27%CI MS m/z 878 ( M + l) ; UMR (CDC13) δ 6·74(1Η,bs),4·80(1Η,m), 4.22(4H,2X CH2,m),1·30(6Η,2X CH3,m) 〇 管胞例A 9 -2 ’ -Π- (Z某)Z二硫基中窨諾辛H 將化合物史賓諾辛Η (720 mg,1.003 mmol)溶於乾二 氯乙烷(15 ml)。加入DMAP (二異戊基甲基膦酸鹽,80 mg ),接著加入乾三乙胺(2 ml)。在室溫及氮氣下攪拌反應 混合物。加入乙基乙二醯基氯化物(1 ml)。於攪拌1小時 後,Μ甲苯(50 ml)及EtO Ac (100ml)稀釋反應混合物。將 溶液連續Μ鹽水、5%aq.NaHC〇3(3x ),及水(IX )清洗。 WMa2C〇3乾燥有機層並於減壓下濃縮。殘餘物在閃蒸Si〇2 管柱(110 g/Et0Ac)中純化以獲得化合物史賓諾辛Η之2,- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) C— (請先閱讀背面之注意事項再填寫本頁) 訂 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(5〇 ) 0-(乙基)乙二醯基史賓諾幸Η ; 668rog,81%CI MS m/z81 8(M+1) ; i-HMR (CDC13) δ 6.69(1H , bs) , 5·22(1Η , dd :3.0,1.8 Hz),4·27(2Η,q : 7.2 Hz),1·29(3Η,t ·· 7.2 Hz);元素分析:對CuHs 7 NO! 3估計值:C 64.60,H 8.26,N 1.71 ;實際值:C64.63,Η 8·41,N 1,80。The compound spinoxin IX (261 mg, 0.364 mmol) was dissolved in dry pyridine (3 ml). DMAP (diisoamylmethylphosphonate, 60 rag) was added followed by diethyl chlorothiophosphate (152 mg, 125αζ 1, 0.80 rarool). The reaction mixture was stirred at room temperature under nitrogen. After 12 hours, toluene (5 ^ ml) and Et0Ac (50 ml) were added. The solution was extracted with M brine and then M5% aq. NaHC03. The organic layer was dried over MNa2SO4 and concentrated under reduced pressure. The residue was purified in a flashed SiO 2 column (30 g / Et0Ac) to obtain the compound 2'R- (diethyl) thiophosphate spinoxin; 8.4 mg, 27% CI MS m / z 878 ( M + l); UMR (CDC13) δ 6.74 (1Η, bs), 4.80 (1Η, m), 4.22 (4H, 2X CH2, m), 1.30 (6Η, 2X CH3, m). Example of tracheid A 9 -2 '-Π- (Z) Z dithio in hydraxin H The compound spinoxin IX (720 mg, 1.003 mmol) was dissolved in dry dichloroethane (15 ml). DMAP (diisoamylmethylphosphonate, 80 mg) was added, followed by dry triethylamine (2 ml). The reaction mixture was stirred at room temperature under nitrogen. Ethyl ethylenedifluoride chloride (1 ml) was added. After stirring for 1 hour, the reaction mixture was diluted with M toluene (50 ml) and EtO Ac (100 ml). The solution was washed successively with M saline, 5% aq. NaHC03 (3x), and water (IX). The WMa2CO3 organic layer was dried and concentrated under reduced pressure. The residue was purified in a flashed Si0 2 column (110 g / Et0Ac) to obtain the compound Spinoloxine 2-This paper size applies the Chinese National Standard (CNS) Α4 size (210X297 mm) C— ( Please read the notes on the back before filling this page) Order 487559 Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of the invention (50) 0- (ethyl) ethoxybenzyl Spinolox; 668rog 81% CI MS m / z81 8 (M + 1); i-HMR (CDC13) δ 6.69 (1H, bs), 5.22 (1Η, dd: 3.0, 1.8 Hz), 4.27 (2Η, q : 7.2 Hz), 1 · 29 (3Η, t ·· 7.2 Hz); Elemental analysis: CuHs 7 NO! 3 Estimated value: C 64.60, H 8.26, N 1.71; Actual value: C64.63, Η 8.41 , N 1,80.

窨脓例Α10-2’-Π-三氡乙醯基中窨諾辛H 將化合物史賓諾辛Η (295 mg,0.411 mmol)溶於乾吡 啶(5 ml)。加入三氯乙醯基氯化合物(1 ml,過量)及在室 溫及氮氣下攪拌反應混合物14小時。加入甲苯(50 ml)及 Et0Ac(50 ml)。M5%aq.NaHC〇3萃取溶液。MNa2S〇4乾燥 有機層並於減壓下濃縮。殘餘物在閃蒸Si〇2管柱(60g/ EtOAc)中純化以獲得化合物2 ’ -0-三氯乙醯基史賓諾辛Η ;249 mg,70%CI MS m/z 866 (M + 5),862 (M + 1) ; LR (CDCla) δ 6·70(1Η,bs),5.18(1H,/dd : 2·2,1,8Hz) ,2.16(6Η,2x CH3,s) 〇 啻)fe例A 11-2’_Π-氡7,醮某中客諾卒Η 將化合物史賓諾辛Η (306 mg,0.43 ππηοΐ)溶於乾吡 啶(5 ml)。逐滴加入氯化氯乙醯(0.50 ml)。在室溫及氮 氣下撹拌反應混合物。於3小時後,加入甲苯(50 ml)及 Et0Ac(50 ml)。連續Μ鹽水、5%aq,NaHC〇3及水清洗溶液 。以2^匕^25〇4乾燥有機層並於減壓下濃縮。殘餘物在閃 蒸Si〇2管柱(80s/Et0Ac)中純化以提供化合物2’-0-氯乙醯 基史賓諾辛 Η ; 71 mg,21% HMR (CDC13)36,72(1H ,bs),5· 16 (1H,dd : 2.2*,1.8 Hz),3,69 (2H,bs); - 53 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) r--^抑衣------1T----- (請先閱讀背面之注意事項再填寫本頁) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(51 ) &quot;C-NMR(CDCl3) d 169.9('C = 0),41·4 (-CH2Cl)PPin。 甯敝例A 12- (3 ’R )-2夂酮基-3 甲氬基-3 ’ -(硫甲基)甲某 中客諾辛Η_ 將化合物史賓諾辛Η (3.10 g,4.32 irnnol)溶於乾 DMS0(8 ml)。在室溫及氮氣下攪拌此混合物及加入三乙胺 (3 g,7當量),並接著加入Py-S〇3錯合物(2·06 s,12·9 mmol)。在室溫下攪拌反應混合物14小時。加入甲苯(100 ml)及 Et0Ac(100 ml)。連縝 Μ 鹽水、5%aq.NaHC〇3 及水萃 取溶液。M K2C〇3乾燥有機層並於減壓下濃縮。殘餘物在 閃蒸Si〇2管柱(Si〇2/EtOAc)中純化及接著藉由HPLC在逆相 C-18管柱Μ 10%水之甲醇溶液作為移動相進行分離。所獲 得之純溶析份經蒸發可提供化合物(3’R)-2’-酮基-3’-甲 氧基-3’-(硫甲基)甲基史賓諾辛Η ; 697 mg,39% IR ν 1738、1721、1661、1038 cnrhEI MS m/z 776 (M + ); ^H-NMR (CDC13) 5 6.71UH,bs),3·99(1Η,m : Wh/2 = 18 Hz),3.53(3H,CH3,s),3·36(3Η,CH3,s),2.19(6H, 2x CH3,bs),2.08(3H,CH3,s) 〇 啻施例A 13-2 醢某-2’-表中窨諾垒H及2’-宪中窨 諾辛Η_ 將化合物2’-酮基史賓諾辛Η (2.95 g,4.12 mmol)溶 於乾Et2〇(60 ml)。將溶液於氮氣下冷卻至0°C及加入Li(T -BuO)3A1H(97%,1·62 g,6Λ8 mmol,1·5當量)。在0T 下持續攪拌20分鐘。將反應混合物以鹽水小心地驟冷。加 入乙醚(50 ml)並使相分離。M5%aq.NaHC〇3(4x )清洗有 — -54 · 本紙張尺度適用中關家標準(CNS ) A4規格(210X 297公慶)Symptoms A10-2'-Π-Trisinoacetamidine Inoxin H was dissolved in Spinoxin (295 mg, 0.411 mmol) in dry pyridine (5 ml). Trichloroacetamido chloride compound (1 ml, excess) was added and the reaction mixture was stirred at room temperature under nitrogen for 14 hours. Add toluene (50 ml) and Et0Ac (50 ml). M5% aq. NaHC03 extraction solution. The organic layer was dried over MNa2SO4 and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (60 g / EtOAc) to obtain compound 2'-0-trichloroethinyl spinosinoxine; 249 mg, 70% CI MS m / z 866 (M + 5 ), 862 (M + 1); LR (CDCla) δ 6.70 (1Η, bs), 5.18 (1H, / dd: 2.2, 1, 8Hz), 2.16 (6Η, 2x CH3, s) 〇 啻) Fe case A 11-2'_Π- 氡 7, a certain sinosome Η Η The compound spinoxin Η (306 mg, 0.43 ππηοΐ) was dissolved in dry pyridine (5 ml). Add chloroacetamidine (0.50 ml) dropwise. The reaction mixture was stirred at room temperature under nitrogen. After 3 hours, toluene (50 ml) and Et0Ac (50 ml) were added. Continuous M saline, 5% aq, NaHC03 and water washing solution. The organic layer was dried over 2 × 25 × 4 and concentrated under reduced pressure. The residue was purified in a flashed Si02 column (80s / Et0Ac) to provide compound 2'-0-chloroethenylspinoxine; 71 mg, 21% HMR (CDC13) 36, 72 (1H, bs ), 5.16 (1H, dd: 2.2 *, 1.8 Hz), 3,69 (2H, bs);-53-This paper size applies to China National Standard (CNS) A4 (210X 297 mm) r-- ^ Yi ------ 1T ----- (Please read the notes on the back before filling out this page) 487559 Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (51) &quot; C-NMR (CDCl3) d 169.9 ('C = 0), 41.4 (-CH2Cl) PPin. Example A 12- (3 'R) -2 fluorenone-3 methylarginyl-3'-(thiomethyl) methoxoloxinol _ The compound spinoxinol (3.10 g, 4.32 irnnol ) Dissolved in dry DMS0 (8 ml). This mixture was stirred at room temperature under nitrogen and triethylamine (3 g, 7 eq.) Was added, followed by Py-S03 complex (2.06 s, 12.9 mmol). The reaction mixture was stirred at room temperature for 14 hours. Add toluene (100 ml) and Et0Ac (100 ml). Flail Μ saline, 5% aq. NaHC03 and water extraction solution. The organic layer was dried over MK2CO3 and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (SiO 2 / EtOAc) and then separated by HPLC on a reverse phase C-18 column M 10% water in methanol as a mobile phase. The obtained pure eluate was evaporated to provide compound (3'R) -2'-keto-3'-methoxy-3 '-(thiomethyl) methyl spinosinol; 697 mg, 39% IR ν 1738, 1721, 1661, 1038 cnrhEI MS m / z 776 (M +); ^ H-NMR (CDC13) 5 6.71UH, bs), 3.99 (1Η, m: Wh / 2 = 18 Hz ), 3.53 (3H, CH3, s), 3.36 (3Η, CH3, s), 2.19 (6H, 2x CH3, bs), 2.08 (3H, CH3, s) 〇 Example A 13-2 醢 some -2'-Epicyclic Nuo Barrier H and 2'-Xuanzhong Nuo Xinxin _ The compound 2'-keto-spinoxin (2.95 g, 4.12 mmol) was dissolved in dry Et20 (60 ml). The solution was cooled to 0 ° C under nitrogen and Li (T-BuO) 3A1H (97%, 1.62 g, 6Λ8 mmol, 1.5 equivalents) was added. Stir for 20 minutes at 0T. The reaction mixture was carefully quenched with brine. Ether (50 ml) was added and the phases were separated. M5% aq.NaHC〇3 (4x) Cleaning Yes — -54 · This paper size is applicable to Zhongguanjia Standard (CNS) A4 specification (210X 297 public holidays)

經濟部中央標準局員工消費合作社印製 487559 A7 * B7_ , 五、發明説明(52 ) 機層,Manh.K2C〇3乾燥省機層並於減壓下濃縮。殘餘物 在閃蒸Si〇2管柱(Si〇2/EtOAc)中純化。因此可獲得在氧化 矽或藉由HPLC在018/乙腈-MeOH-水(60-30-10)上未分離 之2’-差向異構體醇。將2’-醇類(1.84 g,2.56 mmol)溶 於乾 CH2C12 (10 ml)。加人吡啶(5 ml)及 DMAP(80 mg),接 著加入Ac 2 0(3 ml,過量)。在室溫及氮氣下攪拌8小時。 MEtOAc (50 ml)及苯(50 ml)稀釋反應混合物。溶液連續 Μ 鹽水(2X )及5%aq.NaHC〇3(2X )清洗。MNazSO* 乾燥有 機層及在減壓下濃縮。殘餘物在閃蒸Si〇2管柱中曆析(230 -400 m,120 g/EtOAc)M 獲得純化合物 a)2’-〇-乙醯基-2’ -表史賓諾辛 Η ; 1.176 g,60%,iH-NMR (CDC13)56.67 (1H,bs),4·83(1Η,d: 3.8 Hz),4.52(1H,dd: 10.0, 3·8 Hz),3·47(6Η,2XCH3,s),2·14(6Η,2XCH3,s) ,2·01(3Η,CH3,s)ppm。加入化合物 2’-0-乙醯基-2’-表 -史賓諾辛 h (280 mg,0·368 mmol)溶於EtOH(5ml),及接 著加入10% CO 3溶液(3 ml)。在室溫及氮氣下攪拌反 應混合物15分鐘。加入鹽水(10 ml),接著加入EtOAc (50 ml)nhe PhH(50 ml)。使相分離。Μ水(3X)清洗有機層, MK2C〇3乾燥並於減壓下濃縮。殘餘物閃蒸Si〇2管柱(80 g /EtOAc)中純化K獲得化合物b)2’-表-史賓諾辛Η ; 228mg •86% ^-NMRiCDClajSe.eTdH^bsi^.eSdH^S.eHz ),3.55(3H,CH3,s),3·46(3Η,CH3,s) , 2·14(6Η, CH3 , s)ppm ; 13C-NMR(CDCl3) 5 203.2 、 172.9 、 147·9 。 144·7、144.5、129.7、120·3、103.9、97.6、86.1、 -55 - 本紙張尺度適用中國國家標隼(CNS ) A4規格(21〇X 297公釐) ^ 裝 訂 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作衽印製 487559 kl ______ B7_ , 五、發明説明(53 ) 84·9、81·1、77·3、77.卜 74·1、73.0、67.6、65.4、 61.3、61·1、49·8、48·2、48.1、46·5、42·0、41·7、 41·2(2Χ C) , 37,9、 37·0、 34·8 、 34·6 、 31·4、 30·6、 28·9、22·2、19.5、18.9、18.2、16.6、9,9ρρπι。 啻施例Α14-2Ό-三田甚砂烷基史賓諾辛Η_ 將化合物史賓諾辛Η (1.59 g,2.21 nunol)溶於 CH2C12(10 ml)並加入DMAP(0.80 g)。在室溫及氮氣下搜 拌此混合物。將TMS三氟甲基磺酸鹽(0.90 ml,過量)經由 注射針筒緩緩導入混合物中並持續攪拌1小時。加入EtOAc (50ml)及 PhH(50 ml)。M5%aq.NaHC〇3(3x )清洗溶液。 MK2C〇3乾燥有機層並於減壓下濃縮。殘餘物在閃蒸Si〇2 管柱(100 g/EtOAc)中純化Μ獲得化合物二甲基矽烷 基史賓諾辛 Η ; 1.615 s,92% m.P.=163°C (EtzO) ; EI MS 791(M+) ; 4-NMR (CDC13) δ 6·69(1Η , bs) , 3·81(1Η ,dd : 2.6 , 2,0Hz) , 3·46(3Η , CHa , s) , 3·38(3Η , CH3 ,s),2」6(6H,2X CH3,bs)ppm 〇 管遍例A 15-2’-0-乙甚中窨諾辛H_ _將化合物史賓諾辛H (2.21 g,3.08 mmol)溶於 CH2C12(60 ml),加入10%Na0H水溶液(25 1111)及1(2(:〇3固 體(5g),接著加入硫酸二乙酯(8 ml,過量)。在室溫及氮 氣下剌烈攬拌反應混合物48小時。加入H2〇(50 ml)及 CH2Cl2(50inl),使相分雛,有機層ΜΗ2〇(2Χ)清洗,K K2C〇3乾燥並於減壓下濃縮。殘餘物在閃蒸5丨〇2管柱層析( 230-400ιη,250 g/Et0Ac)中分離。純溶析份可提供化合物 -56 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(2ΚΓΧ 297公釐) -裝-- (請先閲讀背面之注意事項再填寫本頁)Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 * B7_, V. Description of the invention (52) Machine layer, Manh. K2C03 dried the machine layer and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (SiO 2 / EtOAc). It is thus possible to obtain 2'-epimeric alcohols which are not separated on silica or by HPLC on 018 / acetonitrile-MeOH-water (60-30-10). 2'-Alcohols (1.84 g, 2.56 mmol) were dissolved in dry CH2C12 (10 ml). Add human pyridine (5 ml) and DMAP (80 mg), followed by Ac 2 0 (3 ml, excess). Stir at room temperature under nitrogen for 8 hours. The reaction mixture was diluted with MEtOAc (50 ml) and benzene (50 ml). The solution was washed successively with M saline (2X) and 5% aq. NaHC03 (2X). MNazSO * The organic layer was dried and concentrated under reduced pressure. The residue was elutriated (230-400 m, 120 g / EtOAc) in a flashed Si02 column to obtain the pure compound a) 2'-〇-ethylamyl-2'-epispinoxin; 1.176 g, 60%, iH-NMR (CDC13) 56.67 (1H, bs), 4.83 (1Η, d: 3.8 Hz), 4.52 (1H, dd: 10.0, 3 · 8 Hz), 3.47 (6Η, 2XCH3, s), 2.14 (6Η, 2XCH3, s), 2.01 (3Η, CH3, s) ppm. Compound 2'-0-Ethyl-2'-epi-Spinoxin h (280 mg, 0.368 mmol) was added to dissolve in EtOH (5 ml), followed by 10% CO3 solution (3 ml). The reaction mixture was stirred at room temperature under nitrogen for 15 minutes. Brine (10 ml) was added, followed by EtOAc (50 ml) nhe PhH (50 ml). The phases are separated. The organic layer was washed with M water (3X), dried over MK2CO3 and concentrated under reduced pressure. The residue was purified by flash distillation in a Si02 column (80 g / EtOAc) to obtain compound b) 2'-epi-Spinoxin; 228 mg • 86% ^ -NMRiCDClajSe.eTdH ^ bsi ^ .eSdH ^ S. eHz), 3.55 (3H, CH3, s), 3.46 (3Η, CH3, s), 2.14 (6Η, CH3, s) ppm; 13C-NMR (CDCl3) 5 203.2, 172.9, 147.9. 144 · 7, 144.5, 129.7, 120 · 3, 103.9, 97.6, 86.1, -55-This paper size is applicable to China National Standard (CNS) A4 (21 × X 297 mm) ^ Binding (please read the first Please fill in this page again for attention) Printed by the Central Bureau of Standards of the Ministry of Economic Affairs for consumer cooperation 487559 kl ______ B7_, V. Description of the invention (53) 84 · 9, 81.1, 77 · 3, 77. Bu 74 · 1, 73.0 , 67.6, 65.4, 61.3, 61.1, 49 · 8, 48 · 2, 48.1, 46 · 5, 42.0, 41.7, 41.2 (2 × C), 37, 9, 37 · 0, 34 · 8, 34 · 6, 31.4, 30 · 6, 28 · 9, 22.2, 19.5, 18.9, 18.2, 16.6, 9,9ρριι.啻 Example A14-2Ό-Sandasinyl SpinolsinΗ The compound SpinolsinΗ (1.59 g, 2.21 nunol) was dissolved in CH2C12 (10 ml) and DMAP (0.80 g) was added. This mixture was searched at room temperature under nitrogen. TMS trifluoromethanesulfonate (0.90 ml, excess) was slowly introduced into the mixture via a syringe and kept stirring for 1 hour. EtOAc (50 ml) and PhH (50 ml) were added. M5% aq. NaHC03 (3x) washing solution. The organic layer was dried over MK2CO3 and concentrated under reduced pressure. The residue was purified in a flashed Si02 column (100 g / EtOAc) to obtain the compound dimethylsilyl spinosynoxine; 1.615 s, 92% mP = 163 ° C (EtzO); EI MS 791 (M + ); 4-NMR (CDC13) δ 6.69 (1Η, bs), 3.81 (1Η, dd: 2.6, 2,0Hz), 3.46 (3Η, CHa, s), 3.38 (3Η, CH3, s), 2 "6 (6H, 2X CH3, bs) ppm 〇 Tube example A 15-2'-0-Ethyl acetonoxin H_ _ the compound Spinoxin H (2.21 g, 3.08 mmol ) Soluble in CH2C12 (60 ml), add 10% aq. NaOH solution (25 1111) and 1 (2 (: 03 solid (5 g), followed by diethyl sulfate (8 ml, excess). At room temperature under nitrogen The reaction mixture was stirred vigorously for 48 hours. H2O (50 ml) and CH2Cl2 (50 inl) were added, the phases were separated, the organic layer was washed with MgSO 2 (2 ×), dried with K 2 CO 3 and concentrated under reduced pressure. The residue It was separated by flash column 5 230 (250-400 μm, 250 g / Et0Ac). Pure eluent can provide compound -56-this paper size is applicable to China National Standard (CNS) A4 size (2KΓ × 297) Li)-Pack-(Please read the precautions on the back before filling this page)

、1T 會 487559 A7 ___ B7 _ ' 五、發明説明(54 ) 2,-0-乙基史賓諾辛 Η ; 63¾ mg, 28¾ Cl MS ra/z 746 (M + 1); iH-HMR(CDCl3)56.71(lH, bs), 3.61(2H, CH2, ra), 3·49(3Η, CH3, s), 3·42(3Η, CH3, s), 2·17(6Η, 2xCHa ,s), 1.18 (3H, CHa, t:7*0 Hz)ppm; 13C-NMR (CDC13) δ67·0( - CH2-),16.0(-CH3)ppm; C42HB7N〇1〇 之元素分析 :估計值:C 67.61, Η 9·07, N 1·88;實際值:C 67.80 ,Η 1.87, N9.20 〇 罗嫵例A16-中窨諾辛1^夕(2’R)-(乙基)碳_ 經濟部中央標準局員工消費合作社印製 I ^--衣-- (請先閱讀背面之注意事項再填寫本頁) # 將三苯基膦(6,5 g,24.8 mmol)溶於乾THF(30 ml)中 。添加二乙基偶氮二羧酸酯(4.8 ml · 5.32 g,30.5 mmol )及在室溫下攪拌混合物5分鐘。加入純乙醇(1.43 ml ♦ 1. 14 g,24.8 mmol)。於再攪拌5分鐘後,導入化合物(1.20 g,1.67 mmol)。在室溫及氮氣下持續.攪拌24小時。加入 乙酸乙基酯(50 ml)及苯(100 ml)。K鹽水、5%a,q.NaHC 〇3(2X )及水(IX )連縯清洗溶液。MK2C〇3乾燥有機層並 於減壓下濃縮。殘餘物在閃蒸Si〇2管柱(120 g/EtOAc)中 分離Μ獲得史賓諾辛Η之物(2’R)-(乙基)碳酸酯化合物; 233 mg, 18¾ IR v 1747 &gt; 1720 &gt; 1645 &gt; 1263 cm'1; NMR(CDC13) δ 6.74(1H, bs), 4.95(1H, dd:3.3, 1,8 Hz) ,4·19 (2H, q:7.1 Hz)ppm; C43Hs7N0i2 之元素分析:估 計值:C 65·37, Η 8·55, ,Ν 1·97;實際值:C 65,44, Η 8·49, Μ 2·05 〇 管_例A 17-2 三氣甲碏醢某中窨諾辛Η_ 將史賓諾辛Η化合物(〗.12 g,2.95mmol)溶於乾1,2- _____ _ 57 _ 本紙張尺度適财關家縣(CNS ) A4規格(210X 297公楚) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(55 ) 二氯乙烷(3 ml)中。加入、〖t啶(3 ml)。在氮氣下將溶液冷 卻至Ot:。加入三氟甲磺酸酐(1.20 ral,7,0 mmol)。在授 拌1小時後,加入PhH(50 ml)及Et0Ac(100 ml)。溶液以5 %a.q.NaHC〇3(3x )清洗。MK2C〇3乾燥有機層並於減壓下 濃縮。殘餘物在閃蒸Si〇2管柱(160 g/EtOAc)中分離Μ獲 得2’-0_三氟甲磺基史賓諾辛Η ; 1.77 g,71%IR ν 1415 、1212、1068 及 918 cm·1; iH-NMIHCDClaMe^dH, bs ),4.93(1H,dd:2.8, 1·9 Hz)ppm。 管嫵例△18-2’-〇1-丙基中客諾垒1^_ 將化合物史賓諾辛Η (1.22 g,1.70 mmol)溶於 CH2C12(20 ml)並加入25%NaOH水溶液(15 ml),接著加入 K2 CO 3 (2 g)、四丁基銨氯化物(1.2 g)及苄基三乙基銨氯 化物(1.5 g)。加入1-碘丙烷(10 ml)及在室溫及氮氣下劇 烈攪拌反應混合物48小時。加入CH2C 12(20 ml)並使相分 離。將有機層Μ水(2X )清洗,以K2C〇3乾燥並於減壓下濃 縮。殘餘物在閃蒸5丨〇2管柱層析(120 g/EtOAc)中分離。 純溶析份之濃縮物可提供化合物2f-0-n-丙基史賓諾辛Η ;535 mg, 41¾) 1H-NMR (CDC 13) δ 6.67 (1H, bs), 2.13( 6H, 2xCH3, x), 0·81 (3H, CH3, t:7.4 Hz)ppm; CuHwNOiD之元素分析:估計值:C 67.95, H 9.15, N 1·84;實際值:C 67.74, ,H9.37, H 1,84。 管淪例A 19-2夂〇1-戍基中IT諾垒Η_ 將化合物史賓諾辛Η (1.02 g,1.42 mmol)溶於 _________________- RO _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ------^裝------訂----- 费J丨丨 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 _____ B7 五、發明説明(56 ) CH2C12(20 ml)並加入25%、aOH水溶液(15 ml),接著加入 K2CO 3(3.5 g)、四丁基銨氯化物(0.8 g)及苄基三乙基銨 氯化物(1.3 g)。加入1-碘丙烷(15 ml)及在室溫及氮氣下 劇烈攬拌反應混合物72小時。加入CH2C 12(20 ml)並使相 分離。將有機層K水(3X )清洗,以1(2(:〇3乾燥並於減壓下 濃縮。殘餘物在閃蒸$丨〇2管柱層析(200 g/EtOAc)中分離 。純溶析份之濃縮物可提供化合物2 ’ 戊基史賓諾辛 Η ’ 559 mg, 50% iH-NMR (CDCI3) δ 6.69 (1H, bs), 2·16 (6Η, 2χ CH3, s), 0.82 (3Η# CH3, t: 7·4 Hz) ppm; Elemental Analysis: for C45H73NO10 calc. C 68.58, H 9.34, N 1.78; found C 68.29, H 9.32, N 1.80. 審浦Γ例A 苄基中W諾辛H_;_ 將化合物史賓諾辛H (1.48 g,2,06 mmol)溶於 CH2C12 (20 ml)並加入25%NaOH水溶液(15 ml),接著加入 K2 CO a (3 g)、四丁基銨氯化物(0.85 g)及苄基三乙基銨氯 化物(1.2 g)。加入氯化苄基(10 ml)及在室溫及氮氣下劇 烈攪拌反應混合物72小時。加入CH2C12(20 ml)並使相分 離。將有機層Μ水(3X )清洗,MK2C〇3乾燥並於減壓下濃 縮。殘餘物在閃蒸Si〇2管柱層析(200 g/Et0Ac)中分離。 純溶析份之濃縮物可提供化合物2’-0-¥基史賓諾辛Η ; 806 mg, 48% iH-NMR (CDC13) δ 7.,24 (5Η, m), 6.67 (1H, bs), 4·62 (2Η, m) , 3.60 (1H, dd: 2.5, 1.6 Hz), 2.14 (6H, 2x CH3, s) ppm; Elemental Analysis : for C47H69NO10 calc. C 69.86, H 8.61, N 1.73; found C 69.78, H 8.93, N 1.81. __-59 -__ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ϊ AW· 1T (請先閱讀背面之注意事項再填寫本頁) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(57 ) 管_例八21-2’-0-7,醢某中客諾辛Q_ 將化合物史賓諾辛Q(11.0 mg,0.015 mmol)溶於乾 CH2CU(3 ml)。加入三乙胺(5 ml)。在室溫及氮氣下攪拌 溶液並加入Ac20 (0.70 ml,過量)。於20小時後,加入EtO Ac(50 ml)及 PhH(20 ml)。Μ 鹽水、5%a.q.NaHC〇3 (4X ) 及水(lx )連續清洗溶液。MK2C〇3乾燥有機層並於減壓下 濃縮。殘餘物在閃蒸Si〇2管柱(5 g/EtOAc)中純化Μ獲得 化合物2’-0-乙醯基史賓諾辛d ; 11.0 mg, 95% iH-NMR (CDCI3) δ 6.74 (1H, bs), 5.46 UH, bs), 5·13 (1H, dd: 2.4, 1.8 Hz), 2.02 (3H, CH3, s), 1.70 (3H, CH3, bs) ppm. 管胞例A 22_3’-0-n_丙某中客諾辛J_ 將化合物史賓諾辛J (331 mg,0.433 mmol)溶於 CH2C12(10 ml)並加入15%NaOH水溶液(5 ml),接著加入 K2 CO 3(0.70 g)、四丁基銨氯化物(0.3 g)及苄基三乙基銨 氯化物(0.83 g)。加入卜碘丙烷(4.0 ml)及在室溫及氮氣 下劇烈攪拌反應混合物48小時。加入CH2C12 (50 ml)及水( 50 ml)並使相分離。將有機餍Μ水(2X )清洗,MK2C03乾 燥並於減壓下濃縮。殘餘物在閃蒸Si〇2管柱(80 g/EtOAc) 中純化。純溶析份之濃縮物可提供化合物丙基史 賓諾辛 J ; 156 mg » 86¾ ^-HMR (CDCla) δ 6.65 (1Η, bs), 2.11 (6H, 2x CH3, s), 0.84 (3H, CH3, t: 7.3 Hz) ppm; 13C-NMR (CDCI3) δ72·4 (0-CH2-), 23.8 (-CH2-), 11.2 (CH3) ppm. 當腋例A 23-3 基史賓諾辛J__ -60 - 本紙張尺度適用中國國家標準(CNS ) M規格(21〇X 297公釐) -------il?----i-----· (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 ^ __ B7____ 五、發明説明(58 ) 將化合物史賓諾辛J (747 mg,1.04 mmol)溶於 CH2C12(20 ml)並加入15%NaOH水溶液(10 ml),接著加入 K2C〇3(1.10 g)及苄基三乙基銨氯化物(1·2 g)。加入1-碘 乙烷(5.5 ml)及在室溫及氮fc下劇烈攬拌反應混合物48小 時。加入CH2C12 (50 ml)及水(50 ml)並使相分離。將有機 層Μ水(2X )清洗,MK2C〇3乾燥並於減壓下濃縮。殘餘物 在閃蒸Si〇2管柱(100 g/EtOAc)中純化。純溶析份之濃縮 物可提供a)化合物史賓諾辛J (192 mg)及b)化合物3’-0_ 乙基史賓諾辛J ; 401 mg, 70% 1H-NMR (CDCI3) δ 6.65 (1Η, bs), 3.53 (2H, q: 7.2 Hz), 2.12 (6H, 2x CH3, s), 1·14 (3H, CH3, t:7.2 Hz) ppm; 13C-NMR (CDCI3) δ 66·1、 1T meeting 487559 A7 ___ B7 _ 'V. Description of the invention (54) 2, -0-ethylspinoxine Η; 63¾ mg, 28¾ Cl MS ra / z 746 (M + 1); iH-HMR (CDCl3) 56.71 (lH, bs), 3.61 (2H, CH2, ra), 3.49 (3Η, CH3, s), 3.42 (3Η, CH3, s), 2.17 (6Η, 2xCHa, s), 1.18 (3H, CHa, t: 7 * 0 Hz) ppm; 13C-NMR (CDC13) δ67 · 0 (-CH2-), 16.0 (-CH3) ppm; Elemental analysis of C42HB7N010: Estimated value: C 67.61, Η 9 · 07, N 1 · 88; actual value: C 67.80, Η 1.87, N9.20 妩 Example A16-Nonoxin 1 ^ (2'R)-(ethyl) carbon _ Central Ministry of Economy Printed by the Bureau of Consumers of the Bureau of Standards I ^-clothing-(Please read the notes on the back before filling this page) # Dissolve triphenylphosphine (6,5 g, 24.8 mmol) in dry THF (30 ml) in. Diethyl azodicarboxylate (4.8 ml · 5.32 g, 30.5 mmol) was added and the mixture was stirred at room temperature for 5 minutes. Add pure ethanol (1.43 ml ♦ 1. 14 g, 24.8 mmol). After stirring for another 5 minutes, the compound (1.20 g, 1.67 mmol) was introduced. Continue at room temperature under nitrogen. Stir for 24 hours. Add ethyl acetate (50 ml) and benzene (100 ml). K brine, 5% a, q. NaHC 03 (2X) and water (IX) successively washing solution. The organic layer was dried over MK2CO3 and concentrated under reduced pressure. The residue was separated in a flash SiO 2 column (120 g / EtOAc) to obtain Spinoloxine (2'R)-(ethyl) carbonate compound; 233 mg, 18¾ IR v 1747 &gt; 1720 &gt; 1645 &gt; 1263 cm'1; NMR (CDC13) δ 6.74 (1H, bs), 4.95 (1H, dd: 3.3, 1,8 Hz), 4.19 (2H, q: 7.1 Hz) ppm; Elemental analysis of C43Hs7N0i2: Estimated value: C 65 · 37, Η 8.55,, Ν 1.97; Actual value: C 65,44, Η 8.49, Μ 2 · 05 〇 Example A 17-2 III Pneumocarbamate, a medium carbamoxicin, _ Dissolve the spinocinol compound (〗. 12 g, 2.95 mmol) in dry 1, 2- _____ _ 57 _ This paper is suitable for Guancai County (CNS) A4 specifications (210X 297 Gongchu) 487559 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (55) in dichloroethane (3 ml). Add, tidine (3 ml). The solution was cooled to Ot: under nitrogen. Trifluoromethanesulfonic anhydride (1.20 ral, 7,0 mmol) was added. After 1 hour of incubation, PhH (50 ml) and Et0Ac (100 ml) were added. The solution was washed with 5% a.q. NaHC03 (3x). The organic layer was dried over MK2CO3 and concentrated under reduced pressure. The residue was separated in a flash SiO 2 column (160 g / EtOAc) to obtain 2'-0_trifluoromethanesulfinospinoxine; 1.77 g, 71% IR ν 1415, 1212, 1068, and 918 cm · 1; iH-NMIHCDClaMe ^ dH, bs), 4.93 (1H, dd: 2.8, 1.9 Hz) ppm. Example of tube △ 18-2'-〇1-propyl in the nucleus 1 ^ _ The compound spinoxin (1.22 g, 1.70 mmol) was dissolved in CH2C12 (20 ml) and 25% NaOH aqueous solution (15 ml), followed by K2CO3 (2 g), tetrabutylammonium chloride (1.2 g) and benzyltriethylammonium chloride (1.5 g). 1-iodopropane (10 ml) was added and the reaction mixture was stirred vigorously at room temperature under nitrogen for 48 hours. CH2C 12 (20 ml) was added and the phases were separated. The organic layer was washed with water (2X), dried over K2CO3 and concentrated under reduced pressure. The residue was separated by flash column chromatography (120 g / EtOAc). Concentrate of pure solubilized fractions can provide compound 2f-0-n-propyl spinosynoxine; 535 mg, 41¾) 1H-NMR (CDC 13) δ 6.67 (1H, bs), 2.13 (6H, 2xCH3, x ), 0 · 81 (3H, CH3, t: 7.4 Hz) ppm; Elemental analysis of CuHwNOiD: Estimated value: C 67.95, H 9.15, N 1.84; Actual value: C 67.74,, H9.37, H 1, 84. Case No. A 19-2 夂 〇1- 戍 基 的 诺诺 ΗΗ Dissolve the compound Spinoloxine (1.02 g, 1.42 mmol) in _________________- RO _ This paper size applies Chinese National Standard (CNS) A4 Specifications (210X 297mm) ------ ^ Installation ------ Order ----- Fee J 丨 丨 (Please read the precautions on the back before filling this page) Staff of Central Bureau of Standards, Ministry of Economic Affairs Printed by the consumer cooperative 487559 A7 _____ B7 V. Description of the invention (56) CH2C12 (20 ml) and added 25%, aOH aqueous solution (15 ml), followed by K2CO 3 (3.5 g), tetrabutylammonium chloride (0.8 g ) And benzyltriethylammonium chloride (1.3 g). 1-iodopropane (15 ml) was added and the reaction mixture was stirred vigorously at room temperature under nitrogen for 72 hours. CH2C 12 (20 ml) was added and the phases were separated. The organic layer was washed with K water (3X), dried over 1 (2: 0 and concentrated under reduced pressure. The residue was separated by flash column chromatography (200 g / EtOAc). Pure solvent Concentrate of the fraction can provide compound 2 'pentylspinoxine Η 559 mg, 50% iH-NMR (CDCI3) δ 6.69 (1H, bs), 2.16 (6Η, 2χ CH3, s), 0.82 ( 3Η # CH3, t: 7.4 Hz) ppm; Elemental Analysis: for C45H73NO10 calc. C 68.58, H 9.34, N 1.78; found C 68.29, H 9.32, N 1.80. Example A W Nosin in benzyl H _; _ The compound Spinoloxine H (1.48 g, 2,06 mmol) was dissolved in CH2C12 (20 ml) and 25% NaOH aqueous solution (15 ml) was added, followed by K2 CO a (3 g), tetrabutyl Ammonium chloride (0.85 g) and benzyltriethylammonium chloride (1.2 g). Add benzyl chloride (10 ml) and stir the reaction mixture vigorously at room temperature under nitrogen for 72 hours. Add CH2C12 (20 ml) The phases were allowed to separate. The organic layer was washed with water (3X), dried with MK2CO3 and concentrated under reduced pressure. The residue was separated by flash SiO2 column chromatography (200 g / Et0Ac). Pure dissolution Servings of the concentrate provide compound 2'-0- ¥ kispinoxine; 806 mg, 48% iH-NMR (CDC13) δ 7., 24 (5Η, m), 6.67 (1H, bs), 4.62 (2Η, m), 3.60 (1H, dd: 2.5, 1.6 Hz), 2.14 (6H, 2x CH3, s) ppm; Elemental Analysis: for C47H69NO10 calc. C 69.86, H 8.61, N 1.73; found C 69.78, H 8.93, N 1.81. __- 59 -__ This paper standard applies Chinese national standard ( CNS) A4 specification (210X 297 mm) ϊ AW · 1T (Please read the notes on the back before filling out this page) 487559 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (57) Regulations 221-2'-0-7, 醢 A Zhongke Nuoxin Q_ The compound Spinoxin Q (11.0 mg, 0.015 mmol) was dissolved in dry CH2CU (3 ml). Triethylamine (5 ml) was added. The solution was stirred at room temperature under nitrogen and Ac20 (0.70 ml, excess) was added. After 20 hours, EtO Ac (50 ml) and PhH (20 ml) were added. M saline, 5% a.q. NaHC03 (4X) and water (1x) were continuously washed. The organic layer was dried over MK2CO3 and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (5 g / EtOAc) to obtain the compound 2'-0-ethylspinoxin d; 11.0 mg, 95% iH-NMR (CDCI3) δ 6.74 (1H, bs), 5.46 UH, bs), 5.13 (1H, dd: 2.4, 1.8 Hz), 2.02 (3H, CH3, s), 1.70 (3H, CH3, bs) ppm. Trachea case A 22_3'-0 -n_ 丙 某 中 诺诺辛 J_ The compound Spinoxin J (331 mg, 0.433 mmol) was dissolved in CH2C12 (10 ml) and 15% NaOH aqueous solution (5 ml) was added, followed by K2 CO 3 (0.70 g ), Tetrabutylammonium chloride (0.3 g) and benzyltriethylammonium chloride (0.83 g). Add iodopropane (4.0 ml) and stir the reaction mixture vigorously at room temperature under nitrogen for 48 hours. Add CH2C12 (50 ml) and water (50 ml) and separate the phases. The organic 餍 M water (2X) was washed, the MK2C03 was dried and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (80 g / EtOAc). Concentrate of pure solubilized fractions can provide compound propyl spinosynoxin J; 156 mg »86¾ ^ -HMR (CDCla) δ 6.65 (1Η, bs), 2.11 (6H, 2x CH3, s), 0.84 (3H, CH3 , t: 7.3 Hz) ppm; 13C-NMR (CDCI3) δ72 · 4 (0-CH2-), 23.8 (-CH2-), 11.2 (CH3) ppm. When axillary case A 23-3 base Spinozin J__- 60-This paper size applies Chinese National Standard (CNS) M specification (21〇X 297mm) ------- il? ---- i ----- · (Please read the precautions on the back first Refill this page) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A7 ^ __ B7____ V. Description of the invention (58) The compound Spinoxin J (747 mg, 1.04 mmol) was dissolved in CH2C12 (20 ml) and added 15% NaOH aqueous solution (10 ml), followed by K2CO3 (1.10 g) and benzyltriethylammonium chloride (1.2 g). Add 1-iodoethane (5.5 ml) and stir the reaction mixture vigorously at room temperature under nitrogen fc for 48 hours. Add CH2C12 (50 ml) and water (50 ml) and separate the phases. The organic layer was washed with water (2X), dried over MK2CO3 and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (100 g / EtOAc). Concentrate of pure solubilized fractions can provide a) compound Spinoxin J (192 mg) and b) compound 3'-0_ ethylspinoxin J; 401 mg, 70% 1H-NMR (CDCI3) δ 6.65 ( 1Η, bs), 3.53 (2H, q: 7.2 Hz), 2.12 (6H, 2x CH3, s), 1 · 14 (3H, CH3, t: 7.2 Hz) ppm; 13C-NMR (CDCI3) δ 66 · 1

(〇一CH2_), 16.3 (CH3) ppm; Elemental Analysis: for C42H67NO10 calc. C 67.62, H 9.05, N 1.33; found C 67.91, H 9.33, M 2.00. 管胞例A 24-3’ -0-7,某中窨諾辛K___ 將化合物史賓諾辛K (30.6 mg,0.043 mmol)溶於 CH2C12(5 ml)。加入15%HaOH水溶液(5 ml),接著加入K2 C03 (0.300 g)及苄基三乙基銨氯化物(0.41 g)。加入1-碘 乙烷(2.0 ml)及在室溫及氮氣下劇烈攪拌反應混合物72小 時。加入CH2C12 (50 ml)及水(50 ml)並使相分離。將有機 層Μ水(2X )清洗,MK2C〇3乾燥並於減壓下濃縮。殘餘物 在閃蒸Si〇2管柱(10 g/EtO^c)中純化。純溶析份之濃縮物 可提供a)化合物(15.1 mg)及b)化合物3’-0_乙基史賓諾辛 K ; 5 · 5 mg,34% ) 1H-NMR (CDCI3) δ 6.72 (1Η, bs.) , 3.32 (1H, m) , 3.57 (2H, m) , 2.13 (6H, 2x CH3, s), 1.17 (3H, CH3, C: 7.3 Hz) ppm. (請先閱讀背面之注意事項再填寫本頁) -裝 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 487559 A7 ___^ B7 _ , 五、發明説明(59 ) 啻_例A 25-3 基中窨諾辛L_一 將化合物史賓諾辛L (330 mg,0.451 mraol)溶於 CH2C12 (15 ml)。加入20% NaOH水溶液(10 ml),接著加入 K2C〇3(1.30 g)及苄基三乙基銨氯化物(1.1 g)。加入1-碘 乙烷(5.0 ml)及在室溫及氮氣下劇烈攪拌反應混合物96小 時。加入CH2C12(50 ml)及水(50 ml)並使相分離。將有機 層Μ水(2X )清洗,MK2C〇3乾燥並於減壓下濃縮。殘餘物 在閃蒸Si〇2管柱(85 g/EtOAc)中純化。純溶析份之濃縮物 可提供化合物3’-0_乙基史賓諾辛L ; 127 mg, 37% 1H-NMR (CDCI3) δ 6.64 (1Η# bs), 5·37 (1Η, bs), 3·60 (1Η, m), 2·12 (6Η, 2XCH3, s), 1·17 (3Η, CH3, t: 7.4 Hz) ppm; 13C-NMR (CDCI3) δ 66·1 (0-CH2-), 16.3 (CH3) ppm. 富敝例A 26-3’-0-熥丙某中客諾卒J_ 將化合物史賓諾辛J (370 mg,0.515 ππποί)溶於 CH2C12(15 ml)。加入15%NaOH水溶液(10 ml),接著加入 K2C〇3(1.40 g)及苄基三乙基銨氯化物(0.98 g)。加入溴 化烯丙基(3.0 ml)及在室溫及氮氣下剌烈攪拌反應混合物 28小時。加入CH2C12(50 ml)及水(50 ml)並使相分離。將 有機層以水(2X )清洗,MK2C〇3乾燥並於減壓下濃縮。將 殘餘物溶於甲苯(10 ml)並加熱至迴流溫度10分鐘。使溶 液冷卻至室溫並於減壓下濃縮。殘餘物在閃蒸Si〇2管柱( 80 g/EtOAc)中純化。純溶析份之濃縮物可提供化合物3^ 〇-烯丙基史賓諾辛 J ; 121 mg, 31% iH-NMR (CDC13〉δ 6.67 (1H, bs), 5.77 (1Η, π\), 5.22 (1H, bd: 17.2 Hz) , 5.03 (1H, bd: 10.3 Hz), 4.07 (2H, bd: 4.2 Hz), 2.13 (6H, 2x CH3, s) ppm; Elemental Analysis: for C43H67NO10 calc. C 68.14, H 8.91, N 1.85; found C 63.38, H 9.10, N 1.77. (請先閱讀背面之注意事項再填寫本頁) 一裝- 訂 經濟部中央標準局員工消費合作社印製 487559 A7 ______^ B7 五、發明説明(6〇 ) 管細例A 27-3 钕丙甚中客諾辛J_ 將化合物史賓諾辛J (392 mg,0.546 mmol)溶於 CH2C12(15 ml)。加入15%HaOH水溶液(10 ml),接著加入 K2C〇3(1.50 g)及苄基三乙基銨氯化物(1·10 g)。加入溴 化炔丙基(溶於甲苯之80%溶液;4.0 ml)及在室溫及氮氣 下劇烈攬拌反應混合物40小時。加入CH2C12 (50 ml)及水( 50 ml)。使相分離。將有機層K水(2X )清洗,WK2C〇3乾 燥並於減壓下濃縮。將殘餘物溶於甲苯(10 ml)並加熱至 迴流溫度20分鐘。使溶液冷卻至室溫並於減壓下濃縮。殘 餘物在閃蒸Si〇2管柱(80 g/Et0Ac)中純化。純溶析份之濃 縮物可提供化合物3^0-炔丙基史賓諾辛J ; 138 mg, 33% λΗ-ΝΜΕ (CDCI3) δ 6.66 (1Η, bs), 4.22 (2H, m), 3.66 (1H, dd: 9.4, 3.3 Hz), 2.37 (1H, dd: 2.4, 2.4 Hz), 2.12 (6H, 2x CH3, s) ppm; Elemental Analysis: for C43H65NO10 calc. C 68.32, H 8.57, N 1.85; found C 63.39, H 8.62, N 1.75. 啻胞例A 28-3’-0-(環丙某)申某中窨諾辛J_ 將化合物史賓諾辛J (470 mg,0.655 mmol)溶於 CH2C12(10 ml)。加入15%NaOH水溶液(15 ml),接著加入 K2C〇3(1.50 g)及苄基三乙基銨氯化物(1.10 g)。加入(環 / 丙基)甲基溴化合物(.09 ml)及在室溫及氮氣下劇烈攪拌 反應混合物72小時。加入CH2C12 (50 ml)及水(50 ml)。使 相分離。將有機層Μ水(2 乂)清洗,MKzCO 3乾燥並於減壓(〇 一 CH2_), 16.3 (CH3) ppm; Elemental Analysis: for C42H67NO10 calc. C 67.62, H 9.05, N 1.33; found C 67.91, H 9.33, M 2.00. Cases A 24-3 '-0-7 In a certain sinomenoxin K___ The compound spinoxin K (30.6 mg, 0.043 mmol) was dissolved in CH2C12 (5 ml). A 15% aqueous solution of HaOH (5 ml) was added, followed by K2C03 (0.300 g) and benzyltriethylammonium chloride (0.41 g). Add 1-iodoethane (2.0 ml) and stir the reaction mixture vigorously at room temperature under nitrogen for 72 hours. Add CH2C12 (50 ml) and water (50 ml) and separate the phases. The organic layer was washed with water (2X), dried over MK2CO3 and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (10 g / EtO ^ c). Concentrate of pure solubilized fractions can provide a) compound (15.1 mg) and b) compound 3'-0_ethylspinoxin K; 5.5 mg, 34%) 1H-NMR (CDCI3) δ 6.72 (1Η , bs.), 3.32 (1H, m), 3.57 (2H, m), 2.13 (6H, 2x CH3, s), 1.17 (3H, CH3, C: 7.3 Hz) ppm. (Please read the precautions on the back first (Fill in this page again)-The paper size of this paper applies the Chinese National Standard (CNS) A4 (210X 297 mm). Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. 487559 A7 ___ ^ B7 _, 5. Description of the invention (59) _ Example A 25-3 Glucoxanthinololone-A compound Spinoloxin L (330 mg, 0.451 mraol) was dissolved in CH2C12 (15 ml). A 20% aqueous NaOH solution (10 ml) was added, followed by K2CO3 (1.30 g) and benzyltriethylammonium chloride (1.1 g). Add 1-iodoethane (5.0 ml) and stir the reaction mixture vigorously at room temperature under nitrogen for 96 hours. CH2C12 (50 ml) and water (50 ml) were added and the phases were separated. The organic layer was washed with water (2X), dried over MK2CO3 and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (85 g / EtOAc). Concentrate of pure solubilized fractions can provide compound 3'-0_ethylspinoxin L; 127 mg, 37% 1H-NMR (CDCI3) δ 6.64 (1Η # bs), 5.37 (1Η, bs), 3 · 60 (1Η, m), 2 · 12 (6Η, 2XCH3, s), 1 · 17 (3Η, CH3, t: 7.4 Hz) ppm; 13C-NMR (CDCI3) δ 66 · 1 (0-CH2- ), 16.3 (CH3) ppm. Enriched Example A 26-3'-0-Yan Bing, a sinomenox J_ The compound Spinoloxin J (370 mg, 0.515 ππποί) was dissolved in CH2C12 (15 ml). A 15% NaOH aqueous solution (10 ml) was added, followed by K2CO3 (1.40 g) and benzyltriethylammonium chloride (0.98 g). Bromoallyl (3.0 ml) was added and the reaction mixture was stirred vigorously at room temperature under nitrogen for 28 hours. CH2C12 (50 ml) and water (50 ml) were added and the phases were separated. The organic layer was washed with water (2X), dried over MK2CO3 and concentrated under reduced pressure. The residue was dissolved in toluene (10 ml) and heated to reflux temperature for 10 minutes. The solution was cooled to room temperature and concentrated under reduced pressure. The residue was purified in a flashed SiO 2 column (80 g / EtOAc). Concentrate of pure solubilized fractions can provide compound 3 ^ 〇-allyl Spinolsin J; 121 mg, 31% iH-NMR (CDC13> δ 6.67 (1H, bs), 5.77 (1Η, π \), 5.22 (1H, bd: 17.2 Hz), 5.03 (1H, bd: 10.3 Hz), 4.07 (2H, bd: 4.2 Hz), 2.13 (6H, 2x CH3, s) ppm; Elemental Analysis: for C43H67NO10 calc. C 68.14, H 8.91, N 1.85; found C 63.38, H 9.10, N 1.77. (Please read the precautions on the back before filling out this page) One Pack-Order Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 ______ ^ B7 V. Description of the invention (60) A detailed example of tube A 27-3 Neproxen J_ Norpin J_ Dissolve the compound Spinoxin J (392 mg, 0.546 mmol) in CH2C12 (15 ml). Add 15% HaOH aqueous solution (10 ml), followed by K2CO3 (1.50 g) and benzyltriethylammonium chloride (1 · 10 g). Added propargyl bromide (80% solution in toluene; 4.0 ml) and at room temperature The reaction mixture was stirred vigorously under nitrogen for 40 hours. CH2C12 (50 ml) and water (50 ml) were added. The phases were separated. The organic layer was washed with K water (2X), dried with WK2CO3 and concentrated under reduced pressure. The residue was dissolved in toluene (10 ml) and heated to reflux temperature for 20 minutes. The solution was cooled to room temperature and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (80 g / Et0Ac). The concentrate of the pure eluate can be Provide compound 3 ^ 0-propargyl Spinolsin J; 138 mg, 33% λΗ-ΝΜΕ (CDCI3) δ 6.66 (1Η, bs), 4.22 (2H, m), 3.66 (1H, dd: 9.4, 3.3 Hz ), 2.37 (1H, dd: 2.4, 2.4 Hz), 2.12 (6H, 2x CH3, s) ppm; Elemental Analysis: for C43H65NO10 calc. C 68.32, H 8.57, N 1.85; found C 63.39, H 8.62, N 1.75 Case A 28-3'-0- (Cyclopropyl) Shen Zhongzhong Nuoxin J_ The compound Spinoxin J (470 mg, 0.655 mmol) was dissolved in CH2C12 (10 ml). 15% NaOH aqueous solution (15 ml) was added, followed by K2CO3 (1.50 g) and benzyltriethylammonium chloride (1.10 g). Add (cyclo / propyl) methyl bromide (.09 ml) and stir the reaction mixture vigorously at room temperature under nitrogen for 72 hours. Add CH2C12 (50 ml) and water (50 ml). The phases are separated. The organic layer was washed with water (22), dried with MKzCO 3 and decompressed under reduced pressure.

經濟部中央標準局員工消費合作社印製 487559 A7 _____ B7 五、發明説明(61 ) 下濃縮。殘餘物在閃蒸SiO&gt;管柱(90 g/EtOAc)中純化。純 溶析份之濃縮物可提供a)化合物史賓諾辛J (216 mg)及b) 化合物3’_0_(環丙基)甲基史賓諾辛J ; 25.1 rog,9% IMR (CDC13) 3 6·71(1Η,bs),3·07(1Η,in),2·17(6Η, 2XCH3,s),0.48UH,m),0·18(1Η,m)ppm〇 蜜腋例A 2Q-3’-0-(氤)田基中窨諾辛J_ 將化合物史賓諾辛J (510 mg,0.71 mmol)溶於 CH2C12(5.0 ml)。加入K2C〇3(1.10 g)。將反應燒瓶浸於 水浴(10°C)中並隨著剌烈攪拌加入10% NaOH水溶液(10 ml ),接著加入苄基三乙基銨氯化物(1.20 g)。加入氯碘甲 烷(5.0 ml)加入及在室溫及氮氣下劇烈攪拌反應混合物72 小時。加入CH2C12(100 ml)及水(50 ml)。使相分離。將 有機層以水(2X )清洗,MK2C〇3乾燥並於減壓下濃縮。殘 餘物在閃蒸Si〇2管柱(70 g/EtOAc)中純化。純溶析份之濃 縮物可提供a)化合物(111 mg)及b)化合物3’U氯)甲基 史賓諾辛 J ; 120 mg,28%”NMR (CDC13) δ 6.66 (1Η, bs), 4.70 (2H, bs) , 3.74 (1H, dd: 9.5, 3.4 Hz), 2.12 (6H, 2x CH3, s) ppm; Elemental Analysis: for C41H64NO10CI calc. C 64.25, H 3.42, N 1.83; found C 64.49, U 8.37, N 1.74. 實施例A 30-中嘗諾辛L之3’-0-(五氪苯基)-硫羰某碳酸 酷_-_ ί 將化合物史賓諾辛L (733 mg,1·0 mmol)溶於乾吡啶 (5 ·0 ml)。在室溫(水浴)及氮氣下授拌。於5分鐘內,逐 滴加入(五氟笨基)氯硫羰基碳酸酯(1.5 nil,過量)。於10 -64 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇&gt;&lt; 297公釐) -® 裝· (請先閱讀背面之注意事項再填寫本頁)Printed by the Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 _____ B7 V. The description of the invention (61) is concentrated. The residue was purified in a flash SiO &gt; column (90 g / EtOAc). Concentrate of pure solubilized fractions provides a) compound Spinozin J (216 mg) and b) compound 3'_0_ (cyclopropyl) methyl Spinosin J; 25.1 rog, 9% IMR (CDC13) 3 6.71 (1Η, bs), 3.07 (1Η, in), 2.17 (6Η, 2XCH3, s), 0.48UH, m), 0.18 (1Η, m) ppm 2Q-3'-0- (氤) Tian Jizhong Onoxin J_ The compound Spinoxin J (510 mg, 0.71 mmol) was dissolved in CH2C12 (5.0 ml). K2CO3 (1.10 g) was added. The reaction flask was immersed in a water bath (10 ° C) and 10% aqueous NaOH (10 ml) was added with vigorous stirring, followed by benzyltriethylammonium chloride (1.20 g). Chloroiodomethane (5.0 ml) was added and the reaction mixture was stirred vigorously at room temperature under nitrogen for 72 hours. Add CH2C12 (100 ml) and water (50 ml). The phases are separated. The organic layer was washed with water (2X), dried over MK2CO3 and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (70 g / EtOAc). The concentrate of pure solubilized fractions can provide a) compound (111 mg) and b) compound 3'U chloro) methyl spinosinol J; 120 mg, 28% "NMR (CDC13) δ 6.66 (1Η, bs) , 4.70 (2H, bs), 3.74 (1H, dd: 9.5, 3.4 Hz), 2.12 (6H, 2x CH3, s) ppm; Elemental Analysis: for C41H64NO10CI calc. C 64.25, H 3.42, N 1.83; found C 64.49 , U 8.37, N 1.74. Example A 30-Zhongtaoxin L-3'-0- (pentaphenyl) -thiocarbonyl carbonate _-_ ί The compound Spinoxin L (733 mg, (1.0 mmol) was dissolved in dry pyridine (5.0 ml). Stirred at room temperature (water bath) under nitrogen. Within 5 minutes, (pentafluorobenzyl) chlorothiocarbonyl carbonate (1.5 nil) was added dropwise. , Excess). At 10 -64-This paper size applies the Chinese National Standard (CNS) Α4 specification (21〇 &gt; &lt; 297 mm)-® Packing (Please read the precautions on the back before filling this page)

、1T 經濟部中央標準局員工消費合作社印製 487559 A7 ______ B7_ 五、發明説明(62 ) 分鐘後,加入 PhH(50 ml)及 Et0Ac(50 ml)。溶液 K5 !Caq· NaHC〇3(3x )。有機層Manh. Na2S〇4乾燥並減壓濃縮。殘 餘物在閃蒸Si〇2管柱(80 g/EtOAc)中純化Μ獲得史賓諾辛 L之3’-0-(五氟苯基)-硫羰基碳酸酯;712 mg,74%,4- NMR (CDCI3) δ 6.69 (1Η, bs}, 5.46 (1H, dd: 9.5, 3.2 Hz), 5.40 (1H, bs), 3.77 (1H, dd: 3.1, 2.0 Hz), 2.23 (6H, CH3, s) t 1.64 (3H, CH3, bs) ppm; 13C-NMR (CDCI3) δ 191.5 (C=S), 37.0 (C3.-O) ppm. 奮_例A 31-.V-去氬-中客諾辛L_ 將化合物史賓諾辛L之3^0-(五氟苯基)-硫羰基碳酸 酯(690 mg,0.72 mmol)溶於乾甲苯(10 ml)。在室溫及氮 氣下加入氫化三-η-丁基錫(0.50 ml,1.86 mmol)。接著 加入AIBN(20 mg)。將反應混合物加熱至迴流溫度15分鐘 。於冷卻至室溫後,於減壓下濃縮溶液。殘餘物在閃蒸Si 〇2管柱(75 g/EtOAc)中純化Μ獲得化合物3’-去氧賓諾辛 L ; 236 mg,46%,UMR (CDC13) δ 6.68(1Η, bs), 5·39 (1Η, bs), 3·53 (2Η, m), 2·15 (6Η, 2xCH3, s), 1·63 (3Η, CH3, bs) ppm; Elemental Analysis: for C41H65NO9 calc. c 68.78, H 9.15, N 1.96; found C 68.70, H 8.87, N 2.03. 管)fe例A 32-中害諾辛.1夕:T-〇-(M丙基)礆酪酷_ 將化合物史賓諾辛J (330 mg,0.46 mmol)溶於乾 HMP A (3.5 ml)。加入碳酸銀(〇·66 g)。將反應混合物在室 溫及氮氣下攪拌5分鐘。導入2-碘丙烷(1.5 ml)。將反應 混合物攪拌18小時。加入Et0Ac(20 ml)及PhH(100 ml)。 _ - 65 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) .--«辦衣-- (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, 1T 487559 A7 ______ B7_ V. Description of the invention (62) minutes, add PhH (50 ml) and Et0Ac (50 ml). Solution K5! Caq.NaHC03 (3x). The organic layer was dried with Manh. Na2SO4 and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (80 g / EtOAc) to obtain 3'-0- (pentafluorophenyl) -thiocarbonyl carbonate of Spinoloxin L; 712 mg, 74%, 4 -NMR (CDCI3) δ 6.69 (1Η, bs), 5.46 (1H, dd: 9.5, 3.2 Hz), 5.40 (1H, bs), 3.77 (1H, dd: 3.1, 2.0 Hz), 2.23 (6H, CH3, s) t 1.64 (3H, CH3, bs) ppm; 13C-NMR (CDCI3) δ 191.5 (C = S), 37.0 (C3.-O) ppm. Fen_Example A 31-.V-Deargon-China Passenger Nosin L_ The 3 ^ 0- (pentafluorophenyl) -thiocarbonyl carbonate (690 mg, 0.72 mmol) of the compound Spinoxin L was dissolved in dry toluene (10 ml). Hydrogenation was added at room temperature under nitrogen. Tri-η-butyltin (0.50 ml, 1.86 mmol). Then AIBN (20 mg) was added. The reaction mixture was heated to reflux temperature for 15 minutes. After cooling to room temperature, the solution was concentrated under reduced pressure. The residue was flashed Purification in a SiO 2 column (75 g / EtOAc) to obtain compound 3'-deoxybinoxin L; 236 mg, 46%, UMR (CDC13) δ 6.68 (1Η, bs), 5.39 (1Η, bs), 3.53 (2Η, m), 2.15 (6Η, 2xCH3, s), 1.63 (3Η, CH3, bs) ppm; Elemental Analysis: for C41H65NO9 calc. c 68.78, H 9.15, N 1.96 ; F ound C 68.70, H 8.87, N 2.03. Tube) fe Example A 32-neutral nosin. 1 eve: T-〇- (Mpropyl) 礆 casein _ will compound Spinozin J (330 mg, 0.46 mmol) was dissolved in dry HMP A (3.5 ml). Silver carbonate (0.66 g) was added. The reaction mixture was stirred at room temperature under nitrogen for 5 minutes. Introduce 2-iodopropane (1.5 ml). The reaction mixture was stirred for 18 hours. Et0Ac (20 ml) and PhH (100 ml) were added. _-65-The size of this paper is applicable to Chinese National Standard (CNS) Α4 specification (210 × 297 mm) .-- «Handling-(Please read the precautions on the back before filling this page)

、1T 經濟部中央標準局員工消費合作社印製 487559 A7 _ B7 五、發明説明(63 ) 將有機層以水(3 X )清洗,'MK2CO 3乾燥並於減壓下濃縮。 殘餘物在閃蒸Si〇2管柱(20 g/EtOAc)中分離Μ獲得a)化合 物(98 mg)及b)化合物史賓諾辛J之3’-0-(異丙基)碳酸酯 ;87 mg t 34%) ^MR (CDCla) δ 6.68(1H » bs) » 4.84(2H ,m),3,54(3H,m),2·14(6Η,2X CH3,s),1·23(6Η, 2XCH3,δ : 6.2 Hz)ppra;元素分析:對 C44HG3NO12 之估 計值,C 65,73,Η 8· 65,Η 1.74 ;實際值,C 65.63, Η 8.78,N 1,75 〇 管敝例A m 二Μ Λ醯某中W諾辛I,_ 將化合物史賓諾辛L (244 mg,0.33 mmol)溶於乾吡 啶(4 ml)。加入二氯乙酸酐(0.50 ml,過量)並於室溫及 氮氣下持縯攪拌16小時。加入Et0Ac(50 ml)及PhH(100 ml )。將溶液M5%a.q.HaHC〇3(3x )清洗。Manh.K2C〇3乾燥 有機層並於減壓下濃縮。殘餘物在閃蒸Si〇2管柱(80 g/Et OAc)中純化以獲得化合物3夂0-二氯乙醯基史賓諾辛L ; 129 mg,46% El MS ιπ/ζ 342 (M+); 1H-NMR (CDCI3) δ 6.71 (1H, bs)# 5.93 (1H, s), 5.43 (1H, bs), 5.14 (1H, dd: 9.6, 3.2 Hz), 3.57 (3H, m), 2.13 (6H, 2x CH3, s), 1.66 (3H, CH3, s) ppm· 實施例A 34-3 ’ -0-二氡Z醮某中窨諾辛_ 將化合物史賓諾辛J (302 mg,0.42 mmol)溶於乾吡 啶(5 ml)。加入二氯乙酸酐(〇·50 ml,過量)並於室溫及 氮氣下持續攪拌16小時。加入Et〇Ac(50 ml)及PhH(100 ml )。將溶液 K 5% a. q. NaHCOb (3 X )清洗。M anh. K2C〇3 乾燥 —_—_ __ - 66 - 本紙張尺度適用中國國家標準(CNS ) A4規格(710 X 297公釐) 一~一 I—^----* ® 批衣------1T------ (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 _ B7__;_ 五、發明説明(64 )Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, 1T 487559 A7 _ B7 V. Description of the invention (63) The organic layer was washed with water (3 X), 'MK2CO 3 was dried and concentrated under reduced pressure. The residue was separated in a flash SiO 2 column (20 g / EtOAc) to obtain a) a) compound (98 mg) and b) a 3'-0- (isopropyl) carbonate of the compound Spinoxin J; 87 mg t 34%) ^ MR (CDCla) δ 6.68 (1H »bs)» 4.84 (2H, m), 3,54 (3H, m), 2.14 (6Η, 2X CH3, s), 1.23 (6Η, 2XCH3, δ: 6.2 Hz) ppra; Elemental analysis: Estimated value of C44HG3NO12, C 65,73, Η 8.65, Η 1.74; Actual value, C 65.63, Η 8.78, N 1,75 〇 tube 敝Example A Dioxin I, XX, Nosin I, _ The compound Spinoxin L (244 mg, 0.33 mmol) was dissolved in dry pyridine (4 ml). Add dichloroacetic anhydride (0.50 ml, excess) and stir at room temperature under nitrogen for 16 hours. Et0Ac (50 ml) and PhH (100 ml) were added. The solution M5% a.q.HaHC03 (3x) was washed. The organic layer was dried over Manh. K2CO3 and concentrated under reduced pressure. The residue was purified in a flashed SiO 2 column (80 g / Et OAc) to obtain the compound 3 夂 0-dichloroacetamido Spinozin L; 129 mg, 46% El MS ιπ / ζ 342 (M +) ; 1H-NMR (CDCI3) δ 6.71 (1H, bs) # 5.93 (1H, s), 5.43 (1H, bs), 5.14 (1H, dd: 9.6, 3.2 Hz), 3.57 (3H, m), 2.13 ( 6H, 2x CH3, s), 1.66 (3H, CH3, s) ppm · Example A 34-3 ′ -0-Dimethyl Z 醮 a certain midoxin_ The compound Spinoxin J (302 mg, 0.42 mmol) was dissolved in dry pyridine (5 ml). Dichloroacetic anhydride (0.5 ml, excess) was added and stirring was continued for 16 hours at room temperature under nitrogen. EtoAc (50 ml) and PhH (100 ml) were added. Solution K 5% a. Q. NaHCOb (3 X) was washed. M anh. K2C〇3 Drying —_—_ __-66-This paper size is applicable to China National Standard (CNS) A4 (710 X 297 mm) one to one I — ^ ---- * ® batch clothing- ---- 1T ------ (Please read the notes on the back before filling out this page) Printed by the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 _ B7__; _ 5. Description of the invention (64)

乾燥有機層並於減壓下縢縮。殘餘物在閃蒸Si〇2管柱(80 g/EtOAc)中純化Μ獲得化合物3^0-二氯乙醯基史賓諾辛 J ; 293 mg,84% 4-NMR (CDC13) δ 6.66 (1Η, bs)# 5.95 (1H, s), 5.07 (1H, dd: 8.7, 3.2 Hz), 3.52 (扣,m), 2.15 (6H, 2x CH3, s) ppm; Elemental Analysis: for C42H63NO11CI2 calc, c 60.36, H 7.66, N 1.70; found C 60.59, H 7.65, N 1.96. 管敝例A 基中客諾宰,J_ 將化合物史賓諾辛J (296 mg,0.41 mmol)溶於 CH2C12(5.0 ml)。加入K2C〇3(l,10 g)。將反應燒瓶浸於 水浴(ΙΟΡ)中並隨著劇烈撹拌加入15% NaOH水溶液(10 ml ),接著加入苄基三乙基銨氯化物(0.88 g)。加入卜碘丁 烷(3.0 ml)加入及在室溫及氮氣下劇烈授拌反應混合物40 小時。加入CH2C12(100 ml)及水(50 ml)。使相分離。將 有機層Μ水(2X )清洗,MK2C〇3乾燥並於減壓下濃縮。殘 餘物在閃蒸Si〇2管柱(60 g/Et0Ac)中純化。純溶析份之濃 縮物可提供a)化合物(211 mg)及b)化合物3’丁基史 賓諾辛 J ; 20·5 mg,22%”NMR (CDCl3)S 6.71 (1H, bs), 3.58 (2H, m), 2.18 (6H, 2x CH3, s), 0.38 (3H, CH3, t: 7.3 Hz) ppm; 13C-NMR (CDCI3) δ 70.5 (0-CH2), 32.8 (CF‘2), 30.4 (CH2), 14.5 (CH3) PPm. 啻淪例a 基丁醢y中窨諾宰j * 將化合物史賓諾辛J (359 mg,0.50 mmol)溶於乾吡 啶(4 ml)。加入N,N-二甲基胺吡啶(66 mg) ◦將反應物在 氮氣下冷卻至10°C (水浴)。‘加入氯化異丁醯(2.0 ml ’過 本纸張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) I 5 裝 訂 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(65 ) 量)並在室溫及氮氣下持缜攬拌70小時。加入EtOAc (50 ml )及PhH(100 ml)。有機層M5%aq,NaHC〇3 (3X )清洗。K anh.K2C〇3乾燥有機層並於減壓下濃縮。殘餘物在閃蒸 Si〇2管柱(80g/Et0Ac)中纯化Μ獲得3夂0-異丁醯基史賓諾 辛J ; 364 mg# 92% 1H-NMR (CDCI3) δ 6.70 (1Η, bs), 5.02 (1H, dd: 9.6, 3.2 Hz), 3.57 (2H, m)# 3.49 (1H, dd: 3.2, 1.8 Hz), 2.16 (6H, 2x CH3, s), 1.15 (6H, 2x CH3, d: 7.0 Hz) ppm; Elemental Analysis: for C44H69NO11 calc. C 67.06, H 8.82, N 1.78; found C 66.78, H 8.86, N 1.75. 審施例A 特戊醯基中W諾辛J _ 將化合物史賓諾辛J (426 mg,0.59 nnnol)溶於乾吡 啶(4 ml)。加入N,N-二甲基胺吡啶(116 rag)。將反應物在 氮氣下冷卻至101C (水浴)。加入氯化特戊醯(2.0 ml,過 量)並在室溫及氮氣下持續攪拌70小時。加入EtOAc (50 ml )及 PhH(100 ml)。有機層M5%aq.NaHC〇3 (3x )清洗。以 anh.K2C〇3乾燥有機層並於減壓下濃縮。殘餘物在閃蒸 Si〇2管柱(80g/Et0Ac)中純化K獲得3’-0_特戊醯基史賓諾 辛 J ; 433 mg, 91% El MS m/z 802 (M+); 1H-NMR (CDCI3) δ 6.65 (1H, bs), 4.94 (1H, dd: 9.8, 3.2 Hz), 3.52 (2H, 3·45 (1H, dd: 3.2, 1.8 Hz), 2.14 (6H, 2x CH3, s), 1.14 (9H, 3x CH3, s) ppm. 實施例A .Ί8-5. 二S -3 ’ 基中窨諾辛,J_ 將化合物5,6-二氫-史賓諾辛J (399 mg,0.554 mmol )溶於 CH2C12(5.0 ml)。加入 K2C〇3(1.10 g)。將反應燒瓶 ____- 68 -_ 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) - 裝 訂 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 ------‘ B7 五、發明説明(66 ) 浸於水浴(10°C )中並隨著劇烈攪拌加入15%NaOH水溶液( 10 ml),接著加入四丁基銨氫硫酸鹽(〇·90 g)。加入1-碘 乙烷(3 ♦ 0 m 1)加入及在室溫及氮氣下劇烈攪拌反應混合物 72小時。加入CH 2 C12 (100 ml)及水(50 ml)。分離相。有 機層以水(2父),以1(2(:〇3乾燥及(^2(:12(10〇1111)及水(50 ml)。使相分離。將有機層K水(2X )清洗,MK2C〇3乾燥 並於減壓下濃縮。殘餘物在閃蒸Si〇2管柱(100 g/EtOAc) 中純化。純溶析份之濃縮物可提供5,6-二氫-3’-0-乙基史 賓諾辛 J ; 217 mg, 52% 丄只-NMR (CDCI3) δ 6.72 (1Η, bs), 3.57 (1H, m), 3.49 (2H, m), 2.13 (6H, 2XCH3, s), 1.14 (3H, CH3, t: 7.3 Hz) ppm; Elemental Analysis: for C42H69NO10 calc. C 67.44, H 9.30, N 1.87; found C 67.64, H 8.95, N 1.87. 管)ife例A 39-5.6-二氩-3 ’ 丙基中W諾辛J_ 將化合物5,6-二氫-史賓諾辛J (8 mg,0.119 mmol )溶於 CH2C12(3.0 ml)。加入K2C〇3(0.68 g)。將反應燒瓶 浸於水浴(10t:)中並隨著劇烈攬拌加入20%Na0H水溶液(6 ml),接著加入四丁基銨氫硫酸鹽(0.81 g)。加入1-碘丙 烷(1.20 πι 1)加入及在室溫及氮氣下劇烈攪拌反應混合物 20小時。加入CH2C12(100 ml)及水(50 ml)。分離相。有 機層 Μ水(2X ),MK2C〇3乾燥及 CH2C12(100 nil)及水(50m 1)。使相分離。將有機層科水(2X )清洗,MK2C〇3乾燥並 於減壓下濃縮。殘餘物在閃蒸Si〇2管柱(25 g/EtOAc)中純 化。纯溶析份之濃縮物可提供5,6-二氫-3’-0-丙基史賓諾 辛J ; * ____- 69 -_ _ 本紙張尺度適用}國國家標準(CNS ) A4規格(2!OX 297公釐) &quot; I------=-I-♦-裝------訂----- (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 A7 B7 J^發明説明(67 ) 55.0 mg, 60% 1H-NMR (CDCI3) δ 6.78 (1H, bs), 3.55 (3H,rn&gt; , 2·16 (6H, 2x CH3, s) , 0.89 (3H, CH3, t: 7.5 Hz) ppm; 13C-NHR (CDcl3) 572.5 (O-CH2-), 23.9 (CH2) and 11.2 (CH3) ppm. 管施例△40-2’-表-2’-[1-71某中窨諾辛1^_ 將化合物2’-0-乙醯基-2’-史賓諾辛Η (502 ms ,0·664 mmol)溶於 CH2C12(4.0 ml)。加入 K2C03(1.10 g) 。將反應燒瓶浸於水浴(l〇°C )中並隨著劇烈攪拌加入20%The organic layer was dried and shrunk under reduced pressure. The residue was purified in a flash SiO 2 column (80 g / EtOAc) to obtain the compound 3 ^ 0-dichloroethenylspinoxin J; 293 mg, 84% 4-NMR (CDC13) δ 6.66 (1Η , bs) # 5.95 (1H, s), 5.07 (1H, dd: 8.7, 3.2 Hz), 3.52 (button, m), 2.15 (6H, 2x CH3, s) ppm; Elemental Analysis: for C42H63NO11CI2 calc, c 60.36 , H 7.66, N 1.70; found C 60.59, H 7.65, N 1.96. Tuberculosis Example A Keluozhai, J_ The compound Spinoxin J (296 mg, 0.41 mmol) was dissolved in CH2C12 (5.0 ml). K2CO3 (1, 10 g) was added. The reaction flask was immersed in a water bath (100P) and 15% aqueous NaOH (10 ml) was added with vigorous stirring, followed by benzyltriethylammonium chloride (0.88 g). Add iodobutane (3.0 ml) and stir the reaction mixture vigorously at room temperature under nitrogen for 40 hours. Add CH2C12 (100 ml) and water (50 ml). The phases are separated. The organic layer was washed with water (2X), dried over MK2CO3 and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (60 g / EtoAc). The concentrate of pure solubilized fractions can provide a) compound (211 mg) and b) compound 3'butyl spinosinoxin J; 20.5 mg, 22% "NMR (CDCl3) S 6.71 (1H, bs), 3.58 (2H, m), 2.18 (6H, 2x CH3, s), 0.38 (3H, CH3, t: 7.3 Hz) ppm; 13C-NMR (CDCI3) δ 70.5 (0-CH2), 32.8 (CF'2), 30.4 (CH2), 14.5 (CH3) PPm. Example a. Butyridine y. Indoxazone j * The compound Spinoxin J (359 mg, 0.50 mmol) was dissolved in dry pyridine (4 ml). N was added , N-dimethylaminopyridine (66 mg) ◦The reaction was cooled to 10 ° C (water bath) under nitrogen. 'Isobutyl chloride (2.0 ml) was added. The Chinese standard (CNS) ) A4 size (210 X 297 mm) I 5 Binding (please read the notes on the back before filling this page) Printed by the Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 5. The invention description (65) It was stirred at room temperature under nitrogen for 70 hours. EtOAc (50 ml) and PhH (100 ml) were added. The organic layer was M5% aq, washed with NaHC03 (3X). The organic layer was dried with Kan. K2CO3 and dried over Concentrated under reduced pressure. The residue was purified in a flashed Si02 column (80g / Et0Ac). Obtained 3 夂 0-Isobutyryl Spinozin J; 364 mg # 92% 1H-NMR (CDCI3) δ 6.70 (1Η, bs), 5.02 (1H, dd: 9.6, 3.2 Hz), 3.57 (2H, m ) # 3.49 (1H, dd: 3.2, 1.8 Hz), 2.16 (6H, 2x CH3, s), 1.15 (6H, 2x CH3, d: 7.0 Hz) ppm; Elemental Analysis: for C44H69NO11 calc. C 67.06, H 8.82 , N 1.78; found C 66.78, H 8.86, N 1.75. Examination example A Wnosin J in Tentamidine _ The compound Spinoxin J (426 mg, 0.59 nnnol) was dissolved in dry pyridine (4 ml) Add N, N-dimethylaminopyridine (116 rag). Cool the reaction to 101C (water bath) under nitrogen. Add pivalamidine chloride (2.0 ml, excess) and continue stirring at room temperature under nitrogen 70 hours. Add EtOAc (50 ml) and PhH (100 ml). The organic layer was washed with M5% aq. NaHC03 (3x). The organic layer was dried over anh. K2CO3 and concentrated under reduced pressure. The residue was purified K in a flashed Si02 column (80g / Et0Ac) to obtain 3'-0_t-pentylspinyl Spinoxin J; 433 mg, 91% El MS m / z 802 (M +); 1H- NMR (CDCI3) δ 6.65 (1H, bs), 4.94 (1H, dd: 9.8, 3.2 Hz), 3.52 (2H, 3.45 (1H, dd: 3.2, 1.8 Hz), 2.14 (6H, 2x CH3, s ), 1.14 (9H, 3x CH3, s) ppm. Example A. Ί8-5. Di-S-3'yl indoxoxine, J_ Compound 5,6-dihydro-spinoxin J (399 mg , 0.554 mmol) is dissolved in CH2C12 (5.0 ml). K2C03 (1.10 g) is added. The reaction flask is ____- 68 -_ This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm)- Binding (Please read the precautions on the back before filling this page) Printed by the Consumers 'Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 ------' B7 V. Description of the invention (66) Immerse in a water bath (10 ° C) With vigorous stirring, add 15% NaOH aqueous solution (10 ml), followed by tetrabutylammonium hydrogen sulfate (0. 90 g). Add 1-iodoethane (3 ♦ 0 m 1). The reaction mixture was stirred vigorously under nitrogen for 72 hours. CH 2 C12 (100 ml) and water (50 ml) were added. The phases were separated. Organic Water (2 fathers), 1 (2 (0) dried and (2 (: 12 (1001111)) and water (50 ml). The phases were separated. The organic layer was washed with K water (2X) and MK2C 〇3 was dried and concentrated under reduced pressure. The residue was purified in a flash SiO2 column (100 g / EtOAc). The concentrate of the pure eluate provided 5,6-dihydro-3'-0- Ethyl Spinozin J; 217 mg, 52% 丄 -NMR (CDCI3) δ 6.72 (1Η, bs), 3.57 (1H, m), 3.49 (2H, m), 2.13 (6H, 2XCH3, s), 1.14 (3H, CH3, t: 7.3 Hz) ppm; Elemental Analysis: for C42H69NO10 calc. C 67.44, H 9.30, N 1.87; found C 67.64, H 8.95, N 1.87. Tube) Example A 39-5.6-Diargon W'oxin J_ in 3'-propyl The compound 5,6-dihydro-spinoxin J (8 mg, 0.119 mmol) was dissolved in CH2C12 (3.0 ml). K2CO3 (0.68 g) was added. The reaction flask was immersed in a water bath (10t :) and 20% NaOH aqueous solution (6 ml) was added with vigorous stirring, followed by tetrabutylammonium hydrogen sulfate (0.81 g). 1-iodopropane (1.20 μm 1) was added and the reaction mixture was stirred vigorously at room temperature under nitrogen for 20 hours. Add CH2C12 (100 ml) and water (50 ml). Separated phases. Organic layer M water (2X), MK2CO3 drying and CH2C12 (100 nil) and water (50ml). The phases are separated. The organic layer was washed with water (2X), dried over MK2CO3 and concentrated under reduced pressure. The residue was purified in a flashed SiO 2 column (25 g / EtOAc). Concentrate of pure solubilized fraction can provide 5,6-dihydro-3'-0-propyl spinolsin J; * ____- 69 -_ _ Applicable to this paper size} National National Standard (CNS) A4 Specification (2 ! OX 297 mm) &quot; I ------ =-I- ♦ -pack ------ order ----- (Please read the notes on the back before filling this page) Central Ministry of Economy Printed by the Consumer Bureau of Standards Bureau A7 B7 J ^ Invention Note (67) 55.0 mg, 60% 1H-NMR (CDCI3) δ 6.78 (1H, bs), 3.55 (3H, rn &gt;, 2 · 16 (6H, 2x CH3) , s), 0.89 (3H, CH3, t: 7.5 Hz) ppm; 13C-NHR (CDcl3) 572.5 (O-CH2-), 23.9 (CH2) and 11.2 (CH3) ppm. Tube Example △ 40-2 ' -表 -2 '-[1-71 中 中 诺辛辛 1 ^ _ Compound 2'-0-ethynyl-2'-spinoxin (502 ms, 0.664 mmol) was dissolved in CH2C12 4.0 ml). K2C03 (1.10 g) was added. The reaction flask was immersed in a water bath (10 ° C) and 20% was added with vigorous stirring.

NaOH水溶液(10ml),接著加入四丁基銨氫硫酸鹽(0.82 g) 。加入1-碘乙烷(1.20 ml)加入及在室溫及氮氣下剌烈攪 拌反應混合物22小時。加入CH2C12(100 nil)及水(50 ml) 。分離相。有機層K水(2x),MK2C〇3乾燥及CH2C12(100 ml)及水(50ml)。使相分離。將有機層K水(2 X)清洗,Μ K2C〇3乾燥並於減壓下濃縮。殘餘物在閃蒸Si〇2管柱(80g/Aqueous NaOH (10 ml) followed by tetrabutylammonium hydrogen sulfate (0.82 g). 1-Iodoethane (1.20 ml) was added and the reaction mixture was stirred vigorously at room temperature under nitrogen for 22 hours. Add CH2C12 (100 nil) and water (50 ml). Separated phases. The organic layer was K water (2x), dried with MK2CO3 and CH2C12 (100 ml) and water (50 ml). The phases are separated. The organic layer was washed with K water (2 ×), dried over MgSO 2 and concentrated under reduced pressure. The residue was flashed in a Si02 column (80g /

EtOAc)中純化。純溶析份之濃縮物可提供2’-表-2’-0-乙 基史賓諾辛 Η ; 132 mg, 27% XH-NMR (CDCI3) δ 6.66 (1Η, bs), 4.70 (1H, d: 3.7Hz), 2.12 (6H, 2xCH3, s), 1.14 (3H, CH3, t: Hz) ppm; 13C-NMR (CDCI3) δ 66.8 (O-CH2-) and 16.2 (CH3) ppm. 管_例A 4卜5.6-二氣'V-n-n-丁基Φ窨諾辛J__ 將化合物5,6-二氫-史賓諾辛J (93 mg,0.129 mmol )溶於 CH2C12(3.0 ml)。加 &gt;K2C03 (0.70 g)。將反應燒瓶 浸於水浴(10¾ )中並随著劇烈搜拌加入20%Na0H水溶液( 10 ml),接著加入四丁基銨氫硫酸鹽(0,66 g)。加入1-碘 丁烷(2.0 m 1)加入及在室溫及氮氣下劇烈攪拌反應混合物 ___-70 -____ 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 11 ; —Aw· I 訂 (請先閲讀背面之注意事項再填寫本頁) 487559 A7 ____ B7 五、發明説明(68 ) 20小時。加入CH2C12 (100 ml)及水(50 ml)。分離相。有 機層 Μ水(2X ),MK2C〇3乾燥及 CH2C12(100 ml)及水(50 m 1)。使相分離。將有機層以水(2x )清洗,MK2C〇3乾燥並 於減壓下濃縮。殘餘物在閃蒸Si〇2管柱(25 g/EtOAc)中純 化。纯溶析份之濃縮物可提供5,6-二氫-3’-0-丁基史賓諾 辛 J ; 63 mg, 63% ^-H-NMR (CDCI3) δ 6.78 (1Η, bs) , 3 .57 (3H, m) , 2.16 (6H, 2x CH3 # s), 0.37 (3H, CH3, t: 7.2 Hz) ppm; Elemental Analysis : for C44H73NO10 calc. C 63.10, H 9.43, N 1.80; found C 68.23, 9.65, N 1.33. 奮施例A 42~~2’-0-(S_甲基- N- 午基碳亞胺基硫基)史賓諾 辛Η __ 於冷(0°C )、經適當攪拌之氫化納(於礦物油中之50% 經濟部中央標準局員工消費合作社印製 分散液,12.0 mg,0·14 mmol)的無水THF(1.5 raL)懸浮液 中,在2-3分鐘內逐滴加入史賓諾辛Η (0.1 g,0.14 mmol )之THF(1.5 mL)溶液。在0°C下攪拌混合物30分鐘,接著 以利用注射器的方式加入一部份N-苄基異硫氰酸酯(25 u 1,0.18 ππποί)。移開冷卻浴並在室溫下攪拌混合物4·5 hr。接著加人一部份甲基碘(30/i 1,0.48 fflinol)並將混合 物授拌30分鐘。接著於減壓下去除溶劑並將殘餘物溶於無 水乙醚(20 inL)。藉由經過矽藻土過濾去除任何不可溶物 質並Μ乙醇沖洗。合併濾液並清洗以留下〇· 13 g無色油狀 之粗2f-0-(S-甲基苄基碳亞胺基硫基)史賓諾辛Η : IMIUCDCU) δ 2.48(s,1,SCH3),5·40(ιη,1,Η-2,)。 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 487559 A7 —-____ . B7 五、發明説明(69 ) 啻飾例A H2夂0-三Μ乙醯亞胺基中害諾辛Η X504447 於冷(0°C)、經適當攪拌之氫化納(於礦物油中之50% 分散液,12.0 mg,0· 26 mmol)的無水THF (2.0 mL)懸浮液 中,在2-3分鐘内逐滴加人史賓諾辛Η (0.1 g,0.14 mmol )之THF(2.0 raL)溶液。在下攪拌混合物20分鐘,接著 Μ加入一部份三氯乙請(2〇以L ’ 0.2 nunol)及在0°C下攪拌 2小時0接著加入一部份冰醋酸(16/i L ’ 0·27 mmol)並於 冷卻狀態下授拌反應混合物10分鐘。接著減壓去除溶劑及 使粗2 \〇-三氯乙醯亞胺基史賓諾辛Η藉由氧化矽(40 mL) 之閃蒸層析純化,利用3%甲醇之二氯甲烷溶液為溶析液 。可獲得白色泡沫體狀之純2’- 三氯乙醯亞胺基史賓諾 辛 Η (95 mg,79% ) : iNMlUCDCh) δ 5.30(m,1,H-2’), 8.36(s,1,=ΝΗ);質譜(Cl,CHd,m/z(rel.強度)861 (MtT,4),142 (100)。 管_例A 44-3 三氟甲碏醢基中W諾垒J_ 於冷(_10°C )、經適當攪拌之史賓諾辛J (0.2 g, 0.28 mmol)及乾 CH2Cl2(5 roL)之乾 Bit 唯(0.1 mL,1.26 mmol)溶液,藉由注射器的方式加入一部分triflic acid( 60 μ L,0.35 mmol)。在-101C下將所得之橙棕色溶液攪拌 1.5 h,接著以CH2C12 (20 mL)稀釋並連續Κ水(5 niL)、飽 和Na2C〇3 (4 mL),再K水(5 mL)清洗,最後乾燥M (MgS〇4 )。濃縮物留下216 mg(91%)3’-0-三氟甲磺醯基史賨諾辛 J,其純度足供使用而無需進一步純化:lNMR(CDCl3) δ 4.98(dd , 1 , Η-3·)。 - 72 - 本ί氏張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐1 (請先閱讀背面之注意事項再填寫本頁) 衣· 訂 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(7〇 ) 實_例八4 5-卜0 (2.3·4-三-0-71基-[-(^-鼠李糖基)中客 諾辛A 9-Psa : L-鼠李煻基)中窨諾辛A 9-Pm之3 : ΐ潖合物 於冷(0°C)、經適當攪拌之史賓諾辛A 9-Psa(2.1 g ,3.86 mmol)及吡啶對-甲苯磺酸酯(1.3 g,5.17 mmol) 之乾CH2C 1 2 (200 ml)溶液,該溶液包含粉末狀之4A分子篩 分物(2.6 g),在20分鐘内,逐滴加入0_(2,3,4_三-0-乙 基-ct-L-鼠李糖吡哺糖基)三氯亞胺逐乙酸酯(5.0 g, 12.75 mmol)之 CH2C12(20 mL)溶液。在 0°C、3 小時後,再 加入一部份亞胺酯(2.0 g)之CH2C12 (6 mL)溶液。接著移 走冷卻浴並在室溫下攪拌反應混合物16小時。接著加入更 多的亞胺酯(0.8 g)。再7個小時後,使反應混合物經矽藻 土過濾,以CH2C12(25 mL)清洗矽藻土並合併濾液及K飽 和Na2C〇3 (2X 80 mL)清洗並乾燥(MgS〇4)。濃縮物留下 11.5 g殘餘物,將該殘餘物經過氧化矽(700 mL)之閃蒸層 析,使用3%MeOH之CH2C12溶液為溶析液,以產生2.0 g( 67% )化合物a) 9-0-(2,3,4-三-0-乙基-ct 鼠李糖基)史 賓諾辛A 9-Psa: 9-0-(2,3,4-三-0-乙基-々-1^-鼠李糖 基)史賓諾辛A 9-Psa之3 : 1混合物。混合物藉由HPLC, 經由 21.4 nim(i.d.)x20 cm(l)Rainin 逆相 C18 管柱,使用 4%H2〇(含有0,01%NH40H)之甲醇溶液為溶析液分離成10 個約200 rag的部分。-變旋異搆物首先析出。化合物b) 9-0-(2,3,4-三-0-乙基-/3-1^-鼠李糖基)史賓諾辛/\9-Psa : 0·35 g ;無色泡沫體;IMR (CDC13) δ 4.36(s,1, 本纸張尺度適用中國國家標準(CNS ) A4規格(21QX 297公釐) (請先閱讀背面之注意事項再填寫本頁)EtOAc). Concentrate of pure solubilized fractions can provide 2'-Table-2'-0-ethylspinoxine; 132 mg, 27% XH-NMR (CDCI3) δ 6.66 (1Η, bs), 4.70 (1H, d : 3.7Hz), 2.12 (6H, 2xCH3, s), 1.14 (3H, CH3, t: Hz) ppm; 13C-NMR (CDCI3) δ 66.8 (O-CH2-) and 16.2 (CH3) ppm. A 4 Bu 5.6-Digas' Vnn-butyl 窨 窨 窨 辛 xinoxin J__ Compound 5,6-dihydro-spinoxin J (93 mg, 0.129 mmol) was dissolved in CH2C12 (3.0 ml). Add &gt; K2C03 (0.70 g). The reaction flask was immersed in a water bath (10¾) and 20% NaOH aqueous solution (10 ml) was added with vigorous stirring, followed by tetrabutylammonium hydrogen sulfate (0,66 g). Add 1-iodobutane (2.0 m 1) and stir the reaction mixture vigorously at room temperature under nitrogen ___- 70 -____ This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) 11; —Aw · I order (please read the notes on the back before filling this page) 487559 A7 ____ B7 V. Description of invention (68) 20 hours. Add CH2C12 (100 ml) and water (50 ml). Separated phases. Organic layer M water (2X), dried with MK2CO3 and CH2C12 (100 ml) and water (50 ml). The phases are separated. The organic layer was washed with water (2x), dried over MK2CO3 and concentrated under reduced pressure. The residue was purified in a flashed SiO 2 column (25 g / EtOAc). Concentrate of pure solubilized fractions can provide 5,6-dihydro-3'-0-butyl spinosynox J; 63 mg, 63% ^ -H-NMR (CDCI3) δ 6.78 (1Η, bs), 3 .57 (3H, m), 2.16 (6H, 2x CH3 # s), 0.37 (3H, CH3, t: 7.2 Hz) ppm; Elemental Analysis: for C44H73NO10 calc. C 63.10, H 9.43, N 1.80; found C 68.23 , 9.65, N 1.33. Fenshi Example A 42 ~~ 2'-0- (S_methyl-N-ammonium carbodiimidothio) spinoxin Η __ Yu cold (0 ° C), after Properly stirred suspension of sodium hydride (50% in mineral oil, printed dispersion, 12.0 mg, 0.14 mmol) in the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs, in 2-3 minutes of anhydrous THF A solution of spinosynox (0.1 g, 0.14 mmol) in THF (1.5 mL) was added dropwise. The mixture was stirred at 0 ° C for 30 minutes, and then a portion of N-benzyl isothiocyanate (25 u 1,0.18 ππποί) was added by using a syringe. Remove the cooling bath and stir the mixture at room temperature for 4.5 hours. Then add a portion of methyl iodide (30 / i 1, 0.48 fflinol) and mix the mixture for 30 minutes. The solvent was then removed under reduced pressure and the residue was dissolved in anhydrous ether (20 inL). Any insoluble matter was removed by filtration through diatomaceous earth and rinsed with ethanol. The filtrates were combined and washed to leave 0.13 g of crude 2f-0- (S-methylbenzylcarbimidothio) spinosinol: IMIUCDCU δ 2.48 (s, 1, SCH3 as a colorless oil ), 5.40 (ιη, 1, Η-2,). This paper size applies to China National Standard (CNS) A4 (210X 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 —-____. B7 V. Description of the invention (69) Decoration example A H2 夂 0 -Trimethylammonium dioxinoxine X504447 in cold (0 ° C), properly stirred sodium hydride (50% dispersion in mineral oil, 12.0 mg, 0.26 mmol) in anhydrous THF (2.0 mL) of the suspension, a solution of human spinoxin (0.1 g, 0.14 mmol) in THF (2.0 raL) was added dropwise over 2-3 minutes. Stir the mixture for 20 minutes, then add a portion of trichloroethane (20 to L'0.2 nunol) and stir at 0 ° C for 2 hours. 0 Then add a portion of glacial acetic acid (16 / i L'0 · 27 mmol) and the reaction mixture was allowed to cool for 10 minutes. The solvent was then removed under reduced pressure and the crude 2 \ -trichloroacetimino spinosinol was purified by flash chromatography on silica (40 mL) using 3% methanol in dichloromethane as the eluent. liquid. Pure white 2'-trichloroacetimidospinoxine (95 mg, 79%): iNMlUCDCh) δ 5.30 (m, 1, H-2 '), 8.36 (s, 1 , = ΝΗ); Mass spectrum (Cl, CHd, m / z (rel. Intensity) 861 (MtT, 4), 142 (100). Tube_Example A 44-3 W Nuo barrier in trifluoromethane group J_ Yu Cold (_10 ° C), properly stirred Spinoxin J (0.2 g, 0.28 mmol) and dry CH2Cl2 (5 roL) in dry Bit Vita (0.1 mL, 1.26 mmol) solution, add part by syringe triflic acid (60 μL, 0.35 mmol). The resulting orange-brown solution was stirred at -101C for 1.5 h, then diluted with CH2C12 (20 mL) and continuously K water (5 niL), saturated Na2CO3 (4 mL) , And then washed with K water (5 mL), and finally dried M (MgS04). The concentrate leaves 216 mg (91%) of 3'-0-trifluoromethanesulfonylstiloxine J, which is pure enough for use. Without further purification: lNMR (CDCl3) δ 4.98 (dd, 1, Η-3 ·).-72-This 氏 Zhang scale is applicable to the Chinese National Standard (CNS) Α4 specification (210X 297 mm 1 (please read the back first) Please note this page, please fill in this page) Clothing · Order 487559 Central Bureau of Standards, Ministry of Economic Affairs Printed by the Industrial and Consumer Cooperatives A7 B7 V. Description of the invention (70) Example 8 4 5-Bu 0 (2.3 · 4-tri-0-71 radical-[-(^-rhamnosyl)) A 9-Psa: L-rhamnolide) in the case of oxoxin A 9-Pm 3: admixture of spinoxin A 9-Psa (2.1 g, 3.86) in cold (0 ° C), with appropriate stirring mmol) and pyridine p-toluenesulfonate (1.3 g, 5.17 mmol) in dry CH2C 1 2 (200 ml). The solution contains powdered 4A molecular sieves (2.6 g), dropwise within 20 minutes. Add a solution of 0_ (2,3,4_tri-0-ethyl-ct-L-rhamnylpyrimosyl) trichloroimine acetate (5.0 g, 12.75 mmol) in CH2C12 (20 mL) After 3 hours at 0 ° C, another portion of a solution of imidate (2.0 g) in CH2C12 (6 mL) was added. Then the cooling bath was removed and the reaction mixture was stirred at room temperature for 16 hours. Then more was added Imide (0.8 g). After another 7 hours, the reaction mixture was filtered through diatomaceous earth, the diatomaceous earth was washed with CH2C12 (25 mL), and the filtrate was combined with K saturated Na2CO3 (2X 80 mL) and washed. Dry (MgS04). The concentrate left 11.5 g of residue, which was subjected to flash chromatography on silica (700 mL) using 3% MeOH in CH2C12 as eluent to give 2.0 g (67%) of compound a) 9 -0- (2,3,4-tri-0-ethyl-ct rhamnosyl) Spinoxin A 9-Psa: 9-0- (2,3,4-tri-0-ethyl- 々-1 ^ -rhamnosyl) Spinoxin A 9-Psa 3: 1 mixture. The mixture was separated by HPLC through a 21.4 nim (id) x 20 cm (l) Rainin reverse-phase C18 column using 4% H2O (containing 0.01% NH40H) in methanol as the eluent into about 200 rags. part. -Atropisomers first precipitate. Compound b) 9-0- (2,3,4-tri-0-ethyl- / 3-1 ^ -rhamnosyl) Spinoxin / \ 9-Psa: 0.35 g; colorless foam ; IMR (CDC13) δ 4.36 (s, 1, this paper size applies Chinese National Standard (CNS) A4 specification (21QX 297 mm) (Please read the precautions on the back before filling this page)

、1T f 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(71 ) H-1’),4.45 (m,2,H-l”,H-9)。化合物 c)9-0-(2,3,4-三-0-乙基-α-L-鼠李糖基)史賓諾辛A 9-Psa; 1·2 g, 無色泡沫體;IMR (CDC13) δ 4.43(bd,1,H-l”),4·47( s,1,H -1 ’)。 實淪例Α -腼基史窨諾辛丄 將氯丁二醯亞胺(104.7 mg,0.78 mmol)之二氯甲 烷(2.6 ml)懸浮液在氮氣下冷卻至-78°C。將異丙硫醚(12 5&quot; 1,0.86 mmol)加至懸浮液中並將混合物在-781C下攪 拌0.5 hr。接著將史賓諾辛J (184· 6 rag,0,26 mmol)之 二氯甲烷(1 ml)溶液媛媛加入。當添加完成時,將溶液在 -78°C下攪拌6.25 hr,及接著加入三乙胺(109以L,0.78 min〇 1),及將溶液加去至室溫使圼紅色。於加熱後,加入 Et2〇(6 mL)5%MeOH之二氯甲烷溶液為溶析液纯化,Μ獲 得無色半-固體之3’-醒基史賓諾辛J (151.2 mg,82%)。 部份1NMR (CDCM δ 6.87(bs,1H),5.88(d,1H) ; 5·81( dt,1Η) ; 5,03 (s,1Η) ; 4·70 (m,1Η) ; 4,44 (bd,1Η); 4.35(bd,1H) ; 13HMR (CDC 13) δ 204,203 ppid 〇 管胞例A 47-(4’R)_4’-去甲氢某-4’_胺基中窨諾辛A · 於4’-酮基史賓諾辛K (115.3 mg,0.16 mmol)之甲醇 (2 m 1)溶液中,加入乙酸鞍(149.3 mg * 1 · 9 mmo 1),接著 加入氰硼氫化物(10 mg,0.16 mmol)。在室溫下攪拌反應 混合物7小時。接著M IN HC1稀釋混合物並Μ乙醚清洗。 接著Μ新鮮乙醚萃取。KMgS〇4乾燥,及在減壓下於室溫 蒸發。藉由層析在氧化矽上分離粗產物,於單一步驟中Μ -74 - 本纸張尺度適用中國國家標準(CNS ) Α4規格(210.Χ 297公釐) I-----If (請先閱讀背面之注意事項再填寫本頁) 、11 經濟部中央標準局員工消費合作社印製 487559 A7 _____ B7 五、發明説明(72 ) 10%甲醇之二氯甲烷溶液及接著Μ 50%甲醇之二氯甲烷溶 液進行溶析。(4 D-4夂去甲氧基-4’-胺基史賓諾辛A (23 .3 mg ; 20%產率)為無色玻璃狀物,經分離後為極性最大 的物質。FDMS,m/e(相對強度)717 (60) : 716(M*,100) ,142(35) , 114(30) 〇 啻細例A 48-2’-氯基- 3’-烯某-关甲氬某-中嘗諾辛Η 依實施例3所述方法進行反應Μ製備史賓諾辛A 9-Psa,利用史賓諾辛Η分別與史賓諾辛J (5.02gm,7.0 mmol)、N-氯丁二醯亞胺(2·68 gm,20 mmol)、二氯甲院( 90 inL),二甲硫醚(3.1 roL,42.0 mmol),三乙胺(2.8 mL ,21.0 mmol)及碳酸鉀(12·8 gm,92.2 mmol)之 35: 65 混 合物。可得史賓諾辛A 9-Psa (2.32 gm ; 94%產率,以史 賓諾辛J為基準)及21-氧-3 烯基4’-去甲氧基-史賓諾辛 k Η (290 mg ; 55%產率,Μ史賓諾辛Η為基準),FDMS,m/ e(相對強度)684 (M+,30),683 (100),為白色固體。 啻_例A 49-2 (a-L-2.3.4-三甲某鼠李煻基)中窨諾 辛Η 3·- 三-0-甲某鼠李糖某)中嘗諾辛,1 於史賓諾辛Η及史賓諾辛J (分別為35 : 65,1.0 gm ,1.44 mmol)於無水二氯甲烷之溶液中,加入1-溴_2,3,4 -三-0-乙醯基鼠李糖1 (1.26 g,3.57 mmol),接著加入二 異丙胺(301 ml,1·73 mmol)及接著加入三氟甲基磺酸銀 (456.8 mg,1.73 mmol)。反應混合物在室溫及暗室下攬 拌2天。混合物接著以二氯甲烷稀釋及Μ水清洗。過滤二 氯甲烷以去除不溶性物質,MMgSO 4乾燥,及在室溫及減 -75 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公慶) |衣--- (請先閱讀背面之注意事項再填寫本頁) 、11 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(73 ) 壓下濃縮。藉由氧化矽上之層析自未反應之起始物質分離 出粗產物,M5%MeOH之CH2C12溶液為溶析液。粗產物混 合物藉由製備型HPLC在C18管柱中純化,K乙睛:甲醇: 0.1%心4(^。(42.5:42.5:12.5至 45:45:10以90分鐘之 線性梯度)為溶析液。所得化合物a)2’-(a -L-2,3,4-三-0 -甲基鼠李糖基)史賓諾辛Η (47 mg),FDMS,m/s(相對強 度)990 (ΙΓ,100)及化合物 1&gt;)3’-(3-1^2,3,4-三-0-甲基鼠 李糖基)史賓諾辛J (16 mg),FDMS,m/e(相對強度)990 ( M+,25),989 (70),988 (70),為白色固體。 iFisher, E·; Bergmann, M·; A· Chem. Ber· 1920, 53, 2363, 富敝例A 50-2’-(H-锊某)亞防某中W諾辛Η 於粗2’-酮基史賓諾辛Η (238.3 mg,0.33 mmol)及羥 基胺氫氯化物(24.9 mg,0.36 mmol)之纯乙醇(10 ml)溶 液,加入無水乙酸鈉(60.0 mg,0.73 nunol)。在室溫下攪 拌反應混合物3小時。接著Μ二氯甲烷稀釋混合物,以水 、鹽水清洗,KNa2 S0 4乾燥及於室溫及減壓下蒸發。產物 藉由氧化矽之層析純化* Μ 5%甲醇之二氯甲烷溶液為溶 析液。所獲得之2’-(Ν-羥基)亞胺基史賓諾辛Η (73.9 rag) 為白色固體,FDMS,in/e (相對強度)731 (fT,50),73 (100 )° 啻腋例A 51-4夂酾某中窨諾辛Κ 利用史賓諾辛K (1.49 gin,2.07 nunol)依實施例A 46 所述方法進行反應。可得4’-嗣基史賓諾辛K (1.48 gin ; -76 - 本紙張尺度適用中國國家標準(CNS ) A4規格(2!0X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 、•&quot;口 -—J— I HJ. · 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(74 ) 約100%產率),為具黏性白色固體,FDMS,ro/e (相對強度 )715(M♦,:100)。 啻_例A 52-2 ’ - (N-經某)亞胺某-4 ’ -去甲—氯基-3 ’4 ·-去-氳 中客諾辛Η ____ 利用2·-氧-3;-烯基-4’-去甲氧基史賓諾辛Η (579.8 mg,0.85 nunol)為起始物質,依實施例A 50所述方法進行 反應。可得2’-(N-羥基)亞胺基-4’-去甲氧基-33,4’-去氬 史賓諾辛Η (223 mg,42%產率,K回收之起始物質為基 準)稍白色固體。FDMS,m/e (相對強度)699 (M+,70),698 (100) 〇 g _例A 53-9-0-2 4-三-0-乙基-a -L-鼠李糖基史賓諾 幸A 9-Pm举戍二酪鹽_ 將化合物9-0-2,3,4-三-0-乙基- a -L-鼠李糖基)史 賓諾辛 A 9-Psa(99.6 mg,0.128 mmol)溶於 2 mL 丙酮及 加入戊二酸(8.5 mg,0.064 mmol)之2 mL丙酮溶液。將溶 液攪拌3小時後,接著在減壓下去除溶劑。可獲得化合物 9-0-2,3,4-三-0-乙基-(1-1^鼠李糖基史賓諾辛义9砰33 半戊二酸鹽* 105.7 mg,分析估計值,對C^HziNio· 1/2 (C5H0〇4) : C 66.48,Η 8·99,Ν 1·67 ;實際值 C 66.30 ,Η 8·58 * Ν 1·71 ; mp.76-82lC。 管嫩例A 54-3’ -Π-Ζ某中窨諾辛J半戍二酴錄_ 將化合物3’-0_乙基史賓諾辛J (130.4 mg,0.174 mmol)溶於2 mL丙酮及加入戊二酸(11.5 mg,0.087 mmol) 之2 inL丙酮溶液。將溶液攪拌隔夜。蒸發溶劑可獲得3'-0 一 ΊΊ 一 本纸張尺度適用中國园家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)1T f 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (71) H-1 '), 4.45 (m, 2, Hl ", H-9). Compound c) 9-0- (2,3,4-tri-0-ethyl-α-L-rhamnosyl) Spinoxin A 9-Psa; 1.2 g, colorless foam; IMR (CDC13) δ 4.43 (bd, 1, Hl "), 4.47 (s, 1, H -1 '). Example A-Benzyl sulfoxanoxine A suspension of chloropreneimine (104.7 mg, 0.78 mmol) in dichloromethane (2.6 ml) was cooled to -78 ° C under nitrogen. Isopropyl sulfide (125 &quot; 1, 0.86 mmol) was added to the suspension and the mixture was stirred at -781C for 0.5 hr. Then a solution of Spinozin J (184. 6 rag, 0, 26 mmol) in dichloromethane (1 ml) was added. When the addition was complete, the solution was stirred at -78 ° C for 6.25 hr, and then triethylamine (109 L, 0.78 min. 1) was added, and the solution was added to room temperature to make the ochre red. After heating, Et20 (6 mL) in 5% MeOH in dichloromethane was added to purify the eluent, and M was obtained as a colorless semi-solid 3'-pentyl spinosin J (151.2 mg, 82%). 1NMR (CDCM δ 6.87 (bs, 1H), 5.88 (d, 1H); 5.81 (dt, 1Η); 5,03 (s, 1Η); 4.70 (m, 1Η); 4,44 (bd, 1Η); 4.35 (bd, 1H); 13HMR (CDC 13) δ 204,203 ppid 〇 Cyst example A 47- (4'R) _4'-dehydrohydrogen-4'_amino Nosin A · To a solution of 4'-ketospinoxin K (115.3 mg, 0.16 mmol) in methanol (2 m 1), add saddle acetate (149.3 mg * 1 · 9 mmo 1), followed by cyanoborohydride (10 mg, 0.16 mmol). The reaction mixture was stirred at room temperature for 7 hours. Then the mixture was diluted with M IN HC1 and washed with ether. Then extracted with fresh ether. KMgSO was dried and evaporated under reduced pressure at room temperature. Separate the crude product on silica by chromatography, in a single step M -74-This paper size applies to China National Standard (CNS) A4 specification (210. × 297 mm) I ----- If ( Please read the precautions on the back before filling this page), 11 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 _____ B7 V. Description of the Invention (72) 10% methanol in dichloromethane solution and then 50% methanol The dichloromethane solution was eluted. (4 D-4 夂 desmethoxy-4'-aminospinoxin A (23.3 mg; 20% yield) is a colorless glass, which is the most polar substance after separation. FDMS, m / e ( Relative strength) 717 (60): 716 (M *, 100), 142 (35), 114 (30) 〇 啻 Detailed example A 48-2'-Chloro-3'-ene-Methyl-Methyl Argon-Middle Spinoxin 反应 was reacted according to the method described in Example 3 to prepare Spinoxin A 9-Psa. Spinoxin 与 was used with Spinoxin J (5.02gm, 7.0 mmol) and N-chloroprene respectively. Stilbene imine (2.88 gm, 20 mmol), chloroform (90 inL), dimethyl sulfide (3.1 roL, 42.0 mmol), triethylamine (2.8 mL, 21.0 mmol), and potassium carbonate (12 · 8 gm, 92.2 mmol) in a 35: 65 mixture. Spinozin A 9-Psa (2.32 gm; 94% yield based on Spinozin J) and 21-oxy-3 alkenyl 4 ' -Demethoxy-spinoxin k Η (290 mg; 55% yield, based on M-spinoxin Η), FDMS, m / e (relative strength) 684 (M +, 30), 683 (100 ) As a white solid.例 _Example A 49-2 (aL-2.3.4-Rhamnosaurus sylvestris) in Chinese 窨 Nosin Η 3 · -Tri--0-Rhamnos sylvestris in Chinese) tastes Nosin, 1 in Spinoxin And Spinozin J (35:65, 1.0 gm, 1.44 mmol, respectively) in a solution of anhydrous dichloromethane, and 1-bromo_2,3,4-tri-0-ethynylrhamnose 1 was added. (1.26 g, 3.57 mmol), followed by diisopropylamine (301 ml, 1.73 mmol) and then silver trifluoromethanesulfonate (456.8 mg, 1.73 mmol). The reaction mixture was stirred at room temperature and in a dark room for 2 days. The mixture was then diluted with dichloromethane and washed with water. Filter dichloromethane to remove insoluble matter, dry with MMgSO 4 and reduce the temperature at room temperature and minus -75-This paper size applies Chinese National Standard (CNS) A4 specification (210X297 public celebration) | Clothing --- (Please read the back first Note: Please fill in this page again), 11 487559 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (73) It is concentrated under pressure. The crude product was separated from the unreacted starting material by chromatography on silica. The CH2C12 solution of M5% MeOH was the eluent. The crude product mixture was purified by preparative HPLC in a C18 column, K acetonitrile: methanol: 0.1% Xin 4 (^. (42.5: 42.5: 12.5 to 45:45:10 with a linear gradient of 90 minutes) as the elution Compound a) 2 '-(a -L-2,3,4-tri-0-methylrhamnosyl) Spinoxin (47 mg), FDMS, m / s (relative strength) 990 (ΙΓ, 100) and compound 1>) 3 '-(3-1 ^ 2,3,4-tri-0-methylrhamnosyl) Spinoxin J (16 mg), FDMS, m / e (relative intensity) 990 (M +, 25), 989 (70), 988 (70), as a white solid. iFisher, E .; Bergmann, M .; A. Chem. Ber. 1920, 53, 2363, Rich Example A 50-2 '-(H- 锊) Asia Defense W. NosingΗ in rough 2'- A solution of ketospinoxine (238.3 mg, 0.33 mmol) and hydroxylamine hydrochloride (24.9 mg, 0.36 mmol) in pure ethanol (10 ml) was added to anhydrous sodium acetate (60.0 mg, 0.73 nunol). The reaction mixture was stirred at room temperature for 3 hours. The mixture was then diluted with M dichloromethane, washed with water and brine, dried over KNa2S04 and evaporated at room temperature under reduced pressure. The product was purified by silica chromatography * M 5% methanol in dichloromethane was used as the eluent. The obtained 2 '-(N-hydroxy) imino-spinodinolide (73.9 rag) was a white solid, FDMS, in / e (relative strength) 731 (fT, 50), 73 (100) ° 啻 axillary cases A 51-4: A certain intermediate Nosin K was reacted using Spinozin K (1.49 gin, 2.07 nunol) according to the method described in Example A 46. Available 4'- 嗣 基 Spinozin K (1.48 gin; -76-This paper size is applicable to China National Standard (CNS) A4 specifications (2! 0X 297 mm) (Please read the precautions on the back before filling this page ) 、 · &Quot; 口 -—J— I HJ. · 487559 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (74) about 100% yield), is a sticky white solid, FDMS, ro / e (relative intensity) 715 (M ♦, 100).例 _Example A 52-2 '-(N- via a certain) imine a-4' -nor-chloro-3 '4 · -to- 氲 neutronoxin ____ using 2-oxygen -3; -Alkenyl-4'-demethoxyspinoxine (579.8 mg, 0.85 nunol) was used as the starting material, and the reaction was carried out according to the method described in Example A50. 2 '-(N-Hydroxy) imino-4'-desmethoxy-33,4'-deargon spinosynoxine (223 mg, 42% yield, the starting material for K recovery is Benchmark) Slightly white solid. FDMS, m / e (relative intensity) 699 (M +, 70), 698 (100) 〇g _Example A 53-9-0-2 4-tri-0-ethyl-a-L-rhamnosyl spine Nuoxin A 9-Pm is an example of bis-butyric salt_ Compound 9-0-2,3,4-tri-0-ethyl-a-L-rhamnosyl) Spinoxin A 9-Psa (99.6 mg, 0.128 mmol) was dissolved in 2 mL of acetone and a solution of glutaric acid (8.5 mg, 0.064 mmol) in 2 mL of acetone was added. After the solution was stirred for 3 hours, the solvent was then removed under reduced pressure. Compound 9-0-2,3,4-tri-0-ethyl- (1-1 ^ rhamnospinyl spinosynin 9 bang 33 hemiglutarate * 105.7 mg can be obtained. C ^ HziNio · 1/2 (C5H0〇4): C 66.48, Η 8.99, Ν 1.67; actual value C 66.30, Η 8.58 * Ν 1.71; mp.76-82lC. Tube tender example A 54-3 '-Π-Z A certain midoxoxin J semi-analcoholic _ _ Compound 3'-0_ ethylspinoxin J (130.4 mg, 0.174 mmol) was dissolved in 2 mL of acetone and glutaric acid was added 2 inL acetone solution of acid (11.5 mg, 0.087 mmol). Stir the solution overnight. Evaporate the solvent to get 3'-0. A paper size is applicable to China Garden Standard (CNS) A4 (210X 297 mm). (Please read the notes on the back before filling this page)

487559 A7 __. B7 五、發明説明(75 ) -乙基史賓諾辛J半戊二酸鹽,131 mg。分析估計值,對 CuHuNO&quot;· 1/2(C5H0〇4) : C 65.82,Η 8,81,Ν 1·72; 實際值 C 65·65,Η 8,46,Ν 1.72; mp.75-82QC。 啻施例A 55-3 ’-Ο-十五氘Ζ某中窨諾辛J半戍二醜翰 將化合物3’-0-十五氘乙基史賓諾辛J (97.4 mg, 0.129 mmol)溶於3 mL丙酮及加入戊二酸(8.6 mg,0.065 mmol)之2 niL丙酮溶液。將溶液在室溫下攪拌2小時。減 壓下蒸發溶劑可獲得化合物3’-0-十五氘乙基史賓諾辛J 半戊二酸鹽,102 mg。分析估計值,對C42HS2N(hQD5 · 1 /2(C5H8(U) : C 65·02,Η 9.27,N 1.70;實際值 C 65.12,Η 9·01,Ν 1·85; mp.104- 114〇C。 管淪例A 56-5.卜二氩-3^0-η-丙基中窨諾辛J半戍二酴 鹽_ 將化合物5,6-二氫丙基史賓諾辛J (88.3 mg ,0.115 mmol)溶於3 inL丙酮及加入戊二酸(7.5 mg, 0,056 mmol)之2 inL丙酮溶液。將溶液在室溫下攪拌隔夜 。在減壓下蒸發溶劑,獲得化合物5,6-二氫-3’丙基 史賓諾辛J半戊二酸鹽,86,1 mg。分析估計值,對 C43H71NO&quot; - l/2(C5Ha〇4) : C 65·99,Η 9.12,N 1.69; 實際值C65*30,Η 10·00,Ν 1·77 ; mp.74-84°C。 啻_例A 57-.V -η-ζ基中窨諾辛L半rg二酪鹽 將化合物3’-0-乙基史賓諾辛L (84.2 mg,〇·11〇 mmol)溶於3 mL丙嗣及加入戊二酸(7 · 5 mg,0 · 056 mmo 1) 之3 mL丙銅溶液。將溶液在室溫下攪伴隔夜。在減壓下蒸 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐)487559 A7 __. B7 V. Description of the Invention (75) -Ethyl Spinosin J Hemovalerate, 131 mg. Analyze estimated values for CuHuNO &quot; · 1/2 (C5H0〇4): C 65.82, Η 8,81, Ν 1.72; actual value C 65 · 65, Η 8,46, Ν 1.72; mp.75-82QC . Example A 55-3 '-O-Fifteen deuterium Zn Some of the novosin J half a dioxin dissolves the compound 3'-0-pentadeutero ethyl spinosin J (97.4 mg, 0.129 mmol) To 3 mL of acetone and glutaric acid (8.6 mg, 0.065 mmol) in 2 niL of acetone was added. The solution was stirred at room temperature for 2 hours. The solvent was evaporated under reduced pressure to obtain the compound 3'-0-pentadecylethyl spinosin J hemiglutarate, 102 mg. Analyze the estimated values for C42HS2N (hQD5 · 1/2 (C5H8 (U): C 65 · 02, Η 9.27, N 1.70; actual values C 65.12, Η 9 · 01, Ν 1.85; mp.104-114〇 C. Examples of tube A 56-5. Dioxane-3 ^ 0-η-propyl chrysinoxine J semi-stilbene disulfonium salt_ Compound 5,6-dihydropropylspinoxin J (88.3 mg , 0.115 mmol) was dissolved in 3 inL acetone and a 2 inL acetone solution of glutaric acid (7.5 mg, 0,056 mmol) was added. The solution was stirred at room temperature overnight. The solvent was evaporated under reduced pressure to obtain compound 5,6-di Hydrogen-3'propyl Spinocinol J hemiglutarate, 86,1 mg. Analytical estimate for C43H71NO &quot;-l / 2 (C5Ha〇4): C 65 · 99, Η 9.12, N 1.69; Actual Value C65 * 30, Η 10 · 00, Ν 1.77; mp. 74-84 ° C. 啻 _ Example A 57-.V-η-ζ group innosine L half rg di caseinate compound 3 ' -0-Ethyl Spinocinol L (84.2 mg, 0.10 mmol) was dissolved in 3 mL of propionate and 3 mL of a solution of propylene copper with glutaric acid (7.5 mg, 0. 056 mmo 1) was added. The solution is stirred at room temperature overnight. Steamed under reduced pressure. The paper is sized to the Chinese National Standard (CNS) A4 (210X 297 mm).

I- -1 - I I (請先閱讀背面之注意事項再填寫本頁) 、11 經濟部中央標準局員工消費合作社印製 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(76 ) 發溶劑,獲得化合物3*-0-乙基史賓諾辛L半戊二酸鹽, 91.0 mg。分析估計值,對CnHsgNOiD · l/2(C5H8〇4) ·· C66.16,Η 8·90,Ν 1·69;實際值 C65.43,Η 9.16,N 1.69 ; mp.77-82t! 〇I- -1-II (Please read the precautions on the back before filling out this page), 11 Printed by the Consumers 'Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 5. Description of the invention (76 ) Solvent, to obtain compound 3 * -0-ethylspinoxin L hemiglutarate, 91.0 mg. Analyze the estimated values for CnHsgNOiD · 1/2 (C5H8〇4) · C66.16, Η 8.90, N 1.69; actual values C65.43, Η 9.16, N 1.69; mp.77-82t! 〇

管施例八58-(3,5)-4’-关申_:^-关氯-3,-「(1?)-(〇-甲氯 基,α -丙醯氯)甲基1Φ窨諾辛J及(3’S)-A1 去甲'V-去氬'V-「(S)-(a -甲氬基,a -¾ 醯氯)甲基1中窨諾辛J 將化合物3*-0-三氟甲磺醯基史賓諾辛J (488 ms, 0,574 ππηοΐ)溶於乾DMF(20 niL)。加入丙酸筢化合物與丙 酸(1.09 g,過量)。將反應混合物冷卻至室溫,同時Μ 660 W超音波振盪(55%振幅)15分鐘。加入PhH (70 ml)及 Et0Ac(70 ml)。M2%aq.NaHC〇3 溶液(2X )及飽和 aq. NaHC〇3(lx )清洗溶液。將有機相MK2C〇3乾燥並於減壓下 濃縮。殘餘物藉由Si〇2閃蒸管柱層析純化以獲得混合物( 275 mg)。此樣品接著藉由重復RF C-18 HPLC(MeOH-H2〇 : 90-10)以獲得化合物a) (3’S)-4’-去甲-3’-[(10-U -甲氧 基,cx-丙醯氧)甲基]史賓諾辛J ; 62 mg,23%) : IMIU CDC13)5 5.96(1H,d: 9.2 Hz)4.99(lH,s)ppm及化合物 b )(3’S)-4·-去甲-3’-去氧-3’_[(S)~(oc-甲氧基,oc-丙醯 氧)甲基]史賓諾辛 J ; 84 mg,31% : IMMCDCIO δ 5·89 (·1Η,dd: 9·4,1.2 Hz),4·99(1Η,bs)。化合物 C(3’)之 立體異構化學可藉由NOEDS及分子模型结果而證實。 -79 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先間讀背面之注意事項再填寫本頁)Example 8 58- (3,5) -4'-guanshen_: ^ -guanchloro-3,-"(1?)-(〇-methylchloro, α-propanyl chloride) methyl 1Φ 窨Norsin J and (3'S) -A1 Nor'V-Deargon'V-"(S)-(a -Methylarginyl, a -¾ 醯 chloro) methyl 1 Nornosine J will compound 3 *- 0-trifluoromethanesulfenylspinoxin J (488 ms, 0,574 ππηοΐ) was dissolved in dry DMF (20 niL). The phosphonium propionate compound and propionic acid (1.09 g, excess) were added. The reaction mixture was cooled to room temperature At the same time, 660 W ultrasonic vibration (55% amplitude) for 15 minutes. Add PhH (70 ml) and Et0Ac (70 ml). M2% aq. NaHC〇3 solution (2X) and saturated aq. NaHC〇3 (lx) The solution was washed. The organic phase MK2CO3 was dried and concentrated under reduced pressure. The residue was purified by Si02 flash column chromatography to obtain a mixture (275 mg). This sample was then repeated by repeating RF C-18 HPLC (MeOH-H20: 90-10) to obtain compound a) (3'S) -4'-nor-3 '-[(10-U-methoxy, cx-propionyloxy) methyl] Spinol Xin J; 62 mg, 23%): IMIU CDC13) 5 5.96 (1H, d: 9.2 Hz) 4.99 (lH, s) ppm and compound b) (3'S) -4 · -demethyl-3'-deoxy- 3 '_ [(S) ~ (oc-methoxy, oc-propylhydrazone (Oxy) methyl] Spinocinin J; 84 mg, 31%: IMMCDCIO δ 5.89 (· 1Η, dd: 9.4, 1.2 Hz), 4.99 (1Η, bs). Compound C (3 ' ) The stereoisomeric chemistry can be confirmed by NOEDS and molecular model results. -79-This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page )

、1T 487559 A7 B7 五、 發明説明(77 基)申基1中曹諾辛 將化合物3’-0-三氟甲磺醯基史賓諾辛J (496 mg, 0.583 mraol)溶於乾DMF(14 mL)。加入氯化鋰(1.80 g,過 量)。將反應混合物冷卻至室溫,同時K超音波振盪(660W ,52%振幅)7分鐘。溶液以稀釋之鹽水(2X )及水(2X )清 洗。有機層MK2C〇3乾燥、過濾及減壓濃縮。將殘餘物在 短Si〇2/EtOAc管柱中純化及接著重複地藉由RP C-18 HPLC (MeOH-H2〇 : 92-8)純化。純化記錄所產生之差向異構物( 3’5)-4'-去甲-3’-去氧[1?/5-3-氯-3-甲氧基)甲基]史賓諾 辛 J ;45mg,ll%:5.02(0.5H,s),5,00(0.5H,s), 4.57(0,5 H,d: 9.5 Hz),4.55(0.5 H,d: 4.5 Hz), 2.16(6 Η,2x CH3,s) 〇 富施例AfiO_(:TS)_4’-去甲-3夂去氬「(R)-(rr-氟,α -甲 氬某)甲基1中窨諾辛·:[ (3’5;)-4’-去甲-3^ 去氬f (S) - ( cr -氣,σ -甲氬某)申基1中窨諾 辛J_ 經 濟 部 中 央 標 準 局 員 工 消 費 合 社 印 製 (請先閱讀背面之注意事項再填寫本頁) 將化合物史賓諾辛J (697 mg,0.97 mmol)溶於乾甲 苯(10 mL)。在氮氣下拌隨攪拌加入吡啶(1 ml)及二乙胺 硫三氟化合物(D AST ;0· 70 mmol,0.85 g,5,2 ππηοΐ)。 使反應混合物立刻升溫至沸點。於10分鐘後,使溶液冷卻 至室溫。加入苯(50 ml)及EtO Ac (75 ml)。Μ 5% aq. NaHCOa水溶液清洗溶液。有機層MK2C〇3乾燥並於減壓下 湄縮。殘餘物藉由閃蒸Si〇2管柱(80 g/EtOAc)分離以獲得 白色固體(626 mg)。此樣品之一部份(400 mg)係進一步利 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 80 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(78 ) 用 RF C-18 HPLC,(MeOH-H2〇 : 90-10)分離Μ 獲得化合物 a)( 3’5)-4’-去甲-3’_去氧[(1〇-(«-氟,《-甲氧基)甲基]史 賓諾辛 J ; 82 rog,21% ·· IMIUCDCUSS.Uidd: 66·3 ,5.4Hz)ppm及化合物 b) (3’S)-4’-去甲-3*-去氧[(S)-(ct -氟,α -甲氧基)甲基]史賓諾辛J ; 292 mg,64% ): ^MRiCDCla) 5 5.26(dd : 65.1 * 8.6 Hz) ppm 〇 富觖例 AfU-H’S,2’S)-n’-(2’S)lg 基 _2’-去 M-氣中 客諾辛H_ 將化合物史賓諾辛H (916 mg,1.28 mmol)溶於乾甲 苯(15 mL)。加入吡啶(1.8 ml)。將溶液在氮氣下加熱至 迴流溫度。在加熱過程開始時,加入DAST (0.62 ml,4.6 mmol)。於沸騰10分鐘後,將反應混合物冷卻至室溫並小 心地 K5%aq.NaHC〇3 驟冷。加入苯(50 ml)及 EtOAc(75 ml )。M5%aq.NaHC〇3(3x )清洗溶液。有機層以K2C〇3乾燥 並於減壓下濃縮。殘餘物藉由閃蒸Si〇2管柱(100 g/Et0Ac )純化,收集溶析份可獲得化合物(l’S,2’S)-[l-(2’S)] 甲基-2’-去氧-氟史賓諾辛Η ; 992 mg,72% : IMIU CDC13) δ 4.99(dd : 52·8,7·0 Hz)ppm。 管胞例A fi2-3’(E)-(N-n-丁基)亞胺蓽中窨諾辛J_ 將化合物3^0-三氟甲磺醯基史賓諾辛J (591 mg, 〇·695 ιαπιοί)溶於乾 DMF(20 mL)。加入 15%TBAF/Al2〇3( 2·7 g,過量)。將反應燒瓶置於水冷卻浴中並以660 W超音 波振盪(55%振幅)10分鐘。加入Et0Ac(5 0 ml)及PhH(70 ml)。過滤溶液,K水(3x )萃取及MK2C〇3乾燥。有機層 _ 81 _ 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝· 經濟部中央標準局員工消費合作社印製 487559 A7 ___ B7__ 五、發明説明(79 ) 於減壓下萃取。殘餘物藉由閃蒸層析管柱(Si〇2,75 g/Et 0Ac)分雛Μ提供化合物(3’((E)-(N-n-丁基)亞胺基史賓諾 辛 J ; 144 mg,23% : IMRiCDCM 34·81(1Η,d: 2·0 Hz)ppm 0, 1T 487559 A7 B7 V. Description of the invention (77 group) Zoynin in compound Shen 3 dissolves compound 3'-0-trifluoromethanesulfonylspinoxin J (496 mg, 0.583 mraol) in dry DMF (14 mL). Add lithium chloride (1.80 g, excess). The reaction mixture was cooled to room temperature while K-ultrasonic (660 W, 52% amplitude) was oscillated for 7 minutes. The solution was washed with diluted saline (2X) and water (2X). The organic layer MK2CO3 was dried, filtered and concentrated under reduced pressure. The residue was purified on a short SiO2 / EtOAc column and then repeatedly purified by RP C-18 HPLC (MeOH-H20: 92-8). Epimeric (3'5) -4'-nor-3'-deoxy [1? / 5-3-chloro-3-methoxy) methyl] spinoxin produced by purification records J; 45mg, ll%: 5.02 (0.5H, s), 5,00 (0.5H, s), 4.57 (0,5 H, d: 9.5 Hz), 4.55 (0.5 H, d: 4.5 Hz), 2.16 (6 Η, 2x CH3, s) 〇 Rich example AfiO _ (: TS) _4'-nor-3 夂 argon "(R)-(rr-fluorine, α-methyl argon) methyl 1 methylpyridine Xin: [(3'5;)-4'-demethyl-3 ^ deargon f (S)-(cr-gas, σ-methylargon) Shen Ji 1 Zhong Nuoxin J_ Central Bureau of Standards, Ministry of Economic Affairs Printed by Employee Consumer Corporation (please read the notes on the back before filling this page) Dissolve the compound Spinoxin J (697 mg, 0.97 mmol) in dry toluene (10 mL). Stir under nitrogen and add pyridine (1 ml) and diethylaminethiotrifluoro compound (D AST; 0.70 mmol, 0.85 g, 5,2 ππηοΐ). The reaction mixture was immediately warmed to the boiling point. After 10 minutes, the solution was cooled to room temperature. Benzene (50 ml) and EtO Ac (75 ml) were added. M 5% aq. NaHCOa aqueous solution was washed. The organic layer MK2C03 was dried and reduced under reduced pressure. The residue was evaporated by flash evaporation. 2 column (80 g / EtOAc) separation to obtain a white solid (626 mg). A part of this sample (400 mg) is further optimized. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 80 487559 Printed by A7 B7, Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (78) RF C-18 HPLC, (MeOH-H2O: 90-10) was used to isolate M to obtain compound a) (3'5) -4 '-Desmethyl-3'_deoxy [(1〇-(«-fluoro," -methoxy) methyl] Spinozin J; 82 rog, 21% · · IMIUCDCUSS. Uidd: 66 · 3, 5.4Hz) ppm and compound b) (3'S) -4'-nor-3-3-deoxy [(S)-(ct-fluoro, α-methoxy) methyl] Spinoxin J; 292 mg , 64%): ^ MRiCDCla) 5 5.26 (dd: 65.1 * 8.6 Hz) ppm 〇 Rich example AfU-H'S, 2'S) -n '-(2'S) lg radical_2'-to M-gas in the noroxin H_ The compound spinoline H (916 mg, 1.28 mmol) was dissolved in dry toluene (15 mL). Pyridine (1.8 ml) was added. The solution was heated to reflux temperature under nitrogen. At the beginning of the heating process, DAST (0.62 ml, 4.6 mmol) was added. After boiling for 10 minutes, the reaction mixture was cooled to room temperature and carefully quenched with K5% aq. NaHC03. Add benzene (50 ml) and EtOAc (75 ml). M5% aq. NaHC03 (3x) washing solution. The organic layer was dried over K2CO3 and concentrated under reduced pressure. The residue was purified by flashing a Si02 column (100 g / Et0Ac), and the eluate was collected to obtain the compound (l'S, 2'S)-[l- (2'S)] methyl-2'-deoxy-fluoro history. Binoxine Η; 992 mg, 72%: IMIU CDC13) δ 4.99 (dd: 52 · 8, 7.0 Hz) ppm. Example of tracheids A fi2-3 '(E)-(Nn-butyl) imine hydrazone oxoxine J_ Compound 3 ^ 0-trifluoromethanesulfonyl spinosinoxine J (591 mg, 〇 · 695 ιαπιοί ) Dissolved in dry DMF (20 mL). 15% TBAF / Al203 (2.7 g, excess) was added. The reaction flask was placed in a water cooling bath and sonicated (55% amplitude) at 660 W for 10 minutes. Et0Ac (50 ml) and PhH (70 ml) were added. The solution was filtered, extracted with K water (3x) and dried over MK2CO3. Organic layer _ 81 _ This paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) (Please read the precautions on the back before filling this page)-Installed · Printed by the Central Consumers Bureau of the Ministry of Economic Affairs 487559 A7 ___ B7__ 5. Description of the invention (79) Extraction under reduced pressure. The residue was separated by flash chromatography column (SiO2, 75 g / Et 0Ac) to provide compound (3 '((E)-(Nn-butyl) imino spinosinol J; 144 mg , 23%: IMRiCDCM 34 · 81 (1Η, d: 2.0 Hz) ppm 0

蜜瓶例A 63-3 ?i;氘Z某中窨諾辛J 將化合物史賓諾辛J (882 mg,1.22 mmol)溶於二氯 甲烷(5 ml)。加入K2CO3 (1.42 g)。將反應燒瓶置於水冷 卻浴(ca. 10°C )。在攪拌時,加入 15%aq.NaOH(15 ml), 接著加入 ΤΕΒΑ-Π(0·92 g)及 NBiuHSOWO.30 g)。接著加 入C2D3I(5 g: 31 mmol)及在室溫下將反應混合物劇烈攪 拌48小時。接著加入二氯甲烷(100 ml)及水(1〇〇 ml)。於 萃取後進行相分離。有機層以水(2 X )清洗及在減壓下濃 縮。殘餘物在閃蒸Si〇2管柱(120 g/Et0Ac)中純化Μ獲得 化合物3’-0-十五氘乙基史賓諾辛J ; 815 rag,88% : IMlUCDCla) δ 6·64(1Η,bs),4.69(1H,d : 1.2 Hz), 3·43(3Η,CH3,s),3·36(3Η,CH3,s),2·10(6Η,2x CH3 » s)ppm° 啻細例A 64-3 ·-关氬-3,-偶Μ中窨諾辛J (1 : 1 3 ’R及3 ’S 滔合物)及(:TS)-4’-去甲_3’_去氯-3’-[( RS)_(a~偶氡,a -甲氯某)甲基1史賓告辛Honey bottle example A 63-3? I; deuterium Z in a certain unit of oxanosin J The compound spinoxin J (882 mg, 1.22 mmol) was dissolved in dichloromethane (5 ml). K2CO3 (1.42 g) was added. The reaction flask was placed in a water cooling bath (ca. 10 ° C). While stirring, 15% aq. NaOH (15 ml) was added, followed by ΤΒΑ-Π (0.92 g) and NBiuHSOWO. 30 g). C2D3I (5 g: 31 mmol) was then added and the reaction mixture was stirred vigorously at room temperature for 48 hours. Dichloromethane (100 ml) and water (100 ml) were then added. Phase separation was performed after extraction. The organic layer was washed with water (2X) and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (120 g / Et0Ac) to obtain the compound 3'-0-pentadecylethylspinoxin J; 815 rag, 88%: IMlUCDCla) δ 6.64 (1Η , Bs), 4.69 (1H, d: 1.2 Hz), 3.43 (3Η, CH3, s), 3.36 (3Η, CH3, s), 2.10 (6Η, 2x CH3 »s) ppm ° 啻Detailed example A 64-3 · -guan argin-3,-ΜMinosinoxin J (1: 1 3 'R and 3' S borohydride) and (: TS) -4'-demethyl_3 ' _Dechloro-3 '-[(RS) _ (a ~ Couple, a -methyl chloride) methyl 1 Spence

A 將化合物3’-0-三氟甲磺醯基(440'fflg,〇·518 mmol) 溶於乾DMP(20 ml)中。加入叠氮化納(1.44 g ’過量)。在 室溫下,將混合物超音波振盪(660W,55%振幅)1〇分鐘。 -82 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) •裝· 、vm 487559 經濟部中央標準局員工消費合作社印製 A7 _____. B7 五、發明説明(8〇 ) 加入 Et0Ac(50 ml)及 PhH(100 ml)。以 5%aq.KHC〇3 溶液(3 x )。有機層Manh.K2C〇3乾燥,過滤及在減壓下濃縮。殘 餘物藉由閃蒸管柱層析KSi〇2(50 g/EtOAc)並藉由RPC-18 HPLC (MeOH-H2〇: 88-12)以獲得化合物 a)3’_ 去氧-3’-偶氮史賓諾辛J ((1 : 1 3’R及3’S混合物);40 mg,10% :iNMlHCDCh) δ 4·83(0.5Η,d : 2·4Η),4·64(0·5Η,d : 2· 8 Hz),3.95(0.5Η,m),3.85(0·5Η,dd : 2·8,4.0Hz) ,3·81(0.5Η,in),2.17(6H,2XCH3,s)ppro 及化合物 b)( 3’S)-4’_ 去甲-3’-去氧-3'-[(RS)-(a-偶氮,α-甲氧基) 甲基]史賓諾辛 J ; 101 mg,26% : IMR (CDCM 3 5.00 ( 0·5Η , s) , 4·98(0·5Η , s) , 4·520·5Η , d : 9·9 Hz), 4,35(0.5H,d : 9.9Hz),2·14(6Η,2X CH3,s)ppm 〇 啻胞例 A 4’-去甲-去氢-氡, α -甲氬基)甲基1中窨諾辛.I 將化合物3’-0-三氟ΐ磺醯基史賓諾辛J (448 mg, 0.574 mmol)溶於乾DMF (20 ml)中。加入氯化鋰(1.80 g ,過量)。將混合物冷卻至室溫,同時使混合物超音波振 盪(660W,52% 振幅)7分鐘。加入PhH(70 ml)及Et0Ac(50 in 1)。溶液K稀釋之鹽水(2 x )及水(2 x )清洗。有機層K K 2C〇3乾燥、過滤及減壓濃縮。將殘餘物在短Si〇2/EtOAc管 柱中純化及接著重複地藉由RP C-18 HPLC(MeOH-H2〇: 92-8)純化。純化記錄所產生之(3’去甲-3’-去氧-3’-[ (RS)-a -氯,cx-甲氧基)甲基]史賓諾辛J的差向異構物 ;45 mg,11% : 5.02(0.5H,s),5·00(0·5 H,s), 本紙張尺度適用中國國家標準(CNS ) Α&lt;4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁) 裝- 訂 線 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(81 ) 4·57(0·5 H,d: 9.5 Hz),4.55(0,5 H,d: 4.5 Hz), 2· 16 (6 Η,2X CH3,s)。 當脓例A 66-5.fi-二氩-2’-Π_乙某中窨諾辛ϋ_ 將化合物5,6-二氫史賓諾辛?1(462 1^,0.64 111111〇1) 溶於二氯甲烷(6 ml)。加入碳酸鉀粉末(1·〇 g)。將反應 燒瓶置於水冷卻浴(ca, 10°C)。在攪拌時,加入l〇%aq· NaOH(15 ml),接著加入NBiwHS〇4(0.30 g)固體。接著加 入碘乙烷(4.0 ml)。在室溫及氮氣下將反應混合物劇烈攪 拌46小時。加入二氯甲烷(100 ml)及水(100 ml)。於萃取 後進行相分離。有機層ManheK2C〇3乾燥及在減壓下濃縮 。殘餘物在閃蒸Si〇2管柱(80 g/EtOAc)中纯化Μ獲得化合 物5,6-二氫-2·-0-乙基史賓諾辛Η ; 336 mg,70% : IMMCDCM δ 6.69(1H,bs),4.59(1H,bs),3.37(3H, CH3,s),3·30(3Η,CH3,s),2·06(6Η,2X CH3,s)ppmA Compound 3'-0-trifluoromethanesulfonyl (440'fflg, 0.518 mmol) was dissolved in dry DMP (20 ml). Sodium azide (1.44 g 'excess) was added. The mixture was sonicated (660 W, 55% amplitude) for 10 minutes at room temperature. -82-This paper size is in accordance with Chinese National Standard (CNS) A4 (210X 297mm) (Please read the notes on the back before filling out this page) • Equipment, vm 487559 Printed by the Consumer Cooperative of the Central Standards Bureau, Ministry of Economic Affairs A7 _____. B7 V. Description of the invention (80) Add Et0Ac (50 ml) and PhH (100 ml). With 5% aq. KHC03 solution (3 x). The organic layer, Manh. K2CO3, was dried, filtered and concentrated under reduced pressure. The residue was subjected to flash column chromatography KSiO2 (50 g / EtOAc) and by RPC-18 HPLC (MeOH-H20: 88-12) to obtain compound a) 3'_deoxy-3'- Azo Spinozin J ((1: 1 3'R and 3'S mixture); 40 mg, 10%: iNMlHCDCh) δ 4 · 83 (0.5Η, d: 2 · 4Η), 4.64 (0 · 5Η , D: 2 · 8 Hz), 3.95 (0.5Η, m), 3.85 (0 · 5Η, dd: 2.8, 4.0Hz), 3.81 (0.5Η, in), 2.17 (6H, 2XCH3, s ) ppro and compound b) (3'S) -4'_ nor-3'-deoxy-3 '-[(RS)-(a-azo, α-methoxy) methyl] Spinozin J ; 101 mg, 26%: IMR (CDCM 3 5.00 (0 · 5Η, s), 4.98 (0 · 5Η, s), 4 · 520 · 5Η, d: 9.9 Hz), 4,35 (0.5 H, d: 9.9 Hz), 2.14 (6 Η, 2X CH3, s) ppm 〇 啻 Case A 4'-nor-dehydro-fluorene, α-methylargonyl) methyl 1 in the noroxin. I Compound 3'-0-trifluorosulfonylsulfenylspinoxin J (448 mg, 0.574 mmol) was dissolved in dry DMF (20 ml). Add lithium chloride (1.80 g, excess). The mixture was cooled to room temperature while the mixture was sonicated (660W, 52% amplitude) for 7 minutes. Add PhH (70 ml) and Et0Ac (50 in 1). Rinse with saline (2 x) and water (2 x) diluted with solution K. The organic layer K K 2CO 3 was dried, filtered and concentrated under reduced pressure. The residue was purified on a short SiO2 / EtOAc column and then repeatedly purified by RP C-18 HPLC (MeOH-H20: 92-8). Purification records of the (3'demethyl-3'-deoxy-3 '-[(RS) -a-chloro, cx-methoxy) methyl] spinoisin J epimers; 45 mg, 11%: 5.02 (0.5H, s), 5.0 (0.5 H, s), this paper size applies Chinese National Standard (CNS) Α &lt; 4 size (210X 297 mm) (Please read first Note on the back, please fill out this page again) Binding-487559 Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (81) 4 · 57 (0 · 5 H, d: 9.5 Hz), 4.55 ( 0,5 H, d: 4.5 Hz), 2.16 (6 Η, 2X CH3, s). When pus example A 66-5.fi-Diargon-2’-Π_B in a certain middle-nosinoxine_ Will the compound 5,6-dihydrospinoxin? 1 (462 1 ^, 0.64 111111〇1) was dissolved in dichloromethane (6 ml). Potassium carbonate powder (1.0 g) was added. Place the reaction flask in a water cooling bath (ca, 10 ° C). While stirring, 10% aq. NaOH (15 ml) was added, followed by NBiwHS04 (0.30 g) solid. Then add iodoethane (4.0 ml). The reaction mixture was stirred vigorously at room temperature under nitrogen for 46 hours. Dichloromethane (100 ml) and water (100 ml) were added. After extraction, the phases were separated. The organic layer ManheK2CO3 was dried and concentrated under reduced pressure. The residue was purified in a flash SiO 2 column (80 g / EtOAc) to obtain compound 5,6-dihydro-2.-0-ethylspinoxine; 336 mg, 70%: IMMCDCM δ 6.69 ( 1H, bs), 4.59 (1H, bs), 3.37 (3H, CH3, s), 3.30 (33, CH3, s), 2.06 (6Η, 2X CH3, s) ppm

O 管胞例A 67-5·6-二氣攀2,_0_11-而基中客諾辛Η_ 將化合物5,6-二氫史賓諾辛Η (488 mg,0.68 mmol) 溶於二氯甲烷(8 ml)。加入碳酸鉀粉末(1.1 g)。將反應 燒瓶置於水冷卻浴(ca. 10°C )。在攪拌時,加入10%aq· Na0H(20 ml) *接著加入NBluHS〇4(0.95 g)固體。接著加 入碘η-丙烷(4.0 in 1)。在室溫及氮氣下將反應混合物劇烈 攪拌46小時。加入二氯甲烷(100 ml)及水(100 ml)。於萃 取後進行相分離。有機層Manh.K2C〇3乾燥及在減壓下濃 縮。殘餘物在閃蒸3!〇2管柱(80 s/EtOAc)中純化以獲得化 一 84 _ 本紙張尺度適用中國國家標準(CNS ) Λ4現格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝_O Example of tracheid A 67-5 · 6-Diqipan 2, _0_11- and Kezhongkexinuoxin _ Compound 5,6-dihydrospinoxine 488 (488 mg, 0.68 mmol) was dissolved in dichloromethane (8 ml). Add potassium carbonate powder (1.1 g). The reaction flask was placed in a water cooling bath (ca. 10 ° C). While stirring, 10% aq · Na0H (20 ml) was added * followed by NBluHS04 (0.95 g) solid. Iodine n-propane (4.0 in 1) was then added. The reaction mixture was stirred vigorously at room temperature under nitrogen for 46 hours. Dichloromethane (100 ml) and water (100 ml) were added. After extraction, the phases were separated. The organic layer Manh. K2CO3 was dried and concentrated under reduced pressure. The residue was purified in a flashed 3.02 column (80 s / EtOAc) to obtain Huayi 84 _ This paper size is applicable to the Chinese National Standard (CNS) Λ4 grid (210X 297 mm) (Please read the back (Please fill in this page again)

、1T 487559 經濟郎中夬標隼局員工消費合作社印裂 A7 B7 五、發明説明(82 ) 合物5,6 -二氫- -丙基史賓諾辛Η ; 355 mg,69% : IMIHCDCla) δ 6·72(1Η,bs),4·63(1Η,d : 1·3 Hz), 3·41 (3H,CH3,s),3·34(3Η,CH3,s),2· 10(6H,2x CH 3,s),0·67(3Η,CH3,t : 7·4 Hz)ppm。 實施例A 68-3’-表中曹諾辛J_ 將化合物3'-酮基-史賓諾辛J (3.61 g,5.04 mmol) )溶於乙醚(100 ml)。溶液在氮氣下冷卻至0°C。加入一部 份二-t-丁氧基錯氫化鋰(1.45 g; 97%,5.53 mmol)。在 0°C下持續授拌15分鐘,接著導入剩餘之LTBAH(105 g, 4.00 mrool)。再持續攪拌35分鐘。加入苯(60 ml)。在0°C 下利用飽和鹽水(20 ία 1)使過量之氫化物媛慢地分解。使 相分離。有機層連續Μ鹽水-H2〇(8 : 1)、M10%aq.Na0H 溶液,及以水清洗。有機相Manh.K2C〇3乾燥,過濾及在 減壓下濃縮。所獲得之產物(3.215 g,89% )係藉由閃蒸 管柱層析(160 g,Si〇2/EtOAc)以獲得95%純化合物3’-表 史賓諾辛 J ; 2.715 g,75% : ιΗ- NMR (CDCI3) δ 6·63 (1H, bs), 4.71 (1H, bs), 4.55 (1H, ra), 4.28 (2H, m), 4.04 (1H, m), 3.78 (1H, m), 3.49 (1H, m), 3.33 (3H, CH3, s), 3.31 (3H, CH3, s), 2.11 (6H, 2x CH3, s) ppm. 實施例A 69-3’-恙-.V-D-三氩申碏臓甚中客諾幸.T_ 將化合物3’-表史賓諾辛J (1,53 g,2·13 mmol)溶於 乾二氯甲烷(20 ml)。加入吡啶(5·0 ml,乾)。將溶液在 氮氣下冷卻至0°C。K注射器之方式媛慢地導入三氟甲磺 酸酐(1.0 ml,過量)。在(TC下持續攪拌16小時。加入 ________________ - 85 - 本紙張尺度適用中國國家標準(CNS ) Λ4規格(2!OX.297公釐) I--------^------1T------# (請先閲讀背面之注意事項再填寫本頁) 487559 A7 B7 五、發明説明(83 )1T 487559 Economic Cooperative Standards Bureau Employees' Cooperative Cooperative Print A7 B7 V. Description of the Invention (82) Compound 5,6-dihydro-propylpropyl Spinocinol 355 mg, 69%: IMIHCDCla) δ 6 72 (1Η, bs), 4.63 (1Η, d: 1.3 Hz), 3.41 (3H, CH3, s), 3.34 (3Η, CH3, s), 2.10 (6H, 2x CH 3, s), 0.67 (3 Η, CH3, t: 7.4 Hz) ppm. Example A 68-3'-Table Caoxin J_ Compound 3'-keto-spinoxin J (3.61 g, 5.04 mmol)) was dissolved in ether (100 ml). The solution was cooled to 0 ° C under nitrogen. Add a portion of lithium di-t-butoxyhydrogen hydride (1.45 g; 97%, 5.53 mmol). Mixing was continued for 15 minutes at 0 ° C, and then the remaining LTBAH (105 g, 4.00 mrool) was introduced. Stirring was continued for another 35 minutes. Add benzene (60 ml). Slowly decompose excess hydride with saturated brine (20 ία 1) at 0 ° C. The phases are separated. The organic layer was successively M brine-H20 (8: 1), M10% aq. NaOH solution, and washed with water. The organic phase, Manh. K2CO3, was dried, filtered and concentrated under reduced pressure. The obtained product (3.215 g, 89%) was obtained by flash column chromatography (160 g, SiO2 / EtOAc) to obtain 95% pure compound 3'-epispinoxin J; 2.715 g, 75 %: ιΗ- NMR (CDCI3) δ 6.63 (1H, bs), 4.71 (1H, bs), 4.55 (1H, ra), 4.28 (2H, m), 4.04 (1H, m), 3.78 (1H, m), 3.49 (1H, m), 3.33 (3H, CH3, s), 3.31 (3H, CH3, s), 2.11 (6H, 2x CH3, s) ppm. Example A 69-3'- 恙-. VD-tri-arsenide is very good. T_ Compound 3'-epispinoxin J (1,53 g, 2.13 mmol) was dissolved in dry dichloromethane (20 ml). Add pyridine (5.0 ml, dry). The solution was cooled to 0 ° C under nitrogen. In the K syringe method, trifluoromethanesulfonic anhydride (1.0 ml, excess) was slowly introduced. Continue stirring at (TC for 16 hours. Add ________________-85-This paper size applies to Chinese National Standard (CNS) Λ4 specification (2! OX.297 mm) I -------- ^ ---- --1T ------ # (Please read the notes on the back before filling out this page) 487559 A7 B7 V. Description of the invention (83)

Et0Ac(50 ml)及 PhH(100 1111)。以稀釋鹽水(2/)及5%39. KHC〇3溶液(2X )萃取溶液。有機層以anh.Na2S〇4、過濾及 在減壓下濃縮。殘餘物在閃蒸Si〇2管柱(1〇〇 g/E tO Ac) Μ 獲得化合物3’-表-3’-0-三氟甲磺醯基史賓諾辛j ; ι36 g,75% ): 1H-NMR (CDCI3) δ 6.69 (1Η, bs), 5.03 (1H# dd: 3.2, 3.5 Hz), 4.63 (1H, bs), 3.90 (ih, dq·· 3·9, 6.4 Hz), 3.39 (3H, CH3, s), 3.35 (3H, CH3, s), 2.13 (tSH, 2x CH3,s) ppm. 實施径[A 70 - 3’-〇-(α,a三氣- 丁條基中脊 諾辛J____ 將化合物史賓諾辛J (790 mg,1.10 mmol)溶於乾二 氯甲烷(5 ml)。加入碳酸鉀(1.1 g),接著加入15% aq.氫 氧化納溶液(15 1111),811』1^〇4(0,8〇8)及4-溴-1,1,2-三 氟丁烯(3.0 g,過量)。加入DMSOU.O ml)。在室溫及氮 氣下持續攪拌16小時。加入二氯甲烷(100 ml)及水(100 ml)。在萃取後,使相分離。有機相KK2C〇3乾燥,過濾及 在減壓下濃縮。殘餘物在閃蒸Si〇2管柱(100 g/EtOAc)以 獲得化合物3’-0-U , α ,/?-三氟-7 -丁烯)-α -基史賓諾 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 辛 J ; 194 mg,21% ) : [NMRiCDCl:!) 5 6.66(1H,bs),6·28 (1H# m: WH/2= 65 Hz) 5.43 (1H, m: WH/2= 60 Hz), 5.28 (1H, d: 17.4 Hz); 5.02 (1H, dd: 11.4, 1.4 Hz)# 2.13 (6H, 2x CH3· s) ppm and (b) recovered compound Spinosyn J (520 mg, 75%). 及(b)回收化合物史賓諾辛J (520 mg,75%)。 實施例A 71-2’甚中客諾辛J__ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 487559 A7 __ ~ B7 五、發明説明(84 ) 將3’-_史賓諾辛J (755 mg,1.05 mmol)溶於乾THF (10 ml)中。加人四乙基矽烷(1.0 ml),接著加入15% BimNF/A12〇3(0.55 g,過量)。在室溫及氮氣下搅拌反應 混合物16小時。加入苯(70 ml)及EtOAc (30 ml)。K 5% aq .KHCOa溶液(2X )。KK2C〇3乾燥有機層,過滤及在減壓下 濃縮。殘餘物在閃蒸Si〇2管柱(120 g/EtOAc)K獲得U)3^ -酮基史賓諾辛J (290 mg,38%)及(b)化合物2’-表-3’-酮基史賓基 J ; 375 mg,50% UMlUCDCUSe.eOUH ,bs),5.06( 1H,d : 4.1 Hz),3.39 (3H,CH3,s),2·08 (3H,2XCH3,s)ppm0 富細例A72-2’-表-3夂恙中窨諾辛J_ 將化合物表-3’-酮史賓諾辛J (305 rag,0.426 mmol)溶於乾THF(10 ral)並加入乾乙醚(10 ml)。將該溶液 冷卻至0°C及在氮氣下授拌並君入一部份Li (t-BuO)3AlH( 200 mg,0.76 ππποί)。在此溫度下持續攪拌30分鐘。之後 Μ鹽水小心地驟冷。使混合物在Et2〇與含有5%NaOH之水 間分配。有機餍連續K含有5%NaOH之水及5%aq,KHC〇3 (2 X )清洗,MK2C〇3乾燥,過滤及在減壓下濃縮K獲得僅含 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 2’-表-3’-表史賓諾辛J之白色泡沫體;303 rog,99% 1H_ NMR (CDCI3) δ 6.61 (1Η, bs), 4.78 (1H, d: 3.3 Hz), 3.84 (1H, dq: 9.8, 6.3 Hz) , 3.37 (3H, CH3, s) ; 3.35 (3H, CH3,s), 2.14 (6H, 2xCH3,s) ppm. , 管确例A -宪-.V -表-3 ’ -0-乙基史W諾辛J_ 將化合物2*-表表史賓諾辛J (250 ms,0·348 mmo 1)溶於二氯甲烷(5 m 1)。加入碳酸鉀(1 . 0 g)。將燒瓶 ___- 87 -__ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 一 經濟部中央標準局員工消費合作社印製 487559 A7 - B7 ~ ______ 五、發明説明(85 ) 置於冷卻浴(10°C ),加入20%Ha0H(20 ml),接著加入 BiuNHS〇4(0.71 g)、碘乙烷(2,0 ml)及 DMS0(5 ml)。在氮 氣下劇烈授拌反應混合物60小時。加入二氯甲烷(1〇〇 ml) 及水(100 ml)。於萃取後,使相分離。有機層以K2C〇3乾 燥,過滤及在減壓下濃縮。殘餘物在閃蒸Si〇2管柱(30 g/Et0Ac (50 ml) and PhH (100 1111). The solution was extracted with dilute brine (2 /) and 5% 39. KHC03 solution (2X). The organic layer was filtered with anh. Na2S04, and concentrated under reduced pressure. The residue was flashed in a Si02 column (100g / EtO Ac) to obtain the compound 3'-Table-3'-0-trifluoromethanesulfonylspinoxin j; 36 g, 75%) : 1H-NMR (CDCI3) δ 6.69 (1Η, bs), 5.03 (1H # dd: 3.2, 3.5 Hz), 4.63 (1H, bs), 3.90 (ih, dq ·· 3.9, 6.4 Hz), 3.39 (3H, CH3, s), 3.35 (3H, CH3, s), 2.13 (tSH, 2x CH3, s) ppm. Implementation diameter [A 70-3'-〇- (α, atrigas-butanyl) Spinosin J____ The compound Spinozin J (790 mg, 1.10 mmol) was dissolved in dry dichloromethane (5 ml). Potassium carbonate (1.1 g) was added, followed by 15% aq. Sodium hydroxide solution (15 1111 ), 811′1 ^ 〇4 (0,8〇8) and 4-bromo-1,1,2-trifluorobutene (3.0 g, excess). DMSOU. 0 ml was added). Stirring was continued at room temperature under nitrogen for 16 hours. Dichloromethane (100 ml) and water (100 ml) were added. After extraction, the phases were allowed to separate. The organic phase KK2CO3 was dried, filtered and concentrated under reduced pressure. The residue was flashed in a SiO2 column (100 g / EtOAc) to obtain the compound 3'-0-U, α, /?-Trifluoro-7-butene) -α-base Spino Central Bureau of Economics Printed by the employee consumer cooperative (please read the precautions on the back before filling this page) Xin J; 194 mg, 21%): [NMRiCDCl :!) 5 6.66 (1H, bs), 6.28 (1H # m: WH / 2 = 65 Hz) 5.43 (1H, m: WH / 2 = 60 Hz), 5.28 (1H, d: 17.4 Hz); 5.02 (1H, dd: 11.4, 1.4 Hz) # 2.13 (6H, 2x CH3 · s ) ppm and (b) recovered compound Spinosyn J (520 mg, 75%). and (b) recovered compound Spinosyn J (520 mg, 75%). Example A 71-2 'Very Zhongke Nuoxin J__ This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 487559 A7 __ ~ B7 V. Description of the invention (84) Will 3' -_ Shi Binnuo Xin J (755 mg, 1.05 mmol) was dissolved in dry THF (10 ml). Tetraethylsilane (1.0 ml) was added followed by 15% BimNF / A1203 (0.55 g, excess). The reaction mixture was stirred at room temperature under nitrogen for 16 hours. Add benzene (70 ml) and EtOAc (30 ml). K 5% aq. KHCOa solution (2X). The organic layer was dried over KK2CO3, filtered and concentrated under reduced pressure. The residue was obtained by flash evaporation on a Si02 column (120 g / EtOAc) K) U ^ 3 ^ -ketospinoxin J (290 mg, 38%) and (b) compound 2'-Table-3'-one Base Spencer J; 375 mg, 50% UMlUCDCUSe.eOUH, bs), 5.06 (1H, d: 4.1 Hz), 3.39 (3H, CH3, s), 2.08 (3H, 2XCH3, s) ppm0 Rich examples A72-2'-Table-3 窨 Nanosin J_ Dissolve the compound Table-3'-keto Spinosin J (305 rag, 0.426 mmol) in dry THF (10 ral) and add dry ether (10 ml ). The solution was cooled to 0 ° C and stirred under nitrogen and a portion of Li (t-BuO) 3AlH (200 mg, 0.76 ππποί) was introduced. Stirring was continued at this temperature for 30 minutes. The M brine was then carefully quenched. The mixture was partitioned between Et20 and water containing 5% NaOH. Organic 餍 continuous K water containing 5% NaOH and 5% aq, KHC〇3 (2X) was washed, MK2CO3 was dried, filtered and concentrated under reduced pressure. K obtained only printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy (Please read the precautions on the back before filling this page) 2'-Table-3'-Table Spinocin J white foam; 303 rog, 99% 1H_ NMR (CDCI3) δ 6.61 (1Η, bs), 4.78 (1H, d: 3.3 Hz), 3.84 (1H, dq: 9.8, 6.3 Hz), 3.37 (3H, CH3, s); 3.35 (3H, CH3, s), 2.14 (6H, 2xCH3, s) ppm. Example A-Constitution-.V-Table-3--0-Ethyloxinoxin J_ Compound 2 *-Epoxyspinoxin J (250 ms, 0.348 mmo 1) was dissolved in dichloride Methane (5 m 1). Potassium carbonate (1.0 g) was added. Flask ___- 87 -__ This paper size applies Chinese National Standard (CNS) A4 (210X297 mm). Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economy. 487559 A7-B7 ~ ______ 5. Description of the invention (85) In a cooling bath (10 ° C), 20% Ha0H (20 ml) was added, followed by BiuNHS04 (0.71 g), iodoethane (2.0 ml), and DMS0 (5 ml). The reaction mixture was stirred vigorously under nitrogen for 60 hours. Dichloromethane (100 ml) and water (100 ml) were added. After extraction, the phases were allowed to separate. The organic layer was dried over K2CO3, filtered and concentrated under reduced pressure. The residue was flashed in a Si02 column (30 g /

EtOAc)以提供2’-表-3’-表乙基史賓諾辛J,43mg 17% 1H-NMR (CDC13) δ 6.72 (1Η, bs) , 4.81 (1H, d: 4.0 Hz), 4.01 (1H, m) 3.36 (3H, CH3,s), 3·33 (3H, CH3,s), 2·16 (6H, 2xCH3' s) ppm. 啻确例A 74-3’ -去氬-.V -氣中窨諾宰(:TM構物之ΐ .· 1 遐合物)_ 將3’_表史賓諾辛J (570 mg,0.794 mmol)溶於乾二 二氯甲烷(10 ml)。將溶液在氮氣下冷卻至-25 °C。經由注 射器之方式導入二乙基胺硫三氟化物(315 ml,2.38 mmol )。在-25 Ό及氮氣下持績攪拌3小時,接著於30分鐘內, 升高溫度。加入吡啶(0.5 ml)及在室溫下再持續攪拌15分 鐘。使混合物在 CH2C12(100 ml)與 5%aq.KHC〇3(150 ml) 間分分配。有機層連續M5%aq.KHC〇3清洗,MK2C〇3乾燥 ,過濾及在減壓下濃縮。殘餘物在閃蒸Si〇2管柱(1〇〇 s/ EtOAc)及接著藉由RP C-18 HPLC(10%水之甲醇溶液獲 得化合物3f-去氧-3^氟史賓諾辛J,3、-F: 3’b-F之 1 ·· 1 混合物,168 mg,29%,M-MMIUCDCI:]) δ 6.68 (1Η, bs), 4.60 (1H, nm), 4.36 (0.5 H, ddd: 44.6, 2.9, 2.5 Hz), 3.38 (1.5 H, CH3, s), 3.36 (1.5 H, CH3,s), 3.33 (1·5 H, CH3, s), 3·32 (1·5 H, CH3, s), 2.12 (6Ht 2x CH3,s) ppm. _ _ - 88 ~ 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)EtOAc) to provide 2'-Table-3'-epiethylspinoxin J, 43mg 17% 1H-NMR (CDC13) δ 6.72 (1Η, bs), 4.81 (1H, d: 4.0 Hz), 4.01 (1H , m) 3.36 (3H, CH3, s), 3.33 (3H, CH3, s), 2.16 (6H, 2xCH3 's) ppm. 啻 Case A 74-3' -Deargon-.V- Nuozai in the air (: TM compound ΐ. · 1 complex) _ 3'_ epispinoxin J (570 mg, 0.794 mmol) was dissolved in dry dichloromethane (10 ml). The solution was cooled to -25 ° C under nitrogen. Diethylamine thiotrifluoride (315 ml, 2.38 mmol) was introduced via an injector. Stir for 3 hours under -25 Torr and nitrogen, then raise the temperature within 30 minutes. Add pyridine (0.5 ml) and continue stirring for another 15 minutes at room temperature. The mixture was partitioned between CH2C12 (100 ml) and 5% aq. KHC03 (150 ml). The organic layer was washed successively with M5% aq.KHC03, dried with MK2CO3, filtered and concentrated under reduced pressure. The residue was flashed in a Si02 column (100s / EtOAc) and then compound 3f-deoxy-3 ^ fluorospinoxin J was obtained by RP C-18 HPLC (10% water in methanol), 3.-F: 1 ·· 1 mixture of 3'bF, 168 mg, 29%, M-MMIUCDCI:]) δ 6.68 (1Η, bs), 4.60 (1H, nm), 4.36 (0.5 H, ddd: 44.6 , 2.9, 2.5 Hz), 3.38 (1.5 H, CH3, s), 3.36 (1.5 H, CH3, s), 3.33 (1.5 H, CH3, s), 3.32 (1.5 H, CH3, s), 2.12 (6Ht 2x CH3, s) ppm. _ _-88 ~ This paper size applies to China National Standard (CNS) Α4 specification (210X 297 mm) (Please read the precautions on the back before filling this page)

、1T 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(86 ) g倫例A 75-:T_n-Se某中客諾辛,J_ 將3’-表史賓諾辛J (14δ mg,0.206 mmol)溶於乾二 甲苯(3 ml)。在室溫及氮氣下攪拌溶液及加入二苯基膦( 118 mg,0·45 mmol),接著加入酿(42.5 mg,0.45 mmol) 。於攪拌15分鐘後,於混合物加入二乙基偶氮二羧鹽酯( DEAD,75 ml (95% ) * 0.45 mmol)。在室溫下攪拌 16小時 ,接著 MPhH(70 ml)及 Et0Ac(50 ml)稀釋,M5%aq. KHC〇3清洗,及Μ碳酸鉀乾燥。殘餘物在閃蒸Si〇2管柱純 化及接著在RP C-18 HPLC管柱(12%水之甲醇溶液)中分離 ,以獲得(a)回收3’-表史賓諾辛J (101 mg ; 68%)及(b) 化合物3’-0-苯基史賓諾辛J ; 3.1 mg,1.9% iH_ NHR (CDCI3) 57.28 (2H, m), 6.99 (3H, m), 6.76 (IH.bs), 4.84 (1H, d: 1.6 Hz) # 4.54 (1H, dd: 9.4, 3.1 Hz), 3.53 (3H, CH3, s) , 3.46 (3H, CH3, s), 2.11 (6H, 2x CH3, s) ppm. 啻脓例A 7卜中窨諾辛J夕.V-n-(S-笼某)二硫碳酪翰 史賓諾辛J (1.20 mg,1.67 mmol)溶於乾二氯甲烷( 10 ml)。加入吡啶(乾,2 ml),接著加人DMAP(70 mg)。 在室溫及氮氣下攪拌反應混合物,在水溶中冷卻。經由注 射器方式緩慢地加入苯基氯二硫甲酸酯(1.80 ml,過量) 。混合物接著在室溫及氮氣下攪拌16小時。加入PhH(70 ,1T 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (86) g Case A 75-: T_n-Se a certain customer Nosing, J_ will be 3'-Table Spence Nosing J 14δ mg, 0.206 mmol) was dissolved in dry xylene (3 ml). The solution was stirred at room temperature under nitrogen and diphenylphosphine (118 mg, 0.45 mmol) was added, followed by fermentation (42.5 mg, 0.45 mmol). After stirring for 15 minutes, diethyl azobiscarboxylate (DEAD, 75 ml (95%) * 0.45 mmol) was added to the mixture. Stir at room temperature for 16 hours, then dilute with MPhH (70 ml) and Et0Ac (50 ml), wash with M5% aq. KHC03, and dry with potassium carbonate. The residue was purified on a flash SiO 2 column and then separated on an RP C-18 HPLC column (12% water in methanol) to obtain (a) the recovered 3'-epispinoxin J (101 mg (68%) and (b) compound 3'-0-phenylspinoxin J; 3.1 mg, 1.9% iH_NHR (CDCI3) 57.28 (2H, m), 6.99 (3H, m), 6.76 (IH.bs ), 4.84 (1H, d: 1.6 Hz) # 4.54 (1H, dd: 9.4, 3.1 Hz), 3.53 (3H, CH3, s), 3.46 (3H, CH3, s), 2.11 (6H, 2x CH3, s ) ppm. Symptomatic case A 7 Bu Zhongxinxin J Xi. Vn- (S-cage) dithiocarbazone Spinoloxin J (1.20 mg, 1.67 mmol) dissolved in dry dichloromethane (10 ml ). Pyridine (dry, 2 ml) was added followed by human DMAP (70 mg). The reaction mixture was stirred at room temperature under nitrogen and cooled in water. Slowly add phenylchlorodithioformate (1.80 ml, excess) via syringe. The mixture was then stirred at room temperature under nitrogen for 16 hours. Add PhH (70,

ml)及Et0Ac(70 ml)。有機層M5%KHC〇3(4X )清洗,MK2 C〇3乾燥及在減壓下濃縮。殘餘物Μ閃蒸Si〇2管柱(120 g/ EtOAc)分離Μ提供化合物3’-0_(S-苯基)二硫碳酸鹽;780 mg,54% lW NMR 一 89 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) •澤. 〇59 A7ml) and Et0Ac (70 ml). The organic layer was washed with M5% KHC03 (4X), and MK2CO3 was dried and concentrated under reduced pressure. The residue was separated by flashing a Si02 column (120 g / EtOAc). The compound 3'-0_ (S-phenyl) dithiocarbonate was provided; 780 mg, 54% lW NMR-89. National Standard (CNS) A4 Specification (210X 297mm) (Please read the notes on the back before filling this page) • Ze. 〇59 A7

經濟部中央標準局員工消費合作社印製 五、發明説明(87 ) (CDC13) δ·50 (2H, m), 7.33 (3H, ra), 6.63 (1H, bs), 5.73 (3H, m), 4.69 UH, bs)' 3.32 (3H, CH3, s), 3.12 (3H, CH3/ s), 2.15 (6H, 2XCH3, s) ppm· 窨fe例A 77-史賓諾辛J之3’-0-(五氟宏某)硫羰碳_翰 史賓諾辛J (1·52 mg,2.12 mmol)溶於乾乙腈(15 ml )。加入DM AP (0.84 g,6,88 mmol)並溶解。溶液在氮氣下 冷卻至0 °C。逐滴緩慢地加入五氟苯基氯硫羧甲酸酯(1.60 ml,10.0 mmol)。將反應混合物在室溫攪拌16小時。加入 PhH(70 ml)及 Et0Ac(50 ral)cM5%KHC〇3(3x)萃取溶液 並MK2C〇3乾燥。於減壓下濃縮有機層。殘餘物以閃蒸 Si〇2管柱(120 g/EtOAc)分離以提供化合物3’-0-(五氟苯 基)硫羰碳酸鹽;1.77 g,88%,π-ΝΜΙ? (CDC13) δ 6.65 (1Η, bs), 5.42 (1H, dd: 9.4, 3.2 Hz), 3.41 (3H# CH3, s), 3·39 (3H, CH3, s), 2.10 (6H, 2x CH3,s) ppm· · 奮細例A 78'V -Π - Γ (:TR) 'V-去氢Φ窨諾垒J 1 -3 基中 ir諾辛·ι,(.vm及crskv-烯丙某'v-去氬 中窨諾幸J夕1 :1滔合物,及(:TS)'V-烯 丙基-3, _去氯中曹諾辛J _ 將化合物史賓諾辛J之3'-0-(五氟苯基)硫羰碳酸酯( 1·65 g , 1.75 ramol) (1.52 mg,2.12 mmol)溶於乾甲苯( 25 ml)。加入烯丙基三丁基錫(1,70 nil,5.32 mmol),接 著加入AIBN(180 mg)。在氮氣下將混合物加熱至迴流溫度 20小時。將混合物冷卻、濃縮及直接置入閃蒸Si〇2管柱( 220 g/EtOAc)。經純化之溶析份進一步藉由RP C-18 HPLC (10%水之甲醇溶液)以提供化合物3)3’-0-[(3 1)-3’-去 __________ 90 _ _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐1 (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of Invention (87) (CDC13) δ · 50 (2H, m), 7.33 (3H, ra), 6.63 (1H, bs), 5.73 (3H, m), 4.69 UH, bs) '3.32 (3H, CH3, s), 3.12 (3H, CH3 / s), 2.15 (6H, 2XCH3, s) ppm 窨 fe Case A 77- Spinozin J-3'-0 -(Pentafluoromacro) thiocarbonyl carbon_Horspinoxin J (1.52 mg, 2.12 mmol) was dissolved in dry acetonitrile (15 ml). DM AP (0.84 g, 6,88 mmol) was added and dissolved. The solution was cooled to 0 ° C under nitrogen. Pentafluorophenylchlorothiocarboxate (1.60 ml, 10.0 mmol) was slowly added dropwise. The reaction mixture was stirred at room temperature for 16 hours. PhH (70 ml) and Et0Ac (50 ral) cM5% KHC03 (3x) extraction solution were added and dried with MK2CO3. The organic layer was concentrated under reduced pressure. The residue was separated on a flash SiO 2 column (120 g / EtOAc) to provide compound 3'-0- (pentafluorophenyl) thiocarbonyl carbonate; 1.77 g, 88%, π-NM 1? (CDC13) δ 6.65 (1Η, bs), 5.42 (1H, dd: 9.4, 3.2 Hz), 3.41 (3H # CH3, s), 3.39 (3H, CH3, s), 2.10 (6H, 2x CH3, s) ppm · · A detailed example A 78'V -Π-Γ (: TR) 'V-dehydrogenation 窨 窨 Nuo barrier J 1 -3 ir nuosin · ι, (.vm and crskv-allyl' v-go Arsenic in argon syrup J 1: 1, and (: TS) 'V-allyl-3, _dechlorinated Caoxin J _ will be compound Spinozin J-3'-0- (Pentafluorophenyl) thiocarbonyl carbonate (1.65 g, 1.75 ramol) (1.52 mg, 2.12 mmol) dissolved in dry toluene (25 ml). Allyl tributyltin (1,70 nil, 5.32 mmol) was added Then, AIBN (180 mg) was added. The mixture was heated to reflux temperature under nitrogen for 20 hours. The mixture was cooled, concentrated and placed directly into a flash SiO 2 column (220 g / EtOAc). Purified fractions Further, RP C-18 HPLC (10% water in methanol) was used to provide compound 3) 3'-0-[(3 1) -3'-Go to __________ 90 _ _ This paper standard applies Chinese national standard (C NS) A4 specification (210X 297 mm 1 (Please read the precautions on the back before filling this page)

、1T 線 487559 A7 B7 五、發明説明(88 )1T line 487559 A7 B7 V. Description of the invention (88)

氧史賓諾辛J ]-3^基史賓諾辛J ; 373 mg 30% iH-NMR (CDCI3) δ 6.66 (1Η, bs), 4.59 (1H, bs), 3.52 (2H, m), 3.28 (3H# CH3,s), 3.24 (3H,CH3,s), 2.12 (6H, 2x CH3, s) ppm; Elemental Analysis :for Ca〇Hi24N2〇19 calc. C 67.77, H 8.32; N 1.93, found C 67.69, H 3.70; N 2.24,及化合物b) (3’R)及(3’S) 3 烯丙基-3’-去氧史賓 諾辛J之1 ·· 1混合物;144 mg,11%。混合物進一步藉由 重複在5微米Rainin管柱上之RP C-18 HPLCK獲得化合物c )(3’S)-3’_烯丙基-3夂去氧史賓諾辛J ; 窨細例A 79-H4R)二氣-3’(ΓΠ -(甲氯羰基)亞甲某 -3’-去氬中窨諾辛J_ 將化合物3' (E)-(甲氧羰基)亞甲基-3’-史賓諾辛J ( 308 mg,0.39 mmol)溶於Et2〇(10 ml)。加入冰醋酸(5 ml )。在室溫下攪拌混合物並加入1^8^〇^(180 1^,過量)。 經 濟 部 t 央 標 準 局 員 工 消 合 作 社 印 製 在室溫及氮氣下持續攪拌16小時。加入PhH( 100 ml)及EtO Ac(50 ml)。以稀釋鹽水(2X ),接著M5%aq.NaHC〇3萃取 。有機層Manh.K2C〇3乾燥,過滤並於減壓下濃縮。殘餘 物Μ閃蒸Si〇2管柱(55 g,EtOAc)纯化以提供化合物(14R) -13,14/?-二氫-3* (E)-(甲氧羰基)亞甲基-3’-去氧史賓諾 辛 J ; 222 mg,72%) INMR (CDC13)5 6.13 (1H# d: 1.6 Hz), 4.89 (1H, d: 4.1 Ηζ)/4.3β (1H, d: 6.3 Hz), 3.79 (1H, dd: 1.7, 6.3 Hz), 3.61 (3H, CH3, s), 3.39 (3H, CH3, s), 3.21 (3H, CH3, s)% 2.11 (6H, 2x CH3# s) ppm. 例A 80-3’(E)-(羥基甲基)亞申某关氬中窨諾辛 J—’(14S,21S,)-1 · ?卜去氬 _l 3· 1 4-二氣-1 -91 (請先閱讀背面之注意事項再填寫本頁) 本纸張尺度適财關家標準(CNS ) Α4規格(H1GX 297公屢) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(89 )Oxy Spinnoxin J] -3 ^ Spinnoxin J; 373 mg 30% iH-NMR (CDCI3) δ 6.66 (1Η, bs), 4.59 (1H, bs), 3.52 (2H, m), 3.28 ( 3H # CH3, s), 3.24 (3H, CH3, s), 2.12 (6H, 2x CH3, s) ppm; Elemental Analysis: for Ca〇Hi24N2019 calc. C 67.77, H 8.32; N 1.93, found C 67.69 , H 3.70; N 2.24, and compound b) (3'R) and (3'S) 3 allyl-3'-deoxyspinoxin J 1-1 mixture; 144 mg, 11%. The mixture was further compound C obtained by repeating RP C-18 HPLCK on a 5 micron Rainin column.) (3'S) -3'_allyl-3 夂 deoxyspinoxin J; 窨 Detailed Example A 79-H4R ) Digas-3 '(ΓΠ-(methylchlorocarbonyl) methylene-3'-deargon in oxoxine J_ The compound 3' (E)-(methoxycarbonyl) methylene-3'-spin Nosin J (308 mg, 0.39 mmol) was dissolved in Et20 (10 ml). Glacial acetic acid (5 ml) was added. The mixture was stirred at room temperature and 1 ^ 8 ^ 〇 ^ (180 1 ^, excess) was added. Economy Department of the Central Bureau of Standards Consumer Cooperative printed at room temperature and under nitrogen for 16 hours. PhH (100 ml) and EtO Ac (50 ml) were added. Diluted saline (2X), followed by M5% aq. NaHC〇3 Extraction. The organic layer was dried over Manh. K2CO3, filtered and concentrated under reduced pressure. The residue was purified by flashing a Si02 column (55 g, EtOAc) to provide compound (14R) -13,14 /?-II Hydrogen-3 * (E)-(methoxycarbonyl) methylene-3'-deoxyspinoxin J; 222 mg, 72%) INMR (CDC13) 5 6.13 (1H # d: 1.6 Hz), 4.89 (1H, d: 4.1 Ηζ) /4.3β (1H, d: 6.3 Hz), 3.79 (1H, dd: 1.7, 6.3 Hz), 3.61 (3H, CH3, s), 3. 39 (3H, CH3, s), 3.21 (3H, CH3, s)% 2.11 (6H, 2x CH3 # s) ppm. Example A 80-3 '(E)-(hydroxymethyl) Yashenguan argon窨 诺辛 J — '(14S, 21S,) -1 ·? Bu argon_l 3 · 1 4-Digas-1 -91 (Please read the precautions on the back before filling this page) The paper size is suitable Financial Customs House Standard (CNS) Α4 specification (H1GX 297 public) 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (89)

.21-二锊某'V (K)-(锊基甲基)亞甲基-.V -去 氬-1.2卜斷中窨諾辛J 將化合物3’(E)-(甲氧羰基)亞甲基-3’-去氧史賓諾辛 J (340 mg,0.44 mmol)溶於乾二氯甲烷(5 ml)。加入乾T HF(1.5 ml)。在氮氣下將溶液冷卻至0°C及添加DIBALH( 1.95 ml,1.0 Μ之環己烷溶液,1.95 mmol)。持續攪拌45 分鐘。在0°C下逐滴加入飽和之NH4〇H-NH4Cl(l : 1)溶液。 加入PhH(100 ml)及Et0Ac(70 ml),及以飽和之心4〇11-NH4C1(1 ·· 1)溶液,接著K2N aq. HaOH,及最後K5%aq. KHCOa溶液(2X )萃取。有機層以K2C〇3乾燥,過滹並於減 壓下濃縮。殘餘物以閃蒸Si〇2管柱(30 g/EtOAc)分離以提 供化合物8)3’(E)-(羥基甲基)亞甲基-3’-去氧史賓諾辛J ;91mg,28% iHNMR (CDCl3)56.71(lH,bs),5.87(lH ,t : 6.2 Hz),4.51 (1H,d : 3·9 Hz),3·33 (3H,CH3,s ),3.31 (3H,CH3,s),2·16(6Η,2x CH3,s)ppra ·。及化 合物b)13,14cc -二氫-1,21S-二羥基-3’(E)-(羥甲基)亞甲 基-3·-去氧1,2卜斷史賓諾辛J ; 104 mg,( CDC13)55,82(1H,t: 6.1 Hz),4.47(1H,d: 3.9Hz), 3.29(3H,CH3,s),3.26(3H,CH3),2·78(2Η,m),2.12 (6H,2XCH3,s)ppm0 管例A 81 -4夂fl-n-丙某中窨諾宰K__ 史賓諾辛K (322 mg,0.448 mmol)溶於乾二氯甲烷(4 ml)。加人碳酸鉀(1.1 g)。將燒瓶置於水浴(ca.+10°C )。 加入 15%NaOH水溶液(25 ml),接著加入 Bu4NHS〇4(1.2 g) -92 - 本紙依尺度適用中國國家標準(CNS ) Α4規格(2丨0X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 、τ.21-Difluorene'V (K)-(fluorenylmethyl) methylene-.V-Deargon-1.2 Benzanosin J Compound 3 '(E)-(methoxycarbonyl) Methyl-3'-deoxyspinoxin J (340 mg, 0.44 mmol) was dissolved in dry dichloromethane (5 ml). Add dry T HF (1.5 ml). The solution was cooled to 0 ° C under nitrogen and DIBALH (1.95 ml, 1.0 M solution in cyclohexane, 1.95 mmol) was added. Continue stirring for 45 minutes. A saturated solution of NH4OH-NH4Cl (1: 1) was added dropwise at 0 ° C. PhH (100 ml) and Et0Ac (70 ml) were added, and a solution of saturated heart 4〇11-NH4C1 (1 ·· 1) was added, followed by extraction with K2N aq. HaOH, and finally K5% aq. KHCOa solution (2X). The organic layer was dried over K2CO3, filtered, and concentrated under reduced pressure. The residue was separated on a flash SiO 2 column (30 g / EtOAc) to provide compound 8) 3 '(E)-(hydroxymethyl) methylene-3'-deoxyspinoxin J; 91 mg, 28% iHNMR (CDCl3) 56.71 (lH, bs), 5.87 (lH, t: 6.2 Hz), 4.51 (1H, d: 3.9 Hz), 3.33 (3H, CH3, s), 3.31 (3H, CH3, s), 2.16 (6Η, 2x CH3, s) ppra. And compound b) 13,14cc-dihydro-1,21S-dihydroxy-3 '(E)-(hydroxymethyl) methylene-3 · -deoxy1,2, Spinoloxin J; 104 mg, (CDC13) 55, 82 (1H, t: 6.1 Hz), 4.47 (1H, d: 3.9Hz), 3.29 (3H, CH3, s), 3.26 (3H, CH3), 2.78 (2Η, m ), 2.12 (6H, 2XCH3, s) ppm0 Tube Example A 81 -4 夂 fl-n-Bing Zhongzhong Nuozai K__ Spinoxin K (322 mg, 0.448 mmol) dissolved in dry dichloromethane (4 ml ). Add potassium carbonate (1.1 g). Place the flask in a water bath (ca. + 10 ° C). Add 15% NaOH aqueous solution (25 ml), and then add Bu4NHS〇4 (1.2 g) -92-This paper applies the Chinese National Standard (CNS) A4 specification (2 丨 0X 297 mm) according to the standard (Please read the notes on the back first Fill out this page again), τ

T 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(9〇 ) 、碘η-丙烷(3.0 ml)及DMS0(4 ml)。於16小時後,導入額 外之Bii4NHS04 (0.70 g)。在室溫及氮氣下劇烈授拌,共持 續60小時。加入水(100 ml)及二氯甲烷(100 ml)。於萃取 後,使相分離。有機層Manh. K2C〇3乾燥、過滹及在減壓 下乾燥。殘餘物在閃蒸Si〇2管柱(100 g/EtOAc)中分離Μ 提供化合物4’-0-η-丙基史賓諾辛Κ ; 225 mg,66% Μ-NMR (CDCla) S6.66(lH,bs),4.75(lH,bs),3.67(lH ,in),3·39(6Η,2X CH3,s),2.13(6H,2X CH3,s), 0.82(3H, CH3 , t: 7.4 Hz) , 0·71(3Η, CH3 , t: 7.4Hz) ppm ° 窨_例八82_甲基-2.3.4-三-0-乙基-[-鼠李糠蚍〇南糖苷 將甲基L-鼠李糖吡喃糖苷(Fischer, E, Chem. Ber., 189 5, 28, 1 158)為 c(及 /3 成苷異構物(21.0 s,0.118 mole)加入已適當攪拌之50% U/w)氫氧化納水溶液、DMSO (100 rol)及四丁基銨氫硫酸鹽(20.0 g,0.059 mmol)之混 合物中。將碘乙烷(75.0 mL)加入該混合物中。在反應之 前20-30分鐘内可看到微放熱反應(外部冷卻、冰浴係用Μ 維持反應溫度接近25°C)。於反應3小時後,再加入75 ml Μ上之碘乙烷。再3小時後,再加入7 5 in 1M上之碘乙烷及 超過50% NaOH溶液(200 ml)。再3小時後,再加入70 ml Μ 上之碘乙烷及超過50%Na0H溶液(100 ml),及將混合物攪 拌隔夜,總反應時間為24小時。K水(200 ml)稀釋混合物 及盡量K二氯甲烷萃取。二氯甲烷萃取物以鹽水(200 ml) 清洗,乾燥(MgSO 4)及蒸發。非晶形殘餘物以己烷研製( -93 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210&gt;; 297公釐) (請先閱讀背面之注意事項再填寫本頁) 裝 訂 線T 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (90), iodine-propane (3.0 ml) and DMS0 (4 ml). After 16 hours, additional Bii4NHS04 (0.70 g) was introduced. Stir vigorously at room temperature under nitrogen for a total of 60 hours. Water (100 ml) and dichloromethane (100 ml) were added. After extraction, the phases were allowed to separate. The organic layer was dried with Manh. K2CO3, dried over Celite and dried under reduced pressure. The residue was separated in a flashed SiO 2 column (100 g / EtOAc) to provide the compound 4'-0-η-propyl spinosinol K; 225 mg, 66% M-NMR (CDCla) S6.66 ( lH, bs), 4.75 (lH, bs), 3.67 (lH, in), 3.39 (6Η, 2X CH3, s), 2.13 (6H, 2X CH3, s), 0.82 (3H, CH3, t: 7.4 Hz), 0.71 (3%, CH3, t: 7.4Hz) ppm ° Example 8 82_methyl-2.3.4-tri-0-ethyl-[-rhamnofur glucoside glycoside will be methyl L-rhamnopyranoside (Fischer, E, Chem. Ber., 189 5, 28, 1 158) is c (and / 3 glycoside isomers (21.0 s, 0.118 mole). % U / w) in a mixture of an aqueous sodium hydroxide solution, DMSO (100 rol) and tetrabutylammonium hydrogen sulfate (20.0 g, 0.059 mmol). Iodoethane (75.0 mL) was added to the mixture. A slight exothermic reaction can be seen within 20-30 minutes before the reaction (external cooling, ice bath system is used to maintain the reaction temperature close to 25 ° C). After 3 hours of reaction, an additional 75 ml of iodoethane was added. After another 3 hours, add 75 i of 1M ethyl iodide and more than 50% NaOH solution (200 ml). After another 3 hours, add 70 ml of iodoethane and more than 50% NaOH solution (100 ml), and stir the mixture overnight. The total reaction time is 24 hours. Dilute the mixture with K water (200 ml) and extract as much as possible with dichloromethane. The dichloromethane extract was washed with brine (200 ml), dried (MgSO4) and evaporated. Amorphous residue was developed with hexane (-93-This paper size applies Chinese National Standard (CNS) A4 specifications (210 &gt;; 297 mm)) (Please read the notes on the back before filling this page) Binding Line

487559 唾齊印中失瞎养¾員工消費合作社印製 A7 —^ __ B7__五、發明説明(91 ) 300 ml)並過濾。將所收集之固體Μ己烷(100 mL)及合併 濾液並濃縮,產生42.0 g粗產物。以900 ml氧化矽進行閃 蒸層析,利用10%乙酸乙酯之己烷溶液為溶析液。於預溶 析出800 ml後收集200 ml溶析份。由溶析份3-11所獲得之 乾淨的甲基2,3,4-三-0-乙基鼠李糖吡喃苷(25.5 g, 82%)為無色油狀物:MNMR (CDCU) 3 4,64(d,1,H-1 (α -成苷異構物)),3.89(dp,1,H-5),3.50-3.80 (m,8 ),3.33(s,3,0CH3),3.23(t,1,H-4),l,30(d,3,H -6),1·15-1·25(πι,9,CH2CH3)。 管瓶例A 83-2,3.4-三-fl-7,基-1,鼠李糖 將甲基2,3,4-三-0-乙基-1^鼠李糖吡喃糖苷(11.0呂 ,0.042 mol)於110 ml之4: l(v/v)三氟乙酸:水之溶液 在室溫下攪拌24小時。將溶液在減壓下(〜1.0 mm,30-35°C)濃縮至接近乾,及將殘餘物以二氯甲烷(200 inL)稀 釋。分離水相及有機相並Μ飽和碳酸氫納溶液(40 inL)、 鹽水(40 rnL)及乾清洗有機相接著K硫酸鎂乾燥,及濃縮 ,餘留11.0 g粗產物。以950 mL氧化矽進行閃蒸層析,使 用25%乙酸乙酯之己烷溶液為溶析液,獲得9.5 g (91%) 純三乙基鼠李搪,為α及/3差向異構物混合物及接近無色 之油狀物:iHNMlHCDCh) δ 5*18(m,1,Η-1),3·6-3·95( πι,8),3·25(ιη,1,Η-4),2·48(€ΐ,1,0Η),1.15-1.35( m , 12) 0 啻_例八84-0-(2.3.4-三-0-乙基-(7-丨,鼠李糖吡喃糖基) -三氛 imitate__ __- 94 -_ 本紙張尺度適用中國國家標準(CNS ) Λ4規格(2!0X297公釐) (請先閱讀背面之注意事項再填寫本頁) .裝· -5Ϊ» 線 487559 經濟部中央標隼局員工消費合作社印製 A7 B7 五、發明説明(92 ) 將一部分剛經蒸餾之三氯乙腈(12.0 inL,0· 12 mmol) 添加至冷(0-5 °C)、適當攪拌之三乙基鼠李糖(2,2 g, 8.86 mmol)之乾二氯甲院(80 inL)溶液。部分部分添加之 方式將60%氫化鈉之礦物油(0.35 g,8.87 mmol為100%) 溶液在1-2分鐘内添加至溶液中。(注意:發泡及氫氣釋出 )。於反應20分鐘後,移除冷卻浴並在室溫下攪拌混合物 5.5小時。接著將混合物再冷卻至0-5 °C及加入一部份矽膠 (6.0 g)。於攪拌10分鐘後,過滹混合物及利用二氯甲烷( 25 mL)清洗所收集之固體。在減壓下(〜25 mm,30-35 °C) 將合併滹液及洗液蒸發乾燥並將殘餘物以己烷(60 niL)處 理,藉此分離一些絮凝固體。於保持30分鐘後,將固體過 滤(矽藻土)及Μ己烷清洗(25 mL)。接著將合併之滹液及 洗液在減壓下(〜25 nun,30-35°C)濃縮至乾,殘留2.9 g 淺黃色油狀之粗imidate,藉由iHNMR光譜分析可知僅含差 向異構物及純度足以直接使用無需進一步純化1(注意: i mi date無法進行氧化矽層析及在減壓下(〜〇,1 mm)之短 路蒸餾中會分解):iHNMR(CDCl3) 5 8.54(s , 1/ NH), 6.22 (S/ 1, H-l), 3.6-3.95 (m, 9), 3.35 (tt 1, H-4)# 1.34 (d, 3, K-6 ) , 1 · 1-1.3 (m,i 9 ).487559 Lost blind support in print ¾ Printed by employee consumer cooperative A7 — ^ __ B7__ V. Description of the invention (91) 300 ml) and filtered. The collected solid M hexane (100 mL) and the combined filtrates were concentrated and concentrated to give 42.0 g of crude product. Flash chromatography was performed with 900 ml of silica, using 10% ethyl acetate in hexane as the eluent. After 800 ml of pre-precipitation, 200 ml of lysate was collected. The clean methyl 2,3,4-tri-0-ethylrhamnopyranoside (25.5 g, 82%) obtained from fractions 3-11 was a colorless oil: MNMR (CDCU) 3 4,64 (d, 1, H-1 (α-glycoside isomer)), 3.89 (dp, 1, H-5), 3.50-3.80 (m, 8), 3.33 (s, 3,0CH3) , 3.23 (t, 1, H-4), 1, 30 (d, 3, H -6), 1.15-1.25 (π, 9, CH2CH3). Vial example A 83-2,3.4-tri-fl-7, yl-1, rhamnose methyl 2,3,4-tri-0-ethyl-1 ^ rhamnopyranoside (11.0 (0.042 mol) in 110 ml of a 4: 1 (v / v) trifluoroacetic acid: water solution was stirred at room temperature for 24 hours. The solution was concentrated under reduced pressure (~ 1.0 mm, 30-35 ° C) to near dryness, and the residue was diluted with dichloromethane (200 inL). The aqueous and organic phases were separated and the saturated sodium bicarbonate solution (40 inL), brine (40 rnL), and the dry washed organic phase were then dried over magnesium sulfate, and concentrated to leave 11.0 g of crude product. 950 mL of silica was used for flash chromatography, and 25% ethyl acetate in hexane was used as the eluent to obtain 9.5 g (91%) of pure triethyl rhamnolide, which was α and / 3 epimers. Mixture and nearly colorless oily substance: iHNMlHCDCh) δ 5 * 18 (m, 1,)-1), 3.6 ~ 3.95 (π, 8), 3.25 (ιη, 1, Η-4 ), 2.48 (€ ΐ, 1,0Η), 1.15-1.35 (m, 12) 0 啻 _Example 8 84-0- (2.3.4-tri-0-ethyl- (7- 丨, rhamnolide Sugar Pyranosyl) -Sanmo imitate__ __- 94 -_ This paper size applies the Chinese National Standard (CNS) Λ4 specification (2! 0X297 mm) (Please read the precautions on the back before filling this page). Installation · -5Ϊ »Line 487559 Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of the invention (92) Add a portion of freshly distilled trichloroacetonitrile (12.0 inL, 0 · 12 mmol) to cold (0-5 ° C), properly stirred solution of triethyl rhamnose (2,2 g, 8.86 mmol) in dry dichloromethane (80 inL). 60% sodium hydride in mineral oil (0.35 g) , 8.87 mmol is 100%) The solution is added to the solution within 1-2 minutes. (Note: foaming and hydrogen (Released). After 20 minutes of reaction, the cooling bath was removed and the mixture was stirred at room temperature for 5.5 hours. Then the mixture was cooled again to 0-5 ° C and a portion of silicone (6.0 g) was added. Stir for 10 minutes After that, the mixture was washed through the mixture and the collected solid was washed with dichloromethane (25 mL). The combined mash and washing solution were evaporated to dryness under reduced pressure (~ 25 mm, 30-35 ° C) and the residue was washed with hexane. Treatment with alkane (60 niL) to separate some flocculated solids. After holding for 30 minutes, the solid was filtered (diatomaceous earth) and washed with hexane (25 mL). The combined mash and washings were then decompressed (~ 25 nun, 30-35 ° C) and concentrated to dryness, leaving 2.9 g of crude imidate as a pale yellow oil. According to iHNMR spectrum analysis, it was found that it contained only epimers and was pure enough to be used directly without further purification 1 ( Note: i mi date cannot be subjected to silica chromatography and decomposed by short-circuit distillation under reduced pressure (~ 〇, 1 mm): iHNMR (CDCl3) 5 8.54 (s, 1 / NH), 6.22 (S / 1 , Hl), 3.6-3.95 (m, 9), 3.35 (tt 1, H-4) # 1.34 (d, 3, K-6), 1.1-1.3 (m, i 9).

實施例A85-3’(E)-(甲氯羰某)Ώ甲甚'v-去氬中客諾辛 J (3 ’ (Z)-(甲氯羰基)亞田甚-.V-杏氬中客諾 辛J 將化合物3’-酮基史賓諾辛J (609 mg,0.851 mmol) 溶於乾甲苯(25 ml)中。添加甲氧羰基亞甲基三苯基正膦( ___ - 95 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ---------裝-- (請先閱讀背面之注意事項再填寫本頁)Example A85-3 '(E)-(Methylchlorocarbonyl) Methylmethoxine'v-Deargonin Knosin J (3' (Z)-(Methylchlorocarbonyl) Yatianxi-.V-Apricotine Zhongke Nuoxin J Dissolve the compound 3'-ketospinoxin J (609 mg, 0.851 mmol) in dry toluene (25 ml). Add methoxycarbonylmethylenetriphenylphosphorane (___-95- This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) --------- installed-(Please read the precautions on the back before filling this page)

、1T 線 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(93) 2.2g,過量)。將反應混合物在氮氣下加熱至迴流溫度2小 時。冷卻至室溫並直接在閃蒸Si〇2管柱(220 g/EtOAc)上 層析。合併具有預期極性之溶析份並在減壓下濃縮以獲得 粗產物(584 g)。樣品藉重複RP C-18 HPLC(12%H2〇之甲 醇溶液)分離以獲得:回收起始3’-酮基史賓諾辛J (49mg) ,化合物a)3’(Z)-(甲氧羰基)亞甲基-3’-去氧史賓諾辛J ;45 mg » 7.5% 1HNMR(CDCl3)d 6.68 (1H, bs), 6,13 (1H, bs), 3.68 (3H, CH3, s), 3.33 (3H, CH3, s), 3·30 (3H, CH3 s), 2.16 (6Ht 2x CH3, s) ppm, 及化合物b),31 (E)-(甲氧羰基)亞甲基-3’-去氧史賓諾辛 J ; 242 mg » 40% ^NMR (CDCla) δ 6.64 (1H, bs), 6.16 (1H, 1 · 8 Hz) , 3 ·· 58 (3H, CH3 , s) , 3.37 (3H, CH3' s), 3.19 (3H, CH3.S), 2.08 (6H, 2x CH3, s) ppm. 實施例中W諾辛A 9-Psa 於3’-酮基史賓諾辛J (1·89 gm,2.64 mmol)之甲醇( 100 ml)溶液中,加入碳酸鉀(無水;1.82 gin : 13.2 mmol )及將混合物在室溫下攪拌2小時。接著加入乙醚(100 ml) 並過滤混合物。濾液在室溫下蒸發Μ獲得黃色固體。將黃 色固體溶於二氯甲烷中並Κ水、接著是鹽水清洗並以硫酸 鎂乾燥。接著在減壓下蒸發二氯甲烷,獲得無色半固體( 1.53 gin)。藉由閃蒸層析法純化半固體,以5%甲醇之二 氯甲烷溶液一 10%甲醇之二氯甲烷溶液為單一步驟梯度, 獲得史賓諾辛A 9-Psa(1.09 gm,76%產率),為白色偏 _____- 96 -_ 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁) 裝·Line 1T 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (93) 2.2g, excess). The reaction mixture was heated to reflux temperature under nitrogen for 2 hours. Cooled to room temperature and chromatographed directly on a flash SiO 2 column (220 g / EtOAc). The eluates having the desired polarity were combined and concentrated under reduced pressure to obtain a crude product (584 g). Samples were separated by repeated RP C-18 HPLC (12% H2O in methanol) to obtain: recovery of the starting 3'-keto spinosinol J (49 mg), compound a) 3 '(Z)-(methoxycarbonyl) ) Methylene-3'-deoxyspinoxin J; 45 mg »7.5% 1HNMR (CDCl3) d 6.68 (1H, bs), 6,13 (1H, bs), 3.68 (3H, CH3, s) , 3.33 (3H, CH3, s), 3.30 (3H, CH3 s), 2.16 (6Ht 2x CH3, s) ppm, and compound b), 31 (E)-(methoxycarbonyl) methylene-3 '-Deoxyspinoloxacin J; 242 mg »40% ^ NMR (CDCla) δ 6.64 (1H, bs), 6.16 (1H, 1.8 Hz), 3.58 (3H, CH3, s), 3.37 (3H, CH3 's), 3.19 (3H, CH3.S), 2.08 (6H, 2x CH3, s) ppm. In the example, Wnosin A 9-Psa and 3'-ketospinoxin J ( To a solution of 1.89 gm, 2.64 mmol) in methanol (100 ml), potassium carbonate (anhydrous; 1.82 gin: 13.2 mmol) was added, and the mixture was stirred at room temperature for 2 hours. Diethyl ether (100 ml) was then added and the mixture was filtered. The filtrate was evaporated at room temperature to obtain a yellow solid. The yellow solid was dissolved in dichloromethane and washed with water, followed by brine and dried over magnesium sulfate. Dichloromethane was then evaporated under reduced pressure to obtain a colorless semi-solid (1.53 gin). The semi-solid was purified by flash chromatography using a 5% methanol in dichloromethane solution and a 10% methanol in dichloromethane solution as a single step gradient to obtain Spinoxin A 9-Psa (1.09 gm, 76% product Rate), it is white. _____- 96 -_ This paper size applies Chinese National Standard (CNS) Λ4 specification (210X 297 mm) (Please read the precautions on the back before filling this page).

、1T 經濟部中央標準局員工消費合作社印製 487559 A7 __B7 五、發明説明(94 ) 離之玻璃狀物。, 1T Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 __B7 V. Description of the invention (94) The glass object.

g嫵例Α 87Ί ’ -酾基-中W諾辛Q 依實施例A 46所述方法進行反應,Μ史賓諾辛L ( 997.4 mg,1.36 mmol)為起始物質’並得到無色半固體之 3*-酮基史賓諾辛D (850 mg)。NMR顯示產物含有二異丙基 硫之不純物,但產物可使用而無需進一步純化。 窨旆例A 88-中窨諾辛D 9-Psa 依實施例A 86所述方法進行反應,Μ 3酮基史賓諾 辛D (770 mg,1 . 06 mmo 1)為起始物質,並得到無色玻璃 狀之史賓諾辛D 9-Psa(246 mg,42%產率)。 富嫵例A 89-2’基-史窨諾辛_Η 將乙硫醚(1.8 mL,16·74 mmol)在2-3分鐘內逐滴加 入冷(-78°C)、氮氣覆蓋之N-氯丁二醯亞胺之懸浮液(1.7 g,12.73 mmol)。所得溶液在_78°C下攪拌30分鐘,當維 持在&lt;-65°C之反應溫度時,接著在1〇分鐘内逐滴加入史賓 諾辛 Η(3·0 g,4.18 mmol)之二氯甲烷(25raL)。在- 78°C 維持3小時後,當持在〈-65°C之反應溫度時’在5分鐘内 逐滴加入二乙胺(4.1 ml,29.47 mmol)。接著移開冷卻浴 並容許在20-30分鐘期間將反應物加熱至室溫。加入二氯 甲烷(80 ml)及以 0.2N HC1(150 mL)及鹽水(100 niL)清洗 並Μ硫酸鎂乾燥。餘留之濃縮物為4·2 g半固體。經氧化 矽(325 niL)上之閃蒸層析,K 3%甲醇之二氯甲烷溶液為 溶析液並獲得無色泡沬體之史賓諾辛Η的2 (2 · 8 g, 93% ) : WNMR (CDC13) 54.68(S,l,H-l,),4.12(cl, 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)g. Example A 87 ′ ′-Amidyl-MesoWnosin Q was reacted according to the method described in Example A 46, M Spinoxin L (997.4 mg, 1.36 mmol) was used as the starting material and a colorless semi-solid 3 * -Ketospinoxin D (850 mg). NMR showed that the product contained impurities of diisopropylsulfur, but the product was used without further purification. Example A 88-Mesanosine D 9-Psa The reaction was performed according to the method described in Example A 86. M 3 ketospinoxin D (770 mg, 1.06 mmo 1) was used as the starting material, and Colorless glassy Spinoxin D 9-Psa (246 mg, 42% yield). Enriched Example A 89-2'yl-Stilanosin_Η Ethyl sulfide (1.8 mL, 16.74 mmol) was added dropwise to cold (-78 ° C), nitrogen-covered N over 2-3 minutes. -A suspension of chloropreneimine (1.7 g, 12.73 mmol). The resulting solution was stirred at _78 ° C for 30 minutes, and while maintaining the reaction temperature at &lt; -65 ° C, then spinosynoxine (3.0 g, 4.18 mmol) was added dropwise over 10 minutes. Dichloromethane (25raL). After maintaining at -78 ° C for 3 hours, while holding the reaction temperature at <-65 ° C ', diethylamine (4.1 ml, 29.47 mmol) was added dropwise over 5 minutes. The cooling bath was then removed and the reaction was allowed to warm to room temperature over a period of 20-30 minutes. Dichloromethane (80 ml) was added, washed with 0.2N HC1 (150 mL) and brine (100 niL), and dried over magnesium sulfate. The remaining concentrate was 4 · 2 g of semi-solid. After flash chromatography on silica (325 niL), K 3% methanol in dichloromethane was used as the eluent to obtain 2 (2 · 8 g, 93%) of spinosinol, a colorless foamed carcass. : WNMR (CDC13) 54.68 (S, l, Hl,), 4.12 (cl, This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) (Please read the precautions on the back before filling this page )

487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(95 ) 1,H-3’),3·97(ιη,1,H-5,)。 管_例A 90-中窨諾辛A 9-Psa , 將2*-酮基史賓諾辛Η (1.0 g,1.39 mmol)、對甲苯 磺酸醯阱(0.32 g,1.75 mmol)及三丙胺(0.33 ml,1·75 mmol)於1,4-二噁烷(40 ml)之溶液伴隨攪拌、在氮氣下加 熱至迴流溫度30小時。接著在減壓下去除溶劑並將殘餘物 在氧化矽(100 mL)上層析,使用5%甲醇之二氯甲烷溶液 為溶析液Μ獲得無色泡沫體之史賓諾辛A 9-Psa(0.39 g 52%): iHNMR (CDC13) δ 6.78 (br s, 1, H-13), 4.63 (m, 1, H-21) 4.43 (m, 2, H-l&quot;, H-9), 2.23 (s, 6, N(CH3)2· 奮施例A 91-中W諾辛R 9-Psa 依實施例3所述方法進行反應,M史賓諾辛Μ (199.3 mg,0,28 mmol)為起始物質。於藉由氧化矽上之層析進行 初步純化後,在一步驟中,Μ 7%甲醇之二氯甲烷溶液接 著Κ 10%甲醇之二氯甲烷溶液溶析。藉由製備型HPLC在C 18管柱分離,Κ乙睛:甲醇:0.1%醋酸銨(30 : 30 ·· 40至 32.5 : 32,5 : 35之60分鐘的線形梯度)。所得為白色固體 之史賓諾辛 B 9-Psa(49 mg,33% 產率),FDMS,m/e(相 對強度)530 (M+,60),529 (100)。487559 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of Invention (95) 1, H-3 '), 3.97 (ιη, 1, H-5,). Tube_Example A 90-Mesanosin A 9-Psa, 2 * -ketospinoxin (1.0 g, 1.39 mmol), p-toluenesulfonic acid radon (0.32 g, 1.75 mmol), and tripropylamine ( A solution of 0.33 ml, 1.75 mmol) in 1,4-dioxane (40 ml) was heated to reflux temperature under nitrogen for 30 hours with stirring. The solvent was then removed under reduced pressure and the residue was chromatographed on silica (100 mL). Spinoloxin A 9-Psa (a colorless foam was obtained using 5% methanol in dichloromethane as the eluent M ( 0.39 g 52%): iHNMR (CDC13) δ 6.78 (br s, 1, H-13), 4.63 (m, 1, H-21) 4.43 (m, 2, H-l &quot;, H-9), 2.23 (s, 6, N (CH3) 2 · Fen Example A 91-Medium Wnosin R 9-Psa The reaction was performed according to the method described in Example 3, M Spinoxin M (199.3 mg, 0, 28 mmol) Is the starting material. After preliminary purification by chromatography on silica, in one step, M 7% methanol in dichloromethane solution followed by K 10% methanol in dichloromethane solution. HPLC separation on a C 18 column, acetonitrile: methanol: 0.1% ammonium acetate (a linear gradient of 60 minutes from 30: 30 ·· 40 to 32.5: 32,5: 35). Spinoloxine was obtained as a white solid. B 9-Psa (49 mg, 33% yield), FDMS, m / e (relative strength) 530 (M +, 60), 529 (100).

窨瓶例A 氯丙基史賓諾辛L 及氬丙基史賓諾辛 L· 在氮氣環境中,將化合物3·-0-η-丙基史賓諾辛L ( 1.07 g,1.38nunol)溶於二氯甲烷(25 ml)及添加 m-CBPA( 標準(叫 Α4· ( 2ωχ 297公慶 y -98 (請先閱讀背面之注意事項再填寫本頁)Bottle Example A Chloropropyl Spinolsin L and Argon Propyl Spinolsin L · Under a nitrogen atmosphere, the compound 3-0-η-propyl Spinolsin L (1.07 g, 1.38 nunol) was dissolved in dichloromethane. Methyl chloride (25 ml) and added m-CBPA (standard (called Α4 · (2ωχ 297 public holiday y -98 (Please read the precautions on the back before filling in this page)

經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(96 ) 50%,1.88 g,5.44 mmol)及將反應物攪拌24小時。Μ乙 酸乙酯(50 mL)稀釋反應混合物並Μ 10%硫酸氫鈉溶液(3 萃取,接著藉由飽和碳酸氫納溶液(3 X 25 ml)萃取。Μ鹽 水(25 ml)清洗有機層及以無水碳酸鉀乾燥物Μ獲得黃色 固體(0,80 g)。藉由逆相HPLC(甲醇:0.1%aq.氫氧化銨 ,90: 10)純化粗產物 K 獲得(5R,6S)-5,6-乙氧-3’-0-n-丙烷基史賓諾辛L (26.6 mg,2.4%):部分1HNMR δ 6.68 (bs,1Η),4.78(s,1Η),4.67U,1Η),4.37(d,1Η), 4,21(q,1H),3.58(m,1H);及及(5R,6S)-5,6-乙氧-3·-0-n-丙基史賓諾辛 L (114 mg,10·4%):部分1HNMR δ 6,54(bs,1Η),4.78(s,1Η),4·63(ιη,1Η),4*38(d,1Η ),4.20(m,1H),3.60U,1H)。Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 V. Description of the invention (96) 50%, 1.88 g, 5.44 mmol) and stir the reaction for 24 hours. The reaction mixture was diluted with ethyl acetate (50 mL) and extracted with a 10% sodium bisulfate solution (3 extraction, followed by extraction with a saturated sodium bicarbonate solution (3 X 25 ml). The organic layer was washed with brine (25 ml) and washed with Anhydrous potassium carbonate dried to obtain a yellow solid (0,80 g). The crude product K was purified by reverse-phase HPLC (methanol: 0.1% aq. Ammonium hydroxide, 90: 10) to obtain (5R, 6S) -5,6 -Ethoxy-3'-0-n-propanyl spinosynoxine L (26.6 mg, 2.4%): part 1HNMR δ 6.68 (bs, 1Η), 4.78 (s, 1Η), 4.67U, 1Η), 4.37 ( d, 1Η), 4,21 (q, 1H), 3.58 (m, 1H); and (5R, 6S) -5,6-ethoxy-3 · -0-n-propyl spinosinoxin L ( 114 mg, 10.4%): part 1HNMR δ 6,54 (bs, 1Η), 4.78 (s, 1Η), 4.63 (ιη, 1Η), 4 * 38 (d, 1Η), 4.20 (m, 1H), 3.60U, 1H).

管Ife例A93-3’-0.N-雙-(三氘甲基)中窨諾辛M 將史賓諾辛J (1.34 g,1.87 mmol)溶於二氯甲烷(8 ml)。加入碳酸鉀(1.0 g),接著加入20%氫氧化鈉溶液( 20 ml)、四丁基銨氫硫酸鹽(0,77 g)及二氘甲基碘(5.0 g )。將反應混合物劇烈攪拌20小時。於逐漸完成時,將粗 混合物懸浮於間二甲苯(25 ml)並加熱至迴流溫度1小時。 接著冷卻混合物及在矽膠(乙酸乙酯)上層析以提供白色固 體之Π,Ν-雙(三氘甲基)史賓諾辛Μ (0·883 g,64%): MS m/z 737。CuHhDsNOh之分析的估計值:C, 66,73 ; Η, 8.06;Ν, 1·90。實際值:C, 66.92 ; Η, 7,84 ; Ν 2.13。In the case of Ife Example A93-3'-0.N-bis- (tri-deuteromethyl), sinoglutinol M was dissolved in spinoline J (1.34 g, 1.87 mmol) in dichloromethane (8 ml). Potassium carbonate (1.0 g) was added, followed by 20% sodium hydroxide solution (20 ml), tetrabutylammonium hydrogen sulfate (0,77 g), and deuterium methyl iodide (5.0 g). The reaction mixture was stirred vigorously for 20 hours. Upon completion, the crude mixture was suspended in m-xylene (25 ml) and heated to reflux temperature for 1 hour. The mixture was then cooled and chromatographed on silica gel (ethyl acetate) to provide Π, N-bis (trideuteryl) spinoxin M (0.883 g, 64%) as a white solid: MS m / z 737 . CuHhDsNOh analysis estimates: C, 66, 73; Η, 8.06; N, 1.90. Actual value: C, 66.92; Η, 7,84; Ν 2.13.

管敝例A 94-3’ - (Ζ)-(羧某)亞田甚中窨諾宰J ___-99 -_ 本紙悵尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁)Case No. A 94-3 '-(Z)-(Carboxy) Yatian and Zhongzhong Nuozhai J ___- 99 -_ This paper's standard is applicable to China National Standard (CNS) A4 (210 X 297 mm) ( (Please read the notes on the back before filling out this page)

487559 經濟部中央標準局員工消費合作社印製 A7 ____ B7五、發明説明(97 ) 將(甲氧羰基)亞甲基史賓諾辛J (80 mg,0.104 mmol )溶於THF (5 ml)。加入甲醇(3 ml)及飽和氫氧化鋰溶液(3 ml)。在氮氣下授拌混合物6小時及加入乙醇(2 ml),接著 濃縮混合物。將殘餘物溶於乙酸乙酯(50 in 1)並以鹽水清 洗3次。以硫酸納乾燥有機曆,濃縮及藉由HPLC (80 : 20, 甲醇/水)Μ獲得白色偏離固體3 ’ - (Z)-(羧基)亞甲基史賓 諾辛 J (42 mg,53%) : iHHMRS 6*68(s, 1H):5.28(s,1H )» 3.41 (s, 3H),3.34(s, 3H)。 啻細例A 95-4 表中窨諾辛K 將化合物4’-酮史賓諾辛Κ (235 mg,0.328 mmol)溶 於乾THF (10 ml)。添加乾乙醚(10 ml)及在氮氣及〇°C下冷 卻溶液。在劇烈攪拌時,添加氫化三第三丁氧鋁鋰(1.94 mg ,0.74 mmo 1)。於30分鐘後,小心地加入飽和鹽水,接著 加人乙醚(100 ral)。Μ2Ν氬氧化鈉/鹽水溶液清洗混合物3 次,接著K5%碳酸氫納水溶液清洗。有機層Μ碳酸鉀乾 燥,過濾及在減壓下濃縮以獲得4’-表史賓諾辛Κ (206 mg# 87%) as a white solid: 1H NMR 6 6.65 (s, 1 H) , 4.84 (s, 1 H), 3.64 (m, 2 H), 3.40 (s, 3 H), 3.34 (s, 3 H)· 啻瓶例A 9β-4’-弄中窨諾辛A M甲基碘處理化合物4·-酮史賓諾辛K (149 mg,0.20 7 mmo 1),並接著在間二甲苯中加熱至迴流溫度,依照合 成化合物3’-0,N-雙(三氘甲基)史賓諾辛Μ,利用碳酸鈾( 1·2 g)、20%氫氧化納水溶液(25 ml)、甲基碘(5.0 ml) 及四丁銨氫硫酸鹽(0.80 g)。藉由HPLC在矽膠上(乙酸乙 __________~ 100 一 1纸張尺度適用中國國家標準(〇叫/\4規格(210&gt;&lt;297公潑) '~~— (請先閲讀背面之注意事項再填寫本頁) .裝· 、-ir 線 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(98 ) 酯)純化粗熱解產物並額外藉由HPLC (86: 14,甲醇/水)纯 化。所得化合物為白色固體之4 表史賓諾辛A (74 mg ’ ” iH NMR δ 6.67 (s,丄 H) , 4.84 (s, 1 Η), 3.74 (q, J = 6.8 , 1 Η), 3.46 (st 3 Η), 3.34 (s, 3 Η), 3.37 (S/ 3 Η).487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 ____ B7 V. Description of the Invention (97) (Methoxycarbonyl) methylene spinosinoxin J (80 mg, 0.104 mmol) was dissolved in THF (5 ml). Add methanol (3 ml) and saturated lithium hydroxide solution (3 ml). The mixture was stirred under nitrogen for 6 hours and ethanol (2 ml) was added, then the mixture was concentrated. The residue was dissolved in ethyl acetate (50 in 1) and washed 3 times with brine. The organic calendar was dried over sodium sulfate, concentrated and HPLC (80:20, methanol / water) was used to obtain a white off solid 3 '-(Z)-(carboxy) methylene spinosinol J (42 mg, 53%). ): iHHMRS 6 * 68 (s, 1H): 5.28 (s, 1H) »3.41 (s, 3H), 3.34 (s, 3H).啻 Detailed example A 95-4 窨 oxin K The compound 4'-keto spinosin K (235 mg, 0.328 mmol) was dissolved in dry THF (10 ml). Dry ether (10 ml) was added and the solution was cooled under nitrogen at 0 ° C. While vigorously stirring, lithium tri-tert-butoxide was added (1.94 mg, 0.74 mmo 1). After 30 minutes, saturated brine was carefully added, followed by ether (100 ral). The mixture was washed 3 times with M2N sodium argon oxide / saline solution, followed by K5% aqueous sodium bicarbonate solution. The organic layer was dried with potassium carbonate, filtered and concentrated under reduced pressure to obtain 4'-epispinoxin K (206 mg # 87%) as a white solid: 1H NMR 6 6.65 (s, 1 H), 4.84 ( s, 1 H), 3.64 (m, 2 H), 3.40 (s, 3 H), 3.34 (s, 3 H) 4 · -keto spinosynoxine K (149 mg, 0.20 7 mmo 1), and then heated to reflux temperature in m-xylene according to the synthetic compound 3'-0, N-bis (trideuterylmethyl) spine Northyn M, using uranium carbonate (1.2 g), 20% aqueous sodium hydroxide solution (25 ml), methyl iodide (5.0 ml), and tetrabutylammonium hydrogen sulfate (0.80 g). By HPLC on silica gel (ethyl acetate __________ ~ 100—1 paper size applies to Chinese national standards (〇call / \ 4 specifications (210 &gt; &297; 297)) '~~ — (Please read the precautions on the back first (Fill in this page again.) Packing, -ir Printed by the Consumers Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs, printed 487559 A7 B7 V. Description of the invention (98) Ester) Purified crude pyrolysis product and additional HPLC (86: 14, methanol / Water) purification. The obtained compound was 4 Table Spinoxin A (74 mg ') iH NMR δ 6.67 (s, 丄 H), 4.84 (s, 1 Η), 3.74 (q, J = 6.8, 1 Η), 3.46 (st 3 Η), 3.34 (s, 3 Η), 3.37 (S / 3 Η).

啻腋例A 97 _4’-三氟甲基-4’_表中曹諾辛K 將化合物4’-酮史賓諾辛Κ (170 rag,0.2 37 mmol)溶 於乾THF(10 ml)。在氮氣及0°C下攪拌並添加三氟甲基(三 甲基)矽烷(241 mg,1.69 mmol)。在0°C下持續攪伴6小時 。於逐漸完成後,將粗產物溶於二氯甲烷(5 ra 1)。加入水 (1 ml)、氯化苄基三乙銨(100 mg)及KHF 2 (300 mg)並攪拌 混合物2小時。將一般逐漸完成所提供之粗產物K在矽膠 上(乙酸乙酯)純化並額外藉由HPLC (88: 12,甲醇/水)純 化K提供4’-三氟甲基-4’-表史賓諾辛K (65 mg,35%)之 白色固體:1·Η NMR δ6.70 (s, 1H), 4.81 id, J=2.2, 1H), 3.35 (q# J = 6.4, 1 H), 3.47 (S/ 3 H), 3.44 (s, 3H); 13C NMR (APT) d 76.0 (q, J -26, quaternary).啻 Axillary case A 97 _4'-trifluoromethyl-4'_ In the table, Caoxin K was dissolved in compound 4'-keto spinosin K (170 rag, 0.2 37 mmol) in dry THF (10 ml). Stir under nitrogen at 0 ° C and add trifluoromethyl (trimethyl) silane (241 mg, 1.69 mmol). Continue stirring at 0 ° C for 6 hours. After gradual completion, the crude product was dissolved in dichloromethane (5 ra 1). Water (1 ml), benzyltriethylammonium chloride (100 mg) and KHF 2 (300 mg) were added and the mixture was stirred for 2 hours. The crude product K provided was generally purified on silica gel (ethyl acetate) and gradually purified by HPLC (88: 12, methanol / water) to provide 4'-trifluoromethyl-4'-episphin Northing K (65 mg, 35%) as a white solid: 1 · Η NMR δ 6.70 (s, 1H), 4.81 id, J = 2.2, 1H), 3.35 (q # J = 6.4, 1 H), 3.47 (S / 3 H), 3.44 (s, 3H); 13C NMR (APT) d 76.0 (q, J -26, quaternary).

啻_例/\叩-(?^.65)-3’-去氯-5,6-乙氧-3’-亞甲某史1 謀宰 J 及(5S· 6R) - :Γ -去氢-5. fi-Z Μ 'V -亞 田甚中窨諾辛J 將化合物3·-去氧-3’-亞甲基史賓諾辛J (640 mg, 0.896 mmol)溶於二氯甲烷(100 ml)。將溶液冷卻至0°C及 —_______~ 101 -_____ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)啻 _ 例 / \ 叩-(? ^. 65) -3'-dechlorin-5,6-ethoxy-3'-methylene history 1 Mou J and (5S · 6R)-: Γ-dehydrogenation -5. Fi-Z Μ 'V -Yatian Shizhong Xanoxin J Compound 3 · -deoxy-3'-methylene spinosin J (640 mg, 0.896 mmol) was dissolved in dichloromethane ( 100 ml). Cool the solution to 0 ° C and —_______ ~ 101 -_____ This paper size applies Chinese National Standard (CNS) A4 (210X 297 mm) (Please read the precautions on the back before filling this page)

487559 A7 B7 五、發明説明(99 ) 以一部份一部份之方式加入m-CPBA(1.06 g, ca. 3 πιιηοΐ) 。在0 °C下持續攪拌1小時。加入1 0%亞硫酸氫鈉溶液(1 00 ml),接著加入二氯甲烷(150 ml)。於萃取後,使相分離 ,及以一般方式逐漸進行反應有機相。Μ矽膠管柱純化及487559 A7 B7 V. Description of the invention (99) Add m-CPBA (1.06 g, ca. 3 πιηηΐ) part by part. Stirring was continued for 1 hour at 0 ° C. A 10% sodium bisulfite solution (100 ml) was added, followed by dichloromethane (150 ml). After extraction, the phases are separated and the organic phase is gradually reacted in a general manner. Purification of Μ silica gel column and

接著藉由HPLC(88: 12,甲醇/水)分離以獲得a)化合物(5R ,6S)-3’-去氧-5, 6-乙氧-3’-亞甲基史賓諾辛J (20 mg,3 % )白色固體: iH NMR δ 6.64 (s, 1 H) , 5.23 (C, J = 1-7, 1 Η); 5.07 (d, J = 1.5; 1 H), 4.69 (d, J = 1.6, 1 H), 3.41 (s; 3 H), 3.26 (s, 3H); 及(5$,6!〇-3’-去氧-5,6-乙氧-3’-亞甲基史賓諾辛』(170 mg,26%)白色固體: 1hNMRS6.47 (s, 1H), 5.18 (s, 1 H), 5.02 (S, 1 H), 4.64 (s, 1 H), 3.36 (s, 3 H), 3.20 (s, 3H). 富旆例A 99-:r_ U&quot;' ( ( (Φ窨諾辛J 'V -0-)某)甲基)¾某 3W-三氣甲基)H-cHaziHne 將3-(4-(溴甲基)苯基-3-二氟甲基-3^(3丨32卜丨以(It was then separated by HPLC (88:12, methanol / water) to obtain a) compound (5R, 6S) -3'-deoxy-5, 6-ethoxy-3'-methylene spinosin J ( 20 mg, 3%) white solid: iH NMR δ 6.64 (s, 1 H), 5.23 (C, J = 1-7, 1 Η); 5.07 (d, J = 1.5; 1 H), 4.69 (d, J = 1.6, 1 H), 3.41 (s; 3 H), 3.26 (s, 3H); and (5 $, 6! 〇-3'-deoxy-5,6-ethoxy-3'-methylene "Kispinoxin" (170 mg, 26%) white solid: 1hNMRS6.47 (s, 1H), 5.18 (s, 1 H), 5.02 (S, 1 H), 4.64 (s, 1 H), 3.36 (s, 3 H), 3.20 (s, 3H). Rich example A 99-: r_ U &quot; '(((Φ (诺辛辛 J' V -0-) some) methyl) ¾ some 3W-three gases Methyl) H-cHaziHne converts 3- (4- (bromomethyl) phenyl-3-difluoromethyl-3 ^ (3 丨 32b) to (

6.0 g, 21.5 mmol)溶於二氯甲烷(6 ml)。將史賓諾辛J (1·75 g,2.4 mmol)之二氯甲烷溶液(5 ml)加入此溶液中 經濟部中央標準局員工消費合作社印袋 (請先閲讀背面之注意事項再填寫本頁) ,接著加入四丁基銨氫硫酸鹽(1. 1 g)及25%氫氧化納水 溶液。劇烈攪拌反應混合物20小時。逐漸完成及在矽膠( , 乙酸乙酯)上層析K提供化合物(4”’(((史賓諾辛J _3 ’ - 0-)基)甲基)苯基 3W-三氟甲基)-3wH-diazir ine (1· 393 g ,62% ),為白色固體: ESI MS m/z 916 (Μ + 1).6.0 g, 21.5 mmol) was dissolved in dichloromethane (6 ml). Add Spinozin J (1.75 g, 2.4 mmol) in dichloromethane solution (5 ml) to this solution. Printed in the printed bag of the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) ), Then add tetrabutylammonium hydrogen sulfate (1.1 g) and 25% aqueous sodium hydroxide solution. The reaction mixture was stirred vigorously for 20 hours. Gradually complete and chromatograph K on silica gel (, ethyl acetate) to provide compound (4 "'((((Spinoxin J_3'-0-) yl) methyl) phenyl 3W-trifluoromethyl))- 3wH-diazir ine (1.339 g, 62%) as a white solid: ESI MS m / z 916 (Μ + 1).

Anal. Calcd for C49H68F3N3O10: C, 64.24; H, 7.48; N, 4.58. Found: C, 64.13; H, 7.60; N, 4.69. _____- 102 -___ 本紙張尺度適用中國國家標李(CNS ) A4規格(210 X 297公釐) 487559 A7 ----- B7五、發明説明(1〇〇) 經濟部中央標準局員工消費合作社印裝 啻搁例A 100-3’-Π-Μ丙烯某中窨諾辛J 史賓諾辛J (3.74g,4.92 mmol)之3’-0-乙酸酯溶於 乾THF(50 ml)中。加入乾吡啶(10 ml)及將溶液在氮氣下 冷卻至-78°C。媛緩加入0.5 M Tebbe試劑之甲苯溶液(25 ml , 12.5mrnol)。於在-78°C下攪拌30分鐘後,將溫度升高 至+ 25 °C並持續攪拌1小時。混合物冷卻至0°C並非常慢地 加入15%氫氧化納水溶液(20 ml)。之後,加入乙醚(150 ml)。一般逐漸進行反應及在矽膠(乙酸乙酯)上層析Μ提 供化合物3’-0_異丙烯基史賓諾辛J (1.99 g, 53%),為 白色固體:INMR δ 6.65 (s, 1 Η), 4.20 (m, 2H), 3.84 (m, 2H), 3.41 (s, 3 Η), 3.34 (s, 3H), 1.75 (s, 3H). Anal. Calcd for C43H67NO10: C, 68.13; H, 8.91; N, 丄.85. Found: C, 68.10; H, 8,99; U, 2.09. 啻餱例A 思丙基Φ客諾宰J 將3,-0-畢丙烯基史賓諾辛J (0.828 g,1.09 mmol) 溶於乾甲苯(12 ml)。加入三乙基矽烷(338 g,〇·9 ramol) 。在氮氣下將混合物冷卻至+10°C及在1分鐘内加入TFA (9 1 , 2 mg,8fflinol)。持續搜拌5分鐘,接著加入三乙胺(1·5 ml )。一般逐漸進行反應及在矽膠(乙酸乙酯)上層析以獲得 產物,該產物額外藉由HPLC (90 : 10,甲醇/水)純化以提 供3,-0-異丙基史賓諾辛J (218 mg,26% ),為白色固體 (請先閱讀背面之注意事項再填寫本頁) •裝· 、-口 線 本纸張尺度適用中國國家標率(CNS ) A4規格(21〇X297公釐) -103 - _ 487559 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(1〇1 ) 1H MMR 5 6.71 (s, 1 Η), 3.73 (m, 1Η), 3.51 (s, 3 Η), 3.45 (s, 3H). Anal. Calcd for 1 C43H69NO10: C, 67.95; H, 9.15; N, 1.84. Found: C; 68.20; H, 9.03; N, 1.35. 脊黻例A 102-化合物3 ·:Ίη-丙基中客諾辛J 及化合物3 V-0-n-丙基中客諾辛L (40-15%) 夕潖合物 將史賓諾辛J (60%-85%)及史賓諾辛L (40-15%)之 技術混合物溶於二氯甲烷(50 ml)。加入碳酸鉀(12 g)及2 0%氫氧化鈉水溶液(100 ml),接著加入η-丙基碘(35 ml) 、四丁基銨氫硫酸鹽(4.6 g)及DMS0 (50 ml)。將混合物劇 烈攪拌72小時。一般逐漸進行反應及在矽膠(乙酸乙酯)上 層析以提供化合物3’-0-11-丙基史賓諾辛」(60%-85%)及 化合物3’-0-n-丙基史賓諾辛L (40-15%)之混合物(8.87 g),為白色固體:iHNMRSeJSU, 1H),5*37(s, ca.0.2 Η) , 0.85(t, J=7.4, 3H)。 蜜旆例A 103-化合物3 ’-0-n_丙基Φ W諾辛J MO% -85%) 及化合物:Γ-Π-n-丙基中W諾辛L UO-15% ) 撺檬酸鹽之滔合物 將化合物3’-0-η-丙基史賓諾辛J (60%-85%)及化合 物3’-0-η-丙基史賓諾辛L (40-15%)之混合物(205 mg, 0.275 111111〇1)溶於丙_(8 1111)並加入檸檬酸單水物(57.9 mg,0.275 mmol)之丙酮(3 ml)溶液及攪拌溶液2小時。藉 -104 - (請先閱讀背面之注意事項再填寫本頁) -裝·Anal. Calcd for C49H68F3N3O10: C, 64.24; H, 7.48; N, 4.58. Found: C, 64.13; H, 7.60; N, 4.69. _____- 102 -___ This paper size applies to China National Standard (CNS) A4 specifications (210 X 297 mm) 487559 A7 ----- B7 V. Description of the invention (100) Printing and decoration of the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A 100-3'-Π-Μ Propylene Nosin J Spinnoxin J (3.74 g, 4.92 mmol) of 3'-0-acetate was dissolved in dry THF (50 ml). Dry pyridine (10 ml) was added and the solution was cooled to -78 ° C under nitrogen. Slowly add 0.5 M Tebbe reagent in toluene (25 ml, 12.5 mrnol). After stirring at -78 ° C for 30 minutes, the temperature was raised to + 25 ° C and stirring was continued for 1 hour. The mixture was cooled to 0 ° C and 15% aqueous sodium hydroxide solution (20 ml) was added very slowly. After that, diethyl ether (150 ml) was added. The reaction is generally carried out gradually and chromatography on silica gel (ethyl acetate) to provide the compound 3'-0_isopropenyl Spinozin J (1.99 g, 53%) as a white solid: INMR δ 6.65 (s, 1 Η ), 4.20 (m, 2H), 3.84 (m, 2H), 3.41 (s, 3 Η), 3.34 (s, 3H), 1.75 (s, 3H). Anal. Calcd for C43H67NO10: C, 68.13; H, 8.91; N, 丄 .85. Found: C, 68.10; H, 8,99; U, 2.09. Example A: Sylpropene Knozai J will be 3, -0- Propenyl Spinozin J ( 0.828 g, 1.09 mmol) was dissolved in dry toluene (12 ml). Triethylsilane (338 g, 0.9 ramol) was added. The mixture was cooled to + 10 ° C under nitrogen and TFA (91, 2 mg, 8fflinol) was added over 1 minute. Continue to search for 5 minutes, and then add triethylamine (1.5 ml). The reaction is generally performed gradually and chromatographed on silica gel (ethyl acetate) to obtain the product, which is additionally purified by HPLC (90:10, methanol / water) to provide 3, -0-isopropylspinoxin J ( 218 mg, 26%), is a white solid (please read the precautions on the back before filling in this page) • The size of the paper is applicable to China National Standards (CNS) A4 specifications (21 × 297 mm) ) -103-_ 487559 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs V. Invention Description (1〇1) 1H MMR 5 6.71 (s, 1Η), 3.73 (m, 1Η), 3.51 (s, 3 Η), 3.45 (s, 3H). Anal. Calcd for 1 C43H69NO10: C, 67.95; H, 9.15; N, 1.84. Found: C; 68.20; H, 9.03; N, 1.35. Spine case A 102-compound 3 :: Ίη-propyl borneoxine J and compound 3 V-0-n-propyl borneoxine L (40-15%) Evening compound will be Spinoxin J (60% -85% ) And the technical mixture of Spinozin L (40-15%) was dissolved in dichloromethane (50 ml). Potassium carbonate (12 g) and 20% aqueous sodium hydroxide solution (100 ml) were added, followed by η-propyl iodide (35 ml), tetrabutylammonium hydrogen sulfate (4.6 g) and DMS0 (50 ml). The mixture was stirred vigorously for 72 hours. The reaction is generally carried out gradually and chromatographed on silica gel (ethyl acetate) to provide compound 3'-0-11-propylspinoxin "(60% -85%) and compound 3'-0-n-propylspinol A mixture of nosin L (40-15%) (8.87 g) as a white solid: iHNMRSeJSU, 1H), 5 * 37 (s, ca. 0.2 Η), 0.85 (t, J = 7.4, 3H). Honeydew Example A 103-Compound 3 '-0-n_propyl Φ W Nosin J MO% -85%) and Compound: Γ-Π-n-propyl W Nosin L UO-15%) The salt of the acid salt compound 3'-0-η-propyl spinosynoxin J (60% -85%) and compound 3'-0-η-propyl spinosynoxin L (40-15%) The mixture (205 mg, 0.275 111111〇1) was dissolved in propyl (8 1111) and a solution of citric acid monohydrate (57.9 mg, 0.275 mmol) in acetone (3 ml) and the stirred solution were added for 2 hours. Borrow -104-(Please read the notes on the back before filling out this page)

、1T 線 本纸張尺度適用中國國家標準(CNS ) Α4規格〖210X297公釐) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(102) 由旋轉式蒸發器去除溶劑以獲得化合物3 ’ 丙基史賓 諾辛J (60%-85%)及化合物3’-0-n-丙基史賓諾辛L (40-15%)擰檬酸鹽之混合物(254 mg)。 啻敝例A 1 04-化合物5. fi-二氩-3 ’ -0-η-丙基中窨諾辛J ( 60% -85%)及仆合物3 η-丙基中曹諾辛 L (40-15%)^ 滔合物 將化合物3'-0-η-丙基史賓諾辛J (60%-85%)及化合 物3’-0-n-丙基史賓諾辛L (40-15%)之混合物(8.35 g)溶 於乙醇(250 ml)。加入環己烷(60 ml)。在氮氣下將混合 物冷卻至0C及加入10% Pd/C催化劑(7.0 g)。媛和地加熱 反應混合物至迴流溫度3小時。接著冷卻至〇 °C及加入H比啶 (2ml),過滤催化劑,濃縮滤液,接著溶於乙醚(300 ml) 。一般逐漸完成可提供化合物5,6-二氬-3’丙基史賓 諾辛』(60%-85%)及化合物3’-〇1-丙基史賓諾辛1^(4〇-15% )之混合物(7.40 g),為白色固體: 1H NMR δ 6.73 (s, ca. 0.8 Η), 6.63 (S/ ca. 0.2 H)# 5.37 (s, ca. 0.2 H), 0.84 (t, J = 7.4, 3 H). 奮施例A 合物5.6-二氣'V_n-n-丙基中W諾辛J ( 60% -85%)及化合物:Γ-Π-η-丙基中窨諾辛 T』U0-15%)撺樹泯会物 將化合物5,6-二氫-3’-0-n-丙基史賓諾辛J (60%-85 %)及化合物-丙基史賓諾辛L (40-15%)之混合物( 205 mg,0,269 mmol)溶於丙酮(8 ml)並加入擰檬酸單水 物(56.7ms,0.269 mmol)之丙酮(3 ml)溶液及授拌溶液2 -105 - 本紙張尺度適用中國國家標準(CMS ) A4規格(210乂2()7公釐) (請先閱讀背面之注意事項再填寫本頁) -° ^齊郎中夬矂隼苟員工消費合作社印製 487559 A7 B7 五、發明説明(1〇3 ) 小時。藉由旋轉式蒸發器去除溶劑Μ獲得化合物3’_0-η-丙基史賓諾辛J (60%-85%)及化合物3’-0-η-丙基史賓諾 辛L (40-15%)擰懞酸鹽之混合物(211 mg)。 啻賺例A 106-化合物5 二氩-3’ - Π-μ-Μ丙基中客諾卒J 將3’-0_異丙烯基史賓諾辛J (280 mg,0.369 mmol) 在20分鐘内與三乙基砂烧(110 mg,0,94 mmol)及TFA(340 mg,3.0 mmol)作用,依照化合物3 f-0-異丙基史賓諾辛 J (實施例A 101)之步驟。於HPLC(90 : 10,甲醇/水)分離 粗產物後,可獲得5,6-二氫-3’-0&quot;^-異丙基史賓諾辛」( 47 mg,17% ),為白色固體:ESI MS m/z 763 (M + 1)。 奮施例A 107-3 乙某-N-甲酼基-中客諾辛Μ及化合物 3 ^0-Ζ基中窨諾宰Μ 將3’-0-乙基史賓諾辛J (2.20 g,2·95 mmol)溶於乙 醚(25 ml)。接著將溶液加至在氮氣下預迴流30分鐘之乙 酸納(10.3 g)的乙醇(50ml)及水(20 ml)溶液中。接著加 入碘(4.8 g),於5分鐘後,接著加入0.2N氫氧化納水溶液 。在50°C下持續攪拌10分鐘。將反應混合物與飽和亞硫酸 氫納溶液(200 ml)合併及Μ —般方式逐漸進行反應。在矽 膠上進行閃蒸層析(乙酸乙酯),接著為30%乙醇之乙酸乙 酯溶液以提供a) 3 ’ -0-乙基-Ν-甲醯基-史賓諾辛Μ (0.380 s,17%)為黃色玻璃狀固體:ESI MS πι/ζ 760 (Μ + 1);及 化合物b) 3’-0-乙基史賓諾辛Μ (0.799 g,37%),為白 色偏離固體:ESI MS m/z 732 (M + 1)。 啻敝例A 1 08-N-「2W -(甲氬羰某)7.烯基1 - 3 ’ -0-乙基-史曹 ______- 106 -_ 本纸ί長尺度適用中國國家標準(CNS ) A4規格(210X.297公釐) 裝 訂 線 (請先閱讀背面之注意事項再填寫本頁) 487559 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(104) 諾辛Μ 將3·-0-乙基史賓諾辛Μ (455 mg,〇· 622 mmol)溶於 乾二氯甲烷(20 ml)。加入丙炔酸甲酯(2.20 ml,過量)及 將混合物在室溫及氮氣下攪拌。於18小時後’逐漸進行反 應並在矽膠管柱(乙酸乙酯)上純化以獲得[2~-(甲氧羰 基)乙烯基]-3’-0-乙基-史賓諾辛Μ (454 mg,89% ),為 白色固體:ESI MS m/z 816(M + 1)。 啻_例A H)9-(4W (((中窨諾辛Η -2 · -0-)基)甲基)笼基 1&quot;-三氣甲基)-3wH-diazirine 將史賓諾辛Η (1.40 g, 1.95 mmol)及3-(4-(溴乙基) 苯基-3-二氟甲基-3[1-€1133卜{1^(2.7〇8,9.7 111111〇1)依照 3…—(4W (((史賓諾辛J -3 基)甲基)苯基3&quot;'-三氟甲基) - 3&quot;Ml-diazirine之方法步驟反應。可獲得3W-(41((史賓 諾辛Η -2 基)甲基)苯基3&quot;#_三氟甲基)-31- diazirine(251 mg,14%)為白色固體:ESI MS m/z 916 (M+l) 〇 啻瓶例 A 110-3W- (4W ( ( (3 ’ -0-Z 基 Φ W 諾辛 M -N-)基)甲 基-)苯基- 3&quot;’ —^ 氣甲基)- miazirine 將3’-0-乙基史賓諾辛M(79 mg, 0.108 mmol)溶於乾 DMF中(5 ml)。加入三乙胺(0.50 ml),接著加入3-(4-(溴 甲基)苯基-3-三氟甲基- H- diazirined.O g, 3.6 mmol) 之乾二氯甲烷溶液(4 m 1)。在室溫及暗室下攪拌混合物, 及在矽膠(乙酸乙酯)上層析以獲得3W- (4W ( ( (3 ’ -0-乙基史 賓諾辛M-N-)基)甲基-)苯基-三氟甲基)-3…Η- -107 - 本紙張尺度適用中國國家標準(CNS ) Λ·4規格(210Χ 297公釐) (請先閱讀背面之注意事項再填寫本頁) 裝------訂-------線1. The paper size of the 1T line is applicable to the Chinese National Standard (CNS) A4 specifications [210X297 mm] 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 5. Description of the invention (102) The solvent is removed by a rotary evaporator to obtain A mixture of compound 3'-propyl spinosinol J (60% -85%) and compound 3'-0-n-propyl spinosinol L (40-15%) citrate (254 mg). Example A 1 04-Compound 5. fi-Diargon-3 '-0-η-propyl midoxin J (60%-85%) and 3 η-propyl midoxoxin L (40-15%) ^ The compound will be compound 3'-0-n-propyl spinosynoxin J (60% -85%) and compound 3'-0-n-propyl spinosynoxin L (40- 15%) of the mixture (8.35 g) was dissolved in ethanol (250 ml). Cyclohexane (60 ml) was added. The mixture was cooled to 0C under nitrogen and 10% Pd / C catalyst (7.0 g) was added. The reaction mixture was heated to reflux temperature for 3 hours. It was then cooled to 0 ° C and Hbitidine (2 ml) was added. The catalyst was filtered and the filtrate was concentrated and then dissolved in ether (300 ml). Generally gradually completed can provide compound 5,6-diargon-3'propyl spinosinoxin '(60% -85%) and compound 3'-〇1-propyl spinosinoxin 1 ^ (4〇-15%) Mixture (7.40 g) as a white solid: 1H NMR δ 6.73 (s, ca. 0.8 Η), 6.63 (S / ca. 0.2 H) # 5.37 (s, ca. 0.2 H), 0.84 (t, J = 7.4, 3 H). Fen Example A Compound 5.6-Digas' V_n-n-propyl W-Nosin J (60% -85%) and Compound: Γ-Π-η-propyl-Moroxine T 』U0-15%) Neem tree meeting will compound 5,6-dihydro-3'-0-n-propyl spinosinol J (60% -85%) and compound-propyl spinosin L (40-15%) of the mixture (205 mg, 0,269 mmol) was dissolved in acetone (8 ml) and a solution of citric acid monohydrate (56.7ms, 0.269 mmol) in acetone (3 ml) and the stirring solution 2- 105-This paper size applies Chinese National Standard (CMS) A4 specification (210 乂 2 () 7mm) (Please read the precautions on the back before filling out this page)-° ^ Printed by Qilang Zhongyugou Consumer Cooperative System 487559 A7 B7 V. Description of the invention (103) hours. The solvent M was removed by a rotary evaporator to obtain the compound 3'_0-η-propyl spinosynoxine J (60% -85%) and the compound 3'-0-η-propyl spinosynoxine L (40-15% ) A mixture of salt of manganese (211 mg). Example A 106-Compound 5 Diargon-3 '-Π-μ-Mpropyl Propoxynol J J 3'-0_isopropenyl Spinozin J (280 mg, 0.369 mmol) in 20 minutes Interaction with triethyl charcoal (110 mg, 0,94 mmol) and TFA (340 mg, 3.0 mmol), following the procedure of compound 3f-0-isopropylspinoxin J (Example A 101). After separation of the crude product by HPLC (90:10, methanol / water), 5,6-dihydro-3'-0 &quot; ^-isopropylspinoxin "(47 mg, 17%) was obtained as a white solid : ESI MS m / z 763 (M + 1). Fen Example A 107-3 Ethyl-N-formyl-Chokenoroxine M and Compound 3 ^ 0-Zyl-Chrysene NozzleM 3'-0-Ethyl Spinoxin J (2.20 g, 2.95 mmol) was dissolved in ether (25 ml). The solution was then added to a solution of sodium acetate (10.3 g) in ethanol (50 ml) and water (20 ml) pre-refluxed under nitrogen for 30 minutes. Next, iodine (4.8 g) was added, and after 5 minutes, 0.2N aqueous sodium hydroxide solution was added. Stirring was continued for 10 minutes at 50 ° C. The reaction mixture was combined with a saturated sodium bisulfite solution (200 ml) and the reaction was gradually performed in a general manner. Flash chromatography (ethyl acetate) on silica gel followed by 30% ethanol in ethyl acetate to provide a) 3'-0-ethyl-N-formyl-spinoxin M (0.380 s , 17%) is a yellow glassy solid: ESI MS π / ζ 760 (M + 1); and compound b) 3'-0-ethylspinoxin M (0.799 g, 37%), as a white off solid: ESI MS m / z 732 (M + 1). Example A 1 08-N- "2W-(methyl argonyl) 7. Alkenyl 1-3 '-0-ethyl-Shi Cao ______- 106 -_ This paper applies the long-term standard of China ( CNS) A4 size (210X.297 mm) gutter (please read the notes on the back before filling this page) 487559 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Α7 Β7 V. Description of the invention (104) Nosin M will 3 · -0-Ethyl Spinoxin M (455 mg, 0.622 mmol) was dissolved in dry dichloromethane (20 ml). Methyl propionate (2.20 ml, excess) was added and the mixture was stirred at room temperature and Stir under nitrogen. After 18 hours, 'react gradually and purify on a silica gel column (ethyl acetate) to obtain [2 ~-(methoxycarbonyl) vinyl] -3'-0-ethyl-spinnow Sin M (454 mg, 89%) as a white solid: ESI MS m / z 816 (M + 1). Example AH) 9- (4W (((中 窨 诺辛 Η -2 · -0-) Group) methyl) cage 1 &quot; -trifluoromethyl) -3wH-diazirine Spinoloxine (1.40 g, 1.95 mmol) and 3- (4- (bromoethyl) phenyl-3-difluoro Methyl-3 [1- € 1133, {1 ^ (2.7〇8, 9.7 111111〇1) in accordance with 3 ...- (4W (((Spinnock J-3 Methyl) phenyl 3 &quot; '-trifluoromethyl)-3 &quot; Ml-diazirine method step reaction. 3W- (41 ((Spinoxin A-2 -methyl) methyl) phenyl 3 &quot;# _Trifluoromethyl) -31- diazirine (251 mg, 14%) is a white solid: ESI MS m / z 916 (M + l) 〇 Example A 110-3W- (4W (((3 '-0 -Z group Φ W Nosin M -N-) yl) methyl-) phenyl-3 &quot; '— ^ Gas methyl)-miazirine 3'-0-ethyl Spinoxin M (79 mg, 0.108 mmol ) Dissolved in dry DMF (5 ml). Triethylamine (0.50 ml) was added, followed by 3- (4- (bromomethyl) phenyl-3-trifluoromethyl-H-diazirined.O g, 3.6 mmol) of dry dichloromethane solution (4 ml 1). The mixture was stirred at room temperature in a dark room and chromatographed on silica gel (ethyl acetate) to obtain 3W- (4W (((3 '-0-ethyl Binoxin MN-) yl) methyl-) phenyl-trifluoromethyl) -3 ... Η- -107-This paper size applies to Chinese National Standard (CNS) Λ · 4 specification (210 × 297 mm) (Please (Read the precautions on the back before filling out this page.)

垣齋印中_麥¾員X.消費合泎fi印製 487559 A7 ___ B7 五、發明説明(1〇5 ) diazirine(90 mg,90%),為黃色玻璃狀固體:ESI MS m /z 930 (M+1)。 啻淪例A 1 1 1 -3’ -烯丙基Ύ -宪中審諾辛.1 將3·-酮基史賓諾辛J (3.40 g,4.799 mmol)溶於乙 醚(40 ml)。在氮氣及+10°C下劇烈搅拌溶液並加入烯丙基 三丁錫(4.0 ml,過量)。於5分鐘後,緩慢地導入全氯化 鋰(20.0 g)。維持劇烈攪拌20小時。加入更多的乙酸乙酯 (100 ml)及使反應物逐漸進行反應。使粗產物在矽膠(乙 酸乙酯)上層析以獲得3’-烯丙基-3’-表史賓諾辛J (2.32 g, 62¾),為白色固體:mMR δ 6·66 (s, 1 Η), 5.72 (m, 3 H), S.09 (m, 2 H), 3.4S (s, 3 Η), 3.35 (s, 3 H)· ESI MS m/z 753 (M + 1). 窨敝例A 1 1 2 - (14R/S -3 f -烯丙某- Ή. 1 4-二氩-3 ’ -表中窨 諾鱼』 3’-烯丙基-3’-表史賓諾辛J (1.14 g,1.50 mmol)溶 * 於乾二氯甲烷(12 ml)。將溶液在氮氣下冷卻至-78°C及痂 入一部分氯化二苯晒基(650 mg, 3.32 mmol)。10分鐘後 ,將混合物加熱至〇°C。再過10分鐘後,加入三乙胺( 0.50 ml)及在0°C下持缡攪拌10分鐘。逐漸進行反應及在 在矽膠(乙酸乙酯)上層析K獲得白色固體(1.028 g)。將 此物質溶於乾甲苯(20 ml)。加入氩化三-η-丁基錫(1.80 ' ml,過量)及ΑΙΒ1Η110 mg)。混合物在氮氣下加熱至迴流溫 度15分鐘。於冷卻至室溫後,混合物在減壓下濃縮並藉由 矽膠(乙酸乙酯)層析進行纯化。接著藉由HPLC分離(92 : 8 -108 _ 本紙張尺度剌巾關家縣(CNS ) A4規格(21G X.:W公釐)~~ - — 批衣-- (請先閱讀背面之注意事項再填寫本頁)Yuanzhai Yinzhong _ Mai ¾ member X. Consumption combined with fi print 487559 A7 ___ B7 V. Description of the invention (105) diazirine (90 mg, 90%), yellow glassy solid: ESI MS m / z 930 (M + 1). Example A 1 1 1 -3'-Allylpyrene-Xinzhong Nosin. 1-3-Ketospinoxin J (3.40 g, 4.799 mmol) was dissolved in ethyl ether (40 ml). Stir the solution vigorously under nitrogen at + 10 ° C and add allyltributyltin (4.0 ml, excess). After 5 minutes, lithium perchloride (20.0 g) was introduced slowly. Maintain vigorous stirring for 20 hours. More ethyl acetate (100 ml) was added and the reaction was allowed to proceed gradually. The crude product was chromatographed on silica gel (ethyl acetate) to obtain 3'-allyl-3'-epispinoxin J (2.32 g, 62¾) as a white solid: mMR δ 6.66 (s, 1 Η), 5.72 (m, 3 H), S.09 (m, 2 H), 3.4S (s, 3 Η), 3.35 (s, 3 H) ESI MS m / z 753 (M + 1)窨 敝 例 A 1 1 2-(14R / S -3 f -Allyl-Ή. 1 4-Diargon-3 '-Minodon in the table 3'-Allyl-3'-Table history Binoxin J (1.14 g, 1.50 mmol) was dissolved in dry dichloromethane (12 ml). The solution was cooled to -78 ° C under nitrogen and a portion of diphenylsulfanyl chloride (650 mg, 3.32 mmol) was added. ). After 10 minutes, the mixture was heated to 0 ° C. After another 10 minutes, triethylamine (0.50 ml) was added and the mixture was stirred at 0 ° C for 10 minutes. The reaction was gradually carried out and the reaction was carried out in silicone (ethyl acetate Esters) were chromatographed on K to obtain a white solid (1.028 g). This material was dissolved in dry toluene (20 ml). Tri-n-butyltin argon (1.80 'ml, excess) and AIB (110 mg) were added. The mixture was heated to reflux temperature under nitrogen for 15 minutes. After cooling to room temperature, the mixture was concentrated under reduced pressure and purified by silica gel (ethyl acetate) chromatography. Then separated by HPLC (92: 8 -108 _ this paper size Guanjia County (CNS) A4 size (21G X .: W mm) ~~--batch of clothes-(Please read the precautions on the back first (Fill in this page again)

、1T 線 經濟部中央標準局員工消費合作社印製 487559 A7 _____ B7 _ 五、發明説明(1〇6 ) ,甲醇/水)Μ提供(14R/S-3’-烯丙基-13,14-二氫-3’-表 史賓諾辛J (188 rag, 16% ),為白色固體:iHNMR δ 5· 45-5.75U, 3H), 5·04(πι, 2H)〇ESI MS m/z 760 (M + 1)。Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs of the 1T line 487559 A7 _____ B7 _ V. Description of the invention (106), methanol / water) M Provide (14R / S-3'-allyl-13,14- Dihydro-3'-epispinoxin J (188 rag, 16%) as a white solid: iHNMR δ 5.45-5.75U, 3H), 5.04 (π, 2H) .ESI MS m / z 760 (M + 1).

窨腧例A 1 iKh合物5,6-二氩-.V -弄_N-.V -丙基中窨諾辛 J及化合物5. fi-二氣'V -羌'V -丙基中窨諾 辛J 將化合物3’-烯丙基-3’-表史賓諾辛J (218 mg, 0.28 7 mmol)溶於乙醇(30 ml)。在氮氣下冷卻溶液至0°C。加 入10% Pd/C (911 mg),接著加入環己烷(10 ml,使用前未 純化)。將混合物在氮氣下加熱至迴流溫度3小時。加入三 乙胺(1 ml)。於逐漸進行反應及在矽膠上曆析後,粗產物 在HPLC上分離(94:6,甲醇/水)。可獲得a)化合物5,6-二 氫-3夂表丙基史賓諾辛J (28 mg, 12¾),為黃色玻 璃狀固體:k NMR δ 8·04 (s, 1H), 6.31 (s, 1 H), 3.47 (S, 3 Η), 3.39 (S/ 3 Η), 2.71 (S/ 1·5 Η), 2·19 (s, ca. ca. 1.5 H)· ESI MS m.‘z 7όό (M + 1) (M + l)及化合物b)5,6-二氫-3’-表-3T-丙基史賓諾辛J (94 mg, 43%)為白色固體: XH NMR δ 6.75 (s, 1 Η), 3.42 (s, 3 Η), 3.34 (s, 3 Η), 2.13 (s, 6 Η).Example A 1 iKh compound 5,6-diargon-.V-non-N-.V-propyl midoxine J and compound 5. fi-digas 'V-羌' V -propyl Panaxine J Compound 3'-allyl-3'-epispinoxin J (218 mg, 0.28 7 mmol) was dissolved in ethanol (30 ml). The solution was cooled to 0 ° C under nitrogen. Add 10% Pd / C (911 mg), followed by cyclohexane (10 ml, unpurified before use). The mixture was heated to reflux temperature for 3 hours under nitrogen. Add triethylamine (1 ml). After gradual reaction and analysis on silica gel, the crude product was separated on HPLC (94: 6, methanol / water). A) Compound 5,6-dihydro-3 夂 epipropylspinoxin J (28 mg, 12¾) was obtained as a yellow glassy solid: k NMR δ 8 · 04 (s, 1H), 6.31 (s, 1 H), 3.47 (S, 3 Η), 3.39 (S / 3 Η), 2.71 (S / 1.5 Η), 2.19 (s, ca. ca. 1.5 H), ESI MS m.'z 7ό (M + 1) (M + l) and compound b) 5,6-dihydro-3'-epi-3T-propyl spinosinol J (94 mg, 43%) is a white solid: XH NMR δ 6.75 (s, 1 Η), 3.42 (s, 3 Η), 3.34 (s, 3 Η), 2.13 (s, 6 Η).

啻倫例A 114-3 ’-Ω-7ι烯某中客諾辛J 將史賓諾辛J (1.2 g,1.67 mmol)溶於乙基乙烯基醚 (50 ml,過量)。加入乙酸汞(3.5 g)。在氮氣下將混合物 加熱至迴流溫度4小時。於逐漸進行反應及在矽膠(乙酸乙 -109 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) I---------批衣-- (請先閱讀背面之注意事項再填寫本頁)Example A 114-3 ′ -Ω-7ιene Sinokinexin J Spinoxinine J (1.2 g, 1.67 mmol) was dissolved in ethyl vinyl ether (50 ml, excess). Add mercury acetate (3.5 g). The mixture was heated to reflux temperature under nitrogen for 4 hours. In the process of gradual reaction and silicon rubber (ethyl acetate-109-this paper size applies to Chinese National Standard (CNS) A4 size (210X 297 mm) (Notes for filling in this page)

、1T 線 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(1〇7 ) 酿)上層析後可獲得V-O-乙烯基史賓諾辛J (163 mg,13¾ ),為白色固體:ESI MS ιπ/ζ 744 (M + 1)。 例A 1 1 5-3 ’ -Ο- (N-眯唑)碏醯基中窨諾辛J 將史賓諾辛J (2· 40 g,3.34 mmol)溶於二甲基甲醯 胺(15 ml)。在氮氣下將溶液冷卻至〇°C並加入咪唑(6.8 g ,過量)。將混合物攪拌10分鐘。之後,將硫醯氯(1· 90 ml)經注射器媛慢地導入,使混合物升溫至室溫並持續攪 拌16小時。一般逐漸進行反應及在矽膠(乙酸乙酯)上層析 Μ提供咪唑)磺醯基史賓諾辛J (1.52 g, 54%) 為白色固體:ESI MS m/z 848 (M + 1)。 富确例A 1 4T -去甲-3 ’ - (R)(甲氢基)亞甲某中害諾辛J 將3’-0-(N-咪唑)磺醯基史賓諾辛J (1.21 g, 1.43 mmol)溶於乾甲苯(20 ml)。加入氯化苄基三乙胺(5,0 g, 過量)及在氮氣下將溶液加去至迴流溫度。於5小時後,在 減壓下濃縮混合物。藉由矽膠上之層析(乙酸乙酯)純化粗 產物並接著藉由HPLC分離(90: 1,甲醇/水)Μ獲得4夂去 甲-3*-(Ε)(甲氧基)亞甲基史賓諾辛J (61 mg, 6¾),為白 色固體: η NMR δ 6.70 (s, 1 Η), 6.15 (d, JT = 2.0, 1 Η), ς.ΟΟ (s, 1 Η), 4.68 (q, J= 6.6, 1 H), 3.60 (s# 3 H), 3.20 (s, 3 H).1. 1T line 487559 Printed by A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the invention (107). VO-vinyl Spinozin J (163 mg, 13¾) can be obtained after chromatography. It is white. Solid: ESI MS ιπ / ζ 744 (M + 1). Example A 1 1 5-3 '-Ο- (N-oxazole) fluorenyl in glutinosin J Spinoloxin J (2.40 g, 3.34 mmol) was dissolved in dimethylformamide (15 ml). The solution was cooled to 0 ° C under nitrogen and imidazole (6.8 g, excess) was added. The mixture was stirred for 10 minutes. Then, thionine chloride (1.90 ml) was slowly introduced through a syringe, and the mixture was warmed to room temperature and continuously stirred for 16 hours. The reaction is generally carried out gradually and chromatographed on silica gel (ethyl acetate). M provides imidazole) sulfinospinoxin J (1.52 g, 54%) as a white solid: ESI MS m / z 848 (M + 1). Full example A 1 4T-Nor-3 '-(R) (methyl) methylene in a certain harmful Nosing J J 3'-0- (N-imidazole) sulfonyl Spinoxin J (1.21 g , 1.43 mmol) was dissolved in dry toluene (20 ml). Benzyltriethylamine chloride (5.0 g, excess) was added and the solution was added to reflux temperature under nitrogen. After 5 hours, the mixture was concentrated under reduced pressure. The crude product was purified by chromatography on silica gel (ethyl acetate) and then separated by HPLC (90: 1, methanol / water) to obtain 4 夂 nor-3 *-(E) (methoxy) methylene Kespinoxin J (61 mg, 6¾) as a white solid: η NMR δ 6.70 (s, 1 Η), 6.15 (d, JT = 2.0, 1 Η), ς.ΟΟ (s, 1 Η), 4.68 (q, J = 6.6, 1 H), 3.60 (s # 3 H), 3.20 (s, 3 H).

鬣施例A 1 17-5.6-二氩'V-O-Z烯某中客諾辛.J 將 5,6 -二 M -史賓諾辛 J (1.85 g, 2.57 mmol)溶於 乙烯醚(50 ml,過濾)。加入乙酸汞(4.2 g,過量)。將反 應混合物加熱至迴流溫度4小時。接著加入碳酸納固體(10 ____ - 110 - 本纸張尺度適用巾) A4規格(2i()x 297公塵~~ —- (請先閱讀背面之注意事項再填寫本頁)Example A 1 17-5.6-Diargon'VOZene in a certain guest Nosin. J Dissolved 5,6-di-M-spinoxin J (1.85 g, 2.57 mmol) in vinyl ether (50 ml, filtered ). Add mercury acetate (4.2 g, excess). The reaction mixture was heated to reflux temperature for 4 hours. Then add sodium carbonate solids (10 ____-110-towels suitable for this paper size) A4 size (2i () x 297 public dust ~~ —-(Please read the precautions on the back before filling this page)

487559 經濟郎中央標隼局員工消費合作社印製 A7 B7 五、發明説明(1〇8) g)。一般逐漸進行反應及在矽膠(乙酸乙酯)上層析以提供 5,6-二氫_3、0-乙烯基史賓諾辛](1.〇2 8,53%): lU NMR δ 6.74 (s, 1 Η), β.31 (da, Ji = 16.9, =6·5, 1 Η), 4.30 (m, 2 Η), 3.90 (m, 2 Η), 3.38 (s, 3 Η), 3·3ό (s, :· H)_ 窨胞例A 118-2 烯某中害諾辛Η 依照5,6-二氫-3’-0-乙烯史賓諾辛J所述步驟使史賓 諾辛Η(2·03 g, 2.83 mmol)與丁基乙烯基醚反應及自反 應混合物分離。所得2’-0_乙烯基史賓諾辛H (1.09g, 52¾ )為白色固體:ESI MS m/z 744 (M + 1)。 管_例六119-中客諾辛,;[(二甲基)磷酸酯 將史賨諾辛J (0,903 g, 1.26 mmol)溶於乾吡啶(2.5 ml)。將溶液在氮氣下冷卻至Ot:及加入四溴化碳(0.91 g, 2.75 mmol)。於攪拌5分鐘後,經由注射器媛慢地導入三 甲基磷P(0Me)3(0.38 ml, 3.12 mmol)。移開冷卻浴及將 混合物在室溫下攪拌3小時。一般逐漸進行反應及在矽膠( 15%乙醇之乙酸乙酯溶液)上層析K提供史賓諾辛J之3 ’ -〇-(二甲基)磷酸酯(0.910 g, 88¾),為白色固體^ESI ME m/z 826 (M+l) ° 管油;例A120-中客諾辛1&quot;[之2’-0-(二甲基)磷酸酯 將史賓諾辛Η (0.65 g, 0.905 mmol)與四溴化碳( 0.63 g, 1.90 mmol)及三甲基鱗(0·30 ml, 2*46 mmol) ’ 依史賓諾辛J之3’-0-(二甲基)磷酸酯所述步驟反應。此 • 提供史賓諾辛Η之2Ί-(二甲基)磷酸酯(〇.230g, 31%), 為白色固體:ESI MS ro/z 826 (M + 1)。 _- 111 -_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 29*7公釐) I 裝 訂 線 (請先閱讀背面之注意事項再填寫本頁) 487559 經濟部中央標準局員工消費合作社印製 A7 _______ B7_ 五、發明説明(1〇9 ) 啻敝例A 121-(148)-13.14_二氩-:^-0-乙基-史富諾辛」4 將3’-0_乙基史賓諾辛M(810 mg, 1.106 ππηοΐ)溶於 乾乙醚(80 ml)中。加入一部分氫化三第三丁氧鋁氫鋰(97 %粉末),1.48g, 5.6 mmol)。在氮氣及室溫下攪拌混合物 5小時。接著將溶液冷卻至0°C及媛慢地以飽和食鹽水驟冷 (5 ml)。加入更多的乙醚(100 ml)及將混合物Μ 2N氫氧化 鈉水溶液萃取(2次)及以飽和碳酸氫納溶液萃取(1次)。有 機層Μ無水碳酸鉀乾燥、過滤及濃縮。粗產物在矽膠(2〇 %乙醇之乙酸乙酯溶液)上層析Μ獲得(MS)-13,14-二氫-乙基-史賓諾辛M(766 mg, 94%),為白色固體; 丄H NMR δ 4.68 (s, 1 H), 4.60 (m, 1 H〉, 3.42 (s, 3 H), 3.35 (s, 3 H), 2.29 (s, 3 Η), 0.98 (d, J = 3 Η). 啻腧例A 1 22 - 4-二氫-3 · -o-乙基-史賓諾辛Μ 將(14S)-13,14-二氫- 3^0-乙基史賓諾辛 Μ (326 mg, 0,444 mmol)溶於乾二氯甲烷(1〇 ml)中。加入三乙胺(3.0 ml)及碘乙烷(2.0 ml,過量)。在氮氣及室溫下攪拌混合 物4小時。一般逐漸進行反應及在矽膠(15%乙醇之乙酸乙 酯溶液)上層析以提供(14S)-13,14-二氫乙基-史賓 諾辛 M(337 mg, 99%),為白色固體:ESI MS m/z 762 (M + l)〇 宵晰例 1 2·ν Π 4S) -13 · 14-二—Μ _3 ’二Q-丙基史賓諾辛 J fh 合物(1R/1S· 15R·— 21S)-15-去氯-1,15 -氩- 3,-0-n-丙某-12卜斷-中畜諾宰J 1-坐熵胳及ih合物Π 5 R ) - 15 -去氢-1 5 -铧基:Γ - - 112 - (請先閱讀背面之注意事項再填寫本頁) •裝- 訂 線 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 487559 A7 s^__:__^__ 五、發明説明(”〇 )487559 Printed by the Consumers' Cooperative of the Central Economic Standards Bureau of Economic Lang A7 B7 V. Description of Invention (108) g). The reaction is generally carried out gradually and chromatographed on silica gel (ethyl acetate) to provide 5,6-dihydro-3,0-vinyl spinosinol] (1.02 8,53%): 1U NMR δ 6.74 ( s, 1 Η), β.31 (da, Ji = 16.9, = 6.5, 1 Η), 4.30 (m, 2 Η), 3.90 (m, 2 Η), 3.38 (s, 3 Η), 3 · 3ό (s,: ·· H) _ Cell example A 118-2 Dioxin, a moderately harmful oxinol. Follow the steps described in 5,6-Dihydro-3'-0-ethylene Spinoxin J to make Spinox Octane (2.03 g, 2.83 mmol) was reacted with butyl vinyl ether and separated from the reaction mixture. The resulting 2 &apos; -0-vinyl spinnosin H (1.09 g, 52¾) was a white solid: ESI MS m / z 744 (M + 1). Tube_Example 6 119-Zhongguoxin ,; [(Dimethyl) phosphate Shiluoxin J (0,903 g, 1.26 mmol) was dissolved in dry pyridine (2.5 ml). The solution was cooled to Ot under nitrogen: and carbon tetrabromide (0.91 g, 2.75 mmol) was added. After stirring for 5 minutes, trimethyl phosphorus P (0Me) 3 (0.38 ml, 3.12 mmol) was slowly introduced via a syringe. The cooling bath was removed and the mixture was stirred at room temperature for 3 hours. The reaction is generally carried out gradually and chromatography on silica gel (15% ethanol in ethyl acetate) K provides Spinoxin J 3'-〇- (dimethyl) phosphate (0.910 g, 88¾) as a white solid ^ ESI ME m / z 826 (M + l) ° Pipe oil; Example A120-Zhongke Nuoxin 1 &quot; [of 2'-0- (dimethyl) phosphate will be Spinoxin Η (0.65 g, 0.905 mmol) with carbon tetrabromide (0.63 g, 1.90 mmol) and trimethyl scale (0 · 30 ml, 2 * 46 mmol) 'Espinoxin J-3'-0- (dimethyl) phosphate The steps react. This • Provides 2 (-(dimethyl) phosphate (0.230 g, 31%) of spinosinol, as a white solid: ESI MS ro / z 826 (M + 1). _- 111 -_ This paper size applies to Chinese National Standard (CNS) A4 (210X 29 * 7 mm) I binding line (please read the precautions on the back before filling this page) 487559 Employee Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs Print A7 _______ B7_ V. Description of the invention (109) Example A 121- (148) -13.14_ Diargon-: ^ -0-ethyl-sufunoxin 4) 3'-0_b Kirspinoxin M (810 mg, 1.106 ππηοΐ) was dissolved in dry ether (80 ml). A portion of lithium tri-tertiary aluminum butoxide (97% powder), 1.48 g, 5.6 mmol) was added. The mixture was stirred under nitrogen at room temperature for 5 hours. The solution was then cooled to 0 ° C and slowly quenched with saturated saline (5 ml). More diethyl ether (100 ml) was added and the mixture was extracted with M 2N aqueous sodium hydroxide solution (twice) and extracted with saturated sodium bicarbonate solution (once). The organic layer M was dried over anhydrous potassium carbonate, filtered and concentrated. The crude product was chromatographed on silica gel (20% ethanol in ethyl acetate) to obtain (MS) -13,14-dihydro-ethyl-spinoxin M (766 mg, 94%) as a white solid.丄 H NMR δ 4.68 (s, 1 H), 4.60 (m, 1 H>, 3.42 (s, 3 H), 3.35 (s, 3 H), 2.29 (s, 3 Η), 0.98 (d, J = 3 Η). Example A 1 22-4-dihydro-3 · -o-ethyl-spinoxin M (14S) -13,14-dihydro-3 ^ 0-ethylspinno Octane (326 mg, 0,444 mmol) was dissolved in dry dichloromethane (10 ml). Triethylamine (3.0 ml) and iodoethane (2.0 ml, excess) were added. The mixture was stirred under nitrogen at room temperature 4 Hours. The reaction is generally performed gradually and chromatographed on silica gel (15% ethanol in ethyl acetate) to provide (14S) -13,14-dihydroethyl-spinoxin M (337 mg, 99%), As a white solid: ESI MS m / z 762 (M + l). Example 1 2 · ν Π 4S) -13. 14-di-M_3'di-Q-propyl spinosyn J fh compound (1R / 1S · 15R · — 21S) -15-Dechlorin-1,15-Argon-3, -0-n-Bingmou-12 Bu-Junu Nuozai J 1-Entropy and ih compound Π 5 R)-15 -Dehydro-1 5 -fluorenyl: Γ--112-(Please read the precautions on the back before (Fill in this page) • Binding-Binding This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297 mm) 487559 A7 s ^ __: __ ^ __ 5. Description of the invention ("〇)

0-n-丙某中客諾辛tJ 在16小時之期間内,根據(14S)-13,14-二氫-3^0-乙 基史賓諾辛Μ之步驟,使3'-0-n-丙基史賓諾辛J (1.87g, 2.46 mmol)與氫化三第三丁氧鋁鋰(97¾粉末,2.02 g, 7.71 mmol)之乙醚(100 ml)溶液反應。一般逐漸進行反應 及在矽膠(乙酸乙酯)上層析Μ提供a) (14S)-13, 14-二氫-3 f -0_n-丙基史賓諾辛J (1. 19 g, 63¾),為白色固體: 1H NMR ^ 4.70 (s, 1H), 4.64 (m, 1H), 3.43 (s, 3 H), 3.41 (s, 3 H), 2.15 (s, 6 Η), 1·〇4 (山 J = 6.8' 3 H); 及b)化合物(0.66 g)之混合物,其進一步藉由HPLC(88:12 ,甲醇/水)分析 Μ 獲得 c)(1R/1S, 15R, 21S)-15-去氧-1, 15-氧-3*-0-n-丙基-1,21-斷-史賓諾辛J 1-半縮醛(77 m s, «),為白色固體: h NMR δ 5.38 (s, 0·5 Η), 5.03 (d, J = 7, 0.5 Η), 3·49 (s' 3 Η), 3.40 (s' 3 Κ) , 2.15 (S/ 6 Η) , 1.02 (broadened d, J = 6.8, 3 Η) . ESI MS m/z 764 (M + 1); ,·及d)(15R)-15-去氧-15-羥基3’-0-n-丙基史賓諾辛J ( 44 rog,2.3¾),為白色固體: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) NMR δ 5.79 (d, J = 9·8, 1 Η), 5·72 (s' 1 Η), 5·7 0 (d, J = 9·3, 1 Η), (s, 1Η), 4.64 (m, 1Η), 3.47 (,s, 3 Η), 3.42 (s' 3 Η), 0·90 (d; J = 6.6, 3 H). , 在3小時之期間内,根據d4S)-13, 14-二氫-3,-0-乙 —— -------------- 113 -___ 本紙悵尺度適用中國國家標準(CNS ) A4規格(210:&lt;297公釐) 經濟部中央標準局員工消費合作社印製 487559 A7 __ _ B7__ 五、發明説明(111 ) 基史賓諾辛Μ所述步驟使5,6-二氫-3 ’ -Ο-η-丙基史賓諾辛 J (1.88 g,2.47min〇l)與氫化三第三丁氧鋁鋰(97%粉末, 2.40 g, 9.16πππο1)之乙醚(100 ml)溶液反應。於逐漸進 行反應及及在矽膠(乙酸乙酯)上層析可提供(14S)-5,6,13 ,14-四M-3’-〇-n-丙基史賓諾辛J (1.440 g, 76¾),為白 色固體:INMR δ 4·66 (d, J: 丄.4, 1 Η), 4.64 (m, 1 Η), 3·41 (s, 3 Η), 3·34 (s, 3 Η), 2.09 (s, 3 Η), 1.00 (d, J = 6.6, 3 Η).0-n-Cinnosine tJ within 16 hours, according to the steps of (14S) -13,14-dihydro-3 ^ 0-ethylspinoxin M, make 3'-0-n -Propyl Spinozin J (1.87 g, 2.46 mmol) was reacted with a solution of lithium tri-tertiary aluminum butoxide (97¾ powder, 2.02 g, 7.71 mmol) in ether (100 ml). The reaction is generally carried out gradually and chromatography on silica gel (ethyl acetate) to provide a) (14S) -13, 14-dihydro-3 f -0_n-propyl Spinozin J (1. 19 g, 63¾), As a white solid: 1H NMR ^ 4.70 (s, 1H), 4.64 (m, 1H), 3.43 (s, 3 H), 3.41 (s, 3 H), 2.15 (s, 6 Η), 1.04 ( Shan J = 6.8 '3 H); and b) a mixture of compounds (0.66 g), which was further analyzed by HPLC (88:12, methanol / water) to obtain c) (1R / 1S, 15R, 21S) -15 -Deoxy-1, 15-oxy-3 * -0-n-propyl-1,21-branched-spinoxin J 1-hemiacetal (77 ms, «) as a white solid: h NMR δ 5.38 (s, 0.5 Η), 5.03 (d, J = 7, 0.5 Η), 3.49 (s '3 Η), 3.40 (s' 3 Κ), 2.15 (S / 6 Η), 1.02 ( broadened d, J = 6.8, 3 Η). ESI MS m / z 764 (M + 1);, and d) (15R) -15-deoxy-15-hydroxy 3'-0-n-propyl spine Northing J (44 rog, 2.3¾), white solid: Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) NMR δ 5.79 (d, J = 9 · 8, 1 Η), 5.72 (s' 1 Η), 5.70 (d, J = 9.3, 1 Η), (s, 1Η), 4.64 (m, 1Η), 3.47 (, s, 3 Η), 3.42 (s' 3 Η ), 0 · 90 (d; J = 6.6, 3 H)., Within 3 hours, according to d4S) -13, 14-dihydro-3, -0-B-------- ------- 113 -___ The size of this paper is applicable to the Chinese National Standard (CNS) A4 specification (210: &lt; 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 __ _ B7__ V. Description of the invention (111) The steps described for spinosynoxine M include 5,6-dihydro-3'-O-n-propyl spinosinin J (1.88 g, 2.47 min) and lithium lithium tri-butoxide (97% powder, 2.40 g, 9.16πππο1) in ether (100 ml) was reacted. Upon gradual reaction and chromatography on silica gel (ethyl acetate), (14S) -5,6,13,14-tetra M-3'-〇-n-propyl spinosinoxin J (1.440 g, 76¾), white solid: INMR δ 4.66 (d, J: 丄 .4, 1 Η), 4.64 (m, 1 Η), 3.41 (s, 3 Η), 3.34 (s, 3 Η), 2.09 (s, 3 Η), 1.00 (d, J = 6.6, 3 Η).

g瓶例A 125-3f-0-(2-甲氢Ζ基)_中曹諾辛J 將史賓諾辛 J (718 mg, 1,00 ππποί)溶於 DMS0(1.4 ml )及二氯甲烷(1·4 ml)。加入碳酸鉀(0·90 g, 6·5 mmol) 、20%氫氧化納水溶液(5.2 ml)、四-η-丁銨氫硫酸鹽(339 mg,1.00 mmol)及溴化 2-甲氧乙基(1.00 ml, 10.6 mmol) 。混合物在乙醚及水間分配。Μ乙醚萃取有機層。合併之 有機層以水清洗(3次)及以飽和碳酸氫納清洗、Μ無水碳 酸鉀乾燥及蒸發以產生黃色油狀物。將此油在逆相管柱( Kromasil’ C18,氧化砂 ODS, 100Α, 10ra,球形,25cmX 20 nun)中層析,利用88¾甲醇及12¾水(含有0.1¾ v/v cone.氫氧化銨水溶液)Μ產生白色非晶形固體(249 mg, 32¾)。iHNMR d 3·78 (m, 2H) , 3.38(s, 3H)。 ,g bottle example A 125-3f-0- (2-methylhydrozyl) _Zhongcaoxin J Dissolve Spinozin J (718 mg, 1,00 ππποί) in DMS0 (1.4 ml) and dichloromethane (1.4 ml). Add potassium carbonate (0.90 g, 6.5 mmol), 20% aqueous sodium hydroxide solution (5.2 ml), tetra-η-butylammonium hydrogen sulfate (339 mg, 1.00 mmol) and 2-methoxyethyl bromide Base (1.00 ml, 10.6 mmol). The mixture was partitioned between ether and water. The organic layer was extracted with ether. The combined organic layers were washed with water (3 times) and washed with saturated sodium bicarbonate, dried over anhydrous potassium carbonate and evaporated to give a yellow oil. This oil was chromatographed in a reverse-phase column (Kromasil 'C18, oxidized sand ODS, 100A, 10ra, spherical, 25cmX 20 nun) using 88¾ methanol and 12¾ water (containing 0.1¾ v / v cone. Ammonium hydroxide aqueous solution ) M yielded a white amorphous solid (249 mg, 32¾). iHNMR d 3.78 (m, 2H), 3.38 (s, 3H). ,

啻施例A -甲氬甲甚-中害諾辛J 將史賓諾辛J (359 mg, 0.500 mmol)溶於二氯甲烷(2 m 1)及將,所得溶液冷卻至0°C。Μ單一部份加入二異丙基 乙基胺(105 ml, 0.600 mmol)並接著Μ分成數部分之方式 裝 訂 务 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) 經濟部中央標準局員工消費合作社印裝 487559 A7 B7 ____ ___ 五、發明説明(112 ) 加入溴甲基甲基醚(9(U, 50 ml ,0♦ 5 mmol)。立即生成之 沈澱物在數分鐘後可復溶。混合物係在0¾下攪拌2. 5小時 ,及在室溫下再攪拌2.5小時。混合物冷卻至0 °C及加入額 外之胺(0.32 ml, 1.8 mmol)及溴化物(0.15 ml, 1·7 mmo 1)。混合物再攪拌1小時。加入飽和碳酸氫納水溶液(3 ml)及將混合物在室溫下搅拌17小時。Μ二氯甲烷稀釋混 合物並Μ碳酸氫納溶液、水(2次)、飽和碳酸氫納溶液及 鹽水(2次)清洗。Μ無水碳酸鉀乾燥混合物及蒸發Μ生成 黃色油。將此油在逆相管柱UromasiT C18,氧化矽0DS ,100A, ΙΟπι,球形,25cmX20 nun)中曆析,利用85¾甲醇 及15¾水(含有0.1% v/v cone.氫氧化銨水溶液)Μ產生白 色玻璃狀固體(87 rog,3S!)。INMR d 3·45 (s, 3Η) ; MS 111/2762.6 (^1咄之估計值為 762.5)。啻 Example A-methylarginine and even-nosinoxin J Spinnoxin J (359 mg, 0.500 mmol) was dissolved in dichloromethane (2 ml) and the resulting solution was cooled to 0 ° C. Adding diisopropylethylamine (105 ml, 0.600 mmol) in a single part and binding it in several parts (please read the notes on the back before filling this page) This paper size applies Chinese national standards ( CNS) Λ4 specification (210X297 mm) printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 ____ ___ V. Description of the invention (112) Added bromomethyl methyl ether (9 (U, 50 ml, 0 ♦ 5 mmol) ). The immediately formed precipitate can be reconstituted after a few minutes. The mixture is stirred for 2.5 hours at 0¾ and 2.5 hours at room temperature. The mixture is cooled to 0 ° C and additional amine (0.32 ml) is added. , 1.8 mmol) and bromide (0.15 ml, 1.7 mmo 1). The mixture was stirred for an additional hour. A saturated aqueous sodium bicarbonate solution (3 ml) was added and the mixture was stirred at room temperature for 17 hours. The mixture was washed with sodium bicarbonate solution, water (twice), saturated sodium bicarbonate solution, and brine (twice). The mixture was dried with anhydrous potassium carbonate and evaporated to form a yellow oil. This oil was placed on a reverse-phase UromasiT C18 , Silicon Oxide 0DS, 100A, ΙΟπι, spherical , 25cm × 20 nun), using 85¾ methanol and 15¾ water (containing 0.1% v / v cone. Ammonium hydroxide aqueous solution) to produce a white glassy solid (87 rog, 3S!). INMR d 3.45 (s, 3Η); MS 111 / 2762.6 (^ 1 咄 estimated value is 762.5).

富敝例A 127-5. 二g -.V-甲氯甲基-Φ嘗諾辛J 將3夂甲氧甲基-史賓諾辛J (243 mg, 0.319 mmol)及 鈀/活性碳(10% , 200 mg)置於25-ml圓底燒瓶中。添加乙 醇(7.25 ml)及環己烷(1.75 ml, 17.3 mmol)及將所得溶 液加熱至迴流溫度3小時。使混合物連缜經由矽藻土及 PTFE濟膜(Gelman, Acrodisc 13CR, 0.2mro)過滤。混合物 在減壓下濃縮並將殘餘物在逆相管柱(Kromasil ’ C18 ,氧化矽 0DS, 100A, 10m,球形,25cmX20 mm)中層析, 利用85¾甲醇及15¾水(含有0.1¾ v/v cone.氫氧化銨水溶 液)K 產生非晶形固體(68 mg, 28»:)。 MS πι/ζ 764.7 (M + Η之估計值為764.5)。 ____- 115 -_ 張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) •裝· 訂 A7Enrichment example A 127-5. Dig -.V-methylchloromethyl-Φtanoxine J 3 methoxymethyl-spinoxin J (243 mg, 0.319 mmol) and palladium / activated carbon ( 10%, 200 mg) in a 25-ml round bottom flask. Ethanol (7.25 ml) and cyclohexane (1.75 ml, 17.3 mmol) were added and the resulting solution was heated to reflux temperature for 3 hours. The mixture was filtered through diatomaceous earth and a PTFE membrane (Gelman, Acrodisc 13CR, 0.2mro). The mixture was concentrated under reduced pressure and the residue was chromatographed in a reverse-phase column (Kromasil 'C18, silica 0DS, 100A, 10m, spherical, 25cm × 20 mm) using 85¾ methanol and 15¾ water (containing 0.1¾ v / v cone. Aqueous ammonium hydroxide) K produces an amorphous solid (68 mg, 28 »:). MS π / ζ 764.7 (estimated value of M + 76 764.5). ____- 115 -_ Zhang scale is applicable to China National Standard (CNS) Α4 specification (210X 297 mm) (Please read the precautions on the back before filling this page) • Binding and ordering A7

經濟部中央標準局員工消費合作社印製 1、發明説明(”3)Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 1. Description of Invention ("3)

當敝例Α128-:Γ-0-氤甲基-中客謀幸[及3’_0-三甲基矽 院某-中曹諾辛LCurrent example A128-: Γ-0- 氤 methyl-Zhongke fortune [and 3’_0-trimethyl silicon

將史賓諾辛 L(366 mg, 0,500 mmol)溶於 DMF(1 ml)及 將溶液冷卻至-15 °C。逐滴加入1.0 M光刻膠增附劑(〇· 53 ml, 0.53 πιπιοΠΚ產生非常深色的溶液,其容許在〇°C下 維持65小時。反應混合物在乙酸乙酯及飽和碳酸氫納間分 配。有機層以碳酸氫鈉水溶液稀釋液,Μ硫代硫酸納稀釋 液及鹽水清洗。混合物以無水硫酸鎂乾燥及在減壓下去除 溶劑以產生深色油(380 mg)。將油置於逆相管柱 Uromasil· C18,氧化矽 ODS, 100A, l〇m,球形,25cm X20 mro)中層析,利用90¾甲醇及10¾水(含有〇.U v/v con c.氫氧化銨水溶液)Μ產生二種產物,3 氰甲基-史賓諾 辛 L (48 mg, 12V), MNMR d 4.25,4,44(abq, J = 14.9, 2[〇;}^1!1/2 771.6(^1 + 1]之估計值為771.5);及3’-0-三甲基矽烷基-史賓諾辛L (241 mg, 60%), iHNMR d 0· 19 (s, 9H); MS m/z 804.7 (M + H 之估計值為 804.5)。 啻朐例A 129'V-O-碳-t-丁氯甲基-中窨諾辛J 將史賓諾辛J (718 mg, 1.00 mmol)及四_n_ 丁基銨氫 硫酸鹽(34 mg, 0.10 mmol)溶於二氯甲烷(3.5 ml)。將t-丁基溴乙酸酯(2.95 ml, 20.0 ππηοΐ)及粉末狀氫氧化鉀( l.Og, 15 ininoDM單一部分連續加入並將反應混合物在室 溫下攪拌。於40分鐘後,再加入四-η-丁基銨氫硫酸鹽(64 mg , 0.2 mino 1)。再60分鐘後,混合物Μ水稀釋及Μ二氯 甲烷(1次)及乙酸乙酯(1次)萃取。將合併之有機層Κ水(2 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210Χ297公釐) I 裝 訂 線 (請先閱讀背面之注意事項再填寫本頁) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(114 ) 次)、飽和碳酸氫納及鹽水清洗,Μ碳酸鉀及硫酸鎂乾燥 及蒸發Κ產生黃色油(4.13 g)。將此油置於減壓下(0.9 托)2小時K產生油(2.3 g)。將該油於矽膠(165 g)上Μ乙 酸乙酯,接著為10¾甲醇之乙酸乙酯溶液進行層析以產生 白色泡沫體(295 mg, d 4.24,4.19 (ab q, J = 16.5, 2H), 1·49 (s, 9H); MS m/z 832·7(Μ + Η之估計 值831.5)。 窨瓶例A 1 30-4”-Ν-去甲基-4”Ν_ (2-氣乙基)5 · 6_二氣-3 ’ -0-丙基中窨諾辛J 根據實施例CZ之方法由卜溴-2-氟乙烷(0.20 ml, 0.34 2.7 mmol)、碘化鈉(0·04 g, 0·3 mmol)、(i-Pt)2NEt (0.4〇1111,0*3〇8,2.3 111111〇1)、4”-1去甲基-5,6-二氫 3’_0-丙基史賓諾辛 J(0.300 g, 0.401 mmol),及 DMF 製備 化合物。MPLC(25:7至50:50乙酸乙酯/環己烷)以獲得白色 粉末狀之4”-Η-去甲基-4”N - (2-氟乙基)5,6-二氫-3 丙 基史賓諾辛J。 啻施例A 131-4” -N-「3’-Π-(9-笏某甲氬羰基)θ -丙胺醮基 窨諾辛J及:Γ-ί!-(θ -丙胺醯基)史賓諾 · 將三甲胺(0.25 ml, 0.18 g, 1.8 mraol)及 HC = C(Me)0C0Cl(0.10 ml, O.llg, 0.92 mmol)依序加至 Fmoc-N(H)-b-Ala-C00H (0.26 g, 0·84 minol)0°C、史賓 諾辛 J (0.502 s, 0·699 ππηοΐ),及 DMAP(0.02 g, 0.2 nun 〇 1)之二氯甲烷溶液(4 in 1)之0它溶液。於2小時後,將混 _- 117 -__ 本紙張尺度適用中國國家標準(CNS ) A4規格(210乂297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝· 訂 線 經濟部中央標準局員工消費合作社印製 487559 A7 • B7 五、發明説明(115 ) 合物加熱至室溫20小時。使混合物蒸發。MPLC(Si〇2, 0: 100至20:80甲醇/二氯甲烷)以獲得0.17 g(243〇之4”U 3,-0-(9-芴基甲氧基羰基)冷-丙胺醯基]史賓諾辛J為白色 粉末:1^(111 + }^)預期值.:1011.6。實際值:1011.6及3’-0-(/3-丙胺醯基)史賓諾辛J, 0.21 g, (38¾),為白色粉末 :MS (ra + H+ &amp; m + 2HM 預期值:789.5 &amp; 395·2。實際值: 395.5。Fmoc基在反應條件下易去保護,可視為生產本發 明之產物。 啻腧例A U2_4”-N_去甲基U-二氣- 丙基中曹諾辛Spinoloxine L (366 mg, 0,500 mmol) was dissolved in DMF (1 ml) and the solution was cooled to -15 ° C. 1.0 M photoresist adhesion promoter (0.53 ml, 0.53 πιποοΚ was added dropwise to produce a very dark solution that was allowed to stand at 0 ° C for 65 hours. The reaction mixture was partitioned between ethyl acetate and saturated sodium bicarbonate The organic layer was washed with a dilute aqueous solution of sodium bicarbonate, a dilute solution of sodium thiosulfate and brine. The mixture was dried over anhydrous magnesium sulfate and the solvent was removed under reduced pressure to give a dark oil (380 mg). Phase column Uromasil · C18, silica ODS, 100A, 10m, spherical, 25cm X20 mro) chromatography, using 90¾ methanol and 10¾ water (containing 0. U v / v con c. Ammonium hydroxide aqueous solution) Μ Two products were produced, 3 cyanomethyl-spinoxin L (48 mg, 12V), MNMR d 4.25, 4,44 (abq, J = 14.9, 2 [〇;} ^ 1! 1/2 771.6 (^ 1 + 1) (771.5); and 3'-0-trimethylsilyl-spinoxin L (241 mg, 60%), iHNMR d 0 · 19 (s, 9H); MS m / z 804.7 (Estimated value of M + H is 804.5). Example A 129'VO-Carbon-t-Butylchloromethyl-Mesanosin J J Spinoxin J (718 mg, 1.00 mmol) and four _n_ Butyl ammonium hydrogen sulfate (34 mg, 0.10 mmol) was dissolved in dichloromethane (3. 5 ml). T-butyl bromoacetate (2.95 ml, 20.0 ππηοΐ) and powdered potassium hydroxide (1.0 g, 15 ininoDM) were added continuously in one portion and the reaction mixture was stirred at room temperature. For 40 minutes After that, tetra-n-butylammonium hydrogen sulfate (64 mg, 0.2 mino 1) was added. After 60 minutes, the mixture was diluted with water and extracted with methylene chloride (once) and ethyl acetate (once). .The combined organic layer K water (2 paper sizes applicable to Chinese National Standards (CNS) Λ4 specifications (210 × 297 mm) I gutter (please read the precautions on the back before filling this page) 487559 Central Bureau of Standards, Ministry of Economic Affairs Printed by employees' consumer cooperatives A7 B7 5. Description of the invention (114 times), saturated sodium bicarbonate and brine cleaning, drying and evaporation of potassium potassium carbonate and magnesium sulfate to produce a yellow oil (4.13 g). This oil was placed under reduced pressure Oil (2.3 g) was produced at 2 hours under K (0.9 torr). The oil was chromatographed on silica gel (165 g) with ethyl acetate followed by a 10¾ methanol in ethyl acetate solution to give a white foam (295 mg , d 4.24, 4.19 (ab q, J = 16.5, 2H), 1.49 (s, 9H); MS m / z 832 · 7 (Μ + The estimated value of Η is 831.5). Bottle Example A 1 30-4 "-N-desmethyl-4" N_ (2-Gasethyl) 5 · 6_Digas-3'-0-propyl Zhongnosin J According to Example CZ Methods: Bromo-2-fluoroethane (0.20 ml, 0.34 2.7 mmol), sodium iodide (0.04 g, 0.3 mmol), (i-Pt) 2NEt (0.4〇1111,0 * 3〇8) , 2.3 111111〇1), 4 "-1 demethyl-5,6-dihydro 3'_0-propyl spinosinol J (0.300 g, 0.401 mmol), and DMF to prepare compounds. MPLC (25: 7 to 50:50 ethyl acetate / cyclohexane) to obtain 4 "-fluorene-desmethyl-4" N-(2-fluoroethyl) 5,6-dihydro-3propylspinoxin as a white powder J. 啻 Example A 131-4 "-N-" 3'-Π- (9-A certain methyl argonyl group) θ-propylamine hydrazone Jinoxin J and: Γ-ί!-(Θ -propylamine hydrazone ) Spino · Trimethylamine (0.25 ml, 0.18 g, 1.8 mraol) and HC = C (Me) 0C0Cl (0.10 ml, O.llg, 0.92 mmol) were sequentially added to Fmoc-N (H) -b- Ala-C00H (0.26 g, 0.84 minol) 0 ° C, Spinozin J (0.502 s, 0 · 699 ππηοΐ), and DMAP (0.02 g, 0.2 nun 〇1) in dichloromethane solution (4 in 1) Zero solution. After 2 hours, it will be mixed _- 117 -__ This paper size applies Chinese National Standard (CNS ) A4 size (210 乂 297 mm) (Please read the notes on the back before filling out this page)-Assembling and routing Printed by the Central Consumers Bureau of the Ministry of Economic Affairs Consumer Cooperative 487559 A7 • B7 V. Description of the invention (115) The contents were heated to room temperature for 20 hours. The mixture was allowed to evaporate. MPLC (SiO 2, 0: 100 to 20: 80 methanol / dichloromethane) to obtain 0.17 g (243 4 of 4 ”U 3, -0- (9- Fluorenylmethoxycarbonyl) cold-propylamine fluorenyl] Spinoxin J is white powder: 1 ^ (111 +} ^) expected value: 1011.6. Actual value: 1011.6 and 3'-0-(/ 3- Alaninyl) Spinozin J, 0.21 g, (38¾), white powder: MS (ra + H + &amp; m + 2HM Expected value: 789.5 &amp; 395.2. Actual value: 395.5. Fmoc group is reacting It is easy to be deprotected under the conditions and can be regarded as the product of the present invention. Example A U2_4 ”-N_desmethyl U-digas-propyl Zhongcaoxin

A 將 F-TEDA(0.98 g, 2.8 mmol)添加至 5,6-二氫-3f-0-η-丙基史賓諾辛J (0.94 g, 1.23 mmol)之CH3CN溶液(10 m)。於10分鐘後,有機層在乙酸乙酯及0.1 M鹽酸間分配〇 有機層依序以碳酸氫鈉及鹽水清洗。有機層以硫酸鎂乾燥 、過滤及蒸發。MPLC (Si〇2 , 5:95至10 :90甲醇/二氯甲烷) Μ獲得0.64 g (70%)之4”去甲基-5,6-二氫-3、0-丙基 史賓諾辛J,為白色粉末,亦可回收(5,6-二氫-3’-0-n -丙基史賓諾辛J 0.25 g(27%))。A Add F-TEDA (0.98 g, 2.8 mmol) to a solution of CH6-CN (10 m) in 5,6-dihydro-3f-0-η-propyl spinosinol J (0.94 g, 1.23 mmol). After 10 minutes, the organic layer was partitioned between ethyl acetate and 0.1 M hydrochloric acid. The organic layer was washed sequentially with sodium bicarbonate and brine. The organic layer was dried over magnesium sulfate, filtered and evaporated. MPLC (SiO 2, 5:95 to 10:90 methanol / dichloromethane) M 0.64 g (70%) of 4 ”demethyl-5,6-dihydro-3,0-propyl spinosyn J, which is a white powder, can also be recovered (5,6-dihydro-3'-0-n-propyl spinosinol J 0.25 g (27%)).

啻施例A 1H1 表-中窨諾辛K 在15分鐘内,將0-(2,3-二-0-甲基-4-0-苯甲醯基 -L-鼠李糖基-Dtt喃糖基)三氯乙醯imidate(5.5 g, 11·5 roraol)之二氯甲烷溶液(60 ml)逐滴加入已經適當授拌之史 賓諾辛A 9-Psa(1.25 2.30 rorool)及吡啶錨對甲笨磺酸 鹽(0.815 g, 3.24 mmol)之乾二氣甲院(120 ml)的含有粉 ____- 118 ~___ 本纸張尺度適用中國國家標準(CNS ) Α·4規格(2i〇X 297公釐) (請先閱讀背面之注意事項再填寫本頁)啻 Example A 1H1 Table-Mesanosine K within 15 minutes, 0- (2,3-bis-0-methyl-4-0-benzylidene-L-rhamnosyl-Dttan Glycosyl) trichloroacetamide imidate (5.5 g, 11.5 roraol) in dichloromethane solution (60 ml) was added dropwise with properly mixed Spinoxin A 9-Psa (1.25 2.30 rorool) and pyridine anchor The powder containing methanesulfonate (0.815 g, 3.24 mmol) in dry diqijiayuan (120 ml) ____- 118 ~ ___ This paper size applies the Chinese National Standard (CNS) Α · 4 specification (2i〇 X 297 mm) (Please read the notes on the back before filling this page)

487559 A7 ______ Β7 五、發明説明(”6 ) 末化4A分子篩分物(2.0 g)的溶液中。在室溫下攪拌4天, 將混合物Μ矽藻土過滤,Μ二氯甲烷(100 m l)清洗矽藻土 及Μ飽和碳酸納(2X60 ml)及鹽水(75 ml)清洗合併之濾 (請先閱讀背面之注意事項再填寫本頁) 液及洗液。濃縮後餘留8.2 g殘餘物,將其K氧化矽(650 m 1)進行閃蒸層析,利用3¾甲醇之二氯甲烷溶液以產生1.1 8(58¾)之偶合產物,無色泡沫體之3α :1/3差向異構物。 將此物質溶於甲醇(30 in 1)及添加無水碳酸鈣至該溶液中( 0.98 g, 7.1 mmol)。在室溫下攪拌該溶液6小時,藉由逐 滴加入2N鹽酸(6.8 in 1) Μ酸化且接著在減壓下濃縮至接近 乾。殘餘物在水(40 ml)及二氯甲烷(150 ml)間分配。有 機萃取物接著Μ飽和碳酸氫納(40 ml)及鹽水(40 ιαί)清洗 及Μ硫酸鎂乾燥。濃縮後餘留0.72 g粗去苯甲醯化產物。 藉由氧化矽(80 m 1)之閃蒸層析法純化,利用《甲醇之二 氯甲烷溶液Μ產生0.5g乾淨產物,其為史賓諾辛K及1'-表 '史賓諾辛K之3:1混合物。藉由HPLCM41.4 mmx 25 cm(l)487559 A7 ______ B7 V. Description of the invention ("6) Finalized 4A molecular sieve (2.0 g) solution. Stirred at room temperature for 4 days, filtered the mixture diatomaceous earth, M dichloromethane (100 ml) Wash the diatomaceous earth and M saturated sodium carbonate (2X60 ml) and brine (75 ml) and wash the combined filter (please read the precautions on the back before filling this page) and the washing solution. After concentration, 8.2 g of residue is left. The K silica (650 m 1) was subjected to flash chromatography using 3¾ methanol in dichloromethane to produce a coupling product of 1.18 (58¾), a 3α: 1/3 epimer of a colorless foam. This material was dissolved in methanol (30 in 1) and anhydrous calcium carbonate was added to the solution (0.98 g, 7.1 mmol). The solution was stirred at room temperature for 6 hours, and 2N hydrochloric acid (6.8 in 1) was added dropwise. M acidified and then concentrated to near dryness under reduced pressure. The residue was partitioned between water (40 ml) and dichloromethane (150 ml). The organic extract was followed by M saturated sodium bicarbonate (40 ml) and brine (40 ιαί ) Washed and dried with magnesium sulfate. After concentration, 0.72 g of crude debenzylated product remained. By flash of silica (80 m 1) Purification by chromatography, using 0.5 M methanol in dichloromethane solution to produce 0.5 g of clean product, which is a 3: 1 mixture of Spinoxin K and 1'-epi 'Spinoxin K. By HPLCM 41.4 mmx 25 cm (l)

Rain in逆相C18(8_)管柱,利用15%水(含有0.0U氫氧化 銨)之甲醇溶液為溶析液,將產物分離成3個約180 mg的部 分。卢-差向異構物,表-史賓諾辛K首先析出:110 mg; 經濟部中央標準局員工消費合作社印製 無色泡沬體; 1η NMR (CDC13) 5 6.79 (st 1, H-13), 4.63 (m, 1, H-21), 4.45 (m, H-l1, H- 1&quot;, H-9); MS m/z 435 (10), 175 (5), 142 (100), 71 (90).Rain in reverse-phase C18 (8_) column, using 15% water (containing 0.0U ammonium hydroxide) in methanol as the eluent, the product was separated into three parts of about 180 mg. Lu-Epimer, Table-Spinnockin K first precipitated: 110 mg; colorless foamed carcass printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs; 1η NMR (CDC13) 5 6.79 (st 1, H-13 ), 4.63 (m, 1, H-21), 4.45 (m, H-l1, H-1 &quot;,H-9); MS m / z 435 (10), 175 (5), 142 (100), 71 (90).

窨嫵例A 134-4’丙S裔某中窨諾卒K 在室溫下將一部分丙酸酐(0.1 ml, 0.77 πιπιοί)加入 已經適當授拌之史賓諾辛K(72 rag, 0·1 mmol)及DMAP(〜2 -119 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 487559 A7 ___B7 _ _ 五、發明説明(117 ) mg)之乾吡啶(1·0 ml)之溶液中,並將混合物攪拌20小時 。於減壓下去除吡啶,殘餘物溶於二氯甲烷(25 ml)及將 該二氯甲烷溶液以水(5 ml)、飽和碳酸納溶液(25 ml)、 鹽水(5 m Π清洗並以硫酸鎂乾燥。滤除乾燥試劑後,將二 氯甲烷溶液濃縮至約6 ml且K聚乙烯吡啶(0,3 g)攪拌15 分鐘以中和產物中之任何殘餘的丙酸鹽。於樹脂之過滤作 用後,蒸發二氯甲烷並餘留85 mg粗產物。藉由氧化矽(30 m Π之閃蒸層析法純化,利用3¾甲醇之二氯甲烷溶液Μ產 生71 mg無色泡沫體之4’-0-丙醯基史賓諾辛Κ ^ΗΝΜΙίδ 6.76 (s, 1, Η-13), 5.02 (t, 1, Η-4·), 4·87 (s, 1, Η-1·), 4.66 (m, 1, Η-21), 4·42 (br d, 1, H-1&quot;), 4.32 (m, 1, H-9); MS m/z 773 (2), 231 (15), 142 (70), 71 (100). 窨确例A m中客諾辛A夕(9_0-(2,3,4'三-0-甲基-卜鼠 査_ nH:脑煻某)類似物 化合物9-0-(2,3,4-三-0-甲基-D-鼠李糖基吡喃糖基) 史賓諾辛A ,在位置1 1之3 · 5 a : 1 /3差向異構物混合物,係 藉由與實施例A45相同之步驟製備,產率為82¾,係由0·54 g(1.0 mmol)史賓諾辛 A 9-Psa、0·35 g(1.4 mmol)Utt 啶鎌 對甲苯硫酸及2.0 g (5.7 mmol)0-(2,3,4-甲基-α-D-鼠 李糖吡喃糖基)-三氯乙醯imidate製備。°^及々差向異構 , 物係藉由逆相HPLCK C18结合之矽膠進行,利用10¾水(含 有0.1 %氫氧化銨)之甲醇溶液。冷差向異搆物最先析出。 /3差向異構物:85 mg;無色泡沬體;1HNMR(CDCU56.78 (s,1H, Η-13),4·66 (m,1H, H-21),4.40 (m,3H,H- -120 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)Example A 134-4 'A certain middle-aged patient, Kronozo K, added a portion of propionic anhydride (0.1 ml, 0.77 πιπιοί) at room temperature to Spinozin K (72 rag, 0.1 mmol) and DMAP (~ 2 -119-This paper size applies to the Chinese National Standard (CNS) A4 specification (210X 297 mm). Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. 487559 A7 _B7 _ _ V. Description of the invention (117 ) mg) of dry pyridine (1.0 ml), and the mixture was stirred for 20 hours. Pyridine was removed under reduced pressure, the residue was dissolved in dichloromethane (25 ml) and the dichloromethane solution was washed with water (5 ml), saturated sodium carbonate solution (25 ml), brine (5 m) and sulfuric acid Dry with magnesium. After filtering off the drying reagent, the dichloromethane solution was concentrated to about 6 ml and K polyvinylpyridine (0,3 g) was stirred for 15 minutes to neutralize any residual propionate in the product. Filtered on the resin After the action, dichloromethane was evaporated and 85 mg of crude product remained. Purified by flash chromatography using silica (30 m Π, using 3¾ methanol in dichloromethane solution M to produce 71 mg of 4'- colorless foam). 0-Propanyl Spinozin K ^ ΗΝΜΙίδ 6.76 (s, 1, Η-13), 5.02 (t, 1, Η-4 ·), 4.87 (s, 1, Η-1 ·), 4.66 ( m, 1, Η-21), 4.42 (br d, 1, H-1 &quot;), 4.32 (m, 1, H-9); MS m / z 773 (2), 231 (15), 142 (70), 71 (100). 窨 Analogous compounds of Knosin A (9_0- (2,3,4'tri-0-methyl-buchacha_nH: brain 煻) analog compounds 9-0- (2,3,4-tri-0-methyl-D-rhamnosylpyranosyl) Spinoxin A, position 1 1 of 3 · 5 a: 1/3 differential Mixture of isomers Example A45 was prepared in the same procedure with a yield of 82¾, which was made up of 0.54 g (1.0 mmol) Spinoxin A 9-Psa, 0.35 g (1.4 mmol) Utt pyridyl p-toluene sulfuric acid and 2.0 g ( 5.7 mmol) 0- (2,3,4-methyl-α-D-rhamnopyranosyl) -trichloroacetamide imidate. ° ^ and 々 epimerization, the system is by the reverse phase HPLCK C18 combined with silica gel was performed using 10¾ water (containing 0.1% ammonium hydroxide) in methanol. The cold epimer was first precipitated. / 3 epimer: 85 mg; colorless foamed body; 1HNMR ( CDCU56.78 (s, 1H, Η-13), 4.66 (m, 1H, H-21), 4.40 (m, 3H, H- -120-This paper size applies to China National Standard (CNS) A4 specifications ( 210X 297 mm) (Please read the notes on the back before filling this page)

487559 A7 B7 五、發明説明(118 1”,Η-1’,Η-9)。α差向異構物:270 mg;無色泡沫體; ^HMRCCDCla) 5 6.76(s, 1H, H-13), 4.82 (m, 1H,H-21) ,4.40 (m, 3H, H-l”), 4.28 (m, 1H, H-9); MS m/z 499 (2) , 189 (10), 142 (70), 71 (100)。 啻脓例八136-厂-0-(2.2.2-三氟71某)中¥諾辛3 將一部分60%氫化納之礦物油(224 mg, 5.6 mmol為 100¾)之懸浮液添加至冷(0-5°C),經適切授拌之史賓諾辛 J(500 mg, 0.7 mmol)之無水 THF(20 ml)溶液中。當 出時已停止(於約10分鐘後),逐滴加入三氟乙基triflate (J. Org.Chem* 1973, 38, 3673; Tetrahedron 1965, 21 ,1) (0.9g, 3.2 mmol)。1小時後去除冷卻浴,及反應物仍 在室溫下攪拌4小時。混合物再冷卻至0-5°C ,及在15分鐘 内逐滴加入水(20 ml)。混合物K乙醚(2 X 50 ml)萃取。 有機萃取物Μ鹽水(25 ml)清洗及Μ硫酸鎂乾燥。藉由氧 化矽(120 ml)之閃蒸層析法純化,利用3¾甲醇之二氯甲烷 溶液為溶析液。部分純化之產物(150 mg)藉由41.4 rain(i. dJX25 mm(l) Rainin逆相C8 (8仰1)管柱純化,利用10 %水(含有0 · 1氫氧化铵)之甲醇溶液為溶析液,以產生58 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) mg之乾淨3’-0-(2,2,2_三氟乙基)史賓諾辛J產物,其為 無色泡沫體: Ί 。 1H NMR (CDC13) δ 6.7.6 (S/ 1H, H-13), 4.81 (s, 1H, H-l'), 4.67 (m, 1H, H-21), 4.42 (d, 1H; H-1M), 4.30 (m, 1H, H-9), 4.06 (m# 2H, CF3CH2O). 置施例A 137r.m2, 3,4-三-0-Z某卜α -鼠李糖pH;睏锸 -121 - 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(119!) 基)中窨諾宰·1及:Γ-Π - (2. 3· 4-三-Π-Ζ某卜 /3 -鼠李糠pH;喃煻基)中W諾辛J 在位置Γ&quot;之α :/3之9:1之差向異構物混合物(0.33 g, 62¾產率)係獲自於史賓諾辛J (0.4 g, 0.56mmol)、Btt暗 鐵對甲苯磺酸鹽(0.18 g, 0.72 mmol)及 0-(2,3,4-三-0-乙基α-L-鼠李糖基吡喃糖基(0.18 g, 0.72 mmol)及0_(2 ,3,4-三-0-乙基-oc -L-鼠李糖基吡喃基)三氯乙醯imidate (1,6 g, 4,08 mmol)之反應,藉由與實施例A45相同之步驟 。混合物係藉由逆相HPLCMC18结合之氧化矽(8 mm)管柱( 41·1 mro(i.d.)X25 cro(l)),使用 6¾ 水(含有 0.15¾ 氫氧化 銨)之甲醇溶液作為溶析液。々差向異搆物最先析出。/3 差向異構物:5 mg;無色泡沫體;4心!?(00(:13)56.76(3, 1H, H-13), 4.81 (d, J = 2.2, 1H, Η-1Ί, 4.67 (m, 1H, H-21), 4,49(s, 1H, H-l&quot;), 4·42 (dd, J=8.8, 1·4, 1H, Η-Γ’),4·30 (m, 1H, H-9)。α 差向異構物:85 mg; 無色泡沫體;41 — 1?(00(:13)36.76(3,1H, H-13), 5·02 (d, J=1.5, 1Η, Η-1&quot;), 4·79 (d, J=1.5, 1Η, H-l”), 4.67 (m, 1H, H-21), 4.42(dd, J = 8.5, 1.5, 1H, H-1,T) ,4.27 (in, 1H, H-9); MS m/z 948 (100)。487559 A7 B7 V. Description of the invention (118 1 ", Η-1 ', Η-9). Alpha epimer: 270 mg; colorless foam; ^ HMRCCDCla) 5 6.76 (s, 1H, H-13) , 4.82 (m, 1H, H-21), 4.40 (m, 3H, Hl ”), 4.28 (m, 1H, H-9); MS m / z 499 (2), 189 (10), 142 (70 ), 71 (100). Symptomatic case 8 136-Plant-0- (2.2.2-Trifluoro71) ¥ Nosin 3 A part of a suspension of 60% sodium hydrogenated mineral oil (224 mg, 5.6 mmol of 100¾) was added to the cold ( 0-5 ° C), in a solution of Spinozin J (500 mg, 0.7 mmol) in anhydrous THF (20 ml) after proper mixing. When it had stopped (after about 10 minutes), trifluoroethyl triflate (J. Org. Chem * 1973, 38, 3673; Tetrahedron 1965, 21, 1) (0.9 g, 3.2 mmol) was added dropwise. The cooling bath was removed after 1 hour, and the reaction was still stirred at room temperature for 4 hours. The mixture was cooled to 0-5 ° C and water (20 ml) was added dropwise over 15 minutes. The mixture was extracted with ether (2 X 50 ml). The organic extract was washed with brine (25 ml) and dried over magnesium sulfate. Purified by flash chromatography on silica (120 ml) using 3¾ methanol in dichloromethane as the eluent. Partially purified product (150 mg) was purified on a 41.4 rain (i.dJX25 mm (l) Rainin reverse-phase C8 (8 ° 1)) column using 10% water (containing 0.1 ammonium hydroxide) in methanol as Dissolve to produce 58 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) mg of clean 3'-0- (2,2,2_trifluoroethyl) Spinozin J product as a colorless foam: 。. 1H NMR (CDC13) δ 6.7.6 (S / 1H, H-13), 4.81 (s, 1H, H-1 '), 4.67 (m, 1H, H-21), 4.42 (d, 1H; H-1M), 4.30 (m, 1H, H-9), 4.06 (m # 2H, CF3CH2O). Example A 137r.m2, 3,4- Three-0-Z a certain α-rhamnose pH; sleepy-121-This paper size is applicable to the Chinese National Standard (CNS) Λ4 specification (210X 297 mm) 487559 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (119!) Base) Zhong Nuo Zai 1 and: Γ-Π-(2. 3 · 4-Tri-Π-Z Moubu / 3-Rhamnus bran pH; sulfanyl) W Nuoxin J in position Γ &quot; α: / 3 of 9: 1 epimer mixture (0.33 g, 62¾ yield) was obtained from Spinoxin J (0.4 g, 0.56 mmol), Btt dark Iron p-toluenesulfonate (0.18 g, 0.72 mmol) and 0- (2,3,4-tri-0-ethylα-L-rhamnylpyranosyl (0.18 g, 0.72 mmol) and 0_ (2,3,4-tri-0-ethyl-oc-L-rhamnosylpyranyl) trichloroacetimidate (1,6 g, 4,08 mmol) The same procedure is used for A45. The mixture is a silica (8 mm) column (41 · 1 mro (id) X25 cro (l)) combined with reverse phase HPLCMC18, using 6¾ water (containing 0.15¾ ammonium hydroxide) in methanol The solution was used as the eluent. The epimers were first precipitated. / 3 epimers: 5 mg; colorless foam; 4 cores! (00 (: 13) 56.76 (3, 1H, H-13 ), 4.81 (d, J = 2.2, 1H, Η-1Ί, 4.67 (m, 1H, H-21), 4,49 (s, 1H, H-l &quot;), 4.42 (dd, J = 8.8 , 1 · 4, 1H, Η-Γ '), 4 · 30 (m, 1H, H-9). Alpha epimer: 85 mg; colorless foam; 41 — 1? (00 (: 13) 36.76 (3,1H, H-13), 5.02 (d, J = 1.5, 1Η, Η-1 &quot;), 4.79 (d, J = 1.5, 1Η, Hl ”), 4.67 (m, 1H, H-21), 4.42 (dd, J = 8.5, 1.5, 1H, H-1, T), 4.27 (in, 1H, H-9); MS m / z 948 (100).

管胞例A 去氣关氯- .V-烯基-史賓諾辛J 將一部分2,2,2-三氟乙醇(15a 1, 0.21 roraol)加入冷 (0°C)60% 氫化納之礦物油 7.5 mg, 0·188 mmol 為 100%)之 懸浮液之乾DMF (2. 5 ml)並於冷藏下攪拌20分鐘。將一部 份;Γ-0-三氟甲磺醯基-3’-表-史賓諾辛J (1〇〇 mg, 〇」18 -122 - 本紙張尺度適用中國國家標準(cns ) A4規格(2丨〇:&lt; 297公釐) (請先閱讀背面之注意事項再填寫本頁) -5-口 487559 經濟部中央標準局員Η消費合作社印策 Α7 Β7 五、發明説明(12〇 ) mmo 1)加入目前乾淨溶液中,並將混合物在室溫下攪拌18 小時。加入矽膠(2 0 0 in g ),攪拌混合物1 〇分鐘,接著過據 及將所收集之氧化矽以二氯甲烷清洗。合併濾液及洗液並 在減壓下濃縮至乾並將殘餘物溶於乙酸乙酯(20 ml)。接 著以鹽水(10 ml)清洗乙酸乙酯溶液及K硫酸鎂乾燥。蒸 發溶劑餘留76mg殘餘物,將其K氧化矽(10 ml)閃蒸層析, 利用3¾甲醇之二氯甲烷溶液為溶析液K獲得43 mg之4 ' -去氫-3’-去氧-3’-烯基-史賓諾辛J,為無色泡沬體·· y NMR (CDC13) δ 4·72 (d, J=3.3, 1H, H-31); 13C NMR (CDCI3) δ 160·0 (C-4丨), 87.9 (C-3·).Tracheostomy case A Degassing and Chlorine-.V-alkenyl-Spinoxin J Add a portion of 2,2,2-trifluoroethanol (15a 1, 0.21 roraol) to cold (0 ° C) 60% hydrogenated A suspension of mineral oil (7.5 mg, 0.188 mmol, 100%) in dry DMF (2.5 ml) was stirred under refrigeration for 20 minutes. A part; Γ-0-trifluoromethanesulfonyl-3'-epi-Spinoxin J (100mg, 〇 ″ 18 -122-This paper size applies to China National Standard (cns) A4 specifications (2 丨 〇: &lt; 297 mm) (Please read the notes on the back before filling out this page) 1) Add to currently clean solution and stir the mixture at room temperature for 18 hours. Silicone (200 in g) was added, and the mixture was stirred for 10 minutes, and then the collected silica was washed with dichloromethane. The filtrate and washings were combined and concentrated to dryness under reduced pressure and the residue was dissolved in ethyl acetate (20 ml). Then, the ethyl acetate solution was washed with brine (10 ml) and dried over magnesium sulfate. The solvent left 76 mg of the residue, and its K silica (10 ml) was flash-chromatographed to obtain 43 mg of 4′-dehydro-3′-deoxygenate using 3¾ methanol in dichloromethane as eluent K. -3'-alkenyl-Spinostin J, a colorless foamed carcass. Y NMR (CDC13) δ 4.72 (d, J = 3.3, 1H, H-31); 13C NMR (CDCI3) δ 160 · 0 (C-4 丨), 87.9 (C-3 ·).

啻嫵例A 139-3^0-丙蓽中窨諾辛L 將粉末狀氫氧化鉀(lg)添加至史賓諾辛L (0.732g, 1.0 mmol)、溴化四丁基鋰(0.1 ππηοΐ)及溴化η-丙基(2.7 22.0 mmol)之二氯甲烷(3 ml)溶液及在氮氣及25°C攪 拌1.5小時。加入水(10 ml)並分離層。K二氯甲烷(3 X 20 ml)萃取水層並Μ硫酸納乾燥合併之萃取物、過濾並濃縮 。Μ戊烷研磨以獲得丙基史賓諾辛L (0.72 g, 93¾) ,為無色玻璃狀物。EMI MS, m/z 774.7 (Mf)。A 例 A 139-3 ^ 0-propyl hydraxoxine L powdered potassium hydroxide (lg) was added to spinosynoxine L (0.732g, 1.0 mmol), tetrabutyllithium bromide (0.1 ππηοΐ ) And a solution of n-propyl bromide (2.7 22.0 mmol) in dichloromethane (3 ml) and stirred under nitrogen at 25 ° C for 1.5 hours. Water (10 ml) was added and the layers were separated. The aqueous layer was extracted with K dichloromethane (3 X 20 ml) and the combined extracts were dried over sodium sulfate, filtered and concentrated. Milled with pentane to obtain propyl spinosinol L (0.72 g, 93¾) as a colorless glass. EMI MS, m / z 774.7 (Mf).

窨_例A 丙甚中客諾辛J &amp; L 將粉末狀氫氧化鉀(U)添加至史賓諾辛J &amp; L (0.732 g,1.0 mmol)、溴化四 丁基鋰(〇·〇32 g, 0.1 πιπιοΠ 之溴 丙烷(5 ml))溶液及在氮氣及25¾下攪拌3小時。添加乙醚 (20 ml)及水(10 ml)並分離相。以乙醚(2 X 20 rol)萃取水 層及Μ硫酸鎂乾燥經合併乙醚萃取物,過濾並濃縮。以戊 本纸ί長尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)例 _ Example A Propoxoloxin J &amp; L Powdered potassium hydroxide (U) was added to Spinoxin J &amp; L (0.732 g, 1.0 mmol), tetrabutyllithium bromide (〇 · 〇32 g, 0.1 μm of bromopropane (5 ml)) solution and stirred for 3 hours under nitrogen and 25¾. Ether (20 ml) and water (10 ml) were added and the phases were separated. The aqueous layer was extracted with ether (2 × 20 rol) and dried over magnesium sulfate. The combined ether extracts were filtered, and concentrated. This paper applies the Chinese National Standard (CNS) Λ4 specification (210X297 mm) on a long scale (please read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印製 487559 A7 _ B7__ 五、發明説明(121 ) 烷研磨以獲得3’-0-丙基史賓諾辛J&amp;L(0.71 g, 92!ϋ), 為無色玻璃狀物。3’-0_丙基史賓諾辛」之〖^[^,111/2 760.2 (1^)。3’-0-丙基史賓諾辛 L 之 EMI MS, πι/ζ 774.3 ( MM。Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 _ B7__ V. Description of the invention (121) Alkane grinding to obtain 3'-0-propyl Spinozin J &amp; L (0.71 g, 92! Ϋ), colorless glass Thing. 3’-0_propyl spinosinoxin ”^ [^, 111/2 760.2 (1 ^). EMI MS of 3'-0-propyl Spinozinol L, π / ζ 774.3 (MM.

啻觖例/V 141 -3 ’ 基中客諾卒K 將粉末狀氫氧化鉀(lg)添加至史賓諾辛L (0.732 g,1.0 mmol)、溴化四丁基鋰(0.032 g, 0.1 mmol)之溴 乙烷(5 ml))溶液及在氮氣及25 °C下攪拌0.5小時。添加乙 醚(20 ml)及水(10 ml)並分離相。K乙醚(2 X 20 ml)萃取 水曆及以硫酸鎂乾燥經合併乙醚萃取物,過濾並濃縮。K 戊烷研磨K獲得3’-0_乙基史賓諾辛L (0.72 g, 94¾),為 無色玻璃狀物。3’-0_丙基史賓諾辛J之EMI MS, m/z 760.3(ΜΜ。Example / V 141 -3 'Kezhongnuol K Add powdered potassium hydroxide (lg) to spinoxin L (0.732 g, 1.0 mmol), tetrabutyl lithium bromide (0.032 g, 0.1 mmol) in ethyl bromide (5 ml)) and stirred under nitrogen at 25 ° C for 0.5 hours. Ether (20 ml) and water (10 ml) were added and the phases were separated. K ether (2 X 20 ml) extraction The water calendar and dried over magnesium sulfate The combined ether extracts were filtered, and concentrated. K was milled with pentane to obtain 3'-0_ethylspinoxin L (0.72 g, 94¾) as a colorless glass. EMI MS of 3 &apos; -0-propyl Spinozinol J, m / z 760.3 (MM.

當施例A 141 - 3 , - 0 -丙基史審諾辛QWhen Example A 141-3,-0 -propyl sinotropin Q

將史賓諾辛Q (732 mg, 1 mmol)、溴化四丁基鋰(34 mg, 0·1 mmol)、1-溴丙院(4 ml, 24 mmol),及二氣甲燒 (1 ml)置入具有磁石攪拌配備之50 ml圓底燒瓶。在室溫 下及水浴中攪拌溶液及加人一部分氫氧化鈉(500 rag, 7.5 mmo 1 , M 85¾純、使用前機械粉化為主)。將所得之混合物 攪拌2小時,並接著藉由在25 ml乙酸乙酯及5 ml水間分配 而逐漸完成反應,分離相,Μ 1 X 5 m 1水、1 X 5 m 1飽和氯 化鈉清洗醚相,K硫酸鎂乾燥,及以旋轉式蒸發器去除溶 劑。殘餘物藉由30 g矽膠進行層析,以乙醇/乙酸乙酯/己 烷(2 : 50 : 50)為溶析液以獲得化合物3 丙基史賓諾辛Q _________;_~ 124 一_____ 本紙浪尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)Spinoloxin Q (732 mg, 1 mmol), tetrabutyllithium bromide (34 mg, 0.1 mmol), 1-bromopropane (4 ml, 24 mmol), and digas methylbenzene (1 ml) into a 50 ml round bottom flask equipped with a magnetic stirrer. Stir the solution at room temperature and in a water bath and add a portion of sodium hydroxide (500 rag, 7.5 mmo 1, M 85¾ pure, mainly mechanically powdered before use). The resulting mixture was stirred for 2 hours, and then the reaction was gradually completed by partitioning between 25 ml of ethyl acetate and 5 ml of water. The phases were separated and washed with M 1 X 5 m 1 water, 1 X 5 m 1 saturated sodium chloride. The ether phase was dried over K magnesium sulfate and the solvent was removed on a rotary evaporator. The residue was chromatographed using 30 g of silica gel with ethanol / ethyl acetate / hexane (2: 50: 50) as the eluent to obtain compound 3 Propyl Spinoxin Q _________; _ ~ 124 I_____ The wave scale applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) (Please read the precautions on the back before filling this page)

487559 A7 B7 五、發明説明(122 ) ’其為白色脆質泡沫體(β1〇 mg,純度97·5%,由HpLC分析 B部分 藉由Μ非煻忡衍半物敗代胺摧修飾假煻轩配某化 合物 管細例Β1-1 醯基-Φ客諾辛A 1 7-Psa 將史賓諾辛A(2.00 gin, 2.73 mmol)之冰醋酸(50 ml) 溶液加熱至迴流溫度5小時並接著在室溫下攪拌12小時。 將反應混合物蒸發至一小體積,並接著倒入鉋和碳酸氫鈉 溶液。Μ乙醚萃取水性混合物。將乙醚部分Μ鹽水清洗, Κ碳酸鉀乾燥及在室溫及減壓下蒸發,可獲得黃色玻璃狀 物(1.48 gm)。藉由在氧化矽上之層析分離產物,Μ40%甲 己烷之乙酸乙酯溶液為溶析液。所分離之17-0-乙醯基-史 賓諾辛A 17-Psa(478,9 mg,產率28¾)為白色固體,FDMS, m/e (相對強度)632 (M+-H, 100),及所分離之史賓諾辛A 17-Psa(846,2 mg,產率52%)係為無色玻璃狀物。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 窨細例B2-17-0-(3-二甲基胺丙醮基)中窨諾辛A 17-Psa 將化合物17-0-(丙醯基)史賓諾辛A 17-Psa(206.3 mg ,0.32 mmol)溶於冰浴之二甲胺(5 ml)中並將反應混合物 封蓋及在-5°C下授拌2小時。接著當二甲胺經由酸洗氣器 蒸餾時,容許反應混合物加熱至室溫。殘餘物溶於HC 1水 溶液並Μ乙醚洗滌。Μ 5N氫氧化鈉鹼化水溶液並以新鮮乙 醚萃取。將由鹼萃取物所得之乙醚以鹽水清洗,Μ碳酸納 乾燥及在室溫及減壓下乾燥。所得之17-0-(3-二甲基胺丙 醯基)史賓諾辛A 17-Psa(177.1 mg, 80¾產率),為無色玻 璃狀物,FDMS, m/e (相對強度)689 (M、100)。 -125 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印掣 487559 A7 B7 _ 五、發明説明(123) 管施例(3-丙醯基)中窨諾辛A 17-Psa 於史賓諾辛 A 17-Psa(364.3 mg, 0.61 mmol)之氯仿 溶液(10 ml)中,添加丙醯基氯化物(75 ml, 0.92 mmol) 中並接著加入二異丙基乙胺(160 ml, 0.92 nunol)。將反 應混合物加熱至迴流溫度6小時,接著再添加丙醯基氯化 物(75 ml, 0.92 nnnol),及二異丙基乙胺(160 ml, 0.92 ππηο 1)及將混合物再迴流12小時。反應混合物接著冷卻至 室溫並Μ二氯甲烷稀釋。二氯甲烷Μ飽和碳酸氫納清洗, Μ碳酸鉀乾燥及在室溫及減壓下蒸發。祖物質藉由在氧化 矽上層析,M2(U乙酸乙酯之二氯甲烷溶液溶析。所得17-0-(3-丙醯基)史賓諾辛A 17_Psa(322 mg, 82%產率),為無 色玻璃狀物,FDMS, m/e (相對強度)643 (M~H, 100)。 富life例B4-17-CI -(氣乙醮基)中客諾辛A 17-Psa 依實施例B3所述進行反應,Μ史賓諾辛A 17-Psa( 205.4 mg, 0.35 mmol)為起始物質,及氯乙醯基氯化物, 及利用40¾乙酸乙酯之己烷溶液作為層析溶析液。所得之 17-0-(氯乙醯基)史賓諾辛A 17-Psa(194.7 mg, 83¾產率) ,為白色偏離玻璃狀物,FDMS, m/e (相對強度)666 (tT -Η, 100), 190 (20) 〇 管敝例- (4-氣丁 @基)中客諾幸A 17-Psa 依實施例B3所述進行反應,Μ史賓諾辛A 17-Psa( 206.4 mg, 0.35 mmol)為起始物質,及氯丁醯基氯化物, 及利用35¾乙酸乙酯之己烷溶液作為層析溶析液。所得之 17-0-(氯丁醇基)史賓諾辛A 17-Psa(224.3 mg, 92¾產率 __- 126 -_ 本紙張尺度適用中國國家標率(CNS ) A4規格(210X 297公釐) &quot;&quot;&quot;&quot;&quot;一 (請先閱讀背面之注意事項再填寫本頁)487559 A7 B7 V. Description of the invention (122) 'It is a white brittle foam (β10mg, purity 97.5%, analyzed by HpLC, Part B is modified by M non-derivative half-degraded amines to modify the pseudochrysalis. A detailed example of a compound compound tube B1-1 fluorenyl-Φ-kerosin A 1 7-Psa Heat the solution of Spinozin A (2.00 gin, 2.73 mmol) in glacial acetic acid (50 ml) to reflux temperature for 5 hours and It was then stirred at room temperature for 12 hours. The reaction mixture was evaporated to a small volume, and then poured into a planer and sodium bicarbonate solution. The ethereal mixture was extracted with ether. The ether portion was washed with brine, dried with potassium carbonate and at room temperature. And evaporation under reduced pressure to obtain a yellow glass (1.48 gm). The product was separated by chromatography on silica, and the ethyl acetate solution of M40% methylhexane was the eluent. 17-0 -Ethyl-Spinoxin A 17-Psa (478,9 mg, yield 28¾) is a white solid, FDMS, m / e (relative strength) 632 (M + -H, 100), and the history of separation Binoxin A 17-Psa (846, 2 mg, 52% yield) is a colorless glass. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the notes on the back first) Please fill in this page again.) 窨 Detailed example B2-17-0- (3-Dimethylamine propionyl) inoxoxine A 17-Psa The compound 17-0- (propionyl) spinoxin A 17-Psa (206.3 mg, 0.32 mmol) was dissolved in dimethylamine (5 ml) in an ice bath and the reaction mixture was capped and allowed to stir at -5 ° C for 2 hours. Then, when dimethylamine was passed through an acid wash, During the distillation, the reaction mixture was allowed to warm to room temperature. The residue was dissolved in HC1 aqueous solution and washed with ether. M 5N aqueous sodium hydroxide was basified and extracted with fresh ether. The ether obtained from the alkaline extract was washed with brine, and M Sodium carbonate was dried and dried at room temperature under reduced pressure. The resulting 17-0- (3-dimethylaminopropylammonium) spinosin A 17-Psa (177.1 mg, 80¾ yield) was a colorless glass Material, FDMS, m / e (relative strength) 689 (M, 100). -125-This paper size applies to China National Standard (CNS) A4 (210X 297 mm). Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. 487559 A7 B7 _ V. Description of the invention (123) In the example (3-propionyl), anoxine A 17-Psa in spinoxin A 17-Psa (364.3 mg, 0.61 mmol) in chloroform ( 10 ml) Add propionyl chloride (75 ml, 0.92 mmol) followed by diisopropylethylamine (160 ml, 0.92 nunol). The reaction mixture was heated to reflux temperature for 6 hours, followed by addition of propylammonium chloride (75 ml, 0.92 nnnol), and diisopropylethylamine (160 ml, 0.92 ππηο 1) and the mixture was refluxed for another 12 hours. The reaction mixture was then cooled to room temperature and diluted with dichloromethane. The dichloromethane was washed with saturated sodium bicarbonate, dried with potassium carbonate and evaporated at room temperature under reduced pressure. The ancestral substance was chromatographed on silica, and M2 (U ethyl acetate in dichloromethane solution was eluted. The obtained 17-0- (3-propanyl) spinosin A 17_Psa (322 mg, 82% product Ratio), is a colorless glass, FDMS, m / e (relative strength) 643 (M ~ H, 100). Life-rich example B4-17-CI-(Acetofluorene) Zhongkexin A 17-Psa The reaction was carried out as described in Example B3. M Spinoxin A 17-Psa (205.4 mg, 0.35 mmol) was used as the starting material, and chloroacetamido chloride, and 40¾ ethyl acetate in hexane solution was used as a layer. The leaching solution was separated. The obtained 17-0- (chloroethenyl) spinoxin A 17-Psa (194.7 mg, 83¾ yield) was white and deviated from glass, FDMS, m / e (relative strength) 666 (tT-Η, 100), 190 (20) 〇 Example of tube-(4-Air but @@) Zhongke Nuoxing A 17-Psa The reaction was performed as described in Example B3, M Spinoxin A 17 -Psa (206.4 mg, 0.35 mmol) as the starting material, and chlorobutyryl chloride, and the use of 35¾ ethyl acetate in hexane as the chromatographic eluate. The obtained 17-0- (chlorobutanol group) history Binoxin A 17-Psa (224.3 mg, 92¾ Yield __- 126 -_ This paper size applies to China's national standard rate CNS) A4 size (210X 297 mm) &quot; &quot; &quot; &quot; &quot; a (please read the Notes on the back to fill out this page)

經濟部中央標隼局員工消費合作社印製 487559 A7 _ B7__ 五、發明説明(124) ),為白色偏離玻璃狀物,FDMS, m/e (相對強度)696 ( M+ , 100) , 189 (20)。 啻瓶例Β6-17-Π -(二甲基胺Z醮基)Φ客諾幸A 17-Psa 依實施例B2所述進行反應,以17-0-(氯乙醯基)史賓 諾辛A 17_Psa(99.4 mg, 0.15 mmol)為起始物質。所得之 17-0-(二甲基胺乙醯基)史賓諾辛A17_Psa(79.1 mg, 78¾ 產率)為米黃色玻璃狀物,FDMS, m/e (相對強度)675 ( M*-H, 100)。 奮脓例Β7-17-Π-U-碘某)中窨諾辛A 17-Psa 於 17-0-(4-氯丁醇基)史賓諾辛 A 17-Psa(91,9 mg, 0·13 mmol)之丙酮(3 ml)溶液中,添加碘化納(198 rag, 1 . 3 mm〇 1)。當沈澱形成時,使反應混合物加熱至迴流溫 度18小時。將混合物冷卻至室溫,以水稀釋及Μ二氯甲烷 萃取。以碳酸鉀乾燥二氯甲烷及在室溫及減壓下蒸發。可 獲得 17-0-(4-碘丁醇基)史賓諾辛 A 17-Psa(94.7 mg, 93% 產率),為米黃色玻璃狀物,FDMS, m/e (相對強度)832 ( !_0), 786 (M、H, 100), 704 (20), 377 (30)。 啻施例B8-17-0- U-二甲某防丁醇)中曹諾幸A 17-Psa 依實施例B2所述進行反應,以17-0-(4-碘丁醇基))史 賓諾辛A 17-Psa(216.9 mg, 0.28 mmol)為起始物質。所 得之17-0-U-二甲基胺丁醇)史賓諾辛A 17-Psa(155.7 mg ,79¾產率)為米黃色玻璃狀物,FDMS, m/e (相對強度) 704 (r, 100) 〇 實施例B9-17-0 - (N ’ _甲甚- (I春基Z酿酯)中曹諾幸Α Π ________~ 127 —___ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A7 _ B7__ V. Description of the invention (124)), white deviation from glass, FDMS, m / e (relative intensity) 696 (M +, 100), 189 (20 ). Example of flask B6-17-Π-(dimethylamine Zfluorenyl) Φ Kerosyn A 17-Psa The reaction was performed as described in Example B2, and 17-0- (chloroethenyl) spinosyn A 17_Psa (99.4 mg, 0.15 mmol) was the starting material. The obtained 17-0- (dimethylamine ethylammonium) spinosyn A17_Psa (79.1 mg, 78¾ yield) was a beige glass, FDMS, m / e (relative strength) 675 (M * -H , 100). Cases of struggling pus B7-17-Π-U-iodine) indoxoxine A 17-Psa in 17-0- (4-chlorobutanol group) spinoxin A 17-Psa (91,9 mg, 0 · To a solution of 13 mmol) in acetone (3 ml) was added sodium iodide (198 rag, 1.3 mm). When a precipitate formed, the reaction mixture was heated to reflux temperature for 18 hours. The mixture was cooled to room temperature, diluted with water and extracted with methylene chloride. The dichloromethane was dried over potassium carbonate and evaporated at room temperature under reduced pressure. 17-0- (4-iodobutanol) Spinoxin A 17-Psa (94.7 mg, 93% yield) was obtained as a beige glass, FDMS, m / e (relative strength) 832 ( ! _0), 786 (M, H, 100), 704 (20), 377 (30).啻 Example B8-17-0- U-dimethyl antibutanol) Cao Nuoxing A 17-Psa The reaction was carried out as described in Example B2, with a history of 17-0- (4-iodobutanol)) Binoxin A 17-Psa (216.9 mg, 0.28 mmol) was used as the starting material. The obtained 17-0-U-dimethylamine butanol) Spinoxin A 17-Psa (155.7 mg, 79¾ yield) was a beige glass, FDMS, m / e (relative strength) 704 (r , 100) 〇 Example B9-17-0-(N '_ Jiashi-(I Chunji Z brew ester) in the Cao Nuo Xing A Π ________ ~ 127 —___ This paper size applies to China National Standard (CNS) A4 specifications (210X 297mm) (Please read the notes on the back before filling this page)

經濟部中央標準局員工消費合作社印製 487559 A7 —一 _ B7__ 五、發明説明(125 ) -Psa 於17-0-(4-氯乙醯基)史賓諾辛A 17-Psa(150.5 mg, 0.23 mmol)之氯仿(7 ml)溶液中,添加二異丙胺(59 β 1, 0· 34 mmol),接著添加卜甲基哌H秦(38 y 1 , 0· 34 mmol)。 使反應混合物在室溫下攪拌1小時,接著加熱至迴流溫度 2,5小時。將混合物冷卻至室溫3天。接著再加入1 -甲基哌 嗪(0.5 ml)及使混合物加熱至迴流溫度4小時。反應混合 物接著冷卻至室溫並倒入飽和碳酸氫鈉溶液,並以乙醚萃 取。Μ鹽水清洗乙醚部分,Μ硫酸鎂乾燥及在室溫及減壓 下蒸發。藉由在氧化矽上進行層析純化粗產物,M 7¾甲醇 之二氯甲烷溶液再M 20¾甲醇之二氯甲烷溶液析出(單一步 驟)。所得17-0-(^1’-甲基4-哌_基醋酸)史賓諾辛&amp;17-Psa(63.1 mg, 38¾產率),為無色玻璃狀物,PDMS, m/e ( 相對強度)730 (M\ 100),731 (80)。 啻淪例嗎D林甚ZSg酯)中窨諾辛A 17-Psa 依實施例B9所述進行反應,K 17-0-(氯乙醯基)史賓 諾辛 A 17-Psa(152.3 mg, 0.23 mmoi),及嗎啉(一次加 0. 5 ml)為起始物質。迴流14小時並K二氯甲烷萃取,所 獲得之17-0-(Ν-嗎啉基乙酸酯)史賓諾辛A 17-Psa(141.3 mg; 86%產率)為白色偏離玻璃狀物,FDMS, m/e (相對強 度)717 (ΪΓ , 100)。 啻敝例1^1-17-0-(2-(1-咪_基)Z職某)中窨諾辛Α 17-Ρμ 於氫化納(50%之礦物油懸浮液;15.81^,0.33111111〇1)之 THF(5 ml)溶液中,加入咪唑基(23.1 mg, 0.34 mmol)。 -128 ·* 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) — (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 — a _ B7__ V. Description of the invention (125) -Psa at 17-0- (4-chloroethenyl) Spinoxin A 17-Psa (150.5 mg, To a solution of 0.23 mmol) in chloroform (7 ml), diisopropylamine (59 β 1, 0.34 mmol) was added, followed by pemipine HQ (38 y 1, 0.34 mmol). The reaction mixture was allowed to stir at room temperature for 1 hour and then heated to reflux temperature for 2,5 hours. The mixture was cooled to room temperature for 3 days. Then 1-methylpiperazine (0.5 ml) was added and the mixture was heated to reflux temperature for 4 hours. The reaction mixture was then cooled to room temperature and poured into a saturated sodium bicarbonate solution and extracted with ether. The ether portion was washed with M brine, dried over magnesium sulfate and evaporated at room temperature under reduced pressure. The crude product was purified by chromatography on silica. M 7¾ methanol in dichloromethane solution and M 20¾ methanol in dichloromethane were precipitated (single step). The obtained 17-0-(^ 1'-methyl 4-piperidylacetic acid) spinosinol &amp; 17-Psa (63.1 mg, 38¾ yield) is a colorless glass, PDMS, m / e (relative Intensity) 730 (M \ 100), 731 (80). Example: Dinoxyl ZSg ester) Benoxin A 17-Psa was reacted as described in Example B9, K 17-0- (chloroethenyl) spinoxin A 17-Psa (152.3 mg, 0.23 mmoi), and morpholine (add 0.5 ml at a time) as starting materials. Reflux for 14 hours and extract with K dichloromethane. The obtained 17-0- (N-morpholinoacetate) Spinoxin A 17-Psa (141.3 mg; 86% yield) is white and off-glass. , FDMS, m / e (relative intensity) 717 (ΪΓ, 100). Example 1 ^ 1-17-0- (2- (1-Mi_yl) Z) Mr. Nosin A 17-Pμ in sodium hydride (50% mineral oil suspension; 15.81 ^, 0.33111111. 1) To a solution of THF (5 ml), imidazolyl (23.1 mg, 0.34 mmol) was added. -128 · * This paper size applies to China National Standard (CNS) A4 (210X 297 mm) — (Please read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(126 ) 將 17-0-溴乙醯基史賓諾辛 A 17-Psa(201,l mg,0.28 mmol )加入混合物中,及在室溫下攪拌反應混合物2小時。混合 物以二氯甲烷稀釋,及Μ水清洗。接著鹽清洗二氯甲烷部 分,Μ碳酸鉀乾燥,及在室溫及減壓下蒸發。粗產物藉由 藉由在氧化矽上進行層析純化,Μ5%乙醇之乙酸乙酯溶液 溶析。所得17-0-(2-(卜眯唑基)乙醯基)史賓諾辛/\17砰53 (117 mg, 60¾產率),為無色玻璃狀物,FDMS, m/e (相對 強度)699 (M*,100),698 (40), 189 (40), 101 (70)。Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 V. Description of the invention (126) Add 17-0-bromoethenyl spinosyn A 17-Psa (201, 1 mg, 0.28 mmol) to the mixture, and The reaction mixture was stirred at room temperature for 2 hours. The mixture was diluted with dichloromethane and washed with water. The methylene chloride portion was then washed with salt, dried over potassium carbonate, and evaporated at room temperature under reduced pressure. The crude product was purified by chromatography on silica, eluting with 5% ethyl acetate in ethyl acetate. The obtained 17-0- (2- (oxazolyl) ethynyl) spinoxin / \ 17bang 53 (117 mg, 60¾ yield) is a colorless glass, FDMS, m / e (relative strength ) 699 (M *, 100), 698 (40), 189 (40), 101 (70).

富瓶例B1 2-17-0- (2- (4- (2-嘧啶基卜卜六氣Dlt. P井基)乙西宿 基)中窨諾辛A 依實施例B11所述進行反應,M 17-0-(溴乙醯基)史賓 諾辛 A 17-Psa(209.6 mg, 0.29 mmol),及 2-(卜六氫吡畊 基)嘧啶為起始物質,及利用5%甲醇之二氯甲烷為層析溶 析液。所獲得之17-0-(2-(4-(2-嘧啶基卜卜六氫吡畊基) 乙盤_基)史賓諾辛A 17-Psa(233.6 mg, 97¾產率),為白色 偏離玻璃狀物,FDMS, m/e (相對強度)717 (Μ、60), 794 (100)。Rich bottle example B1 2-17-0- (2- (4- (2-pyrimidinyl buhexyl Dlt. P well-based) ethicinyl) Zhongnosin A was reacted as described in Example B11, M 17-0- (bromoethenyl) Spinoxin A 17-Psa (209.6 mg, 0.29 mmol), and 2- (buhexahydropyridyl) pyrimidine as starting materials, and 5% methanol Dichloromethane is a chromatographic eluate. The obtained 17-0- (2- (4- (2-pyrimidinylbubuhexylpyridinyl) ethanyl group_spinoxin A 17-Psa ( 233.6 mg, 97¾ yield), white off-glass, FDMS, m / e (relative strength) 717 (M, 60), 794 (100).

啻施例R1 3-17-0- (2- U-甲防甚啶某)Ζ臟甚)中窨諾 辛 A 依實施例B11所述進行反應,M 17-0-(溴乙醯基)史賓 諾辛 A 17-Psa(201.8 mg, 0.28 mmol),及 4-二甲基胺哌 啶為起始物質,在室溫下攪拌3天,及利用10¾甲醇之二氯 甲烷溶液及接著100¾甲醇(單一步驟)為溶析液。所獲得之 17-0-(2-(4-甲胺基-1-峨啶基)乙醯基)史賓諾辛/\17卄^ _- 129 -_ 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) &quot; (請先閱讀背面之注意事項再填寫本頁)啻 Example R1 3-17-0- (2-U-Metoprolidine) Zirconium) Indoxacin A was reacted as described in Example B11, M 17-0- (Bromoethenyl) Spinozin A 17-Psa (201.8 mg, 0.28 mmol), and 4-dimethylamine piperidine as starting materials, stirred at room temperature for 3 days, and using a solution of 10¾ methanol in dichloromethane and then 100¾ Methanol (single step) was the eluent. The obtained 17-0- (2- (4-methylamino-1-eridinyl) ethenyl) Spinoxin / \ 17 卄 ^ _- 129 -_ This paper size applies to Chinese national standards ( CNS) A4 specification (210X297mm) &quot; (Please read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印製 487559 A7 ____ B7 五、發明説明(127 ) (104.2 μ, 49¾產率),為白色固體,FDMS, m/e (相對強 度)759 (M*, 100)。 當旆例B1 4-1 7-0- (4-批啶羰某)史寶諾辛A 17-Psa 於異菸鹼酸(50.7 rag, 0.41 mmol)之二氯甲烷(10 ml )懸浮液中,添加DMAP(18.5 mg, 0·4 mmol)及史賓諾辛A 17-Psa(202.1 mg, 0.34 ππποί),並接著添加 DCC(107.8mg ,0.52mmol)。將反應混合物在室溫下攪拌2.5天,及接著 以乙醚稀釋並過濾。濾液在室溫及減壓下蒸發。殘餘物藉 由藉由在氧化矽上進行層析純化,Μ 50%乙酸乙酯之己烷 溶液溶析。所得之17-0-(4-吡啶羰基)史賓諾辛A 17_Psa (116*1 mg, 7«產率),為無色玻璃狀物,FDMS, ra/e (相 對強度)696 (M、100) ,694 (40)。 富細例Β15-17-Π-(六氣蚍阱Z醢基)Φ窨諾辛A 17-Psa 依實施例B11所述進行反應,M17-0-(溴乙醯基)史賓 諾辛A 17-Psa(206.4 rag, 0.29 mmol),及六氫吡P井為起 始物質。所得17-0-(六氫吡畊乙醯基)史賓諾辛A 17-Psa (127,1 mg, 61%產率),為米黃色固體,FDMS, m/e (相對 強度)791 (40), 718 (40), 717 (M+, 65)。 富敝例(N-甲基U甫酪甚)中W諾辛A 17-Psa 依實施例B14所述進行反應,K史賓諾辛A 17-Psa(20 7.7 mg, 0.36 mmol)及 甲基腩胺酸(63.7 mg, 0·43 mmol)為起始物質。所得17-0-(1甲基-L-腩胺酸基)史賓 諾辛A 17-Psa(65.9 mg, 43%產率,K回收之史賓諾辛A 17-Psa 為基準),FDMS, m/e (相對強度)703 (95), 702 ( - 130 _ 本紙張尺度適用中國國家標準(CNS ) Λ·4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)Printed by the Employees' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 ____ B7 V. Description of the invention (127) (104.2 μ, 49¾ yield), white solid, FDMS, m / e (relative intensity) 759 (M *, 100) . Example B1 4-1 7-0- (4-Pyridinylcarbonyl) Sporoxin A 17-Psa in a suspension of isonicotinic acid (50.7 rag, 0.41 mmol) in dichloromethane (10 ml) , DMAP (18.5 mg, 0.4 mmol) and Spinoxin A 17-Psa (202.1 mg, 0.34 ππποί) were added, followed by DCC (107.8 mg, 0.52 mmol). The reaction mixture was stirred at room temperature for 2.5 days, and then diluted with ether and filtered. The filtrate was evaporated at room temperature under reduced pressure. The residue was purified by chromatography on silica, and 50% ethyl acetate in hexane was eluted. The obtained 17-0- (4-pyridylcarbonyl) spinosyn A 17_Psa (116 * 1 mg, 7 «yield) is a colorless glass, FDMS, ra / e (relative strength) 696 (M, 100 ), 694 (40). Rich example B15-17-Π- (Six-gas trap Z 蚍 group) Φ 窨 Nosin A 17-Psa The reaction was carried out as described in Example B11, M17-0- (Bromoethenyl) Spinoxin A 17-Psa (206.4 rag, 0.29 mmol), and hexahydropyridine P were the starting materials. The obtained 17-0- (hexahydropyridine ethylspinyl) spinosyn A 17-Psa (127,1 mg, 61% yield) was a beige solid, FDMS, m / e (relative strength) 791 ( 40), 718 (40), 717 (M +, 65). In the rich case (N-methyl Ubutyrate), W Nuoxin A 17-Psa was reacted as described in Example B14. K Spinoxin A 17-Psa (20 7.7 mg, 0.36 mmol) and methyl Amidine (63.7 mg, 0.43 mmol) was the starting material. The obtained 17-0- (1methyl-L-amidate) Spinoxin A 17-Psa (65.9 mg, 43% yield, based on Spinoxin A 17-Psa recovered by K), FDMS , m / e (relative strength) 703 (95), 702 (-130 _ This paper size applies to the Chinese National Standard (CNS) Λ · 4 size (210X297 mm) (Please read the precautions on the back before filling this page)

487559 經濟部中央標準局員工消費合作社印製 A7 __B7五、發明説明(128 ) M*,100) 0 宵碑MR17-17-fl-「N-(2-六氣蚍啶乙基)1胺乙醯基史賓諾 辛 A 17-Psa 依實施例B14所述進行反應,以17-0 -溴乙醯基史賓諾 辛 A 17-Psa(205.1 mg, 0.29 ππηοΐ)及 1-(2-胺乙基)-六氫 吡啶為起始物質。在氧化矽上層析後,K 10¾甲醇之二氯 甲烷溶為溶析液,產物進一步藉由在C18管柱上進行逆相 HPLC Μ 乙腈:甲醇:0.1¾ 乙酸銨(35:35:30 至 45:45:10,於 60分鐘內之線形梯度)Μ獲得17-0-[N-(2-六氫吡啶乙基)] 胺乙醯基史賓諾辛A 17-Psa(ll mg, 5%產率),為白色固 體,FDMS, ro/e (相對強度)760 (90), 759 (M+, 100)。 管)fe例B18-17-0 - (Z氢羰基乙醯基)史賓諾辛A 17-Psa 依實施例B3所述進行反應,Μ史賓諾辛A 17-Psa( 207.7 mg, 0.35 mmol)及氯化丙二酸二乙酯(484 ml, 3.78 mmol;僅添加广次)。所得17-0-(乙氧羰基乙醯基) 史賓諾辛A 17-Psa(153.6 mg, 62¾產率),為無色固體, FDMS, m/e (相對強度)704 (M+, 100), 189 (51)。 依實施例B3所述進行反應,Μ史賓諾辛A 17-Psa( 4·06 g, 6.9 ππηοΐ)及溴乙醯基湞化物為起始物質,及利 用10¾乙酸乙酯之二氯甲烷溶液為層析溶析液。所得之· 17-0M溴乙醯基)史賓諾辛A 17-Psa(2.92 g, 59¾產率), 為白色偏離固體,FDMS, m/e (相對強度)712(M\ 50), 713(85)。 -131 - (請先閱讀背面之注意事項再填寫本頁)487559 Printed by A7 __B7, Employee Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs V. Description of Invention (128) M *, 100) Fluorenylspinoxin A 17-Psa The reaction was performed as described in Example B14, using 17-0-bromoethylspinoxin A 17-Psa (205.1 mg, 0.29 ππηοΐ) and 1- (2-aminoethyl ) -Hexahydropyridine as the starting material. After chromatography on silica, K 10¾ methanol in dichloromethane was dissolved as the eluent. The product was further subjected to reverse phase HPLC on a C18 column. M acetonitrile: methanol: 0.1 ¾ Ammonium acetate (35:35:30 to 45:45:10, linear gradient within 60 minutes) M obtains 17-0- [N- (2-hexahydropyridylethyl)] amine ethylspinoloxin A 17-Psa (11 mg, 5% yield), a white solid, FDMS, ro / e (relative strength) 760 (90), 759 (M +, 100). Tube) B18-17-0-( Z hydrocarbonylethinyl) Spinoxin A 17-Psa The reaction was performed as described in Example B3, M Spinoxin A 17-Psa (207.7 mg, 0.35 mmol) and diethyl chloride malonate ( 484 ml, 3.78 mmol; added only a wide number of times). 17-0- (ethoxycarbonylethenyl) obtained Spinozin A 17-Psa (153.6 mg, 62¾ yield), a colorless solid, FDMS, m / e (relative strength) 704 (M +, 100), 189 (51). The reaction was performed as described in Example B3, M Spineau Octyl A 17-Psa (4.06 g, 6.9 ππηοΐ) and bromoacetamidine are used as starting materials, and a dichloromethane solution of 10¾ ethyl acetate is used as a chromatographic eluate. The obtained 17-0M Ethyl bromide) Spinoxin A 17-Psa (2.92 g, 59¾ yield), white deviation from solid, FDMS, m / e (relative intensity) 712 (M \ 50), 713 (85). -131 -(Please read the notes on the back before filling this page)

訂 .¾. 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(129) 實施例Β20-17-Π-(對胺基笼Z醢基)中客諾辛A 17-Psa 將化合物17-Ο-(對硝基苯乙醯基)史賓諾辛A17-Psa (101·6 mg, 0.134 mmol)溶於乙醇(5 ml)並添加氯化錫( 11)(142.6 mg, 0.75mra〇l)。溶液之黃色迅速消失及取代 為白色懸浮液。反應加熱迴流溫度3.5小時,冷卻至室溫, 及容許維持隔夜。於逐漸反應形成殘餘物後,藉由在矽膠 上(乙酸乙酯/己烷)層析純化殘餘物,K提供17-0-(對胺 基苯乙醯基)史賓諾辛A 17-Psa(45.3 mg, 46¾產率),為白 色固體,FDMS m/z 723。CuHwNOi 〇分析之估計值:C, 68.03; Η, 7·94; Ν, 19·3·.實際值:C, 67.53; H, 7.91 ;Ν, 2·41 。 奮施例Β2卜(鄱-氡笼甲醮基)中窨諾辛A 17-Psa 依實施例B46所述製備化合物,利用郯-氯苯甲酸(51 mg, 0·32πππο1)、DMAP(47 mg, 0.38 mmol),史賓諾辛 A 17~Psa(135 mg, 0.228 mmol),及DCC(49 mg, 0·23 mmol )。所得之17-CM鄰-氯苯甲醯基)史賓諾辛A 17-Psa (69 rag, 41¾),為白色固體,FDMS m/z 729。 啻施例B22-17-0-(間-氡笼7,醢基)中窨諾辛A 17-Psa 依實施例B46所述製備化合物,利用間-氯苯乙酸( 42·3 mg, 0.24mmol)、DMAP(45.2 mg, 0·37 mmol),史賓 諾辛 A 17-Psa(134«4 mg, 0.22 mmol),及 DCC(51.2 mg, 0.24 mmol)。所得之17-0-(間-氯苯乙醯基)史賓諾辛A 17 -Psa(101.5 mg, 60¾),為白色固體♦· FDMS πι/ζ 742。 實施例B23-17-0-甲職某中W諾辛A 17-Psa 本紙張尺度適用中國國家標隼(CNS ) Λ4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)Order. ¾. This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (129) Example B20-17-Π- ( P-Amine cage (Zylenyl) Sinokine A 17-Psa Dissolve the compound 17-〇- (p-nitrophenylethylethyl) spinoxin A17-Psa (101 · 6 mg, 0.134 mmol) in ethanol (5 ml) and tin chloride (11) (142.6 mg, 0.75 ml) was added. The yellow color of the solution quickly disappeared and replaced with a white suspension. The reaction was heated at reflux temperature for 3.5 hours, cooled to room temperature, and allowed to stand overnight. After a gradual reaction to form a residue, the residue was purified by chromatography on silica gel (ethyl acetate / hexane). K provided 17-0- (p-aminophenethylfluorenyl) Spinoxin A 17-Psa (45.3 mg, 46¾ yield) as a white solid, FDMS m / z 723. CuHwNOi 〇 Estimated value of analysis: C, 68.03; Η, 7.94; Ν, 19.3 ·. Actual value: C, 67.53; H, 7.91; Ν, 2.41. Benoxin A 17-Psa in Fen Example B2 ((鄱-氡 氡 甲 醮 基)) was prepared as described in Example B46, using 郯 -chlorobenzoic acid (51 mg, 0.332πππο1), DMAP (47 mg , 0.38 mmol), Spinozin A 17 ~ Psa (135 mg, 0.228 mmol), and DCC (49 mg, 0.23 mmol). The obtained 17-CM-o-chlorobenzylidene) Spinoxin A 17-Psa (69 rag, 41¾) was a white solid with FDMS m / z 729.啻 Example B22-17-0- (m-Phenyl cage 7, fluorenyl) Phenoxin A 17-Psa The compound was prepared as described in Example B46, using m-chlorophenylacetic acid (42.3 mg, 0.24 mmol ), DMAP (45.2 mg, 0.37 mmol), Spinoxin A 17-Psa (134 «4 mg, 0.22 mmol), and DCC (51.2 mg, 0.24 mmol). The obtained 17-0- (m-chlorophenethylfluorenyl) spinosin A 17-Psa (101.5 mg, 60¾) was a white solid. FDMS π / ζ 742. Example B23-17-0-Woxining A 17-Psa of a middle school in the first grade This paper size is applicable to Chinese National Standard (CNS) Λ4 specification (210X297 mm) (Please read the precautions on the back before filling this page)

487559 經濟部中央標準局員工消費合作社印褽 A7 B7 五、發明説明(13〇 ) 將化合物史賓諾辛A17-Psa(104 mg, 0.18 mmol)溶 於苯(5 ml)並添加二甲基甲醯胺二甲基縮醛(0.10g, 〇·84 mmol)。將溶液加熱至迴流溫度2小時,冷卻至室溫,及減 壓蒸發溶劑。藉由在矽膠上(乙酸乙酯/己烷梯度,20:30 至50:50)層析纯化殘餘物,Μ提供17-0-甲醯基史賓諾辛A 17-Psa(35.8 mg, 32.8¾),為白色固體:FDMS ιη/ζ: 618。 啻餱例B24-17-0 -(鄱茏甲醯基)笼甲酼基)Φ g諾辛A Ϊ7_Ρ s_a 依實施例B46所述步驟製備化合物,利用2-苯甲酸(83 m g , 0.3 6 m m ο 1) , D M A P (3 8 m g , 0.31 m m ο 1),史賓諾辛 A 17 - P s a (15 0 m g , 0 ♦ 2 5 m m o 1),及 D C C (5 8 m g , 0 ♦ 2 8 m m o 1) 。所得之17-0-(鄰苯甲醯基)苯甲醯基)史賓諾辛A 17-Psa (37.6!1^,18.5%),為白色固體:?01^111/2 799。 啻_例B25-1 7-0 -(鄱氪笼Z醯某中客諾辛A 1 7-Psa 依實施例B46所述步驟製備化合物,利用2-氯苯乙酸( 69 mg, 0·40 mmol), DMAP(38 mg, 0.31 mmol),史賓諾 辛 A17-Psa(148 mg, 0·25 mmol),及 DCC(64 mg,(K31 mmol)。所得之17_0_(鄰氯苯乙醯基史賓諾辛A 17-Psa(92 mg, 49¾),為白色固體·· FDMS m/z 743、745。CuHssCh 〇 Cl 分析之估計值♦♦ (:,66·25; Η, 7.46。實際值:C,66.23 ;Η, 7.36 〇487559 Employees' Cooperative Cooperative A7 B7 of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (13) The compound Spinoxin A17-Psa (104 mg, 0.18 mmol) was dissolved in benzene (5 ml) and dimethylformamide was added. Amine dimethyl acetal (0.10 g, 0.84 mmol). The solution was heated to reflux temperature for 2 hours, cooled to room temperature, and the solvent was evaporated under reduced pressure. The residue was purified by chromatography on silica gel (ethyl acetate / hexane gradient, 20:30 to 50:50), and M provided 17-0-formamyl spinosin A 17-Psa (35.8 mg, 32.8¾ ) As a white solid: FDMS ιη / ζ: 618. Example B24-17-0-(Acetylenyl) Cryptamino) Φ g Nosin A Ϊ7_Ρ s_a The compound was prepared according to the procedure described in Example B46, using 2-benzoic acid (83 mg, 0.3 6 mm ο 1), DMAP (3 8 mg, 0.31 mm ο 1), Spinozin A 17-P sa (15 0 mg, 0 ♦ 2 5 mmo 1), and DCC (5 8 mg, 0 ♦ 2 8 mmo 1) . The obtained 17-0- (o-benzylidene) benzylidene) Spinoxin A 17-Psa (37.6! 1 ^, 18.5%) was a white solid:? 01 ^ 111/2 799.例 _Example B25-1 7-0-(鄱 氪 醯 Z 醯 A certain kenosine A 1 7-Psa According to the procedure described in Example B46, the compound was prepared using 2-chlorophenylacetic acid (69 mg, 0.4 mg ), DMAP (38 mg, 0.31 mmol), Spinoxin A17-Psa (148 mg, 0.25 mmol), and DCC (64 mg, (K31 mmol). Nosin A 17-Psa (92 mg, 49¾), white solid · FDMS m / z 743, 745. CuHssCh 〇Cl analysis estimated value ♦♦ (:, 66 · 25; Η, 7.46. Actual value: C , 66.23; Η, 7.36 〇

背脓例鄱笼某笼甲醯基中IT諾辛A 依實施例B46所述步驟製備化合物,利用2-苯基苯甲 酸(78 mg,〇·39 mmol),DMAP(37 rag, 0.30 mmol),史賓 適用中國國家標华(CNS )八4規格(ZIOXN7公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 4, 經濟部中央標準局員工消費合作社印製 487559 A7 _:____^__ 五、發明説明(131 ) 諾辛 A17-Psa(142 mg, 〇·24 mmol),及 DCC(60 mg, 〇·29 mmol)。所得之17-0-(鄰苯基苯甲醯基史賓諾辛A 17-Psa( 70 mg, 38¾),為白色固體:FDMS ιη/ζ 770。 當嫵例Β27-17-Π-(鄱.對-二氛苯乙醯基)史賓諾 依實施例B46所述步驟製備化合物,利用2,4-二氯苯 乙酸(66 mg, 0·32 mmol), DMAP(52 mg, 0,26 mmol),史 賓諾辛 A17-Psa(142 mg,〇·24 romol),及 DCC(55 mg, 0.26 mmol)。所得之〇-(鄰,對-二氯苯乙醯基)史賓諾辛A 17-Psa(108,5 mg, 57.9%),為白色固體:FDMS m/z 777 〇 啻敝例Β28-17-Π-(鄱-里丙基笼甲醯基)史賓諾辛Α_ 17τ.Ρ_Μ 依實施例Β46所述步驟製備化合物,利用2-異丙基·苯 甲酸(72 rag, 0·43 mmol), DMAP(43 mg, 0·35 mmol),史 賓諾辛 A17-Psa(171 mg,0·28 mmol),及 DCC(72 rag,0.35 mmol)。所得之17-0-(鄰-異丙基苯甲醯基)史賓諾辛A 17 -Psa(76.7 mg, 36*0S〇,為白色固體:FDMS ro/z 737。 。(:nHeQ(ha分析之估計值·· C, 70.0δ; Η, 8.21。實際值 :C, 70.33; Η, 8.28。 啻敝例B2Q-17-0-(%!3 ·鄱-二氡笼^醢基)史曹諾辛A 17-Psa 依實施例B46所述步驟製餚化合物,利用2,6-二氯苯 甲酸(61 mg, 0·30 mmol), DMAP(40.6 mg, 0.332 mmol), 史賓諾辛 A17-Psa(131 mg, 0.22 romol),及 DCC(59 rag, 0.28 mmol)。所得之17-0-(鄰,郯-二氯苯乙醯基)史賓諾 辛A17-Psa(101πιg,58.5¾),為白色固體:FDMSIn/z777 _- 134 -_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐1 (請先閱讀背面之注意事項再填寫本頁)A case of back pus. IT nosin A in a mesityl in a cage. Compounds were prepared according to the procedure described in Example B46. 2-Phenylbenzoic acid (78 mg, 0.39 mmol) and DMAP (37 rag, 0.30 mmol) were used. , Shibin applies China National Standards (CNS) 8 4 specifications (ZIOXN7 mm) (Please read the precautions on the back before filling out this page) Order 4, printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 _: ____ ^ __ V. Description of the invention (131) Nosin A17-Psa (142 mg, 0.24 mmol), and DCC (60 mg, 0.29 mmol). The obtained 17-0- (o-phenylbenzylspinyl spinosin A 17-Psa (70 mg, 38¾) was obtained as a white solid: FDMS ιη / ζ 770. As an example B27-17-Π- (鄱. P-Dichlorophenethylsulfonyl) Spinois prepared by the procedure described in Example B46 using 2,4-dichlorophenylacetic acid (66 mg, 0.32 mmol), DMAP (52 mg, 0,26 mmol ), Spinozin A17-Psa (142 mg, 0.24 romol), and DCC (55 mg, 0.26 mmol). The resulting O- (o-, p-dichlorophenethylfluorenyl) spinosin A 17-Psa (108,5 mg, 57.9%), as a white solid: FDMS m / z 777 〇 Example B28-17-Π- (fluorenyl-propylpropylcarboxamidine) Spinozin A_ 17τ. P_M The compound was prepared according to the procedure described in Example B46, using 2-isopropyl · benzoic acid (72 rag, 0.43 mmol), DMAP (43 mg, 0.35 mmol), spinosin A17-Psa (171 mg, 0.28 mmol), and DCC (72 rag, 0.35 mmol). The resulting 17-0- (o-isopropylbenzyl) spinoxin A 17-Psa (76.7 mg, 36 * 0S 〇, is a white solid: FDMS ro / z 737 ... (: nHeQ (estimated value of ha analysis · C, 70.0δ; Η, 8.21. Actual value: C, 70.33; Η, 8.28. 啻 敝 Example B2Q-17 -0-(%! 3 · 鄱-二氡 cage ^ base) Shi Caoxin A 17-Psa Compounds were prepared according to the procedure described in Example B46, using 2,6-dichlorobenzoic acid (61 mg, 0.30 mmol), DMAP (40.6 mg, 0.332 mmol), Spinozin A17-Psa (131 mg, 0.22 romol), and DCC (59 rag, 0.28 mmol). The resulting 17-0- (o-, pyrene-dichlorophenethylfluorenyl) spinosin A17-Psa (101πιg, 58.5¾), white solid: FDMSIn / z777 _- 134 -_ This paper size is applicable to China National Standard (CNS) A4 specification (210X 297 mm 1 (Please read the notes on the back before filling (This page)

訂 487559 經濟部中央標準局員工消費合作社印製 A7 _ B7 五、發明説明(132) 啻脓例Β30-ΐ7-Π-¥基中窨諾宰A 1 7-Psa 將化合物史賓諾辛A 17-Psa(120 mg, 0.20 mmol)溶 於5 ml二甲基甲醯胺及並添加氧化銀(50 mg, 0.21 nunol) 及溴化苄基(120 mg, 0.70 mraol)。將反應物攪拌1小時並 於此期間内再添加溴化苄基(200 mg, 1.4 mmol)及氧化銀 (40 mg, 0.42 mmol)。將反應物再攪拌12小時,之後將反 應物加熱至8〇-90°C及於3小時内每小時添加溴化苄基(100 mg)及氧化銀(20 mg)。將反應物冷卻至室溫,並以乙醚( 50 m 1),過滤及Μ去離子水,再Μ鹽水清洗濾液。以硫酸 鎂乾燥乙醚溶液及在減壓下濃縮。藉由在矽膠上(乙酸乙 酯/己烷梯度,20: 80至50: 50)層析純化殘餘物,Κ提供17- 0-苄基史賓諾辛A 17-Psa(6.3 mg, 4.5%),為無色玻璃狀 物:FDMS m/z 618:部分 NMR 5 7.41-7.36 (m, 5Η), 6.78 (bs, 1Η), 5.90 (dd, 1H), S.BKdt, 1H), 5.18 (dd, 2H) ; 4.90 (m, 1H) , 4.86 (dd, 1H) , 4.68 (m, 1H) , 4.33 (q, 1H) · 管_例1^1-17-(1-(對.間(二氛茏乙醯基)Φ賓諾辛A 17_Psa 依實施例B46所述步驟製備化合物,利用3,4-二氯苯 乙酸(136 mg, 0.66 mmol), DMAP(70 mg, 0.57 mmol), 史賓諾辛 A17-psa(170 mg, 0·29 mraol),及 DCC(70 mg, 0.34 mmol)。所得之17-0-(對,間(二氯筆乙藤基)史賓諾 辛八17砰33(171.2 1^,76.5%)為白色固體:「01^111/2中 776、777、778、779、780、、C4iH52〇i〇Cl2分析之估計值: C, 63.32; H,7*00; C1, 9.12。實際值:C, 63,37; Η -135 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(2丨ox297公釐) 一 ~ (請先閱讀背面之注意事項再填寫本頁)Order 487559 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 _ B7 V. Description of the invention (132) Example of pus pus B30-ΐ7-Π- ¥ Jinzhong Nozai A 1 7-Psa Will be compound Spinozin A 17 -Psa (120 mg, 0.20 mmol) was dissolved in 5 ml of dimethylformamide and silver oxide (50 mg, 0.21 nunol) and benzyl bromide (120 mg, 0.70 mraol) were added. The reaction was stirred for 1 hour and additional benzyl bromide (200 mg, 1.4 mmol) and silver oxide (40 mg, 0.42 mmol) were added during this period. The reaction was stirred for another 12 hours, after which the reaction was heated to 80-90 ° C and benzyl bromide (100 mg) and silver oxide (20 mg) were added every hour for 3 hours. The reaction was cooled to room temperature, and the filtrate was washed with ether (50 ml), filtered, and deionized water, and then with brine. The ether solution was dried over magnesium sulfate and concentrated under reduced pressure. The residue was purified by chromatography on silica gel (ethyl acetate / hexane gradient, 20:80 to 50:50) to provide 17-0-benzyl spinosin A 17-Psa (6.3 mg, 4.5%) , Is a colorless glass: FDMS m / z 618: partial NMR 5 7.41-7.36 (m, 5Η), 6.78 (bs, 1Η), 5.90 (dd, 1H), S.BKdt, 1H), 5.18 (dd, 2H); 4.90 (m, 1H), 4.86 (dd, 1H), 4.68 (m, 1H), 4.33 (q, 1H)茏 Acetyl) Φ Binoxin A 17_Psa The compound was prepared according to the procedure described in Example B46 using 3,4-dichlorophenylacetic acid (136 mg, 0.66 mmol), DMAP (70 mg, 0.57 mmol), Spinol Sin A17-psa (170 mg, 0.29 mraol), and DCC (70 mg, 0.34 mmol). The resulting 17-0- (y, m (dichlorobi ethenyl) spinoxin 8 17 bang 33 (171.2 1 ^, 76.5%) is a white solid: "Estimated value of 776, 777, 778, 779, 780, C4iH52〇Cl2 Cl2 analysis in 01 ^ 111/2: C, 63.32; H, 7 * 00; C1, 9.12. Actual values: C, 63, 37; Η -135-This paper size applies to China National Standard (CNS) Α4 specifications (2 丨 ox297 mm) 1 ~ (Please read the precautions on the back before filling this page )

、1T, 1T

487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(133) 6.91; C1, 9.31 。 靑带例R22-1 7-0-(對(H二甲基胺)苯甲醯基)客諾幸A 17-Psa 依實施例B46所述步驟製備化合物,利用2,6-二甲基 胺苯甲酸(30 mg, 0.18 mmol),DMAP (22 mg,0.18 mmol ),史賓諾辛 A17_Psa(98 mg, 0.16 mmol),及 DCC(40 mg ,0,19 mmol)。所得之17-0_(對(N,N-二甲基胺)苯甲醯基) 賓諾辛 A 17-Psa(39.5 mg, 32¾)為白色固體:FDMS ιη/ζ 777。C42H53N〇iQ 分析之估計值:C, 68.36; Η, 8.06; N, 1.90。實際值·♦ C, 68.20; Η, 8,28; N, 2.12。 啻敝例B33-17-0-(對甲氬笼甲醮基)窨諾辛A 17-Psa 依實施例B46所述步驟製備化合物,利用4-甲氧基苯 甲酸(44 mg, 0*29 mmol), DMAP (41 mg, 0·33 mmol), 史賓諾辛 A17-Psa(108 mg, 0.18 mmol),及 DCC(44 mg, 0.21 nunol)。所得之17-0-(對甲氧苯甲釀基)賓諾辛六17-Psa(101.7Iπg,76.4¾)為白色固體:FDMSπl/z 724、725。 富觖例R:U-17-0-(¾ φ酼基V客諾辛A 1 7-Psa 依實施例B46所述步驟製備化合物,利用苯甲酸(33 mg, 0:27 mmol), DMAP (28 mg, 0.23 mmol),史賓諾辛 A1 7-Psa(98 mg, 0·17 mmol),及DCC(41 mg,0.20 mmol)0 所得之17-0-(苯甲醯基)賓諾辛A 17_Psa(71.0 mg, 61.7¾ )為白色固體:FDMS m/z 695〇C4〇H54〇i〇分析之估計值:C ,69.14;11,7.83。實際值:(:,69.35;1^7.69。 窨确例對-里丙某荥申醜某)畜諾辛A 17-Psa __ - 136 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公趁) ' (請先閱讀背面之注意事項再填寫本頁)487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of Invention (133) 6.91; C1, 9.31. Example R22-1 7-0- (p- (H-dimethylamine) benzylidene) Chernosine A 17-Psa The compound was prepared according to the procedure described in Example B46, using 2,6-dimethylamine Benzoic acid (30 mg, 0.18 mmol), DMAP (22 mg, 0.18 mmol), spinoxin A17_Psa (98 mg, 0.16 mmol), and DCC (40 mg, 0,19 mmol). The resulting 17-0_ (p- (N, N-dimethylamine) benzylidene) Pinocinin A 17-Psa (39.5 mg, 32¾) was a white solid: FDMS ιη / ζ 777. Estimated value for C42H53N0iQ analysis: C, 68.36; Η, 8.06; N, 1.90. Actual values ♦ C, 68.20; Η, 8,28; N, 2.12. Example B33-17-0- (p-methylarginylmethylfluorenyl) Phenoxine A 17-Psa The compound was prepared according to the procedure described in Example B46 using 4-methoxybenzoic acid (44 mg, 0 * 29 mmol), DMAP (41 mg, 0.33 mmol), Spinozin A17-Psa (108 mg, 0.18 mmol), and DCC (44 mg, 0.21 nunol). The obtained 17-0- (p-methoxybenzyl) binnosin VI 17-Psa (101.7 Iπg, 76.4¾) was a white solid: FDMSπl / z 724, 725. Rich Example R: U-17-0- (¾ 酼 酼 V 客 V oxinoxin A 1 7-Psa The compound was prepared according to the procedure described in Example B46, using benzoic acid (33 mg, 0:27 mmol), DMAP ( 28 mg, 0.23 mmol), Spinoxin A1 7-Psa (98 mg, 0.17 mmol), and DCC (41 mg, 0.20 mmol) 0 A 17_Psa (71.0 mg, 61.7¾) is a white solid: FDMS m / z 695 ° C40H54 ° i Estimated value for analysis: C, 69.14; 11, 7.83. Actual: (:, 69.35; 1 ^ 7.69.窨 Confirmation-Li Bingmou Shen Choumou) Nuoxin A 17-Psa __-136-This paper size is applicable to China National Standard (CNS) A4 size (210X297). (Please read the precautions on the back first (Fill in this page again)

487559 經濟部中央標準局員工消費合作社印製 A7 ____ . B7 五、發明説明(134 ) 依實施例B46所述步驟製備化合物,利用4-異丙基苯 甲酸(58 mg, 0.35 mmol), DMAP (51 mg, 0·41 mmol),史 賓諾辛 A 17-Psa(129 mg, 0.21 mmol),及 DCC(80 mg, 0.38 nunol)。所得之17-0-(對-異丙基苯甲醯基)賓諾辛A 17-Psa)(33.1mg,20.5¾),為白色固體:FDMSIn/Z 736。 窖細例R^-1 7-(1-¾ 7,臓甚曹諾辛A 17-Psa 依實施例B46所述步驟製備化合物,利用苯基乙酸( 30 mg, 0.22 mmol), DMAP (4 mg, 0·34 mmol),史賓諾辛 A 17-Psa(121 mg, 0·21 mmol),及 DCC(47 mg,0*22 mmol )。所得之17-0-苯乙醯基賓諾辛A 17-Psa(86.0 rag, 59·3 t),為白色固體:FDMS m/z 分析之估計值 :C, 69·47; Η, 7·96。實際值:C, 69·28; Η, 7·94。 審胞例Β 37-17-Π -(對田氬茏乙醯基)史賓諾辛A 17_Psa 依實施例B46所述步驟製備化合物,利用4-甲氧基苯 基乙酸(39 mg, 0·23 mmol),DMAP (45 mg, 0·36 mmol), 史賓諾辛 A 17-Psa(123 mg, 0.20 mmol),及 DCC(67 mg, 0.32 mmol)。所得之17-0-(對甲氧苯乙醯基)史賓諾辛A 17-Psa(97.8 mg, 63.5¾),為白色固體:FDMS ro/z 739。 管胸例B38-17_n -(對- 基苯乙醯基)史曹諾辛A 17-Pm 依實施例B46所述步驟製備化合物,利用4-硝基聚基 乙酸(86 mg,0·47 mmol),DMAP (66 mg,0.54 mmol), 史賓諾辛 A 17-Psa(255 mg,0.43 mmol),及 DCC(100 rag, 0.48 mmo 1 )。所得之對-硝基苯乙驢基)史賓諾辛 A17-Psa(194.1, 59.6%),為白色固體:FDMS m/z 753。 _- 137 -__ 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) (請先閱讀背面之注意事項再填寫本頁)487559 A7 ____ printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. B7 V. Description of the Invention (134) The compound was prepared according to the procedure described in Example B46, using 4-isopropylbenzoic acid (58 mg, 0.35 mmol), DMAP ( 51 mg, 0.41 mmol), Spinozin A 17-Psa (129 mg, 0.21 mmol), and DCC (80 mg, 0.38 nunol). The obtained 17-0- (p-isopropylbenzyl) binoxin A 17-Psa) (33.1 mg, 20.5¾) was obtained as a white solid: FDMSIn / Z 736. Cell example R ^ -1 7- (1-¾ 7, 臓 cazonoxin A 17-Psa The compound was prepared according to the procedure described in Example B46, using phenylacetic acid (30 mg, 0.22 mmol), DMAP (4 mg , 0.34 mmol), Spinoxin A 17-Psa (121 mg, 0.21 mmol), and DCC (47 mg, 0 * 22 mmol). The resulting 17-0-phenethylbinoxin A 17-Psa (86.0 rag, 59 · 3 t), white solid: FDMS m / z analysis estimate: C, 69 · 47; Η, 7.96. Actual value: C, 69 · 28; Η, 7.94. Cell Examination Example B 37-17-Π-(p-Tyridine ethylacetinyl) Spinoxin A 17_Psa The compound was prepared according to the procedure described in Example B46 using 4-methoxyphenylacetic acid (39 mg, 0.23 mmol), DMAP (45 mg, 0.36 mmol), Spinoxin A 17-Psa (123 mg, 0.20 mmol), and DCC (67 mg, 0.32 mmol). The resulting 17-0 -(P-methoxyphenethylfluorenyl) Spinozin A 17-Psa (97.8 mg, 63.5¾) as a white solid: FDMS ro / z 739. Tube chest B38-17_n-(p-methylphenethylacetin) Based) stropoxin A 17-Pm The compound was prepared according to the procedure described in Example B46, using 4-nitropolyacetic acid (86 mg, 0.47 mmol), DMAP (66 mg, 0.54 mmol), Spinol Xin A 17-Psa (255 mg, 0.43 m mol), and DCC (100 rag, 0.48 mmo 1). The obtained p-nitrophenylethyl donkeyyl) Spinozin A17-Psa (194.1, 59.6%), as a white solid: FDMS m / z 753. _- 137 -__ This paper size applies to Chinese National Standard (CNS) A4 (21 OX 297 mm) (Please read the precautions on the back before filling this page)

,ιτ, ιτ

經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(135 )Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 V. Description of Invention (135)

CnH55N〇12分析之估計值:c,65·32; Η,7·35; Ν,1·86 。實際值:C, 65·58; Η, 7·54; H,2·05。 窨脓例7-η-(間-sa基^乙醯基i.史賓諾辛Α 17-Ρ...α 依實施例Β46所述步驟製備化合物,利用3-硝基苯基 乙酸(86 mg, (Κ37 mmol),DMAP (62 mg, 0·50 mmol), 史賓諾辛 A 17-Psa(185 mg,〇·31 mmol),及 DCC(83 mg, 0.40 mmol)。所得之17-0-(間-硝基苯乙醯基)史賓諾辛A 17 - Psa(166,l, 70.3%),為白色固體:C4iH55N〇12 分析之 估計值:C, 65.32; Η, 7·35; N,1.86。實際值:C, 65.13; H, 7.49; N, 1·92 。 管施例Β40 -17_0_(間—*▲緩甲本乙5^基)史省ife辛A 17_Psq 依實施例B46所述步驟製備化合物,利用3_三氟甲苯 基乙酸(101 mg, 〇·49 mmol),DMAP (64 mg, 0·52 mmol) ,史賓諾辛 A 17-Psa(274 mg,〇·46 mmol),及 DCC(109 mg ,0,52 mmol)。所得之〇-(間-三氟甲苯乙醯基)史賓諾辛A 17-Psa(302.2 mg, 84.6%),為白色固體:〇42心5〇1〇厂3分 析之估計值:C, 64.93; Η, 7. 14。實際值:C, 65 ♦ 07; Η ,7·39 〇 富确例Β41-17-衷-0-甲基史賓諾辛A 17-P、a 依實施例B47所述步驟製備化合物,利用17-表-史賓諾辛 A 17 - P s a (2 0 in g,〇 ♦ 〇 3 3 m m ο 1) , P「〇 t ο n S p ο n g e ®(5 ms, 0,03 mmol)及三甲基氧鑷四氟硼酸鹽(14 mg, 0.065 mmol)。所得之17-表甲基史賓諾辛A 17-Psa (7. 1 mg, 35¾),為白色固體:部分 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)Estimated value for CnH55N012 analysis: c, 65 · 32; Η, 7.35; Ν, 1.86. Actual values: C, 65 · 58; Η, 7.54; H, 2.05. Purulent Example 7-η- (meta-sayl ^ ethynyl i. Spinoxin A 17-P ... α Compounds were prepared according to the procedure described in Example B46 using 3-nitrophenylacetic acid (86 mg, (Κ37 mmol), DMAP (62 mg, 0.50 mmol), Spinoxin A 17-Psa (185 mg, 0.31 mmol), and DCC (83 mg, 0.40 mmol). The resulting 17- 0- (m-nitrophenylethylethyl) Spinosin A 17-Psa (166, l, 70.3%), white solid: C4iH55N12 Estimated value for analysis: C, 65.32; Η, 7.35 N, 1.86. Actual values: C, 65.13; H, 7.49; N, 1.92. Example of tube B40 -17_0_ (between— * ▲ 甲 甲 本 B5 ^ 基) history province ifexin A 17_Psq according to the example The compound was prepared according to the procedure described in B46, using 3-trifluorotolylacetic acid (101 mg, 0.49 mmol), DMAP (64 mg, 0.52 mmol), spinoxin A 17-Psa (274 mg, 0.005) 46 mmol), and DCC (109 mg, 0,52 mmol). The resulting 0- (m-trifluorotoluylacetamido) spinoxin A 17-Psa (302.2 mg, 84.6%) was obtained as a white solid: 〇42 Heart 5 〇10 Factory 3 analysis estimated value: C, 64.93; Η, 7. 14. Actual value: C, 65 ♦ 07; Η, 7.39 〇 Rich example B41-17- heart-0- Methyl Spinozin A 17-P, a The compound was prepared according to the procedure described in Example B47, using 17-epi-Spinoxin A 17-P sa (20 in g, 〇 ♦ 〇3 3 mm ο 1), P "〇t ο n S p ο nge ® (5 ms, 0,03 mmol) and trimethyloxy tweezer tetrafluoroborate (14 mg, 0.065 mmol). The resulting 17-epimethylspinoxin A 17-Psa (7.1 mg, 35¾ ), Is a white solid: part of the paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 mm) (Please read the precautions on the back before filling this page)

、-ιτ 487559 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(136) NMR δ 6.71 (bs, 1H), 5.88 (dd, 1H), 5.81 (dt, 1H), 4.90 (m, 1H), 4.84 (s, 1H)' 4·32 (q, 1H)' 4.77-4.62 (m, 2H)# 3.56 (s, 3H), 3.50 (s, 6H)/ 3.45 (s, 3H). 常嘛j例R42-17-D-(間-甲氯苯乙醯基)史曹諾辛A 17-Psa 依實施例B46所述步驟製備化合物,利用3-甲氧苯基 乙酸(98 mg, 〇·59 mmol),DMAP (71 mg, 0*58 mmol), 史賓諾辛 A 17-Psa(290 mg,0·49 mmol),及 DCC(112 mg ,0.54 nunol)。所得之17-0-(間-甲氧苯乙醯基)史賓諾辛 A 17_Psa(308.7 mg, 85.1¾),為白色固體:C42H58〇h 分 析之估計值·· C, 68· 27; Η, 7.91。實際值:C, 68.25; Η ,7.92 。 窨旆例Β4Π7-0-(四氣D飛喃-2-基)史窨諾辛A C-17-Psa 將史賓諾辛^\〇17砰53(0.50^0.85 111111〇1),3,4-二氫- 2H-H® 哺(0.45 mL, 0.41 g, 4.9 mmol)與 TsOH· HC1 (0.01 g, 0.05 mmol)之二氯甲烷(4 ml)溶液的溶液攪拌 24小時。混合物在乙醚及碳酸氫鈉間分配。有機層Μ鹽水 清洗,Μ硫酸鎂乾燥,過濾及蒸發。MPLC(二氧化矽,50: 50,乙醚/己烷)可得0.35 g(61%)之17-0-(四氫哌喃_2_基 )史賓諾辛A C-17-Psa,為1:1非鏡相異構物之混合物及乾 淨的無色玻璃狀物。 , 管施例Β44-17-Π-(4-硝基笼甲醯基)-17-羌-中窨諾辛A 17 z£sa 二甲基偶氮羧酸鹽(0.4 ml, 2.49 nunol)之苯溶液在2 -3分鐘内,在室溫下,添加至適當攪伴之史賓諾辛A 17- -139 - _ (請先閲讀背面之注意事項再填寫本頁)、 -Ιτ 487559 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (136) NMR δ 6.71 (bs, 1H), 5.88 (dd, 1H), 5.81 (dt, 1H), 4.90 (m, 1H), 4.84 (s, 1H) '4.32 (q, 1H)' 4.77-4.62 (m, 2H) # 3.56 (s, 3H), 3.50 (s, 6H) / 3.45 (s, 3H). Example R42-17-D- (m-Methylchlorophenethylfluorenyl) stronocin A 17-Psa The compound was prepared according to the procedure described in Example B46, using 3-methoxyphenylacetic acid (98 mg, 〇. · 59 mmol), DMAP (71 mg, 0 * 58 mmol), Spinoxin A 17-Psa (290 mg, 0.49 mmol), and DCC (112 mg, 0.54 nunol). The obtained 17-0- (m-methoxyphenethylfluorenyl) Spinozin A 17_Psa (308.7 mg, 85.1¾) was a white solid: estimated value of C42H58〇h analysis ·· C, 68 · 27; Η , 7.91. Actual value: C, 68.25; Η, 7.92. Example B4Π7-0- (Four-gas D-Franan-2-yl) SHINOXIN A C-17-Psa will be Spinoxin ^ \ 〇17bang 53 (0.50 ^ 0.85 111111〇1), 3, A solution of 4-dihydro-2H-H® (0.45 mL, 0.41 g, 4.9 mmol) and TsOH · HC1 (0.01 g, 0.05 mmol) in dichloromethane (4 ml) was stirred for 24 hours. The mixture was partitioned between ether and sodium bicarbonate. The organic layer was washed with brine, dried over magnesium sulfate, filtered and evaporated. MPLC (silicon dioxide, 50: 50, ether / hexane) yields 0.35 g (61%) of 17-0- (tetrahydropiperan_2_yl) Spinoxin A C-17-Psa, 1: 1 mixture of non-mirror isomers and clean, colorless glass. Example of tube B44-17-Π- (4-nitrocagerazinyl) -17-fluorene-midinoxine A 17 z £ sa Dimethylazocarboxylate (0.4 ml, 2.49 nunol) Add benzene solution to Spinozin A 17- -139-_ at room temperature within 2-3 minutes (Please read the precautions on the back before filling this page)

Order

本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 487559 A7 —____ B7_ 五、發明説明(137 )This paper size applies to China National Standard (CNS) A4 (210X 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 —____ B7_ V. Description of the Invention (137)

Psa((K3 g,0.51 mmol),三苯基膦(0.65 g, 2·49 mmol) 及對硝基苯甲酸(0.37 g, 2.20 mmol)之苯溶液(12 ml)。 所得溶液在室溫下攪拌48小時。去除溶劑及將殘餘物在氧 化矽(150ml)上進行閃蒸層析,利用2.5¾丙酮之二氯甲烷 溶液作為溶析液,Μ獲得110 mg 17-0-(4-硝基苯甲醯基) -17-表-史賓諾辛A 17-Psa。由2:1之丙酮/水中再结晶樣 品,該樣品為無色針狀物。mp 159-1QOC; NMR (CDC13) δ 7.32 (s, 1Η, Η-13), 5.59 (m, 1Η, Η-17), 4.97 (m, 1Η, Η-21), 4.87 (d, 1Η, Η-1·), 4.34 (m, 1H, H-9); MS m/z 740 (100)· 富施例Β45-Ϊ7-0 - (4-硝某笼7,艢某)-1 7-羌-中窨諾辛A 1 7 - Psa 將一部分1,3-二環己基碳化二亞胺(21 mg, 0.11 mm〇 1)在室溫下添加至一已適當授拌之4-硝基-苯基乳酸( 20 mg, 0.11 mmol), 4-二甲基胺基 Dtt 啶(3 mg, 0.024 mmol)及 17 -表-史賓諾辛 A-17-Psa (59 mg, 0.1 mmol)之二 氯甲烷(2 ml)溶液。所得混合物在室溫下攪拌2小時,接 著以更多二氯甲烷(2.0 ml)稀釋及濾除不溶物。蒸發滤液 及將殘餘物在氧化矽(25 ml)上進行閃蒸層析,利用25¾乙 酸乙酯之甲烷溶液為溶析液Μ獲得17-0- (4-硝基苯乙醯 , 基)-17-表-史賓諾辛A 17-Psa(70 mg),為無色發泡體: 工1{ NMR (CDCI3) δ 8.23 (d, 2H), 7.S0 (d,2H), 7.12 (s, 1H, H-13), 5.28 (m, 1H; H-17)# 4.90 (m, 1H, H-21), 4.84 (d, 1H, H-l*), 4.30 (m, 1H, H-9), 3.78 (s' 2H, CH2C〇2); MS m/z 752 (100)· 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 一 (請先閱讀背面之注意事項再填寫本頁)Psa ((K3 g, 0.51 mmol), triphenylphosphine (0.65 g, 2.49 mmol) and p-nitrobenzoic acid (0.37 g, 2.20 mmol) in benzene solution (12 ml). The resulting solution was at room temperature Stir for 48 hours. Remove the solvent and perform flash chromatography on silica (150ml) using 2.5¾acetone in dichloromethane as the eluent to obtain 110 mg of 17-0- (4-nitro Benzamidine) -17-epi-Spinoxin A 17-Psa. A sample recrystallized from acetone / water in 2: 1, the sample is a colorless needle. Mp 159-1QOC; NMR (CDC13) δ 7.32 (s, 1Η, Η-13), 5.59 (m, 1Η, Η-17), 4.97 (m, 1Η, Η-21), 4.87 (d, 1Η, Η-1 ·), 4.34 (m, 1H, H-9); MS m / z 740 (100) · Rich Example B45-Ϊ7-0-(4-Nitrogen in a cage 7, 艢 a) -1 7- 羌-中 窨 诺辛 A A 1 7-Psa will A portion of 1,3-dicyclohexylcarbodiimide (21 mg, 0.11 mm〇1) was added to a properly mixed 4-nitro-phenyllactic acid (20 mg, 0.11 mmol) at room temperature, 4 -A solution of dimethylamino Dttidine (3 mg, 0.024 mmol) and 17-epi-Spinoxin A-17-Psa (59 mg, 0.1 mmol) in dichloromethane (2 ml). The resulting mixture was placed in a chamber Stir at temperature for 2 hours, It was then diluted with more dichloromethane (2.0 ml) and filtered to remove insolubles. The filtrate was evaporated and the residue was subjected to flash chromatography on silica (25 ml) using 25¾ ethyl acetate in methane as the eluent. Μ obtained 17-0- (4-nitrophenethylhydrazone,)-17-epi-spinoxin A 17-Psa (70 mg), as a colorless foam: 1 {NMR (CDCI3) δ 8.23 (d, 2H), 7.S0 (d, 2H), 7.12 (s, 1H, H-13), 5.28 (m, 1H; H-17) # 4.90 (m, 1H, H-21), 4.84 ( d, 1H, Hl *), 4.30 (m, 1H, H-9), 3.78 (s' 2H, CH2C〇2); MS m / z 752 (100) · This paper size applies to Chinese National Standard (CNS) A4 specifications (210X 297 mm) 1 (Please read the precautions on the back before filling this page)

487559 經濟部中央標準局員工消費合作社印裝 A7 B7五、發明説明(138 ) 管敝例B46-17-0-(對_氡笼乙_基)中曹諾辛A 17-Psa 將化合物對-氯苯乙酸(50 mg, 0.29 mmol),及二甲 基胺吡啶(DMAP, 50 mg, 0·40 mmol)溶於二氯甲烷(8 ml) 及於該溶液中加入史賓諾辛A 17-Psa(164.7 mg, 0.279 mmol),並接著加入二環己基碳化二亞胺(DCC, 66 mg, 0.32 mmol)。將反應物攪拌隔夜。將反應物過濾K去除固 體及在矽膠上層析(乙酸乙酯/己烷梯度,20: 80至50: 50) Μ提供17-0-(對氯苯乙醯基)史賓諾辛A 17-Psa(128.4 mg ,61.8%),為白色固體:?〇}^111/2 743。〇411155〇1〇(:1分 析之估計值:C, 66.25; Η, 7.46。實際值:C, 65.98; Η, 7.31 ° . 審觖例B47-1 7-0-甲某中窨諾辛Α Ϊ7-Psa 將化合物史賓諾辛A 17-Psa(267 mg, 0,452 mmol)溶 於二氯甲燒(5 ml)並加人 Proton Sponge® (107 mg, 0,50 mmol)及三甲基氧鎌四氟硼酸鹽(104 mg, 0.702 nunol)。 將混合物攪拌3小時並逐漸反應形成白色绒毛狀固體)0.20 g)。固體藉由逆相層析(甲醇/水90:1)純化K提供17-0- 甲基史賓諾辛A 17-Psa(135.8 mg, 49.6%),為白色固體:1尺 (film) 2969, 2933, 2825, 1722, 1661, 1458, 1377, 1103, 1034 cnT1; 13C NMR δ 202.80, 172.31, 147.01, 143.71, 129.15, 123.73,.95.22, 82.19, 32.09, 30.86, 77.53, 76.05, 75.86, 67.75, 60.73, 53.30, 57.51, 57.33, 49.33, 47.42, 46.55, 46.11, 41.23, 40.91, 21.22, 36.11, 34.24, 30.93, 30.39, 27.88, 20.19, 17.61, 17.02, 9.19. , Π部分:胺補取代甚肉夕倏飾 富細例基中客諾辛B 於史賓諾辛Β (200 mg, 0.28 nunol)之氮仿溶液(5 ml) 中,加入二異丙基乙基胺(72.7 “ 1, 0.42 mmol)並接著 加入乙醯氯(30 μ 1 , 0.42 mmol)。反應混合物在室溫下 _ - 141 -_ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (138) Case B46-17-0- (Pair _ 氡 乙 乙 _ 基) Cao Nuoxin A 17-Psa The compound is- Chlorophenylacetic acid (50 mg, 0.29 mmol) and dimethylaminopyridine (DMAP, 50 mg, 0.40 mmol) were dissolved in dichloromethane (8 ml), and Spinoxin A 17- Psa (164.7 mg, 0.279 mmol), followed by dicyclohexylcarbodiimide (DCC, 66 mg, 0.32 mmol). The reaction was stirred overnight. The reaction was filtered to remove solids and chromatographed on silica gel (ethyl acetate / hexane gradient, 20:80 to 50:50) to provide 17-0- (p-chlorophenethylfluorenyl) Spinoxin A 17 -Psa (128.4 mg, 61.8%), as a white solid:? 〇} ^ 111/2 743. 〇411155〇1〇 (: 1 Estimated value of analysis: C, 66.25; Η, 7.46. Actual value: C, 65.98; Η, 7.31 °. Examination example B47-1 7-0-A Zhongzhong Nosin A Ϊ7-Psa Dissolve the compound Spinoxin A 17-Psa (267 mg, 0,452 mmol) in dichloromethane (5 ml) and add Proton Sponge® (107 mg, 0,50 mmol) and trimethyl oxygen Sickle tetrafluoroborate (104 mg, 0.702 nunol). The mixture was stirred for 3 hours and gradually reacted to form a white fluffy solid (0.20 g). The solid was purified by reverse phase chromatography (methanol / water 90: 1) K to provide 17-0-methyl spinosin A 17-Psa (135.8 mg, 49.6%) as a white solid: 1 foot (film) 2969 , 2933, 2825, 1722, 1661, 1458, 1377, 1103, 1034 cnT1; 13C NMR δ 202.80, 172.31, 147.01, 143.71, 129.15, 123.73, .95.22, 82.19, 32.09, 30.86, 77.53, 76.05, 75.86, 67.75, 60.73, 53.30, 57.51, 57.33, 49.33, 47.42, 46.55, 46.11, 41.23, 40.91, 21.22, 36.11, 34.24, 30.93, 30.39, 27.88, 20.19, 17.61, 17.02, 9.19., Part Ⅱ: Amine supplementation to replace meat meat evening Decorate the rich and detailed example of Kenosin B in Spinozin B (200 mg, 0.28 nunol) in a solution of nitrogen (5 ml) and add diisopropylethylamine (72.7 "1, 0.42 mmol) And then add acetyl chloride (30 μ 1, 0.42 mmol). The reaction mixture at room temperature _-141 -_ This paper size applies to China National Standard (CNS) A4 size (210X297 mm) (Please read the note on the back first) (Fill in this page again)

、1T', 1T '

487559 Α7 Β7 經濟部中央標準局員工消費合作社印製 五、發明説明(139) 攪拌0.5小時。混合物接著Μ二氯甲烷稀釋及以飽和碳酸 氫納稀釋。將二氯甲烷部分以碳酸鉀乾燥,及在室溫及減 壓下蒸發。產物藉由在氧化矽上層析而純化,以5¾甲醇之 二氯甲烷溶液溶析。可得N-乙醯基史賓諾辛B(239 nig,約 100¾產率),為無色玻璃體,FDMS, πι/e,(相對強度)759 ( M+-H, 10), 714 (60), 189(50), 170(50), 101(100)。 富_例(:2-眇笼甲醯某中窨諾辛B 依實施例C1所述步驟進行反應,史賓諾辛B(200 mg ,0.28 mmol)及苯甲醯氯為起始物質。所得N-苯甲醜基史 賓諾辛B(227.4 mg,約100¾產率),為淺黃色玻璃狀體, FDMS, m/e (相對強度)821 (M+-H, 5), 776 (20), 232 ( 30) , 189 (35) , 103 (100)。 啻敝例m烯丙基中窨諾辛B 依實施例C1所述步驟進行反應,史賓諾辛B(200mg, 0.28 mmo 1)及溴化烯丙基為起始物質。將反應物在室溫下 授拌4天,接著在室溫及減壓下蒸發,及40¾乙酸乙酯之己 烷溶液係用作層析溶析液。所得之烯丙基史賓諾辛B ( 148.9 mg, 70%產率)為無色玻璃狀物,FDMS, m/e (相對 強度)757 (M+-H, 100)。 啻倫例甲基中窨諾辛B 依實施例C1所述步驟進行反應,以史賓諾辛B(200mg, 0.28 mmol)及溴化苄為起始物質。所得之N-苯甲基史賓諾 辛B(216.6 mg, 96¾產率)為無色玻璃狀物,FDMS, ra/e ( 相對強度)807 (Μ^Η, 100)。 -142 - (請先閱讀背面之注意事項再填寫本頁)487559 Α7 Β7 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (139) Stir for 0.5 hours. The mixture was then diluted with M dichloromethane and diluted with saturated sodium bicarbonate. The methylene chloride portion was dried over potassium carbonate and evaporated at room temperature under reduced pressure. The product was purified by chromatography on silica and eluted with 5¾ methanol in dichloromethane. N-Ethylspinoxin B (239 nig, about 100¾ yield) is obtained as a colorless vitreous body, FDMS, π / e, (relative strength) 759 (M + -H, 10), 714 (60), 189 (50), 170 (50), 101 (100). Enrichment example: (2) Cinnamoxib, a certain midoxinoxine B was reacted according to the procedure described in Example C1. Spinoxin B (200 mg, 0.28 mmol) and benzamidine chloride were used as starting materials. N-benzyl spinyloxin B (227.4 mg, about 100¾ yield), pale yellow glassy body, FDMS, m / e (relative strength) 821 (M + -H, 5), 776 (20), 232 (30), 189 (35), 103 (100). For example, m-Allyl was treated with oxoxin B according to the procedure described in Example C1. Spinoxin B (200 mg, 0.28 mmo 1) and The allyl bromide was the starting material. The reaction was stirred at room temperature for 4 days, then evaporated at room temperature and under reduced pressure, and a hexane solution of 40¾ ethyl acetate was used as the chromatographic eluate. The obtained allyl spinoxin B (148.9 mg, 70% yield) was a colorless glass, FDMS, m / e (relative strength) 757 (M + -H, 100). Acetone B was reacted according to the procedure described in Example C1. Spinoxin B (200 mg, 0.28 mmol) and benzyl bromide were used as starting materials. The obtained N-benzyl spinosin B (216.6 mg, 96¾) Yield) is a colorless glass, FDMS, ra / e (relative strength) 807 (Μ ^ Η, 100). -14 2-(Please read the notes on the back before filling this page)

、1Τ1T

本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 487559 A7 B7 經濟郎中央樣參局員工消費合作社印製 五、發明説明(140 ) 富_例「R-N-甲基中窨諾辛A碘化物 於史賓諾辛Α(111·6 mg, 0·15 mmol)之氯仿(5 ml) 溶液,添加甲基碘(200^ Π。在室溫下攪拌反應混合物24 小時接著再加入甲基碘(200 ^1),及在室溫下再攪丨半反應 混合物24小時。接著在室溫及減壓下蒸發溶劑及Μ乙醚壓 研殘餘物。所得之Ν-甲基史賓諾辛Α碘化物(101 mg, 76¾ 產率),為白色偏離固體,FDMS, m/e (相對強度)747 (M + ,100) 0 蜜腧例氢基史曹諾辛A 於81.2%純史賓諾辛以2*07 3111,2.83 111111〇1)之二氯 甲烷(100 ral)的冰冷卻溶液,添加間-氯過氧苯甲酸(450 mg, 2.57 mmol)。使反應混合物升溫至室溫1小時,及接 著於室溫下攪拌反應混合物5小時。藉由添加碳酸氫鈉溶 液使反應物驟冷。分雛有機相,以硫酸鎂乾燥,及在室溫 及減壓下蒸發。藉由在氧化矽上層析純化產物,M10%甲 醇之二氯甲烷溶液進行溶析。所得之N-氧基史賓諾辛A ( 1.59 gm, 92¾產率),Μ淺黃色玻璃狀物,FDMS, m/e (相 對強度)762.9 (20), 731·8(Μ〜0, 40), 686·8 (100), 401.7 (25)。 啻输例禪基Φ窨諾辛A 反應依實施例C13所述進行反應,MN-氧基史寳諾辛 Α(509·8 mg, 0.68 mmol)為起始物質。於反應中形成白色 沈澱及藉由過濾分離。沈澱物接著Μ乙醚壓研。在室溫及 減壓下蒸發乙醚及將殘餘物溶於甲醇(20 οι 1)並加人硼氬 -143 - (請先閱讀背面之注意事項再填寫本頁) -裝·This paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 487559 A7 B7 Printed by Economic Consumers Central Sample and Staff Bureau Consumer Cooperatives V. Description of the invention (140) Rich _ Example "RN-Methyl Zano Acetone A iodide in Spinoxin A (111 · 6 mg, 0 · 15 mmol) in chloroform (5 ml), methyl iodide (200 ^ Π was added. The reaction mixture was stirred at room temperature for 24 hours and then added Methyl iodide (200 ^ 1), and stirred at room temperature for a further half of the reaction mixture for 24 hours. Then the solvent was evaporated at room temperature under reduced pressure and the residue was triturated with ethyl ether. The resulting N-methyl spinoline Octane A iodide (101 mg, 76¾ yield), white deviation from solid, FDMS, m / e (relative strength) 747 (M +, 100) 0 Melamine Example Hydrogenated Schistoxin A at 81.2% pure Spinolol The ice-cooled solution of 2 * 07 3111, 2.83 111111〇1) in dichloromethane (100 ral) was added, and m-chloroperoxybenzoic acid (450 mg, 2.57 mmol) was added. The reaction mixture was allowed to warm to room temperature for 1 hour. And then the reaction mixture was stirred at room temperature for 5 hours. The reaction was quenched by the addition of sodium bicarbonate solution. The organic phase was separated and sulfur was added. The magnesium acid was dried, and evaporated at room temperature under reduced pressure. The product was purified by chromatography on silica, and eluted with M10% methanol in dichloromethane. The resulting N-oxyspinoxin A (1.59 gm , 92¾ yield), M light yellow glass, FDMS, m / e (relative strength) 762.9 (20), 731.8 (M ~ 0, 40), 686.8 (100), 401.7 (25). The following example was performed: The reaction was performed as described in Example C13, and MN-oxysporoxin A (509 · 8 mg, 0.68 mmol) was used as the starting material. A white precipitate was formed during the reaction. Separated by filtration. The precipitate was then triturated under ether. The ether was evaporated at room temperature under reduced pressure and the residue was dissolved in methanol (20 οι 1) and added with boron argon-143-(Please read the precautions on the back before (Fill in this page)

、1T, 1T

本纸張尺度適用中國國家標準(CNS ) Α4規格(21〇:&lt; 297公t ) 487559 A7 B7 五、發明説明(1^) 經 ★ 部 t矣 標 準 局 員 工 消 合 作 社 印 製 化納(258 mg, 6.82 mmol)及將反應混合物在室溫下攪拌7 小時。混合物接著在室溫及減壓下蒸發至小體積及K乙醚 稀釋。以水、鹽水清洗乙醚部分,K碳酸鉀乾燥及在室溫 及減壓下蒸發。在氧化矽上藉由層析分離產物,Μ70ΪΚ乙 酸乙酯之己烷溶液進行溶析。所得4”-羥基史賓諾辛A( 92.1 mg, 19¾產率),為無色玻璃狀物,為3:1異搆混合物 ,FDMS, ra/e (相對強度)704 (M、80), 591 (30), 190 ( 70) , 115 (100)。 富旅例C8-3” . 4”-二氫-4”-脫胺中W諾辛C N-氧基史賓諾辛A(505.9 nig, 0.68 mmol)在氮氣下加 熱至120°C。氣體在115°C下開始釋出,並繼續加熱直室氣 體停止釋出(約15分鐘)。接著將混合物媛慢冷卻至室溫。 在氧化矽上藉由層析分雛產物,K 5%甲醇之二氯甲烷溶液 溶析。所得3”,4”-二氫-4”-脫胺史賓諾辛C(91 mg, 19¾產 率),FDMS, m/e (相對強度)696 (M+, 80), 589 (20), 189 (50), 101 (100), 甲醯基史賓諾辛 B(43.3 mg; 9¾ 產率),史賓諾辛M102.1 mg; 21¾產率),及史賓諾辛B( 114.5 ms; 23¾產率),所有皆為無色玻璃狀物。 啻敝例C9-N - (fT -苄基-3-㈣丨股甲基)Φ嘗諾辛C 於史賓諾辛C(213.6 mg, 0.3 nunol)之甲醇(2 ml)溶 液中,加入N-苄基-3-吲哚羧基醛(83.7 mg, 0.36 mmol) 。在室溫下攪拌反應混合物20小時,並加入氰基硼氬化納 (43.5 mg, 0.7 ππηοΐ)。在室溫下再授拌2小時。TLC (以10 %甲醇之二氯甲烷溶液溶析)顯示反應不完全,然而,在室 -144 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 裝· 、1ΤThis paper size applies to China National Standard (CNS) A4 specifications (21〇: &lt; 297 g t) 487559 A7 B7 V. Description of the invention (1 ^) Printed by the Ministry of Standards, Bureau of Standards and Consumers Cooperative (258) mg, 6.82 mmol) and the reaction mixture was stirred at room temperature for 7 hours. The mixture was then evaporated to a small volume at room temperature under reduced pressure and diluted with K ether. The ether portion was washed with water, brine, dried over potassium carbonate and evaporated at room temperature under reduced pressure. The product was separated by chromatography on silica and the hexane solution of M70ΪK ethyl acetate was eluted. The obtained 4 ”-hydroxyspinoxin A (92.1 mg, 19¾ yield) is a colorless glass, a 3: 1 isomeric mixture, FDMS, ra / e (relative strength) 704 (M, 80), 591 (30), 190 (70), 115 (100). Rich travel example C8-3 ". 4" -dihydro-4 "-deamine W-nosin C N-oxyspinoxin A (505.9 nig, 0.68 mmol) was heated to 120 ° C under nitrogen. The gas began to release at 115 ° C, and continued to heat the chamber gas to stop the release (about 15 minutes). The mixture was then slowly cooled to room temperature. The product was separated by chromatography on silica, K 5% methanol in dichloromethane. The obtained 3 ”, 4” -dihydro-4 ”-deamine spinosynox C (91 mg, 19¾ yield), FDMS, m / e (relative strength) 696 (M +, 80), 589 (20), 189 (50), 101 (100), formamyl spinosin B (43.3 mg; 9¾ yield), spinosin M102.1 mg; 21¾ yield), and spinosin B (114.5 ms; 23¾ yield), all of them are colorless glass. 啻 敝 Example C9-N-(fT -benzyl-3-㈣ 丨 share methyl) Φ Trioxin C in Spinoxin C (213.6 mg, 0.3 nunol) in methanol (2 ml), N-benzyl-3-indole carboxylic aldehyde (83.7 mg, 0.36 mmol) was added. The reaction mixture was stirred at room temperature for 20 hours, and sodium cyanoborohydride ( 43.5 mg, 0.7 ππηοΐ). Incubate for another 2 hours at room temperature. TLC (dissolved in 10% methanol in dichloromethane solution) showed incomplete reaction. However, in the chamber -144-Chinese paper standard applies to this paper size. (CNS) Α4 specification (210X 297mm) (Please read the precautions on the back before filling in this page)

經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(142 )Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 V. Description of Invention (142)

溫及減壓下蒸發溶劑至小體積。接著Μ二氯甲烷稀釋混合 物。以水、鹽水清洗二氯甲烷部分,Κ碳酸鉀乾燥及在室 溫及減壓下蒸餾。在氧化矽上藉由層析分離產物,M7(U 乙酸乙酯之己烷溶液溶析。所得之N-(N、苄基跺甲 基)史賓諾辛C(83.8 mg, 30¾產率),為淡黃色玻璃狀物, FDMS, m/e (相對強度)1140 (15), 923 (M、100)。 啻施例C10-H-去甲基甲_基中曹諾辛J 於史賓諾辛J(990.4 mg, 1.38 ππηοΐ)之無水二氯甲烷 (25 ml)溶液中,加厶Ptt啶鍾重鉻酸鹽(622.6 mg, 1.65 mmol)。反應混合物在室溫下授拌3.75天及接著經由矽藻 土過濾。K新鮮二氯甲烷清洗矽藻土。合併二氯甲烷部分 並在室溫及減壓下蒸發二氯甲烷。在氧化矽上藉由層析分 離產物,Μ乙酸乙酯溶析。所得之N-去甲基-N-甲醯基史 賓諾辛J(360 mg, 36¾產率),為白色固體,EIMS, ro/e ( 相對強度)732 (M+, 40), 715 (100), 175 (20), 101 ( 25) 〇 蜜施例Π 1-N-苄基中W諾辛A痗ih翰 反應依實施例C5所述進行反應,Μ史賓諾辛A(100 mg, 0,14 mmol)及溴化苄基為起始物質,並迴流6天。所 得之苄基史賓諾辛A溴化鹽(86.6 mg, 69¾產率.),為一白 色偏離固體,FDMS, m/e (相對強度)976 (10), 822 (Mf ,100) , 189 (60) , 142 (100)。The solvent was evaporated to a small volume under mild reduced pressure. The mixture was then diluted with M dichloromethane. The dichloromethane portion was washed with water, brine, dried with potassium carbonate, and distilled under reduced pressure at room temperature. The product was separated by chromatography on silica, M7 (U ethyl acetate in hexane solution. The resulting N- (N, benzylfluorenylmethyl) spinosin C (83.8 mg, 30¾ yield) , Is a light yellow glass, FDMS, m / e (relative strength) 1140 (15), 923 (M, 100). 啻 Example C10-H-desmethylformyl group Cao Nuoxin J Yu Shibin To a solution of Nosin J (990.4 mg, 1.38 ππηοΐ) in anhydrous dichloromethane (25 ml) was added Pt-pyridinium dichromate (622.6 mg, 1.65 mmol). The reaction mixture was stirred at room temperature for 3.75 days and It was then filtered through celite. K was washed with fresh methylene chloride. The methylene chloride portions were combined and the methylene chloride was evaporated at room temperature under reduced pressure. The product was separated by chromatography on silica, ethyl acetate. Eluate. The obtained N-desmethyl-N-methylspinyl spinosin J (360 mg, 36¾ yield) is a white solid, EIMS, ro / e (relative strength) 732 (M +, 40), 715 (100), 175 (20), 101 (25) 〇 Example No. 1-N-benzyl in the W-Nosin A 痗 ih Han reaction was carried out as described in Example C5, M Spinoxin A (100 mg, 0,14 mmol) and benzyl bromide as starting materials, and refluxed for 6 days. The obtained benzyl spinosin A bromide (86.6 mg, 69¾ yield.) Was a white off solid, FDMS, m / e (relative strength) 976 (10), 822 (Mf, 100), 189 ( 60), 142 (100).

窨細例去甲基-(二甲基防)-4”-氮雜環丙烯S中曹 諾辛A ________- 145 -_ 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 % 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(143 ) 於史賓諾辛C(205.2 mg, 0.29 mmol)之乙腈(2 ml)溶 液,加入一氯乙醛(39,1 mg, 0.62 mmol)。在室溫下攪拌 反應混合物2天。逆相HPLC(M4«乙請、44¾甲醇及12¾ ( 0.5¾乙酸銨溶液溶析)顯示反應不完全。混合物接著Μ食包 和碳酸氫納溶液稀釋並Μ二氯甲烷萃取。二氯甲烷部分接 著Μ鹽水清洗,Μ碳酸鉀乾燥及在室溫及減壓下蒸發,所 得之無色玻璃狀物(199 mg)。藉由製備型HPLC在C18管柱 上分離產物,Μ乙睛··甲醇:0.1¾乙酸銨(35 :35:30至45: 45 :10之90分鐘線形梯度溶析)。所得之4”-去甲基-(二甲基 胺)-4”_氮雜環丙烯基史賓諾辛A(30 mg, 1«產率),為白 色固體,EIMS, m/e (相對強度)729 (M' 100)。 啻施例C12-4”-去甲基二甲基防)-4”-氬基中窨諾辛A 於N-氧基史賓諾辛A(203.8 mg, 0.27 mniol)之苯(10 ml)溶液,加入乙酸酐(500 ml)。反應混合物在室溫下授 拌5天。混合物接著在室溫及減壓下蒸發。殘餘物(於室溫 靜置6天後)藉由在氧化矽上層析K分離,Μ 2 . 5¾甲醇之二 氯甲烷溶析。所得之a) 4”-去甲基二甲基胺)-4”-氧基史 賓諾辛A(59.9 mg, 32¾產率),為不安定無色玻璃狀物, FDMS, m/e (相對強度)704 (MH、10), 592 (90), 190( 95), 101 (100),及化合物b)N-乙醯基史賓諾辛B(69.2 mg ,34¾產率),為無色玻璃狀物。 啻_例(:14-)^-^-甲基胺某甲臟某)中曹諾辛8 史賓諾辛B化合物(200 mg, 0.278 mmol)與異氮酸甲 ____- 146 - _- 本纸張尺度適用中國國家標準(CNS ) A4規格(2丨〇&gt;&lt;297公釐) (請先閱讀背面之注意事項再填寫本頁)窨 Detailed examples of demethyl- (dimethyl-prevent) -4 ”-azacyclopropene S. Caoxin A ________- 145 -_ This paper size applies to the Chinese National Standard (CNS) Λ4 specification (210X 297 mm) (Please read the precautions on the back before filling out this page) Order% 487559 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (143) Acetonitrile in Spinozin C (205.2 mg, 0.29 mmol) (2 ml) solution, monochloroacetaldehyde (39,1 mg, 0.62 mmol) was added. The reaction mixture was stirred at room temperature for 2 days. Reverse-phase HPLC (M4 «Ethyl, 44¾ methanol and 12¾ (0.5¾ ammonium acetate solution) Dissolution) showed that the reaction was incomplete. The mixture was then diluted with sodium bicarbonate solution and sodium bicarbonate solution and extracted with dichloromethane. The dichloromethane part was washed with brine, dried with potassium carbonate and evaporated at room temperature under reduced pressure. It is a colorless glass (199 mg). The product was separated on a C18 column by preparative HPLC. M ethyl acetate · methanol: 0.1¾ ammonium acetate (35:35:30 to 45:45:10 90 minutes linear Gradient elution). The obtained 4 ”-desmethyl- (dimethylamine) -4” _azacyclopropenyl spinoxin A (30 mg , 1 «yield), as a white solid, EIMS, m / e (relative strength) 729 (M '100). 啻 Example C12-4" -desmethyldimethylprene) -4 "-argon Panaxine A in benzene (10 ml) solution of N-oxyspinoxin A (203.8 mg, 0.27 mniol), and acetic anhydride (500 ml) was added. The reaction mixture was stirred at room temperature for 5 days. The mixture was then stirred at Evaporate at room temperature and under reduced pressure. The residue (after standing at room temperature for 6 days) was separated by chromatography on silica with K and M 2. 5¾ methanol in dichloromethane. The resulting a) 4 ”- Demethyldimethylamine) -4 ”-oxyspinoxin A (59.9 mg, 32¾ yield), a restless, colorless glass, FDMS, m / e (relative strength) 704 (MH, 10) , 592 (90), 190 (95), 101 (100), and compound b) N-acetylspinoloxin B (69.2 mg, 34¾ yield), which is a colorless glass. 例 _Example (: 14 -) ^-^-Methylamine, methylamine, and some) Caoxoxin 8 Spinoxin B compound (200 mg, 0.278 mmol) and methyl isocyanate ____- 146-_- This paper is applicable to China National Standard (CNS) A4 Specification (2 丨 〇 &lt; 297 mm) (Please read the precautions on the back before filling in this page)

487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(144) 酯(0.30 g, 5,26 mmol)合併於1〇 ml甲苯中及將混合物在 室溫下攪拌3天。反應混合物在乙醚/水間分配並分層。經 萃取之水層以3X25 ml乙醚萃取並合併乙醚萃取物。以5 m 1鹽水溶液清洗乙醚萃取物,K無水硫酸鎂乾燥及在減壓 下濃縮。殘餘物利用中等壓力之氧化矽管柱(230-400 in, 二氯甲院:甲醇,9 5 : 5 , v / v)層析Μ獲得N - (N ’ -甲基胺基 甲醯基)史賓諾辛B(0.14 g, 之元素分487559 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (144) Esters (0.30 g, 5,26 mmol) were combined in 10 ml of toluene and the mixture was stirred at room temperature for 3 days. The reaction mixture was partitioned between ether / water and the layers were separated. The extracted aqueous layer was extracted with 3 × 25 ml of ether and the ether extracts were combined. The ether extract was washed with 5 ml of a saline solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was chromatographed on a silica column (230-400 in, dichloromethane: methanol, 95: 5, v / v) under moderate pressure to obtain N- (N'-methylaminomethylmethyl). Spinozin B (0.14 g, elemental fraction

析:估計值 C, 65.09; Η, 8.31; N 3.31;實際值 C, 64.80; Η, 8.31; Η, 3.34; FAB MS (m/z) 775 (M + 1) 〇 窖細例Cl 5-N-甲烷碏蹢甚中客諾辛B 將史賓諾辛B化合物(200 mg, 0.279 mmol)溶於5rol二 氯甲烷中,並添加甲烷磺醯氯(0.11 0.96 mmol)及二 異丙基乙基胺(0.13 g, 1.00 mmol)。在室溫下攪拌2小時 ,接著倒入乙醚及水各10 ml。產生分層並M2 X 10 ml水 萃取水層。合併乙醚萃取液,以10 ml鹽水溶液清洗,K 硫酸鎂乾燥,並在減壓下濃縮。所得殘餘物在中等壓力之 氧化矽管柱(230-400 m,二氯甲烷:甲醇,95:5,v/v) 中層析K獲得化合物N-甲烷磺醯基史賓諾辛B(0.14 g, 63 SOcCuHssNOhS 之元素分析:估計值 C, 61.86; Η, 8.23 i_N 1.76;實際值 C, 61·73; Η, 7·83; Ν, 1.65。Analysis: Estimated value C, 65.09; Η, 8.31; N 3.31; Actual value C, 64.80; Η, 8.31; Η, 3.34; FAB MS (m / z) 775 (M + 1) 〇 Example of cell Cl 5-N -Methocarbinol B, Spinoxin B (200 mg, 0.279 mmol) was dissolved in 5rol dichloromethane, and methanesulfonyl chloride (0.11 0.96 mmol) and diisopropylethyl were added. Amine (0.13 g, 1.00 mmol). Stir at room temperature for 2 hours, then pour 10 ml of ether and water each. The layers were generated and the aqueous layer was extracted with M2 X 10 ml water. The ether extracts were combined, washed with 10 ml of a saline solution, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was chromatographed in a silica column (230-400 m, dichloromethane: methanol, 95: 5, v / v) under moderate pressure to obtain compound N-methanesulfonylspinoxin B (0.14 g). Element analysis of SOcCuHssNOhS, 63: estimated value C, 61.86; Η, 8.23 i_N 1.76; actual value C, 61 · 73; Η, 7.83; Ν, 1.65.

啻例C16-N-Z氯基羰基中客諾垒R 將史賓諾辛B化合物(214 mg, 0.298 mmol)溶於5 ml 二氯甲烷並加入氯甲酸乙酯(0.15 g, 0.14 mmol)與二異 丙基乙基胺(0.12 g, 0.93 mmol)。將反應物在室溫下搅 -147 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公f ) (請先閱讀背面之注意事項再填寫本頁)Example C16-NZ Chlorinyl R in chlorocarbonyl group Spinoloxin B compound (214 mg, 0.298 mmol) was dissolved in 5 ml of dichloromethane and ethyl chloroformate (0.15 g, 0.14 mmol) was added with diiso Propylethylamine (0.12 g, 0.93 mmol). Stir the reactants at room temperature -147-This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 male f) (Please read the precautions on the back before filling this page)

、1T 經濟部中央標準局負工消費合作社印製 487559 A7 B7 五、發明説明(145 )Printed by 1T Central Laboratories of Ministry of Economic Affairs and Consumer Cooperatives 487559 A7 B7 V. Description of Invention

拌2小時。將反應物倒入10 ml水/10 ml乙醚並分層。M2 X 10 ml乙醚萃取水層。合併乙醚萃取物及Μ 10 ml飽和碳 酸氫納清洗並接著Μ 10 in 1鹽水清洗。將乙醚溶液以無水 硫酸鎂乾燥,過濾及在減壓下濃縮。在中等壓力之氧化矽 管柱(230-400 in,二氯甲烷:甲醇,95:5, ν/ν)層析Μ獲得 Ν-乙氧基羰基史賓諾辛B(〇.19 g, 80¾)。C43Hb7N〇12之元 素分析··估計值C, 65·38; Η, 8.55; Ν 1·77;實際值C, 64,80; Η, 8.53; Ν, 1.24; FAB MS (m/z) 790 (M + l) 〇 富瓶例C17-N-三氟甲基基史嘗諾辛B 將史賓諾辛B化合物(118.9 mg, 0.165 mmol)溶於5 ml二氯甲烷並添加二異丙基乙基胺(0.10 g, 0.77 mmol) 及三氟乙酸酐(0·10 g, 〇·48 mmol)。將反應物在室溫下 攪拌20小時。將反應物倒入乙醚/飽和碳酸鈉溶液中並分 層。M2X 10 ml乙醚萃取水層。合併乙醚萃取物及K30 m 1鹽水溶液清洗萃取物,K無水硫酸鎂乾燥,及在減壓下 濃縮。在中等壓力之氧化矽管柱(230-400 ro,二氯甲烷/己 烷,40:60, v/v)層析K獲得化合物N-三氟甲基乙醯基史 賓諾辛8。〇42^2川11「3元素分析:估計值C, 61·97; H, 7·52; Ν 1·31;實際值 C,(30.88; Η, 7.60; Ν, 1·46; FAB MS (m/z)813(M+l)。Stir for 2 hours. The reaction was poured into 10 ml of water / 10 ml of ether and the layers were separated. The aqueous layer was extracted with M2 X 10 ml ether. The ether extracts were combined and washed with 10 ml of saturated sodium bicarbonate followed by M 10 in 1 brine. The ether solution was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Chromatography on a medium pressure silica column (230-400 in, dichloromethane: methanol, 95: 5, v / v) to obtain N-ethoxycarbonyl spinosyn B (0.19 g, 80¾ ). Elemental analysis of C43Hb7N012 · Estimated value C, 65 · 38; Η, 8.55; Ν 1.77; actual value C, 64,80; Η, 8.53; Ν, 1.24; FAB MS (m / z) 790 ( M + l) 〇 Rich bottle example C17-N-trifluoromethyl histanosin B. Spinoxin B compound (118.9 mg, 0.165 mmol) was dissolved in 5 ml dichloromethane and diisopropylethyl was added. Amine (0.10 g, 0.77 mmol) and trifluoroacetic anhydride (0.10 g, 0.48 mmol). The reaction was stirred at room temperature for 20 hours. The reaction was poured into an ether / saturated sodium carbonate solution and the layers were separated. The aqueous layer was extracted with M2X 10 ml ether. The ether extract and the K30 ml 1 saline solution were combined to wash the extract, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. Chromatography K on a medium pressure silica column (230-400 ro, dichloromethane / hexane, 40:60, v / v) yielded the compound N-trifluoromethylacetamido binoxin 8. 〇42 ^ 2 Sichuan 11 "3 element analysis: estimated value C, 61 · 97; H, 7.52; Ν 1.31; actual value C, (30.88; Η, 7.60; Ν, 1.46; FAB MS ( m / z) 813 (M + 1).

啻胞例C18-N -串艢基中W諾辛B 將史賓諾辛B化合物(107.3 mg, 0.150 ίππιοί)添加至 10.0 ml甲酸乙酯及將混合物加熱至迴流溫度。在迴流溫 度下1小時後,將反應物冷卻至室溫並於減壓下去除溶劑 本紙張尺度適用中國國家標準(CNS ) A4規格(210X2()7公螯) (請先閱讀背面之注意事項再填寫本頁)Cell Example C18-N-Pyridoxine W-Nosin B Add the Spinoxin B compound (107.3 mg, 0.150 Γπιοί) to 10.0 ml of ethyl formate and heat the mixture to reflux temperature. After 1 hour at reflux temperature, cool the reactants to room temperature and remove the solvent under reduced pressure. The paper size is applicable to Chinese National Standard (CNS) A4 specifications (210X2 () 7 male chelate) (Please read the precautions on the back first) (Fill in this page again)

487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(146 )487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of Invention (146)

。在中等壓力之氧化矽管柱(230-400 πι,二氯甲烷/甲醇9 5:5, v/v)層析Μ獲得化合物卜甲醯基史賓諾辛B; 103.1 mg, 92,3%。〇41^:^〇11元素分析:估計值 C,66.02;H, 8.51; Ν 1·88;實際值 C, 64.67; Η, 8·75; Ν, 2·03; FAB MS (m/z) 745 (M + l)〇 窖_例CIQ-N-flg基甲醯某申窨諾辛C 將氰酸銀(3.7 g, 24 mmol)懸浮於10 ml苯中並加入 四氯化矽(1 g , 5.8 ιηπιο 1)。反應立即改變顏色,由淺灰 至深紫色懸浮液。加熱反應物至迴流溫度1小時,冷卻至 室溫並濾除任何固體。濾液在減壓下濃縮K獲得無色油狀 之四氰酸矽。溶解所有四氰酸矽於10 ml苯中並加入化合 物史賓諾辛C(93mg, 0.132 ππποί)於2ml苯中之溶液。將所 得溶液加熱至迴流溫度30分鐘。將反應物冷卻至室溫並於 減壓下濃縮。將20 in 190¾異丙醇/水添加至殘餘物中並將 反應加熱至迴流溫度30分鐘。冷卻至室溫並於減壓下濃縮 。殘餘物懸浮於二氯甲烷並過濾K去除固體。殘餘物在重 力氧化矽管柱(230-400 m,二氯甲烷/甲醇95:5, v/v)層 析以獲得化合物胺基甲醯基史賓諾辛C(28.2 mg, 28.6¾ )〇C4i)Hs2N2〇ii 元素分析:估計值 c, 64·32; Η, 8·37; N 3·75;實際值 C, 64.04; Η, 8.12; Ν, 4.04;FAB MS (m/ z) 746 (M.l)。 啻倫例C20-N-三氣申碏臓基中客 將史賓諾辛B化合物(136 mg, 0.189 mmol)溶於5 ml二氯甲烷並添加二異丙基乙基胺(0.10 g, (K77 ramol) -149 - 本紙張尺度適用中國國家標孪(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁). Chromatography on a medium pressure silica column (230-400 μm, dichloromethane / methanol 9 5: 5, v / v) to obtain the compound dimethoxenyl spinosin B; 103.1 mg, 92,3%. 〇41 ^: ^ 〇11 Elemental analysis: estimated value C, 66.02; H, 8.51; Ν 1.88; actual value C, 64.67; Η, 8.75; Ν, 2.03; FAB MS (m / z) 745 (M + l). Example: CIQ-N-flg methyl formamidine Shenuoxin C. Silver cyanate (3.7 g, 24 mmol) was suspended in 10 ml of benzene and silicon tetrachloride (1 g , 5.8 ιηπιο 1). The reaction changed color immediately, from light gray to dark purple suspension. The reaction was heated to reflux temperature for 1 hour, cooled to room temperature and any solids were filtered off. The filtrate was concentrated under reduced pressure to obtain silicon tetracyanate as a colorless oil. Dissolve all silicon tetracyanate in 10 ml of benzene and add a solution of the compound Spinozin C (93 mg, 0.132 ππποί) in 2 ml of benzene. The resulting solution was heated to reflux temperature for 30 minutes. The reaction was cooled to room temperature and concentrated under reduced pressure. 20 in 190¾ isopropanol / water was added to the residue and the reaction was heated to reflux temperature for 30 minutes. Cool to room temperature and concentrate under reduced pressure. The residue was suspended in dichloromethane and filtered to remove solids. The residue was chromatographed on a gravity silica column (230-400 m, dichloromethane / methanol 95: 5, v / v) to obtain the compound aminoformyl spinoxin C (28.2 mg, 28.6¾). ) Hs2N2〇ii elemental analysis: estimated value c, 64 · 32; Η, 8.37; N 3.75; actual value C, 64.04; Η, 8.12; Ν, 4.04; FAB MS (m / z) 746 (Ml ). Example: C20-N-Sanqi Shenjiji Dissolve Spinoxin B compound (136 mg, 0.189 mmol) in 5 ml of dichloromethane and add diisopropylethylamine (0.10 g, ( K77 ramol) -149-This paper size is applicable to China National Standard (CNS) A4 (210X 297mm) (Please read the precautions on the back before filling this page)

487559 經濟部中央標準局員工消費合作社印製487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs

A7 B7 五、發明説明(147 ) 及三氟甲磺酸酐(〇.1〇 g, 0,3 5 ππηοΐ)。將反應物在室溫 下攪拌1小時。將反應物倒入乙醚/飽和碳酸納各20m 1之溶 液中。分層並Μ 2 X 10 in 1乙醚萃取水層。合併乙醚萃取物 及Κ 25 m 1鹽水溶液清洗萃取物,Μ無水硫酸鎂乾燥,及 在減壓下濃縮。在中等壓力之氧化矽管柱(230-400 m,二 氯甲烷/己烷,50:50, v/v)層析K獲得化合物N-三氟甲磺 醯基史賓諾辛8。〇41心2_12$「3元素分析:估計值(:, 57·94; Η,7·35; N 1.65;實際值 C,58.07; H, 7.52; 1.70;FAB MS (ιη/ζ) 849 (Μ + 1)。 實施例C2卜中窨諾宰A (E)-丙-1 &quot;Μ:希酪卜:Τ-銨翰.及 乙基f中W諾辛B 甲基(Z)-丙烯酸卜 3W-銨鹽 將史賓諾辛A化合物(0.68 g, 0.929 mmol)溶於二氯 甲烷(3 ml)並添加水(50 ml)。混合物在0¾下攪拌並加入 一部分丙酸乙酷(Aldrich, 2.20 g, 22.4 mmol)。移開冷 卻浴並將反應物混合物攪拌30分鐘,接著將其超音波振盪 (於50 W Fishers超音波洗淨機)12分鐘。之後,加入二 噁烷(400 m 1)及在減壓下去除溶劑。殘餘物藉由閃蒸層析 法在矽膠(230-400 m,80 g/ THF,接著是甲醇,接著是 15¾水的甲醇溶液)。層析所得之純溶析份可得a)乙基[史 賓諾辛B N-2W-甲基U)-丙烯酸]-3&quot;、銨鹽(296 mg, 38!U:IR v 1720, 1635,1645及 1610 cnr1; 4-NMR ( CDCla) d 7.35 (1H, bs), 6*70 (1H, bs), 2,60 (3H, CH3, bs), 1.95 (3H,CH3,s)ppiu;及化合物 b)史賓諾辛 -150 - 本纸張尺度適用中國國家標準(CNS ) A4規格(2i〇X 297公釐) (請先閲讀背面之注意事項再填寫本頁)A7 B7 V. Description of the invention (147) and trifluoromethanesulfonic anhydride (0.10 g, 0.35 ππηοΐ). The reaction was stirred at room temperature for 1 hour. The reaction was poured into a 20 ml each of ether / saturated sodium carbonate solution. The layers were separated and the aqueous layer was extracted with M 2 X 10 in 1 ether. The ether extract and the K 25 m 1 saline solution were combined to wash the extract, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. Chromatography K on a medium pressure silica column (230-400 m, dichloromethane / hexane, 50:50, v / v) yielded the compound N-trifluoromethanesulfonyl-spinoxin 8. 〇41 心 2_12 $ "3 element analysis: estimated value (:, 57 · 94; Η, 7.35; N 1.65; actual value C, 58.07; H, 7.52; 1.70; FAB MS (ιη / ζ) 849 (Μ + 1). Example C2 Buenosae A (E) -propane-1 &quot; M: Greek casein: T-ammonium. And W. nosin B methyl (Z) -acrylic acid in ethyl f 3W-ammonium salt Spinoxin A compound (0.68 g, 0.929 mmol) was dissolved in dichloromethane (3 ml) and water (50 ml) was added. The mixture was stirred at 0¾ and a portion of ethyl propionate (Aldrich, 2.20 g, 22.4 mmol). Remove the cooling bath and stir the reaction mixture for 30 minutes, then sonicate it (at a 50 W Fishers ultrasonic washer) for 12 minutes. After that, add dioxane (400 m 1 ) And the solvent was removed under reduced pressure. The residue was purified by flash chromatography on silica gel (230-400 m, 80 g / THF, followed by methanol, followed by 15¾ water in methanol). The pure solution obtained by chromatography Fractions can be obtained a) ethyl [Spinoxin B N-2W-methyl U) -acrylic acid] -3 &quot;, ammonium salts (296 mg, 38! U: IR v 1720, 1635, 1645 and 1610 cnr1; 4-NMR (CDCla) d 7.35 (1H, bs), 6 * 70 (1H, bs), 2,60 (3H, CH3, bs), 1.9 5 (3H, CH3, s) ppiu; and compound b) Spinozin-150-This paper size is applicable to China National Standard (CNS) A4 (2i0X 297 mm) (Please read the notes on the back first (Fill in this page again)

-I -屢— -— I 訂 經濟部中央標準局員工消費合作社印象 487559 A7 _ B7___ 五、發明説明(148 ) A N-[(E)-丙-Γ〃-烯酸]_3&quot;'-$安鹽(316 mg, 42%):IR η 1720, 1655, ΙΘΟδοιπ·1 ^H-NMRiCDCla) d 7.04 (1H, d: 17 Hz),6.72 (1H, bs), 6.47 (1H, d: 17 Hz), 3.35 ( 3H, CH3,bs), 3.28 (3H, CH3, bs)ppm。 窨敝例C22-»窨諾辛B N_ (2W-甲基-(Z) _丙-Γ&quot;-烯酸上 m 將史賓諾辛B化合物(192 mg, 0.267 nunol)溶於乾二 氯甲烷(25 ml)。加入一部分丙酸甲酯(Aldrich 1· 80 s, 21.4 1)。反應混合物在室溫及氮氣下攪拌5小時。溶 劑及過量之丙酸乙酯皆於減壓下去除。殘餘物在閃蒸矽膠 管柱(230-400 m, 50 g/ THF)上純化。純溶析份可獲得史 賓諾辛B 甲基-(Z)-丙-Γ&quot;-烯酸)-3…-S旨(205 mg, 95¾)^H-HMRCCDCla) d 7.38 (1H, d:12.8Hz), 6.70 (1H ,bs), 4.50 (1H, d: 12.8 Hz)ppm。-I-Repeated---I set the impression of the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 _ B7___ V. Description of the invention (148) A N-[(E) -propyl-Γ〃-enoic acid] _3 &quot; '-$ Ann salt (316 mg, 42%): IR η 1720, 1655, ΙΘΟδοιπ · 1 ^ H-NMRiCDCla) d 7.04 (1H, d: 17 Hz), 6.72 (1H, bs), 6.47 (1H, d: 17 Hz ), 3.35 (3H, CH3, bs), 3.28 (3H, CH3, bs) ppm. Example C22- »Phenoxin B N_ (2W-methyl- (Z) _prop-Γ &quot; -enoic acid on m. Spinoxin B compound (192 mg, 0.267 nunol) was dissolved in dry dichloromethane (25 ml). A portion of methyl propionate (Aldrich 1.80 s, 21.4 1) was added. The reaction mixture was stirred at room temperature under nitrogen for 5 hours. The solvent and excess ethyl propionate were removed under reduced pressure. The residue The product was purified on a flashed silica gel column (230-400 m, 50 g / THF). The pure eluate was used to obtain Spinoxin B methyl- (Z) -propyl-Γ &quot; -enoic acid) -3 ... -S purpose (205 mg, 95¾) ^ H-HMRCCDCla) d 7.38 (1H, d: 12.8Hz), 6.70 (1H, bs), 4.50 (1H, d: 12.8 Hz) ppm.

管确例[23-N-(氤某)甲基Φ窨諾辛B 將史賓諾辛B化合物(263 mg, 0.370 mmol)溶於乾二 氯甲烷(7 ml)。溶液在室溫及氮氣下攪拌。添加三乙胺( 1·0 ml),接著加入溴乙腈(1.2 ml ,過量)。反應混合物 在室溫下搜拌3天。添加乙酸乙酯(50 ml)及PhH(50 ml), 溶液連續Μ水(3 x )及5¾碳酸氫納(2 x )清洗。有機層以無 水碳酸鉀乾燥並於減壓下濃縮。殘基接著在0.005托下乾 燥3小時Μ獲得化合物(氰基)甲基史賓諾辛B (260 mg, 9«):13OHMR(CDCl3) d 117·8 (CN)及 43.8(N-CH2-CN) ppm 0 -151 - 本紙伕尺度適用中國國家標率(CNS ) Λ·4規格(:M〇x 297公釐)Example of tube [23-N- (氤 a) methyl Φ 窨 oxinol B] Spinoxin B compound (263 mg, 0.370 mmol) was dissolved in dry dichloromethane (7 ml). The solution was stirred at room temperature under nitrogen. Triethylamine (1.0 ml) was added, followed by bromoacetonitrile (1.2 ml, excess). The reaction mixture was stirred at room temperature for 3 days. Ethyl acetate (50 ml) and PhH (50 ml) were added, and the solution was washed successively with M water (3 x) and 5¾ sodium bicarbonate (2 x). The organic layer was dried over anhydrous potassium carbonate and concentrated under reduced pressure. The residue was then dried at 0.005 Torr for 3 hours to obtain the compound (cyano) methyl spinosin B (260 mg, 9 «): 13OHMR (CDCl3) d 117.8 (CN) and 43.8 (N-CH2- CN) ppm 0 -151-The standard of this paper is applicable to China National Standards (CNS) Λ · 4 specifications (: M〇x 297 mm)

In ϋ^ϋ —^ϋ·— t --y .1 Hall (J- .1* ,.!Λ:-·· 1111 n (請先閱讀背面之注意事項再填寫本頁)In ϋ ^ ϋ — ^ ϋ · — t --y .1 Hall (J- .1 *,.! Λ:-·· 1111 n (Please read the precautions on the back before filling this page)

、1T ψ 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(149)1T ψ 487559 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of Invention (149)

密黻例Π24-4”-Ν-乙基中窨諾辛B 烷基化步驟Α:攪拌史賓諾辛Β化合物(0.50 g, 0.70 mmol)之DMF(1.5 ml)溶液,並將該溶液在氮氣環境下依序 Μ 碘乙焼(〇 · 11 m 1,〇 . 21 g,1 · 4 m m ο 1)及(i - P r) 2 N E t ( 0.36 mL, 0,27 g,2.1 mmol)處理。於20小時後,混合物M ca. linL之1M硫代硫酸納溶液處理K分解任何殘餘的碘。 所得混合物在乙醚及飽和食鹽水間分配。有機層Μ鹽水清 洗,Μ硫酸鎂乾燥、過濾及在減壓下濃縮以產生0.61 g。 殘基藉由MPLC純化(氧化矽,5:95甲醇/乙酸乙酯)Μ獲得 0.47 g(9(U)4”-N-乙基史賓諾辛Β白色粉末。C42Hb7N〇1〇 之分析估計值:C, 67.62; Η, 9.05; 1.88。實際值: C, 67.11; Η, 9·73; Ν, 1.92 及 C, 67·17; Η, 9·54; Ν ,1.98。 .Key Example Π24-4 "-N-Ethylinosinoxine B Alkylation Step A: Stir a solution of Spinoxin B compound (0.50 g, 0.70 mmol) in DMF (1.5 ml), and place the solution in Sequential M iodoacetam (0.11 m 1, 0.21 g, 1.4 mm ο 1) and (i-P r) 2 NE t (0.36 mL, 0, 27 g, 2.1 mmol) in sequence under nitrogen Treatment. After 20 hours, the mixture M ca.linL in 1M sodium thiosulfate solution treated K to decompose any residual iodine. The resulting mixture was partitioned between ether and saturated brine. The organic layer was washed with brine, dried over magnesium sulfate, and filtered And concentrated under reduced pressure to yield 0.61 g. The residue was purified by MPLC (silica, 5:95 methanol / ethyl acetate) to obtain 0.47 g of (9 (U) 4 ”-N-ethylspinoxin B White powder. Analytical estimate of C42Hb7N010: C, 67.62; Η, 9.05; 1.88. Actual: C, 67.11; Η, 9.73; Ν, 1.92 and C, 67 · 17; Η, 9.54 ; Ν, 1.98 ...

實瓶例丙蓽)中審諾辛B 依據實施例24烷基化步驟A所述製備化合物,利用史 賓諾辛 Β(0·50 g, 0·70 ιαιαοί), DMF (1.5 mL), 1-碘丙烷 (〇·14 mL, 0.24 g, 1·4 mmol),及(i-Pr)2NEt(0.36 ml, 0.27 s, 2.1 mmol)。藉由MPLC純化(氧化矽,2:98甲醇/ 乙酸乙酯)Μ獲得0.41 g (77%)之4”-Ν-(1-丙基)史賓諾辛 B,為白色粉末。C43HSsN〇1Q之分析估計值:C, 67,96; Η ,9,15; Ν,1.84。實際值:C, 68·06; Η, 9.25; Ν, 1.97 Ο 實-fe例(]2β~4” - Ν~~(2-甲基-丙基)申客諾幸Β 依據實施例24烷基化步驟Α所述製備化合物,利用史 --- -152 - 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐)Real bottle example C.P.) Intermediate Nosin B was prepared according to the alkylation step A of Example 24 using Spinoxin B (0.50 g, 0.70 ιαιαοί), DMF (1.5 mL), 1 -Iodopropane (0.14 mL, 0.24 g, 1.4 mmol), and (i-Pr) 2NEt (0.36 ml, 0.27 s, 2.1 mmol). Purified by MPLC (silica, 2:98 methanol / ethyl acetate) to obtain 0.41 g (77%) of 4 "-N- (1-propyl) spinoxin B as a white powder. C43HSsNO1Q Analyzed estimated value: C, 67,96; Η, 9,15; Ν, 1.84. Actual value: C, 68 · 06; Η, 9.25; Ν, 1.97 〇 Real-fe case (] 2β ~ 4 ”-Ν ~~ (2-Methyl-propyl) Shenke Nuoxing B The compound was prepared according to the alkylation step A of Example 24, and the history of its use --- -152-This paper is in accordance with the Chinese National Standard (CNS) Λ4 specification (210X297 mm)

If —ϋ nail ιϋ_ϋ man ^tmeemw IM§ isne im tmmml iai (請先閲讀背面之注意事項再填寫本頁)If —ϋ nail ιϋ_ϋ man ^ tmeemw IM§ isne im tmmml iai (Please read the notes on the back before filling this page)

、1T 487559 A7 B7 五、發明説明(150 ) 賓諾辛 B(0.95 g, 1.3 mmol), DMF (2.8 mL), 1~ 碘-2-甲 基丙院(0.32 iuL, 0·51 g,2·8 mmol),及(i-Pr)2NEt( 0·73 ml, 0.54 g, 4·2 mmol)。藉由MPLC纯化(氧化矽, 50:50甲醇/乙酸乙酯)Μ獲得0.07 g (7¾)之4”-Ν-Π-丙 基)史賓諾辛Β ,為白色粉末。C 4 4 Η 7 i NO i (]之分析估計值: C, 68.28; Η, 9·25; N,1.81。實際值:C,68.33; Η, 9·26; Η, 1.88 。、 1T 487559 A7 B7 V. Description of the invention (150) Binoxin B (0.95 g, 1.3 mmol), DMF (2.8 mL), 1 ~ Iodine-2-methylpropane (0.32 iuL, 0.51 g, 2 8 mmol), and (i-Pr) 2NEt (0.73 ml, 0.54 g, 4.2 mmol). Purified by MPLC (silica, 50:50 methanol / ethyl acetate) to obtain 0.07 g (7¾) of 4 "-N-Π-propyl) Spinoxin B as a white powder. C 4 4 Η 7 Analyzed estimated value of i NO i (]: C, 68.28; Η, 9.25; N, 1.81. Actual value: C, 68.33; Η, 9.26; Η, 1.88.

窨敝例[27-4”-Ν-(2-甲基-丙-卜基)中窨諾幸R 依據實施例24烷k化步驟A所述製餚化合物,利用史 賓諾辛 B(0.95 g, 1·3 mraol), DMF (2.8 mL),環丙烷甲 基溴化物(0.27 mL, 0·38 g, 2.8 raraol),碘化鈉(0.05 g ,0·3 mmol)及(i-Pr)2NEt(0.73 ml, 0.54 g, 4.2 mmol) 。藉由MPLC純化(氧化矽,2:98甲醇/乙酸乙酯)M獲得〇·3 4g (33%)之4”-Ν-(2-甲基-丙-1-基)史賓諾辛Β,為白色 粉末。CuHhNOh之分析估計值:C, 68.45; Η, 9·01; Ν, 1·81。實際值:C, 68·36; Η,9·22; N, 1.76 。For example, [27-4 "-N- (2-methyl-propanyl-boxy) was prepared in accordance with Example 24. The compound was prepared according to the alkylation step A described in Example 24 using Spinoxin B (0.95 g, 1.3 mraol), DMF (2.8 mL), cyclopropane methyl bromide (0.27 mL, 0.38 g, 2.8 raraol), sodium iodide (0.05 g, 0.3 mmol), and (i-Pr ) 2NEt (0.73 ml, 0.54 g, 4.2 mmol). Purified by MPLC (silica, 2:98 methanol / ethyl acetate) M to obtain 0.3 g (33%) of 4 "-N- (2-formaldehyde) (Propyl-prop-1-yl) spinosyn B, a white powder. CuHhNOh analytical estimates: C, 68.45; Η, 9.01; Ν, 1.81. Actual values: C, 68 · 36; Η, 9.22; N, 1.76.

啻敝例C28~N- (Ν ’ - (1 . 1 -二甲基Ζ氬基羰基)甘胺醯基)史 窨諾辛R 經濟部中央標準局員工消費合作社印裝 (請先閱讀背面之注意事項再填寫本頁) 肽偶合步驟Α:將-15°C攪拌之Boc-Gly-〇H (0♦ 16g, 0·91 ππηοΐ)及 B0P-C1(0.23 g, 0·90 mmol)之二氯甲院(7 ml)溶液在氮氣環境下以N-甲基福嗎啉(〇·12 ml,0·11 s, 1 . 1 mia〇 Π處理。於1. 5小時後,混合物依序以史賓諾辛B ( 0·50 s, 0.70 mmol)及 N-甲基福嗎啉(〇·12 ml,0.11 g, 11.1 mmol)處理。溫度維持在-15°C 4小時,接著使物質逐 本纸浪尺度適用中國國家標準(CMS ) A4規格(210X297公慶) 487559 經濟部中央標準局員工消費合作社印裝 A7 B7 五、發明説明(151 )Example C28 ~ N- (N '-(1. 1 -DimethylZargonylcarbonyl) glycinamido) Shi Nuoxin R Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the Note: Please fill in this page again) Peptide coupling step A: Boc-Gly-〇H (0 ♦ 16g, 0.91 ππηοΐ) and B0P-C1 (0.23 g, 0.90 mmol) which are stirred at -15 ° C The solution of chloroform (7 ml) was treated with N-methylformmorpholine (0.12 ml, 0.11 s, 1.1 mia〇Π) under a nitrogen atmosphere. After 1.5 hours, the mixture was sequentially treated with Spinosin B (0.550 s, 0.70 mmol) and N-methylformmorpholine (0.12 ml, 0.11 g, 11.1 mmol) were treated. The temperature was maintained at -15 ° C for 4 hours, and then the substance was removed gradually. The paper scale is applicable to the Chinese National Standard (CMS) A4 specification (210X297 public holiday) 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 5. Invention Description (151)

漸回溫至室溫10小時。混合物在減壓下蒸發,及藉由MPLC (氧化矽,50:50至100:0乙酸乙酯/己烷)純化殘餘物Μ提 供〇.61g (99¾)之Ν-(Ν’-(1,1-二甲基乙氧基羰基)甘胺醯 基)史賓諾辛队為白色粉末。丫4 71]74丨12〇13之分析估計值: C,64.51; Η, 8.52; Η, 3,20。實際值:C, 63.76; Η, 8.62; Ν, 3·29,及 C, 63.78; Η, 8.60; N,3.43。 窨施例(Ν ’ - Π . 1 -二甲基乙氬基羰基)-/3 -丙胺醯基 )中窨諾辛B 此化合物係根據實施例28所述之呔偶合部分製備化合 物,其中係利用^(:-/3 413-(^(0.178,0.9〇111111〇1)及8(^-Cl(0,23 g, (K90 mmol)之二氯甲烷(7ml)溶液在氮氣環境 下以N-甲基福嗎啉(2X0.12 ml, 0.22g,2.2 mmol)及史賓 諾辛 B(0.50 g, 0.70 mmol)。藉由 MPLC(氧化矽,70:30 至 100:0乙酸乙酯/己烷)純化殘餘物Μ提供0.62g (99¾)之N -(Ν’-(1,1-二甲基乙氧基羰基丙胺醯基)史賓諾辛B 為白色粉末。C4BH76N2〇13之分析估計值:C, 64·84; H, 8·62; N,3.15。實際值:C, 64·38; H,8.67; N, 3.22。 富例C30-N-(N’-(Sg基甲氬基羰某X-丙防醯基)史嘗諾 S-β 此化合物係根據實施例28所述之肽偶合部分製備化合 物,其中係利用(^2^13-011(0.218,0.94 111111〇1)及80卩-Cl (0*2 34g, 0.94 mmol)、二氯甲烷(7ml)、N-甲基福嗎 啉(2X0.12 ml, 0.22g, 2.2 mmol)及史賓諾辛 Β(0·50 g, 0.70 mmol)。藉由MPLC(氧化矽,75 :25乙酸乙酯/己烷) -154 - Λ--«---- (請先閱讀背面之注意事項再填寫本頁) 、\''卩 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐)Gradually warm to room temperature for 10 hours. The mixture was evaporated under reduced pressure, and the residue M was purified by MPLC (silica, 50:50 to 100: 0 ethyl acetate / hexane) to provide 0.61 g (99¾) of N- (N ′-(1, 1-Dimethylethoxycarbonyl) Glycinamido) Spinoxin is a white powder. Ah 4 71] 74 丨 12〇13 Analytical estimates: C, 64.51; Η, 8.52; Η, 3,20. Actual values: C, 63.76; Η, 8.62; Ν, 3.29, and C, 63.78; Η, 8.60; N, 3.43.窨 Example (N ′-Π. 1 -Dimethylethylargonylcarbonyl)-3 -propylamine fluorenyl) oxoxine B This compound is a compound prepared according to the hydrazine coupling moiety described in Example 28, wherein Use a solution of ^ (:-/ 3 413-(^ (0.178, 0.9〇111111〇1) and 8 (^-Cl (0,23 g, (K90 mmol) in dichloromethane (7ml) under a nitrogen atmosphere with N -Methylformmorpholine (2X0.12 ml, 0.22g, 2.2 mmol) and Spinoxin B (0.50 g, 0.70 mmol). By MPLC (silica, 70:30 to 100: 0 ethyl acetate / Hexane) purification residue M provided 0.62 g (99¾) of N- (N '-(1,1-dimethylethoxycarbonylpropylamidinyl) spinosin B as a white powder. Analysis of C4BH76N203 Estimated value: C, 64 · 84; H, 8.62; N, 3.15. Actual value: C, 64 · 38; H, 8.67; N, 3.22. Rich cases C30-N- (N '-(Sg) Argonyl carbonyl X-propanyl) stilano S-β This compound is a compound prepared according to the peptide coupling portion described in Example 28, which is based on (^ 2 ^ 13-011 (0.218, 0.94 111111〇1 ) And 80 卩 -Cl (0 * 2 34g, 0.94 mmol), dichloromethane (7ml), N-methylformmorpholine (2X0.12 ml, 0.22g, 2.2 mmol), and spinosyn B (0 50 g , 0.70 mmol). By MPLC (silica, 75:25 ethyl acetate / hexane) -154-Λ-- «(Please read the precautions on the back before filling this page), \ ''卩 The paper size is applicable to China National Standard (CNS) A4 (210X 297mm)

487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(152 ) 純化殘餘物Μ提供〇.68g (99%)之(苯基甲氧基羰基 )-L-丙胺醯基)史賓諾辛B為白色粉末° CsiH/iNJu之分 析估計值:C, 66.36; Η, 8·08; N, 3· 03。實際值:C,2旋轉 異構體 ^H-NMIUCDCI:]) 7·3-7·4 (Μ, 5Η),[5·06 + 5·10 y 5.04(5+2d, J=12.23 y 12.3, Σ =2H],2,87 y 2.76 (25, Σ=3Η)。487559 A7 B7 printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (152) Purification residue M provides 0.68 g (99%) of (phenylmethoxycarbonyl) -L-propylamine fluorene Neusin B is a white powder ° CsiH / iNJu Analytical estimated value: C, 66.36; Η, 8.08; N, 3.03. Actual value: C, 2 rotamers ^ H-NMIUCDCI:]) 7 · 3-7 · 4 (M, 5Η), [5 · 06 + 5 · 10 y 5.04 (5 + 2d, J = 12.23 y 12.3 , Σ = 2H], 2,87 y 2.76 (25, Σ = 3Η).

管旆例C3卜N- (N ’ . N* -二甲基甘胺驢.蓋史賓諾辛B 此化合物係根據實施例28所述之肽偶合部分製備化合 物,其中係利用 H(Me2)Gly-0H(0,09 g,0·9 ππποί)及川卜 Cl(0.254g, 0.98 mmol)、二氯甲烷(7ml)、N-甲基福嗎啉 (2X0.12 ml, 0.22g, 2.2 mmol)及史賓諾辛 B(0.50 g, 0·70 mmo 1) 0 藉由MPLC(氧化矽,5:95甲醇/二氯甲烷)純 化殘餘物以提供0.23g (41¾)之二甲基甘胺醯基 史賓諾辛B,為白色粉末。之分析估計值:C, 65.8U H,8.79; N,3,49。實際值.:C, M + H+ 估計值 803.5 實際值 803.6。Example C3: N- (N '. N * -dimethylglycine donkey. Gaspinoxin B. This compound was prepared according to the peptide coupling moiety described in Example 28, where H (Me2) was used. Gly-0H (0,09 g, 0.9 ππποί) and Chuan Cl (0.254g, 0.98 mmol), dichloromethane (7ml), N-methylformoline (2X0.12 ml, 0.22g, 2.2 mmol ) And Spinozin B (0.50 g, 0.70 mmo 1) 0 The residue was purified by MPLC (silica, 5:95 methanol / dichloromethane) to provide 0.23 g (41¾) of dimethylglycine醯 Base Spinozin B, a white powder. Analytical estimated value: C, 65.8UH, 8.79; N, 3, 49. Actual value: C, M + H + Estimated value 803.5 Actual value 803.6.

啻饰i例C32-N-(Nf -甲甚疏代胺基甲醯基)史賓諾辛B 史賓諾辛B( 203 mg, 〇·28 mmol)溶於10 ml甲苯並添 加甲基異氮酸酯(100 mg, 1· 36 mmol),及攪拌溶液1小時 。於逐漸進行反應後,粗混合物在矽膠(1 :1,乙酸乙酯/ 己烷)上層析以提供N- (r -甲基硫代胺基甲醯基)史賓諾辛 B(0,14 g, 64%),為白色固體,MS m/z 791.)-L-丙胺醯 基)史賓諾辛8為白色粉末。〇421^6«2〇1。$之分析估計值:0 ,63.77; Η,8.41; N, 3.54。實際值··(:,63.57,Η, 8.42 -155 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) η--W--^^衣-- (請先閱讀背面之注意事項再填寫本頁) -一口 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(153) N, 3.63 〇Example I C32-N- (Nf-methylsothioaminomethylamido) Spinoxin B Spinoxin B (203 mg, 0.28 mmol) was dissolved in 10 ml of toluene and methyl isopropyl was added Nitrate (100 mg, 1.36 mmol), and the solution was stirred for 1 hour. After the reaction gradually proceeded, the crude mixture was chromatographed on silica gel (1: 1, ethyl acetate / hexane) to provide N- (r-methylthioaminomethylmethyl) spinosin B (0, 14 g, 64%), as a white solid, MS m / z 791.)-L-propylaminomethyl) Spinoxin 8 as a white powder. 〇421 ^ 6 «2〇1. Analytical estimates of $: 0, 63.77; Η, 8.41; N, 3.54. Actual value ·· (:, 63.57, Η, 8.42 -155-This paper size applies to the Chinese National Standard (CNS) A4 specification (210X 297 mm) η--W-^^ clothing-(Please read the (Please note this page and fill in this page again)-Yikou 487559 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (153) N, 3.63 〇

啻胞例cm (N ’ · N 二甲基甲眯基)中客諾宰R 史賓諾辛C (102 mg, 0.14 mmol)溶於二甲基甲醯胺 二甲基乙縮醛(5 ml)及將溶液加熱至迴流溫度30分鐘。反 應物冷卻至室溫且將溶劑在減壓下蒸發。粗產物係藉由矽 膠上(95:5罗醇/乙酸乙酯)之層析純化Μ提供N-(H’,N’-二甲基甲咪基)史賓諾辛Β(56·2 rog, 5150,為一黃褐色固 體:FDMSm/z 758。Serotonin cm (N '· N dimethylformyl) Spinoloxacin C Spinoxin C (102 mg, 0.14 mmol) dissolved in dimethylformamide dimethyl acetal (5 ml ) And the solution was heated to reflux temperature for 30 minutes. The reaction was cooled to room temperature and the solvent was evaporated under reduced pressure. The crude product was purified by chromatography on silica gel (95: 5 rolol / ethyl acetate) to provide N- (H ', N'-dimethylmethylimidyl) spinosin B (56 · 2 rog , 5150, as a yellow-brown solid: FDMS m / z 758.

窨晰例C34-N- (N ' N ’ -二甲基胺基甲酼某)中窨諾辛BExample C34-N- (N'N'-dimethylaminoformamidine) in oxoxine B

史賓諾辛B(0.10 g, 0.14 mmol)溶於二甲基胺基甲醯 基氯化物(0.1 g, 0·93 nnuol),將N, N-二異丙基乙胺(0. 10 g, 0.77 mole)溶解於二氯甲烷(10 ml)及攪拌24小時 。溶劑在減壓下蒸發及使殘餘物在矽膠上(95 : 5乙酸乙酯 /甲.醇)層析純化。可提供N- (hT ,Ν’-二甲基胺基甲醯基)史 賓諾辛 B(76.8 mg, 70¾),為白色固體:FDMS πι/ζ 788。 窖敝例C35-N-宰醯基中嘗諾辛B 史賓諾辛B(98 mg, 0·14 mmol)溶於二氯甲烷(5 nil) 及Η,Ν-二異丙基乙胺(26 mg, 0·2 ππηοΐ)及添加辛醯基氯 化物(30 0.18 ππηοΐ)及將反應物攪拌20小時。於逐漸 完成反應後,殘餘物藉由矽膠上(95:5甲醇/乙酸乙酯)之 層析純化以提供Ν-辛醯基史賓諾辛B(61.9 mg, 53·8!〇: F D M S m / 2 8 4 4 · C 4 β Η 7 7 Ν 0 1 1 : C,6 8 . 2 9 ; Η,9 ♦ 19 ; Ν , 1.6 5 。實際值:C, 68.03; Η, 9.29; Ν, 1.84。 啻敝刚亞S尚基中害諾辛__Β 本纸張尺度適用中國國家標準(CNS ) Λ4規格(21GX 297公釐) (請先閱讀背面之注意事項耳填寫本頁) 费· 059 059 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(154) 史賓諾辛Β(1·01 mg, 1.40 mmol)懸浮於水(10 ml)並 於冰浴中冷卻至〇 °C。於此冷懸浮液中添加1N H ’C 1 (10 m 1) 及攪拌反應物直至所有固體溶解。(注意··稍加熱是必要的 ,Μ便溶解所有固體)。將溶液冷卻下來至0°C及添加硝酸 鈉(500 mg, 7.2 nunol)且在〇°C下攪拌反應物。在反應期 間,反應過程會形成白色沈澱。於2小時後,加入額外的 亞硝酸納(500 mg, 7.2 πιπιοΓ)並再攪拌反應物1小時。藉 由真空過滹收集固體,且以冷水清洗(2 X )。固體經風乾 可得Ν-亞硝基史賓諾辛B(1.00g, 95¾),為白色固體: FDMS m/z 748。分析 之估計值:C, 64·32;Η, 8·37; Ν,3.75。實際值:C, 64·52; Η, 8.26; Ν, 3.45。 富life例C37-N-Sg甲騎某中窨諾辛Β 依實施例C78所述方法製備化合物,利用史賓諾辛Β ( 109 mg, 0.152 mmol), Ν,Ν-二異丙基二乙胺(0.1 g, 0.8 mmol),及苯碌驢基氯化物(26.3 mg, 0.15 mmol)。 可得N-苯甲醯基史賓諾辛B(78.6 mg, 60.5¾),為白色固 體:FDMS m/z 857 〇Spinozin B (0.10 g, 0.14 mmol) was dissolved in dimethylaminomethylamidinyl chloride (0.1 g, 0.93 nnuol), and N, N-diisopropylethylamine (0.10 g , 0.77 mole) was dissolved in dichloromethane (10 ml) and stirred for 24 hours. The solvent was evaporated under reduced pressure and the residue was purified by chromatography on silica gel (95: 5 ethyl acetate / methanol). Available as N- (hT, N'-dimethylaminomethylamido) binoxine B (76.8 mg, 70¾) as a white solid: FDMS π / ζ 788. Casein C35-N-Zepinyl Spinoxin B (98 mg, 0.14 mmol) was dissolved in dichloromethane (5 nil) and N, N-diisopropylethylamine ( 26 mg, 0.2 ππηοΐ) and octyl chloro chloride (30 0.18 ππηοΐ) were added and the reaction was stirred for 20 hours. After the reaction was gradually completed, the residue was purified by chromatography on silica gel (95: 5 methanol / ethyl acetate) to provide N-octyl spinoxin B (61.9 mg, 53 · 8! 〇: FDMS m / 2 8 4 4 · C 4 β Η 7 7 Ν 0 1 1: C, 6 8. 2 9; Η, 9 ♦ 19; Ν, 1.6 5. Actual value: C, 68.03; Η, 9.29; Ν, 1.84.啻 敝 Gangya S Shangji Zhongnuo Xinxin __Β This paper size applies Chinese National Standards (CNS) Λ4 specifications (21GX 297 mm) (Please read the notes on the back first and fill out this page) Fee · 059 059 Economy Printed by A7 B7, Consumer Cooperatives of the Ministry of Standards, Ministry of Standards 5. Description of the invention (154) Spinoxin B (1.01 mg, 1.40 mmol) was suspended in water (10 ml) and cooled to 0 ° C in an ice bath. To this cold suspension was added 1N H 'C 1 (10 m 1) and the reaction was stirred until all the solids were dissolved. (Caution ... A little heating is necessary, and M will dissolve all solids). Cool the solution down to 0 ° C and add sodium nitrate (500 mg, 7.2 nunol) and stir the reaction at 0 ° C. During the reaction, a white precipitate formed during the reaction. After 2 hours, additional nitrous acid was added (500 mg, 7.2 πιπιοΓ) and stir the reaction for an additional hour. The solid was collected by vacuum filtration and washed with cold water (2X). The solid was air-dried to obtain N-nitroso spinosinoxin B (1.00 g, 95¾), as a white solid: FDMS m / z 748. Estimated value for analysis: C, 64 · 32; Η, 8.37; Ν, 3.75. Actual value: C, 64 · 52; Η, 8.26; Ν, 3.45 Life-enriching example C37-N-Sg Mesocene Sinopinoxin B The compound was prepared according to the method described in Example C78, using Spinoxin B (109 mg, 0.152 mmol), Ν, Ν-diisopropyl di Ethylamine (0.1 g, 0.8 mmol) and benzyl chloride (26.3 mg, 0.15 mmol). N-benzylidene spinosyn B (78.6 mg, 60.5¾) was obtained as a white solid: FDMS m / z 857 〇

窖施例C38-N-亞笼兩甚中客諾辛C 化合物史賓諾辛C (106 mg, 0. 15 mmol )、苯甲醛(0. 1 g, 0· 9 mmol)及樟腦磺酸(5 mg)溶於苯(15 ml)及將反應 物加熱至迴流溫度1小時。在減壓下蒸發溶劑及藉由在矽 膠上(乙酸乙酯/己烷梯度20: 80至40: 60)層析純化殘餘物 Μ提供N-亞苯甲基史賓諾辛C(65.5 rag, 55.0%),為白色 固體:FDMS ιη/ζ 746,791。 ______;_- 157 -_ 本紙浪尺度適用中國國家標準(CNS ) A4規格(2i〇X 297公釐) ----r--y---- (請先閱讀背面之注意事項再填寫本頁) 訂 487559 A7 B7 五、發明説明(155) 啻胞例C39-N、N-二乙醢某中客諾幸Γ 依實施例C78所述方法製餚化合物,利用史賓諾辛C( 102 mg, 0.144 mmol), Ν,Ν-二異丙基二乙胺(0.1 g, 0·8 mmol),及乙驢基氯化物(0.1, 1 mmol)。可得Ν,Μ -二乙驢 基史賓諾辛C,為白色固體:FDMS m/z 787。分析CuHbs^ 〇12之估計值:(:,65.54;夂8.31。實際值:(:,64.64;1 8.08。 啻_例C40-N. N-二7,醯基中嘗諾辛ί: 依實施例C79所述方法製餚化合物,利用史賓諾辛C ( 81 mg, 0.11 mmol),異氰酸甲酉旨(0.5 g, 0.9 mmol)。可 得化合物N,N_二乙醯基史賓諾辛C (61.8 mg, 71.0¾),為 白色固體:FDMS m/z 760。会析C41Hb4N2〇h之估計值:C ,64.71; Η, 8.48; N 3.68。實際值:C, 64·48; Η, 8,70; Ν 3,59 。 窨瓶例C41-4”-去甲基-(二甲基胺基)- 4”- (Ν-(闷- (2-羥基 .3. 5-二-t_可基茏基)亞胺基申富諾辛 去甲基二甲蓽胺基)-4”-羥 .5-二-t-可某笼蓽)亞胺蓽中客諾辛A 將化合物史賓諾辛C(0.55g, 0·78ππηο1)溶於甲醇/四 氫呋喃(6:1)並加入1,3-二-t-丁基-1,2-苯醌(228 mg, 1.03 ramol)及攪拌反應物24小時。在此反應期間,反應物 由深紅色變成淺黃綠色。藉由旋轉式蒸發器去除溶劑及藉 由矽膠(乙酸乙酯/己烷,1:1)上之層析純化粗綠色固體以 提供化合物4”-去甲基-(二甲基胺基)4”- (N- (E) - (2-徑基, -158 - ____ ----一-------0 II (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ^7559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(156) 3,5-二-卜可基苯基)亞胺基史賓諾辛A(228 mg, 32.2%): 部分1H-NMR d 6.78 (bs, 1Η), 6·65 (s, 1Η), 6·62 (s, 1H), 5.88 (dt, 1H), 5.80 (dt, 1H), 4.86 (s, 1H), 4.67 (m, 1H), 4,63 (d, 1H), 4.32 (q, 1H), 4·15 (bs ,1H), 3·70-3·62 (m, 2H);及 4”-去甲基-(二甲基胺基)-4&quot;-(N-(Z)-(2-羥基,3,5-二-t-可基苯基)亞胺基史賓諾 辛 A (343 mg, 48·51):部分1H-NMR δ6·78 (bs, 1H), 6·74 (s, 1H), 6·63 (s, 1H), 5.88 (dd, 1Η),5·δ1 (dt ,1H), 4.86 (s, 1H), 4.69 (m, 1H) ,4.63 (d, 1H), 4.32 (q, 1H), 3.68 (m, 1H)。 窨施例C42-4&quot;-去甲基-(二甲某胺基)-4”-氯基中客諾宰A 將化合物4’’-去甲基-(二甲基胺基)-4”- [N- (E) - (2-羥 基,3,5-二-t-丁基苯基)亞胺基史賓諾辛A(204 mg, 0.225 mole)懸浮於甲醇/四氫呋喃ΛΚ, 6:1:1 (8 roL)中, 及經由添加四氫呋喃(6 mL)使化合物溶解。於此溶液中添 加草酸二水物(60 mg, 0.47 ππηοΐ)及將反應物攪拌20小時 ,接著在50-60 °C下加熱4小時。於逐漸反應完成後,藉由 矽膠(乙酸乙酯/己烷,1 :1)上之迴旋加速器層析純化殘餘 物Μ提供化合物4”-去甲基-(二甲基胺基)-4”-氧基史賓諾 辛六(43.2 11^,27.3%),為白色固體:部分1[11(^56.75 (bs, 1Η), 5.86 (dd, 1Η), 5·77 (dt, 1Η), 4.96 (dd, 1H), 4.82 (s, 1H), 4·65 (m, 1H), 4·29 (q, 1H), 4.00 (q, 1H), 3·70 (m, 1H)。 啻例[43- -4”-去甲基-(二甲甚Sg某)-4’’-锊基史賓 ________- 159 -__ 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X 297公釐) —------4----- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 487559 A7 B7 • __ 五、發明説明(157 )Cellar Example C38-N-Subcage Dikenoxin C Compound Spinoxin C (106 mg, 0.15 mmol), benzaldehyde (0.1 g, 0.9 mmol), and camphorsulfonic acid ( 5 mg) was dissolved in benzene (15 ml) and the reaction was heated to reflux temperature for 1 hour. The solvent was evaporated under reduced pressure and the residue was purified by chromatography on silica gel (ethyl acetate / hexane gradient 20:80 to 40:60) to provide N-benzylidene spinosin C (65.5 rag, 55.0%) as a white solid: FDMS ηη / ζ 746,791. ______; _- 157 -_ This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (2i0X 297 mm) ---- r--y ---- (Please read the notes on the back before filling in this Page) 487 559559 A7 B7 V. Description of the invention (155) Cell example C39-N, N-diethyl, a certain nuocoxine Γ Compounds were prepared according to the method described in Example C78, using Spinoxin C (102 mg, 0.144 mmol), Ν, Ν-diisopropyldiethylamine (0.1 g, 0.8 mmol), and ethylammonium chloride (0.1, 1 mmol). N, M-diethyl donkey base Spinoxin C was obtained as a white solid: FDMS m / z 787. Analyze the estimated value of CuHbs ^ 〇12: (:, 65.54; 夂 8.31. Actual value: (:, 64.64; 1 8.08.) _ Example C40-N. N-two 7, 醯 in the base to taste Nuoxin :: according to the implementation The compound described in Example C79 was prepared using spinoxin C (81 mg, 0.11 mmol) and methyl isocyanate (0.5 g, 0.9 mmol). Compound N, N-diethylspinyl Octyl C (61.8 mg, 71.0¾) as a white solid: FDMS m / z 760. Estimated value of C41Hb4N2Oh: C, 64.71; Η, 8.48; N 3.68. Actual: C, 64 · 48; Η , 8,70; Ν 3,59. Example C41-4 "-Demethyl- (dimethylamino) -4"-(N- (Sulmonium- (2-hydroxy.3. 5-di- t_cobenzylidene) iminosufunoxine desmethyldimethylamidoamine) -4 "-hydroxy.5-di-t-coke cage 荜) imine 客 kenoxin A compound Spinozin C (0.55g, 0.78ππηο1) was dissolved in methanol / tetrahydrofuran (6: 1) and added with 1,3-di-t-butyl-1,2-benzoquinone (228 mg, 1.03 ramol) and The reaction was stirred for 24 hours. During this reaction, the reaction changed from dark red to pale yellow-green. The solvent was removed by a rotary evaporator and the solvent was removed by silica gel (ethyl acetate / hexane, 1: 1). A crude green solid was isolated and purified to provide compound 4 "-desmethyl- (dimethylamino) 4"-(N- (E)-(2-diameter group, -158-____ ---- a --- ---- 0 II (Please read the notes on the back before filling this page) Order the paper size printed by the Employees' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs to apply the Chinese National Standard (CNS) A4 (210X 297 mm) ^ 7559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the Invention (156) 3,5-Di-Bocylphenyl) Imino Spinosin A (228 mg, 32.2%): Part 1H- NMR d 6.78 (bs, 1Η), 6.65 (s, 1Η), 6.62 (s, 1H), 5.88 (dt, 1H), 5.80 (dt, 1H), 4.86 (s, 1H), 4.67 ( m, 1H), 4,63 (d, 1H), 4.32 (q, 1H), 4.15 (bs, 1H), 3.70-3 · 62 (m, 2H); and 4 ”-desmethyl -(Dimethylamino) -4 &quot;-( N- (Z)-(2-hydroxy, 3,5-di-t-cophenylphenyl) imino spinosin A (343 mg, 48 · 51): Partial 1H-NMR δ 6.78 (bs, 1H), 6.74 (s, 1H), 6.63 (s, 1H), 5.88 (dd, 1Η), 5.δ1 (dt, 1H), 4.86 (s, 1H), 4.69 (m, 1H), 4.63 (d, 1H), 4.32 (q, 1H), 3.68 (m, 1H).例 Example C42-4 &quot; -Demethyl- (dimethylamino) -4 "-Chlorinozepine A The compound 4" -desmethyl- (dimethylamino) -4 " -[N- (E)-(2-hydroxy, 3,5-di-t-butylphenyl) imino spinosin A (204 mg, 0.225 mole) suspended in methanol / tetrahydrofuran Λκ, 6: 1 : 1 (8 roL), and the compound was dissolved by adding tetrahydrofuran (6 mL). To this solution was added oxalic acid dihydrate (60 mg, 0.47 ππηοΐ) and the reaction was stirred for 20 hours, followed by heating at 50-60 ° C for 4 hours. After the gradual reaction was completed, the residue was purified by cyclotron chromatography on silica gel (ethyl acetate / hexane, 1: 1) to provide compound 4 "-desmethyl- (dimethylamino) -4" -Spinoxin 6 (43.2 11 ^, 27.3%) as a white solid: part 1 [11 (^ 56.75 (bs, 1Η), 5.86 (dd, 1Η), 5.77 (dt, 1Η), 4.96 (dd, 1H), 4.82 (s, 1H), 4.65 (m, 1H), 4.29 (q, 1H), 4.00 (q, 1H), 3.70 (m, 1H). Example [ 43- -4 ”-desmethyl- (dimethylformate Sg) -4”-锊 基斯宾 ________- 159 -__ This paper size is applicable to China National Standard (CNS) A4 (21〇X 297 mm) ) —------ 4 ----- (Please read the notes on the back before filling out this page) Order printed by the Central Consumers Bureau of the Ministry of Economic Affairs and printed by the Consumer Cooperative 487559 A7 B7 • __ 5. Description of the invention (157)

諾宰A 將化合物4”-去甲基-(二甲基胺基)-4”-氧基史賓諾辛 A(78 mg, 0,11 mmole)溶於乙醚(10 niL)並於冰浴中冷卻 至0 °C。於此冷溶液中添加氫化三第三丁氧化鋰(48 mg , 0*19 mmol)及攪拌反應物20分鐘。反應物Μ飽和氯化鈉(3 ml)驟冷、逐漸進行反應,及藉由矽膠(乙酸乙酯/己烷, 1 :1)上之迴旋加速器層析純化殘餘物Μ提供化合物(4”S)-4’’-去甲基-(二甲基胺基)-4”-羥基史賓諾辛A (46.6 mg, 59.7%,為無色玻璃狀:部分1H-NMR δ 6.78 (bs, 1H), 5.88 (dd, 1H) , 5.81 (dt, H), 4.86 (s, 1H), 4.67 (瓜,1H) , 4.50 (d, 1H) , 4.32 (q, 1H), 3·66 (m, 1H ),3.34-3.23 (m, 3H)ί 13C-NMR δ 202.81, 172.55, 147.54, 144.12, 129.33, 128.80, 103·14, 95.45, 82·27, 81·06, 80·85, 77,72, 76.68, 76.06, 75·71, 71.54, 67.94, 60.94, 59.01, 57.70, 49.44, 47.60, 46·04, 41.52, 41·16, 37·38, 36·28, 34·32, 34*19, 31.42, 30.62, 30.12, 28.39, 21.53, 8.01, 17.80, 16·21, 9·35·Nuozai A Compound 4 "-desmethyl- (dimethylamino) -4" -oxyspinoxin A (78 mg, 0,11 mmole) was dissolved in ether (10 niL) and placed in an ice bath Cool to 0 ° C. To this cold solution was added lithium tertiary butyl butoxide (48 mg, 0 * 19 mmol) and the reaction was stirred for 20 minutes. The reactant M was quenched with saturated sodium chloride (3 ml), the reaction was gradually performed, and the residue M was purified by cyclotron chromatography on silica gel (ethyl acetate / hexane, 1: 1) to provide compound (4 "S ) -4 "-desmethyl- (dimethylamino) -4" -hydroxyspinoxin A (46.6 mg, 59.7%, colorless glassy: part 1H-NMR δ 6.78 (bs, 1H) , 5.88 (dd, 1H), 5.81 (dt, H), 4.86 (s, 1H), 4.67 (melon, 1H), 4.50 (d, 1H), 4.32 (q, 1H), 3.66 (m, 1H ), 3.34-3.23 (m, 3H) ί 13C-NMR δ 202.81, 172.55, 147.54, 144.12, 129.33, 128.80, 103 · 14, 95.45, 82 · 27, 81 · 06, 80 · 85, 77,72, 76.68 , 76.06, 75 · 71, 71.54, 67.94, 60.94, 59.01, 57.70, 49.44, 47.60, 46 · 04, 41.52, 41 · 16, 37 · 38, 36 · 28, 34 · 32, 34 * 19, 31.42, 30.62 , 30.12, 28.39, 21.53, 8.01, 17.80, 16 · 21, 9 · 35 ·

窖細例C44-去甲某-(二甲某胳某卜4&quot;-Ζ醮氯基 中客諾辛A * 將化合物(4”S)-4”-去甲基(二甲基胺基)-4”_羥基史 賓諾辛A(10 mg, 0.14 mmol)溶於二氯甲烷並加人乙酸酐( 0.05 g, 0.5 mmol)及吡啶(0.1 g, 1 mmol)及攪拌反應物 2小時。逐漸反應完成可獲得化合物(4 ”S) -4”-去甲基-(二 -160 _ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)Example of cellar C44-Normone- (Dimethylammonium 4 &quot; -Z-Chlorochlorinoxine A * The compound (4 "S) -4" -desmethyl (dimethylamino) -4 ”-hydroxyspinoxin A (10 mg, 0.14 mmol) was dissolved in dichloromethane and added with acetic anhydride (0.05 g, 0.5 mmol) and pyridine (0.1 g, 1 mmol) and the reaction was stirred for 2 hours. Gradually complete the reaction to obtain the compound (4 "S) -4" -desmethyl- (di-160 _ This paper size applies to China National Standard (CNS) A4 specifications (210X 297 mm) (Please read the precautions on the back first (Fill in this page again)

487559 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(158) 甲基胺基卜4”-乙醯氧基史賓諾辛Α(5·7 mg,57¾),為無 色玻璃狀物;部分1H-NMR5 6.75 (bs, 1Η),5·86 idd’487559 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs Α7 Β7 V. Description of the invention (158) Methylaminob 4 ”-acetoxyspinoxin A (5 · 7 mg, 57¾), a colorless glass ; Part 1H-NMR5 6.75 (bs, 1Η), 5.86 idd '

1H), 5.77 (dt, 1H), 4.83 (s ,1H), 4.66 (m , 1H), 4. 49 (dd, 1H),4 • 42 (ddd, 1H, c f = ll • 0, 9.4, 4 • 7), 4· 29 (q, 1H ) , 3 · 63 (m, 1H); 13C-NMR δ 147 • 64, 129*33, 128.77, 103· 02, 95. 39, 82. 24, 81.01, 80.74 &gt; 77.68, 76.77, 76.01, 73.13, 72.82, 67.92 » I 60.95, 59 •01, 57 .71, 49 .42, 47 • 58, 46. .01, 41. 48, 41 • 14, 37 .35, 36 •25, 34 • 27, 34 ♦ 17, 30. t 12, 30. 03, 29 • 68, 28 ♦39, 27 ,76, 21 • 53, 21 ♦ 17, 17, ,99, 17· 79, 16 .13, 9. 34 〇 實 旆例C45 -N-去甲 棊-N 一甲 醯華 -中客諾 辛D 將化合物N-去甲基_N_甲醯基-史賓諾辛ΙΗ1·08 g; 1.47 mmol)溶於甲酸乙酯(25 ml)及在迴流溫度下加熱溶 液14小時。藉由旋轉式蒸發器蒸發溶劑及藉由逆相HPLC( 甲醇/0.1¾ aq.氫氧化ί安,85:15)K提供N-去甲基甲醯 基-史賓諾辛D (645.6 mg, 57.6%),為白色泡沫體:部分 'H'NMR δ 8,09 &amp; 8.06 (s, 1H), 6.77 (bs, 1H), 5.49 (bs, 1H), 4.86 (s, 1H), 4.67 (m, 1H), 4.50 (d, 1H) ,4·30 (q, 1H), 3·60 (m, 1H). 窨倫例(:4(^4”-1「(2.4-二氮笼基)胺某羰莽1中客諾辛8 根據實施例C80之方法,由2,4-二氟苯基異氰酸酯( 78 ml, 98 mg, 0.63 nunol)及史賓諾辛 Β(0·30 g, (K42 mmol)製備化合物。MPLC(Si〇 2, 50:50, EtOAc/己烷 ΪΚ 獲 -161 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(2l〇x 297公釐) (請先閱讀背面之注意事項再填寫本頁)1H), 5.77 (dt, 1H), 4.83 (s, 1H), 4.66 (m, 1H), 4. 49 (dd, 1H), 4 • 42 (ddd, 1H, cf = ll • 0, 9.4, 4 • 7), 4.29 (q, 1H), 3.63 (m, 1H); 13C-NMR δ 147 • 64, 129 * 33, 128.77, 103 · 02, 95. 39, 82. 24, 81.01, 80.74 &gt; 77.68, 76.77, 76.01, 73.13, 72.82, 67.92 »I 60.95, 59 • 01, 57 .71, 49 .42, 47 • 58, 46. .01, 41. 48, 41 • 14, 37 .35 , 36 • 25, 34 • 27, 34 ♦ 17, 30. t 12, 30. 03, 29 • 68, 28 ♦ 39, 27, 76, 21 • 53, 21 ♦ 17, 17,, 99, 17 · 79 , 16 .13, 9. 34 〇Example C45 -N-Nordinyl-N Monomethyl Hua-Nacoxine D The compound N-desmethyl_N_methylmethyl-spinoxin I 1 · 08 g; 1.47 mmol) was dissolved in ethyl formate (25 ml) and the solution was heated at reflux temperature for 14 hours. The solvent was evaporated by a rotary evaporator and N-desmethylformyl-spinoxin D (645.6 mg, by a reverse phase HPLC (methanol / 0.1¾ aq. Hydroxide, 85:15) K 57.6%), as a white foam: Partial 'H'NMR δ 8,09 &amp; 8.06 (s, 1H), 6.77 (bs, 1H), 5.49 (bs, 1H), 4.86 (s, 1H), 4.67 ( m, 1H), 4.50 (d, 1H), 4.30 (q, 1H), 3.60 (m, 1H). Cases of Lulun (: 4 (^ 4 "-1" (2.4-diazepine) ) Amoximine Carboximide 1 Intranoxine 8 According to the method of Example C80, 2,4-difluorophenyl isocyanate (78 ml, 98 mg, 0.63 nunol) and Spinoxin B (0.30 g, (K42 mmol) to prepare the compound. MPLC (Si〇2, 50:50, EtOAc / Hexane ΪΚ obtained -161-This paper size applies to China National Standard (CNS) A4 size (2 l0x 297 mm) (Please read first (Notes on the back then fill out this page)

經濟部中央標準局員工消費合作社印製 487559 A7 ’ B7 _ 五、發明説明(159 ) 得0.36 g(99%)4”-N-[(2,4-二氟苯基)胺基羰基]史賓諾辛 B,為白色粉末♦· MS (ιπ + ΗΟ預期值:873.5 °實際值: 873.8 〇 啻旆例(3.4-二氟笨基)胺基羰基]史賓諾辛B 根據實施例C80之方法,由3,4-二氟苯基異氰酸酯( 0.12 g, 0.64 mmol)及史賓諾辛 Β(〇·3〇 g,0.42 mmol)製 備化合物。MPLC(Si〇2, 64:40 至 100:0,EtOAc/己烷)Μ 獲 得0.38 g (99¾) 4”-Ν-[(3,4-二氟苯基)胺基羰基]史賓諾 辛Β,為白色粉末:MS (iu + H+)預期值:905.4。實際值: 905.6。 啻瓶例C48-4”-N-『(4-田氬某.¾某)胺基羰基1Φ窨諾辛B 根據實施例C80之方法,由4-甲氧基苯基異氰酸酯( 81 ml, 93 mg, 0.63 mmol)及史賓諾辛 B(0.30 g, 0.42 mmol)製備化合物。MPLC (Si〇2, 64:40, EtOAc/己烷)Μ 獲得0.36 g (99%)4”-N-[(4-甲氧基苯基)胺基羰基]史賓 諾辛B,為白色粉末:MS U + HM預期值:867,5。實際值 :867.8 〇Printed by the Consumers 'Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7' B7 _ 5. Description of the invention (159) 0.36 g (99%) 4 ”-N-[(2,4-difluorophenyl) aminocarbonyl] Pinoxin B, a white powder. MS (ιπ + ΗΟ expected value: 873.5 ° actual value: 873.8) Example (3.4-difluorobenzyl) aminocarbonyl] Spinoxin B according to Example C80 Method: Compounds were prepared from 3,4-difluorophenyl isocyanate (0.12 g, 0.64 mmol) and spinosyn B (0.30 g, 0.42 mmol). MPLC (SiO2, 64:40 to 100: 0, EtOAc / hexane) M to obtain 0.38 g of (99¾) 4 ”-N-[(3,4-difluorophenyl) aminocarbonyl] spinosin B, as a white powder: MS (iu + H +) Expected value: 905.4. Actual value: 905.6. 啻 Bottle example C48-4 "-N-" (4- Tian argon. ¾) amine carbonyl 1 Φ 窨 Nuoxin B According to the method of Example C80, from 4-A Compound was prepared with oxyphenyl isocyanate (81 ml, 93 mg, 0.63 mmol) and spinosyn B (0.30 g, 0.42 mmol). MPLC (SiO2, 64:40, EtOAc / hexane) Μ 0.36 g (99%) 4 "-N-[(4-methoxyphenyl) aminocarbonyl] Spinoxin B, white powder: MS U + HM expected value: 867,5. Actual value: 867.8 〇

啻細例(卜丙某)中窨諾辛B 根據實施例C81之方法,由卜碘丙烷(0.14 ml, 0.24 g , 1 · 4 m m ο 1)、( i - P r) 2 H E t (0 · 3 6 m 1 , 0 ♦ 2 7 g , 2 ♦ 1 m m ο 1 )、史賓諾辛 Β(0·50 g, 0.70 nunol)、及 DMF(1.5 ml)製備 化合物。MPLC (Si〇2, 50:50, EtOAc/己烷)M 獲得 0,41 g (77¾) 4&quot;-N-(l-丙基)史賓諾辛B,為白色粉末。 C43HhN0iq 之分析:估計值·· C, 67,9δ; Η, 9.15; _____- 162 - 本纸張尺度iA用中國國家標準(CNS ) Α4規格(210X297公釐) &quot; (請先閱讀背面之注意事項再填寫本頁)啻 Nosin B in the detailed example (Bu Bingmou) According to the method of Example C81, bupropion (0.14 ml, 0.24 g, 1 · 4 mm ο 1), (i-P r) 2 HE t (0 · 36 m 1, 0 ♦ 2 7 g, 2 ♦ 1 mm ο 1), Spinoxin B (0.50 g, 0.70 nunol), and DMF (1.5 ml) to prepare the compound. MPLC (SiO2, 50:50, EtOAc / hexane) M to obtain 0,41 g (77¾) 4 &quot; -N- (l-propyl) spinosin B, as a white powder. Analysis of C43HhN0iq: Estimated value · C, 67,9δ; Η, 9.15; _____- 162-Chinese National Standard (CNS) Α4 specification (210X297 mm) for paper size iA &quot; (Please read the note on the back first (Fill in this page again)

經濟部中央標準局員工消費合作社印製 487559 . A7 B7 五、發明説明(16〇 ) Ν,1·84。實際值:C, 68·06; Η, 9·25; N,1,97。 啻腧例C 5 〇 - 4· ” - Ν - -甲基-1 -丙基)史曹諾辛Β 根據實施例C81之方法,由1-碘-2-甲基丙烷(0,32 ml ,0·51 g, 2.8 mmol)、 (i_Pr)2NEt(0.73 ml, 0·54 g, 4·2 mmol)、史賓諾辛 B(0.95 g, 1·3 mmol)、及 DMF(2.8 ml)製備化合物。MPLC (Si〇 2, 50:50, EtOAc/己烷)M 獲 得0.07 g (7¾) 4”-N-(2-甲基-卜丙基)史賓諾辛B,為白 色粉末(亦可回收史賓諾辛Β, 0·71 g (75%)):MS (in + HM 預期值:774.5。實際值:774.8。CuHmNOh之分析:估 計值:C, 68.28; Η,9·25;Ν, 1,81。實際值:C, 68.33; Η, 9·25; Ν, 1·88 。Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 487559. A7 B7 V. Description of Invention (16) N, 1.84. Actual values: C, 68 · 06; Η, 9.25; N, 1,97. Example C 5 〇-4 · "-Ν--methyl-1 -propyl) stronoxin B According to the method of Example C81, 1-iodo-2-methylpropane (0,32 ml, 0.51 g, 2.8 mmol), (i_Pr) 2NEt (0.73 ml, 0.54 g, 4.2 mmol), spinosyn B (0.95 g, 1.3 mmol), and DMF (2.8 ml) Compound. MPLC (Si〇2, 50:50, EtOAc / hexane) M to obtain 0.07 g (7¾) 4 "-N- (2-methyl-propyl) spinosyn B, white powder (can also be recovered Spinozin B, 0.71 g (75%)): MS (in + HM expected: 774.5. Actual: 774.8. Analysis of CuHmNOh: estimated value: C, 68.28; Η, 9.25; Ν, 1,81. Actual value: C, 68.33; Η, 9.25; Ν, 1.88.

啻廝例C51 f (環丙某)甲基1Φ曹諾幸R 根據實施例C81之方法,由(溴甲基)環丙烷(0.27 ml, 0·38 g, 2.8 mmol)、Nal(0.05g, 0.3 ιιιιηοΓ)、(i-Pr)2 -N E t (0 · 7 3 m L , 0 ♦ 5 4 g , 4 ♦ 2 m m o 1),史賓諾辛 B (0.9 5 g , 1·3 mmol)、及 DMF(2.8 mL)製備化合物。MPLC (50:50, EtOAc/己烷)K獲得0*34g (33¾) 4”-N-[(環丙基)甲基] 史賓諾辛B,為白色粉末(亦可回收史賓諾辛B, 0.40 g( 42%)史賓諾辛B)cC44Hs3N〇1Q之分析:估計值·· C, 68.45 ;Η, 9.01; N, 1.81。實際值:C, 68.36; Η, 9.22; N, 1·76。Example C51 f (Cyclopropyl) Methyl 1 曹 Cao Xingxing R According to the method of Example C81, (Bromomethyl) cyclopropane (0.27 ml, 0.38 g, 2.8 mmol), Nal (0.05 g, 0.3 ιιιιηηΓ), (i-Pr) 2 -NE t (0.73 m L, 0 ♦ 5 4 g, 4 ♦ 2 mmo 1), Spinozin B (0.9 5 g, 1.3 mmol), And DMF (2.8 mL) to prepare the compound. MPLC (50:50, EtOAc / hexane) K to obtain 0 * 34g (33¾) 4 ”-N-[(cyclopropyl) methyl] spinosyn B, a white powder (also spinosin) B, 0.40 g (42%) Spinozin B) Analysis of cC44Hs3N0Q: Estimated value C, 68.45; Η, 9.01; N, 1.81. Actual value: C, 68.36; Η, 9.22; N, 1 · 76.

管施例C52-4”-N-Z甚-fS.fi-二氩中窨諾宰R 根據實施例C81之方法,由溴乙烷(60 ml, 0.12 g, 0·75 mmol)、(i-Pr)2-NEt (0.20 mL, 0‘15 g,1·1 mmol) 本纸張尺度適用中國國家標準(CNS ) Α4規格(210.Χ 297公釐) I---,--1----- (請先閱讀背面之注意事項再填寫本頁)Example C52-4 "-NZ and even -fS.fi-Nanoze R in diargon According to the method of Example C81, ethyl bromide (60 ml, 0.12 g, 0.75 mmol), (i-Pr ) 2-NEt (0.20 mL, 0'15 g, 1.1 mmol) The paper size is applicable to China National Standard (CNS) A4 specification (210. × 297 mm) I ---,-1 --- -(Please read the notes on the back before filling this page)

、1T 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(161 ) ,5,6-二氫史賓諾辛8(0.27轻,38 111111〇1)、及0{^(2 11^) 製餚化合物。MPLC (40:60, EtOAc/己烷)Μ獲得0.22 g ( 79¾) 4”-N-乙基-5,6-二氫史賓諾辛B,為白色粉末。 CuHhNOh 之分析:估計值:C, 67.44; H, 9.30; N, 1·87。實際值:C, 67·52; H, 9.07; Ν,1·78。 啻胞例L二氣(2-甲基_卜丙基)史W諾辛Β 根據實施例C81之方法,由卜碘-2-甲基丙烷(0·10 ml ,0 . 16 g,0.8 7 m m ο 1)、( i - P r) 2 - N E t (0.2 3 in L , 0 ♦ 17 g, 1.3 1«〇1),5,6-二氫史賓諾辛8(0.318,0.43 111111〇1)、 及 DMF(2 roL)製餚化合物。MPLC(Si〇2, 40:60, EtOAc/己 烷)M獲得0.16 g (48¾) 5,6-二氫-4”-N-(2-甲基-卜丙基 )史賓諾辛B,為白色粉末。C44H73R〇1Q之分析:估計值: C, 68.10; H, 9.48; N, 1.80。實際值:C, 68.10; H, 9.37; N, 1·87 。 窨胞例C!U-4&quot;-N- (2-氟7」基)史賓諾辛Β 根據實施例C81之方法,由卜溴-2-氣乙烷(0.10 nil ,0.17 g, 0·3 mmol)、Nal(0.04 g,(K67 mmol)、(i-Pr )2NEt(0.36 rarool, 0.27 g, 2·1 mmol),史賓諾辛 Β(0·48 g, 0.67 fflinol)、及 DMF(2 raL)製備化合物。MPLC(30:70 至 40:60, EtOAc/己烷)K 獲得 0.30 g (5Μ)4Ί(2-氟乙基 )史賓諾辛Β,為白色粉末。C^H^NOh之分析:估計值: C, 66.03; H, 8.71; N, 1.83。實際值:C, 65· 89; Η, 9.11; Ν, 1·92 。 富瓶例m4”-N-(2.2,2-三氟乙基)史賓諾辛Β _ 164 一 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210.X 297公釐) ----.--ϊ----- (請先閲讀背面之注意事項再填寫本頁), 1T 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (161), 5,6-dihydrospinoxin 8 (0.27 light, 38 111111〇1), and 0 {^ (2 11 ^) Cooking compounds. MPLC (40:60, EtOAc / hexane) M obtained 0.22 g (79¾) 4 "-N-ethyl-5,6-dihydrospinoxin B as a white powder. Analysis of CuHhNOh: Estimated value: C , 67.44; H, 9.30; N, 1.87. Actual values: C, 67 · 52; H, 9.07; Ν, 1.78. Cases of L2 gas (2-methyl-propyl) Β According to the method of Example C81, diiodo-2-methylpropane (0 · 10 ml, 0.16 g, 0.8 7 mm ο 1), (i-P r) 2-NE t (0.2 3 in L , 0 ♦ 17 g, 1.3 1 «〇1), 5,6-dihydrospinoxin 8 (0.318, 0.43 111111〇1), and DMF (2 roL) cooking compounds. MPLC (Si〇2, 40 : 60, EtOAc / hexane) M to obtain 0.16 g (48¾) 5,6-dihydro-4 "-N- (2-methyl-butylpropyl) spinosin B as a white powder. Analysis of C44H73R〇1Q: Estimate: C, 68.10; H, 9.48; N, 1.80. Actual values: C, 68.10; H, 9.37; N, 1.87. Cell Example C! U-4 &quot; -N- (2-Fluoro 7 "yl) Spinoxin B According to the method of Example C81, Br--2-gasethane (0.10 nil, 0.17 g, 0 · 3 mmol), Nal (0.04 g, (K67 mmol), (i-Pr) 2NEt (0.36 rarool, 0.27 g, 2.1 mmol), spinosyn B (0.48 g, 0.67 fflinol), and DMF (2 raL) to prepare the compound. MPLC (30:70 to 40:60, EtOAc / hexane) K yielded 0.30 g (5M) of 4Ί (2-fluoroethyl) spinoxin B as a white powder. C ^ H ^ NOh analysis: Estimated values: C, 66.03; H, 8.71; N, 1.83. Actual values: C, 65 · 89; Η, 9.11; Ν, 1.92. Rich bottle example m4 ”-N- (2.2, 2-Trifluoroethyl) Spinoxin B _ 164 A paper size is applicable to Chinese National Standard (CNS) Λ4 specification (210.X 297 mm) ----.-- ϊ ----- ( (Please read the notes on the back before filling out this page)

、1T 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(162 ) 根據實施例C81之方法,由2,2,2-三氟乙基三氟代甲 燒確酸酯(0.34 g, 1·5 mmol)、(i-Pr)2NEt (0.36 mmol, 0.27 g, 2.1 roraol),史賓諾辛 B(0.38g, 0.53 mraol)、及 DMF(2 mL)製備化合物。MPLC(30:70, EtOAc/己烷)以獲得 〇·32 g (76¾) 4”-H-(2,2,2-三氟乙基)史賓諾辛B,為白 色粉末。C42Hb4N〇1d之分析:估計值:C, 63.06; Η, 8.06 ,· Ν, 1.75。實際值:C, 62.78; Η, 7·97; Ν, 1.66. 實施例「!^-4”-1「2-(^’.丨1’_二甲某胺基)乙某1中曹諾辛1^ 根據實施例C81之方法,由Me2(CH2)2Cl · HC1(0.30 g ,2 ♦ 1 ra m ο 1)、(卜 P t) 2 N E t (0 · 5 0 m L , 0 · 3 7 g , 2 · 9 m m ο 1) ,史賓諾辛 B(0.50 g,0.70 mmol)、及 DMF(2 mL)製備化 合物。MPLC(20:80, Me0H/CH2Cl2)M 獲得 0,04g (7¾) 4” -N- [2- (N、H ’ -二甲基胺基)乙基]史賓諾辛B ,為白色粉末 (亦可回收0.44 g(88%)史賓諾辛B)。MS (m + FT)預期值: 789.5。實際值:789.8。、 1T 487559 Printed by A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (162) According to the method of Example C81, 2,2,2-trifluoroethyl trifluoromethanesulfonate (0.34 g, 1.5 mmol), (i-Pr) 2NEt (0.36 mmol, 0.27 g, 2.1 roraol), spinosyn B (0.38 g, 0.53 mraol), and DMF (2 mL). MPLC (30:70, EtOAc / hexane) to obtain 0.32 g (76¾) 4 "-H- (2,2,2-trifluoroethyl) spinosin B as a white powder. C42Hb4N〇1d Analysis: Estimated value: C, 63.06; Η, 8.06, · Ν, 1.75. Actual value: C, 62.78; Η, 7.97; Ν, 1.66. Example "! ^-4" -1 "2- ( ^ '. 丨 1'_Dimethyamino group) Zomoxin 1 in Yimou 1 ^ According to the method of Example C81, Me2 (CH2) 2Cl · HC1 (0.30 g, 2 ♦ 1 ra m ο 1), (Bu P t) 2 NE t (0 · 50 m L, 0 · 3 7 g, 2 · 9 mm ο 1), Spinozin B (0.50 g, 0.70 mmol), and DMF (2 mL) Compound. MPLC (20:80, Me0H / CH2Cl2) M to obtain 0,04g (7¾) 4 ”-N- [2- (N, H′-dimethylamino) ethyl] spinoxin B, as White powder (0.44 g (88%) Spinoxin B can also be recovered). MS (m + FT) expected: 789.5. Actual value: 789.8.

奮觖例「57-4”-(2-丙某)中嘗諾辛B 根據實施例C81之方法,由2-碘丙烷(0.11 ml, 0.19g ,1 ♦ 1 m ra ο 1)、( i - P t) 2 N E t (0 ♦ 3 0 m L , 0 · 2 2 g , 1 ♦ 7 in m ο 1) ,史賓諾辛 Β(0·40 g, 0.56 nunol)、及 DMF(2 mL)製備化 合物。MPLC(Si〇 2, 50:50, EtOAc/己烧)M 獲得 0·09 g (21¾) 4”-N-(2-丙基)史賓諾辛B,為白色粉末:MS (m + H + )預期值:760.5。實際值·· 760,6。CuHhNOh之分析: 估計值:C, 67.96; H, 9,15; N, 1.34。實際值:C, 68.04 ;Η, 9.32; Ν, 1.85. -165 - 1 本纸張尺度適用中國國家標隼(CNS ) Α4規格(21QX297公釐) (請先閱讀背面之注意事項再填寫本頁)According to the method of Example C81, Fenxiong Example "57-4"-(2-propyl) was prepared from 2-iodopropane (0.11 ml, 0.19g, 1 ♦ 1 m ra ο 1), (i -P t) 2 NE t (0 ♦ 3 0 m L, 0 · 2 2 g, 1 ♦ 7 in m ο 1), Spinozin B (0.40 g, 0.56 nunol), and DMF (2 mL ) Preparation of compounds. MPLC (Si〇2, 50:50, EtOAc / hexane) M to obtain 0.09 g (21¾) 4 "-N- (2-propyl) spinosyn B, white powder: MS (m + H +) Expected value: 760.5. Actual value: 760,6. Analysis of CuHhNOh: Estimated value: C, 67.96; H, 9,15; N, 1.34. Actual value: C, 68.04; Η, 9.32; Ν, 1.85 . -165-1 This paper size applies to China National Standard (CNS) Α4 size (21QX297 mm) (Please read the precautions on the back before filling this page)

、1T ^7559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(163)1T ^ 7559 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of Invention (163)

富施例C58-4”-N-(l-丁某)中W諾辛B 根據實施例C81之方法,由1-碘丁烷(0·13 ml, 0.2U ,1.1 mmol)、 (i-Pr)2NEt(0.30 mL, 0·22 g, 1·7 mmol) 、史賓諾辛Β(0·40 g, 0.56 mmol)及DMF(2 oil)製備化合 物。MPLC(Si〇 2, 50:50 EtOAc/己烷)K 獲得 0.41 g (95¾) 丁基)史賓諾辛B,為白色粉末。MS (πι + Η〃)預期 值:774.5。實際值:774.7。 奮施例C59-4”U”-N- (丁 -1 . 4-二基)Φ曹諾辛Β碘鹽 根據實施例C81之方法,由1,4-二碘丁烷(0.11 ml, 0.26 g, 0.83 mmol) ^ (i-Pr)2NEt (0.30 raL, 0.22 g, 1*7 mmol)、史賓諾辛 B(0.30 g, 0.42 mmol)及 DMF(1 ml) 製備化合物。MPLC(Si〇 2, 25 : 75甲醇/二氯甲烷)M獲得 0.18 g (47¾) 4”_^,4”-11-(丁-1,4-二基)史賓諾辛8碘鹽, 為黃裼色粉末。 富旆例MO-n.d-(戊_1·2-二基)中曹諾宰RM鹽 根據實施例C81之方法,由1,5-二碘丁烷(0.12 ml, 0.26 g, 0.81 mmol) ^ (i-Pr) 2 HE t (0.30 inL, 0.22 g, 1.7 mmol)、史賓諾辛 B(0.30 g, 0·42 mmol)及 DMF(1 ml) 製備化合物。MPLC(Si〇2, 25:75甲醇/二氯甲烷)以獲得 0·10 g (26¾) 4”^,4”叫-(戊-1,2-二基)史賓諾辛8碘鹽, 為黃褐色粉末。 管敝例nfi卜d . 4’Ί (_丁 ::L4-二基)中窨諾宰Π 根據實施例C81之方法,由1,4-二碘丁烷(0.22 ml, 0.52 g, 1.7 mmol) ^ U - P r) a N E t (0 . 44 inL, 0.33 g, 2.5 -166 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) I---*--S----- (請先閱讀背面之注意事項再填寫本頁) 訂 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(164 ) mmol)、史賓諾辛 C(0.60 g, 0.57 mmol)及 DMF(4 ml)製餚 化合物。MPLC(Si〇2, 5:95甲醇/二氯甲烷)M獲得〇·1〇 g (23%)4”^,4”-〖卜(丁-1,4-二基)史賓諾辛(:,為白色粉末 。MS U + HM 預期值:758.5。實際值:758.6。Rich Nosin B in Example C58-4 "-N- (l-Butyl) According to the method of Example C81, 1-iodobutane (0.13 ml, 0.2U, 1.1 mmol), (i- Pr) 2NEt (0.30 mL, 0.22 g, 1.7 mmol), Spinoxin B (0.40 g, 0.56 mmol) and DMF (2 oil) were used to prepare the compounds. MPLC (Si〇2, 50:50 EtOAc / hexane) K to obtain 0.41 g (95¾) butyl) Spinoloxine B as a white powder. MS (π + Η〃) expected: 774.5. Actual: 774.7. Fen example C59-4 "U ”-N- (butyl-1. 4-diyl) Φ Caoxin B iodide salt According to the method of Example C81, 1,4-diiodobutane (0.11 ml, 0.26 g, 0.83 mmol) was obtained. ^ (I -Pr) 2NEt (0.30 raL, 0.22 g, 1 * 7 mmol), spinosyn B (0.30 g, 0.42 mmol) and DMF (1 ml) to prepare the compound. MPLC (Si〇2, 25: 75 methanol / di Chloromethane) M obtained 0.18 g (47¾) 4 ”_ ^, 4” -11- (butyl-1,4-diyl) spinosin 8 iodized salt, which is a yellow-yellow powder. Rich example MO-nd -(Penta-1 · 2-diyl) sinozoline RM salt According to the method of Example C81, 1,5-diiodobutane (0.12 ml, 0.26 g, 0.81 mmol) ^ (i-Pr) 2 HE t (0.30 inL, 0.22 g, 1.7 mmol), Spinozin B (0.30 g, 0.42 mmol ) And DMF (1 ml) to prepare the compound. MPLC (Si〇2, 25:75 methanol / dichloromethane) to obtain 0 · 10 g (26¾) 4 "^, 4" called-(penta-1,2-di Base) Spinozin 8 iodized salt, as a yellow-brown powder. Examples of nfib d. 4 'Ί (_ Ding :: L4-diyl) in the Nuozai according to the method of Example C81, from 1, 4-Diiodobutane (0.22 ml, 0.52 g, 1.7 mmol) ^ U-P r) a NE t (0.44 inL, 0.33 g, 2.5 -166-This paper size applies to Chinese National Standard (CNS) A4 Specifications (210X 297 mm) I --- *-S ----- (Please read the notes on the back before filling this page) Order 487559 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Explain (164) mmol), Spinozin C (0.60 g, 0.57 mmol), and DMF (4 ml) for cooking compounds. MPLC (Si02, 5:95 methanol / dichloromethane) M obtained 0.10 g (23%) 4 "^, 4"-[Bu (Ding-1,4-diyl) Spinozin ( : White powder. MS U + HM Expected: 758.5. Actual: 758.6.

富施例Γ:62-4”-Ν . 4”_N_ (戊·卜二基)史賓諾辛C 根據實施例C81之方法,由1,5-二碘戊烷(0.25 ml, 0*54 g, 1.7 mmol) Λ (i-Pr)2NEt(0.44 mL, 0.33 g, 2.5 mmol)、史賓諾辛C(0.60 g, 0.57 mmol)及 DMF(4 ml)製備 化合物。MPLC(Si〇 2, 50:50乙酸乙酯/己烷)K獲得0.31 8(70%)4”_夂4”叫-(戊-1,4-二基)史賓諾辛(:,為白色粉末 。MS (m + HM 預期值:772.5。實際值:772.7。 窨)ife例(^3-4”叫.4”-1二71基中窨諾辛(: 根據實施例C81之方法,由碘乙烷(0.23 ml, 0.45 g, 2·9 mmol)、(i_Pr)2NEt (0,60 mL, 0.45 g, 3·4 mmol)、 史賓諾辛C(0.40 g, 0.57 mmol)及DMF(2 ml)製餚化合物 。MPLC(Si〇 2, 50 : 50 乙酸乙酯 / 己烷)K 獲得 0.38 g(88%) 4”1,4”-^-二乙基史賓諾辛(:,為白色粉末:1^(111 + ^)預 期值:760.5。實際值:760,7。C43Hs3N〇1Q2分析值: C, 67.96; Η, 9·15; Ν, 1·84。實際值:C, 68.01; H, 9*47; Ν, 1.83. 啻fe例CiU-4&quot;-N.4”U2-丁烯-1.4-二某)中客諾辛C及^: - Ν.ΠΜ 丁二烯-1 .4-二基)Φ 曹諾辛C 根據實施例C81之方法,由1,4-二氯丁-2-烯(0·1〇 ml ,0.12 g, 0.95 mmol) ^ Nal(0.02 g, 0*1 mmol), (i-Pr __ - 167 -__ ^^7度適用中國國家標準(〇?^)/\4規格(210/297公釐) ~~ .—^— (請先閱讀背面之注意事項再填寫本頁)Rich Example Γ: 62-4 ”-N. 4” _N_ (pent.budiyl) Spinoxin C According to the method of Example C81, 1,5-diiodopentane (0.25 ml, 0 * 54 g, 1.7 mmol) Λ (i-Pr) 2NEt (0.44 mL, 0.33 g, 2.5 mmol), Spinoxin C (0.60 g, 0.57 mmol) and DMF (4 ml) were used to prepare the compound. MPLC (Si〇2, 50:50 ethyl acetate / hexane) K obtains 0.31 8 (70%) 4 "_ 夂 4" called-(penta-1,4-diyl) spinosinol (:, is White powder. MS (m + HM expected value: 772.5. Actual value: 772.7.) Ife example (^ 3-4 "called .4" -1 2 71-base nuoxin (according to the method of Example C81, Made from iodoethane (0.23 ml, 0.45 g, 2.9 mmol), (i_Pr) 2NEt (0,60 mL, 0.45 g, 3.4 mmol), spinosin C (0.40 g, 0.57 mmol) and DMF (2 ml) cooking compound. MPLC (SiO 2, 50: 50 ethyl acetate / hexane) K to obtain 0.38 g (88%) 4 ”1,4”-^-diethylspinoxin (:, White powder: 1 ^ (111 + ^) Expected value: 760.5. Actual value: 760, 7. C43Hs3N01Q2 Analytical value: C, 67.96; Η, 9.15; Ν, 1.84. Actual value: C, 68.01; H, 9 * 47; Ν, 1.83. Examples of CiU-4 &quot; -N.4 "U2-butene-1.4-II) Sinokine C and ^:-Ν.ΠΜ butadiene- 1.4-diyl) Φ Caoxin C According to the method of Example C81, 1,4-dichlorobut-2-ene (0.10 ml, 0.12 g, 0.95 mmol) ^ Nal (0.02 g, 0 * 1 mmol), (i-Pr __-167 -__ ^^ 7 degrees apply Chinese national standard (〇? ^) / \ 4 specifications ( 210/297 mm) ~~ .— ^ — (Please read the notes on the back before filling this page)

、1T 487559 A7 ________B7_ 五、發明説明(165 ) )2NEt(0.22 mL,0.16 g, 1.3 mmol)、史賓諾辛C((K29 g ,0.41 mmol)及 DMF(1.5 ml)製餚這些化合物。MPLC(Si〇2 ,20:80乙酸乙酯/二氯甲烷)M獲得0·11 g(35%)4”-N,4” -N-(2-丁烯-1,4-二基)史賓諾辛C,為白色粉末:MS (πι + ΗΜ預期值:765.5。實際值:756.6,及 4”-Ν,4Μ-Ν-(丁二 烯-1,4-二基)史賓諾辛C:0.11 g (35¾),白色粉末:MS ( m + H + )預期值:754.5。實際值:75.8。溫和之室溫氧化作 用已說明此產物之生成。, 1T 487559 A7 ________B7_ 5. Description of the Invention (165)) 2NEt (0.22 mL, 0.16 g, 1.3 mmol), Spinoxin C ((K29 g, 0.41 mmol) and DMF (1.5 ml) to prepare these compounds. MPLC (Si02, 20:80 ethyl acetate / dichloromethane) M obtained 0.11 g (35%) of 4 "-N, 4" -N- (2-butene-1,4-diyl) history Binoxin C, is a white powder: MS (π + Η expected value: 765.5. Actual value: 756.6, and 4 "-N, 4M-N- (butadiene-1,4-diyl) spinosin C: 0.11 g (35¾), white powder: MS (m + H +) Expected value: 754.5. Actual value: 75.8. Mild room temperature oxidation has shown the formation of this product.

窨倫例C65-4”-N-「(6-氡-3-PH;啶基)甲基]史賓諾辛B 根據實施例C81之方法,由(6-氯-3-批啶基)氯甲烷( 0.14 g, 0*86 mmol), (i-Pr) 2 NEt (0.22 inL, 0.16 g, 1.3 mmol)、史賓諾辛 Β(0·30 g, 0.42 nnnol)及 DMF(1 ml) 製備化合物。MPLC(Si〇 2, 25:75至75:25乙酸乙酯/己烷 )K 獲得 0 · 3 0 g (8 6 % ) 4 ” - N - [ (6 ·•氯-3 - utt 陡基)甲基]史賓 諾辛B ,為白裼色粉末。Example: C65-4 "-N-" (6-fluoren-3-PH; pyridinyl) methyl] Spinoxin B According to the method of Example C81, from (6-chloro-3-pyridinyl) Chloromethane (0.14 g, 0 * 86 mmol), (i-Pr) 2 NEt (0.22 inL, 0.16 g, 1.3 mmol), Spinoloxin B (0.30 g, 0.42 nnnol), and DMF (1 ml) Preparation of compound. MPLC (Si02, 25:75 to 75:25 ethyl acetate / hexane) K to obtain 0.30 g (86%) 4 ”-N-[(6 · • chloro-3-utt Acryl) Methyl] Spinoxin B, a white ochre powder.

奮例C66-4”-N-「N · - (2.2-二甲基乙氯基羰基)-丙胺 騎某1中曹諾辛B 經濟部中央標準局員工消費合作社印製 ----.--·----- (請先閱讀背面之注意事項再填寫本頁) 根據實施例C77之方法,由Ν#(2χ0·12 ml, 0.22 g, 2.2 mmol), Boc~N(H)_/3 -Ala-C〇2H (0.17 g, 0.90 mmol )、B0P-C1 (0.23 g, 0.90 nnnol)、史賓諾辛 B(0.50 g, 0.70 mmol)及 CH2C12(7 ml)製備化合物。MPLC(Si〇2, 70: 30 至 100:0 乙酸乙酯 / 己烷)K 獲得 〇·62 g (99!U4”-N-[N’ -(2,2-二甲基乙氧基羰基)-/3 -丙胺醯基]史賓諾辛B,為 白裼色粉末:MS (m + H Μ預期值:889 ♦ 5。實際值:889 · 7 -168 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(2ίΟ·Χ 297公釐) 487559 A7 B7 五、發明説明(166 ) ° C4BH7BN2〇13之分析:估計值·♦ C,64,84; H, 8.62; N, 3·15。實際值:C, 64·38; Η,8·87; Ν, 3·22。 (請先閱讀背面之注意事項再填寫本頁)Fen example C66-4 "-N-" N ·-(2.2-dimethylethylchlorocarbonyl) -propylamine riding 1 printed by Cao Nuoxin B Central Consumers Bureau of the Ministry of Economic Affairs employee consumer cooperatives --------- -· ----- (Please read the precautions on the back before filling this page) According to the method of Example C77, Ν # (2χ0 · 12 ml, 0.22 g, 2.2 mmol), Boc ~ N (H) _ / 3 -Ala-C〇2H (0.17 g, 0.90 mmol), BOP-C1 (0.23 g, 0.90 nnnol), Spinoxin B (0.50 g, 0.70 mmol) and CH2C12 (7 ml) to prepare the compound. MPLC ( Si〇2, 70: 30 to 100: 0 ethyl acetate / hexane) K to obtain 0.62 g (99! U4 "-N- [N '-(2,2-dimethylethoxycarbonyl)- / 3 -propylamine base] Spinoxin B, white ochre powder: MS (m + H MM expected value: 889 ♦ 5. actual value: 889 · 7 -168-This paper size applies to Chinese national standards (CNS ) A4 specification (2ί〇 × X 297 mm) 487559 A7 B7 V. Description of the invention (166) ° Analysis of C4BH7BN2013: Estimated value · C, 64,84; H, 8.62; N, 3 · 15. Actual value : C, 64 · 38; Η, 8.87; Ν, 3.22. (Please read the notes on the back before filling this page)

例C67-Π - fN ·-(茏基甲氯甚羰某)-i -丙防酿甚1中 曹諾辛B 根據實施例C77之方法,由NMM(2x0.12 ml, 0.22 s, 2.2 mmol), Boc~N (H)-L-A 1 a-CO 2 Η (0.21 g, 0.94 niinol )、B0P-C1 (0·24 g, 0,94 mmol)、史賓諾辛 Β(0·50 g, 〇·70 nmol)及 CH2C12(7 ml)製備化合物。MPLC(Si〇2, 75: 25,乙酸乙酯/己烷)以獲得0.68 g (99ίϋ)Π-[Ν’-(苯基 甲氧基羰基)-L-丙胺醯基]史賓諾辛Β,為白色粉末:MS ( m + HM預期值:923.5。實際值:923.7。 啻敝例α8-4”-Ν-「ΝΉ ’ -二甲基甘胺某Π中曹諾辛B 根據實施例C77之方法,由NMM(2x0.12 ml, 0*22 g, 2.2 mmol), Ν (Me)2~G1y-CO2Η (0.09 g, 0.9 mmol) - Β0Ρ-C1 (0·25 g, 0.98 mmol)、史賓諾辛B(0.50 g, 0·70 mmol)及 CH2C12(7 ml)製備化合物。MPLC(Si〇2, 5:95, Me0H/CH2Cl2)K 獲得 0.43 g (77S04”-N-[fT,N’-二甲基 經濟部中央標準局員工消費合作社印製 甘胺醯基)]史賓諾辛B,為白色粉末:MS (m + H‘)預期值: 803.5。實際值:803.6。 啻敝例 「Ν,· N ’ -(戊, 5-二基)-β -丙胺i基.]史Example C67-Π-fN ·-(Methylmethylchlorosulphonate) -i-Protein Bronze 1Zonoxin B According to the method of Example C77, NMM (2x0.12 ml, 0.22 s, 2.2 mmol ), Boc ~ N (H) -LA 1 a-CO 2 Η (0.21 g, 0.94 niinol), B0P-C1 (0 · 24 g, 0,94 mmol), Spinosin B (0 · 50 g, 0.70 nmol) and CH2C12 (7 ml). MPLC (Si02, 75: 25, ethyl acetate / hexane) to obtain 0.68 g (99ίϋ) Π- [N '-(phenylmethoxycarbonyl) -L-propylaminofluorenyl] Spinoxin B , Is a white powder: MS (m + HM expected value: 923.5. Actual value: 923.7. Example α8-4 "-N-" ΝΉ '-dimethylglycine in a certain zonoxin B according to Example C77 Method: NMM (2x0.12 ml, 0 * 22 g, 2.2 mmol), Ν (Me) 2 ~ G1y-CO2Η (0.09 g, 0.9 mmol)-Β0Ρ-C1 (0.25 g, 0.98 mmol), Spinoxin B (0.50 g, 0.70 mmol) and CH2C12 (7 ml) were used to prepare the compound. MPLC (Si〇2, 5:95, Me0H / CH2Cl2) K yielded 0.43 g (77S04 ”-N- [fT, N'-Dimethyl Ethylene Glycoxyl, printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs)] Spinoxin B, white powder: MS (m + H ') Expected value: 803.5. Actual value: 803.6. 啻Example "N, · N '-(pent, 5-diyl) -β-propylamine i-group.] History

賓諾辛B 根據實施洌C77之方法,由ΝΜΜ(2χΟ·12 ιηΐ,0·22 g, 2.2 mmol), N , H (CH 2) 5 -/3 - A 1 a-CO 2 H (0 . 14 g, 0.89 niinol )、B0P-C1 (0.26 g, 1.0 mmol)、史賓諾辛 B(〇,50 g, - 169 -__ 本纸張尺度適用中國國家標準(CNS ) A4規格(2i〇:&lt;297公廣) 487559 A7 ___ . B7 · 五、發明説明(167 ) 0·70 mmol)及 CH2C12(7 ml)製備化合物。MPLC(Si〇2, 5: 95 至 10:90, MeOH/CH2Cl2)M 獲得 〇·54 g (9〇%)4”-N-[N’, IT-(戊-1,5-二基)-/3 -丙胺醯基]史賓諾辛B,為白色粉末 :MS (ιη + Η*)預期值:857.6。實際值:857.8。 富施例C70-4”4卜「N · . ^ -二Z基-θ -芮胺醯基]史賓諾辛E 根據實施例C77之方法,由NMM(0.24 ml, 〇·22 g, 2‘2 mmol &amp; 0·12 ml, 0·11 g, 1·1 mmol), H,N(Et)2- /3 -Ala-C〇2H · HC1 (0·16 g, 0,88 mmol)、B0P-C1 (0·26 g, 1.0 mmol)、史賓諾辛 Β(0·50 g ,0.70 mmol)及CH2C12 (7 ml)製備化合物。MPLC(Si〇2, 5:95 至 10:90, MeOH/ CH2C12)K 獲得 0.46 g (78¾) 4”-N-[N’,N’-二乙基-丙胺醯基]史賓諾辛B,為白色粉末:MS (m + H + )預期值: 845.6。實際值:845.δ。 經濟部中央標準局員工消費合作社印製 啻_例(:7卜4”咄-[«’-(9-笏基甲氢某羰某)-)3-丙胺8?1基1 中客諾辛Β及丙胺醯某)Φ窨諾宰Β 根據實施例C77之方法,由NMM(2x0.12 ml, 0.22 g, 2.2 mraol &amp; 0.12 ml, 0.11 g, 1.1 mmol), Fmoc-H(H)-/3 -Ala-C〇2H(0.26 g, 0.84 mmol)、B0P-C1 (0.23 g, 0.90 nunol)、史賓諾辛B(0.502 g ,0.699 mmol)及 CH2C12 (7 ml)製備化合物。MPLC(Si〇2, 0:100 至 20:80, MeOH/ CH2C12)M 獲得 0.03 g («)4”-Ν-[Ν’-(9-芴基甲氧基羰基 )-/3-丙胺醯基]史賓諾辛Β,為白色粉末:MS (m + ΙΓ)預 期值:1011.6。4”1-(/3-丙胺醯基)史賓諾辛8 0.278(49 %),為白色粉末:MS (m + HM預期值:789.5。實際值: -170 - 本紙張尺度適用中國國家標準(CNS ) Α·4規格(21QX 297公釐) A7 · B7 五、發明説明(168) 789.7。於反應條件下Fmoc基之溫和的去保護作用已說明 此產物之生成。Binoxin B was prepared according to the method of 洌 C77 by NMM (2χΟ · 12 ιηΐ, 0.22 g, 2.2 mmol), N, H (CH 2) 5-/ 3-A 1 a-CO 2 H (0. 14 g, 0.89 niinol), B0P-C1 (0.26 g, 1.0 mmol), Spinozin B (0, 50 g,-169 -__ This paper size applies to China National Standard (CNS) A4 specification (2i〇: &lt; 297 Gongguang) 487559 A7 ___. B7. V. Description of the invention (167) 0.70 mmol) and CH2C12 (7 ml) to prepare the compound. MPLC (Si〇2, 5: 95 to 10:90, MeOH / CH2Cl2) M to obtain 0.54 g (90%) 4 "-N- [N ', IT- (penta-1,5-diyl) -/ 3 -Propanamidinyl] Spinoxin B, white powder: MS (ιη + Η *) Expected value: 857.6. Actual value: 857.8. Rich Example C70-4 "4." N ·. ^- Di-Z-based-theta-amidino] Spinoxin E According to the method of Example C77, NMM (0.24 ml, 0.22 g, 2'2 mmol &amp; 0.12 ml, 0.11 g, 1.1 mmol), H, N (Et) 2- / 3 -Ala-C〇2H · HC1 (0.16 g, 0,88 mmol), BOP-C1 (0.26 g, 1.0 mmol), history Compounds were prepared with binoxin B (0.50 g, 0.70 mmol) and CH2C12 (7 ml). MPLC (Si〇2, 5:95 to 10:90, MeOH / CH2C12) K yielded 0.46 g (78¾) 4 "- N- [N ', N'-Diethyl-propylaminopropyl] Spinosin B, white powder: MS (m + H +) expected: 845.6. Actual value: 845.δ. Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (eg 7: 4 "咄-[« '-(9-Watki Methane)-) 3-propylamine 8? 1 base 1 Β and propylamine 窨 窨 窨 窨 宰 宰 B according to the method of Example C77, from NMM (2x0.12 ml, 0.22 g, 2.2 mraol &amp; 0.12 ml, 0.11 g, 1.1 mmol), Fmoc-H (H)- / 3 -Ala-C0H (0.26 g, 0.84 mmol), BOP-C1 (0.23 g, 0.90 nunol), spinosyn B (0.502 g, 0.699 mmol) and CH2C12 (7 ml) to prepare the compound. MPLC ( Si〇2, 0: 100 to 20:80, MeOH / CH2C12) M to obtain 0.03 g («) 4" -N- [N '-(9-fluorenylmethoxycarbonyl)-/ 3-propylaminofluorenyl] Spinozin B, white powder: MS (m + ΙΓ) Expected value: 1011.6. 4 "1-(/ 3-propylaminofluorenyl) Spinozin 8 0.278 (49%), white powder: MS ( m + HM expected value: 789.5. Actual value: -170-This paper size applies Chinese National Standard (CNS) A · 4 specifications (21QX 297 mm) A7 · B7 V. Description of the invention (168) 789.7. Under reaction conditions The mild deprotection of the Fmoc group has demonstrated the formation of this product.

啻朐例C72-4”-N-(二乙氢基膦臓基)中客諾宰R 將(Et0)2P(0)Cl (91 ml, (Kll g, 〇·63 mmol)及 (i - Pt)2NEt (0.22 ml, 0.16 g, 1.3 mmol)依序添加至史 賓諾辛 Β(0·30 g, 0·42 mmol)之 CH2C12(4 ml)溶液。於2 天後,混合物於(^2(:12與“}](:〇3間平衡。M鹽水清洗有機 層,M(Na2S0d乾燥及過滹及蒸發。MPLC(Si〇2, EtOAc) Μ獲得0.27 g (75%)4”-N-(二乙氧基隣醯基)史賓諾辛B為 白色粉末。 啻_例C73-N-三氣代Z醢基-N-关甲某中客諾幸Π 經濟部中央標準局員工消費合作社印製 -------i----- (請先閱讀背面之注意事項再填寫本頁) 將一部分三氟代乙酸酐(0.16 ml, 1,1 mmol)添加至 冷(0°C )、已適當攪拌之N-去甲基史賓諾辛D(0,4 g, 0.54 mmol)及三乙胺(0.2 ml, l\5 mmol)之乙酸乙酯溶液。移 開冷卻浴並於室溫下攪拌溶液40分鐘,接著倒入冰水(40 ml)中。將產物萃取於乙酸乙酯(3x15 ml)中並Μ飽和 NaHC〇3(6 ml)及鹽水(6 ml)清洗有機萃取物,並以(MgS〇4 )乾燥。蒸發溶劑以餘留0.4 g乾淨之Μ-三氟代乙醯基-N-去甲基史賓諾辛D,為無色泡沫體ΜΗ-NMR (CDC13) δ 6·76 (s, 1Η, Η-13), 5·49 (s, 1Η, Η-5),4·86 (d, 1Η ,Η-1·), 4.66 (、, 1Η, Η-21), 4·51 (d, 1Η, H-l”), 4·30(ιπ, 1Η, FM, 3·0 and 2·88 (s,總計 3Η, N(CH3)) ;MS m/z 139 (70) , 224 (100)。 窨旆例C74-N- (2 . 2 . 2-三氣代Ζ氢基)糖棊-Ν-去甲甚中客 -171 - 本紙浪尺度適用中國國家標準(CNS ) Λ4規格(210.Χ 297公釐) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(169)For example, C72-4 "-N- (diethylhydrophosphinofluorenyl), Kenozo R will be (Et0) 2P (0) Cl (91 ml, (Kll g, 0.63 mmol) and (i- Pt) 2NEt (0.22 ml, 0.16 g, 1.3 mmol) was sequentially added to a solution of Spinoxin B (0.30 g, 0.42 mmol) in CH2C12 (4 ml). After 2 days, the mixture was mixed with (^ 2 (: 12 and "}] (: O3. The organic layer was washed with brine, M (Na2SOd was dried and dried and evaporated. MPLC (SiO2, EtOAc)) 0.27 g (75%) 4"- N- (diethoxy-o-fluorenyl) Spinozin B is a white powder. Example C73-N-Three gas generation Z-fluorenyl-N-Guan Jia, an employee of Sinok Norsk, Ministry of Economic Affairs, Central Standards Bureau Printed by Consumer Cooperatives ------- i ----- (Please read the notes on the back before filling this page) Add a part of trifluoroacetic anhydride (0.16 ml, 1,1 mmol) to the cold ( 0 ° C), properly stirred N-desmethylspinoxin D (0,4 g, 0.54 mmol) and triethylamine (0.2 ml, l \ 5 mmol) in ethyl acetate solution. Remove and cool Bath and stir the solution at room temperature for 40 minutes, then poured into ice water (40 ml). The product was extracted in ethyl acetate (3x15 ml) and saturated with NaHC03 (6 ml) and brine (6 ml). clear The organic extract was dried over (MgS04). The solvent was evaporated to leave 0.4 g of clean M-trifluoroacetamido-N-desmethylspinoxin D as a colorless foam MΗ-NMR ( CDC13) δ 6.76 (s, 1Η, Η-13), 5.49 (s, 1Η, Η-5), 4.86 (d, 1Η, Η-1 ·), 4.66 (,, 1Η, Η -21), 4.51 (d, 1Η, Hl ”), 4.30 (ιπ, 1Η, FM, 3.0 and 2.88 (s, total 3Η, N (CH3)); MS m / z 139 (70), 224 (100). Example C74-N- (2.2. 2-Three-Gas Z-Hydrogenated) Hydroxylamine-N-Norca-Zhongke-171-The standard of this paper is applicable to Chinese national standards (CNS) Λ4 specification (210. × 297 mm) 487559 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (169)

諾宰A 將無水f(2C〇3(0.12 g, 0.87 mmole)添加至已適當攪 拌之史賓諾辛A(1.5 g, 2.0 nunol)及2,2,2_三氯乙基氯甲 酸酯(0.8 ml, 5.5 mmol)之乾苯(20 ml)溶液。在迴流溫 度下將所得混合物加熱48小時,接著冷卻至室溫並倒入冰 水(100 ml)。將產物萃取於乙酸乙酯(3x40 ml)中並以鹽 水(40 ml)清洗有機萃取物,並M (MsSO4)乾燥。將蒸發溶 劑後之殘餘物(2.7 g) Μ氧化矽(170 ml)進行閃蒸層析, 利用2 :1己烷/乙酸乙酯為溶析液以獲得N M 2,2 , 2-三氯代 乙氧基)羰基-N-去甲基史賓諾辛A(1.3 g),為無色泡沬體 :NMR (CDCla) δ 6.76 (s, 1H, H-13), 4.86 (d, 1H, H-l,), 4.75 (m, 3H, C13CCH2, H-21), 4.48 (m, 1H, Η-ΓΊ, 4.32 (m, 1H, H-9) ; MS m/z 189 (100), 302 (28) , 591 (32) , 893 (77)。 窨瓶例C7LN-(2.2.2-三氡代乙氢基)羰某-N-去甲基中W 諾宰Π 於2-3分鐘内,將2,2,2-三氯代氯甲酸酯(0.07 ml, 0.51 nunol)之CH2C12(2 ml)溶液逐滴加入經攪拌之N-去甲 基史賓諾辛D(0.15 g, 0.20 mmol)及吡啶(0.3 ml)的 CH2C12 (4 ml)溶液中。在室溫下攪拌溶液6小時,接著以 水(5 ml)稀釋。分離有機層及連續以1H HC 1(5 ml)、飽和 NaHC〇3(5 ml)及鹽水(5 ml)清洗,並以(MgS〇4)乾燥。濃 縮餘留之殘餘物(0.42 g),該殘餘物餘以氧化矽(90 ml) 進行閃蒸層析,利用2 :1己烷/乙酸乙酯為溶析液K獲得 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) I - - ...... - 4— - In ,&gt;&gt;I— I - - _ - in (請先閱讀背面之注意事項再填寫本頁)Novozymes Anhydrous f (2CO3 (0.12 g, 0.87 mmole) was added to Spinozin A (1.5 g, 2.0 nunol) and 2,2,2-trichloroethylchloroformate, which had been properly stirred (0.8 ml, 5.5 mmol) of dry benzene (20 ml). The resulting mixture was heated at reflux temperature for 48 hours, then cooled to room temperature and poured into ice water (100 ml). The product was extracted in ethyl acetate ( 3x40 ml) and washed the organic extract with brine (40 ml), and dried M (MsSO4). The solvent residue (2.7 g) M silica (170 ml) was subjected to flash chromatography using 2: 1 hexane / ethyl acetate was used as the eluent to obtain NM 2,2,2-trichloroethoxy) carbonyl-N-desmethylspinoxin A (1.3 g) as a colorless foamed carcass: NMR (CDCla) δ 6.76 (s, 1H, H-13), 4.86 (d, 1H, Hl,), 4.75 (m, 3H, C13CCH2, H-21), 4.48 (m, 1H, Η-ΓΊ, 4.32 (m, 1H, H-9); MS m / z 189 (100), 302 (28), 591 (32), 893 (77). Example of a flask C7LN- (2.2.2-tris (2,4-methyl) ethane) ) Carboxamole-N-desmethyl in W Nuozai, in 2-3 minutes, the solution of 2,2,2-trichlorochloroformate (0.07 ml, 0.51 nunol) in CH2C12 (2 ml) Add dropwise N-desmethylspinoxin D (0.15 g, 0.20 mmol) and pyridine (0.3 ml) in a solution of CH2C12 (4 ml). The solution was stirred at room temperature for 6 hours and then diluted with water (5 ml). The organic layer was separated and washed successively with 1H HC 1 (5 ml), saturated NaHC0 3 (5 ml) and brine (5 ml), and dried over (MgS04). The remaining residue was concentrated (0.42 g) The residue was subjected to flash chromatography using silica (90 ml), and 2: 1 hexane / ethyl acetate was used as the eluent K to obtain the paper size applicable to the Chinese National Standard (CNS) A4 (210X 297) %) I--......-4—-In, &gt; &gt; I— I--_ -in (Please read the notes on the back before filling this page)

、1T 487559 A7 ____ _ - B7 五、發明説明(170 ) 0·15 g(803〇之N-(2,2,2-三氯代乙氧基)羰基-N-去甲基史 賓諾辛D,為無色泡沫體:iH_NMR (CDC13) 5 6.76 (s, 1H, Η-13), 5·48 (s, 1H, H-5), 4.86 (d, 1H, H_l,), 4.76 (m, 2H, C13CCH2), 4.66 (m, 1H, H-21), 4·48 (ro ,1H, H-1”),4.30 (m, 1H, H-9), 2·37 and 2.85 (s, 總共 3H, NCH3)。1T 487559 A7 ____ _-B7 V. Description of the invention (170) 0 · 15 g (803〇N- (2,2,2-trichloroethoxy) carbonyl-N-desmethylspinoxin D, colorless foam: iH_NMR (CDC13) 5 6.76 (s, 1H, Η-13), 5.48 (s, 1H, H-5), 4.86 (d, 1H, H_l,), 4.76 (m, 2H, C13CCH2), 4.66 (m, 1H, H-21), 4.48 (ro, 1H, H-1 ”), 4.30 (m, 1H, H-9), 2.37 and 2.85 (s, total 3H, NCH3).

富觥例C76-H- (2, 2 , 2-三氡代乙«基)羰某-N-去甲蓽-7-禪 基中窨諾辛D 經濟部中央標準局員工消費合作社印製 1:: I I I..... 1叫 i - I — y- —-I - - I (請先閱讀背面之注意事項再填寫本頁) 5¾在氧化矽(0·21 g)上之36〇2及第三丁基羥過氧化物 (90%, 0·07 mmol)之CH2C12(3 ml)懸浮液在室溫下攪拌15 分鐘。於該混合物中,於2-3分鐘內,逐滴加入N-三-氯代 乙氧基羰基-N-去甲基史賓諾辛D(0.15 g, (K16 ππηοΐ)之 CH2C12 (2 ml)溶液。在室溫下攪拌混合物1.5小時,接著 過濾。所收集之固體KCH2C12(10 ml)清洗並合併滤液及 以水(5 ml)及鹽水(5 ml)清洗並M (MsS〇4)乾燥。濃縮餘 留之0.11 g殘餘物,該殘餘物係以氧化矽(90ml)進行閃蒸 層析,利用《之甲醇的CH2C12M獲得63 mgN-(2,2,2_三氯 代乙氧基)羰基-N-去甲基-7-羥基史賓諾辛D,為白色泡沫 體 ^H-NMR (CDC13) δ 6*76(s, 1H, H-13), 5.58 (s, 1 Η, Η-5), 4·6-4.9 (m, 4H, Η-1,,H-21, C13CCH2), 4·48 U, 1H, H-l”), 4·40 (m, 1H, H-9)。Rich case C76-H- (2, 2, 2-Tris (3,2'-ethoxy) yl) carbonyl-N-nor-methyl-7-Zenji Zhongyinxinxin D Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 1 :: II I ..... 1 called i-I — y- —-I--I (Please read the precautions on the back before filling out this page) 5¾ 36 on silicon oxide (0 · 21 g) A suspension of 2 and a third butyl hydroxyperoxide (90%, 0.07 mmol) in CH2C12 (3 ml) was stirred at room temperature for 15 minutes. To this mixture, N-tri-chloroethoxycarbonyl-N-desmethylspinoxin D (0.15 g, (K16 ππηοΐ)) CH2C12 (2 ml) was added dropwise over 2-3 minutes. The solution. The mixture was stirred at room temperature for 1.5 hours and then filtered. The collected solid KCH2C12 (10 ml) was washed and the filtrates were combined and washed with water (5 ml) and brine (5 ml) and dried over M (MsS04). The remaining 0.11 g of the residue was concentrated. The residue was subjected to flash chromatography with silica (90 ml), and 63 mg of N- (2,2,2-trichloroethoxy) carbonyl was obtained by using CH2C12M of methanol. -N-desmethyl-7-hydroxyspinoxin D, a white foam ^ H-NMR (CDC13) δ 6 * 76 (s, 1H, H-13), 5.58 (s, 1 Η, Η- 5), 4 · 6-4.9 (m, 4H, Η-1 ,, H-21, C13CCH2), 4.48 U, 1H, Hl "), 4 · 40 (m, 1H, H-9).

富倫例C77-「N ’ - (2,2-二甲基Z氢甚糠某)甘胺醯甚1 中客謀辛B 將 4-甲基嗎啉(ΝΜΜ)(0.12 ml, 0,11 g,1.1 mmol)添 本紙浪又度適用中國國家標準(CNS ) A4規格(210X 297公釐) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(171) 加至-15°C 之 Boc-N(H)-GIy-C〇2H(0.16 g, 0,91 mraol)及 B 0P-C1 (0·23 g, 0·90 mmol)之 CH2C12(7 ml)溶液中。於 1. 5小時後,在減壓下使體積減少約一半。依序加入史賓 諾辛 B(0.50 g ,0.70 mmol)及 NMM(0.12 ml, 0·11 g, 1·1 πιιηο 1)。將混合物加熱至室溫20小時;蒸發混合物。 MPLC(Si〇 2, 50:50 至 100:0, EtOAc/己烷)Μ 獲得 0·61 g ( 991) 4 ”-Ν-[Ν’-(2,2-二甲基乙氧基羰基)甘胺醯基]史賓諾 辛B,為白色粉末:MS (m + HM預期值:875.5。實際值: 875.9 〇Fulleren Case C77- "N '-(2,2-Dimethyl Z Hydrogen Bran) Glycine 醯 1 1 Coke Mou B B 4-methylmorpholine (NMM) (0.12 ml, 0,11 g, 1.1 mmol) This paper is compatible with the Chinese National Standard (CNS) A4 specification (210X 297 mm) 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (171) Add to -15 ° C in Boc-N (H) -GIy-C〇2H (0.16 g, 0,91 mraol) and B 0P-C1 (0.23 g, 0.90 mmol) in CH2C12 (7 ml). In 1 After 5 hours, the volume was reduced by about half under reduced pressure. Spinoxin B (0.50 g, 0.70 mmol) and NMM (0.12 ml, 0.11 g, 1.1 πιηο 1) were added sequentially. The mixture was added Warm to room temperature for 20 hours; evaporate the mixture. MPLC (SiO2, 50:50 to 100: 0, EtOAc / hexane) M to obtain 0.61 g (991) 4 "-N- [N '-(2, 2-dimethylethoxycarbonyl) glycinamido] Spinoxin B, white powder: MS (m + HM expected: 875.5. Actual: 875.9)

窨敝例C78-K-M代乙醢基中W諾辛B 將史賓諾辛B(104.4 mg, 0.145 mmol)溶於二氯甲烷( 5 ml)並加入Ν,Ν -二異丙基乙胺(0.1 g, 0.8 mmol)及二氯 甲烷f (0.1 g, 0*9 mmol)並攪拌反應物1小時。於殘餘物 逐漸反應形成後,藉由矽膠(乙酸乙酯/己烷,50: 50)層析 純化Μ提供N-氯代乙醯基史賓諾辛B(79.1 mg, 68¾),為 無色玻璃狀物:FDMS ra/z 794 CC42HWN0HC1之分析:估 計值:C,63.50, H, 8.12; 1.76。實際值:C, 63.32; H, 8.04; M, 1.58 。 富_例C7Q-N- (N ’ -Z某硫代胺某甲醮蓽)中曹諾辛_£ 將化合物史賓諾辛B(97.8 mg, 0.136 mmol)溶於甲苯 (4 ml)並加入異硫代氰酸乙酯(0.05 g, 0·6 nunol)及將反 應物在迴流溫度下加熱2小時。減壓下去除甲苯溶劑及藉 由矽膠(乙酸乙酯/己烷,梯度20: 80至50: 50)上之層析 純化殘餘物以提供化合物N- (N 乙基硫代胺基甲驢基)史 _____- 174 -_ 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X29*7公釐) ----------0-- (請先閲讀背面之注意事項再填寫本頁) 、11 經濟部中央標準局員工消費合作社印製 487559 A7 * B7 _ 五、發明説明(172 ) 賓諾辛B,為無色玻璃狀物:FDMS m/z 804, 805。Example C78-KM Substituted for Aethynyl W Nuoxin B Spinoloxin B (104.4 mg, 0.145 mmol) was dissolved in dichloromethane (5 ml) and Ν, Ν -diisopropylethylamine ( 0.1 g, 0.8 mmol) and dichloromethane f (0.1 g, 0 * 9 mmol) and the reaction was stirred for 1 hour. After the residue was gradually formed, the residue was purified by silica gel (ethyl acetate / hexane, 50:50) chromatography to provide N-chloroethynylspinoxin B (79.1 mg, 68¾) as a colorless glass. Object: Analysis of FDMS ra / z 794 CC42HWN0HC1: Estimate: C, 63.50, H, 8.12; 1.76. Actual values: C, 63.32; H, 8.04; M, 1.58. Enrichment example C7Q-N- (N'-Z a thioamine and a formamidine) Cao Nuoxin_ Compound Spinoloxin B (97.8 mg, 0.136 mmol) was dissolved in toluene (4 ml) and added Ethyl isothiocyanate (0.05 g, 0.6 nunol) and the reaction was heated at reflux temperature for 2 hours. The toluene solvent was removed under reduced pressure and the residue was purified by chromatography on silica gel (ethyl acetate / hexane, gradient 20:80 to 50:50) to provide the compound N- (Nethylthioaminomethyldonyl) ) History _____- 174 -_ This paper size applies to Chinese National Standard (CNS) Λ4 specification (210X29 * 7mm) ---------- 0-- (Please read the notes on the back before filling This page), 11 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A7 * B7 _ V. Description of the invention (172) Binoxin B, a colorless glass: FDMS m / z 804, 805.

甯敝例CS0-4”-N-「(4-(三氟甲氩基)笼某1胺某糠基中客諾 辛B 將4(三氟甲氧基)苯基異氰酸酯(94 ml, 0.13 g, 0.63 mmol)及 DMF(3 ml, 3 mg, 0,04 mmol)依序添加至0 °C之史賓諾辛B(0.30 g, 0.42 mmol)之乙醚(4 ml)溶液。 將混合物加熱至室溫15分鐘。經由添加甲醇(1 ml)分解過 量之異氰酸酯並蒸發混合物。MPLC(Si〇 2, 50: 50,乙酸 乙酯/己烷)以獲得0*37§(971)4”-^[(4-(三氟甲氧基)苯 基]胺基羰基史賓諾辛B,為白色粉末:MS(m + H + )預期值: 921.5。實際值:921,6。Example CS0-4 "-N-" (4- (trifluoromethyl arginyl) cage 1 amine certain furfuryl kenoxin B will be 4 (trifluoromethoxy) phenyl isocyanate (94 ml, 0.13 g, 0.63 mmol) and DMF (3 ml, 3 mg, 0,04 mmol) were sequentially added to a solution of Spinozin B (0.30 g, 0.42 mmol) in ether (4 ml) at 0 ° C. The mixture was heated 15 minutes to room temperature. Decompose excess isocyanate by adding methanol (1 ml) and evaporate the mixture. MPLC (SiO2, 50: 50, ethyl acetate / hexane) to obtain 0 * 37§ (971) 4 "- ^ [(4- (trifluoromethoxy) phenyl] aminocarbonyl spinosyn B, white powder: MS (m + H +) expected value: 921.5. Actual value: 921.6.

奮細例C81 基中富諾辛B 碘乙综(0·11 ml, 0·21 g, 1·4 mmol)及(i-Pt)2NEt( 0.36 ml, 0.27 g, 2.1 mmol)依序添加至史賓諾辛B(0.05 g, 0.70 mmol)之 DMF(1.5 ml)溶液。藉由 TLC(Si〇2)及 HPLC(C1B)監測反應過程。於顯示充分轉換(1-5天)後,蒸 發反應物。殘餘物在乙酸乙酯及碳酸氫鈉間分配。有機層 Μ鹽水清洗,K(MgS〇4)乾燥,過滤及蒸發。MPLC(Si〇2, 50: 50乙酸乙酯/己烷)Μ獲得0.55 g(89!U4”-N-乙基史 賓諾辛B,為白色粉末:MS(m + H + )預期值:746.5。實際 值·· 746.7。 -175 - 本纸張尺度適用中國國家標隼(CNS ) Λ4規格(2丨0X297公慶1 -------a----衣-- (請先閱讀背面之注意事項再填寫本頁)Casein C81 Funosin B Iodine Ethyl Complex (0.11 ml, 0.21 g, 1.4 mmol) and (i-Pt) 2NEt (0.36 ml, 0.27 g, 2.1 mmol) were sequentially added to the history A solution of binoxin B (0.05 g, 0.70 mmol) in DMF (1.5 ml). The progress of the reaction was monitored by TLC (SiO2) and HPLC (C1B). After showing sufficient conversion (1-5 days), the reaction was evaporated. The residue was partitioned between ethyl acetate and sodium bicarbonate. The organic layer was washed with brine, dried over K (MgS04), filtered and evaporated. MPLC (SiO2, 50: 50 ethyl acetate / hexane) M obtained 0.55 g (89! U4 "-N-ethyl spinosin B, white powder: MS (m + H +) expected value: 746.5 Actual value 746.7. -175-This paper size is applicable to China National Standard (CNS) Λ4 specification (2 丨 0X297 Gongqing 1 ------- a ---- clothing-(Please read first (Notes on the back then fill out this page)

、1T 經濟部中央標準局員工消費合作社印製 487559 , A7 — B7 五、發明説明(173 )、 1T Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559, A7 — B7 V. Description of Invention (173)

富旆例C82 - U”S) -4”-去甲基-(二甲基胺基)- 4”-甲氩某中 審諶辛A 將化合物(4”5)-4”-去甲基_(二甲基胺基)-4”-羥基史 賓諾辛 A (2. 21 g ; 3· 08 mmol)溶於 CH2C12 (60 ml)。添加 水(20ml), 10¾ aq· NaOH (25 ml)及 K2C〇3 固體(5 g),接 著加入硫酸二甲酯(8 m 1 ,過量)。在室溫及氛氣下劇烈攪 拌反應混合物48小時。加入水(50 ml)及CH2C12 (50 ml), Ί吏分層,有機層以H2〇(2X)清洗,以K2C〇3乾燥及在減壓下 濃縮。殘餘物藉由閃蒸3丨〇2管柱層析(230-400 m, 250g/ 乙酸乙酯)分離。Enrichment example C82-U "S) -4" -desmethyl- (dimethylamino)-4 "-methylargon (Dimethylamino) -4 "-hydroxyspinoxin A (2.21 g; 3.08 mmol) was dissolved in CH2C12 (60 ml). Water (20 ml), 10¾ aq · NaOH (25 ml) and K2CO3 solids (5 g) were added, followed by dimethyl sulfate (8 ml, excess). The reaction mixture was stirred vigorously at room temperature under atmosphere for 48 hours. Water (50 ml) and CH2C12 (50 ml) were added, and the layers were separated. The organic layer was washed with H20 (2X), dried over K2CO3, and concentrated under reduced pressure. The residue was separated by flash column chromatography (230-400 m, 250 g / ethyl acetate).

奮施例C83-4”- (S) - 4”-去甲基_ (二甲基胺某)-4”-^気甚 Φ窨謠辛A 將化合物(4”S) -4”-去甲基-(二甲基胺基)-4”-羥基史 賓諾辛 M2.21 g; 3.08 mmol)溶於 CH2C12(60 ml)。添加 水(20ml), 10¾ aq. NaOH (25 ml)及 K2C〇3 固體(5 g),接 著加入硫酸二乙酯(8 m 1,過量)。在室溫及氮氣下劇烈攪 拌反應混合物48小時。加入水(50 ml)及CH2C12 (50 ml), 使分層,有機層以H2〇(2x)清洗,以K2C〇3乾燥及在減壓下 濃縮。殘餘物藉由閃蒸^〇2管柱層析(230-400 m, 250g/ 乙酸乙酯)分離。Fenshi C83-4 "-(S)-4" -desmethyl_ (dimethylamine a) -4 "-^ 窨 Φ 窨 窨 A A compound (4” S) -4 ”-to Methyl- (dimethylamino) -4 "-hydroxyspinoxin M2.21 g; 3.08 mmol) was dissolved in CH2C12 (60 ml). Water (20 ml), 10¾ aq. NaOH (25 ml) and K2CO3 solid (5 g) were added, followed by diethyl sulfate (8 ml 1, excess). The reaction mixture was stirred vigorously at room temperature under nitrogen for 48 hours. Water (50 ml) and CH2C12 (50 ml) were added to separate the layers. The organic layer was washed with H2O (2x), dried over K2C03 and concentrated under reduced pressure. The residue was separated by flash column chromatography (230-400 m, 250 g / ethyl acetate).

窨旆例C84-4”- (S) -4T’_尖申某-(二甲基胺某)-4”-丙氬甚 中窨諶辛A 將化合物4”-(S) -4”-去甲基-(二甲基胺基)-4&quot;-羥基 史賓諾辛 Ml .22 g, 1.70 mmo 1)溶於 CH2C ί 2 (20 ml ):添 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 糾7559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(174) 加水(20 ml),1〇% NaOH水溶液(25 ml),接著加入K2C〇3( 2 g),氯化四丁基銨(1.2 g)及氯化苄基三乙基銨(1.5 g) 。加入卜碘丙烷(10 ml)並在室溫及氮氣下劇烈攪拌反應 混合物48小時。加入二氯甲烷(20 m 1)並使相分離。以水( 2x)清洗有機層,以K2C〇3乾燥及在減壓下濃縮。殘餘物藉 由閃蒸$丨〇2管柱層析(120 g/乙酸乙酯)純化。 實施例C85-4n- ) - 4”-去甲某-(二田某胺某)- 4”-氣申某Example C84-4 "-(S) -4T'_ Jian Shenmou-(dimethylamine a certain)-4"-propyl argon, but also amidin A compound 4 "-(S)-4"- Demethylated- (dimethylamino) -4 &quot; -hydroxyspinoxin Ml. 22 g, 1.70 mmo 1) Soluble in CH2C ί 2 (20 ml): The paper size applies to Chinese National Standard (CNS) A4 specifications (210X 297 mm) (Please read the notes on the back before filling in this page) Revision 7559 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (174) Water (20 ml), 1 0% NaOH aqueous solution (25 ml), followed by K2CO3 (2 g), tetrabutylammonium chloride (1.2 g) and benzyltriethylammonium chloride (1.5 g). Diiodopropane (10 ml) was added and the reaction mixture was stirred vigorously at room temperature under nitrogen for 48 hours. Dichloromethane (20 ml) was added and the phases were separated. The organic layer was washed with water (2x), dried over K2CO3 and concentrated under reduced pressure. The residue was purified by flash column chromatography (120 g / ethyl acetate). Example C85-4n-)-4 "-Normone- (Nita-amine)-4" -Qi Shenmou

史窨諶辛A 將化合物4”- (S) -4”-去甲基-(二甲基胺基)-4”-羥基 史賓諾辛 M510 mg, 0.71 mmol)溶於 CH2C12(5.0 rol)並加 入K2C〇3(l.l〇 g)。將反應燒瓶浸於水浴(i(TC )中並隨劇 烈攪拌添加水溶液(10 ml),接著添加氯化苄基三 乙基鞍(1.20 g)。加入氯碘甲烷(5.0 ml)並在室溫及氮氣 下劇烈攪拌反應混合物72小時。加入二氯甲烷(100 m 1)及 水(50 ml)。使相分離。以水(2x)清洗有機層,以K2C〇3乾 燥及在減壓下濃縮。殘餘物藉由閃蒸S i 0 2管柱層析(70 g/ 乙酸乙酯)純化。Shi Xingxin A Compound 4 ”-(S) -4” -desmethyl- (dimethylamino) -4 ”-hydroxyspinoxin M510 mg, 0.71 mmol) was dissolved in CH2C12 (5.0 rol) K2C03 (110 g) was added. The reaction flask was immersed in a water bath (i (TC)) and an aqueous solution (10 ml) was added with vigorous stirring, followed by benzyl triethyl saddle chloride (1.20 g). Added Chloroiodomethane (5.0 ml) and the reaction mixture was stirred vigorously at room temperature under nitrogen for 72 hours. Dichloromethane (100 ml) and water (50 ml) were added. The phases were separated. The organic layer was washed with water (2x), Dry over K2CO3 and concentrate under reduced pressure. The residue was purified by flash Si02 column chromatography (70 g / ethyl acetate).

實施例C 8 6 - 4 n _ ( S ) - 4 ” -去甲甚-(二曱某胺甚)-4 ” -三甲基 阪烷氬基中窨諶李A 將化合物4”- (S ) -4”-去甲基_(二甲基胺基)-4” _羥基 史賓諾辛 A(510 mg, 0.71 mmol)溶於 CH2C12(10.0 ml)。 加入二甲基胺吡啶(〇 · 80 g )。在室溫及氮氣下攪拌混合物 。經由注射器緩慢地導入三甲基矽烷基三氟甲基磺酸鹽( 〇 · 90 m U過量)並持續擬拌1小時_:·添加乙酸乙酯(50 m 1 ) _ 177 - 本纸張尺度適用中國國家標準r〇NS ) A4規格(210X 297公釐) ~ (請先閲讀背面之注意事項再填寫本頁) ··裝. 加 經濟部中央標準局員工消費合作社印製 487559 A 7 _ B7 五、發明説明(lM ) 及苯(50 ml)。以5¾ aq. NaHC〇3溶液(3x)清洗溶液。有機 層以K2C〇3乾燥及在減壓下乾燥。殘餘物藉由閃蒸〗丨〇2管 柱層析(100 g/乙酸乙酯)純化。Example C 8 6-4 n _ (S)-4 ”-Norso- (diphosphonium amine) -4” -trimethylsane argonyl sulphone A A compound 4 ”-(S ) -4 "-desmethyl_ (dimethylamino) -4" _hydroxyspinoxin A (510 mg, 0.71 mmol) was dissolved in CH2C12 (10.0 ml). Dimethylamine pyridine (〇 · 80 g). Stir the mixture at room temperature under nitrogen. Slowly introduce trimethylsilyl trifluoromethanesulfonate (0.99 U excess) through the syringe and continue to mix for 1 hour. Ester (50 m 1) _ 177-This paper size is applicable to the Chinese national standard rNS) A4 size (210X 297 mm) ~ (Please read the precautions on the back before filling out this page) ·· Packing. + Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards 487559 A 7 _ B7 V. Description of the invention (1M) and benzene (50 ml). Wash the solution with 5¾ aq. NaHC〇3 solution (3x). Dry the organic layer with K2C03 Dry under reduced pressure. The residue was purified by flash column chromatography (100 g / ethyl acetate).

奮施例C87- (4”S卜4’’-去甲某-(二甲基胺基)-4”-乙鹼氬某 中窨銪辛A 將化合物(4”3)-4”-去甲基-(二甲基胺基)-4”-羥基史 賓諾辛A(10 rag, 0.14 mraol)溶於二氯甲烷並加入乙酸酐( 0,05g, 0.5 mmol)及吡啶(0.1 g, 1 mmol),及攪拌反應 物2小時。逐漸反應以獲得化合物(4”S)-4”_去甲基-(二甲 基胺基)-4”_乙醯氧基史賓諾辛A。 窨旆例C88-4”- 去甲基-(二甲基胺基卜4”_氛乙驗Example C87- (4 "S, 4" -normethyl- (dimethylamino) -4 "-ethyl base, arginine, amidin, A, compound (4" 3) -4 "-to Methyl- (dimethylamino) -4 ”-hydroxyspinoxin A (10 rag, 0.14 mraol) was dissolved in dichloromethane and acetic anhydride (0,05 g, 0.5 mmol) and pyridine (0.1 g, 1 mmol), and the reaction was stirred for 2 hours. The reaction was gradually obtained to obtain the compound (4 "S) -4" _desmethyl- (dimethylamino) -4 "_acetamoxyspinoxin A. 窨Example C88-4 "-Demethyl- (dimethylamino group 4" _

g甚中g諾辛A 將化合物4”- (S) -4”-去甲基-(二甲基胺基)-4”-羥基 史賓諾辛A (306 mg,0.43 mmo 1)溶於乾吡啶(5 ml)。逐滴 加入氯乙酸氯化物(〇 . 50 πι 1)。在室溫及氮氣下攪拌反應 混合物。於3小時後,加入甲苯(50 ml)及乙酸乙酯(50 ml )。將溶液連續以鹽水、5¾ NaHC〇3(2X)及水清洗。以無水 Na2S〇4乾燥有機層並在減壓下乾燥。殘餘物藉由閃蒸Si〇2 管柱層析(80 g/乙酸乙酯)純化。 窨施例化合物4”-二氯-4”-去胺基-5,6-二氣史賓g very neutral g nosin A Soluble compound 4 "-(S) -4" -desmethyl- (dimethylamino) -4 "-hydroxyspinoxin A (306 mg, 0.43 mmo 1) in Dry pyridine (5 ml). Chloroacetic acid chloride (0.50 μm 1) was added dropwise. The reaction mixture was stirred at room temperature under nitrogen. After 3 hours, toluene (50 ml) and ethyl acetate (50 ml) were added. ). The solution was successively washed with brine, 5¾ NaHC〇3 (2X) and water. The organic layer was dried over anhydrous Na2SO4 and dried under reduced pressure. The residue was subjected to flash Si02 column chromatography (80 g / Ethyl acetate). 窨 Example Compound 4 "-Dichloro-4" -Deamin-5,6-Digas Speen

諶辛A 將5,6-二氫史賓諾辛A N-氯化物(1.26 g, 1·68 mmol )溶於乾THF(l〇 ml)。將溶液冷卻至_78°C並加入吡啶(5 ml) ·:·在攪拌時,加入三氣乙酸酐(1·8 ml, 2.67 g, 12.7 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) (請先閲讀背面之注意事項再填寫本頁) 裝. 經濟部中央標準局員工消費合作社印製 487559 A7 —____ B7___ 五、發明説明(l〇fc ) mmol)。於16小時後,加入乙醚(120 ml),以稀釋鹽水(2x )萃取混合物,接著以10¾ KHC〇3(2X)萃取,及以K2C〇3乾 燥並於減壓下濃縮。殘餘物藉由閃蒸3丨〇2管柱層析(乙_) 分離以獲得化合物3”,4”-二氫-4”-去胺基-5,6-二氫史賓 諾辛 A(122 mg, 10.5%),為白色固體:l-NMR δ 6.82 ( bs, 1Η), 5.61 (m, 1Η), 5·53 (bd, J = 10 HZ, 1Η), 4.66 (q, J = 6 HZ, 1H), 1.23 (d, J 二 6.3 Hz, 3H), 1 · 19 (d,J = 6 · 6 H z , 3 H) , 1 · 15 (d , J = 7.0 H z:, 3 H) 審旆例CQ0-仆合物5, fi-二氯-N-甲醯某-中客謀幸R及仆i合 物4”-去胺基-5,6-二氣-4”某史窨諾辛C 將5,6-二氫史賓諾辛AC1.43 g, 1.95 mmol)溶於二氯 甲烷(25 m 1)及添加吡啶(6.0 m 1)。將燒瓶冷卻至+10°C。 在氮氣下隨劇烈攪拌加入溴(3.0 ml)。加入水(2.0 ml)並 持續攪拌1小時。添加乙醚(200 ml),混合物連續以水(10 %NaHS〇3)溶液、水及10% 1^(:〇3水溶液萃取,以無水!(2(:〇3 乾燥,過濾及濃縮。將粗産物區分2相等部分。一部分藉 由閃蒸層析(Si〇2/Et2〇)純化並藉由重復RP (018) HPLC (92 ^ :δ, MeOH/H2〇)分離以獲得化合物5,6-二氫-Ν-甲醯基-史 賓諾辛 B(230 mg, 31¾),為白色固體 - NMR δ. 7.95 (b s)及 7·93 (bs,總基 1H), 6.74(bs, 1H), 2·64 (s, 3H) ,1.14 (d, J =5.8 Hz, 3H), 1.05 (d, J = 6.9 Hz, 3H ),1 · 0 2 (d , J = 6 · 3 H z,3 H )及 b)溶析份濃縮至約 5 0 % 4 n _去胺基-5,6 -二氫-4 ” -酮基史賓諾辛C (16 8 m g,约1 2 ίϊί) -179 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)Phenoxin A 5,6-dihydrospinoxin A N-chloride (1.26 g, 1.68 mmol) was dissolved in dry THF (10 ml). Cool the solution to _78 ° C and add pyridine (5 ml) ·: · While stirring, add three gas acetic anhydride (1.8 ml, 2.67 g, 12.7) This paper size applies Chinese National Standard (CNS) A4 specifications ( 210 X 297 mm) (Please read the notes on the back before filling out this page). Packing. Printed by the Employees' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 —____ B7___ 5. Description of the Invention (10fc) mmol). After 16 hours, diethyl ether (120 ml) was added and the mixture was extracted with dilute brine (2x), followed by extraction with 10¾ KHC03 (2X), dried with K2CO3 and concentrated under reduced pressure. The residue was separated by flash column chromatography (ethyl) to obtain compound 3 ", 4" -dihydro-4 "-deamin-5,6-dihydrospinoxin A ( 122 mg, 10.5%) as a white solid: l-NMR δ 6.82 (bs, 1Η), 5.61 (m, 1Η), 5.53 (bd, J = 10 HZ, 1Η), 4.66 (q, J = 6 HZ, 1H), 1.23 (d, J 6.3 Hz, 3H), 1 · 19 (d, J = 6 · 6 H z, 3 H), 1 · 15 (d, J = 7.0 H z :, 3 H ) Examination of the history of CQ0-complex 5, fi-dichloro-N-formamine-Zhongke Mou Xing R and complex 4 ”-deamin-5,6-digas-4” Panaxine C Dissolve 5,6-dihydrospinoxin AC (1.43 g, 1.95 mmol) in dichloromethane (25 m 1) and add pyridine (6.0 m 1). Cool the flask to + 10 ° C Bromine (3.0 ml) was added with vigorous stirring under nitrogen. Water (2.0 ml) was added and stirring was continued for 1 hour. Ether (200 ml) was added, and the mixture was continuously mixed with a solution of water (10% NaHS〇3), water and 10%. 1 ^ (: 〇3 aqueous solution was extracted with anhydrous! (2 (: 〇3 dried, filtered and concentrated. The crude product was divided into 2 equal parts. One part was purified by flash chromatography (Si〇2 / Et2〇) and borrowed. Repeated RP (018) HPLC (92 ^: δ, MeOH / H2〇) To obtain compound 5,6-dihydro-N-methylamidino-spinoxin B (230 mg, 31¾) as a white solid-NMR δ. 7.95 (bs) and 7.93 (bs, total 1H) , 6.74 (bs, 1H), 2.64 (s, 3H), 1.14 (d, J = 5.8 Hz, 3H), 1.05 (d, J = 6.9 Hz, 3H), 1.02 (d, J = The 6 · 3 H z, 3 H) and b) fractions were concentrated to about 50% 4 n -deamino-5,6-dihydro-4 ”-ketospinoxin C (16 8 mg, about 1 2 ίϊί) -179-This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印製 487559 A7 ___ B7 五、發明説明(177 ) 上述步驟在5倍大之規模上重複進行,其導致産生純4 ” -去 胺基-5,6-二氫- 4”-酮基史賓諾辛C(212 mg, 3.1¾),為白 色固體&quot;H-NMR 0' 6,79 (bs, 1H), 4·90 (dd, J = 8.2 Hz, 2.5Hz), 3.95 (q, J = 6.7 HZ); 13C-NMR d 208.7, 203.2, 172.6, 149.6, 145.1, 100.9,95.4, 17.6 (CHa) ,16.1 (CH3), 15·3 (CH3), 9.2 (CH3)·Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A7 ___ B7 V. Description of the Invention (177) The above steps were repeated on a scale 5 times larger, which resulted in the production of pure 4 "-deamin-5,6-dihydro -4 ”-ketospinoxin C (212 mg, 3.1¾) as a white solid &quot; H-NMR 0 '6,79 (bs, 1H), 4.90 (dd, J = 8.2 Hz, 2.5Hz ), 3.95 (q, J = 6.7 HZ); 13C-NMR d 208.7, 203.2, 172.6, 149.6, 145.1, 100.9, 95.4, 17.6 (CHa), 16.1 (CH3), 15.3 (CH3), 9.2 (CH3 ) ·

富旆例C9卜化合物4”-去胺甚-5· 二氫-4 H)-揮某中窜 諶辛C 4”-去胺基-5,6-二氫-4”-酮基史賓諾辛C (192 mg, 0 . 273 mmo 1)溶於乾乙醚(50 m 1)。溶液冷卻至0 °C並加入 一部分氫化三-卜丁基鋁鋰(97%, 145 mg, 0,55 mmol)。 在相同之溫度下持續攪拌15分鐘。接著以鹽水小心地驟冷 反應混合物。加入乙醚(1〇〇 ml)並以Na〇H(2x)萃取混 合物,接著以10¾ KHCCh水溶液萃取,以K2CCh乾燥並濃縮 。粗産物在閃蒸S i0 2管柱(Et0Ac)層析純化並.藉由RP (018 )HPLC (92 :8, MeOH/H2〇)分離以獲得化合物4”_去胺基-5, 6 -二氫-4ff (S)-羥基史賓諾辛C(91 ms,47%),為白色固體: 'H-NMR d 6.81 (bs, 1 Η), 4.43 (bd, J =7.4 Hz, 1H), 3.57 (m, 1 H), 1.21 (d, J =6.1 Hz, 6H), 1.12 (d, J =6·9 Hz, 3H)。Enriched Example C9 Compound 4 "-deaminase-5 · dihydro-4 H) -C4" -deaminyl-5,6-dihydro-4 "-keto Spinolol Octyl C (192 mg, 0.273 mmo 1) was dissolved in dry ether (50 ml 1). The solution was cooled to 0 ° C and a portion of lithium tri-butyl aluminum hydride (97%, 145 mg, 0,55 mmol) was added. Stirring was continued for 15 minutes at the same temperature. Then the reaction mixture was carefully quenched with brine. Diethyl ether (100 ml) was added and the mixture was extracted with NaOH (2x), followed by extraction with 10¾ KHCCh aqueous solution, dried with K2CCh and Concentrated. The crude product was purified by flash chromatography on a Si02 column (Et0Ac) and separated by RP (018) HPLC (92: 8, MeOH / H20) to obtain compound 4 "-deamino-5, 6-Dihydro-4ff (S) -hydroxyspinoxin C (91 ms, 47%) as a white solid: 'H-NMR d 6.81 (bs, 1 Η), 4.43 (bd, J = 7.4 Hz, 1H), 3.57 (m, 1 H), 1.21 (d, J = 6.1 Hz, 6H), 1.12 (d, J = 6.9 Hz, 3H).

富旆例⑺?-化合物4,’_关胺基氧_4” (S」'闬氫基i 富諶辛C 4”-去胺基-5,6-二氫-4”(S卜瘦基史賓諾辛C(66 mg, 0 · 093 mmo 1 )溶於二氯甲烷(1 . 5 ιη丨)°加入碘甲院(2 · 0 m 1 -180 - . 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公發) 丨 f i--衣-- (請先閱讀背面之注意事項再填寫本頁) 、-口 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(178) ),接著加入40¾ NaOH水溶液(3.0 ml)及溴化四丁基磷鐵( 320 mg)。在室溫及氮氣下劇烈攪拌反應混合物並加入粉 末狀K0H(10 ml)及Et 20 ( 100 ml),以水清洗混合物,接著 以10¾ KHC〇3水溶液(2x)清洗。以無水K2C〇3乾燥有機層, 過濾並於減壓下乾燥。殘餘物在閃蒸S i 0 2管柱(C Η 2 C 12 - E t 2 0)純化以提供化合物4 ” -去胺基-5,6 -二氫-4 ” (S)-甲氯基 史賓諾辛C,為白色固體^H-NMR δ 6.82 (bs, 1H), 4.43 (dd, J = 9.4 Hz, 1.9 Hz), 3.52 (s, 3H), 3.46 (s, 3H), 3.45 (s, 3H), 3.32 (s, 3H), 1.25 (d, J = 6·3 Hz, 3H), 1.20 (d, J = 6·1, 3H), 1.14 (d, J 二 6.8 Hz, 3H), 0.77 (t, J = 7.4 Hz, 3H).Is it rich? -Compound 4, '-guanamine oxygen_4 "(S"' hydrazone i Fusinocin C 4 "-deamin-5,6-dihydro-4" (Sb-Spinyl Spinocin C (66 mg, 0 · 093 mmo 1) dissolved in dichloromethane (1.5 ιη 丨) ° Added to Iodine Academy (2 · 0 m 1 -180-. This paper size applies to Chinese National Standard (CNS) A4 specifications (Issued by 210X 297) 丨 f i--yi-- (please read the precautions on the back before filling out this page),-487559 Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description ), Followed by 40 ¾ NaOH aqueous solution (3.0 ml) and tetrabutyl iron phosphate bromide (320 mg). The reaction mixture was stirred vigorously at room temperature under nitrogen and powdered KOH (10 ml) and Et 20 (100 ml) were added. The mixture was washed with water, followed by 10¾ KHC03 aqueous solution (2x). The organic layer was dried over anhydrous K2CO3, filtered and dried under reduced pressure. The residue was flashed in a Si02 column (CΗ2) (C12-Et2 0) purified to provide compound 4 "-deamin-5,6-dihydro-4" (S) -methylchlorospinoxin C, as a white solid ^ H-NMR δ 6.82 ( bs, 1H), 4.43 (dd, J = 9.4 Hz, 1.9 Hz), 3.52 (s, 3H) , 3.46 (s, 3H), 3.45 (s, 3H), 3.32 (s, 3H), 1.25 (d, J = 6.3 Hz, 3H), 1.20 (d, J = 6.1, 3H), 1.14 (d, J 6.8 Hz, 3H), 0.77 (t, J = 7.4 Hz, 3H).

D部分化釋式I化合物之三璟部分h 1 3·丹1 4 ’位晉的修飾 窖旆例旧-(14R) -13, 14-二氮-Φ窨諾辛A 在氮氣環境下,於史賓諾辛A (1.0 gms, 1.37 mmol) 之純乙醇(20 ml)溶液中,於0·5小時内,部分部分地添加 硼氫化鈉(520 mg,13 · 7 mmo 1)。在室溫下攪拌反應混合 物45分鐘,接著藉由添加飽和氯化銨水溶液驟冷。接著以 水稀釋並以二氯甲烷萃取。以K2C〇3乾燥二氯甲烷部分並 在室溫及減壓下蒸發。將産物在氧化矽上藉由層析純化', 以5¾甲醇之氯仿溶液稀釋。因所得之分離效果不佳,故重 覆層析,於回收産物後,以乙酸乙酯稀釋。所得之(14R) -13,14-二氫-史賓諾辛A為無色玻璃狀物,FDMS, m/e (相 對強度)734 (M、100) , 733 (60)。 蓠旆例D2 - (14S) - 5 . 14-四氯-中富 - 181 _ 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 1&gt;ϋϋ' I I i^^F· —·ϋι n&gt;i—^ ϋϋϋ I ml i (請先閲讀背面之注意事項再填寫本頁) 、-s'tv 487559 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(179) 依實施例D5所述進行反應,以史賓諾辛A(106.8 mg, 0.15 mmol)為起始物質。所得(14S)-5,6, 13, 14-四氫-史 賓諾辛A(85.5 mg;産率80%)為無色,稍具黏性之固體, FDMS, m/e (相對強度)736 (M+, 100)。Part D illustrates the third part of the compound of formula I. The modified cell of h 1 3 · Dan 1 4 ′ is an example of old- (14R) -13, 14-diazepine-Φ. In a solution of Spinozin A (1.0 gms, 1.37 mmol) in pure ethanol (20 ml), sodium borohydride (520 mg, 13.7 mmo 1) was partially added within 0.5 hours. The reaction mixture was stirred at room temperature for 45 minutes, and then quenched by the addition of a saturated aqueous ammonium chloride solution. It was then diluted with water and extracted with dichloromethane. The dichloromethane portion was dried over K2CO3 and evaporated at room temperature under reduced pressure. The product was purified by chromatography on silica, diluted with 5¾ methanol in chloroform. Because the obtained separation effect was not good, the chromatography was repeated. After the product was recovered, it was diluted with ethyl acetate. The obtained (14R) -13,14-dihydro-spinosin A is a colorless glass, FDMS, m / e (relative strength) 734 (M, 100), 733 (60). Example D2-(14S)-5. 14-tetrachloro-Zhongfu-181 _ This paper size applies to China National Standard (CNS) A4 (210 x 297 mm) 1 &gt; ϋϋ 'II i ^^ F · — · Ϋι n &gt; i— ^ ϋϋϋ I ml i (Please read the notes on the back before filling this page), -s'tv 487559 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Α7 Β7 V. Description of the invention (179) According to The reaction was carried out as described in Example D5, and Spinoxin A (106.8 mg, 0.15 mmol) was used as a starting material. The obtained (14S) -5,6, 13, 14-tetrahydro-spinoxin A (85.5 mg; yield 80%) was a colorless, slightly viscous solid, FDMS, m / e (relative strength) 736 (M +, 100).

審旆例03- (Ί 4R ) -5、6.13. 1 4-四氯-史賓諾辛A 於(14R)-13,14-二氫史賓諾辛 A(210.3 mg, 0.29 mmol)之苯(9 ml)溶液,加入氯化叁(三苯基膦)铑(1)( 47.2 mg, 0.05 mmol)並將反應混合物置於氫氣環境下。 在室溫下攪拌混合物4天,接著在室溫及減壓下蒸發溶劑 。藉由在氧化矽上層析純化産物,以5%甲醇之二氯甲烷柄 釋。藉由在氧化矽上層析進一步純化産物,以70¾乙酸乙 酯稀釋。所得(14R )-5,6, 13, 14-四氫-史賓諾辛A為無色玻 璃狀物,FDMS, πι/e (相對強度)735 (M' 100)。Examination Example 03- (Ί 4R) -5, 6.13. 1 4-tetrachloro-spinoxin A at (14R) -13,14-dihydrospinoxin A (210.3 mg, 0.29 mmol) (9 ml) solution, tris (triphenylphosphine) rhodium (1) (47.2 mg, 0.05 mmol) was added and the reaction mixture was placed under a hydrogen atmosphere. The mixture was stirred at room temperature for 4 days, and then the solvent was evaporated at room temperature under reduced pressure. The product was purified by chromatography on silica and released with 5% methanol in dichloromethane. The product was further purified by chromatography on silica and diluted with 70¾ ethyl acetate. The obtained (14R) -5,6,13,14-tetrahydro-spinozin A was a colorless glass, FDMS, π / e (relative strength) 735 (M '100).

窨施例[)4- (13R . 14S) 3. 14-璟氯某-中窨謀辛A 於史賓諾辛A(200.7 mg, 0.27 mmol)之甲醇(3 ml)的 冰冷溶液中,加入30¾過氧化氫(41 ml, 1.35 mmol)溶液 及接著加入氫氧化鈉(19 mg, 0.33 mmol)。在〇°C下攪拌 反應混合物1小時,並接箸加熱至室溫:於室溫下攪拌3小 時後,以二氯甲烷稀釋混合物。接箸以水清洗二氯甲烷, 以5%硫代硫酸鈉清洗,以K2C〇3乾燥,並在室溫及減壓下 蒸發。所得之(13R,14S)-13,14-環氧基-史賓諾辛Α(200·2 mg, 99%),為無色玻璃狀物,FDMS, m/e (相對強度)747 (M、100)。 奮旆例H Π 4S) - Γ). . U . 14-四氬-去氩甚 -132 - 本紙張尺度適用中國國家標準(CNS ) Λ4規格(21GX 297公釐) (請先閲讀背面之注意事項再填寫本頁) 、1Τ 487559 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(18〇 ) 於3,-去氧基史賓諾辛J(l〇8.8 mg, 0.16 mmol)之乙 酸乙酯(50 m 1 )溶液中,加入氧化鋁/把(1 〇〇 mg )。將反應 混合物置於60 ps i之氫氣下並在室溫下攪拌8小時。於過 濾催化劑後,在室溫及減壓下蒸發溶劑。藉由在氣化矽上 之層析純化殘餘物,以2 . 5%乙醇之乙酸乙酯溶液稀釋。所 得之(14S)-5,6,13 ,14 -四氫·去氧基史賓諾羊J為白色固體 ,FDMS, m/e (相對強度)707 (65), 706 (MH+, 100)。Example [) 4- (13R. 14S) 3. 14-Chlorine-Medium Moxin A In an ice-cold solution of Spinoxin A (200.7 mg, 0.27 mmol) in methanol (3 ml), add 30¾ solution of hydrogen peroxide (41 ml, 1.35 mmol) followed by sodium hydroxide (19 mg, 0.33 mmol). The reaction mixture was stirred at 0 ° C for 1 hour and then heated to room temperature: after stirring at room temperature for 3 hours, the mixture was diluted with dichloromethane. Then, dichloromethane was washed with water, washed with 5% sodium thiosulfate, dried over K2CO3, and evaporated at room temperature under reduced pressure. The obtained (13R, 14S) -13,14-epoxy-spinoxin A (200 · 2 mg, 99%) was a colorless glass, FDMS, m / e (relative strength) 747 (M, 100). Fen Heng Example H Π 4S)-Γ).. U. 14-tetra-argon-de-argon-132-This paper size is applicable to Chinese National Standard (CNS) Λ4 size (21GX 297 mm) (Please read the note on the back first) Please fill in this page for further information), 1T 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Invention Description (18〇) in 3, -Deoxyspinoxin J (108.8 mg, 0.16 mmol) To a solution of ethyl acetate (50 m 1), alumina / barrel (1000 mg) was added. The reaction mixture was placed under hydrogen of 60 ps i and stirred at room temperature for 8 hours. After the catalyst was filtered, the solvent was evaporated at room temperature under reduced pressure. The residue was purified by chromatography on gasified silicon and diluted with 2.5% ethanol in ethyl acetate. The obtained (14S) -5,6,13,14-tetrahydrodeoxy Spino sheep J is a white solid, FDMS, m / e (relative strength) 707 (65), 706 (MH +, 100).

窨施例D6 - (14S卜1 14-二氫-史賓諾辛A 將史賓諾辛A(454 mg, 0.620 mmol)溶於乙醚(50 ml) 中。在氮氣及室溫下,以劇烈攪拌於此溶液中加入氫化三 丁氧基鋁鋰(475 mg, 97%, 1.81 mmol)。持續攪拌 18 小時。接著以乙酸乙酯(70 m 1)及甲苯(50 m 1)稀釋及小心 地以鹽水驟冷。所得混合物以鹽水(2X )清洗,並接著以5¾ 碳酸氫鈉水溶液(2x)清洗。以無水K2C〇3乾燥及於減壓下 濃縮。藉由在閃蒸Si〇2管柱(30 g, 0.05%Dtt啶之乙酸乙酯 溶液)純化殘餘,以獲得化合物(14S)-1 3,14-二氫-史賓諾 辛A(421 mg, 92%)針狀物(乙酸乙酯-己烷)。111.9.150-152〇C ; [a ] 589 = -77.4°(CHCl3) ; ^-NMR (CDCla, 300 MHz) d 3.56 (1H, m), 3.00 (1H, dd: 9.0, 9.0 Hz), 2.32 (1H, m), 2·14 (6H, 2xCH3, s)ppm; MR FAB MS (Example D6-(14S, 14-Dihydro-Spinoxin A, Spinoxin A (454 mg, 0.620 mmol) was dissolved in ether (50 ml). Under nitrogen and room temperature, vigorously To this solution was added lithium tributoxy aluminum hydride (475 mg, 97%, 1.81 mmol). Stirring was continued for 18 hours. Then diluted with ethyl acetate (70 m 1) and toluene (50 m 1) and carefully It was quenched with brine. The resulting mixture was washed with brine (2X) and then with 5¾ sodium bicarbonate aqueous solution (2x). It was dried over anhydrous K2CO3 and concentrated under reduced pressure. By flashing a Si02 column (30 g, 0.05% Dttidine in ethyl acetate), purify the residue to obtain compound (14S) -1 3,14-dihydro-spinoxin A (421 mg, 92%) needles (ethyl acetate Ester-hexane). 111.9.150-152 ° C; [a] 589 = -77.4 ° (CHCl3); ^ -NMR (CDCla, 300 MHz) d 3.56 (1H, m), 3.00 (1H, dd: 9.0 , 9.0 Hz), 2.32 (1H, m), 2.14 (6H, 2xCH3, s) ppm; MR FAB MS (

MfT) C41FU8N〇la 之分析:估計值:m/z 734.4843;實際 值:m/z 734.4853; CnHuNOi。之分析:估計值:C 67·09, Η 9·20, N 1.91;實際值:C 67·30, Η 9·39, Ν 1 · 95 -183 - 本纸張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) - ·11 n mj^ n^i ϋ^,ιϋ 11.^1 i 1^1 (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印裝 487559 A7 B7 ----------------- 五、發明説明(181 )MfT) Analysis of C41FU8N0la: Estimated value: m / z 734.4843; Actual value: m / z 734.4853; CnHuNOi. Analysis: Estimated value: C 67 · 09, Η 9 · 20, N 1.91; Actual value: C 67 · 30, Η 9 · 39, Ν 1 · 95 -183-This paper size applies to China National Standard (CNS) Α4 Specifications (210 × 297 mm)-· 11 n mj ^ n ^ i ϋ ^, ιϋ 11. ^ 1 i 1 ^ 1 (Please read the precautions on the back before filling this page) Order the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Printing 487559 A7 B7 ----------------- 5. Description of the invention (181)

窨旆例(N-锊基)胺基-13, 14-烯基中窨柒幸A 將史賓諾辛Α(3·54 g, 4·71 nunol)溶於乙醇(80 ml) ,加入10%氫氣化鈉水溶液(15 m 1 ),接箸立刻加入羥基銨 鹽酸鹽(2 . 0 g ,過量)。攪拌反應混合物45分鐘。接著加 入乙酸乙酯(50 ml)及甲苯(100 ml)。以鹽水、接箸以5¾ 碳酸氫鈉(3x)萃取。以K2C〇3乾燥有機層及在減壓下乾燥 。使殘餘物於減壓下完全乾燥並溶放CH2C12(50 ml)。加 入三乙胺(5 m 1:)接著加入甲磺醯氯(2 * 5 m 1:)。於攪拌30分 鐘後,加入甲苯(70 ml)及乙酸乙酯(50 ml)。以5¾磺酸氫 鈉(3x)清洗溶液。有機層以K2C〇3乾燥並在減壓下濃縮。 將殘餘物溶於無水甲苯(30 ml),加入DBUU.O ml)及在迴 流下加熱反應混合物ί在氮氣下)30分鐘。冷卻溶液,加入 甲苯(50 ml)及以水(4χ)萃取溶液。以K2C〇3乾燥及在減壓 下濃縮。藉由閃蒸管柱層析(Si〇2/Et0Ac)分離及接箸藉由 製備型HPLC (塗覆氧化矽之018 , 10%水之甲醇溶液為移動 相)以獲得化合物13 - (N-羥基)胺基-13, 14-烯基史賓諾辛A (1·45 g, 40¾) IR v 1722, 1618, 1120 cml, Cl MS m/z 763 (M + l); UMR (CDCI3, 300 MHz) d 3.55 (1H, m), 2.60 (1H, dd:9.0, 9.0 Hz), 2.36 (1H, bd:5.0 Hz), 2*13 (6H, 2x CH3,s) ppm; 13C-HMR (CDCIg, 300 MHz) d 200·7 (共軛 〇〇), 166.5 (四级 C), 107.8 (四级 C) Ppm °For example, (N-fluorenyl) amino-13, 14-alkenyl, luckily A. Spinoxin A (3.54 g, 4.71 nunol) was dissolved in ethanol (80 ml), and 10 was added. % Sodium hydroxide aqueous solution (15 m 1), and then immediately added hydroxyammonium hydrochloride (2.0 g, excess). The reaction mixture was stirred for 45 minutes. Then add ethyl acetate (50 ml) and toluene (100 ml). Extract with brine, followed by 5¾ sodium bicarbonate (3x). The organic layer was dried over K2CO3 and dried under reduced pressure. The residue was completely dried under reduced pressure and CH2C12 (50 ml) was dissolved. Add triethylamine (5 m 1 :) followed by methanesulfonyl chloride (2 * 5 m 1 :). After stirring for 30 minutes, toluene (70 ml) and ethyl acetate (50 ml) were added. Wash the solution with 5¾ sodium bisulfate (3x). The organic layer was dried over K2CO3 and concentrated under reduced pressure. The residue was dissolved in anhydrous toluene (30 ml), DBUU (0 ml) was added and the reaction mixture was heated under reflux (under nitrogen) for 30 minutes. The solution was cooled, toluene (50 ml) was added and the solution was extracted with water (4x). Dry over K2CO3 and concentrate under reduced pressure. Separate by flash column chromatography (Si〇2 / Et0Ac) and connect by preparative HPLC (silica-coated 018, 10% water in methanol solution as mobile phase) to obtain compound 13 Hydroxyl) amino-13, 14-alkenyl spinosyn A (1.45 g, 40¾) IR v 1722, 1618, 1120 cml, Cl MS m / z 763 (M + l); UMR (CDCI3, 300 MHz ) d 3.55 (1H, m), 2.60 (1H, dd: 9.0, 9.0 Hz), 2.36 (1H, bd: 5.0 Hz), 2 * 13 (6H, 2x CH3, s) ppm; 13C-HMR (CDCIg, 300 MHz) d 200 · 7 (conjugated 0〇), 166.5 (fourth stage C), 107.8 (fourth stage C) Ppm °

)n甚5 ( e )-烯甚-nn-三甲基趵 史窨謀辛A -184 - I - : 1-i- -I In I i ·1 vn urn— ϋϋ ϋ (請先閱讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準 (〇知)八4規格(210\ 297公釐) 經濟部中央標準局員工消費合作社印製 487559 A7 _____ B7_____ 五、發明説明(182 ) 將化合物史賓諾辛A (5 . 6 8 g , 7.7 6 m m ο 1)溶於D M S 0 ( 40 m 1)。將溶液在室溫(水浴)及氮氣下攪拌。添加三甲基 矽烷基氰化物(3 . 0 m 1 )。於擾拌5分鐘後,以一部分一部 分之方式加入L i CN (1. 1 g ,過量)。持續ii拌30分鐘,加 入乙酸乙酯(50 ml)及 PhH (100 ml )。以 10¾ aq· K2C〇3 (3X )溶液萃取。有機層以無水K2C〇3乾燥並於減壓下濃縮。殘 餘物以閃蒸Si〇2管柱(220 g/EtOAc)純化。蒸發純溶析份 以提供化合物(13R) -13-氡基-14, 15 (E)-烯基-15-0-三甲 基矽院基史賓諾辛A ; 5.33 g, 82¾) 4 -NHR (CDC13, 300 MHz) d 5.73 (2H, m) ,4· 74 (2H, m), 4.22 (2H, m), 3.53 (1H, m), 3.14 (1H, bs), 2.13 (6H,. 2xCH 3 , s), 0.09 (9H, 3xCH3, s); CwHriKhQSi:估計值:C 65.03, Η 8·97, N 3.37;實際值:C 64.88, Η 8.95, Η 3·68 審施例 Dfl - (13R . 1 4R&gt; -13-氡基-17-去 g 某-1 1 4-二氣-16 • 17 (F: )-烯基中窨諶辛 A X509471 及(1 2R · 1 4R )-13-氣甚-1 3,14-二氣史窨諶A π的488 將化合物(13R) -13-氰基-14, 15 (Έ)-烯基-15-0-二甲 基矽烷基史賓諾辛H(557 mg, 0.67 mmol)溶於CH2C12(30 ml)。加入水(50 ml)及KHF2 (5.0 g),接著加入氯化四丁 基銨(1 . 36 g )。在室溫及氮氣下攪拌混合物1小時。加入 二氯甲烷(70 ml)及水(50 ml)。使相分離並以水(2x)清洗 有機層,以K2C〇3乾燥並在減壓下濃縮。殘餘物在閃蒸 $1〇2管柱(230-400 m, 100 g/EtOAc)分離以獲得化合物a) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事灰再填寫本頁) 、v&quot; 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(183) (13R, 14R) -13-氰基-17-去氧基-13, 14-二氫-16, 17 (E)-烯 基史賓諾辛 A; 132 mg, 33¾) UMR/CDCh, 300 MHz) d 6.80 (1H, dd:10.2, 4.4 Hz), 4.30 (3H, m), 3.00 (1H ,dd: 9·2, 9.3 Hz), 1·69 (3H, CH3, s); C34H43N〇8之 分析:估計值C 68.09, H 8.23, N 2·33;實際值·· C 67·87, H 8.42, N 2·48 及化合物 b)(13R,14R)-13-氰基-13,14-二氫史賓諾&amp; 290 1^,57%)1[|-_1?(〇0(:13,300 MHz) d 4.26 (4H, m), 2.96 (1H, dd: 9.3, 9.1 Hz), 2·06 (6H, 2x CH3, s), 〇·88 (3H, d: 6.4 Hz); C42HmN2〇h之分析:估計值:C 66*46, Η 8·76, N 3·69 •,實際值:C 66,62,Η 8· 39, N 3.64。 窨旆例CM 0 - (1 M ) - H氳甚-14, 15 (E卜烯某-2 1 -0-二篚 甲烷S基醸某-15-0-三甲某的烷某-中客謀辛Η _X 507995 將化合物2’_0_三氟代甲磺酷基史賓諾辛H(663 mg, 0.78 mmol)溶於乾DMS0(7 ml)中:在室溫及氮氣下攪拌溶 液並加入氰化三甲基矽烷(1.0 m 1 ,過量)。在此時,將反 應混合物冷卻至室溫是必要的。於攪拌5分鐘後,加入一 部分氡化鋰無水粉末(310 mg , 9.4 mmo 1 )。再持續劇烈攪 拌30分鐘。加入乙酸乙酯(50 ml )及PhH (100 ml)。連續以 鹽水萃取溶液,以鹽水及5% aq. NaHC〇3(2X)稀釋。以閃 蒸Si〇2管柱(100 g/EtOAc)純化殘餘物以獲得化合物(13R) -13-氡基-14, 15 (E)-烯基-2,-0-二氣代甲烷磺醯基-15-0-三甲基矽烷基-史賓諾辛H, 507 mg, 69¾ IR v 2238, 本纸張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公t ) ----.——.---0 ! (請先閱讀背面之注意事項再填寫本頁)) n 5 (e) -enex-nn-trimethyl sulfide A-184-I-: 1-i- -I In I i · 1 vn urn— ϋϋ ϋ (Please read the Note: Please fill in this page again.) The size of the paper used for this edition is in accordance with the Chinese National Standard (〇 知) 8-4 specifications (210 \ 297 mm). Printed by the Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 _____ B7_____ 5. Description of the invention (182) The compound Spinozin A (5.68 g, 7.76 mm ο 1) was dissolved in DMS 0 (40 ml). The solution was stirred at room temperature (water bath) under nitrogen. Add trimethylsilyl cyanide (3.0 m 1). After stirring for 5 minutes, add Li CN (1. 1 g, excess) part by part. Continue mixing for 30 minutes and add ethyl acetate (50 ml) and PhH (100 ml). Extract with 10¾ aq · K2CO3 (3X) solution. The organic layer was dried over anhydrous K2CO3 and concentrated under reduced pressure. The residue was purified on a flash SiO 2 column (220 g / EtOAc). The pure eluate was evaporated to provide compound (13R) -13-fluorenyl-14, 15 (E) -alkenyl-15-0-trimethylsilyl spinosin A; 5.33 g, 82¾) 4 -NHR (CDC13, 300 MHz) d 5.73 (2H, m), 4.74 (2H, m), 4.22 (2H, m), 3.53 (1H, m), 3.14 (1H, bs), 2.13 (6H,. 2xCH 3, s), 0.09 (9H, 3xCH3, s); CwHriKhQSi: Estimated value: C 65.03, Η 8.97, N 3.37; Actual value: C 64.88, Η 8.95, Η 3.68 Examination Example Dfl-(13R 1 4R &gt; -13-fluorenyl-17-de-g-1-1 4-digas-16 • 17 (F:) -alkenyl mesityl A X509471 and (1 2R · 1 4R) -13- Qi even -1 3,14-digas 窨 谌 A π 488 will compound (13R) -13-cyano-14, 15 (fluorene) -alkenyl-15-0-dimethylsilyl spinosin H (557 mg, 0.67 mmol) was dissolved in CH2C12 (30 ml). Water (50 ml) and KHF2 (5.0 g) were added, followed by tetrabutylammonium chloride (1.36 g). At room temperature under nitrogen The mixture was stirred for 1 hour. Dichloromethane (70 ml) and water (50 ml) were added. The phases were separated and the organic layer was washed with water (2x), dried over K2CO3 and concentrated under reduced pressure. The residue was flashed $ 1〇2 column (230-400 m, 100 g / EtOAc) Compound a) This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the notice on the back before filling out this page), v &quot; 487559 Printed by A7, Consumers Cooperative of Central Standards Bureau, Ministry of Economic Affairs B7 V. Description of the invention (183) (13R, 14R) -13-cyano-17-deoxy-13, 14-dihydro-16, 17 (E) -alkenyl spinosin A; 132 mg, 33¾ ) UMR / CDCh, 300 MHz) d 6.80 (1H, dd: 10.2, 4.4 Hz), 4.30 (3H, m), 3.00 (1H, dd: 9.2, 9.3 Hz), 1.69 (3H, CH3, s); Analysis of C34H43N〇8: estimated values C 68.09, H 8.23, N 2.33; actual values C 67 · 87, H 8.42, N 2.48 and compound b) (13R, 14R) -13- Cyano-13,14-dihydro Spino &amp; 290 1 ^, 57%) 1 [| -_1? (〇0 (: 13,300 MHz) d 4.26 (4H, m), 2.96 (1H, dd: 9.3 , 9.1 Hz), 2.06 (6H, 2x CH3, s), 〇88 (3H, d: 6.4 Hz); Analysis of C42HmN20h: Estimated value: C 66 * 46, Η 8.76, N 3 · 69 •, Actual values: C 66,62, Η 8.39, N 3.64. Example CM 0-(1 M)-H 氲 even -14, 15 (E buene a -2 1 -0-dimethylmethane S group 醸 a -15-0-trimethyl a alkane-Zhongkemou Xin _X 507995 Dissolve compound 2'_0_trifluoromethanesulfonyl spinosinoxine H (663 mg, 0.78 mmol) in dry DMS0 (7 ml): stir the solution at room temperature under nitrogen and add cyanide Trimethylsilane (1.0 m 1, excess). At this time, it is necessary to cool the reaction mixture to room temperature. After stirring for 5 minutes, a portion of anhydrous lithium halide powder (310 mg, 9.4 mmo 1) is added. Again Stirring was continued vigorously for 30 minutes. Ethyl acetate (50 ml) and PhH (100 ml) were added. The solution was continuously extracted with brine, diluted with brine and 5% aq. NaHC〇3 (2X). Flashed Si02 column (100 g / EtOAc) The residue was purified to obtain compound (13R) -13-fluorenyl-14, 15 (E) -alkenyl-2, -0-digasmethanesulfonyl-15-0-trimethyl Silyl-Spinoxin H, 507 mg, 69¾ IR v 2238, this paper size is applicable to China National Standard (CNS) A4 specification (210 × 297 g t) ----.----.--- 0! (Please read the notes on the back before filling this page)

、1T 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(184) 1734, 1670, 1206, 1149, 1066cm·1; 'H-NMR (CDCIg, 300 MHz) d 5.76 (2H, m), 4.80(3H, m)&gt; 4.24 (2H,ra), 3.19C1H, bs),2.18 (6H, 2XCH], s), 〇·14 (9H, 3xCH3, s) °、 1T 487559 Printed by A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (184) 1734, 1670, 1206, 1149, 1066cm · 1; 'H-NMR (CDCIg, 300 MHz) d 5.76 (2H, m ), 4.80 (3H, m) &gt; 4.24 (2H, ra), 3.19C1H, bs), 2.18 (6H, 2XCH], s), 〇14 (9H, 3xCH3, s) °

富偷例f) 1 1 - ( m 1 41?卜1 3 · 1 4 -二氯-1 3 棊)陵基-史賓諾 辛A 將化合物史賓諾辛Α(1·0 g, 1·3 mmol)溶於10 ml甲 醇並加入羥基銨鹽酸鹽(〇 · 23 g , 3 · 3 mmo 1)。將氫氧化鉀 (0.15 g, 2.6 mmol)添加至溶液中並在室溫下丨覺伴反應物 。在數分鐘内,無色溶液接著變成混濁之白色沈丨殿°在室 溫下攪拌反應物隔夜。於室溫下Μ拌18小時,將白色懸浮 液倒入含有30 m 1飽和磺酸氫鈉溶液及30 m 1乙_之分ί夜漏 斗。分層並以2x50 m 1乙醚萃取水層。合併乙醚萃取物, 以30 m 1鹽水清冼,以無水硫酸鎂乾燥及在減壓下濃縮。 所得化合物為(13R,14R)-13,14-二氫-13-(羥基)胺基史賓 諾辛A; 0.92 g, 8S%,為白色固體。之分析: 估計值·· C 64.37, Η 8.96, N 3.66;實際值:C 64.12,Rich stealing example f) 1 1-(m 1 41? Bu 1 3 · 1 4-dichloro-1 3 棊) Lingji-Spinocin A A compound Spinopin A (1.0 g, 1 · 3 mmol) was dissolved in 10 ml of methanol and hydroxyammonium hydrochloride (0.23 g, 3.3 mmo 1) was added. Potassium hydroxide (0.15 g, 2.6 mmol) was added to the solution and the reactants reacted at room temperature. Within a few minutes, the colorless solution then turned into a cloudy white sink. The reaction was stirred overnight at room temperature. After stirring at room temperature for 18 hours, the white suspension was poured into a night funnel containing 30 ml of a saturated sodium hydrogen sulfonate solution and 30 ml of ethyl acetate. The layers were separated and the aqueous layer was extracted with 2x50 ml of 1 ether. The ether extracts were combined, decanted with 30 ml of brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained compound was (13R, 14R) -13,14-dihydro-13- (hydroxy) aminospinoxin A; 0.92 g, 8S% as a white solid. Analysis: estimated value · C 64.37, Η 8.96, N 3.66; actual value: C 64.12,

Η 8.84, Ν 3.50; MS m/z (FD) 764 (63, 2936, 2972, 1722; ^-NMR (CDCla, 300 Mz) d 5.81 (1H, d), 5.75 (1H, dd) 4.81C1H, s), 3.22 (1H, d), 3.06 (1H, t)。 實施例 D12 - (1 3R · 1 4R ) -1 3 · 1 4-二氤 ·Ί - ( N-田甚-N-羥基) 胺甚中客謀辛A 將化合物史賓諾辛A(1.01 g, 1.36 mmol)溶於5 ml甲 醇並加入Ν -甲基羥基銨鹽酸鹽(〇 . 23 g , 3 . 3 mmo 1 ):.將氫 -187 - 本紙浪尺度適用中國园家標準(CNS ) A4規格(2! 0 X 297公釐) 1- i I m i 1 mp^m —ϋ I (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(185 ) 氣化鉀(148 mg, 2.63 mmol)添加至溶液中並在室溫下攪 拌反應物。在1分鐘後,反應物變混濁。在室溫下攪拌反 應物18小時,並將成分物倒入含有30 m 1飽和磺酸氫鈉溶 液及3 0 m 1二氯甲烷之分液漏斗。分層並以2 X 5 0 m 1二氯甲 烷萃取二氯甲烷層。合併二氯甲烷萃取物,以30 m丨鹽水 清洗,以無水硫酸鎂乾燥及在減壓下濃縮。所得化合物為 (13R, 14R) -13, 14-二氫-13 - (N-甲基羥基)胺基史賓諾 羊A; 0.89 g, 83%,為白色固體。C42H70N2O11之分析·· 估計值:C 64.76, Η 9·06, N 3.60;實際值:C 64.88, Η 9.03, Ν 3.78; MS m/z (FD) 779 (M+l). 實施例D13 - (UR · 1 4R) _13· 1 4-二氯叫X镡甚)胺甚中富謀 辛 A 17-Psa 依實施例Dll所述步驟,利用史賓諾辛A 17-Psa (207 mg, 0.35 mmol),羥基銨鹽酸鹽(96.0 mg, 1.38 mmol), 氫氧化鉀(74.6 mg, 1 . 32 mmol),及5 ml甲醇。所得化合 物(13R,14R )-13,14-二氫-13 -(羥基)胺基史賓諾辛A 17 -Psa, 115 mg, 53%cC33H53N〇1Q 之分析,估計值: C 63.54, Η 8·56, N 2.25;實際值:C 62.66, Η 9.76, Ν 2·11· MS m/z (CI) 624 (Μ + 1)。LR (CDC13, 300Η 8.84, Ν 3.50; MS m / z (FD) 764 (63, 2936, 2972, 1722; ^ -NMR (CDCla, 300 Mz) d 5.81 (1H, d), 5.75 (1H, dd) 4.81C1H, s ), 3.22 (1H, d), 3.06 (1H, t). Example D12-(1 3R · 1 4R) -1 3 · 1 4-Difluorene · Ί-(N-Tian-N-Hydroxy) Ammonium Kemuxin A The compound Spinoxin A (1.01 g , 1.36 mmol) dissolved in 5 ml of methanol and added N-methylhydroxyammonium hydrochloride (0.23 g, 3.3 mmo 1): the hydrogen-187-this paper wave standard applies the Chinese Garden Standard (CNS) A4 specifications (2! 0 X 297 mm) 1- i I mi 1 mp ^ m —ϋ I (Please read the precautions on the back before filling out this page) Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A7 B7 5. Description of the invention (185) Potassium vaporized (148 mg, 2.63 mmol) was added to the solution and the reaction was stirred at room temperature. After 1 minute, the reaction became cloudy. The reaction was stirred at room temperature for 18 hours, and the ingredients were poured into a separatory funnel containing 30 m 1 of a saturated sodium hydrogensulfonate solution and 30 m 1 of dichloromethane. The layers were separated and the dichloromethane layer was extracted with 2 × 50 m 1 of dichloromethane. The dichloromethane extracts were combined, washed with 30 m of brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained compound was (13R, 14R) -13, 14-dihydro-13-(N-methylhydroxy) amino spino sheep A; 0.89 g, 83%, as a white solid. Analysis of C42H70N2O11 ·· Estimated value: C 64.76, Η 9.06, N 3.60; actual value: C 64.88, Η 9.03, Ν 3.78; MS m / z (FD) 779 (M + 1). Example D13-( UR · 1 4R) _13 · 1 4-Dichloro is called X 镡 镡) amine very rich Fuxin A 17-Psa According to the procedure described in Example D11, Spinoxin A 17-Psa (207 mg, 0.35 mmol) , Hydroxyammonium hydrochloride (96.0 mg, 1.38 mmol), potassium hydroxide (74.6 mg, 1.32 mmol), and 5 ml of methanol. Analysis of the obtained compound (13R, 14R) -13,14-dihydro-13- (hydroxy) aminospinoxin A 17 -Psa, 115 mg, 53% cC33H53N01Q. Estimated value: C 63.54, Η 8 · 56, N 2.25; actual: C 62.66, Η 9.76, Ν 2 · 11 · MS m / z (CI) 624 (M + 1). LR (CDC13, 300

Mz) d 5.90 (1H, d), 5.77 (1H, dd), 4.85 (1H, s), 4·83 (1H, m), 4·34 (1H, m), 3.80 (1H, m), 3.30 (1H ,d) 〇 審旆例 f)1 4- ( 1 3R , 1 4R ) -U · 1 4-二氯-13- ( N二亞辛―基-M-氣代Mz) d 5.90 (1H, d), 5.77 (1H, dd), 4.85 (1H, s), 4.83 (1H, m), 4.34 (1H, m), 3.80 (1H, m), 3.30 (1H, d) 〇Examination example f) 1 4- (1 3R, 1 4R) -U · 1 4-dichloro-13- (N-diasinyl-M-gas

&gt;胺某中窨諶辛A -188 - 本纸張尺度適用中國國家標準(CNS ) Λ4規格(21OX297公釐) — -- (請先閲讀背面之注意事項再填寫本頁) IL, 訂&gt; Amine Zhongxinxin A -188-This paper size applies Chinese National Standard (CNS) Λ4 specification (21OX297 mm) —-(Please read the precautions on the back before filling this page) IL, Order

i '發明説明(186) 化合物(13R, 14R) -13, 14-二氫-13-(羥基)胺基史貧詻 辛A (139 mg, 0.181 mmol)溶於5 ml甲苯並添加苯甲醛(44 mg , 0.41 mmo 1)。將反應物加熱至迴流溫度1小時,冷卻 至室溫,並於減壓下濃縮。藉由在中等壓力下以S i 〇 2管柱 (CH2Cl2:CH3〇H, 97:3 (V/V))純化殘餘物以獲得化合物 (13R, 14R) -13, 14-二氫-13-(1亞 ¥ 基-N-氧代)胺基史賓 諾辛A 84 mg, 54¾。^之分析值··估計值:C 67.58, Η 8.51,丨'丨 3.28;實際值:C 67.31, Η 8·43, N 3.11; ^-NMR (CDCla, 300 Mz) d 8.26 (2H, m), 7.44 (3H, 4), 5.90 (1H, d), 5.76 (1H, dt), 4.84 (1H, s) ϋ' ml In : = *ϋ— —^u ...... ·ϋϋ I (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印裂 蓄施例 D15 - Π 3R · 14R ) - m 4-二氯-13 - (N-甲基-N-珲某) 胺基史富諶辛I) 將化合物史賓諾辛D(0. 53 g, 0.71 mmol)懸浮於10 ml甲醇中並加入Η-甲基羥基胺(103 mg, 1 · 24 mmol)。於 此懸浮液中加入氫氧化鉀(103 rag, 1.83 mmol)並在室溫 下攪拌。於攪拌1分鐘後,反應物由可見變得更混濁。在 室溫下攪拌反應物48小時。將反應物倒入含有25 m 1二氯 甲烷及30 m 1飽和碩酸氫鈉之分液漏斗,以無水硫酸鎂乾 燥及在減壓下濃縮。藉由HPLC(C18, CH3〇H:H2〇, 95:5 (V 八))純化殘餘物。所得化合物(131?,141〇-13,14-二氫-13-(N-甲基羥基)胺基史賓諾辛D; 180 mg, 32%·:·注意: 在層析純化期間,化合物(13R, 14R.) -13, 14-二氫-13 - (N-甲基羥基)胺基史賓諾辛D會部分分解成化合物史賓諾 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 訂 經濟部中央標準局員工消費合作社印裳 487559 A7 B7 五、發明説明(187 ) 辛[)。(:43 1172^12〇11之分析:估計值:0 65.12,[19.15, N 3.53;實際值:C 64.96, Η 8.97, N 3.32。4-NMR (CDC13, 300 Mz) d 5.43 (1H, bs), 4.86 (1H, s), 4.80 (1H, m), 4.42 (1H, in.) , 4.28 (1H, m) , 3.68 (1H, m)。 营旆例旧β - (14S)-1 3. 1 4-二氬窨諶辛A 1 7-Psa 將化合物(14S)-13,14-二氫史賓諾辛A(380 mg, 0.518 mmol)懸浮於10 ml水並添加2 ml IN H2SO4。在添 加酸至溶液中時可觀察到無變化。將反應物加熱至95-100 °C ,在此期間固體溶解可得無色溶液。於加熱1小時後, 形成白色沈澱並將反應物冷卻至室溫。藉減壓過濾收集固 體,以3x10 ml冷水清洗並風乾。所得化合物(14S)-13,14 -亡氫-史賓諾辛 A 17-Psa, 284 mg, 93¾。(:33H52〇3 之分 析:估計值:C 66.86, Η 8.84;實際值:C 66.29 9.19; ^-NMR (CDCI3, 300 Mz) d 5.90 (1H, d) , 5.79 (1H, dt), 5·85 (1H, s), 4·76 (1H, m), 4·32 (1H, q) ,3·82 (1H, m)。 窨旆例 D1 7 - (1 4R ) -1 L 1 4-二氤-Φ 害諶辛 A 17-Pm 將化合物(14R)-13,14-二氫史賓諾辛A(397 mg, 0 . 5 41 m m 0 1)懸浮於10 m 1水並添加2 m 1 1 N H 2 S 0 4 :‘在添 加酸至溶液中時可觀察到無變化。將反應物加熱至95-100 °C ,在此期間固體溶解可得無色溶液。於加熱20分鐘後, 開始形成白色沈澱,該沈澱於1小時後復溶。將反應物冷 卻至室溫並形成玻璃狀固體。以2x25 m丨乙醚萃取玻璃狀i 'Explanation of the invention (186) Compound (13R, 14R) -13, 14-dihydro-13- (hydroxy) aminostilbenexin A (139 mg, 0.181 mmol) was dissolved in 5 ml toluene and benzaldehyde (44 mg, 0.41 mmo 1). The reaction was heated to reflux temperature for 1 hour, cooled to room temperature, and concentrated under reduced pressure. The residue was purified by S i 02 column (CH2Cl2: CH3OH, 97: 3 (V / V)) under moderate pressure to obtain compound (13R, 14R) -13, 14-dihydro-13- (1 Benzyl-N-oxo) Amino Spinozin A 84 mg, 54¾. Analytical value of ^ Estimated value: C 67.58, Η 8.51, 丨 '丨 3.28; Actual value: C 67.31, Η 8.43, N 3.11; ^ -NMR (CDCla, 300 Mz) d 8.26 (2H, m) , 7.44 (3H, 4), 5.90 (1H, d), 5.76 (1H, dt), 4.84 (1H, s) ϋ 'ml In: = * ϋ— — ^ u ... ϋϋ I ( Please read the precautions on the back before filling out this page) Example D15-Π 3R · 14R of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs-m 4-Dichloro-13-(N-methyl-N- 珲(A) Aminospoxifen I) Suspoxifen D (0.53 g, 0.71 mmol) was suspended in 10 ml of methanol, and amidine-methylhydroxylamine (103 mg, 1.24 mmol) was added. To this suspension was added potassium hydroxide (103 rag, 1.83 mmol) and stirred at room temperature. After stirring for 1 minute, the reaction changed from visible to more turbid. The reaction was stirred at room temperature for 48 hours. The reaction was poured into a separatory funnel containing 25 m 1 of dichloromethane and 30 m 1 of saturated sodium bisulfate, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The residue was purified by HPLC (C18, CH3OH: H2O, 95: 5 (Va)). Resulting compound (131 ?, 1410-13, 14-dihydro-13- (N-methylhydroxy) amino spinosinoxin D; 180 mg, 32% ·: · Note: During the chromatographic purification, the compound ( 13R, 14R.) -13, 14-dihydro-13-(N-methylhydroxy) amino spinosinoxine D will be partially decomposed into the compound Spinozin. The paper size applies the Chinese National Standard (CNS) A4 specification ( 210X297 mm) Ordered by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economy, Yin Chang 487559 A7 B7 V. Invention Description (187) Xin [). (: Analysis of 43 1172 ^ 12〇11: Estimated value: 0 65.12, [19.15, N 3.53; Actual value: C 64.96, Η 8.97, N 3.32. 4-NMR (CDC13, 300 Mz) d 5.43 (1H, bs ), 4.86 (1H, s), 4.80 (1H, m), 4.42 (1H, in.), 4.28 (1H, m), 3.68 (1H, m). Example of old β-(14S) -1 3 1 4-Diarginoxin A 1 7-Psa Suspend compound (14S) -13,14-dihydrospinoxin A (380 mg, 0.518 mmol) in 10 ml of water and add 2 ml IN H2SO4. No change was observed when the acid was added to the solution. The reactants were heated to 95-100 ° C, during which the solids dissolved to obtain a colorless solution. After heating for 1 hour, a white precipitate formed and the reactants were cooled to room temperature. Warm. The solid was collected by filtration under reduced pressure, washed with 3x10 ml of cold water and air-dried. The resulting compound (14S) -13,14-dehydrogen-spinoxin A 17-Psa, 284 mg, 93¾. (: 33H52〇3 of Analysis: Estimated value: C 66.86, Η 8.84; Actual value: C 66.29 9.19; ^ -NMR (CDCI3, 300 Mz) d 5.90 (1H, d), 5.79 (1H, dt), 5.85 (1H, s) , 4 · 76 (1H, m), 4 · 32 (1H, q), 3 · 82 (1H, m). Example D1 7-(1 4R) -1 L 1 4-Secondary-Φ Harm Sim A 17-Pm will be (14R) -13,14-dihydrospinoxin A (397 mg, 0.541 mm 0 1) suspended in 10 m 1 of water and added 2 m 1 1 NH 2 S 0 4: 'After adding acid No change was observed when it reached the solution. The reactant was heated to 95-100 ° C, during which the solid was dissolved to obtain a colorless solution. After heating for 20 minutes, a white precipitate began to form, and the precipitate was redissolved after 1 hour. The reaction was cooled to room temperature and formed a glassy solid. The glassy was extracted with 2x25 m of ether

本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) ----·&lt;_丨•衣 —I (請先閱讀背面之注意事項再填寫本頁)This paper size applies to China National Standard (CNS) Α4 specification (210 × 297 mm) ---- · &lt; _ 丨 • 衣 —I (Please read the precautions on the back before filling this page)

、1T 487559, 1T 487559

經濟部中央標準局員工消費合作社印I A7 B7 五、發明説明(188) 固體,以2 0 m I鹽水清洗,以無水硫酸纟I乾燥並於減壓下 濃縮。所得化合物(14R)-13,14-二氫-史賓諾辛A 17-Psa, 226 mg, 71¾。(:33H52〇3 之分析:估計值·· C 66.86, Η 8·84;實際值:C66.84, Η 8.90; M-NMR (CDC13, 300 Mz) d 5.88 (1H, dj, 5.67 (1H, dt), 4.85 (1H, s), 4·83 (1H, m),4·34 (1H, q) , 4·01 (1H, m)。Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs I A7 B7 V. Description of the invention (188) Solid, washed with 20 m I of brine, dried over anhydrous sulphuric acid I and concentrated under reduced pressure. The compound (14R) -13,14-dihydro-spinoxin A 17-Psa, 226 mg, 71¾ was obtained. (: Analysis of 33H52〇3: Estimated value · C 66.86, Η 8.84; Actual value: C66.84, Η 8.90; M-NMR (CDC13, 300 Mz) d 5.88 (1H, dj, 5.67 (1H, dt), 4.85 (1H, s), 4.83 (1H, m), 4.34 (1H, q), 4.01 (1H, m).

富旆例D1 8 - 1 4S) -1 1 4-二氣-13-甲基史賓諾辛A 將碘化亞銅(1. 34 g , 7.0 mmo 1 )在氮氣環境下懸浮於 20 m 1無水乙醚中。將反應物在冰浴中冷卻至〇 °C並缓慢地 於3分鐘内加入1.4 Μ之甲基鋰的乙醚(9.0 ml, 12.6 mmol )溶液。將化合物史賓諾辛A(2.04 g, 2.δ0 mmol)之5 ml 乙醚溶液在10分鐘内緩慢地加入反應物中。可得亮黃色溶 液,其將逐漸失去顔色且可得沈澱。於30分鐘後,將反應 物倒入含有25 ml飽和碳酸氫鈉溶液及25 ml乙醚之分液漏 斗中。使層分離並以2x50 ml乙醚萃取水層。過濾乙»以 去除懸浮固體及以25 m 1鹽水清洗,以硫酸鎂乾燥並在減 壓下濃縮。所得殘餘物藉HPLC(C18, CH3〇H:H2〇, 95:5, V /V)以獲得化合物(13R, 14S) -13, 14-二氫-13_甲基史賓諾 辛 Α, 〇·56 g, 27¾。(:42HG3N〇1Q之分析··估計值:C 67.44, Η 9.30, Ν 1·87;實際值:67·47, Η 9.20, N 1.93。MS m/z (Cl) 748 (M + l); LR (CDC 1 3, 300Hz )d 5.85 (1H, d), 5.80 (1H, dt), 4,85 (1H, s),Rich example D1 8-1 4S) -1 1 4-digas-13-methyl spinosin A A cuprous iodide (1.34 g, 7.0 mmo 1) was suspended in a nitrogen atmosphere at 20 m 1 Anhydrous ether. The reaction was cooled to 0 ° C in an ice bath and a 1.4 M solution of methyl lithium in ether (9.0 ml, 12.6 mmol) was slowly added over 3 minutes. A solution of the compound Spinozin A (2.04 g, 2.δ0 mmol) in 5 ml of ether was slowly added to the reaction over 10 minutes. A bright yellow solution is obtained, which will gradually lose its color and a precipitate will be obtained. After 30 minutes, the reaction was poured into a separatory funnel containing 25 ml of a saturated sodium bicarbonate solution and 25 ml of ether. The layers were separated and the aqueous layer was extracted with 2x50 ml of ether. Filter B »to remove suspended solids and wash with 25 ml of brine, dry over magnesium sulfate and concentrate under reduced pressure. The obtained residue was subjected to HPLC (C18, CH3OH: H2O, 95: 5, V / V) to obtain a compound (13R, 14S) -13, 14-dihydro-13-methylspinoxin A, 56 g, 27¾. (: Analysis of 42HG3N01Q · Estimated value: C 67.44, Η 9.30, Ν 1.87; actual value: 67 · 47, Η 9.20, N 1.93. MS m / z (Cl) 748 (M + l); LR (CDC 1 3, 300Hz) d 5.85 (1H, d), 5.80 (1H, dt), 4,85 (1H, s),

4.78 (1H, m), 4.42 (1H, d), 4.33 (1H, q) , 3.66 (1H 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ------Mr----- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印— 487559 A7 ____ B7 _ 五、發明説明(189 ) 實施例 D19 - ( 13R, 14S) -13. 1 4-二 Μ -1 丁 甚中客謀辛 A 將碘化亞銅(1 · 0 g , 5 . 2 mmo 1 )在氛氣環境下懸浮於 20 m 1無水乙醚中。將反應物在冰浴中冷卻至〇 並緩慢地 於5分鐘内加入1·4 Μ之η-丁基鋰的己烷(7.0 ml, 11 mmol )溶液。在0 °C Μ拌30分鐘可得深棕色溶液。將化合物史賓 諾辛A(2.13 g, 2.9 mmol)之5 ml乙醚溶液在5分鐘内緩慢 地加入反應物中。於攪拌15分鐘後,將反應物倒入含有50 ml 50¾濃氫氧化銨水溶液之分液漏斗並以3x30 ml乙醚萃 取。合併乙醚萃取物,以50 ml濃氫氧化鞍及30 ml飽和碳 酸氫鈉水溶液清洗。以硫酸鎂乾燥乙醚溶液並在減壓下濃 縮。所得化合物:(13R,14S)-13,14-二氫-13-n-丁基史賓 諾辛A, 0.53 g, 23%。C45H75〇1Q之分析:估計值:C 68·41, Η 9·57, N 1,77;實際值·· C 68.07, Η 9.51, N 1·82; MS m/z (DCI) 790 (M + l); LR (CDC 1 3, 300Μζ )d 5.85 (1H, d), 5.80(1H, dt), 4.85 (1H, s), 4.79 (1H, m),4.43 (1H, d), 4.29(1H, q), 3·67 (1H, m)。 富旃例1)?0-(145,15^)-13,14-二氣-15-羥基史蒈謠辛_合 將化合物史賓諾辛M600 mg, 0.820 mmol)溶於乾乙 醚(100 ml)。加入氫化三-t-丁氧基鋁鋰(296 mg, 97%, 1. 13 ππηο 1)。於在氮氣下攪拌5分鐘後,將反應混合物冷 卻至 78°C 並加入一部份 LiAlH4(29 mg, 0.763 mmol)。在 -7810/氮氣下持續攪拌25分鐘。接著將冷卻浴改變為 並持續攪拌2小時。接箸缓慢地導入鹽水Π〇 ml)並加入乙 醚(70 ml)。於分離萃取相後,以鹽水(3x)清洗有機層, -192 - 本纸張尺度適用中國國家標準(〇^〉八4規格(210:&lt;297公釐) (請先閱讀背面之注意事項再填寫本頁) 衣. ,tr 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(19〇 ) 以K2C〇3乾燥,過濾及在減壓下濃縮。殘餘物以閃蒸Si〇2 管柱(202/乙酸乙酯)純化並接箸以(:^〇111以〇1;「(^分離( 1 · 〇 ram, 10% EtOH/EtOAc)。這些步驟提供化合物(14S, 15 S) -13,14-二氫-15-羥基史賓諾辛 A, 78 mg, 13%: π-ΝΜΙί (CDCIg, 300 MHz) d 4.80 (1H, d:1.2 Hz), 4.37 (2H, m), 4·25 (2H, m), 3·62 (1H, m), 3·51 (3H, CH3, s), 3·45 (6H, 2xCH3, bs), and 2.19 (6H, 2xCH3, s)ppm。 - (14S. 1 5S . 1 7S . 21S ) -1 , 21 -去氬某-1 3. 1 4-二氫 -1 , 21 -斷-1 . 1 5, 2卜三粹某中g諶辛A及Π 15S) -粹某-中g謀李Α 將史賓諾辛 A(446 rog, 0.610 mmol)溶於乾 Et2〇(60 m 1)。在室溫及氮氣下,隨攪拌添加氫化三-t-丁氧基鋁鋰 (148 mg, 0.583 mmol) .·於 10分鐘後,添加 LiMHa (19 mg ,0.50 nunol)並在RT/M2下持續攪拌50分鐘。將混合物冷 卻至0°C並逐滴加入鹽水以驟冷餘留的氫化物。加入Et2〇 ( 70 ml),於分離萃取層後,以鹽水(3x)清洗有機層,以 K2C〇3乾燥,過濾及在減壓下濃縮。在閃蒸Si〇2管柱(25 g /5¾ Et0H之Et0Ac溶液)上分離殘餘物以獲得化合物a ) (14S ,15S, 17S, 2IS) -1,2卜去氧基-13, 14-二氫-1,21-斷-1, 15, 2卜三羥基史賓諾辛A, 71 mg, 15% : UMR (CDC13, 300 MHz) d 4.86 (1H, d:1.2 Hz), 4.48 (1H, bd:7.5 Hz), 4.30 (2H, m), 3.84 (1H, m), 3.45 (3H, CH3, s) ,3·46 (3H, CH3, s), 3.52(3H, CH3, s)及2·21 (6H, 2 x C Η 3 , s) p p m ,及化合物b )産物之混合物(3 1 3 m g ),將·其 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) -------^--衣-- (請先閱讀背面之注意事項再填寫本頁)4.78 (1H, m), 4.42 (1H, d), 4.33 (1H, q), 3.66 (1H) This paper size applies to China National Standard (CNS) A4 (210X 297 mm) ------ Mr- ---- (Please read the notes on the back before filling out this page) Order the Consumers' Cooperatives Seal of the Central Bureau of Standards of the Ministry of Economic Affairs — 487559 A7 ____ B7 _ 5. Description of the Invention (189) Example D19-(13R, 14S)- 13. 1 4-DiM -1 Ding Shizhong Kemuxin A A cuprous iodide (1.0 g, 5.2 mmo 1) was suspended in 20 m 1 of anhydrous ether under an atmosphere. The reactants were Cool to 0 in an ice bath and slowly add a 1.4 M solution of η-butyllithium in hexane (7.0 ml, 11 mmol) over 5 minutes. Stir at 0 ° C for 30 minutes to obtain a dark brown solution. 5 ml of ether solution of the compound Spinozin A (2.13 g, 2.9 mmol) was slowly added to the reaction within 5 minutes. After stirring for 15 minutes, the reaction was poured into 50 ml of 50 ¾ concentrated ammonium hydroxide The separating funnel of the aqueous solution was extracted with 3x30 ml of ether. The ether extracts were combined, washed with 50 ml of concentrated saddle hydroxide and 30 ml of a saturated sodium bicarbonate aqueous solution. The ether solution was dried over magnesium sulfate and reduced in water. It was concentrated under reduced pressure. The obtained compound: (13R, 14S) -13,14-dihydro-13-n-butyl-spinoxin A, 0.53 g, 23%. Analysis of C45H75〇1Q: Estimated value: C 68 · 41, Η 9.57, N 1,77; actual value C 68.07, Η 9.51, N 1.82; MS m / z (DCI) 790 (M + l); LR (CDC 1 3, 300Μζ) d 5.85 ( 1H, d), 5.80 (1H, dt), 4.85 (1H, s), 4.79 (1H, m), 4.43 (1H, d), 4.29 (1H, q), 3.67 (1H, m). Example 1)? 0- (145,15 ^)-13,14-digas-15-hydroxyl-Hydroxy-Hydro-Synthesis_Spinoxin M600 mg, 0.820 mmol) was dissolved in dry ether (100 ml) . Add lithium tri-t-butoxyaluminum hydride (296 mg, 97%, 1. 13 ππηο 1). After stirring for 5 minutes under nitrogen, the reaction mixture was cooled to 78 ° C and a portion of LiAlH4 (29 mg, 0.763 mmol) was added. Stir under -7810 / nitrogen for 25 minutes. Then change the cooling bath to and continue stirring for 2 hours. Then, saline (10 ml) was slowly introduced and diethyl ether (70 ml) was added. After separating the extracted phases, wash the organic layer with brine (3x). -192-This paper size is in accordance with Chinese National Standards (〇 ^> 8 4 specifications (210: &lt; 297 mm) (Please read the precautions on the back first) (Fill in this page again). Tr. 487559 Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (19) Drying with K2C03, filtering and concentrating under reduced pressure. The residue is flashed Si 〇2column (202 / ethyl acetate) was purified and followed by (: ^ 〇111 to 〇1; "(^ separation (1.0m, 10% EtOH / EtOAc). These steps provided the compound (14S, 15 S) -13,14-dihydro-15-hydroxyspinoxin A, 78 mg, 13%: π-ΝΜΙί (CDCIg, 300 MHz) d 4.80 (1H, d: 1.2 Hz), 4.37 (2H, m ), 4.25 (2H, m), 3.62 (1H, m), 3.51 (3H, CH3, s), 3.45 (6H, 2xCH3, bs), and 2.19 (6H, 2xCH3, s ) ppm.-(14S. 1 5S. 1 7S. 21S) -1, 21-Deargon-1 3. 1 4-dihydro-1, 21-Off-1. 1 5, 2 g 谌 Xin A and Π 15S)-粹--Zhong Mo Mou Li A Spinaloxin A (446 rog, 0.610 mmol) was dissolved in dry Et2O (60 m 1). Stir at room temperature under nitrogen with stirring add Lithium tri-t-butoxyaluminum hydride (148 mg, 0.583 mmol). After 10 minutes, LiMHa (19 mg, 0.50 nunol) was added and stirring was continued for 50 minutes at RT / M2. The mixture was cooled to 0 ° C and brine was added dropwise to quench the remaining hydride. Et20 (70 ml) was added and after separation of the extracted layers, the organic layer was washed with brine (3x), dried over K2CO3, filtered and under reduced pressure. Concentrated. The residue was separated on a flashed Si02 column (25 g / 5¾ Et0H in Et0Ac) to obtain compound a) (14S, 15S, 17S, 2IS) -1,2 Budeoxy-13, 14 -Dihydro-1,21-Breck-1, 15, 2, 2 Trispinoxin A, 71 mg, 15%: UMR (CDC13, 300 MHz) d 4.86 (1H, d: 1.2 Hz), 4.48 ( 1H, bd: 7.5 Hz), 4.30 (2H, m), 3.84 (1H, m), 3.45 (3H, CH3, s), 3.46 (3H, CH3, s), 3.52 (3H, CH3, s) And 2.21 (6H, 2 x C Η 3, s) ppm, and the compound (3 1 3 mg) of the compound b) product, the paper size of this paper shall apply the Chinese National Standard (CNS) A4 specification (210X297 mm) ) ------- ^-yi-- (Please read the notes on the back before filling this page)

、1T 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(19〇Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, 1T 487559 A7 B7 V. Description of Invention (19)

進一步在Chromatotron旋轉盤重覆分離(1.〇 mm, 15%EtOH /EtOAc)。這些分離可提供化合物b) [ (15S)-羥基史賓諾計 A, 79 mg, 17¾ : 13C-NMR (CDCU,75 MHz,低磁場區域 )d 172.22, 144.73, 130.94, 129.73, 128.70, 103.37 ,95.47, 84.49, 82.25, 81·01, 79·03 及 77·70 ppm。 審旆例D22 - (14R) -13, 14-二氣羥甚中客諶辛A 將史賓諾辛Α(2·17 g, 2.96 mmol)溶於乙醇(75 ml) 並在5分鐘内小心地添加硼氫化鈉(1 . 1 g , 29 mmo 1)。將 反應混合物攪拌3小時及小心地以1 N HC 1 (15 m 1)驟冷。於 逐漸反應完成後,將粗物質(1.68 g)藉由在矽膠(二氯甲 烷/甲醇,95: 5)上層析以提供(14R )-13,1 4-二氫史賓諾辛 M635 mg, 29.2%)及(14R)-13,14-二氫-15-羥基史賓諾辛 M317 rag, 14.6%),為白色固體。化合物(141?卜13,14-二 氫-15-羥基史賓諾辛 A : 13C-NMR d 174.75, 131.52, 128.50, 104.16, 95.34, 83.28, 82.26, 80.99, 77.74, 76.15, 76.15, 73.66, 70·29, 67.80, 64·82, 60·83, 58.94, 57.66, 44.90, 44.54, 44.54, 44.26, 42.93, 40.65, 40.38, 39.89, 37.74, 36.84, 34.91, 34.41, 33.84, 31.65, 31.17, 28.07, 19.06, 19.06, 18.36, 17·75, 9·51, 8·77;部分1H-NMR d 7.31(s, 1Η), 5.75 (dd, 1H), 5.87(dr, 1H), 4.81(s, 1H), 4.80 (m, 1H), 4.40-4.25 (m 2H) , 3·95(ηι, 1H)。 審旆例 - (13R , r)R/S)-l 5-揮某-ΚΊ , 14-環氬某中客Further separation was repeated on a Chromatotron rotating disk (1.0 mm, 15% EtOH / EtOAc). These separations provided compound b) [(15S) -Hydroxy Spinolometer A, 79 mg, 17¾: 13C-NMR (CDCU, 75 MHz, low magnetic field region) d 172.22, 144.73, 130.94, 129.73, 128.70, 103.37, 95.47, 84.49, 82.25, 81 · 01, 79 · 03 and 77.70 ppm. Examination Example D22-(14R) -13, 14-Digas Hydroxyl Chloroxine A Dissolve Spinoxin A (2.17 g, 2.96 mmol) in ethanol (75 ml) and be careful within 5 minutes Add sodium borohydride (1.1 g, 29 mmo 1). The reaction mixture was stirred for 3 hours and carefully quenched with 1 N HC 1 (15 m 1). After the gradual reaction was completed, the crude material (1.68 g) was chromatographed on silica gel (dichloromethane / methanol, 95: 5) to provide (14R) -13,1 4-dihydrospinoxin M635 mg , 29.2%) and (14R) -13,14-dihydro-15-hydroxyspinoxin M317 rag, 14.6%), as a white solid. Compound (141? 13,14-dihydro-15-hydroxyspinoxin A: 13C-NMR d 174.75, 131.52, 128.50, 104.16, 95.34, 83.28, 82.26, 80.99, 77.74, 76.15, 76.15, 73.66, 70 29, 67.80, 64 · 82, 60 · 83, 58.94, 57.66, 44.90, 44.54, 44.54, 44.26, 42.93, 40.65, 40.38, 39.89, 37.74, 36.84, 34.91, 34.41, 33.84, 31.65, 31.17, 28.07, 19.06 , 19.06, 18.36, 17.75, 9.51, 8.77; part 1H-NMR d 7.31 (s, 1Η), 5.75 (dd, 1H), 5.87 (dr, 1H), 4.81 (s, 1H), 4.80 (m, 1H), 4.40-4.25 (m 2H), 3.95 (ηι, 1H). Examination example-(13R, r) R / S) -l 5-a certain -KΊ, 14-ring argon A shopper

謀辛A -194 - 本紙悵尺度適用中國國家標準(CNS ) A4堤格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁)Moosin A -194-The size of this paper is applicable to the Chinese National Standard (CNS) A4 (210X297 mm)

、1T 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(192) 將化合物(13R, 14S) -13, 14-璟氧基史賓諾辛A (0.53 g ,〇· 71 mm〇l)溶於乙醇(1〇 ml)並加入硼氫化鈉(36 mg, 〇· 96 mmol)及攪拌反應物3小時。再添加硼氫化鈉(100 mg ,2.64 mmol)及攪拌反應物72小時。將反應物以丙酮(5 ml)驟冷,接著添加IN HC1(1 ml)並逐漸反應完成以獲得 殘餘物,使該殘餘物藉由逆相HPLC(甲醇/0.1% aq.氫氧化 銨,90:10)純化。所得化合物(13R,14S,15S)-15-羥基-l3,14-環氧基史賓諾辛/\(78.9Ing,14.8%):部分1H1MR d 5.8 (d, 1H), 5.60 (dt, 1H), 4.80 (s, 1H), 4.43 (d, 1H), 4.30 (ς, 1H), 4.09 (d, 1H),4.01 (m, 1H), 3.78(111,1[]);及(131^14$,151〇-15-羥基-13,14-環氧基 史賓諾辛 A(7〇 mg, 13¾) : MS m/z 750.6。 窨旆例Π 4S)-1 3. 14-二氯中客諾辛D ‘ 將化合物史賓諾辛D(1.00 g, 1.34 nunol)在氮氣下溶 於無水四氫呋喃(25 ml)並加入氬化三-t-丁氧基鋁鋰( 1.01 g, 3.97 mmol)及攪拌反應物24小時。將反應物以乙 酸乙酯(40 ml.)及鹽水(10 ml)驟冷並使相分離。以乙酸乙 酯(25 m 1)萃取水層並於經由濾紙過濾後使層分離。合併 乙酸乙酯萃取物並以鹽水(25 ml)清洗,以無水磺酸鉀乾 燥及在減壓下濃縮。殘餘物(360 mg)藉由逆相HPLC (甲醇/ 0.1¾ aq·氫氧化銨,95:5)純化以獲得(14S)-13,14-二氫 史賓諾辛DU89 mg, 18·9%),為白色固體:MS m/z 748.7 〇42^3帅1〇之分析:估計值:(:,67.44;19.30;«, 1.87。實際值:(:,67.21;19.20;11,1.69.:. 本纸張尺度適用中國國家標準(CMS ) A4規格(210XM7公釐) (請先閱讀背面之注意事項再填寫本頁)1T 487559 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (192) Compound (13R, 14S) -13, 14-methoxyspinoxin A (0.53 g, 0.71 mm. l) Dissolved in ethanol (10 ml) and added sodium borohydride (36 mg, 0.96 mmol) and stirred the reaction for 3 hours. Additional sodium borohydride (100 mg, 2.64 mmol) was added and the reaction was stirred for 72 hours. The reaction was quenched with acetone (5 ml), then IN HC1 (1 ml) was added and the reaction was gradually completed to obtain a residue, which was subjected to reverse phase HPLC (methanol / 0.1% aq. Ammonium hydroxide, 90%) : 10) Purified. The obtained compound (13R, 14S, 15S) -15-hydroxy-l3,14-epoxy spinosinol / \ (78.9Ing, 14.8%): part 1H1MR d 5.8 (d, 1H), 5.60 (dt, 1H) , 4.80 (s, 1H), 4.43 (d, 1H), 4.30 (ς, 1H), 4.09 (d, 1H), 4.01 (m, 1H), 3.78 (111,1 []); and (131 ^ 14 $, 151〇-15-hydroxy-13,14-epoxy Spinosin A (70 mg, 13¾): MS m / z 750.6. Example Π 4S) -1 3. 14-dichloro Nosin D 'The compound Spinozin D (1.00 g, 1.34 nunol) was dissolved in anhydrous tetrahydrofuran (25 ml) under nitrogen and lithium tri-t-butoxyaluminum argon (1.01 g, 3.97 mmol) was added and The reaction was stirred for 24 hours. The reaction was quenched with ethyl acetate (40 ml.) And brine (10 ml) and the phases were separated. The aqueous layer was extracted with ethyl acetate (25 ml) and the layers were separated after filtration through filter paper. The ethyl acetate extracts were combined and washed with brine (25 ml), dried over anhydrous potassium sulfonate and concentrated under reduced pressure. The residue (360 mg) was purified by reverse-phase HPLC (methanol / 0.1¾ aq · ammonium hydroxide, 95: 5) to obtain (14S) -13,14-dihydrospinoxin DU89 mg, 18.9% ), As a white solid: MS m / z 748.7 〇42 ^ 3 Shuai 10 analysis: estimated value: (:, 67.44; 19.30; «, 1.87. Actual value: (:, 67.21; 19.20; 11, 1.69 .: . This paper size applies Chinese National Standard (CMS) A4 specification (210XM7mm) (Please read the precautions on the back before filling this page)

487559 A7 B7 五、發明説明(193 ) 富施例D25-1 , 21 -去氬基-1 , 2卜斷-1 , 1 5 , 2卜三锊某中窨A. (1 5R/S ) -1 k錚甚中審諾辛 A, (14R . 1 6 . 1 77/) -17-去氬基-1fi, 17-去氣-13,14-二氣中審諶辛A 17-Psa.及(14R)-13, 14-二氪中窨諶辛 A 將化合物史賓諾辛A(5. 12 g, 7.00 mmol)溶於無水乙 醚(75 ml)並冷卻至0°C。將甲醚(15.0 ml , 7. 5 mmol)添 加於氫化鋁鋰(0.5 Μ)之乙二醇溶液並藉由添加水(0 . 30 m 1:)立刻驟冷,接著添加1 5%氫氧化鈉水溶液及水(1 . 0 m 1) 。濾除懸浮固體及在減壓下旋轉蒸發濾液以提供白色固體 (4.62 g)。藉由逆相HPLC (甲醇/0. 1¾ aq.氫氧化鈉,90: 10)以提供化合物1,2卜去氧基-1,21-斷-1, 15, 2卜三羥基 史賓 A(792 mg, 15·«)··部分1H-NMR δ' 5·88-5·72 (m, 2H), 4.82 (s, 1H), 4.40 (d, 1H), 4.35-4.23 (m, 2H ),4.13 (m, 1H), 3.85-3.67 (m, 3H); MS m/z 738.7 ( M + l),及(15R/S)-15-羥基史賓諾辛 AC1.13 g, 22.1%):( 第一異構物)部分1H-NMR d 5·89 (dd, 1H), 5·78-5·72 (請先閱讀背面之注意事項再填寫本百〇487559 A7 B7 V. Description of the Invention (193) Rich Example D25-1, 21-Deargon-1, 2 Bu Broken-1, 1 5, 2 Bu Sanya A. (1 5R / S)- 1 k 铮 Intermediate Novo Axin, (14R. 1 6.6.1 77 /) -17-Deargon-1fi, 17-Degas-13, 14-Di 中 Intermediate Retin A 17-Psa. And (14R) -13, 14-Dipyridine A. Dissolve Spinoxin A (5. 12 g, 7.00 mmol) in anhydrous ether (75 ml) and cool to 0 ° C. Methyl ether (15.0 ml, 7. 5 mmol) was added to a solution of lithium aluminum hydride (0.5 M) in ethylene glycol and immediately quenched by adding water (0.30 m 1 :), followed by 1 5% hydroxide Aqueous sodium solution and water (1.0 m 1). The suspended solid was filtered off and the filtrate was rotary evaporated under reduced pressure to provide a white solid (4.62 g). By reverse phase HPLC (methanol / 0.12 aq. Sodium hydroxide, 90: 10) to provide the compound 1,2 budeoxy-1,21-bran-1, 15, 2, 2 trishydroxyspin A ( 792 mg, 15 · «) · Part of 1H-NMR δ '5.88-5 · 72 (m, 2H), 4.82 (s, 1H), 4.40 (d, 1H), 4.35-4.23 (m, 2H) , 4.13 (m, 1H), 3.85-3.67 (m, 3H); MS m / z 738.7 (M + l), and (15R / S) -15-hydroxyspinoxin AC 1.13 g, 22.1%) : (First isomer) part 1H-NMR d 5.89 (dd, 1H), 5.78-5 · 72 (Please read the precautions on the back before filling this one hundred.

、1T 經濟部中央標準局員工消費合作社印製 (m, 2H) ,4 • 81 (s , 1H), 4.44 -4 · 31 (m, 2H), 4. 26 ( q , 1H) , 4 • 04 (t, 1H), 3.83 (m ,1H); 1 3C -NMR 0' 173.53 ,145.22, 132. 34, 130.14, 128. 29, 103.01, 95 • 46 , 82. 26, 81 . 03, 77. 72, 76.24, 73 • 76, 67 • 89, 64 • 78, 60. 89, 58. 97, 57. 66, 47.65, 46 • 91, 46 • 90, 41 • 39, 40. 64, 39. 62, 37. 39, 36.39, 31 • 20, 30 • 73, 28 .37, 27. 21, 20. 68, 19· 00,18.33, 17. 75, 10. 15, 9.80; MS m/z 734 • Ί (m + 1 )° C41HG7NO1ϋ 之分析: 估 計值 ·· c, -196 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公澄) 487559 A7 • B7五、發明説明(194 ) 67.09; H, 9.20; N, 1.91.實際值:C, 66·96; H, 9.14; Ν, 1·94;(第二異構物)部分1H-NMR δ 5.89 (d, 1H), 5.85-5.74 (m, 2H), 4.84 (s, 1H), 4.46- 4.35 (tn, 2HJ, 4.33-4.25 (m, 2H), 3.67 (m, 1H); 13C -NMR &lt;5 172.24, 144.75, 130.96, 129.77, 128.69, 103 .80 ,95 .40 ,84 • 50, 82.27, 81 .03, 79 .35 ,76.71 9 76· 20, 73· 80, .67· 83, 64 .65,60.87, 58.95, 57. 66, 48. 00, 47. 78, 46. 54, 44.71, 41 · 27, 40. 63, 37 • 44, 36· 94, 36. 36, 32. 02, 31 .36, 29. 65, 27· 10, 19 .54, 19· 05, 18. 34, 17· 73,10. 15, 7 ,40 ;MS m/z 734. 7 (m + 1 )° C41 Η 8 7 N 0 1 0 之分析: 估計值: C, 67· 09; Η, 9. 20; N, 1.91 - 實際 值: C, 66.65; Η, 9 .16 ;N, 1 · 85, 及 (14R ,1 6, 17Z) -17- 去氧基- 16,17- 去氫- 13, 14-二氫 史賓諾 辛A 17 ------·--本-- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 -Psa(54 mg, 1.0%):部分1H-NMR5 (5.78 (dd, 1H), 5.86 (d, 1H), 5.66 (dt, 1H),4.83 (s, 1H) , 4.55 (m, 1H), 4,30 (q, 1H), 3.91 (m, 1H); MS (El) m/z 574, 及(14R)-13,14-二氫史賓諾辛 A(901, 17.6¾)。 窨施例 Ι)2Γ) - (1 5R . 1 4S ) -1 5-去氫甚-15-萍甚-Γ), 6」3 . 1 4-四 氣中g謀辛Α及化合物(1 R/S , 14S,15R , 21 S) -1 Γ) -去氨甚-1 . 1 5-暌-1 , 2-斷-5, Γ). 1 3 . 1 4-四氯中 窨諾辛A 1 -半縮菸 將(14$卜5,6,13,14-四氫史賓諾辛/\(2.6〇8,3.53 mmol)溶於乾Et2〇(:90 ml)。將溶液在氮氣下冷卻至0°C並 加入Li A1H4 (951粉末,268 mg, 6.8 mmol):混合物在 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) 487559 A7 B7 經濟部t-央標準局員工消費合作社印製 五、發明説明(195 ) 下攪拌10分鐘並接著小心地以飽和NH4CI之10%氫氧化銨水 溶液(10 m 1)驟冷。一般逐漸反應完成並在矽膠(乙酸乙酯 ,接著15%乙醇之乙酸乙酯)上層析以提供a) (15R,14S)-15 -去氧基-15-羥基-5,6,13,14-四氫史賓諾辛A(l. 261 g, 48%),為白色固體:NMR δ 4·71 (d, J = 1·2, 1H), 4.47 (d, J = 7.5, 1H), 4.17 (m, 1H), 4.08 (m, 2H), 3.43 (s, 3H), 3.37 (s, 6H), 0.72 (d, j = 6.8, 3Hj, CuHmNOh之分析:估計值:C, 66.73; H, 9.70; N, 1.90。實際值:C, 66.44; H, 9.71; N, 1.82;及 b)化合 物(1R/S, 14S, 15R, 21S) -15-去氧基-1, 15-噁-1,2-斷-5,6, 13,14-四氫史賓諾辛A 1-半縮醛(0,561 g, 21%),為白色 固體 d: ESI MS m/z 740 (M + 1)。 奮施例[)27 - Π 4S )-15-去《甚-15,16 (F:)-烯某 '「),6 . HI 4-, 1T Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (m, 2H), 4 • 81 (s, 1H), 4.44 -4 · 31 (m, 2H), 4. 26 (q, 1H), 4 • 04 (t, 1H), 3.83 (m, 1H); 1 3C-NMR 0 '173.53, 145.22, 132. 34, 130.14, 128. 29, 103.01, 95 • 46, 82. 26, 81. 03, 77. 72 , 76.24, 73 • 76, 67 • 89, 64 • 78, 60. 89, 58. 97, 57. 66, 47.65, 46 • 91, 46 • 90, 41 • 39, 40. 64, 39. 62, 37 39, 36.39, 31 • 20, 30 • 73, 28 .37, 27. 21, 20. 68, 19.0, 18.33, 17. 75, 10. 15, 9.80; MS m / z 734 • Ί (m + 1) ° Analysis of C41HG7NO1ϋ: Estimated value c, -196-This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 Gongcheng) 487559 A7 • B7 V. Description of the invention (194) 67.09; H , 9.20; N, 1.91. Actual values: C, 66 · 96; H, 9.14; Ν, 1.94; (second isomer) part 1H-NMR δ 5.89 (d, 1H), 5.85-5.74 (m , 2H), 4.84 (s, 1H), 4.46- 4.35 (tn, 2HJ, 4.33-4.25 (m, 2H), 3.67 (m, 1H); 13C-NMR &lt; 5 172.24, 144.75, 130.96, 129.77, 128.69 , 103 .80, 95 .40, 84 • 50, 82.27, 81 .03, 79 .35, 76.71 9 76 · 20, 73 · 80, .67 · 83, 64 .65, 60.87, 58.95, 57. 66, 48. 00, 47. 78, 46. 54, 44.71, 41 · 27, 40. 63, 37 • 44, 36 · 94, 36. 36, 32. 02, 31 .36, 29. 65, 27 · 10, 19 .54, 19 · 05, 18. 34, 17 · 73, 10. 15. 7, 7; 40; MS m / z 734. 7 (m + 1) ° Analysis of C41 Η 8 7 N 0 1 0: Estimated value: C, 67 · 09; Η, 9. 20; N, 1.91-actual value: C, 66.65; Rhenium, 9.16; N, 1.85, and (14R, 1 6, 17Z) -17-deoxy-16,17-dehydro-13,14-dihydrospinoxin A 17 --- ------- This-(Please read the notes on the back before filling out this page) Order printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economy-Psa (54 mg, 1.0%): Part 1H-NMR5 (5.78 ( dd, 1H), 5.86 (d, 1H), 5.66 (dt, 1H), 4.83 (s, 1H), 4.55 (m, 1H), 4,30 (q, 1H), 3.91 (m, 1H); MS (El) m / z 574, and (14R) -13,14-dihydrospinoxin A (901, 17.6¾). Example 1) 2Γ)-(1 5R. 1 4S) -1 5-dehydrogen-15-Pingshi-Γ), 6 ″ 3. 1 4-Tetrazine A and compound (1 R / S, 14S, 15R, 21 S) -1 Γ) -Deaminase-1. 1 5- 暌 -1, 2- 断 -5, Γ). 1 3. 1 4-Tetrachlorochloronoroxine A 1-Half-condensed smoke (14 $, 5,6,13,14-tetrahydrospinoxin / \ (2.6〇8, 3.53 mmol) was dissolved in dry Et20 (: 90 ml). The solution was under nitrogen Cool to 0 ° C and add Li A1H4 (951 powder, 268 mg, 6.8 mmol): the mixture applies the Chinese National Standard (CNS) Λ4 specification (210X 297 mm) at the paper size 487559 A7 B7 t-Central Standards Bureau, Ministry of Economic Affairs Printed by the staff consumer cooperative V. Description of the invention (195) Stir for 10 minutes and then carefully quench it with saturated NH4CI in 10% ammonium hydroxide aqueous solution (10 ml). Generally the reaction is gradually completed and the reaction is completed in silicone (ethyl acetate, Then 15% ethanol in ethyl acetate) was chromatographed to provide a) (15R, 14S) -15-deoxy-15-hydroxy-5,6,13,14-tetrahydrospinoxin A (1. 261 g, 48%) as a white solid: NMR δ 4.71 (d, J = 1.2, 1H), 4.47 (d, J = 7.5, 1H), 4.17 (m, 1H), 4.08 (m, 2H), 3.43 (s, 3H), 3.37 (s, 6H), 0.72 (d, j = 6.8, 3Hj, CuHmNOh analysis: Estimated values: C, 66.73; H, 9.70; N, 1.90. Actual values: C, 66.44; H, 9.71; N, 1.82; and b) Compound (1R / S, 14S, 15R, 21S) -15-deoxy-1, 15-oxa-1,2-bran-5,6, 13,14-tetrahydrospinoxin A 1-hemiacetal (0,561 g , 21%) as a white solid d: ESI MS m / z 740 (M + 1). Fen Shi Example [) 27-Π 4S) -15-Go to "even -15,16 (F:)-ene" '), 6. HI 4-

1 14-四気中審IS辛A . 及去氬某- 1 Γ). 1 (UR )-烯甚-Γ). fi · 1 3 _ ,1 4-四氫中審諾辛A (15R, 14S) -15-去氧氧-15-羥基-5,6, 13, , 14-四氫史 賓諾辛MO. 484 g, 0.65 mmol)溶於二氯甲烷(4 ml)。將 溶液在氮氣下冷卻至〇°C及缓慢地加入嗎啉硫三氟化物(1 14-tetrahydro intermediate trial IS Xin A. And deargonium-1 Γ). 1 (UR) -ene even-Γ). Fi · 1 3 _, 1 4-tetrahydro mid trial Nosin A (15R, 14S) -15-deoxy-15-hydroxy-5,6,13,14-tetrahydrospinoxin MO (484 g, 0.65 mmol) was dissolved in dichloromethane (4 ml). The solution was cooled to 0 ° C under nitrogen and morpholine sulfur trifluoride (

0 . 50 m 1 , 4 . 1 mmo 1)。移開冷卻浴並在室溫下持續攪拌4 小時。一般逐漸反應完成並在矽膠(乙酸乙酯:)上層析以提 供産物混合物,其進一步藉由HPLC(90:10, MeOH/H2〇)分 離。所得之:a) (14S)-15-去氧基-15,16( E)-烯基-5,6,13 ,14-四氫史賓諾辛A(48 mg, 10%),為白色固體·· UMR _ 198 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ----.--L---------1T------IP--. (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 ___ B7 ______ 主、發明説明(196 ) 5 5.28 (d, J = 9.9, 1 Η), 4.83 (s, 1 Η), 4.72 (m, 1Η), 4.21 (m, 4Η), 3.52 (s, 3Η), 3·47 (s, 3Η),, 3·46 (s, 3Η), 1·41 (s, 3H); 1&gt;)(14$,151^/3)-15-氣代- 5,6,13,14-四氫史賓諾辛Α(60 mg, 12¾),為白色固體: 'H-NMR ό' 4.96 (d, J = 46.8, 0.4H), 4.19 (dd, J1 = 66, J2 : 9, 0.6 H), 4.83 (d, J 二 1·2, 0.6 H), 4.31 (d, J = 1,2, 0.4 Η), 3·53 (s, 3 Η), 3·46 (s, 6 H); 及(14S)-15 -去氧基-15,16(E) -烯基-5,6,13,14 -四氫史賓 諾辛 A(152 mg, 32%),為白色固髏·♦ UMR δ 5·24 (d, J = 10.8, 1H)&gt; 4.80 (d, J = 1.2, 1H), 4.79 (m, 1H ),4.34 (d, J = 7.4, 1H), 4.20 (m, 3 H), 3.51 (s, 3H) , 3.45 (s, 6H), 1·66 (s, 3H)。 奮旃例[^只-1:^141-申醇基-中賓諾辛八 將氫化鈉(60¾分佈於油中,52 mg, 1· 3 mmol)稱重置 入燒瓶並置於氮氣環氣中。主要將懸浮液以戊烷(2 ml)攪 拌並藉由吸管去除戊烷。在氮氣流下蒸發去除殘餘戊烷ϋ 將經乾燥之MaH懸浮於DMS0 (4 ml),將所得漿液冷卻至15 °C及以單一部分(注意-最初劇烈氣體産生)加入碘化二甲 基氧化鏡(286 mg , 1 . 3 mmo 1)。在該溫度下攪拌反應混合 物40分鐘,同時混合物為清澈溶液。在5分鐘内逐滴加入 史賓諾辛 Aug? mg, 1.13 mmol.)之乾甲苯(1 ml)及 DMS0(1 m 1)溶液。所得溶液在室溫下攪拌2小時。將反應混合物冷 卻至0°C ,以Et2〇稀釋並以飽和碳酸氫鈉溶液及水驟冷。 使混合物在Et2〇及飽和碳酸氫納溶液間分配。以Et2〇萃取 I------.---- (請先閱讀背面之注意事項再填寫本頁)0. 50 m 1, 4.1 mmo 1). Remove the cooling bath and continue stirring for 4 hours at room temperature. The reaction was generally completed gradually and chromatographed on silica gel (ethyl acetate :) to provide the product mixture, which was further separated by HPLC (90:10, MeOH / H2O). Obtained: a) (14S) -15-Deoxy-15,16 (E) -alkenyl-5,6,13,14-tetrahydrospinoxin A (48 mg, 10%), white Solid ·· UMR _ 198-This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) ----.-- L --------- 1T ------ IP -. (Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A7 ___ B7 ______ Master and Invention Instructions (196) 5 5.28 (d, J = 9.9, 1 Η) , 4.83 (s, 1Η), 4.72 (m, 1Η), 4.21 (m, 4Η), 3.52 (s, 3Η), 3.47 (s, 3Η), 3.46 (s, 3Η), 1 41 (s, 3H); 1 &gt;) (14 $, 151 ^ / 3) -15-generation-5,6,13,14-tetrahydrospinoxin A (60 mg, 12¾), white Solid: 'H-NMR ό' 4.96 (d, J = 46.8, 0.4H), 4.19 (dd, J1 = 66, J2: 9, 0.6 H), 4.83 (d, J 2.2, 0.6 H), 4.31 (d, J = 1,2, 0.4 Η), 3.53 (s, 3 Η), 3.46 (s, 6 H); and (14S) -15 -deoxy-15,16 (E ) -Alkenyl-5,6,13,14 -Tetrahydrospinoxin A (152 mg, 32%), white solid crossbone UMR δ 5.24 (d, J = 10.8, 1H) &gt; 4.80 (d, J = 1.2, 1H), 4.79 (m, 1H), 4.34 (d, J = 7.4, 1H), 4.20 (m, 3 H), 3.51 (s, 3H), 3.45 (s, 6H), 1.66 (s, 3H). Fen 旃 Example [^ only -1: ^ 141-Shinolyl-Zinobinoxine Eight sodium hydride (60¾ distributed in oil, 52 mg, 1.3 mmol) was weighed into a flask and placed in a nitrogen ring gas . The suspension was mainly stirred with pentane (2 ml) and the pentane was removed by a pipette. Removal of residual pentane by evaporation under a stream of nitrogen. Suspend the dried MaH in DMS0 (4 ml), cool the resulting slurry to 15 ° C and add iodide dimethyl oxide mirror in a single portion (caution-initial vigorous gas generation). (286 mg, 1.3 mmo 1). The reaction mixture was stirred at this temperature for 40 minutes while the mixture was a clear solution. A solution of Spinolsin Aug? Mg, 1.13 mmol.) In dry toluene (1 ml) and DMS0 (1 ml) was added dropwise over 5 minutes. The resulting solution was stirred at room temperature for 2 hours. The reaction mixture was cooled to 0 ° C, diluted with Et20 and quenched with saturated sodium bicarbonate solution and water. The mixture was partitioned between Et20 and a saturated sodium bicarbonate solution. Extraction with Et2〇 ------.---- (Please read the precautions on the back before filling this page)

、1T 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(197 ) 水層及合併乙醚相並以水清洗(3次),以磺酸氫鈉及鹽稀 釋。混合物以無水磺酸鈉乾燥及在乾氮氣下去除溶劑以産 生白色固體(812 mg)。固體在矽膠(81 g)上層析,以 EtOAc接著以2%MeOH之EtOAc溶液為溶析液以産生白色固體 (785 mg, 93¾) UMR S 損失 6.85 (br s, 1H); MS m/z 746.5 (M + H之估計值,746.5)。、 1T This paper size applies Chinese National Standards (CNS) Λ4 specifications (210X 297 mm) 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (197) Water layer and combined ether phase and washed with water (3 times), diluted with sodium hydrogen sulfonate and salt. The mixture was dried over anhydrous sodium sulfonate and the solvent was removed under dry nitrogen to give a white solid (812 mg). The solid was chromatographed on silica gel (81 g) with EtOAc followed by 2% MeOH in EtOAc as the eluent to give a white solid (785 mg, 93¾). UMR S loss 6.85 (br s, 1H); MS m / z 746.5 (M + H estimate, 746.5).

富施例[)29-13. 14-環氬某-15-羥基史賓諾辛J 化合物13,14-環氧基史賓諾辛以25〇11^,〇.3 111]11〇1) 溶於Et 2 0 (20 m 1)。在氮氣及室溫下劇烈攪拌混合物並加 入氫化三-t-丁氧基鋁鋰(153 mg, 0.6 mmol)。持續攪拌 18小時。以鹽水驟冷反應混合物並以乙醚(3 X 20 m 1)萃取 。合併乙醚萃取物,以無水Na2S〇4乾燥及在減壓下濃縮。 殘餘物在製備型TLC (EtOAc)上純化以提供化合物13, 14-環 氧基-15-羥基史賓諾辛M140 mg, 56%),為白色固體。 m.p. 90-91〇C ; MS m/z 750; ^-NMR (CDC 1 3, 300 MHz) 5.81 (1H, d), 5.62 (1H, d), 4.80 (1H, s), 4.42 (1H, d), 4.30 (1H, m); 13C-NMR (CDCla, 300 MHz) 172.2 ( 内酯 C = 0) , 85·2 (C-OH.)。Rich example [) 29-13. 14-cycloargon-15-hydroxyspinoxin J compound 13,14-epoxyspinoxin with 25〇11 ^, 0.3. 111] At Et 2 0 (20 m 1). The mixture was stirred vigorously under nitrogen at room temperature and lithium tri-t-butoxyaluminum hydride (153 mg, 0.6 mmol) was added. Continue stirring for 18 hours. The reaction mixture was quenched with brine and extracted with ether (3 X 20 ml). The ether extracts were combined, dried over anhydrous Na2SO4 and concentrated under reduced pressure. The residue was purified on preparative TLC (EtOAc) to provide compound 13, 14-epoxy-15-hydroxyspinoxin M140 mg, 56%) as a white solid. mp 90-91〇C; MS m / z 750; ^ -NMR (CDC 1 3, 300 MHz) 5.81 (1H, d), 5.62 (1H, d), 4.80 (1H, s), 4.42 (1H, d ), 4.30 (1H, m); 13C-NMR (CDCla, 300 MHz) 172.2 (lactone C = 0), 85 · 2 (C-OH.).

審施例[)30-1 ·3 · 14-二氯-2-荥甚 ffi Φ g 1¾ 辛 A 在氛氣下,於-30 °C之二異两安(1.01 ml,7·7 mmol) 之THF(20ml)溶液中添加η-丁基鋰(4.8 ml, 7·7 mmol)及 HMPAU.O ml)並冷卻至-4(TC。在10分鐘的期間内將史賓 諾辛Ml.O g, 1·4 mmol)之THF(10 ml)溶液添加至反應混 合物並攪拌1小時。以氯化銨溶液(1〇 ml)驟冷反應混合物 本纸張尺度適用中國國家標準(CNS ) Α4規格(2丨0χ 297公釐) ----·--ϋ----- (請先閱讀背面之注意事項再填寫本頁) 、1Τ 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(邮) 及以乙醚(3x40 ml)萃取。合併乙醚萃取物並以無水 1^23〇4乾燥及在減壓下濃縮。殘餘物在製備型《卩1^之(:18 管柱上層析,以10¾水(0.1¾ NHJH)之甲醇溶液稀釋以獲 得化合物13,14-二氫-2-苯基硒史賓諾辛Μ〇·24 g, 19%), 為白色偏離固體。1Η-NMR (CDC 1 3, 300 MHZ) 7·55 (2H, m), 7,25 (3Η, m), 6.01 (1H, m), 5,85 (1H, m) , 3.97 (1H, d)。Examination example [) 30-1 · 3 · 14-dichloro-2- 荥 ffi ffi g Φ g 1 ¾ A Ambient at -30 ° C bisisoamphenicol (1.01 ml, 7.7 mmol) To THF (20 ml) solution was added η-butyllithium (4.8 ml, 7.7 mmol) and HMPAU.O ml) and cooled to -4 (TC. Spinoloxin M.O. g, 1.4 mmol) in THF (10 ml) was added to the reaction mixture and stirred for 1 hour. The reaction mixture was quenched with ammonium chloride solution (10 ml). The paper size is in accordance with Chinese National Standard (CNS) A4 specification (2 丨 0χ 297 mm) ---- · --ϋ ----- (Please Read the notes on the back before filling this page), 1T 487559 Printed by A7 B7, Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (post) and extraction with ether (3x40 ml). The ether extracts were combined and dried over anhydrous ^ 2304 and concentrated under reduced pressure. The residue was chromatographed on a preparative (1:18) column and diluted with a methanol solution of 10¾ water (0.1¾ NHJH) to obtain compound 13,14-dihydro-2-phenylselenospinoxin Mo · 24 g, 19%), as a white off solid. 1Η-NMR (CDC 1 3, 300 MHZ) 7.55 (2H, m), 7,25 (3Η, m), 6.01 (1H, m), 5,85 (1H, m), 3.97 (1H, d ).

富旆例ΓΚΉ Ί U-二M中富諾辛A 將化合物(2Z)-2,3-二氫史賓諾辛A(20 mg,0·03 mmol)溶於Et 2 0(5 mL)。在氮氣及室溫下劇烈攪拌混合物 並加入氫化三-t-丁氧基鋁鋰(7.6 mg, 0.03 mmol)。於攪 拌18小時後,再加入氫化三-t-丁氣基鋁鋰(7.6 mg, 0· 03 πιπιο 1)。持續攪拌1小時。以鹽水稀釋反應混合物及.以乙醚 (3x15 ml)举取。合併乙醚萃取物,以無水Na2S〇4乾燥及 在減壓下濃縮。殘餘物在製備型HPLC之018管柱純化,以 10%水(含0.1!^[14〇[〇之甲醇溶液溶析以穫得化合物3,14-二氫史賓諾辛Mil mg, 50¾),為白色偏離薄片固體。1Η 一 NMR(CDCl 3, 300 MHz) 5.95 (2H, m) , 4.91 (1Η, s), 4.70 (1H, s); l3C-NMR (CDCla, 300 MHz) 206.1 (C=〇&gt; ,168,9 (内酯 C = 0), 144.7 (四级 C&lt;), 138.0 (四級 C = );MS m/z 732 〇 F:部分化g式丨^三璟部分的017位晉的假搪轩BR基的 飾 窨施例FJ -17-去氩甚_17_胺甚中審諶幸A 17-Pm -201 - · 本紙張尺度適用中國國家標準(CMS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂Example of richness ΓΚΉ 富 Funosin A in U-DiM. Compound (2Z) -2,3-dihydrospinoxin A (20 mg, 0.03 mmol) was dissolved in Et 2 0 (5 mL). The mixture was stirred vigorously under nitrogen at room temperature and lithium tri-t-butoxyaluminum hydride (7.6 mg, 0.03 mmol) was added. After stirring for 18 hours, lithium tri-t-butaneyl aluminum hydride (7.6 mg, 0.03 μm) was added. Stirring was continued for 1 hour. The reaction mixture was diluted with brine and lifted up with ether (3x15 ml). The ether extracts were combined, dried over anhydrous Na2SO4 and concentrated under reduced pressure. The residue was purified on a 018 column of preparative HPLC and eluted with 10% water (a methanol solution containing 0.1! ^ [14〇 [〇 to obtain compound 3,14-dihydrospinoxin Mil mg, 50¾), Off-white flake solid. 1Η-NMR (CDCl 3, 300 MHz) 5.95 (2H, m), 4.91 (1Η, s), 4.70 (1H, s); 13C-NMR (CDCla, 300 MHz) 206.1 (C = 〇 &gt;, 168, 9 (lactone C = 0), 144.7 (fourth-order C &lt;), 138.0 (fourth-order C =); MS m / z 732 〇F: Partially-formed g formula ^ ^ Sanjiao's 017 position BR-based decoration example FJ -17- argon _17_ amine very intermediate test A 17-Pm -201-· This paper size applies Chinese National Standard (CMS) A4 specification (210X297 mm) (please (Please read the notes on the back before filling out this page)

經濟部中央標準局員工消費合作社印製 五Λ發明説明(哨) 於 17-_ 基史賓諾辛 A 17-Psa(318.7 mg, 0.54 mmol) 之甲醇(6 m 1 )溶液中,加入乙酸銨(417 · 1 m g , 5 · 4 in m ο 1) 並接著加入氡硼氫化納(45 mg , 0 · 76 mmo 1 )。在室溫下攪 拌反應混合物5天。在室溫及減壓下蒸發溶劑。殘餘物溶 於IN HC1並以乙醚清洗。接著將水層以5N HaOH鹼化並以 氯化鈉飽和。水層接著以新鮮乙醚萃取。以鹽水清洗乙醚 部分,以K2C〇3乾燥及在室溫及減壓下蒸發。所得之17-去 氧基-17-胺基史賓諾辛A 17-Psa(68.2 mg;産率21¾)為無 色玻璃狀物,為7:1之異構物混合物,FDMS, πι/e (相對強 度)744 (5), 591 (20), 590 (MH+, 40), 112 (100)。 窨旆例E2_ (1 β. 1 7Z) -1 7-去氬甚-Ϊ6 . 1 7-去氩中窨柒辛A 17 -Psa 於Μ-甲基史賓諾辛A碘化物(203.7 mg, 0.23 mmol)之 THF(9 ml)之懸浮液中,添加氫化鈉(50¾之礦物油懸浮液, 42.9 mg , 0.89 mmo 1)。將反應混合物加熱至迴流溫度1小 時,且接箸以乙醚萃取。以鹽水清洗乙醚部分,以K2C〇3 乾燥並在室溫及減壓下濃縮。藉由在氣化矽上層析粗産物 ,以己烷並接箸以40%乙酸乙酯之己烷溶液,以一步驟悌 度溶析◦所得之(16,17Z)-17-去氧基-16, 17-去氫史賓諾 辛A 17-Psa(89.5 mg,産率67¾),為白色玻璃狀物, FDMS, m/e (相對強度)1 144 (20), 573 (M+, 60), 1〇1( 100) 〇 實施例E3 - (16, 17E )-17-去氬某-16, 17-去気中窨諾辛A 1J -Psa, _(17, 18F:) -17-丰氣甚-17. 18-关 Μ 中客諶 • - 202 - 本紙張尺度通用中國國家標準(CNS ) Λ4規格(210 X 297公釐) 丨r-f I (請先閱讀背面之注意事項再填寫本頁) __a ·Five Λ invention notes (whistle) printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs was added to a 17-Pistol Spinoxin A 17-Psa (318.7 mg, 0.54 mmol) in methanol (6 m 1) solution, and ammonium acetate ( 417 · 1 mg, 5 · 4 in m ο 1) and then add sodium borohydride (45 mg, 0 · 76 mmo 1). The reaction mixture was stirred at room temperature for 5 days. The solvent was evaporated at room temperature under reduced pressure. The residue was dissolved in IN HC1 and washed with ether. The aqueous layer was then basified with 5N HaOH and saturated with sodium chloride. The aqueous layer was then extracted with fresh ether. The ether portion was washed with brine, dried over K2CO3 and evaporated at room temperature under reduced pressure. The obtained 17-deoxy-17-aminospinoxin A 17-Psa (68.2 mg; yield 21¾) was a colorless glass, a 7: 1 mixture of isomers, FDMS, π / e (relative Intensity) 744 (5), 591 (20), 590 (MH +, 40), 112 (100). Example E2_ (1 β. 1 7Z) -1 7-deargon and even osmium 6. 1 7-deargon octyl A 17 -Psa in M-methyl spinosin A iodide (203.7 mg, To a suspension of 0.23 mmol) in THF (9 ml) was added sodium hydride (50¾ of mineral oil suspension, 42.9 mg, 0.89 mmo 1). The reaction mixture was heated to reflux temperature for 1 hour, and then extracted with ether. The ether portion was washed with brine, dried over K2CO3 and concentrated under reduced pressure at room temperature. The crude product was chromatographed on gasified silicon, hexane and then 40% ethyl acetate in hexane, and then dissolved in one step. The resulting (16,17Z) -17-deoxy -16, 17-dehydrospinoxin A 17-Psa (89.5 mg, yield 67¾), white glass, FDMS, m / e (relative strength) 1 144 (20), 573 (M +, 60 ), 〇1 (100) 〇 Example E3-(16, 17E) -17- deargon -16, 17- desulfonate inoxin A 1J -Psa, _ (17, 18F :) -17- Fengqi -17. 18- 关 M 客 谌 •-202-The paper size is in accordance with the Chinese National Standard (CNS) Λ4 specification (210 X 297 mm) 丨 rf I (Please read the precautions on the back before filling in this Page) __a ·

、1T 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(2(70) 辛17-卩^及(16,172)-17-去氢基-16.17-去氤中 窨諾辛A 17-Psa 依實施例E2所述進行反應,以史賓諾辛Α(5·1 gm, 6.97 mmol)為起始物質。藉由製備型HPLC在C18管柱上分 離産物,以乙睛··甲醇:0.1 %NH 4 0Ac( 20 :40:40)溶析。所得 之(16, 17E) -17-去氧基-16, 17_去氫史賓諾辛A 17-Psa ( 119 mg;産率 3%), FDMS, m/e (相對強度)572 (Μ、100 ),(17, 18E)-17-去氧基-17, 18-去.氫史賓諾辛 17-Psa (634 fflg;産率 16%), FDMS, m/e (相對強度)572 (Μ、100), 及(16,17Ζ)-17-去氧基-16,17-去氫史賓諾辛A 17-Psa (6 89 mg ;産率17t)皆為白色固體。 富旆例E4- (5R . fiR ) -5- (2-锊基乙氬基卜6-溴史g謠辛A 1_7 - P s a 於史賓諾辛 A(154.1 mg, 0.21 mmol)之乙二醇(5ml) 懸浮液中,加入N-溴丁二醯亞胺(79.8 mg, 0.45 mmol)。 將反應混合物加熱至80 °C 1. 5小時,並接著冷卻至室溫。1T 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (2 (70) Xin 17- 卩 ^ and (16,172) -17-Dehydrogen-16.17-Nuoxin A 17 -Psa The reaction was carried out as described in Example E2, starting with Spinozin A (5.1 gm, 6.97 mmol). The product was separated on a C18 column by preparative HPLC and acetonitrile · methanol : 0.1% NH 4 0Ac (20: 40: 40). The obtained (16, 17E) -17-deoxy-16, 17_dehydrospinoxin A 17-Psa (119 mg; yield 3%), FDMS, m / e (relative strength) 572 (M, 100), (17, 18E) -17-deoxy-17, 18-de. Hydrogen Spinozin 17-Psa (634 fflg; 16% yield), FDMS, m / e (relative strength) 572 (M, 100), and (16,17Z) -17-deoxy-16,17-dehydrospinoxin A 17-Psa ( 6 89 mg; yield 17t) are all white solids. Rich example E4- (5R. FiR) -5- (2-fluorenylethylarginyl 6-bromosulfonyl A-1_7-P sa Yu Shibin To a suspension of norsin A (154.1 mg, 0.21 mmol) in ethylene glycol (5 ml) was added N-bromosuccinimide (79.8 mg, 0.45 mmol). The reaction mixture was heated to 80 ° C for 1.5 hours And then cooled to room temperature

以二氯甲烷稀釋混合物,並以水清洗。接著以鹽水清洗二 氯甲烷部分,以K2C〇3乾燥並在室溫下蒸發。藉由在氯化 矽上層析分離産物,以70%乙酸乙酯之己烷溶液及接箸以 5%甲醇之二氛甲烷溶液溶析。所得化合物a )史賓諾辛A 17-Psa (41.7 mg;産率34¾),為無色玻璃狀物。藉由氯 化矽上之層析進一步純化(5R , 6R ) -5- (2-羥基乙氧基)-6-溴史賓諾辛A 17-Psa ,以70%乙酸乙酯之己烷溶液溶析。 所得化合物b) (5R,6R) -5- (2-羥基乙氣基)-6-溴史賓諾辛A -203 - 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁) 、τ 經濟部中央標準局員工消費合作社印製 487559 A7 * B7 五、發明説明(2〇1 ) 17 - Psa(50.2 mg,産率 33¾),為無色玻璃狀物,FDMS, m/e (•相對強度)734 (〜5), 732 (MH+,60), 189 (100)。 富施例H (5R . 6R ) -5 . fi-璟氬基-1 7-0-二甲某S々烷某中客 17-Psa 於(5S, 6R)-5,6-環氧基史賓諾辛 A 17-Psa (503.7 mg, 0.83 mmol)之乙醚(20 ml)溶液中,添加氯三甲基矽 烷(211 ml, 1,66 mmol)及二異丙基乙胺(289 ml, 1.66 miu〇 1)。在室溫下攪拌反應混合物23小時,接箸加入額外 之氯三甲基矽烷(105 ml, 0.83 1«〇1)及_二異丙基乙胺( 144ml, 0.83 mmol)。在室溫下再攪拌反應混合物18小時 。傾斜倒出乙醚及以新鮮乙醚研磨殘餘沈澱物。合併乙醚 部分,以飽和NaHC03水溶液清洗,以K2C〇3乾燥及在室溫 及減壓下蒸發。藉由在氧化矽上層析純化粗産物,以50¾ 乙酸乙酯之己烷溶液溶析。所得(5R,6R )-5,6-環氧基-17-〇-二甲基矽烷基史賓諾辛A 17-Psa(521.1 mg;産率92¾) ,為無色玻璃狀物,FDMS, m/e (相對強度)679 (75), 678 (M、100) , 190 (30),100 (35.)。 奮施例M - (5R , 6R) U-璟《甚中窨諶辛A 17-Psa 於史賓諾辛A 17-Psa (1.0 gm, 1.71 mmol)之二氯甲 烷(45 ml)溶液中,添加間-氯過氧化苯甲酸(591.7 mg, 3.34 mmol)。在室溫下攪拌反應混合物23小時。以二氯甲 烷稀釋混合物並以飽和NaHC〇3清洗,以K2C〇3乾燥,及在 室溫及減壓下蒸發。藉由在氧化矽上層析純化粗産物,以 15%丙酮之二氛甲烷溶液溶析。所得之(5R,6R)-5,6-環氧 '-204 - 本紙悵尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 衣The mixture was diluted with dichloromethane and washed with water. The dichloromethane portion was then washed with brine, dried over K2CO3 and evaporated at room temperature. The product was separated by chromatography on silicon chloride and eluted with 70% ethyl acetate in hexane and then with 5% methanol in dichloromethane. The obtained compound a) Spinoxin A 17-Psa (41.7 mg; yield 34¾) was a colorless glass. (5R, 6R) -5- (2-Hydroxyethoxy) -6-bromospinoxin A 17-Psa in 70% ethyl acetate in hexane was further purified by chromatography on silicon chloride. Dissolution. Resulting compound b) (5R, 6R) -5- (2-hydroxyethylamino) -6-bromo spinosinoxin A -203-This paper size applies the Chinese National Standard (CNS) Λ4 specification (210X 297 mm) (Please read the notes on the back before filling out this page), τ printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 * B7 V. Description of the invention (2001) 17-Psa (50.2 mg, yield 33¾), It is a colorless glass, FDMS, m / e (• relative strength) 734 (~ 5), 732 (MH +, 60), 189 (100). Fushi Example H (5R. 6R) -5. Fi-fluorenyl-1-7-0-dimethyl-1, S-pentane, and 17-Psa in (5S, 6R) -5,6-epoxy Nosin A 17-Psa (503.7 mg, 0.83 mmol) in diethyl ether (20 ml) was added with chlorotrimethylsilane (211 ml, 1,66 mmol) and diisopropylethylamine (289 ml, 1.66 miu 〇1). The reaction mixture was stirred at room temperature for 23 hours, and then additional chlorotrimethylsilane (105 ml, 0.83 1 «〇1) and -diisopropylethylamine (144 ml, 0.83 mmol) were added. The reaction mixture was stirred for an additional 18 hours at room temperature. The ether was decanted and the residual precipitate was triturated with fresh ether. The ether portions were combined, washed with saturated aqueous NaHC03, dried over K2CO3 and evaporated at room temperature under reduced pressure. The crude product was purified by chromatography on silica and eluted with 50¾ ethyl acetate in hexane. The obtained (5R, 6R) -5,6-epoxy-17-〇-dimethylsilyl spinosin A 17-Psa (521.1 mg; yield 92¾) was a colorless glass, FDMS, m / e (relative strength) 679 (75), 678 (M, 100), 190 (30), 100 (35.). Fenshi M-(5R, 6R) U- 甚 "Verydroxin A 17-Psa in a solution of Spinozin A 17-Psa (1.0 gm, 1.71 mmol) in dichloromethane (45 ml), Add m-chloroperbenzoic acid (591.7 mg, 3.34 mmol). The reaction mixture was stirred at room temperature for 23 hours. The mixture was diluted with dichloromethane and washed with saturated NaHC03, dried over K2CO3, and evaporated at room temperature under reduced pressure. The crude product was purified by chromatography on silica and eluted with 15% acetone in dichloromethane. The obtained (5R, 6R) -5,6-epoxy '-204-The size of this paper is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 mm) (Please read the precautions on the back before filling this page)

、1T 經濟部中央標準局員工消費合作社印製 487559 A7 * B7 ______________—- 五、發明説明(2〇2) 基史賓諾辛A 17-Psa(1.04 gm;産率約100¾),為無色玻 璃狀物,FDMS, m/e (相對強度)607 (M、70), 190 ( 100), 101 (99)。 富旆例E7-1 7-酮基-中賓諾辛A iUsa 於-78°C 之 N-氯丁二醯亞胺(108,6 mg, 0.81 mmol) 之二氯甲烷(2.6 ml)懸浮液中,添加異丙基硫醚U25 ml, 0.86 mmol)0 在-78 °C下攪拌反應混合物30分鐘,接著緩 慢地加戊史賓諾辛A 17-Psa (150·1 mg, 0.25 mmol)之二 氯甲烷溶液(1 ffl 1)。將反應混合物在-78 °C下攪拌3小時, 接著加入三乙胺(109 ml, 0· 78 mmol)並當顔色變成紅色 時,將反應混合物加熱至室溫°接著以二氯甲烷稀釋混合 物,以0.1N HC1,鹽水清洗,以MgS〇4乾燥及在室溫及減 壓下蒸發。藉由在氧化矽上層析純化粗産物,以40¾乙酸 乙酯之己烷溶液溶析。所得之17-酮基-史賓諾辛A 17-Psa (84.7 mg ;産率58¾),為無色玻璃狀物,FDMS, m/e (相 對強度)588 (Μ、100)。 富旆例Ε8 -1 7-去氫某-1 Γ). 17-去氣史賓諾辛_A Ag 於實施例3所述進行反應,以史賓諾辛J(15.02 gm, 21 mmol)為起始物質。將K2C〇3之甲醇溶液處理後,過濾 反應混合物,接箸在室溫及減壓卞蒸發。將殘餘物保持在 室溫下24小時,無需進一步純化,接著以二氯甲烷研製° 接著在室溫及減壓下蒸發二氯甲烷。藉由在氧化矽上層析 純化粗産物,以5¾甲醇之二氛甲烷溶液溶析。所得之粗17 -去氧基-16, 17-去氫史賓諾辛/\ Ag,為黃色半固體及史 -205 - 本紙浪尺度適用中國國家標準(CNS ) A4規格(2l〇x 297公釐) 丨 * (請先閱讀背面之注意事項再填寫本頁) 訂 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(2〇3 ) 賓諾辛A 9-Psa(1.02 gm;産率9%),為無色玻璃狀物。粗 17-去氧基-16,17-去氫史賓諾辛A Ag藉由製備型HPLC在 C18管柱上進一步純化,以乙睛:甲醇:0. 1%NH4〇Ac (35 :35 :30)溶析。所得純17_去氧基-16, 17-去氫史賓諾辛A Ag (1.81 gm; 224 yield),為白色玻璃狀物,FDMS, m/e ( 相對強度)460 (10), 385 (M+, 55), 384 (100)。 富旆例Μ-17-去氬某-17-氡甚-13, 14-二氯-13-氣基中g 諾辛 A 17-Psa 將化合物史賓諾辛A (97 mg, 0.13 mmol)溶於5 mL 甲醇並加入氰化鉀(59.8 mg, 0.92 mmol)並將反應物攪拌 隔夜。於逐漸反應完成後,將粗産物(0.05 g)藉由在矽膠 上層析(乙酸乙酯/己烷20 ·· 80至50 ·· 50梯度)以提供化合物 17-去氧基-17-氰基-13, 14-二氫-13-氡基史賓諾辛A 17-Psa(18,9 mg, 20.2¾),為白色固體:IR (KBr) 3019, 2971, 2933, 2823,2240, 1723, 1481, 1104, 1038, 732 cm-1; 13C NMR (5 171.86, 131.87, 126.64, 121.49 ,120.18, 96.01, 82.72, 81.61, 78.36, 75.98, 68.65 ,61.42, 59.61, 58.36, 56.37, 48.30, 47.09, 46.75, 44.58, 43.41, 41.80, 37.48, 36.57, 34.15, 33.53, 30.23, 28.63, 27.47, 22.97, 22.22, 18.32, 13.26, 10.42; FDMS m/z 628. C42H88N2O1Q 之分析:估計值: C, 66.46; Η, 8·76·實際值:C,65.84; Η, 8.14。 實施例Π0-17-去氛甚,-η-「?〃'-(二甲甚防甚)乙基卜16 ,17-(7.卜惊莘中客柒辛J 17-Psa 本紙張尺度適用中國國家標準(CNTS ) A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(204 ) 將史賓諾辛J (1.20 g, 1.67 mmol)與1-氯-2-二甲基 胺乙烷反應(就地形成其鹽酸鹽),接箸依照3,-0,N-雙(三 氘甲基)史賓諾辛Μ所述步驟進行。在矽膠(乙酸乙酯)上層 析及HPLC分離(88:12, MeOH/H2〇)以提供17-去氧基-3 [2W -(二甲基胺基)乙基卜16, 17- (Z)-烯基史賓諾辛J 17-Psa(:109 mg, 101),為白色固體:UMR δ 6·39 (s, 1 Η), 5.63 (m, 1 H), 2.18(s, 6Η), 1.84 (s, 3Η)。 審旆例Π 1 - (13R . 14S) -13. 1 4-璟《某中g柒辛A,化合物 1 3R · 1 4S ) -16, 1 7-去氤-1 7-璟氬甚-1 · 17 (Z) -— 烯某-1 3.14-璟氬甚中客謀辛A 1 7-Psa,及化_ 会物(1 3R , 1 4S . 1 Μ . 1 7R ) -1 7-去氬基-13 , 14-環 氬甚-1 β」7-璟氨某中客諶辛A 1 7-Psa 將史賓諾辛A (5.06 g, 6.91 mmol)溶於乙醇(35 mL) 。接著加入四氫卩夫喃(15 mL),接著加入10%Na0H水溶液( 15 mL.)及30%過氧化氫水溶液(6 mL,過量)。在室溫下攪 拌4小時。一般逐漸反應形成並在矽膠(乙酸乙酯)上層析, 獲得:a) (13R,14S)-13,14-環氧基史賓諾辛A (3.18 g, 61.5%),為白色固體:ESI MS m/z 748 (Μ + l);及 b)較低 極性化合物的混合物,將其藉由閃蒸矽膠管柱層析(7¾ Et2〇之二氯甲烷溶液)以獲得:c) (13R, 14S) -16, 17-去氫-17-去氧基-16, 17 (Z)-烯基-13, 14-環氧基史賓諾辛A 17-Psa (280 rag, 6·«),為白色固體 ^H-NMR δ 5.40 (m, 1 Η), 3.45 (s, 3H), 3.39 (s, 3H), 3.38 (s, 3H), 1·72 (s, 3H);及 d)(13R,14S, 18S,17R)-17-去氣基-13 -207 - 本紙伕尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 487559 A7 B7 五、發明説明(2〇5) ,14-環氧基-16,17-環氧基史賓諾辛A 17-Psa (97 mg, 2.34),為白色固體:iH-NMR δ4·47 (οι, 1H), 3.81 (s, 1Η), 3.43 (s, 3Η), 3·38 (s, 6Η), 1·37 (s, 3Η)。 甯旆例E12-(2 R/S’)-m7-二氫-17-去氯基-16·17 (E/Z)_ 悌某某中蒈諶辛F__17-Psa 二異丙基胺(0.658 mL, 5·0 mmol)溶於乾 THF(10 niL.) 。將溶液在氮氣下冷卻至-23°C並逐滴加入n-BuLi (2.5M 之己烷溶液2.0 mL, 5.0 mmol)。在-23 °C攪拌30分鐘並 將混合物冷卻至-78 °C。將史賓諾辛F (1 · 03 g,1 · 434 mmol)之乾THF(3 niL)逐滴加入反應混合物中°於5分鐘後, 反應溫度升高至-23°C·於48分鐘後,導入碘乙烷(1·25 m L , 15.6 m m 〇 1)。利用ί覺拌,容許在2 · 5小時内使溫度升 高至室溫。一般逐漸反應形成並在矽膠(乙酸乙酯)上層析 ,以獲得産物(441 mg),將其在矽膠(乙酸乙酯)上重複層 析 ϋ 所提供之(2R/S)-16,17 -二氫-17-去氯基-16, 17(E/Z) -烯基-2-乙基史賓諾辛F 17-Psa (152 mg, 18 %),為白 色固體:lH-NMR δ 6.60 (m,0·33 Η), 6.50 (s, 0.33 Η), 6.29 (s, 0.33Η), 5.60-6.05 (m, 3Η), 4.78 (s, 1H), 3.46 (s, 3H), 3.40 (s, 6H), 0.75-0.92 (3 x t ,6H) . ESI MS m/z 587 (M十 1) ·:· 窨旆例丟-中窨諶辛A 17-Psa 將一部分硼氫化鈉(14 · 2 mg , 0 · 37 mmo 1)添加至冷 (-20°C)之 17-酮基史賓諾辛 A 17-psa (220 mg,0·37 mmol)及氛化姉(III)七水物(140 mg, 〇·37 mmol)之甲醇 本紙張尺度適用中國國家標準(CNS ) A4現格(2丨0X 297公釐) - — * ί ί I-I ϋ^— I (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 經濟部中央標準局員工消費合作社印製 487559 A7 ___ B7 五、發明説明(2〇6 ) (6 mL)溶液(注意:發泡及H2釋出)。將此混合物在_2(TC 攪拌20分鐘,接箸藉由在2_3分鐘内逐滴加入IN HC1 (0.5 mL)以在此溫度下驟冷。接箸以乙醚(40 mL)稀釋混合物並 以鹽水(2x5 niL)清洗有機層並以MgS〇4乾燥。濃縮後留下 290 mg固體殘餘物,其係以氯化矽(40 m 1)閃蒸層析,利 用3¾ MeOH之(^2(:12為溶析液以獲得220 mg白色粉末,其 為17-表-史賓諾辛A 17-Psa及史賓諾辛A 17-Psa之4:1混 合物。藉由逆相HPLC以C18鍵結之氧化矽管柱(41.4 mm ( i.d.) X 25 cm (1))分離,利用15%H2〇之MeOH為溶液液。 史賓諾辛A 17-Psa首先析出。17_表-史賓諾半A 17-Psa: 106 mg;白色粉末;1H MMR (CDCh) δ 6·78 (s, 1Η, Η-13), 4,86 (d, 1Η, Η-1,), 4.83 (m, 1Η, Η-21), 4·32 (m, 1Η,H-9) , 3·90 (m,1Η, Η-17)。 F部份化合物中客諶辛Α夕三璟部分f&gt;5及ΟΓ)位詈的ffe 飾 實施例FI - (!5R . fiR ) - 5- (2-锊某7,«甚)-卜溴中賓諾辛A 於史賓諾辛(1.0 gml 1,37 mmol)及Μ-溴丁二醯亞胺 之(289.5 mg, 1· 63 mmol)之乙二醇(20 ml)懸浮液中,添 加5 N HC 1 (29 5 ui, 1.47mmol)。反應混合物轉變黃色及 在室溫下攪拌1 · 5小時,在此期間顔色褪色為澄清。將混 合物倒入飽和NaHC〇3水溶液並以乙醚萃取。以MgS〇4乾燥 乙隱並在室溫及減壓下蒸發。可得粗(5R,6R.)-5-(2-羥基 乙氧基-6-溴史賓諾辛A (896· 8 mg,産率75%)。?|由 在氣化矽上層析純化化合物,以5%甲醇之二氯甲烷溶液溶 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨ϋ χ 297公釐) —---^--*---衣-- (請先閱讀背面之注意事項再填寫本頁)1. 1T printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 * B7 ______________- V. Description of the invention (202) Kespinoxin A 17-Psa (1.04 gm; yield about 100¾), colorless glass Object, FDMS, m / e (relative intensity) 607 (M, 70), 190 (100), 101 (99). Enrichment Example E7-1 7-keto-Zinobinoxine A iUsa Suspension of N-chlorobutanediimine (108,6 mg, 0.81 mmol) in dichloromethane (2.6 ml) at -78 ° C Add isopropyl sulfide U25 ml, 0.86 mmol). Stir the reaction mixture at -78 ° C for 30 minutes, and then slowly add pentospinoxin A 17-Psa (150 · 1 mg, 0.25 mmol). Dichloromethane solution (1 ffl 1). The reaction mixture was stirred at -78 ° C for 3 hours, then triethylamine (109 ml, 0.78 mmol) was added and when the color turned red, the reaction mixture was warmed to room temperature and then the mixture was diluted with dichloromethane, It was washed with 0.1N HC1, brine, dried over MgS04 and evaporated at room temperature under reduced pressure. The crude product was purified by chromatography on silica and eluted with 40¾ ethyl acetate in hexane. The obtained 17-keto-spinoxin A 17-Psa (84.7 mg; yield 58¾) was a colorless glass, FDMS, m / e (relative strength) 588 (M, 100). Enriched Example E8 -1 7-Dehydrogen-1 Γ). 17-Degassed Spinoxin_A Ag The reaction was performed as described in Example 3, using Spinoxin J (15.02 gm, 21 mmol) as Starting material. After the methanol solution of K2CO3 was treated, the reaction mixture was filtered and evaporated at room temperature under reduced pressure. The residue was kept at room temperature for 24 hours without further purification, followed by trituration with dichloromethane followed by evaporation of the dichloromethane at room temperature under reduced pressure. The crude product was purified by chromatography on silica and eluted with 5¾ methanol in dichloromethane. The obtained crude 17-deoxy-16, 17-dehydrospinoxin / \ Ag, is a yellow semi-solid and the history of -205-The paper scale is applicable to the Chinese National Standard (CNS) A4 specification (2l0x 297) )) 丨 * (Please read the precautions on the back before filling out this page) Order 487559 Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (203) Binoxin A 9-Psa (1.02 gm Yield: 9%) as a colorless glass. Crude 17-deoxy-16,17-dehydrospinoxin A Ag was further purified by preparative HPLC on a C18 column with acetonitrile: methanol: 0.1% NH4〇Ac (35:35: 30) Dissolution. The pure 17_deoxy-16, 17-dehydrospinoxin A Ag (1.81 gm; 224 yield) was obtained as a white glass, FDMS, m / e (relative strength) 460 (10), 385 ( M +, 55), 384 (100). Enriched Example M-17-Deargon-17-Hexan-13, 14-Dichloro-13-Gag Nosin A 17-Psa Dissolve the compound Spinoxin A (97 mg, 0.13 mmol) To 5 mL of methanol, potassium cyanide (59.8 mg, 0.92 mmol) was added and the reaction was stirred overnight. After the gradual reaction was completed, the crude product (0.05 g) was chromatographed on silica gel (ethyl acetate / hexane 20 · 80 to 50 · 50 gradient) to provide compound 17-deoxy-17-cyanide Base-13, 14-dihydro-13-fluorenyl spinosyn A 17-Psa (18,9 mg, 20.2¾) as a white solid: IR (KBr) 3019, 2971, 2933, 2823, 2240, 1723, 1481, 1104, 1038, 732 cm-1; 13C NMR (5 171.86, 131.87, 126.64, 121.49, 120.18, 96.01, 82.72, 81.61, 78.36, 75.98, 68.65, 61.42, 59.61, 58.36, 56.37, 48.30, 47.09, 46.75 , 44.58, 43.41, 41.80, 37.48, 36.57, 34.15, 33.53, 30.23, 28.63, 27.47, 22.97, 22.22, 18.32, 13.26, 10.42; FDMS m / z 628. C42H88N2O1Q analysis: Estimated value: C, 66.46; Η, 8.76 · Actual value: C, 65.84; Thallium, 8.14. Example Π0-17- Deodorant, -η-"? 〃 '-(dimethylformate even) ethyl ester 16, 17- (7. Bu Jingxun Zhongke Xing J 17-Psa This paper size is applicable to Chinese National Standard (CNTS) A4 (210 X 297 mm) (Please read the notes on the back before filling this page) Order 487559 Central Bureau of Standards, Ministry of Economic Affairs A7 B7 printed by employee consumer cooperatives Ming (204) Spinoloxin J (1.20 g, 1.67 mmol) was reacted with 1-chloro-2-dimethylamineethane (the hydrochloride was formed in situ), followed by 3, -0, N -The procedure described for bis (trideuteryl) spinoxin M. Chromatography on silica gel (ethyl acetate) and HPLC separation (88:12, MeOH / H20) to provide 17-deoxy-3 [2W-(dimethylamino) ethylbulfene 16, 17- (Z) -alkenyl spinosinol J 17-Psa (: 109 mg, 101), as a white solid: UMR δ 6.39 (s, 1 Η), 5.63 (m, 1 H), 2.18 (s, 6Η), 1.84 (s, 3Η). Examination example Π 1-(13R. 14S) -13. 1 4- 璟 《中 中 柒 柒 辛A, Compound 1 3R · 1 4S) -16, 1 7-Deuterium-1 7-Sadium Argon-1 · 17 (Z) -—— ene-1 3.14-Sadium Arsenic A 1 7- Psa, and chemical compounds (1 3R, 1 4S. 1 M. 1 7R) -1 7-desarginyl-13, 14-cycloargon and even -1 β "7-ammonium acetamidine A 1 7-Psa Dissolve Spinoxin A (5.06 g, 6.91 mmol) in ethanol (35 mL). Then tetrahydrofuran (15 mL) was added, followed by 10% aqueous NaOH solution (15 mL.) And 30% aqueous hydrogen peroxide solution (6 mL, excess). Stir at room temperature for 4 hours. Generally, it is gradually formed and chromatographed on silica gel (ethyl acetate) to obtain: a) (13R, 14S) -13,14-epoxy spinosin A (3.18 g, 61.5%), as a white solid: ESI MS m / z 748 (M + l); and b) a mixture of less polar compounds, which was subjected to flash silica gel column chromatography (7¾ Et20 in dichloromethane) to obtain: c) (13R, 14S) -16, 17-dehydro-17-deoxy-16, 17 (Z) -alkenyl-13, 14-epoxy Spinozin A 17-Psa (280 rag, 6 · «), White solid ^ H-NMR δ 5.40 (m, 1 Η), 3.45 (s, 3H), 3.39 (s, 3H), 3.38 (s, 3H), 1.72 (s, 3H); and d) (13R , 14S, 18S, 17R) -17-Degas-based-13 -207-The size of this paper is applicable to China National Standard (CNS) A4 (210X 297 mm) (Please read the precautions on the back before filling this page) Order 487559 A7 B7 V. Description of the invention (205), 14-epoxy-16, 17-epoxy spinosin A 17-Psa (97 mg, 2.34), white solid: iH-NMR δ 4.47 (οι, 1H), 3.81 (s, 1Η), 3.43 (s, 3Η), 3.38 (s, 6Η), 1.37 (s, 3Η). Example N12- (2 R / S ')-m7-dihydro-17-dechloro-16 · 17 (E / Z) _ 悌 中 中 蒈 谌 辛 F__17-Psa diisopropylamine (0.658 mL, 5.0 mmol) was dissolved in dry THF (10 niL.). The solution was cooled to -23 ° C under nitrogen and n-BuLi (2.5 mL of a 2.5M hexane solution, 2.0 mL, 5.0 mmol) was added dropwise. Stir at -23 ° C for 30 minutes and cool the mixture to -78 ° C. Spinoloxin F (1.03 g, 1.434 mmol) of dry THF (3 niL) was added dropwise to the reaction mixture. After 5 minutes, the reaction temperature rose to -23 ° C. After 48 minutes , Iodoethane (1.25 m L, 15.6 mm 〇1) was introduced. Use the sensation to allow the temperature to rise to room temperature within 2.5 hours. Usually gradually formed by reaction and chromatography on silica gel (ethyl acetate) to obtain the product (441 mg). Repeat chromatography on silica gel (ethyl acetate). (2R / S) -16,17 provided -Dihydro-17-dechloro-16, 17 (E / Z) -alkenyl-2-ethylspinoxin F 17-Psa (152 mg, 18%) as a white solid: lH-NMR δ 6.60 (m, 0.33 Η), 6.50 (s, 0.33 Η), 6.29 (s, 0.33 Η), 5.60-6.05 (m, 3Η), 4.78 (s, 1H), 3.46 (s, 3H), 3.40 ( s, 6H), 0.75-0.92 (3 xt, 6H). ESI MS m / z 587 (M10 1) 2 mg, 0 · 37 mmo 1) Add to cold (-20 ° C) 17-ketospinoxin A 17-psa (220 mg, 0. 37 mmol) and Aromatic (III) heptahydrate ( 140 mg, 〇 · 37 mmol) of methanol This paper size is applicable to Chinese National Standards (CNS) A4 (2 丨 0X 297 mm)--* ί Ⅱ ^^ I (Please read the precautions on the back before (Fill in this page) Order Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Printed by the Central Standards Bureau of the Ministry of Economic Affairs Printed by the Consumers' Cooperatives of the Central Standards Bureau 487559 A7 ___ B7 V. Description of the Invention (206) (6 mL) solution (note: foaming and H2 release). This mixture was stirred at _2 ° C for 20 minutes, then quenched at this temperature by adding IN HC1 (0.5 mL) dropwise over 2-3 minutes. Then the mixture was diluted with ether (40 mL) and brine The organic layer was washed with (2x5 niL) and dried over MgSO. After concentration, 290 mg of a solid residue was left, which was flash-chromatographed with silicon chloride (40 ml) using 3¾ MeOH (^ 2 (: 12 The eluate was obtained to obtain 220 mg of a white powder, which was a 4: 1 mixture of 17-epi-Spinoxin A 17-Psa and Spinoxin A 17-Psa. C18 was bonded by reverse phase HPLC Silica column (41.4 mm (id) X 25 cm (1)) was separated and 15% H2O in MeOH was used as the solution. Spinozin A 17-Psa was first precipitated. 17_ 表-Spino Semi A 17-Psa: 106 mg; white powder; 1H MMR (CDCh) δ 6.78 (s, 1Η, Η-13), 4,86 (d, 1Η, Η-1,), 4.83 (m, 1Η, Η -21), 4.32 (m, 1Η, H-9), 3.90 (m, 1Η, Η-17). In the F part of the compound, the 谌 (Α, 夕, 璟, 璟) part f &gt; 5 and 0Γ) position Ffe 的 ffe Decorative Example FI-(! 5R. FiR)-5- (2- 锊 some 7, «even)-Brbrinobinoxin A in Spinoxin (1.0 gml 1,37 mmol) and M -Bromobutene To a suspension of hydrazone (289.5 mg, 1.63 mmol) in ethylene glycol (20 ml), 5 N HC 1 (29 5 ui, 1.47 mmol) was added. The reaction mixture turned yellow and stirred at room temperature for 1 5 hours, during which the color fades to clear. The mixture is poured into saturated aqueous NaHC0 solution and extracted with ether. Ethyl acetate is dried over MgS04 and evaporated at room temperature under reduced pressure. Crude (5R, 6R .)-5- (2-Hydroxyethoxy-6-bromo spinosinoxin A (896 · 8 mg, yield 75%). || The compound was purified by chromatography on gasified silica with 5% methanol Dichloromethane solution solution of this paper applies the Chinese National Standard (CNS) A4 specification (2 丨 ϋ χ 297 mm) ----- ^-* --- clothing-(Please read the precautions on the back first (Fill in this page)

、1T 487559 A7 B7__ 五、發明説明(2〇7 ) 析,以擭得(5R,6R )-5-(2-羥基乙氧基)-6-溴史賓諾辛 為白色玻璃狀物,FDMS, m/e (相對強度)873 ( 100),, 1T 487559 A7 B7__ V. Description of the invention (20) Analysis of (5R, 6R) -5- (2-hydroxyethoxy) -6-bromo spinosinol as white glass, FDMS , m / e (relative intensity) 873 (100),

871 (Μ、80K871 (Μ, 80K

奮施例F2- ( 5S . Μ ) - 5,6-二镡甚-5,6-二氩中蒈諾辛A 於史賓諾辛A(487.8 mg, 0.67 mmol)及三甲胺-N-氧 化物二水物(108 .mg, 0.97 mmol)之含水(0.5 ml)之 t-丁 醇(3 m 1 )懸浮液中,加入Dtt旋(6 0 m 1 , 0.7 4 m m ο 1)並接著 加入四氧化鐵(0 . 1 Μ ; 4 0 m 1 , 0.0 0 4 m m ο 1 ) ϋ將反應混合 物在氮氣環境下加熱至迴流溫度19小時。接箸將深色混合 物冷卻至室溫並倒入20¾NaHS〇3水溶液並以乙醚萃取。以 鹽水清洗乙醚部分,以MgS(U乾燥,及在室溫及減壓下蒸 發。藉由氧化矽上之層析純化産物,以7¾甲醇之二氯甲烷 溶液溶析。所得之(5S,6R :)-5,6-二羥基-5,6-二氫史賓諾 辛A(282.1 mg;産率55%),為米黃色固體,FDMS, m/e ( 相對強度)766 (M+, 60), 765 (100)。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 實施例F3- (5R) - 5- (2-揮甚7氬甚)-fi. 7-关氯中窨諶辛A 於(5R,6R)-5-(2-羥基乙氧基)-6-溴史賓諾辛A ( 299.9 mg, 0·34 mmol)之無水 THF (10 ml)溶液中,加入 化鈉(5 0 %之礦物油分散液;6 9 . 3 m g , 1.4 4 m m ο 1 )並釋出 氣體。在室溫下攪拌反應混合物3.5小時,及接著倒入水 中。以乙醚萃取該水部分。以鹽水清洗乙醚部分,以 K2C〇3乾燥及在室溫及減壓下蒸發。藉由氧化矽上之層析 純化産物,以5%甲醇之二氯甲烷溶液溶析。所得之(5R ) -5-(2-羥基乙氧基)-6,7-去氫史賓諾辛A(123.9 mg;産率 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210.X 297公釐) ^7559 經濟部中央標準局員工消費合作社印掣 A7 B7 五、發明説明(2〇8) 50% ,以所回收之起始物質為基準),為淡黃色玻璃狀物 ,FDMS, m/e (相對強度)791·8 (M、100)、,419.5 (30) Ο 富施例F4-(5S · flR )-中窨諾辛A碳p pi旨 於(5S, 6R)-5,6-二氫史賓諾辛 A (85 mg, 0.11 mmol)及碳酸亞乙酯(109.2 mg, 1.2 mmol )之苯(3 ml)溶 液中,添加無水K2C〇3(40.2 mg, 0.29 m πι ο 1)並將混合物 加熱至迴流溫度,於2 · 5小時後,將混合物冷·卻至室溫並 以二氯甲烷稀釋。以水、鹽水清洗二氯甲烷部分,以 K2C〇3乾燥及在室溫及減壓下蒸發。藉由氧化矽上之層析 純化産物,以7%甲醇之二氯甲烷溶液溶析。所得之(5S , 6R )-史賓諾辛A碳酸酯(65.1 mg;産率75%),為白色固體, FDMS, m/e (相對強度.)792 (Mf, 70),791 (100)。Example F2- (5S. M)-5,6-dipyridine-5,6-diargonoxine A in spinoxin A (487.8 mg, 0.67 mmol) and trimethylamine-N-oxidation Dihydrate (108 .mg, 0.97 mmol) in aqueous (0.5 ml) t-butanol (3 m 1) suspension, add Dtt spin (60 m 1, 0.7 4 mm ο 1) and then add Iron tetraoxide (0.1 M; 40 m 1, 0.0 0 4 mm ο 1) ϋ The reaction mixture was heated to a reflux temperature under a nitrogen atmosphere for 19 hours. The dark mixture was then cooled to room temperature and poured into an aqueous solution of NaHSO3 and extracted with ether. The ether portion was washed with brine, dried over MgS (U, and evaporated at room temperature under reduced pressure. The product was purified by chromatography on silica and eluted with 7¾ methanol in dichloromethane. The resulting (5S, 6R :)-5,6-dihydroxy-5,6-dihydrospinoxin A (282.1 mg; yield 55%), beige solid, FDMS, m / e (relative strength) 766 (M +, 60 ), 765 (100). Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page). Example F3- (5R)-5- (2-Wait 7 argon)- fi. 7-guan chloride in hydraxine A in (5R, 6R) -5- (2-hydroxyethoxy) -6-bromo spinosyn A (299.9 mg, 0.34 mmol) in anhydrous THF ( 10 ml) solution, sodium sulfide (50% mineral oil dispersion; 69.3 mg, 1.4 4 mm ο 1) was added and the gas was released. The reaction mixture was stirred at room temperature for 3.5 hours, and then poured into Water. The water portion was extracted with ether. The ether portion was washed with brine, dried over K2CO3 and evaporated at room temperature under reduced pressure. The product was purified by chromatography on silica, 5% methanol in dichloromethane Elution. (5R) -5- (2-Hydroxyethoxylate) ) -6,7-Dehydrospinoxin A (123.9 mg; yield paper size applies to Chinese National Standard (CNS) Λ4 specification (210.X 297 mm) ^ 7559 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (208) 50%, based on the recovered starting material), light yellow glass, FDMS, m / e (relative strength) 791.8 (M, 100) , 419.5 (30) 〇 Rich Example F4- (5S · flR) -Zhongpinoxin A carbon p pi is intended for (5S, 6R) -5,6-dihydrospinoxin A (85 mg, 0.11 mmol) and ethylene carbonate (109.2 mg, 1.2 mmol) in benzene (3 ml), anhydrous K2C03 (40.2 mg, 0.29 m π 1) was added, and the mixture was heated to reflux temperature at 2.5 After hours, the mixture was cooled to room temperature and diluted with dichloromethane. The dichloromethane portion was washed with water, brine, dried over K2CO3 and evaporated at room temperature under reduced pressure. The layer was passed over silica The purified product was separated and eluted with 7% methanol in dichloromethane. The obtained (5S, 6R) -spinoxin A carbonate (65.1 mg; yield 75%) was a white solid, FDMS, m / e. (Relative strength.) 792 (Mf, 70), 791 ( 100).

富施例F5- (!5S . Μ ) -5-乙醅氬甚漳中客柒辛A及(5R,6R ) -5 -乙轆氯基臭-5.fi -二氫史審謀辛A 於史賓諾辛A (511.7 πίδ,0·7 ιπιποί)之冰爵η S12 (〇 in 1) 溶液中,加入Ν-溴丁二醯亞胺(152.9 mg, 0.86 mmol) 反應物在室溫下攪拌24小時並緩慢地倒入5Np NaOH (35 m 1)。接著以NaC 1飽和含水混合物,並以乙醚萃取。以鹽 水萃取乙醚部分,以K2C〇3乾燥及在室溫及減壓下蒸發。 可得粗混合物(544.2 mg)。藉由氧化矽上之層析純化混合 物,以7%甲醇之二氯甲烷溶液溶析,並藉由在C18管柱上 之製備型HPLC分離異構物,以乙腈:甲醇:0.1¾ NH4〇Ac ( 41 : 41 : 18至42 : 42 : 16,以60分鐘線性悌度)溶析。所得(5S -211 - 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)富 例 例 F5- (! 5S. Μ) -5-Ethylpyridine and Zhang Kexinxin A and (5R, 6R) -5 -Ethyl Chloride-5.fi -Dihydro History Trial Xin A In a solution of Spinozin A (511.7 πδ, 0. 7 ιπιποί) of Bing Jue η S12 (〇in 1), N-bromosuccinimide (152.9 mg, 0.86 mmol) was added at room temperature. Stir for 24 hours and slowly pour 5Np NaOH (35 ml). The aqueous mixture was then saturated with NaC 1 and extracted with ether. The ether portion was extracted with brine, dried over K2CO3 and evaporated at room temperature under reduced pressure. A crude mixture was obtained (544.2 mg). The mixture was purified by chromatography on silica, eluted with 7% methanol in dichloromethane, and the isomers were separated by preparative HPLC on a C18 column with acetonitrile: methanol: 0.1¾NH4〇Ac (41: 41: 18 to 42: 42: 16, at 60 minutes linearity). Result (5S -211-This paper size applies to the Chinese National Standard (CNS) Λ4 specification (210X297 mm) (Please read the precautions on the back before filling this page)

、1T, 1T

經濟部中央標準局員工消費合作社印製 發明説明(2〇9) ,6S)-5-乙醯氧基-6-溴史賓諾辛A, FDMS, m/e (相對強度 )874 (50), 873 (98), 872(48), 871 (Mf, 100)及(5R, 6R)-5-乙醯氧基-6-溴-5,6-二氫史賓諾辛A, FDMS, m/e (相對強度)874 (60), 873 (90), 872 (45), 871 (Μ、 100),為白色固體。 奮旆例F6-5 . 6-二淖中窨諾辛A 1 7-Psa 於史賓諾辛A (257.2 mg, 0.35 mmol)之四氯化碩(10 ml)溶液中,添加溴(18 ml, 0.3 5 mmol)。在室溫下攪拌 反應混合物20小時,於此期間内反應物顔色褪色為淡黃色 。在室溫及減壓下蒸發溶劑,然而,TLC (以1(U甲醇之二 氯甲烷溶液溶析)顯示反應不完全。將殘餘物復溶於四氯 化碳(10 ml)並加入溴(18 ul, 0.3 5 mmol)。在室溫下攪 拌反應混合物3天,於該期間反應物顔色褪色。接著以二 氯甲烷稀釋及以5%硫代硫酸鈉清洗。以MgSO 4乾燥二氯甲 烷部分,及在室溫及減壓下蒸發。藉由氧化矽上之層析 純化産物,以3¾甲醇之二氯甲烷溶液溶析。所得之5,6-二溴史賓諾辛A 17-Psa(142.9 mg;産率5«),為白色固 體,FDMS, m/e (相對強度)750 (M+, 10), 189 (30), 101 (100)。 窖旆例二氫史審諾辛A(246088) 史賓諾辛 A (5 0 4 m g ; 0 · 6 9 m in ο 1)之乾苯(3 0 m 1),加 入氛化三(三苯膦)鉤I (50·6 mg; 0· 055 mmol)並將混合物 在氫氣下置於大氣發生器中。以磁石攪拌(未監測溫度)6 小時及接著在氮氣環境下保持19小時,小量之NMR顯示反 -212 - 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) ----.--W----- (請先閱讀背面之注意事項再填寫本頁)Printed by the Central Bureau of Standards of the Ministry of Economic Affairs of the Employees' Cooperative of the Invention (29.0), 6S) -5-Ethoxy-6-bromospinoxin A, FDMS, m / e (relative strength) 874 (50) , 873 (98), 872 (48), 871 (Mf, 100) and (5R, 6R) -5-ethoxyl-6-bromo-5,6-dihydrospinoxin A, FDMS, m / e (relative strength) 874 (60), 873 (90), 872 (45), 871 (Μ, 100), as a white solid. Fenxi F6-5. 6-dioxopineoxine A 1 7-Psa In a solution of spinosyn A (257.2 mg, 0.35 mmol) in tetrakis tetrachloride (10 ml), add bromine (18 ml , 0.3 5 mmol). The reaction mixture was stirred at room temperature for 20 hours, during which the color of the reactants faded to pale yellow. The solvent was evaporated at room temperature and under reduced pressure, however, TLC (dissolved in 1 (U methanol in dichloromethane)) showed incomplete reaction. The residue was redissolved in carbon tetrachloride (10 ml) and bromine ( 18 ul, 0.3 5 mmol). The reaction mixture was stirred at room temperature for 3 days, during which the color of the reactants faded. Then it was diluted with dichloromethane and washed with 5% sodium thiosulfate. The dichloromethane portion was dried with MgSO 4 And evaporated at room temperature under reduced pressure. The product was purified by chromatography on silica and eluted with 3¾ methanol in dichloromethane. The resulting 5,6-dibromospinoxin A 17-Psa ( 142.9 mg; yield 5 «) as a white solid, FDMS, m / e (relative strength) 750 (M +, 10), 189 (30), 101 (100). Case Study Dihydrohistory Nosin A ( 246088) Spinoline A (5 0 4 mg; 0 · 6 9 m in ο 1) of dry benzene (3 0 m 1), with the addition of the atmospheric tris (triphenylphosphine) hook I (50 · 6 mg; 0 · 055 mmol) and the mixture was placed in an atmospheric generator under hydrogen. Stirred with magnet (not monitored temperature) for 6 hours and then maintained under nitrogen environment for 19 hours. A small amount of NMR showed anti-212-paper size Applicable in China Home Standard (CNS) Α4 size (210X297 mm) ----.-- W ----- (Please read the Notes on the back to fill out this page)

、1T 487559 A7 B7 五、發明説明(210 ) 應約完成2/3。加入額外之氯化叁(三苯基膦)铷(50 rog; 〇· 055 mmol)及將混合物置換至氫氣璟境。再磁石攪拌24 小時,在室溫及減壓下蒸發。殘餘物最初Μ由氧化矽上之 閃蒸層析,利用5¾ MeOH之二氯甲烷溶液,所得産物( 489. 1 mg)為黃色玻璃9狀物。産物進一步藉由德他(del ta -)製備型逆相 HPLC 純化,以 CH3CN [38%]·· MeOH[38%]: 〇·〇5% NM4〇AC [24%]至 CH3CH [45%]·· MeOH [45%]: 0.05¾ NH4〇Ac [10%]之梯度溶析。所得5,6-二氫史賓諾辛A (246088) (275.4 mg;産率54%)為淺黃白玻璃狀物。部分 ^-NMR (CDCla δ 6.82(1H, bs) , 4.79(1Η, s), 4.61( 1Η, m), 4.39(1Η, bd) , 4.17(1Η, bq) , 3.23(1Η, m), 2·90(1Η, m), 2·76(1Η, m), 2·50(1Η, in), 0·97(1Η, m) ,0·64(1Η, ι)。1T 487559 A7 B7 V. Description of the invention (210) 2/3 should be completed by appointment. Additional tris (triphenylphosphine) phosphonium chloride (50 rog; 0. 055 mmol) was added and the mixture was replaced with hydrogen. The magnet was stirred for another 24 hours and evaporated at room temperature under reduced pressure. The residue was initially subjected to flash chromatography on silica using 5¾ MeOH in dichloromethane. The resulting product (489. 1 mg) was a yellow glass 9 substance. The product was further purified by delta-preparative reverse-phase HPLC with CH3CN [38%] · MeOH [38%]: 0.005% NM40AC [24%] to CH3CH [45%] · MeOH [45%]: 0.05¾ NH4〇Ac [10%] gradient elution. The obtained 5,6-dihydrospinoxin A (246088) (275.4 mg; yield 54%) was a pale yellow-white glass. Partial ^ -NMR (CDCla δ 6.82 (1H, bs), 4.79 (1Η, s), 4.61 (1Η, m), 4.39 (1Η, bd), 4.17 (1Η, bq), 3.23 (1Η, m), 2 · 90 (1Η, m), 2.76 (1Η, m), 2.50 (1Η, in), 0.97 (1Η, m), 0.64 (1Η, ι).

窨旆例FS- (5S, BR) -5. β-環氬基中客諾辛Α及(T)R . (kS) -璟 g某中客柒辛A 經濟部中央標準局員工消費合作社印製 ----*--m----- (請先閲讀背面之注意事項再填寫本頁) 在氮氣下,(5S,6R)及(5R,6S)-環氧基史賓諾辛Α,Ν-氧化物(2.6 gms ; 3.4 mmol)之300 ml氯仿溶液之6:1混 合物溶液中,加入三苯基硼烷(823 mg, 3.4 mmol)及在室 溫下攪拌6小時。以二氯甲烷稀釋反應物並以IN NaOH清洗 。以1(2(:〇3乾燥二氯甲烷部分,及在減壓下蒸發以獲得白 色偏離玻璃狀物(2.57 gins)。粗物質藉由德他(delta)製 備型逆相 HPLC純化,以 MeOH [42%] :CH3CN [42¾] :0.25% NlUAc [16¾]溶析 22分鐘及接著以 MeOH [45%] :CH3CN [45%] :0.25% NH4〇Ac [10¾]溶析 14 分鐘。所得(5S, 6R),5,6-環 -213 - 本紙張尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) ^59 ^59 經濟部中央標準局員工消費合作社印製 A7 B7 i、發明説明(211) 氧基史賓諾辛 A(0.26 gms, 11¾),部分 UMR (CDCla) d 6·71(1Η, bs), 4·86(1Η, s), 4·71(1Η, m), 4·42(1Η, bd), 4·30(1Η, bq), 2·56(1Η, dr), 2·47(1Η, dd)及(5R ,6S)_環氧基史賓諾辛A(1.3 gms;産率54%)部分1H-NMR( CDCla) δ 6.59(1H, bs), 4.86(1Η, s), 4.68(1Η, m), 4·42(1Η, bd), 4·23(1Η, bq), 2.59UH, dt), 2.45(dd) 皆為白色固體。Example FS- (5S, BR) -5. Β-cycloargonyl keinoxine A and (T) R. (KS)-璟 g A kekexin A of the Central Government Bureau of Consumer Affairs, Ministry of Economic Affairs System ---- *-m ----- (Please read the precautions on the back before filling this page) Under nitrogen, (5S, 6R) and (5R, 6S) -epoxy Spinozin A To a 6: 1 mixture of 300 ml chloroform solution of N-oxide (2.6 gms; 3.4 mmol), triphenylborane (823 mg, 3.4 mmol) was added and stirred at room temperature for 6 hours. The reaction was diluted with dichloromethane and washed with IN NaOH. The dichloromethane portion was dried with 1 (2: 03 and evaporated under reduced pressure to obtain a white off-glass (2.57 gins). The crude material was purified by delta preparative reverse-phase HPLC with MeOH [42%]: CH3CN [42¾]: 0.25% NlUAc [16¾] was eluted for 22 minutes and then MeOH [45%]: CH3CN [45%]: 0.25% NH4OAc [10¾] was eluted for 14 minutes. The obtained ( 5S, 6R), 5,6-Ring-213-This paper size applies to Chinese National Standard (CNS) Λ4 specification (210X 297 mm) ^ 59 ^ 59 Printed by A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs i. Invention Explanation (211) Oxy Spinnoxin A (0.26 gms, 11¾), some UMR (CDCla) d 6.71 (1Η, bs), 4.86 (1Η, s), 4.71 (1Η, m), 4.42 (1Η, bd), 4.30 (1Η, bq), 2.56 (1Η, dr), 2.47 (1Η, dd), and (5R, 6S) _epoxy Spinozin A ( 1.3 gms; yield 54%) 1H-NMR (CDCla) δ 6.59 (1H, bs), 4.86 (1Η, s), 4.68 (1Η, m), 4.42 (1Η, bd), 4.23 ( 1Η, bq), 2.59UH, dt), 2.45 (dd) are all white solids.

窨旆例F9- JR )-璟氬甚中g謠辛D及(5R,6S )-環藍基史 g諾辛D 依實施例F9所述進行反應,以(5S,6R)及(5R,6S)_環 氧基史賓諾辛D,N-氧化物(450 mg, 0.58 mmol)之6:1混合 物為起始物質。所得之(5S, 6R)-環氧基史賓諾辛D (16 · 4 mg, «)部分1H-NMR(CDC13)0' 6·71(1Η, bs), 4.53 (1H, m), 1.40 (3H, s),及(5R,6S)-環氧基史賓諾半0(82.1 mg;産率 191)部分1H-NMR (CDC13.) δ 6·59(1Η, bs), 4.85 (s), 4.6S(1H, m), 4.42(1H, bd), 4.23(1H, bq); 2.56(1H, dt), 2,41(1H, dd), 1.39(3H, s)皆為白色固 體。低産率傜由於在逆相HPLC管柱上之損失。 窨施例F1 0 - ( 55:. 6R )及(5R , 6S)二環氧棊史賓諾產A,Ντ·.氧化 物夕苊合物 於史賓諾辛 Α(212·2 mg, 〇·238 mmol; 82.1¾ 純度) 之10 ml二氯甲烷溶液,加入間-氯過氧化苯甲酸(135 mg, 0.771 mmol)並在室溫下攪拌3小時。在飽和NaHCO 3及二氯 甲烷間分配.:,使相分離及以新鮮二氯甲烷萃取水層。合併 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 、-ιτ 487559 經濟部中央標準局員工消費合作社印— A7 B7 五、發明説明(212) 有機層,以MgS〇4乾燥並於減壓下蒸發,所得白色固體 (246.3 mg)。在氯化矽上層析以純化粗産物,利用10¾ MeOH之二氛甲烷溶液至20%Me0H之二氛甲烷溶液於一步驟 悌度溶析。所得(5S,6R)及(5R,6S)_環氯基史賓諾辛A,N-氧化物之6:1混合物為白色固體(181.2 mg;約100%);部 分1H-NMR(CDC13) δ 6·71及6·60(1Η, s), 4·87(1Η, s), 4.76(ra, 1Η), 4.70(1H, m), 4.32(1H, m), 4.26(1H, m) ,3.42(s), 3.31(s), 3·24 (s)。 富施例m-(5S, 6R)及璟氩基Φ賓諾辛D,N-氯化 物 依實施例F10所述進行反應,以史賓諾辛D(517.9 mg, 0.70 mmol)為起始物質。所得(5S, 6R)及(5R,6S)_環氧基 史賓諾辛D,N-氧化物之6:1混合物(450.4 mg;産率83%), 為黃色玻璃狀物。部分l-NMR (CDC13) 0' 6.71及6.60( 1H, s) ,1·40(3Η, s) ‘Example F9-JR)-argon argonium g oxin D and (5R, 6S)-cyclolanthyl g oxin D D The reaction was performed as described in Example F9, with (5S, 6R) and (5R, 6S) ) _A mixture of 6: 1 epoxy-spinoxin D, N-oxide (450 mg, 0.58 mmol) was used as the starting material. The obtained (5S, 6R) -epoxy spinosinol D (16 · 4 mg, «) 1H-NMR (CDC13) 0 '6.71 (1Η, bs), 4.53 (1H, m), 1.40 ( 3H, s), and (5R, 6S) -epoxy Spinolol half 0 (82.1 mg; yield 191) part 1H-NMR (CDC13.) Δ 6.59 (1Η, bs), 4.85 (s), 4.6S (1H, m), 4.42 (1H, bd), 4.23 (1H, bq); 2.56 (1H, dt), 2,41 (1H, dd), 1.39 (3H, s) are all white solids. Low yields are due to loss on reverse phase HPLC columns. Example F1 0-(55:. 6R) and (5R, 6S) diepoxy 棊 Spinolol A, Nτ ·. Oxide compound in Spinoloxin A (212 · 2 mg, 〇 · 238 mmol; 82.1¾ purity) in 10 ml of dichloromethane, add m-chloroperoxybenzoic acid (135 mg, 0.771 mmol) and stir at room temperature for 3 hours. Partitioned between saturated NaHCO3 and dichloromethane: The phases were separated and the aqueous layer was extracted with fresh dichloromethane. Consolidated paper standards are applicable to China National Standard (CNS) A4 specifications (210X 297 mm) (Please read the notes on the back before filling out this page),-ιτ 487559 Printed by the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs-A7 B7 V. Description of the invention (212) The organic layer was dried over MgS04 and evaporated under reduced pressure to obtain a white solid (246.3 mg). Chromatography on silicon chloride to purify the crude product, using 10¾ MeOH in dihydromethane solution to 20% Me0H in dichloromethane solution in one step. The obtained (5S, 6R) and (5R, 6S) _cyclochlorospinoxin A, N-oxide 6: 1 mixture was a white solid (181.2 mg; about 100%); part 1H-NMR (CDC13) δ 6.71 and 6.60 (1Η, s), 4.87 (1Η, s), 4.76 (ra, 1Η), 4.70 (1H, m), 4.32 (1H, m), 4.26 (1H, m), 3.42 (s), 3.31 (s), 3.24 (s). The rich example m- (5S, 6R) and fluorene arginyl Φ binosin D, N-chloride were reacted as described in Example F10. Spinoloxin D (517.9 mg, 0.70 mmol) was used as the starting material. . The obtained (5S, 6R) and (5R, 6S) -epoxy Spinoxin 6: 1 mixture (450.4 mg; yield 83%) of the spinoxin D, N-oxide was yellow glass. Partial l-NMR (CDC13) 0 '6.71 and 6.60 (1H, s), 1.40 (3Η, s) ‘

奮旅例Π 2 - (5R . 6R ) -Γ), β-二溴-4”-酿1甚中客謀辛Α及(5R,6 R) -5. fi-二淳中窨諶辛B 化合物史賓諾辛M1.98 g, 2.70 mmol)溶於CH2C12( 90 m 1)。加入三乙胺(1 0 m 1 )並將反應混合物冷卻至〇 °C —· 奉苔由劇烈I&quot;覺丨半加入丨臭(5.0 s,27.8 ιπιποΐ.)。 於15分鐘後, 將溫度升高至室溫並再持續Μ拌30分鐘。以CH2C12( 100 m 1)稀釋混合物並連續以水(2x )及10iUlaHS〇3水溶液連續稀 釋:以K2C03乾燥有機層及在減壓下濃縮。殘餘物在閃蒸 Si〇2 管柱(230-400 m,120 g/Et0AC,接箸以 EtOH),以獲 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ----ί--·--衣-- (請先閲讀背面之注意事項再填寫本頁) 、11 487559 經濟部中央標準局員工消費合作社印製 A7 _ . B7___ 五、發明説明(213 ) 得:a)化合物(5R,6R)-5,6-二溴-4”-_基史賓諾辛A (342 mg, 15¾) IR (KBr) v 1720, 1660, 740, 595 cm'1; 1H-NMR (CHClo) d: 6.70 (1H, bs), 4.90 (1H, dd: 7.7, 2.9 Hz), 4,72 (3H; m:WH/2= 12 Hz), 3·95 (1H, q: 6.6 Hz)及 b)化合物(5R,6S)_5,6_ 二溴史賓諾辛 B; 1.22 g ,51%) IR (Or) v 3410, 1720, 1665 cm·1; 1H-NMR( CHCla) δ : 6.71 (1H, bs), 4.78 (3H, m: WH/2= 12 Hz ),2.50 (3H, CH3, s)。Fen Lu Case Π 2-(5R. 6R) -Γ), β-Dibromo-4 ”-Breed 1 Very Zhong Ke Mou Xin A and (5R, 6 R) -5. Fi-Er Chun Zhong Xiu Xin B The compound Spinozin M1.98 g, 2.70 mmol) was dissolved in CH2C12 (90 m 1). Triethylamine (10 m 1) was added and the reaction mixture was cooled to 0 ° C.丨 Half added odor (5.0 s, 27.8 ιπιποΐ.). After 15 minutes, increase the temperature to room temperature and continue to stir for 30 minutes. Dilute the mixture with CH2C12 (100 m 1) and continue with water (2x) And 10iUlaHS〇3 aqueous solution were serially diluted: the organic layer was dried with K2C03 and concentrated under reduced pressure. The residue was flashed in a Si02 column (230-400 m, 120 g / Et0AC, followed by EtOH) to obtain the Paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) ---- ί -------- (Please read the precautions on the back before filling this page), 11 487559 Central Standard of the Ministry of Economic Affairs A7 _. B7___ printed by the Bureau ’s Consumer Cooperatives V. Description of the Invention (213): a) Compound (5R, 6R) -5,6-dibromo-4 ”-_ kispinoxine A (342 mg, 15¾) IR (KBr) v 1720, 1660, 740, 595 cm'1; 1H-NMR (CHClo) d : 6.70 (1H, bs), 4.90 (1H, dd: 7.7, 2.9 Hz), 4,72 (3H; m: WH / 2 = 12 Hz), 3.95 (1H, q: 6.6 Hz) and b) Compound (5R, 6S) _5,6_ dibromo-spinoxin B; 1.22 g, 51%) IR (Or) v 3410, 1720, 1665 cm · 1; 1H-NMR (CHCla) δ: 6.71 (1H, bs ), 4.78 (3H, m: WH / 2 = 12 Hz), 2.50 (3H, CH3, s).

富旆例FH5-氯中窨謀辛A及fi-氧中窨諾辛A 將化合物史賓諾辛A(2.62 g, 3.58 mmol)溶於乾 CH 2 C 12 (30 m 1:)。使溶液在氮氣下冷卻至0 °C。伴隨劇烈 攪拌加入一部分苯基亞硒基氯化物(Aldrich, 98%; 0.909 g, 4.6 5 mmol)。於7分鐘後,導入一部分m-CPBA ( Aldrich,50%; 4·46 g, 12.9 mmol.)。加入CH2CI2 (50 ml )並在0°C下持續攪拌15 min。之後,加入Et3N (5.0 ml) ϋ於再Μ拌10分鐘後,進一步以C Η 2 C 1 2 (10 0 m 1.)稀釋反 應混合物。以10%HaHS03 (2x)清洗溶液。連續以水(lx), 5%MaHC〇3(3x), 5%K2C〇3(lx)及水(lx)清洗有機相,接著 以無水K2C〇3乾燥,過濾及在減壓下濃縮。以閃蒸$丨〇2管 柱(230-400 m, 120 g ; EtOAC為溶析液)純化殘餘物。均 質溶析份之減壓濃縮物藉由TLC以提供白色固體(2.23 g ) 。接著將此物質藉由製備型逆相HPLC[二Millipore RCM 4 0 m m厘,C18 -塗覆之6 ir氧化砂;溶析液·· 10 %水(含有 0.05 v/v % NFUOH)之MeOH溶液]純化·:·所收集之溶析份可 • - 216 - 本纸浪尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 夺· 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(214 ) 獲得5-氯史賓諾辛A,為白色玻璃狀固體(1.188 g, 43%) 。HMR及Η,Η-COSY光譜分析顯示此物質為含有約15% 6-氛史賓諾辛A 6之混合物。利用Rain ίη逆相管柱(具有球 形5m, 100Α, 018塗覆瑱充)且以15¾水(含有0·05 ν/ν % ΝΗ4〇Η)之甲醇溶液為移動相以完成該混合物之235 mg樣品 的分離。所獲得之化合物如下:化合物a) 5-氯史賓諾辛A (91 mg, 39%) CT MS m/z (M + 3) : 769.25, (M + 2) : 768.10, (M + l) 767.10; ^-NMR (CDCia) δ 6.71 Hz (1H, bs), 5.96 (1H, bs), 2.86 (dd: 14.2, 3.2 Hz) ρριϊι; IR (CM . C13) v 1721, 1663, 1 100, 605 cnr1,及化合物 b)6-氯 史賓諾辛 A(35 mg, 15¾) Cl MS: m/z 766 (M + l), 768 (M + 3)。M-NMR (CDC13) d: 6·65 (1H, bs), 5·84 (1H, dd: 3.1, 3.1 Hz)。 C41HhN〇1qC 之元素分析··估計值·· C 64·25, Η 8·42, Ν 1·83;實際值:C 64.29, Η 8.41, Ν 1.79 - 窨旆例F1 4U-順式二揮基-Γ). 二氯中窨謀辛R (分別為ί 5S · 6R)及(US )異構物^ 2 : 1混合物) 將化合物史賓諾辛A(3.26 g, 4.45 mmol)溶於丙酮( 70 ml)。加入水(30 ml),接著加入N_甲基嗎啉-N-氧化物* (645 mg , 5 . 5 mmo 1)。於N-氧化物溶解後,加入OsCU (2 · 5 U-BuOH溶液2.5%, 0.0015 mmol)。在室溫下攪拌反應混 合物。於24小時後,加入EtOAc (100 ml)及苯(100 ml )。 連續以 10%NaHS〇y_K 溶液(lx),水(lx)及 5%NaHC〇3(li&lt;)清 洗混合物。以K2C〇3乾燥有機層並於減壓下乾燥。以閃蒸 本纸張尺度適用中國國家標準(CNS ) A4規格(210;&lt; 297公釐) (請先閱讀背面之注意事項再填寫本頁)Enriched Example FH5-Chloroxine A in Chlorine and Fisoxoxoxin A A. Spinoxin A (2.62 g, 3.58 mmol) was dissolved in dry CH 2 C 12 (30 m 1 :). The solution was allowed to cool to 0 ° C under nitrogen. A portion of the phenylselenylene chloride (Aldrich, 98%; 0.909 g, 4.6 5 mmol) was added with vigorous stirring. After 7 minutes, a portion of m-CPBA (Aldrich, 50%; 4.46 g, 12.9 mmol.) Was introduced. Add CH2CI2 (50 ml) and continue stirring at 0 ° C for 15 min. After that, Et3N (5.0 ml) was added, and the mixture was stirred for 10 minutes, and then the reaction mixture was further diluted with C Η 2 C 1 2 (100 m 1.). Wash the solution with 10% HaHS03 (2x). The organic phase was washed successively with water (1x), 5% MaHC03 (3x), 5% K2CO3 (1x) and water (1x), then dried over anhydrous K2CO3, filtered and concentrated under reduced pressure. The residue was purified using a flash column (230-400 m, 120 g; EtOAC as eluent). The homogeneous eluate was concentrated under reduced pressure by TLC to provide a white solid (2.23 g). This material was then subjected to preparative reverse-phase HPLC [2 Millipore RCM 40 mm centimeter, C18-coated 6 ir oxidized sand; eluate · 10% water (containing 0.05 v / v% NFUOH) in MeOH solution ] Purification ·: · The collected lysate can be collected--216-The paper scale is applicable to Chinese National Standard (CNS) A4 (210X 297 mm) (Please read the precautions on the back before filling this page) 487559 Printed A7 B7 by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (214) 5-Chloropsinosin A was obtained as a white glassy solid (1.188 g, 43%). HMR and osmium, osmium-COSY spectroscopic analysis showed that this substance was a mixture containing about 15% 6-ammonium Spinoxin A 6. 235 mg of Rain η reversed phase column (with spherical 5m, 100Α, 018 coated) was used as the mobile phase with 15¾ water (containing 0.05 ν / ν% ΝΗ4〇Η) in methanol as the mobile phase. Separation of samples. The obtained compounds are as follows: Compound a) 5-chlorospinoxin A (91 mg, 39%) CT MS m / z (M + 3): 769.25, (M + 2): 768.10, (M + l) 767.10; ^ -NMR (CDCia) δ 6.71 Hz (1H, bs), 5.96 (1H, bs), 2.86 (dd: 14.2, 3.2 Hz) ρριϊι; IR (CM. C13) v 1721, 1663, 1 100, 605 cnr1, and compound b) 6-chlorospinoxin A (35 mg, 15¾) Cl MS: m / z 766 (M + 1), 768 (M + 3). M-NMR (CDC13) d: 6.65 (1H, bs), 5.84 (1H, dd: 3.1, 3.1 Hz). Elemental analysis of C41HhN〇1qC ·· Estimated value · C 64 · 25, Η 8.42, Ν 1.83; actual value: C 64.29, Η 8.41, Ν 1.79-窨 旆 Example F1 4U-cis two-base -Γ). Dioxin R (respectively 5 5S · 6R) and (US) isomers ^ 2: 1 mixture in dichloride The compound spinoxin A (3.26 g, 4.45 mmol) was dissolved in acetone ( 70 ml). Water (30 ml) was added, followed by N-methylmorpholine-N-oxide * (645 mg, 5.5 mmo 1). After the N-oxide was dissolved, OsCU (2.5 U-BuOH solution 2.5%, 0.0015 mmol) was added. The reaction mixture was stirred at room temperature. After 24 hours, EtOAc (100 ml) and benzene (100 ml) were added. The mixture was washed successively with 10% NaHSOy_K solution (1x), water (1x) and 5% NaHC03 (li &lt;). The organic layer was dried over K2CO3 and dried under reduced pressure. By flash steaming This paper size applies Chinese National Standard (CNS) A4 specification (210; &lt; 297 mm) (Please read the precautions on the back before filling this page)

、1T 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(215) S i〇2管柱(EtOAc,接著以HUMeOH之EtOAc溶液)分離殘餘 物以獲得5,6-順式二羥基-5,6-二氬史賓諾辛A混合物((5S ,6[〇及(51^,6$)異構物之2:1混合物,2.236 8,66;1;)及5,6 -順式二羥基-5,6-二氫史賓諾辛以(5$,6!0及(51?,63)異搆 物之 2:1混合物(339 mg, 10¾)。UMR (CDCl13)d: 6·72 (1Η, bs), 4.76 (1H, bs) , 3.92 (0.65 H, m;),3.85 ( 0.35 H, m), 2·34 (3H, CH3, s)。1T 487559 A7 B7 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (215) S i02 column (EtOAc, followed by HUMeOH in EtOAc). Hydroxyl-5,6-diargon Spinoxin A mixture ((5S, 6 [〇 and (51 ^, 6 $) isomers of 2: 1 mixture, 2.236 8,66; 1;) and 5,6 -Cis-dihydroxy-5,6-dihydrospinoxin is a 2: 1 mixture of (5 $, 6! 0 and (51?, 63) isomers (339 mg, 10¾). UMR (CDCl13) d: 6.72 (1Η, bs), 4.76 (1H, bs), 3.92 (0.65 H, m;), 3.85 (0.35 H, m), 2.34 (3H, CH3, s).

審旆例F15 - (5s. fiR ) -5,6-二揮某中窨謀辛A&gt;二氛乙烯_ 縮菸及(r)s , 6R ) -5. Γ)-等s (三氯醱氬甚)史賓 諶辛A 將(5s, 6R)-5,6-二羥基-5,6-二氫史賓諾辛A (376 mg, 0.491 mmol)溶於乾 CH2C12(10 ml)。加入吡啶(3 ml ),並接箸加入N, N-二甲基胺基Dtt啶(600 mg)。在室溫及 氮氣下攪拌反應混合物並加入三氯乙醯基氯化物(1. 〇〇 m 1 ,過量)。於 1 hr後,以 EtOAc (100 ml)及PhH (50 ml)稀 釋混合物。連續以鹽水(lx)及5% NaHC〇3水溶液(2x)清洗 溶液,並以Na2S〇4乾燥。於減壓下濃縮有機層。以閃蒸 Si〇2管柱(60 g/Et0Ac)分離殘餘物,以獲得:化合物a) (5s , 6R)-5,6-二羥基史賓諾辛A之二氯乙烯酮縮醛(104 mg ,25¾) IR (CHCla) V 1805, 1722, 1660 cm&quot;1; 'H-NMR (CDCla) d: 6.62 (1H, bs), 4.96 (1H, dd: 7.8, 3.3 Hz), 4.85 (1H, dd:7.8, 3.9 Hz), 2.20 (6H, 2xCHa, s)及化合物b.) (5s,6R) -5,6-雙s (三氯-乙醯氧基)史賓諾辛 A (129 mg, 25%) IR (CHCla) v 1772, 1720, 1662 cm'1 I---.------- (請先閲讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 487559 A7 . B7_ ___ 五、發明説明(216 ) ;^-HMR (CDCIa): 6.76 (1H, bs) , 5.66 (1H, in: WH/2 =8 Hz), 5,50 (1H, dd: 5.7, 3.3 Hz) 2.19 (6H, 2x CH3, s) ppm; Cl MS m/z 1056 (M+l)。 窨妳例「16-5-_某-6.7-烯某-6-镡甚中窨諶辛4 將(5$,6尺)311€1(51^,6$)5,6-順式二經基-5,6-二氫 史賓諾辛A之2 :1混合物(1.51 g, 1.97 mmol)溶於乾 CH2C12 (5 ml)。各別地,將 N-氛丁二醯亞胺(0.793 g, 5.91 mmol)溶於乾 CH2C12 (15 ml)。在-78°C 下,將乙硫醚 (0.83 ml, 7.68 mmol)添加至NCS溶液並在-78°C下攪拌30 分鐘。接著導入二醇溶液並在-78 °C下持續攪拌1 . 5小時。 接著加入三乙胺(2 m 1 ,乾)並於2小時内及氮氣下使溶液 緩慢地逹到室溫。加入EtOAC (50 ml)及PhH (100 ml)。 連續以5¾ NaHC〇3(3x)及水(lx)清洗溶液,並接著以K2C〇3 乾燥及在減壓下濃縮。以閃蒸Si〇2管柱(230-400 m, 120 g, EtOAC,接著以10%Et0H之EtOAc溶液)純化殘餘物,以 獲得1.20 g稍含夾質,可容易地自Et2〇結晶以穫得5-酮基 -6,7-烯基-6-羥基史賓諾辛&amp;(1.01§,674) 11?((:11(:13) v 1720, 1665, 1648 cm'1; 'H-NMR (CDCI3) d: 6.68 ( 1H, bs), 3.84 (1H, dd: 9.2, 9.0 Hz), 2.13 (6H, 2x CH3, s) ; Cl MS m/z 762 (M + l).Examination example F15-(5s. FiR) -5,6- Erhuamou A conspiracy A &gt; Dioxin ethylene_ fuming and (r) s, 6R) -5. Γ)-equal s (trichloromethane Arsenic) Spinelin A (5s, 6R) -5,6-dihydroxy-5,6-dihydrospirinoloxin A (376 mg, 0.491 mmol) was dissolved in dry CH2C12 (10 ml). Pyridine (3 ml) was added, followed by N, N-dimethylamino Dttidine (600 mg). The reaction mixture was stirred at room temperature under nitrogen and trichloroacetamido chloride (1,000 m 1, excess) was added. After 1 hr, the mixture was diluted with EtOAc (100 ml) and PhH (50 ml). The solution was washed successively with brine (1x) and 5% NaHC03 aqueous solution (2x) and dried over Na2SO4. The organic layer was concentrated under reduced pressure. The residue was separated on a flashed Si02 column (60 g / Et0Ac) to obtain: compound a) (5s, 6R) -5,6-dihydroxyspinoxin A dichlorovinyl acetal (104 mg, 25¾) IR (CHCla) V 1805, 1722, 1660 cm &quot;1; 'H-NMR (CDCla) d: 6.62 (1H, bs), 4.96 (1H, dd: 7.8, 3.3 Hz), 4.85 (1H, dd: 7.8, 3.9 Hz), 2.20 (6H, 2xCHa, s) and compounds b.) (5s, 6R) -5,6-bis-s (trichloro-acetoxy) spinosinoxin A (129 mg , 25%) IR (CHCla) v 1772, 1720, 1662 cm'1 I ---.------- (Please read the precautions on the back before filling out this page) The standard of the paper is applicable to Chinese national standards (CNS) A4 specification (210X 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7. B7_ ___ V. Description of the invention (216); ^ -HMR (CDCIa): 6.76 (1H, bs), 5.66 ( 1H, in: WH / 2 = 8 Hz), 5,50 (1H, dd: 5.7, 3.3 Hz) 2.19 (6H, 2x CH3, s) ppm; Cl MS m / z 1056 (M + l).例 Your example "16-5-_some-6.7-enesome-6- 镡 中 中 窨 谌 辛 4 will (5 $, 6 feet) 311 € 1 (51 ^, 6 $) 5,6-cis A 2: 1 mixture (1.51 g, 1.97 mmol) of Benzyl-5,6-dihydrospinoxin A was dissolved in dry CH2C12 (5 ml). Separately, N-aminobutanediamine (0.793 g, 5.91 mmol) was dissolved in dry CH2C12 (15 ml). Ethyl sulfide (0.83 ml, 7.68 mmol) was added to the NCS solution at -78 ° C and stirred at -78 ° C for 30 minutes. Alcohol solution and continuous stirring at -78 ° C for 1.5 hours. Then triethylamine (2 ml, dry) was added and the solution was allowed to slowly simmer to room temperature under nitrogen over 2 hours. EtOAC (50 ml ) And PhH (100 ml). The solution was washed successively with 5¾ NaHC03 (3x) and water (1x), then dried over K2CO3 and concentrated under reduced pressure. A flashing Si02 column (230- 400 m, 120 g, EtOAC, followed by purification of the residue with 10% Et0H in EtOAc) to obtain 1.20 g slightly intercalated, which can be easily crystallized from Et20 to obtain 5-keto-6,7-alkenyl -6-Hydroxy Spinocinol &amp; (1.01§, 674) 11? ((: 11 (: 13) v 1720, 1665, 1648 cm'1; 'H-NMR (CDCI3) d: 6.68 (1H, bs ), 3.84 (1H , dd: 9.2, 9.0 Hz), 2.13 (6H, 2x CH3, s); Cl MS m / z 762 (M + l).

審旆例FI 7- R . 6R) - 5,6-二溴史蒈諾辛A 將化合物史賓諾辛A (1· 59 g, 2·17 mmol)溶於乾 CH 2 C 1 2 (3 m 1 )。將溶液在室溫下攪拌。加入一部分苯基亞 硒基溴化物(98%, 1.05 g, 4.34 mmol) :於攪拌30分鐘後 本紙張尺度適用中國國家標準(CNS ) Α4規格(2l〇X297公釐) (請先閱讀背面之注意事項再填寫本頁) 衣·Examination Example FI 7- R. 6R)-5,6-Dibromostiloxine A Dissolve Spinoxin A (1.59 g, 2.17 mmol) in dry CH 2 C 1 2 (3 m 1). The solution was stirred at room temperature. Add a part of phenylselenylene bromide (98%, 1.05 g, 4.34 mmol): After stirring for 30 minutes, the paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) (Please read the back (Please fill in this page again for attention)

、1T 經濟部中央標準局員工消費合作社印製 487559 A7 . B7 五、發明説明(217) ,將溶液冷卻至0°C。添加MCPBA (2.5 g,約7 mmol)。 在〇°C下持續攪拌30分鐘。接著添加三乙胺(3 ml)並攬拌 10分鐘,將混合物以苯(150 ml)及EtoAc(50 ml)稀釋。連 續以 10%NaHS〇3 (2x)水溶液,鹽水(1χ)及 5%NaHC〇3 (2x)清 冼溶液。以K2C〇3乾燥有機相並在減壓下濃縮。以閃蒸管 柱層析(Si〇2/EtOAC)純化殘餘物並接箸藉由HPLC (018塗 覆,6m, 100 A填充;5¾ H2〇之MeOH溶液為移動相)。純 溶析份可提供a)未反應之化合物史賓諾辛A及b)化合物(5R ,6R)-5,6-二溴史賓諾辛 A (297 mg, 16%) M-NMR (CDC13 )d: 6.69 (1H, bs), 4.74 (3H, m: WH/2= 12 HZ), 2·17 (6H, 2xCH3, s) ppm; Cl MS m/z 894 (M+3) , 882 (H+l) 〇 奮旆例Π 8-5-_基-fi , 7-烯某-fi-(對-氣)苄氬甚中蒈諶辛A 將化合物5-酮基-6,7-烯基-6-羥基史賓諾辛A (556 mg ,0.73 mmol)溶於乾 CH2C12 (10 ml)。添加吡啶(5 ml)及 DMAP (300 mg)。於室溫及氮氣下攪拌溶液並加入對-氯苯 甲醯基氯化物(1.0 ml ,過量)。於15分鐘後,反應混合物 以Et0Ac(50 ml)及PhHUOO ml)稀釋。將溶液連續以鹽水( 2x),水(lx)及5%NaHC〇3 (2x)水溶液稀釋。以Na2S〇4乾燥 有機相及在減壓下濃縮。藉由閃蒸管柱層析(Si 〇2/E tO Ac) 純化殘餘物以獲得化合物5-酮基-6,7-烯基-6-(對-氯:)苄 氣基史賓諾辛 AC634 mg, 96¾) NMR (CDC13) d: 8.03 (2H, bd: 8.4 HZ), 7.41 (2H, bd: 8.4 Hz), 6.73 (1H, bs), 4.09 (lH, dd: 9.3, 9.0 Hz), 2.20 (6H, 2x CH3, -220 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) ----1--.---^^衣-- (請先閱讀背面之注意事項再填寫本頁)1. 1T printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7. B7 5. Description of the invention (217), the solution is cooled to 0 ° C. MCPBA (2.5 g, about 7 mmol) was added. Stirring was continued for 30 minutes at 0 ° C. Add triethylamine (3 ml) and stir for 10 minutes. Dilute the mixture with benzene (150 ml) and EtoAc (50 ml). The solution was successively cleared with 10% NaHS03 (2x) aqueous solution, saline (1x) and 5% NaHC03 (2x). The organic phase was dried over K2CO3 and concentrated under reduced pressure. The residue was purified by flash column chromatography (SiO2 / EtOAC) and then subjected to HPLC (018 coating, 6m, 100 A filling; 5¾ H20 in MeOH solution as mobile phase). Purely soluble fractions can provide a) unreacted compound Spinoxin A and b) compound (5R, 6R) -5,6-dibromo spinosinoxin A (297 mg, 16%) M-NMR (CDC13 ) d: 6.69 (1H, bs), 4.74 (3H, m: WH / 2 = 12 HZ), 2.17 (6H, 2xCH3, s) ppm; Cl MS m / z 894 (M + 3), 882 ( H + 1) 〇 Example: 8-5-_yl-fi, 7-ene, -fi- (p-gas) benzyl argon, and even octyl octyl A. 5-keto-6,7-ene 6-hydroxyspinoxin A (556 mg, 0.73 mmol) was dissolved in dry CH2C12 (10 ml). Add pyridine (5 ml) and DMAP (300 mg). The solution was stirred at room temperature under nitrogen and p-chlorobenzyl chloride (1.0 ml, excess) was added. After 15 minutes, the reaction mixture was diluted with Et0Ac (50 ml) and PhHUOO ml). The solution was serially diluted with brine (2x), water (1x) and 5% NaHC03 (2x) aqueous solution. The organic phase was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by flash column chromatography (Si 〇2 / E tO Ac) to obtain the compound 5-keto-6,7-alkenyl-6- (p-chloro:) benzyl spinoxin AC634 mg, 96¾) NMR (CDC13) d: 8.03 (2H, bd: 8.4 HZ), 7.41 (2H, bd: 8.4 Hz), 6.73 (1H, bs), 4.09 (lH, dd: 9.3, 9.0 Hz), 2.20 (6H, 2x CH3, -220-This paper size applies to Chinese National Standard (CNS) A4 size (210 × 297 mm)) ---- 1 --.--- ^^ clothing-(Please read the note on the back first (Fill in this page again)

、1T 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(218 ) s ) p p m 0 窨施例Π9-5. 雙(三甲甚矽烷氬基)-5,7(8)-二烯中窨謀、 1T 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (218 s) s ppm 0 窨 Example Π9-5. Conspiracy

諾辛A 將化合物5-酮基-6,7-烯基-6-羥基史賓諾辛Α(91 .40 g, 1.84 mmol)溶於乾CH2C12(15 ml)。在室溫及氮氣下攪 拌溶液並加入三乙胺(乾,3 ml)。於15分鐘後,導入三甲 基矽烷基三氟甲基磺酸酯(1.5 ml)並將反應混合物在室溫 下攪拌1小時。以PhH(50 ml)及Et0Ac(100 ml)稀釋混合物 。連續以鹽水(lx), 5¾ NaHC〇3水溶液(3父)及[]2〇(^)萃取 溶液。以K2C〇3乾燥有機層並於減壓下濃縮。在閃蒸Si〇2 管柱(120g / EtoAc +0.2¾ Py)上分離殘餘物以獲得化合 物5,6-雙(三甲基矽烷氧基)-5,7(8)-二烯史賓諾諾辛A( 1.312 g, 794.) lH-NMR (CDCla.) d: 6.69 (lH, bs), 5.48 (1H, dd: 1.9, 0.7 Hz), 0.13 (9H, 3xCH3 s), 0.04 (9H, 3xCH3, s); C47U〇12Si2之元素分析:估計 值:62·29, Η 8·79, N 1.55;實際值:C 62.10, Η 8.84, N 1·41 〇Norsin A The compound 5-keto-6,7-alkenyl-6-hydroxyspinoxin A (91.40 g, 1.84 mmol) was dissolved in dry CH2C12 (15 ml). The solution was stirred at room temperature under nitrogen and triethylamine (dry, 3 ml) was added. After 15 minutes, trimethylsilyl trifluoromethanesulfonate (1.5 ml) was introduced and the reaction mixture was stirred at room temperature for 1 hour. The mixture was diluted with PhH (50 ml) and EtoAc (100 ml). The solution was successively extracted with brine (1x), 5¾ NaHC03 aqueous solution (3 fathers), and [] 20 (^). The organic layer was dried over K2CO3 and concentrated under reduced pressure. The residue was separated on a flashed Si02 column (120g / EtoAc + 0.2¾ Py) to obtain the compound 5,6-bis (trimethylsilyloxy) -5,7 (8) -diene spino Northin A (1.312 g, 794.) lH-NMR (CDCla.) D: 6.69 (lH, bs), 5.48 (1H, dd: 1.9, 0.7 Hz), 0.13 (9H, 3xCH3 s), 0.04 (9H, 3xCH3, s); Elemental analysis of C47U〇12Si2: Estimated value: 62 · 29, Η 8.79, N 1.55; Actual value: C 62.10, Η 8.84, N 1.41 〇

蓄旆例某-6,7-烯甚丁甚二-兩甚的烷氬基 中客柒辛A 將化合物5-酮基-6,7-烯基-6-羥基史賓諾辛A (1 · 02έ g , 1 · 3 4 5 m m ο 1)溶於 C Η 2 C 12 (乾,2 0 m 1) ‘:‘加入吡淀(2 ml)。在室溫及氮氣下攪拌溶液並加入t-BDMS三氣甲基磺 酸鹽(98 %, 471 ml , 2 . 01 mmol)':持續攪拌14小時將 混合物以 EtoAc(80 ml)及 PhH(50 ml)稀釋。以 5%NaHC〇3 -221 - 本纸張尺度適用中國國家標準(CNS ) A4規格(21 〇 X 297公釐) (請先閱讀背面之注意事項再填寫本頁)Example of a ketooctyl A in a -6,7-enylbutadiene-dioxanyl argonyl group. The compound 5-keto-6,7-alkenyl-6-hydroxyspinoxin A (1 · 02έ g, 1 · 3 4 5 mm ο 1) Dissolved in C Η 2 C 12 (dry, 20 m 1) ':' Add pyridine (2 ml). Stir the solution at room temperature under nitrogen and add t-BDMS trigas mesylate (98%, 471 ml, 2.01 mmol) ': Stir continuously for 14 hours and mix the mixture with EtoAc (80 ml) and PhH (50 ml) dilution. Based on 5% NaHC〇3 -221-This paper size is applicable to Chinese National Standard (CNS) A4 (21 〇 X 297 mm) (Please read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印裳 487559 A7 B7 五、發明説明(219 ) (2x)清洗溶液。以K2C〇3乾燥有機層並於減壓下濃縮。藉 由閃蒸管柱層析(230-400m Si〇2, 100 g,EtOAc)純化殘 餘物以獲得化合物5 -酮基-6,7 -烯基-6 -1 - 丁基二-甲基砂 烷氧基史賓諾辛 M 1.030 g, 874) UMR (CDC13) d: 6.66 (1H, bs), 3.81 (1Η, 9.5, 9.3 Hz), 0.84 (9H, 3x CH3, s), 0·09 (3H, CH3, s), 〇·〇5 (3H, CH3, s)。Yin Chang, Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 V. Description of the invention (219) (2x) cleaning solution. The organic layer was dried over K2CO3 and concentrated under reduced pressure. The residue was purified by flash column chromatography (230-400 m SiO 2, 100 g, EtOAc) to obtain compound 5-keto-6,7-alkenyl-6 -1 -butyldi-methyl sand Alkoxy Spinozin M 1.030 g, 874) UMR (CDC13) d: 6.66 (1H, bs), 3.81 (1Η, 9.5, 9.3 Hz), 0.84 (9H, 3x CH3, s), 0 · 09 (3H , CH3, s), 0.05 (3H, CH3, s).

實施例F21 - (5S) Ίβ-二氤-5-羥甚中客柒辛A (Rd - R , A-二氤-6-摔基史窨諾_辛A (6R &gt;-5, 6_二值-fi-遛 基Φ窨諶辛A 將三氣乙酸杀(1 · 12 g , 2 · 6 2 m m ο 1)懸浮於3 0 m 1之 THF:水,2:1 (V/V)中。將史賓諾辛 M0.98 g, 1.34 mmol )添加至此黃色懸浮液中。接著在室溫下攪拌反應物30分 鐘。將反應物以7 mL IN NaOH處理並接著以2.5 mL 0.5M NaBH4之3M NaOH溶液處理。反應物轉呈黑色並支撑沈澱物 。使固體沈降至燒瓶底部並將液體傾倒至含有50 ml乙醚 之分液漏斗中。使層分離並以2x25 niL乙醚萃取水層。合 併乙醚萃取物,以30 niL飽和NaHC〇3水溶液清洗,以K2C〇3 乾燥於減壓下濃縮。藉由中等壓力液相層析(230-400 m, CH2Cl2:Me0H, 95:5 (V/V))純化殘餘物以獲得化合 物 a)(5S)-5,6-二氫-5-羥基史賓諾辛 A(349.7 mg, 30·«) ,部分 UMR (CDC13) d 6·80 (1H, bs), 4.00 (1H, m.) ,2.95 (1H, m) 0.68 (1H, m);部分 13C-NMR (CDCla) d 148.64, 67·40, 45·79, 43.01 35.16 及(6s)-5,6-二氫-卜經基史賓諾辛A及(6R ) -5,6-二氫-6-羥基史賓諾辛A之 -222 - 本纸張尺度適用中國國家標率(CNS ) Λ4規格(210X 297公慶) (請先閱讀背面之注意事項再填寫本頁)Example F21-(5S) β-Difluorene-5-Hydroxyquinone A (Rd-R, A-Difluorene-6-Dimethylsulfonyl-Axin A (6R &gt; -5, 6_II Value-fi-fluorenyl Φ 窨 谌 A A Suspend triacetic acid (1 · 12 g, 2 · 6 2 mm ο 1) suspended in 30 m 1 of THF: water, 2: 1 (V / V) Spinoloxin M 0.98 g, 1.34 mmol) was added to this yellow suspension. The reaction was then stirred at room temperature for 30 minutes. The reaction was treated with 7 mL IN NaOH and then 2.5 mL of 0.5M NaBH4. Treated with 3M NaOH solution. The reaction turned black and supported the precipitate. The solid was allowed to settle to the bottom of the flask and the liquid was poured into a separatory funnel containing 50 ml of ether. The layers were separated and the aqueous layer was extracted with 2x25 niL ether. The ether was combined The extract was washed with 30 niL of saturated aqueous NaHC03 solution, dried over K2CO3 and concentrated under reduced pressure. By medium pressure liquid chromatography (230-400 m, CH2Cl2: Me0H, 95: 5 (V / V) ) The residue was purified to obtain compound a) (5S) -5,6-dihydro-5-hydroxyspinoxin A (349.7 mg, 30 · «), part of UMR (CDC13) d 6 · 80 (1H, bs ), 4.00 (1H, m.), 2.95 (1H, m) 0.68 (1H, m); part of 13C-NMR (CDCla) d 148.64, 6 7 · 40, 45 · 79, 43.01 35.16 and (6s) -5,6-dihydro-Phoenix Spinoxin A and (6R) -5,6-dihydro-6-hydroxy Spinosin A -222-This paper size applies to China National Standards (CNS) Λ4 specifications (210X 297 public holidays) (Please read the precautions on the back before filling this page)

^〇/559 A7 B7 五、發明説明(22〇) 混合物,(6s)-5,6-二氫-6-羥基史賓諾辛A及(6R)-5,6-二 氫-6-羥基史賓諾辛A可藉由HPLC(C-18塗覆,6m, 100 A 填充;10% Η 2 0之MeOH溶液作為移動相.)以提供化合物b.)( 61〇-5,6-二氫-6-羥基史賓諾辛&amp;(7.11^,1%)部分11·!-NMRiCDClo) d 6.84 /1H, bs), 3.48 (1H, m) 2.92 (1M, m) 0.55 (1H, m); 13C-NMR (CDCla) d 148.64, 72.66, 44.86, 43.96, 34.52 及化合物 c)(6S)-5,6-二氫 _6-羥基 史賓諾辛 Α(11·4 mg, 1¾)部分1H-NMR (CDC13) d 6,80 (1H, bs), 4.11 (1H, m) 2.78 (1H, m) 1.40 (1H, m); 13C-HMR (CDCla) d 148.46, 66.52, 38.18, 37.65, 32.95 〇 富旆例F22- (5R . 6R ) -5-乙醅氬某-6-硫代甲氬基中窨諶幸A 化合物史賓諾辛A (2·64 g, 3.61 mmol.)溶液CH3CN( 乾,含有1¾乙硫ffi ; 30 m 1,)。將此溶液雒持在室溫下並添 加二甲基(甲基硫代)銃四氣硼酸酯&lt;1.10 g, 5.61 mmol) 及將混合物超音波振盪(50 W超音波洗淨器)1 0分鐘。添加 無水乙酸鈉粉末(2.5 g ,過量)及超音波振盪1小時。以 EtoAc(50 ml)及 PhH(100 ml)稀釋溶液並以 5%K2C〇3, 5% NaHC〇3水溶液及^0清洗溶液。以Na2S〇4乾燥有機層並於 減壓下濃縮。藉由在Si〇2上之閃蒸管柱層析純化殘餘物並 藉由製備型HPLC(C-18塗覆,6m, 100 A镇充;8¾ H2〇之 MeOH溶液為移動相)。純溶析份可提供化合物(5R,6R)-5-乙醯氧基-6-硫代甲氣基史賓諾辛M2.07 g, 68¾) UMR (CDCla) d: 6.89 (1H, bs.) , 5.31 (1H, dd:2.4, 2.2 Hs 本纸張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝· 訂 線 487559 經濟部中央標隼局員工消費合作社印製 A7 B7 五、發明説明(221 ) ),2·16 (6H, 2xCH3,s),2·11 (3H, CH3, S.),2·01 ( 3H,CH3, s); C44H71N〇12S之元素分析:估計值:C 63,06 ,Η 8.54, N 1·67;實際值:C 63.15, Η 8.77, Μ 1·76 Ο^ 〇 / 559 A7 B7 V. Description of the invention (22〇) Mixture, (6s) -5,6-dihydro-6-hydroxyspinoxin A and (6R) -5,6-dihydro-6-hydroxyl Spinozin A can be prepared by HPLC (C-18 coated, 6m, 100 A filling; 10% Η20 in MeOH solution as mobile phase.) To provide compound b.) (61〇-5, 6- Hydrogen-6-Hydroxy Spinocinol &amp; (7.11 ^, 1%) Part 11 ·! -NMRiCDClo) d 6.84 / 1H, bs), 3.48 (1H, m) 2.92 (1M, m) 0.55 (1H, m ); 13C-NMR (CDCla) d 148.64, 72.66, 44.86, 43.96, 34.52 and compound c) (6S) -5,6-dihydro-6-hydroxyspinoxin A (11.4 mg, 1¾) 1H-NMR (CDC13) d 6,80 (1H, bs), 4.11 (1H, m) 2.78 (1H, m) 1.40 (1H, m); 13C-HMR (CDCla) d 148.46, 66.52, 38.18, 37.65, 32.95 〇 Enriched Example F22- (5R. 6R) -5-Ethyl argon A 6-thiomethyl argonyl group A compound Spinoxin A (2.64 g, 3.61 mmol.) Solution CH3CN (Dry, containing 1¾ ethylsulfur ffi; 30 m 1,). This solution was held at room temperature and dimethyl (methylthio) pyrene tetrakis borate was added <1.10 g, 5.61 mmol) and the mixture was sonicated (50 W ultrasonic cleaner) 1 0 minutes. Add anhydrous sodium acetate powder (2.5 g, excess) and sonicate for 1 hour. The solution was diluted with EtoAc (50 ml) and PhH (100 ml) and the solution was washed with 5% K2CO3, 5% NaHC03 aqueous solution and ^ 0. The organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by flash column chromatography on SiO 2 and preparative HPLC (C-18 coated, 6 m, 100 A ballast; 8¾ H2O in MeOH as mobile phase). Purely soluble fractions can provide compound (5R, 6R) -5-ethoxyl-6-thiomethylaminospinoxin M2.07 g, 68¾) UMR (CDCla) d: 6.89 (1H, bs.) , 5.31 (1H, dd: 2.4, 2.2 Hs) This paper size is applicable to Chinese National Standard (CNS) A4 (210 X 297 mm) (Please read the precautions on the back before filling this page)-Binding line 487559 Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of Invention (221)), 2 · 16 (6H, 2xCH3, s), 2 · 11 (3H, CH3, S.), 2 · 01 (3H , CH3, s); Elemental analysis of C44H71N12S: Estimated value: C 63,06, Η 8.54, N 1.67; Actual value: C 63.15, Η 8.77, Μ 1.76 〇

竄F23- (5R · RR ) 醱気某某碭黯基史窨諾辛A 將化合物(5R, 6R .)-5-乙醯氧基-6-硫代甲氧基史賓諾 辛 Α(1·〇5 g, 1·25 mmol)溶於 CH2CU (1〇〇 ml)。將溶液冷 卻至0°C及在攪拌哼,部分部分地加入間-CPBA (50%, 1·95 g, 5·6μο1)。於 40分鐘後,以 CH2C12 (50 ml)稀釋 反應混合物。連續以10%NaHS〇3水溶液(2x ),水(lx)及5¾ NaHC〇3水溶液(2x)清洗溶液。以Na2S〇4乾燥有機層並於減 壓下濃縮。藉由閃蒸管柱層析(230-400 m Si〇2/Et0Ac, 接著KUEtOH之EtOAc溶液)純化殘餘物以獲得化合物(5R , 6R)-5-乙醯氧基-6-甲基磺醯基史賓諾辛A(966 mg, 89%) IR (CHCla) v 1740, 1724, 1662, 1320, 1135 cm'1; 'H-NMR (CDCla) d: 6.57 (1H, bs), 5.52 (1H, dd:4.5, 4.0 Hz), 2·78 (3H, CH3, s), 2·17 (6H, 2xCH3, s), 1.98 (3H, CH3, s)Channeling F23- (5R · RR) 酦 気 砀 基 窨 窨 窨 窨 窨 窨 Rosin A A compound (5R, 6R.)-5-ethoxy-6-thiomethoxy sparoxin A (1 · 〇 5 g, 1.25 mmol) was dissolved in CH2CU (100 ml). The solution was cooled to 0 ° C with stirring, and m-CPBA (50%, 1.95 g, 5.6 μο1) was partially added. After 40 minutes, the reaction mixture was diluted with CH2C12 (50 ml). The solution was washed successively with 10% NaHS03 aqueous solution (2x), water (1x) and 5¾ NaHC03 aqueous solution (2x). The organic layer was dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by flash column chromatography (230-400 m Si〇2 / Et0Ac, followed by KUEtOH in EtOAc) to obtain compound (5R, 6R) -5-ethoxyl-6-methylsulfonium Kirspinoxin A (966 mg, 89%) IR (CHCla) v 1740, 1724, 1662, 1320, 1135 cm'1; 'H-NMR (CDCla) d: 6.57 (1H, bs), 5.52 (1H, dd: 4.5, 4.0 Hz), 2.78 (3H, CH3, s), 2.17 (6H, 2xCH3, s), 1.98 (3H, CH3, s)

窨旃例F24- (5R, fiR) -Γ)-淳-Γ)-锊某中客柒主J 將化合物史賓諾辛AU.33 g, 1.32 nunol.)溶於DMS0 (1 5 m 1)。加入水(5 m 1.),造成沈澱。在攪拌時導入濃 H 2 SO 4 (1 · 8 mmo 1:)。使沈澱立刻溶解。將溶液冷卻至0 °C 並加入N-溴丁二醯亞胺(322 mg, 1.8 mmol:)。於在〇°CM 拌1 5分鐘後,將反應混合物倒入50 m 1飽和NaHCO 3水溶液 -224 - . ^紙張尺度適用中國國家標準(CNS ) A4規格(21〇&gt;&lt; 297公釐) ' ' (請先閲讀背面之注意事項再填寫本頁)Example F24- (5R, fiR) -Γ) -chun-Γ)-锊 A guest guest J dissolved the compound Spinoxin AU.33 g, 1.32 nunol.) In DMS0 (1 5 m 1) . Water (5 m 1.) was added, causing precipitation. Concentrated H 2 SO 4 (1 · 8 mmo 1 :) was introduced while stirring. The precipitate was allowed to dissolve immediately. The solution was cooled to 0 ° C and N-bromosuccinimide (322 mg, 1.8 mmol :) was added. After stirring for 15 minutes at 0 ° CM, the reaction mixture was poured into 50 m 1 of a saturated NaHCO 3 aqueous solution -224-. ^ The paper size is in accordance with the Chinese National Standard (CNS) A4 specification (21〇 &lt; 297 mm) '' (Please read the notes on the back before filling out this page)

487559 A7 ____:_ B7__ 五、發明説明(222 ) 中:以Et 2 0萃取混合物。將合併之有機萃取物以鹽水清冼 ,以K2C〇3乾燥並於減壓下濃縮。藉由逆相HPLC(C-18 Dynamax管柱,20¾:水之MeOH溶液為移動相)純化殘餘物, 以獲得化合物(5R , 6R) -6-溴-5-羥基史賓諾辛J (1 · 30 g , 86%) Cl MS m/z 828 (M^l); 'H-NMR (CDCla) d: 6.56 (1H, bs), 4.24 (2H, m: WH/2 = 14 Hz), 3.85 (1H, dd: 3.5, 3·5 Hz), 2·05 (6H, 2xCH3, s)。 富旆例F25U-二氫中客謠辛A 9-Psa 將化合物史賓諾辛 A 9-Psa (46.5 mg, 0.0856 mmol) 溶於5 mL甲苯。將參-三苯基膦姥(I)氯化物(8.5 mg, 0.0092 1)加入該溶液中。將燒瓶頂部區域抽真空並導 入氛氣3次。抽真空並導入氫氣3次。將具有球形之燒瓶維 持在氫氣下並加熱至110-120°C。於3.5小時後,將燒瓶冷 卻至室溫並抽空氫氣及以氛氣取代。蒸發甲苯並以20 m 1 取代。以3xl0mL 1M HC1萃取乙醚溶液萃取。合併酸萃取 液並以10 ml 4N NaOH中和。以3x10 mL乙醚萃取中和之懸 浮液,合併乙醚萃取液,以20 mL鹽水清洗,以1(2(:〇3乾燥 及在減壓下濃縮。所得化合物5,6-二氫史賓諾辛A 9_Psa (29·5 mg, 63¾)部分1H-NMR (CDC13) d 6.84 (lH,bs), 1·01 (1H, m), 0.68 (1H, m)。 蓄施例F26-5,6-二氤中窨諶辛A 1 7-Psa 依上述實施例F25所述步驟將化合物史賓諾辛.《17_ Psa (270·8 mg, 0.458 mmol)以32·8 mg [(Ph)3P]3RhCl 處理。於蒸發甲苯後,藉由中等壓力液體層析(230-400 m -225 - 本紙乐尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) (請先閱讀背面之注意事項再填寫本頁) -裝-487559 A7 ____: _ B7__ 5. In the description of the invention (222): extract the mixture with Et 2 0. The combined organic extracts were decanted with brine, dried over K2CO3 and concentrated under reduced pressure. The residue was purified by reverse-phase HPLC (C-18 Dynamax column, 20¾: water in MeOH solution as mobile phase) to obtain compound (5R, 6R) -6-bromo-5-hydroxyspinoxin J (1 · 30 g, 86%) Cl MS m / z 828 (M ^ l); 'H-NMR (CDCla) d: 6.56 (1H, bs), 4.24 (2H, m: WH / 2 = 14 Hz), 3.85 (1H, dd: 3.5, 3.5 Hz), 2.05 (6H, 2xCH3, s). Rich example F25U-Dioxin A 9-Psa in dihydrogen. The compound Spinoxin A 9-Psa (46.5 mg, 0.0856 mmol) was dissolved in 5 mL of toluene. Phenyl-triphenylphosphine phosphonium (I) chloride (8.5 mg, 0.0092 1) was added to the solution. Vacuum the top area of the flask and introduce the atmosphere 3 times. Evacuate and introduce hydrogen 3 times. The spherical flask was maintained under hydrogen and heated to 110-120 ° C. After 3.5 hours, the flask was cooled to room temperature and the hydrogen was evacuated and replaced with an atmosphere. The toluene was evaporated and replaced with 20 m 1. Extract with 3x10 mL of 1M HC1 ether solution. The acid extracts were combined and neutralized with 10 ml of 4N NaOH. The neutralized suspension was extracted with 3x10 mL of ether, the ether extracts were combined, washed with 20 mL of brine, dried over 1 (2 (: 03) and concentrated under reduced pressure. The resulting compound 5,6-dihydrospinoxin A 9_Psa (29 · 5 mg, 63¾) part 1H-NMR (CDC13) d 6.84 (lH, bs), 1.01 (1H, m), 0.68 (1H, m). Storage Example F26-5,6- Dipyridine A 1 7-Psa According to the procedure described in Example F25 above, the compound Spinoloxin was used. "17_ Psa (270 · 8 mg, 0.458 mmol) to 32.8 mg [(Ph) 3P] 3RhCl Dispose. After evaporating toluene, use medium pressure liquid chromatography (230-400 m -225-this paper scale is applicable to China National Standard (CNS) A4 specification (210 × 297 mm)) (Please read the precautions on the back before filling (This page) -pack-

、1T 線 487559 A7 —__ _ B7__ 五、發明説明(223)1T line 487559 A7 —__ _ B7__ V. Description of the invention (223)

Si〇2, CH2Cl2:MeOH, 95:5 (V/V)純化化合物。所得化合 物5,6-二氫史賓諾辛々17-?53(188.1!1^,(39.2%)部分 ^-NMR (CDCI3) d 6.84 (1H, bsj , 3.63 (1H, m) , 1.02 (1H,m), 0.68 (1H, m);部分 13C-NMR (CDC13) d 149.28,72.48, 46·55, 27·00。The compound was purified by SiO2, CH2Cl2: MeOH, 95: 5 (V / V). The obtained compound 5,6-dihydrospinoxin 17-? 53 (188.1! 1 ^, (39.2%) part ^ -NMR (CDCI3) d 6.84 (1H, bsj, 3.63 (1H, m), 1.02 (1H M), 0.68 (1H, m); partial 13C-NMR (CDC13) d 149.28, 72.48, 46 · 55, 27 · 00.

窨旆例F27-5.fi-二氤中g諾辛J 依上述實施例F25所述步驟,利用91.3 mg [(Ph)3P]3 RhCl之20 mL甲苯溶液處理化合物史賓諾辛JU.00 g, 1.39 mmol)。所得化合物5,6-二氫史賓諾辛J(0.70 g, 70%)部分1H-NMR (CDC13) d 6.84 (1H,bs) 3.82 (1H, dt), 1.01 (1M, m), 0·69(1Η, m)。Example F27-5.fi-g Nosin J in dioxin Follow the procedure described in Example F25 above to treat the compound Spinoxin with 91.3 mg [(Ph) 3P] 3 RhCl in 20 mL of toluene solution. g, 1.39 mmol). The obtained compound 5,6-dihydrospinoxin J (0.70 g, 70%) part 1H-NMR (CDC13) d 6.84 (1H, bs) 3.82 (1H, dt), 1.01 (1M, m), 0 · 69 (1Η, m).

審妳例F28-H . fi-二氫中窨諶辛H 將化合物史賓諾辛H (2.57 g, 3.58 mmol)溶於含有 20 ml甲苯之圓底燒瓶中。將[Ph3P]3RhCl (169.2 mg, 0.183 mmol)之5 inL甲苯溶液添加至該無色溶液中。將燒 瓶裝上迴流冷凝器並將燒瓶頂部區域抽真空3次並導入氮 氣。將氮氣抽空3次並導入氫氣。使具有球形之燒瓶維持 在1 atm氫氣下並在油浴中加熱至100-1 l〇°C。於10小時後 ,移開熱源及將燒瓶抽真空3次並於每次抽真空後導入氮 氣。將燒瓶之内容物在氛氣下經由3 ”矽藻土管柱熱過濾&amp; 以100 mL乙醚清洗矽藻土以溶析出殘留化合物。濾液以 3x50 mL IN HC1萃取。合併酸萃取液,以25 mL乙醚逆萃 取,及以50 mL 4N NaOH鹼化。使沈緞之白色固體被萃取 至乙_ (2 X、25 mL )及以25 mL鹽水溶液清洗乙醚萃取物。 本紙張尺度適用中國國家標準(CNS ) Α4規格(2丨0Χ 297公釐) (請先閱讀背面之注意事項再填寫本頁) .裝.Example F28-H. Fi-dihydrodioxine H Dissolve the compound Spinoxin H (2.57 g, 3.58 mmol) in a round bottom flask containing 20 ml of toluene. A 5 inL toluene solution of [Ph3P] 3RhCl (169.2 mg, 0.183 mmol) was added to the colorless solution. The flask was fitted with a reflux condenser and the top area of the flask was evacuated 3 times and nitrogen was introduced. The nitrogen was evacuated 3 times and hydrogen was introduced. The flask with a spherical shape was maintained under 1 atm of hydrogen and heated to 100-1 10 ° C in an oil bath. After 10 hours, the heat source was removed and the flask was evacuated 3 times and nitrogen was introduced after each vacuum. The contents of the flask were filtered under hot air through a 3 "diatomite column & washed with 100 mL of ether to dissolve out the remaining compounds. The filtrate was extracted with 3 x 50 mL IN HC1. The acid extracts were combined and 25 mL Ethyl ether reverse extraction and alkalization with 50 mL 4N NaOH. The white solid of the satin was extracted into ethyl acetate (2 X, 25 mL) and the ether extract was washed with 25 mL of saline solution. The paper dimensions are applicable to Chinese national standards ( CNS) Α4 specification (2 丨 0 × 297 mm) (Please read the precautions on the back before filling this page).

、1T 487559 A7 s_._;_[___ 五、發明説明( 224 ) 經由矽藻土塞過濾乙醚溶液並在減壓下濃縮。所得化合物 5,6-二氫史賓諾辛[1(2.24 8,87.14):(:4(]^5_1(1之分析 值··估計值:C 66.73, Η 9.10, N 1.95;實際值·· C 66·31, Η 9·01, Ν 2·02· Cl MS(m/z) 721 (Μ+1)。 窨旆例F29-5, β-二氤中審諶辛Α半戊二酪鹽 將化合物5,6_二氫史賓諾辛A (232.2 mg, 0.316 mmol)溶於 3 mL 丙酮。添加戊二酸(20,8 mg, 0.157 mmol) 之3 mL丙酮溶液並在室溫下攪拌溶液隔液。在減壓下去除 溶劑以獲得化合物5,6-二氫史賓諾辛A半戊二酸鹽( 250.8 mg)。C41HS7NO1Q· 1/2 (CsH8〇4)之分析:估計值: C 65·31, Η 8·94, N 1 ·75;實際值:C 65·14, Η 8.78, Ν 1·87; mp· 83-92〇C。1T 487559 A7 s _._; _ [___ V. Description of the invention (224) The ether solution was filtered through a plug of diatomaceous earth and concentrated under reduced pressure. The obtained compound 5,6-dihydrospinoxin [1 (2.24 8,87.14) :(: 4 () ^ 5_1 (1Analyzed value ·· Estimated value: C 66.73, Η 9.10, N 1.95; actual value · · C 66 · 31, Η 9 · 01, Ν 2 · 02 · Cl MS (m / z) 721 (M + 1). Example F29-5, β-dioxin intermediate beta glutamate A semiglutarate Dissolve compound 5,6_dihydrospinoxin A (232.2 mg, 0.316 mmol) in 3 mL of acetone. Add 3 mL of glutaric acid (20,8 mg, 0.157 mmol) in acetone and at room temperature The solution was stirred and the solution was separated. The solvent was removed under reduced pressure to obtain the compound 5,6-dihydrospinoxin A hemiglutarate (250.8 mg). Analysis of C41HS7NO1Q · 1/2 (CsH8〇4): Estimated value : C 65 · 31, Η 8.94, N 1 · 75; actual value: C 65 · 14, Η 8.78, Ν 1.87; mp · 83-92 ° C.

實施例F30U-二ffi中客諶辛R 氫化步驟A:將史賓諾辛B (1.10 g, 1.53 mmol)及 (Ph3P)3RhCl(0.05 g, 0.09 nunol)之 PhMe (15 mL)溶液實 於Parr裝置並保持在氫氣環境(45-50 ps i)、104-107 ¾下 2小時。於冷卻至室溫後,將混合物在減壓下蒸發並將殘 餘物脱色(Et2〇/木炭.)並過濾。將濾液在減壓下蒸發並藉 由 MPLC(Si〇2, 5:95 to 10:90 MeOH/CH2Cl2)純化以獲得 - 〇·90 g (82%.)5,6-二氫史賓諾辛B,為白色粉末。 C4〇Hs5N0ia之分析:估計值:C,66.73; Η, 9·10; N, 1.95。實際值·· C, 66.53; Η, 9.14; K, 2.15 :‘ 實施例F3卜化合物m 卜擐氫某-史審諾辛0^合成 將史賓諾辛Q(970 mg, 1.32 mmol)溶於二氛甲烷(150 -227 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐)Example F30U-Dioxin R hydrogenation step A: Spinmexine B (1.10 g, 1.53 mmol) and (Ph3P) 3RhCl (0.05 g, 0.09 nunol) in PhMe (15 mL) solution were dissolved in Parr The device was kept in a hydrogen environment (45-50 ps i), 104-107 ¾ for 2 hours. After cooling to room temperature, the mixture was evaporated under reduced pressure and the residue was decolorized (Et20 / charcoal) and filtered. The filtrate was evaporated under reduced pressure and purified by MPLC (SiO2, 5:95 to 10:90 MeOH / CH2Cl2) to obtain -0.90 g (82%.) 5,6-dihydrospinoxin B, is a white powder. Analysis of C40Hs5N0ia: Estimate: C, 66.73; Η, 9.10; N, 1.95. Actual values: C, 66.53; hydrazone, 9.14; K, 2.15: 'Example F3 Compound m Bu 擐 某-Shishenoxin 0 ^ Synthesis Spinoloxin Q (970 mg, 1.32 mmol) was dissolved Dichloromethane (150 -227-This paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm)

C請先閲讀背面之注意事項再填寫本頁} 裳 訂 線CPlease read the precautions on the back before filling out this page}

487559 A7 - B7 五、發明説明(225 ) 150 ml)。將溶液冷卻至0°C並加入一部分ni-CPBA (1.19 g 約50¾試劑,約3.45 mmol) °於m-CPBA溶解後,立刻將反 應混合物置入冰箱。於40小時後,以10:UlaHS03(2)O,以 水(lx)及以5¾ NaHC〇3 (2x)水溶液萃取反應混合物。有機 層以無水K2C〇3乾燥,過濾及在減壓下濃縮。殘餘物在閃 蒸Si〇2管柱(230-400 m, 70 g / EtOAc)分離。層析均質 溶析份在減壓下濃縮以獲得白色固體(.694 mg)。將由此物 質沈澱之白色固體(88 mg)以乾Et2〇進行沈澱作用。乙醚 溶液,經蒸發後可得化合物(5S,6R)-環氧基-史賓諾辛Q, 606 mg, 61 %) lH-NMR d 6.51 (1H, bs), 4,73 (1H, d: 1.2 Hz), 3.87 (1H, dd^ 1.21 1.8 Hz), 2.16 (6H, bs 2xCH3), 1·31 (3H, s, CH3) ppm。 窨旆例F32- ( 5S . fiR ) Ί β-二氫-5,6-二葬甚中g諾辛(65¾ ) 好(r)R . fiS ) - 5,6-二―氫- 5,6-二禪甚中蒈諶辛Μ ^ 5 % )夕混合物 將史賓諾辛A (3·26 g, 4·45 ππηοΐ)溶於丙酮(70 mL) 。加入水(30 mL),並接箸加入N-甲基嗎啉N-氧化物(645 mg, 5,5 mmol),及四氧化餓(2.5¾之2-甲基-2-丙醇溶液; ^ 16 0 m g , 〇 . 〇 1 5 m m ο 1.) ϋ於1小時後,再加入一部分0 s 0 4 ϊ (300 mg)。於 24小時後,將混合物與 l(UNaHS0 3 (200 mL) 7 I 水溶液合併並逐漸反應。粗産物在具有矽膠(10%Me0H之487559 A7-B7 V. Description of the invention (225) 150 ml). The solution was cooled to 0 ° C and a portion of ni-CPBA (1.19 g of about 50¾ reagent, about 3.45 mmol) was added. After m-CPBA was dissolved, the reaction mixture was immediately placed in a refrigerator. After 40 hours, the reaction mixture was extracted with 10: UlaHS03 (2) O, water (1x), and 5¾ NaHC03 (2x) aqueous solution. The organic layer was dried over anhydrous K2CO3, filtered and concentrated under reduced pressure. The residue was separated on a flash SiO 2 column (230-400 m, 70 g / EtOAc). The chromatographically homogeneous fraction was concentrated under reduced pressure to obtain a white solid (.694 mg). A white solid (88 mg) precipitated from this substance was precipitated with dry Et20. Diethyl ether solution, after evaporation, compound (5S, 6R) -epoxy-spinoxin Q, 606 mg, 61%) lH-NMR d 6.51 (1H, bs), 4,73 (1H, d: 1.2 Hz), 3.87 (1H, dd ^ 1.21 1.8 Hz), 2.16 (6H, bs 2xCH3), 1.31 (3H, s, CH3) ppm.窨 旆 例 F32- (5S. FiR) Ί β-Dihydro-5,6-Secondary Gnosin (65¾) Good (r) R. FiS)-5,6-Di-hydro-5,6 -Erzen very middle hydrazine (M ^ 5%)) mixture Spinoloxin A (3.26 g, 4.45 ππηοΐ) was dissolved in acetone (70 mL). Water (30 mL) was added, followed by N-methylmorpholine N-oxide (645 mg, 5,5 mmol), and tetraoxine (2.5¾ in 2-methyl-2-propanol solution; ^ 160 mg, 〇. 〇1 5 mm ο 1.) ϋ After 1 hour, add another part of 0 s 0 4 ϊ (300 mg). After 24 hours, the mixture was combined with 1 (UNaHS0 3 (200 mL) 7 I aqueous solution and gradually reacted. The crude product was mixed with silica gel (10% Me0H

L ?: EtOAc溶液中.)短閃蒸管柱上純化以提供未分離之(5S,6R卜L ?: EtOAc solution.) Purified on a short flash column to provide unseparated (5S, 6R).

I ] 5,6-二氫 _5,6-二羥基史賓諾辛(65¾)及(5R,6S)_ 5,6-二氫 ^ -5,6-二羥基史賓諾辛A(35;n之混合物(35¾) (2.24 g ,66¾) -228 - 本纸張尺度適用中國國家標準(CNS ) Λ4規格(210Χ 297公釐) (請先閱讀背面之注意事項再填寫本頁) 裝·I] 5,6-dihydro_5,6-dihydroxyspinoxin (65¾) and (5R, 6S) _ 5,6-dihydro ^ -5,6-dihydroxyspinoxin A (35 ; Mixture of n (35¾) (2.24 g, 66¾) -228-This paper size is applicable to the Chinese National Standard (CNS) Λ4 specification (210 × 297 mm) (Please read the precautions on the back before filling this page)

、1T 線 經濟部中央標準局員工消費合作社印製 487559 A7 ——^_:____ 五、發明説明(226 ) ,為白色固體:iH-NMR d 6,71 (s, 1 H),3.93 (m, 0.65 Η), 3·88 (m, 〇·35 Η), 2·11 is, 6 Η)。Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs of the 1T line 487559 A7 —— ^ _: ____ V. Description of the invention (226) is a white solid: iH-NMR d 6,71 (s, 1 H), 3.93 (m , 0.65 Η), 3.88 (m, 0.35 Η), 2.11 is, 6 Η).

啻旆例m-5.fi-二気中窨柒幸R 將史賓諾辛 Β (1·1〇 g, 1.53 mmol)及(Ph3P) 3RhC1 (0,08 g, 0.09 nunol)之 PhMe(15 mL)溶液置於 Parr 裝置上 並處於H2氣體環境(45-50 ps i)及104-107 ¾下。於2小時 後,過濾反應物並蒸發。將殘餘物溶液Et2〇並以木炭漿化 。將漿液過濾並蒸發。MPLC (5:95 MeOH/CH2Cl2)可得 0.90 g (82%)5,6_二氫史賓諾辛B,為白色粉末。 C4〇Hs5N0i之分析:估計值·· C, 66.73; H, 9.10; 1.95,實際值:C,66.53; H, 9.14; N, 2.15。 奮施例F34-5.fi-二気Φ窨諶辛For example, m-5.fi-Secondary R is a PhMe (15 mL) solution was placed on a Parr device under H2 gas environment (45-50 ps i) and 104-107 ¾. After 2 hours, the reaction was filtered and evaporated. The residue solution Et20 was slurried with charcoal. The slurry was filtered and evaporated. MPLC (5:95 MeOH / CH2Cl2) yielded 0.90 g (82%) of 5,6_dihydrospinoxin B as a white powder. Analysis of C40Hs5N0i: estimated value C, 66.73; H, 9.10; 1.95, actual value: C, 66.53; H, 9.14; N, 2.15. Example F34-5.fi- 二 気 Φ 窨 谌 辛

於100 ml Parr容器中,於史賓諾辛D(2.5 g, 3.4 nun 〇1)之純乙醇(60 mL)溶液中,添加10¾ Pd/C及璟己烷。將 此懸浮在120°C下加熱48小時。冷卻後,經由矽藻土墊過 濾反應混合物並在減壓下濃縮以獲得2.4 g 5,6-二氫史賓 諾辛D與史賓諾辛D之2:1混合物。將殘餘物(200 mg)溶於 二氯甲烷(20 mL)並冷卻至 0°C。將 MCPBA (95 mg, 0.45 mmol)添加至反應混合物並在25 °C下攪拌16小時。以碳酸 氫鈉溶液驟冷反應混合物並分層。水層以二氛甲烷(2x20 mL)萃取。將合併之萃取物與10%NaHC03攪拌3小時,以鹽 水清洗,以無水Na2S〇4乾燥並於減壓下濃縮。殘餘物在製 備型HPLC上純化,以C18管柱,以101¾水(0,1¾ NH4〇H )之 甲醇溶析以獲得化合物5,6-二氫史賓諾辛D (1〇 mg) : MS -229 - 尺Zit用中國國家標準(CNS )八4規格(210X297公釐) ----1----衣-- (請先閱讀背面之注意事項再填寫本頁) 、\-'口 487559 A7 B7 五、發明説明(227 ) m/z 748〇 'H-NMR (CDCla, 300 MHz) 6.85 (1H, s), 4·82 (1H, S), 4.65 (1H, m) , 4.42 (1H, d.) , 4.20 (1H, m), 〇·95 (3H, d)。 D-SLiLj义不同搪頷取代胺糖夕修飾 實-1 7-Π-(卜碘-2_去 fi 甚乙醯基- a -L-鼠李糖甚Π中窨諶辛A 17-Psb 於史賓諾芋 A 17-Psa(105.4 mg, 0·18 mmol)之乙請 (0.86 ml)溶液中,添加3,4 -二-0 -乙醯基-6-去氧基-L-己 稀糖(A 1 d r i c h , 5 2 u 1 , 0.3 5 m m 〇 1)並接箸加入N-碘丁二 醯亞te (80.5 mg, 0.36 mmol)。將反應混合物在室溫下Μ 拌19小時。接著以二氯甲烷稀釋深色混合物並以NaHSO 3水 溶液清洗,並接著以5%硫代硫酸鈉清洗。以MgS〇4乾燥二 氯甲烷部分並在室溫下及減壓下蒸發。藉由製備型HPLC純 化産物,以45:45:10/乙睛:甲醇:0.05¾ NIUOAc水溶液溶 析ϋ所得之17-0-(2 -碘-2-去氧基- 3,4-di-〇-乙醯基-α, L-鼠李糖基)]史賓諾辛A 17-Psa(49 mg ;産率29%),為 無色玻璃狀物,FDMS, m/e (相對強度)930 (M〜H, 20), 929 (30), 190 (100)。 富旆例G2_ 17-0- (2-去気甚-α -1,鼠李籃羞丄史窨謠辛A 1 7 -Psa 依下述實施例G3所述進行反應,以17-〇~ (2-去氧基-3 ,4-二-0-乙醯基-a -L-鼠李糖基)史賓諾辛A 17-Psa( 271·2 mg, 0.34 mmol.)為起始物質:·所得Π〜〇-(2-去氧基 -α-L-鼠李糖基)史賓諾辛 A 17-Psa(l87 崎;77:¾ yield) -230 - 本纸張尺度適用中國國家標準(CN’S ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 裝·In a 100 ml Parr container, 10 ¾ Pd / C and hexane were added to a solution of pure ethanol (60 mL) in Spinoxin D (2.5 g, 3.4 nun 〇1). This suspension was heated at 120 ° C for 48 hours. After cooling, the reaction mixture was filtered through a pad of diatomaceous earth and concentrated under reduced pressure to obtain 2.4 g of a 2: 1 mixture of Spinoxin D and Spinoxin D. The residue (200 mg) was dissolved in dichloromethane (20 mL) and cooled to 0 ° C. MCPBA (95 mg, 0.45 mmol) was added to the reaction mixture and stirred at 25 ° C for 16 hours. The reaction mixture was quenched with sodium bicarbonate solution and the layers were separated. The aqueous layer was extracted with dichloromethane (2x20 mL). The combined extracts were stirred with 10% NaHC03 for 3 hours, washed with brine, dried over anhydrous Na2SO4 and concentrated under reduced pressure. The residue was purified on preparative HPLC using a C18 column and eluted with 101¾ water (0,1¾ NH4OH) in methanol to obtain compound 5,6-dihydrospinoxin D (10 mg): MS -229-Ruler Zit uses Chinese National Standard (CNS) 8 4 specifications (210X297 mm) ---- 1 ---- clothing-(Please read the precautions on the back before filling this page), \-'口487559 A7 B7 V. Description of the invention (227) m / z 748〇'H-NMR (CDCla, 300 MHz) 6.85 (1H, s), 4.82 (1H, S), 4.65 (1H, m), 4.42 ( 1H, d.), 4.20 (1H, m), 0.95 (3H, d). D-SLiLj has different meanings, substituted with amine sugar, modified -1-7-Π- (buiodine-2_defiethoxyl-a-L-rhamnose, and even oligoxin A 17-Psb in Spinoline A 17-Psa (105.4 mg, 0.18 mmol) in acetol (0.86 ml) was added with 3,4-di-0-acetamido-6-deoxy-L-hexane Sugar (A 1 drich, 5 2 u 1, 0.3 5 mm 〇1) and then added N-iodobutanyl te (80.5 mg, 0.36 mmol). The reaction mixture was stirred at room temperature for 19 hours. Then The dark mixture was diluted with dichloromethane and washed with aqueous NaHSO 3 solution, followed by 5% sodium thiosulfate. The dichloromethane portion was dried with MgSO 4 and evaporated at room temperature under reduced pressure. The product was purified by HPLC, and the 17-0- (2-iodo-2-deoxy-3,4-di-〇-acetamidine) obtained by eluting the amidine with 45: 45: 10 / acetonitrile: methanol: 0.05¾ NIUOAc aqueous solution was obtained. -Α, L-rhamnosyl)] Spinoxin A 17-Psa (49 mg; yield 29%), colorless glass, FDMS, m / e (relative strength) 930 (M ~ H , 20), 929 (30), 190 (100). Enriched cases G2_ 17-0- (2- Quanxi-α -1, Rhamas basket, Shi Shiyao Xin A 1 7 -Psa as follows Example G3 The reaction was performed with 17-〇 ~ (2-deoxy-3,4-di-0-acetamido-a-L-rhamnosyl) Spinoxin A 17-Psa (271.2 mg, 0.34 mmol.) As starting material: · Π ~ 〇- (2-desoxy-α-L-rhamnosyl) Spinoxin A 17-Psa (l87 Saki; 77: ¾ yield) -230 -This paper size applies to China's National Standard (CN'S) A4 size (210X 297mm) (Please read the precautions on the back before filling this page)

、1T 線 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(228) ,為白色玻璃狀物,FDMS, m/e (相對強度)1432 (20), 752 (30), 720 (M'100), 206 (50)。 奮旆例(λνΐ 7-0- - 2-关氬基--L二鼠—李糖幕)史堇益 辛A 17-Psa 於17-0-(2-碘-2-去氧基- 3,4 -二-〇 -乙醢基- a -L-鼠 李糖基)史賓諾辛A 17_Psa (107.8 mg,0.12 mmol)之甲 醇(9 m 1)溶液,加入甲醇(2 πι 1)之飽和氨溶液°將反應混 合物加蓋並在室溫下攪拌19小時°在室溫及減壓下使混合 物蒸發。藉由氧化矽上之層析純化産物,以5%甲醇之二氯 甲烷溶液溶析。所得17-0-(2-碘-2-去氧基-a -L-鼠李糖 基)史賓諾辛A 17-Psa(74 mg;産率75%),為無色玻璃狀 物,FDMS, m/e (相對強度)848 (MH、20), 591 (100), 189 (65) , 101 (90)。 窨施例G4 -17-0-(2-关気甚-3,4-二-0-乙鹽基- a -L-鼠李 擴基)中窨諶辛A 17-Psa 於17-0 - (2-碘-2-去氯基-3,4-二-0-乙醯基-a -L-鼠 李糖基)史賓諾辛A 17 - P s a (5 15 · 3 m g , 0 · 5 5 m m ο 1)之甲 苯(85 ml)溶液中,添加三-n-丁基矽烷(780 ul, 2.85 mmo 1).接箸添加微量A IBN 。將反應混合物加熱至迴流溫 度30分鐘,及接著冷卻至室溫1 . 5小時。在室溫及減壓下 蒸發混合物。藉由氧化矽上之層析蒸發混合物,以40¾ 乙酸乙酯之己烷溶液溶析:、所得17-0-(2-去氧基-3,4-二 -0-乙醯基-a 鼠李糖基)史賓諾辛A 17-Psa((321.5 mg;産率73¾),為白色徧離玻璃狀物,FDMS, m/e (相對 -231 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 、-?口 ^/559 A7 . B7 五、發明説明(咖), 強度)804 100), 190 (55),101 (70)。1. 1T line 487559 Printed by A7 B7 of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (228), white glass, FDMS, m / e (relative strength) 1432 (20), 752 (30), 720 (M'100), 206 (50). Example of Fenxiong (λνΐ 7-0--2-guanyl group-L two mouse-plum sugar curtain) Shi Weiyixin A 17-Psa on 17-0- (2-iodo-2-deoxy-3,4 -2 -〇-Acetyl-a-L-rhamnosyl) Spinoxin A 17_Psa (107.8 mg, 0.12 mmol) in methanol (9 m 1) solution, and a saturated ammonia solution of methanol (2 π 1) was added ° The reaction mixture was capped and stirred at room temperature for 19 hours. The mixture was evaporated at room temperature under reduced pressure. The product was purified by chromatography on silica and eluted with 5% methanol in dichloromethane. The obtained 17-0- (2-iodo-2-deoxy-a-L-rhamnosyl) Spinoxin A 17-Psa (74 mg; yield 75%) was a colorless glass, FDMS , m / e (relative intensity) 848 (MH, 20), 591 (100), 189 (65), 101 (90).窨 例 G4 -17-0- (2- 关 気 可 -3,4-bis-0-ethyl salt-a-L-rhamnolide) Zhongxin A 17-Psa on 17-0-(2 -Iodo-2-dechloro-3,4-di-0-ethenyl-a-L-rhamnosyl) Spinoxin A 17-P sa (5 15 · 3 mg, 0 · 5 5 mm ο 1) in toluene (85 ml) solution, add tri-n-butylsilane (780 ul, 2.85 mmo 1). Then add a small amount of A IBN. The reaction mixture was heated to reflux temperature for 30 minutes, and then cooled to room temperature for 1.5 hours. The mixture was evaporated at room temperature under reduced pressure. The mixture was evaporated by chromatography on silica and eluted with 40¾ ethyl acetate in hexane: the resulting 17-0- (2-deoxy-3,4-di-0-acetamido-a rat Liglycan) Spinoloxine A 17-Psa ((321.5 mg; yield 73¾), white glass, FDMS, m / e (relative -231-this paper size applies to Chinese National Standard (CNS) A4 specifications (210X297mm) (please read the precautions on the back before filling this page),-? ^ / 559 A7. B7 V. Description of invention (coffee), strength) 804 100), 190 (55), 101 (70).

富旆例G5-.V-去甲氯基史審謠辛C 依下述實施例H1所述進行反應,以3’_去甲氧基史賓 諾辛B (240 mg, 〇·35 mmol)為起始物質。所得之3’-去 甲氧基史賓諾辛C(126.1 mg;産率54%),為淺黃色固體, FDMS, m/e (相對強度)676 (40), 675 (100),674 (1T ,80) , 673 (35)。 奮施例Μ'ν -去甲氯基-1 基中客諶辛A Ϊ7-Ρα 依上述實施例Ε7所述方法進行反應,以3 去甲氧基 史賓諾辛 A 17-Psa (809.8 mg, 1.4 mmol)。所得之之 3’--去甲氣基-17-酮基史賓諾辛A 17-Psa(501.4 mg;産率 64¾),為無色玻璃狀物,FDMS, m/e (相對強度)559 (M + ,45), 558 (100), 159 (10)。 審施例G7-1 7-Π - (2-乙轆胺甚-2-去氫甚'3. 4,6-四-0-乙醯 甚-θ 喃型»萄糖甚中窨諶辛A 17-Psa 將史賓諾辛 A 17-psa (1·0 1.70 mmol), 2-甲基 _ -(3,4,6-三-0-乙醯基_1,2-二去氯基_〇(-0-11麼喃型葡萄基 )-[2,l-d]-2-i®_l#(Nakabayashi,S.;Warren,C.D·; Jeanloz, R. W. Carbohydr. Res. 1986, 150, C7)(0.56 g, 1.70 mmol)及吡啶鐵-對-甲苯_酸鹽(75 mg, 0.30 mraol)之1,2-二氯甲烷(65 mL)溶液在迴流溫度下加熱並攪 拌48小時,接著冷卻至室溫。接箸加入飽和Na2C〇3(2 mL) 並在室溫下攪拌混合物5分鐘及接箸以水(15 mL)及CH2C12 (30 mL)稀釋.:,分離水層並以CH2C12(30 mL)清洗及並將洗 - 232 - 本紙張尺度適用中國國家標準(CMS ) A4規格(210X 297公釐) (鍊先閱讀背面之注意事項再填寫本頁) •裝· 訂 線 487559 Α7 Β7 五、發明説明(23〇 ) 液與有機層合併。接箸將合併之有機層以鹽水(25 mL)清 洗,乾燥(MgS〇4),並濃縮。將殘餘物(1.4 g)以氧化矽( 160 mL)進行閃蒸層析,利用3% MeOH之CH2C12為溶析液, 以擭得0.6 g粗糖基化産物。將其以三部分200 mg藉由逆 相 HPLC 以 Rainin 徼吸收 C18 管柱(41·4 nun (i.d.U25 cm (1))純化,利用10¾水之MeoH溶析液以獲得151 mg 17-0 - (2-乙醯胺基-2-去氧基_3,4,6-四-0-乙醯基-/3 -D-哌 喃型葡萄糖基史賓諾辛A 17-Psa。由1:2 EtOAc/己烷再結 晶之樣品為無色針狀物,mp 199-200 °C; UMR (CDC13) d 6.76 (s, 1H, H-13), 5.66 (d, ΙΗ,ΝΗ), 5.18 (dd, (請先閱讀背面之注意事項再填寫本頁) •裝- 1H, F 卜3”) ,5 •02 (t, 1Η, Η-4”), 4.83 (d, 1H, H-1 4.62 (m, 1H, Η -21), 4·60 (d, J〜 8.2, 1H, Η-1”), 4.28 (m, 1H, Η -9), 4.14 (m, 2H, H-6”), 3.98 (m, 1H, H-2”) Ο 言施例G 8 - 17- 0- (2 ’ 鹼胺基-2-去 氬基-/3 - D-d济喃型 萄糖甚)Ψ客諶辛A 17-Psa 訂 於17-0-(2-乙醯胺基-2_去氧基-b-D-哌喃型«萄糖基 )史賓諾辛 A17-psa (35 mg, 0.038 mmol)之 MeOH (5 mL) 溶液,加入一部分6 0 % N a Η (2 m g )之礦物油分散油。所得 溶液在室溫下攪拌25分鐘,並接著以冰醋酸中和。蒸發溶 劑並以氧化矽(25 mL)閃蒸層析殘餘物,利用12% MeOH之 CH2C 12溶液為溶析液以獲得17-0- (2 乙醯胺基-2-去氧基 -/3-〇-哌喃型葡萄糖基)史賓諾辛/\17-卩33(27 11^),為無 色泡沫體:UMR (CDC13)5 6.83 (s, 1H, Η-13), 4·83 -233 - 本纸張尺度適用中國國家標準(CNTS ) A4規格(210:&lt; 297公釐) 線 哇齊印t!fc票养苟員1.宵費^阼fi,千軚 〇59Enriched example G5-.V-Norchlorochlorohistamine C. The reaction was performed as described in Example H1 below, starting with 3'-demethoxyspinoxin B (240 mg, 0.35 mmol).始 物。 Starting material. The obtained 3'-demethoxyspinoxin C (126.1 mg; yield 54%) was a pale yellow solid, FDMS, m / e (relative strength) 676 (40), 675 (100), 674 (1T , 80), 673 (35). Fenshi Example M′ν-Demethylchloro-1yl Kexin A A 7-Pα The reaction was performed according to the method described in Example E7 above, and 3 demethoxyspinoxin A 17-Psa (809.8 mg, 1.4 mmol). The obtained 3'-normethyl-17-keto spinosinoxin A 17-Psa (501.4 mg; yield 64¾) was a colorless glass, FDMS, m / e (relative strength) 559 (M +, 45), 558 (100), 159 (10). Examination Example G7-1 7-Π-(2-Ethylamine -2-dehydrogen'3. 4,6-tetra-0-Ethyl thio-theta-type »Glucose Acetone A 17-Psa will be Spinoxin A 17-psa (1.00 1.70 mmol), 2-methyl_-(3,4,6-tri-0-ethenyl_1,2-didechloro_ 〇 (-0-11 Moran-type grape-based)-[2, ld] -2-i®_l # (Nakabayashi, S .; Warren, CD ·; Jeanloz, RW Carbohydr. Res. 1986, 150, C7) ( 0.56 g, 1.70 mmol) and 1,2-dichloromethane (65 mL) solution of iron pyridine-p-toluate_ (75 mg, 0.30 mraol) was heated and stirred at reflux temperature for 48 hours, and then cooled to room temperature Warm. Then add saturated Na2CO3 (2 mL) and stir the mixture at room temperature for 5 minutes and then dilute with water (15 mL) and CH2C12 (30 mL) .: Separate the aqueous layer and CH2C12 (30 mL) ) Washing and washing-232-This paper size is applicable to Chinese National Standard (CMS) A4 specification (210X 297mm) (read the precautions on the back of the chain before filling this page) • Binding line 487559 Α7 Β7 V. DESCRIPTION OF THE INVENTION The (23) solution was combined with the organic layer. The combined organic layers were then washed with brine (25 mL), dried (MgS04), and concentrated. The residue (1. 4 g) flash chromatography with silica (160 mL), using 3% MeOH in CH2C12 as eluent, to obtain 0.6 g of crude glycosylation product. 200 mg of the product was divided into three parts by reverse phase HPLC to Rainin 徼 absorption C18 column (41.4 nun (idU25 cm (1)) purification, using MeoH eluate of 10¾ water to obtain 151 mg 17-0-(2-acetamido-2-deoxy _3,4,6-tetra-0-acetamido- / 3-D-piperanylglucospinyl spinosin A 17-Psa. The sample recrystallized from 1: 2 EtOAc / hexane was colorless needles. , Mp 199-200 ° C; UMR (CDC13) d 6.76 (s, 1H, H-13), 5.66 (d, ΙΗ, ΝΗ), 5.18 (dd, (Please read the precautions on the back before filling this page) • Equipment-1H, F (3 ”), 5 • 02 (t, 1Η, Η-4”), 4.83 (d, 1H, H-1 4.62 (m, 1H, Η -21), 4.60 (d , J ~ 8.2, 1H, Η-1 ”), 4.28 (m, 1H, Η -9), 4.14 (m, 2H, H-6”), 3.98 (m, 1H, H-2 ”) 〇 Comments Example G 8-17- 0- (2 'Alkylamino-2-desarginyl-3-Dd Zeranose Glucose) Benzene A 17-Psa Ordered at 17-0- (2-ethyl Amido-2_deoxy-bD-piranyl «glucosyl] Spinoxin A17-psa (35 mg, 0.038 mmo l) in MeOH (5 mL), and a portion of 60% Na N (2 mg) of mineral oil dispersion was added. The resulting solution was stirred at room temperature for 25 minutes and then neutralized with glacial acetic acid. The solvent was evaporated and the residue was flash-chromatographed with silica (25 mL) using 12% MeOH in CH2C 12 as the eluent to obtain 17-0- (2 acetamido-2-deoxy- / 3 -〇-Piranyl glucosyl) Spinoxin / \ 17- 卩 33 (27 11 ^), a colorless foam: UMR (CDC13) 5 6.83 (s, 1H, Η-13), 4.83- 233-This paper size applies the Chinese National Standard (CNTS) A4 specification (210: &lt; 297 mm) Line Wah Qiyin t! Fc ticket support staff 1. Night fee ^ 阼 fi, 1000 軚 〇59

、發明説明(231 ) (s, 1H, Η-Γ), 4.63 (in, 1Η, H-21), 4.58 (d, 1H, H-1”), 4·32 (m, 1H, H-13); MS m/z 102 (100), 189 (75 ),573 (30) , 794 (Mf +H, 12). 窨倫例09-2-(]-乙醸甚-α _卜德糖胺基溴化物気漳酴B旨 將二乙醯基德糖胺氫氯酸酯(Flynn, E. H.; Sigal, Η. V., Jr.; Wiley, P. F.; Gerzon, K. J. Am. Chem. Soc. 1954, 76, 3120) (0.9 g, 3.05 mmol)在室溫下添 加至已適當攪拌之由乙酸酐(0.75 inL)及30%HBr之乙酸( 3.75 mL)溶液製備之溶液中。將該溶液在室溫下攪拌1小 時,接著在10分鐘内,以每次4-5 ml部分部分地加入乙醚 (45 m 1)以沈澱氫溴酸酯産物;最初使油流出但以刮除及 持續攪拌固化。在氛氣下過濾此吸濕性氫溴酸酯,並以乙 K (3x40 mL)清洗,接著在30°C及減壓(-30 mm)下在旋轉 式蒸發器中乾燥以産生2-0-乙醯基-a 德糖胺基溴化物 氫溴酸酯(1. 1 g),為白色偏離粉末。該粉末可直接用於 糖基化反應 ο 1 [ \-WM (CDCla) δ 6.67 (d, 1H, H-l), 4.92 (dd, 1H, H-2), 2·84 (d, 6H, N (CH: 】)2), 2·33 ( ,3H, d 0), 1.37 (d, 3H, H-6)· 審旆例G 1 0 - 17-( 1-( β - D-德搪胺甚)中客銪辛A 17-Psa 將一部分2-0-乙醯基-a 德糖胺基溴化物氫溴酸酯 (1.1 g, 3.0 nunol)添加至適切攪拌之史賓諾辛A 17-Psa( 〇·5 g, 〇·85 mmol)及二甲基吡啶(0.26 mL, 2·2 mmol)之 1 , 2-二氛甲烷溶液。將溶液加熱至60-65°C並在該溫度下 保持24小時,冷卻至25°C及以0.5 N HC1 (5·2 mL)處理 -234 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)Description of the invention (231) (s, 1H, Η-Γ), 4.63 (in, 1Η, H-21), 4.58 (d, 1H, H-1 "), 4.32 (m, 1H, H-13 ); MS m / z 102 (100), 189 (75), 573 (30), 794 (Mf + H, 12). Example of the case 09-2-()-acetamidine-α_budose Dibromide 気 Zhang 酴 B aims to diethyl sulfonyl glycosamine hydrochloride (Flynn, EH; Sigal, Η. V., Jr .; Wiley, PF; Gerzon, KJ Am. Chem. Soc. 1954, 76, 3120) (0.9 g, 3.05 mmol) was added to a solution prepared from acetic anhydride (0.75 inL) and 30% HBr in acetic acid (3.75 mL) at room temperature. Stir for 1 hour, and then add diethyl ether (45 ml) in 4-5 ml portions in 10 minutes to precipitate the hydrobromide product; the oil is initially allowed to flow out but solidified by scraping and stirring continuously. This hygroscopic hydrobromide was filtered under an atmosphere, washed with ethyl K (3x40 mL), and then dried in a rotary evaporator at 30 ° C and reduced pressure (-30 mm) to produce 2-0- Acetyl-a dextrose amino bromide hydrobromide (1.1 g) is a white off-white powder. This powder can be used directly in glycosylation reactions 1 [\ -WM (C DCla) δ 6.67 (d, 1H, Hl), 4.92 (dd, 1H, H-2), 2.84 (d, 6H, N (CH:)) 2), 2.33 (, 3H, d 0) , 1.37 (d, 3H, H-6) · Examination Case G 1 0-17- (1- (β-D-Detamine) and Chinese Kexin A 17-Psa will be part of 2-0-acetamidine -A Desaminoglycine bromide hydrobromide (1.1 g, 3.0 nunol) was added to the well-stirred Spinozin A 17-Psa (0.5 g, 0.85 mmol) and dimethylpyridine ( 0.26 mL, 2 · 2 mmol) of a 1,2-dichloromethane solution. The solution was heated to 60-65 ° C and held at that temperature for 24 hours, cooled to 25 ° C and treated with 0.5 N HC1 (5 · 2 mL) treatment -234-This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X 297 mm) (Please read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印製 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(232 ) 。將混合物在25°C下攪拌10分鐘並接箸以CH2C12 (20 mL) 稀釋。分離有機層並以水(5 mL ),飽和NaHC〇3 (¢3 mL)及鹽 水(5 mL)清洗並乾燥(MgS〇4)。在氧化矽(150 mL)上進行 閃蒸層析以餘留0.6 g濃縮物,利用3% MeOH之(:[]2(:12溶液 為溶析液以獲得0.25 g 17-0-(/3 -D-德糖胺基)史賓諾辛A 17-Psa,為4/3 :1c(之變旋異構物混合物,為白色泡沫體 。將其溶於 MeoH(7 mL)並加入 0.1M NaOMe 之 MeOH(1.5 mL) 溶液。在室溫下將溶液攪拌6小時,接著加入乙酸(10 mL) 並攪拌溶液10分鐘。蒸發溶劑並餘留200 mg of 17-0-(/3 - D-德糖胺基)史賓諾辛A 17-Psa,為4:1 /?/α變旋異構 物混合物。-變旋異構物(80 mg ,白色泡沫體)藉由逆相 HPLC 以 3 部分在 Rainin 018 管柱(41.4 mm (i.d.) X 25 cm (1))分離,利用 45:45:10 CH3CN/MeOH/2% NH4〇Ac 為溶 析液 MH-NMR (CDC13) δ 6·78 (s, 1H, Η-13),4·84 (s ,1Η, Η-ΙΊ, 4.66 Cm, 1Η, Η-21), 4.36 (d, J= 7.1, 1Η, Μ-ΓΊ, 4.30 (m, 1H, H-9); MS m/z 748 (2), 329 (30), 313 (50), 218 (45), 200 (100), 189 (15), 158 (70), 147 (20)。 審旆例CM1 - a -D-胺搪甚淳化物氣溴醅酯 將 D -胺糖(B o e c k , L · D · ; C h i ο,Η · ; E a t ο η,T · E ·; Godfrey, 0. W., Jr.; Michel, K. H.; Nakatsukasa, W • M.; Yao, R. C-F.歐洲專利,〇 375 316 A1 (1990)) (0 · 1 g , 0.6 3 m m o 1)以一部分加入1 in L己涵切丨覺伴、冷藏 (約10°C .) 5 ·· 1 ( v/v)之30¾ HBr之乙酸:乙酸酐混合物‘:將 -235 - 本紙張尺度適用中國國家標準(CNS ) A4規格(]1〇&gt;&lt;297公釐) (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 5. Description of the Invention (232). The mixture was stirred at 25 ° C for 10 minutes and then diluted with CH2C12 (20 mL). The organic layer was separated and washed with water (5 mL), saturated NaHC03 (¢ 3 mL) and saline (5 mL) and dried (MgS04). Flash chromatography on silica (150 mL) to leave 0.6 g of concentrate, using 3% MeOH in (: [] 2 (: 12 solution as eluent to obtain 0.25 g 17-0-(/ 3 -D-deglycosamine) Spinozin A 17-Psa, 4/3: 1c (a mixture of allomeric isomers, as a white foam. It was dissolved in MeoH (7 mL) and added 0.1M NaOMe in MeOH (1.5 mL). Stir the solution for 6 hours at room temperature, then add acetic acid (10 mL) and stir the solution for 10 minutes. Evaporate the solvent and leave 200 mg of 17-0-(/ 3-D- Desaminol) Spinoxin A 17-Psa, a 4: 1 /? / Α alloisomer mixture.-Alloisomers (80 mg, white foam) by reverse phase HPLC with 3 Partially separated on a Rainin 018 column (41.4 mm (id) X 25 cm (1)), using 45:45:10 CH3CN / MeOH / 2% NH4〇Ac as eluent MH-NMR (CDC13) δ 6.78 (s, 1H, Η-13), 4.84 (s, 1Η, Η-ΙΊ, 4.66 Cm, 1Η, Η-21), 4.36 (d, J = 7.1, 1Η, Μ-ΓΊ, 4.30 (m, 1H, H-9); MS m / z 748 (2), 329 (30), 313 (50), 218 (45), 200 (100), 189 (15), 158 (70), 147 (20) Examination Example CM1-a -D-Amine-Etheramine Gas Bromide Esters D- Sugar (B oeck, L · D ·; C hi ο, Η ·; E at ο η, T · E ·; Godfrey, 0. W., Jr .; Michel, KH; Nakatsukasa, W • M .; Yao, R. CF. European Patent, 0375 316 A1 (1990)) (0 · 1 g, 0.6 3 mmo 1) Add 1 in L Jihan cut sensation companion, refrigerate (about 10 ° C.) 5 ·· 1 (v / v) of 30¾ HBr of acetic acid: acetic anhydride mixture ': will -235-This paper size applies Chinese National Standard (CNS) A4 specifications (] 1〇 &gt; &lt; 297mm) (Please read the back first (Notes for filling in this page)

音t&gt; 487559 睦齊郎中央矂隼^員工消費合作社印裝 A7 B7 五、發明説明( 233 ) 所得溶液在冷卻溫度下攪拌10分鐘,接著在室溫下攪拌1 小時。接著在5分鐘内以1.0 m L部分部分地加入乙醚(7 m L )。最初使氫溴酸酯産物中之油流出但以刮除及持續攪拌 固化。在氮氣下過濾此吸濕性氫溴酸酯,並以乙醚(4X10 mL)清冼,接箸在約30°C及減壓下在旋轉式蒸發器中乾燥 。其可立刻用於糖基化反應。産生(Ι-D-胺糖溴化合物氫 溴酸酯:0.17 g (89¾),為白色偏離粉末:tH-NMR ( . CDCI3) 8 6.60 (s, 1H, H-l), 4.22 (m, 1H, H-5),T &gt; 487559 Muqilang Chuo 矂 隼 ^ Printed by the employee consumer cooperative A7 B7 V. Description of the invention (233) The resulting solution was stirred at the cooling temperature for 10 minutes, and then stirred at room temperature for 1 hour. Diethyl ether (7 ml) was then added in portions of 1.0 ml in 5 minutes. The oil in the hydrobromide product was initially allowed to flow out but solidified by scraping and continuous stirring. This hygroscopic hydrobromide was filtered under nitrogen and washed with diethyl ether (4 × 10 mL), and then dried in a rotary evaporator at about 30 ° C under reduced pressure. It can be used immediately for glycosylation. Yield (I-D-amine sugar bromide hydrobromide: 0.17 g (89¾) as a white deviation powder: tH-NMR (. CDCI3) 8 6.60 (s, 1H, Hl), 4.22 (m, 1H, H -5),

2.94 (d, 3H, HCHa), 2.87 (m, 1H, H-4), 2.83 (d, 3H ,HCHa), 2.30(m, 4H, H-2, H-3), 1.68 (d, 3H,H-6)〇 窖旆例CM 2-1”-寿-中窨諾辛A 將 HgBr2 (0·1 g, 0.28 mmol)之 CH2C12 (10 mL)懸浮 液在室溫下快速攪拌10分鐘。(在此期間内溶解約2/3 HgBr2)。利用4A分子篩(0.15 g)粉化並加入史賓諾辛A 17 - P s a (0 · 11 g , 0 · 18 m m 0 1)並Μ拌混合物10分鐘,之後在 1小時内,逐滴加入a 胺糖溴化物氫溴酸酯(0.17g, 0.56 ππηοΠ之CH2C12 (4.0 mL)溶液。再攪拌3小時,加入 飽和Na2C〇3 (4 mL)並Μ拌混合物10分鐘。藉著經由矽藻 土過濾混合物並將所收集之混合物以CH2C12 (15 mL)及水( 5 mL)清洗。合併濾液之有機層並分離洗液及以CH2C12 (15 mL)清洗水層。將合併之有機萃取物連續以10¾ K I水溶液( 2 X 4 mL), 10% HaHC〇3(5 mL)及鹽水(10 mL)清洗並乾燥 (MgS〇4)。蒸發後留下0.15 g殘餘物,其以氧化矽(40 mL) 閃蒸層析,利用4¾ MeOM之(:1^(:12為溶析液以獲得乾淨之 -236 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 、-口 線 經濟部中央標準局負工消費合作社印裝 487559 A7 * B7 ------—-- 五、發明説明(234 ) 糖基化産物(49 mg),為1”-表-史賓諾辛A與史賓諾辛A之 3:1混合物。將此混合物溶於CH3CN(1.5 niL)及藉由HPLC在 二値連續排列之分析 4 · 6 m m (i · d · ) X 2 5 0 m m (1) A p e X 苯基管柱分離變旋異構物,以40:40:20 CH3CN/MeOH/2% Ν Η 4 0 A c為溶析液及流速1 · 5 m L / m i η。約注入3 0次4 0 - 4 5 uL ,每次含有約1. 5 mg所製得之混合物。所獲得之1” -表 史賓諾辛A為無色泡沫體:l-NMR (CDCla) 56.75 (s, 1Η, Η-13), 4.80 (s, 2Η, H-l , H-l”), 4.59 (m, 1Η, H-21), 4.28 (m, 1H, H-9); MS m/z 732 (M+l, 1), 189 (25), 142 (100)。 富施例 G13_1 7-Π - (2,3· 4·卜四-0-乙醅某-/3 -D-DfiH南型 gi 萄搪甚)中g 1¾辛A 17-Ρα 史賓諾辛 A 17-Psa (0.3 g, 0.5 mmol)及 HgBr2(90 mg, 0.25 mmol)之1,2-二氯甲烷(20 mL)溶液,加熱包含 經4A分子篩之粉化物並加熱至迴流溫度及藉蒸餾收集3 mL 溶劑。於此迴流混合物中,在10分鐘内,逐滴加入2,3,4, 6-四-0_乙醯基-a 喃型葡萄糖基溴化物(0.48 g, 1.17 mmol)之二氯甲烷(5 mL)溶液。收集更多溶劑(3 mL) 並接著持續迴流20小時。接著加入更多之溴化物(0 . 15 d 及HgBr2 (90 mg)並持續迴流5小時。接箸將反應混合物冷 卻至室溫並經由矽藻土過濾。所收集之固體以CH 2 C 12 (20 mL)清洗並合併濾液及洗液並連續以1(UKI(2 X 10 mL), 水(15 mL)及鹽水(15 mL)清洗及接著乾燥(MgS〇4)。蒸發 留下0.7 5 g殘餘物,將其在氧化砂(9 0 m L )上閃蒸層析, ' -237 - 本紙浪尺度適用中國國家標準(CNS ) Λ4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) •裝· 訂 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(235 ) 利用 3¾ MeOH 之 CH2C12 以獲得 0.2 g 17-0-(2,3,4,6-四_0- 乙醯基哌喃型葡萄糖基)史賓諾辛a 17-Psa,為無 色泡沫體:UMR (CDCM 6 6·78 (s, 1H, H-13,), 5.20 (m, 1Η, Η-3'), 5.05 (m, 1Η, Η-4”),4·86 (d, l.H, H-l’),4.66 (m, 1Η, Η-21), 4.59 (d, 1Η, H-l”),· 4.30 (m, 1H, H-9), 4.14 (m, 2H, H-6M); MS m/z 921 (M+l, 2), 331 (100), 189 (90)。 . 配糖基、假糖苻配耱某乃其他烷某化中窨諶辛之 製诰2.94 (d, 3H, HCHa), 2.87 (m, 1H, H-4), 2.83 (d, 3H, HCHa), 2.30 (m, 4H, H-2, H-3), 1.68 (d, 3H, H-6) 旆 Example CM 2-1 "-Shou-Zhongxunuoxin A HgBr2 (0.1 g, 0.28 mmol) in CH2C12 (10 mL) suspension was quickly stirred at room temperature for 10 minutes. Dissolve about 2/3 HgBr2) during this period. Powdered with 4A molecular sieve (0.15 g) and added Spinoxin A 17-P sa (0 · 11 g, 0 · 18 mm 0 1) and mix the mixture 10 Minutes, and then within 1 hour, a solution of a glucosamine bromide hydrobromide (0.17 g, 0.56 ππηοΠ in CH2C12 (4.0 mL) was added dropwise. After stirring for another 3 hours, saturated Na2CO3 (4 mL) was added and Μ Mix the mixture for 10 minutes. Filter the mixture through diatomaceous earth and wash the collected mixture with CH2C12 (15 mL) and water (5 mL). Combine the organic layers of the filtrate and separate the washings and wash with CH2C12 (15 mL) Water layer. The combined organic extracts were washed successively with 10¾ KI aqueous solution (2 X 4 mL), 10% HaHC03 (5 mL) and brine (10 mL) and dried (MgS04). After evaporation, 0.15 was left g residue, which was subjected to flash chromatography on silica (40 mL) using 4¾ MeOM (: 1 ^ (: 12 Eluate to get clean -236-This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297mm) (Please read the precautions on the back before filling this page),-Central Bureau of Standards, Ministry of Economy Printed by the Consumers' Cooperatives 487559 A7 * B7 ------------ V. Description of the invention (234) Glycosylated product (49 mg), 1 ”-Table-Spinnock A and Spinnock 3: 1 mixture of Sin A. This mixture was dissolved in CH3CN (1.5 niL) and analyzed by HPLC in a continuous arrangement in dioxin 4 · 6 mm (i · d ·) X 2 50 mm (1) A pe X Separation of isomers with a phenyl column, 40:40:20 CH3CN / MeOH / 2% Ν Η 4 0 A c was used as the eluent and the flow rate was 1.5 m L / mi η. About 30 injections 4 0-4 5 uL each containing about 1.5 mg of the prepared mixture. The obtained 1 "-epispinoxin A is a colorless foam: l-NMR (CDCla) 56.75 (s, 1Η, Η -13), 4.80 (s, 2Η, Hl, Hl ”), 4.59 (m, 1Η, H-21), 4.28 (m, 1H, H-9); MS m / z 732 (M + l, 1) 189 (25), 142 (100).富 例 例 G13_1 7-Π-(2,3 · 4 · Busi-0-Ethyl- / 3-D-DfiH South type gi grape)) g 1¾A A 17-Pα Spinozin A A solution of 17-Psa (0.3 g, 0.5 mmol) and HgBr2 (90 mg, 0.25 mmol) in 1,2-dichloromethane (20 mL). The powder containing 4A molecular sieve was heated and heated to reflux temperature and collected by distillation. 3 mL of solvent. In this refluxing mixture, 2,3,4,6-tetra-0-acetamyl-a glucosyl bromide (0.48 g, 1.17 mmol) in dichloromethane (5 mL) solution. Collect more solvent (3 mL) and continue refluxing for 20 hours. Then more bromide (0.15 d and HgBr2 (90 mg) were added and refluxed for 5 hours. The reaction mixture was then cooled to room temperature and filtered through celite. The collected solids were CH 2 C 12 ( 20 mL) was washed and the filtrate and washings were combined and washed successively with 1 (UKI (2 X 10 mL), water (15 mL) and brine (15 mL) and then dried (MgS04). Evaporation left 0.7 5 g Residue, flash chromatography on oxidized sand (90 m L), '-237-This paper wave scale applies Chinese National Standard (CNS) Λ4 specification (210X 297 mm) (Please read the precautions on the back first (Fill in this page again) • Binding and binding 487559 Printed A7 B7 by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (235) Use CH2C12 of 3¾ MeOH to obtain 0.2 g 17-0- (2,3,4,6 -Tetra_0-ethanylpiranose-type glucosyl) Spinozin a 17-Psa, a colorless foam: UMR (CDCM 6 6.78 (s, 1H, H-13,), 5.20 (m, 1Η, Η-3 '), 5.05 (m, 1Η, Η-4 ”), 4.86 (d, lH, H-l'), 4.66 (m, 1Η, Η-21), 4.59 (d, 1Η , Hl "), · 4.30 (m, 1H, H-9), 4.14 (m, 2H, H-6M); MS m / z 921 (M + l, 2), 331 (100), 189 (90).. Glycosyl groups, pseudosaccharides, and other compounds are produced by other compounds

實施例H1-由中客諶辛B合成中客謀辛C 將史賓諾辛B(l,00 gms, 1.4 mmol.)之甲醇(45 ml)溶 液在氮氣下冷卻至3°C。加入新鮮配製之1M甲氧化鈉之甲 醇溶液(7.1ml, 7.1 mmol)並接著加入一部分碘固體(1.8 8瓜3,7.1111111〇1)。反應物在3°(:攪拌4.5小時。(1^1^顯示 反應完成80¾)並接箸倒入5¾硫代硫酸鈉/稀釋之氫氧化銨 溶液並以乙醚萃取。以鹽水清洗乙醚萃取物,乾燥(ΚΚ〇3 )及在室溫及減壓下濃縮。粗産物藉由逆相HPLC在Cl8管柱 上純化粗産物,以甲醇:乙腈:0.05%乙酸銨(45 :45:10)溶 析,所得之史賓諾辛C (361 mg)°産物之(MS,及1H-NMR) 與天然生産之史賓諾辛C相同。 窨施例H2-中審柒辛D紅 於史賓諾辛 D 9-Psa (132 mg,〇·24 mmol)之水(5 ml )溶液中,逐滴添加1 N Η 2 S 0 4至P Η 1 · 7並使混合物均質化 。將溶液加熱至8(TC 3 · 75小時,在此期間内將油與溶液分 -238 - 本纸張尺度適用中國國家標準(CNS ) A4規格(2!0X_297公屋) (請先閱讀背面之注意事項再填寫本頁)Example H1-Synthesis of Zhongkemouxin C from Zhongkeqinxin B. A solution of Spinoxin B (1,000 gms, 1.4 mmol.) In methanol (45 ml) was cooled to 3 ° C under nitrogen. A freshly prepared methanol solution of 1 M sodium methoxide (7.1 ml, 7.1 mmol) was added and then a portion of the iodine solid (1.8 8 melons 3, 7.1111111101) was added. The reaction was stirred at 3 ° (4.5 hours. (1 ^ 1 ^ shows that the reaction was completed 80¾) and poured into 5¾ sodium thiosulfate / diluted ammonium hydroxide solution and extracted with ether. The ether extract was washed with brine, Dry (CKO3) and concentrate at room temperature under reduced pressure. The crude product was purified by reverse phase HPLC on a Cl8 column and eluted with methanol: acetonitrile: 0.05% ammonium acetate (45:45:10) The obtained product (MS, and 1H-NMR) of Spinoxin C (361 mg) ° is the same as that of Spinoxin C produced in nature. To a solution of D 9-Psa (132 mg, 0.24 mmol) in water (5 ml), 1 N Η 2 S 0 4 to P Η 1 · 7 were added dropwise and the mixture was homogenized. The solution was heated to 8 ( TC 3 · 75 hours, during which oil and solution are separated -238-This paper size applies Chinese National Standard (CNS) A4 specifications (2! 0X_297 public housing) (Please read the precautions on the back before filling this page )

487559 A7 B7 五、發明説明(236 ) 離。將混合物冷卻至室溫並添加二氯甲烷以溶解油。分離 水相並以新鮮二氯甲烷萃取。合併二氯甲烷部分,快速以 IN H2S〇4清洗,以K2C〇3乾燥並至室溫下蒸發以獲得淺黃 色玻璃狀物(82.9 mg)。産物藉由閃蒸層析以5¾ MeOH之二 氯甲烷溶液純化,所得史賓諾辛D Ag(63.6 mg,産率63¾) ,為無色玻璃狀物。487559 A7 B7 5. Description of the invention (236). The mixture was cooled to room temperature and dichloromethane was added to dissolve the oil. The aqueous phase was separated and extracted with fresh dichloromethane. The dichloromethane fractions were combined, washed quickly with IN H2SO4, dried over K2CO3 and evaporated to room temperature to obtain a pale yellow glass (82.9 mg). The product was purified by flash chromatography with 5¾ MeOH in dichloromethane to obtain Spinoxin D Ag (63.6 mg, yield 63¾) as a colorless glass.

窨施例H3-由中窨謠辛A合成中窨諶辛R 將史賓諾辛A(5.0 gms, 5.13 mmol)及乙酸銷三水物( 4.68 gms, 34.4 mmol)之 80% 甲醇 / 水(125 ml)溶液在氮氣 下加熱至47°C。於添加一部分固體形式之碘(1.75 gms, 6 8.0 in m ο 1)後p Η值由10降至8 ,可得棕色。藉由定時間添 加1Ν氫氧化鈉使pH維持在8-9。將反應物加熱2.5小時(在 此期間中顔色褪色成淺黃色),及接箸冷卻至室溫。將溶 液倒入水(250 ml)及氫氧化銨(50 ml)溶液並以乙醚萃取 。以鹽水清洗乙醚萃取物,乾燥U2C〇3),並在室溫及減 壓下濃縮。藉由逆相HPLC在C18管柱上純化粗産物,以甲 醇··乙腈:0.054乙酸銨(45 :45:10)溶析以獲得史賓諾辛B (2·52 gms),其之(MS, UMR, 13C NMR, IR,及 0R) 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 與天然生産之史賓諾辛B相同。 審旃例H4-N-去甲某Φ窨謀李,1 依實施例H3所述進行反應,以史賓諾辛J (105.4 mg, 0.15 mmol)為起始物質;然而,萃取作業偽以二氯甲烷而 非以乙醚進行。所得N-去甲基史賓諾辛J (57.3 mg; 54%) 為淺黃色玻璃狀物。 -239 - 本紙張尺度適用中國國家標準(CNS )^\4規格( 210X 297公釐) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(237 ) , 啻旆例H5-N-去甲基史賓諾辛 依實施例H4所述進行反應,,以史賓諾辛L (102 . 5 mg , 0.14 mmol)為起始物質。所得N-去甲基史賓諾辛L (66.5 mg; 664)為白色玻璃狀物。例 例 H3- Synthesis of Zhongxinxin R from Zhongliyaoxin A Spinyloxine A (5.0 gms, 5.13 mmol) and acetic acid trihydrate (4.68 gms, 34.4 mmol) in 80% methanol / water ( 125 ml) solution was heated to 47 ° C under nitrogen. After adding a portion of iodine in solid form (1.75 gms, 6 8.0 in m ο 1), the pΗ value was reduced from 10 to 8 to obtain brown. The pH was maintained at 8-9 by adding 1N sodium hydroxide at a fixed time. The reaction was heated for 2.5 hours (during which time the color faded to pale yellow) and then cooled to room temperature. The solution was poured into a solution of water (250 ml) and ammonium hydroxide (50 ml) and extracted with ether. The ether extract was washed with brine, dried (U2CO3), and concentrated under reduced pressure at room temperature. The crude product was purified on a C18 column by reverse-phase HPLC, and eluted with methanol · · acetonitrile: 0.054 ammonium acetate (45:45:10) to obtain Spinoxin B (2.52 gms), which (MS , UMR, 13C NMR, IR, and OR) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the notes on the back before filling this page) The same as Spinozin B produced by nature. Examination Example H4-N-Normosome 窨 Mou Li, 1 The reaction was performed as described in Example H3, with Spinozin J (105.4 mg, 0.15 mmol) as the starting material; however, the extraction operation was pseudo-two Chloromethane is carried out instead of ether. The resulting N-desmethylspinoxin J (57.3 mg; 54%) was a pale yellow glass. -239-This paper size applies to Chinese National Standards (CNS) ^ \ 4 specifications (210X 297 mm) 487559 Printed by A7 B7, Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (237), Example H5-N -Demethylspinoxin was reacted as described in Example H4, starting with Spinoxin L (102.5 mg, 0.14 mmol). The resulting N-desmethylspinoxin L (66.5 mg; 664) was a white glass.

窖偷例Hfi-N-去甲基史g諶辛K 依實施例H4所述進行反應,以史賓諾辛U101.5 mg, 0.14 nunol)為起始物質。所得N-去甲基史賓諾辛K(79.3 mg; 81%)為白色玻璃狀物。In the cellar case, Hfi-N-desmethylsigmaoxine K was reacted as described in Example H4, with Spinoxin U101.5 mg, 0.14 nunol) as the starting material. The resulting N-desmethylspinoxin K (79.3 mg; 81%) was a white glass.

奮施例H7-H-去甲基史窨諾辛D 將史賓諾辛D (5 · 10 g m s , 6.8 % m m ο 1)及乙酸鈉(10.3 gm, 125 mmol)之80%甲醇/水(500 ml)懸浮液加熱至50°C ,同時使氮氣成泡吹過液體15分鐘(pH = 8.96)。在添加 一部分固體形式之碘(3.15 gms, 12.4 mmol)時,pH降低 至pH 8 ,可得棕色。藉由定時間添加IN氫氧化鈉使pH維 持在8-9。將反應物加熱1.5小時(在此期間中顔色褪色成 淺黃色),及接著冷卻至室溫。加入10%亞硫酸氫鈉(100 mL )以中和未反應的碘。在旋轉式蒸發器中濃縮反應物至 總體積為150 mL並以3x100 mL乙酸乙酯萃取溶液。合併乙 酸乙酯萃取物並以鹽水溶液(100 mL)清洗。以碳酸鉀乾燥 乙酸乙酯溶液並在旋轉式蒸發器中濃縮。可得5.0 gm黃 色油。粗産物藉由閃蒸層析(500 mL Si〇2, CH2Cl2:CH3〇H ,95:05)純化以獲得N-去甲基史賓諾辛D(3.79 g ms,75.8 %):部分1H-KMR(CDC 1 3, 300Mz) 6·68 (1H, bs), 5·50 (1H, bs), 4.86. (1R, s), 4.67 (1H, m), 4.46 (1H, bd -240 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ----:--·--―丨 (請先閲讀背面之注意事項再填寫本頁) 訂 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明( 238 ) · ),4·30 (1H, bd), 2·43 (6H, s), 1·72(3Η, s” 啻旆例Η8-Ν, Ν-二去甲基史賓諶辛!( 依實施例HI所述進行反應,以去甲基史賓諾辛K( 891 mg, 1.27 mmol)為起始物質;然而,萃取作業係以乙 酸乙酯非以乙醚進行。所得N , N -二去甲基史賓諾辛K ( 463.6mg)為無色玻璃狀物。 奮旆例H9-中客柒辛F 17-Psa 依史賓諾辛E 17-Psa(實施例H10)所述,由35 mg ( 0.049 mmol)史賓諾辛F製備化合物。所獲得之史賓諾辛F 17-Psa24 mg (88%),為無色泡沫體·· HMR (CDCls) δ 6.75 (br s, 1H, H-13), 5.83 (d, 1H, H-5), 5.75 (dt ,1H, H-6), 4.82 (s, 1H, H-lf) 4.65 (m, 1H, H-21), 4.28 fm, 1H, H-9), 4.15 (m, 1H, H-17), 3.52 (s, 3H ,4,-0CH3), 3·46 (s, 6H, 2,-, 3’-0CH3), 1.25 (d, 3H, H-6’); MS m/z 576 (2)。 審旆例H1 0 -中窨諶辛R 1 7 -假糖苷基化合物 於經適當攪拌之35 mg史賓諾辛E之水(0.7 mL)溶液中 ,加入一部分IN H2S〇4(0.1 mL)溶液。將所得溶液加熱至 90-100 °C並於該溫度下保持24小時。在此期間内分離所得 之假糖苷配基化合物。接著將混合物冷卻至室溫並將粗産 物萃取至二氯甲烷中。接著以飽和NaC U青洗有機萃取物並 乾燥(MgS〇4:)。蒸發後留下粗17-假糖苷配基化合物,將其 藉由矽膠之層析純化,使用《甲醇之CH 2 C 12溶液為溶析液 ,以擭得26 mg (92¾)史賓諾辛E 17-假糖苷配基化合物, -241 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ----Γ--.---- (請先閱讀背面之注意事項再填寫本頁) 丁 、言 487559 A7 _ B7 _ 五、發明説明( 239) · 1無色泡沫體:4_〇!?(00(:13)0'6.74(1^3,11],[1-13), 5.83 (d, 1H ,H-5), 5.75, (dt,lH, H-6), 4.81 (s ,1H, H-1’)4,72 (m, 1H, H-21), 4.28 H-9), 3·52 (s, 3H, 4,-0CH3), 3·46 (s, 6H, 2,-, 3,-0CH3) ,1 · 13 (d, 3H, H-22) ; MS m/z 576 (2)。 I部分去氬甚鼠査搪衍牛物 窨施例T1 去甲甚-2 关氬某中窨諾幸η 經濟中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 將化合物2’-去氧基史賓諾辛Q (940 mg, 1.31 mmol) 溶於熱70%Me0H/30%pH 9緩衝液(40 ml)中。添加乙酸鈉三 水物(1 . 3 gms , 9.6 mmo 1),及將懸浮液加熱至47°C。接 著加入固體形式之碘(438 mg, 17 mmol)。於47°C下攪拌 4小時後,加入額外的碘(150 · 8 mg , 0.59 mmo 1 )。將混合 物在47°C下再攪拌4小時,並接箸冷卻至室溫及再攪拌12 小時。將溶液倒入5%硫代硫酸鈉中並以Et20萃取。以鹽水 清洗Et20部分,乾燥(K2C〇3),並在室溫下蒸伋。殘餘物 在矽膠管柱(5% MeOH/CH2Cl 2)上層析並提供N-去甲基-2 ^ -去氧基史賓諾辛QU62.7 mg;産率56%,以回收之起始物 質為基準),為淺粉红色固體;FDMS, m/z (相對強度) 702(100), 159(10)。 審施例I2-N-去甲某-3’-去Μ基史省謀羊,f 依實施例II所述進行反應,以3’-去氧基.史賓諾辛J (1.51 gms, 2.16 mmol)為起始物質。所得N-去甲基_3’ -去氧基史賓諾辛J (937.6 mg;産率63%),為白色固體; FDMS, m/e (相對強度)687 (100) 159 (10). -242 - 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 經濟部中央標準局員工消費合作社印製 487559 A7 __B7___ 五、發明説明(24〇 ) 實施例13-3、去氬甚中窨諾辛J 17-Psa 將3’-去氧基史賓諾辛J (25,7.2 mg, 0.37 mmol)懸浮 於IN H2S〇4(5 ml)溶液中並加熱至迴流溫度2.25小時。接 著將混合物冷卻至室溫,以CH2C12稀釋並以水清洗。接箸 以鹽水清洗CH2C12部分,乾燥(K2C〇3)並在室溫下蒸發。 殘餘物在矽膠管柱(50% EtOAc/己烷)上層析以提供3 去 氧基史賓諾辛 J 17-Psa(112 rag;産率 54%); FDMS. m/e,( 相對強度)560 (100), 159/16)。 富施例T4-9-0-(1 -四氣_喃基)史窨諾辛 A 9-Psa ( α及 /¾里構物夕混合物) 將化合物史賓諾辛A 9-Psa (106.6 mg, 0.20 mmol) 溶於苯(10 ml )中#加人二氣脈喃(21 ml, 0.23 mraol)及 接著加入催化量之對甲苯磺酸。將混合物加熱至迴流溫度 16小時。因為未觀察到反應,加入更多的二氫哌喃(200 ml)。將混合物以迪安-斯達克(Dean/Stark)阱迴流6小時 接著冷卻至室溫。以CH2Cld#釋混合物並以IN NaOH清洗 。以鹽水清洗CH2C12部分,乾燥(K2C〇3)及在室溫下濃縮 。將殘餘物(105 mg,大部分是史賓諾辛A 9-Psa)溶於苯 (10 ml),並加入二氫哌喃(200 ml, 2.2 mmol),接箸加 入對甲苯磺酸(42.9 mg, 0.23 mmol)。混合物在室溫下攪 拌1小時,及接著以Et20稀釋。以飽和NaHC〇3、鹽水清洗 Et2〇部分,乾燥U2C〇3)並於室溫下蒸發。殘餘物在矽膠 板(100% EtOAc,接箸 10% Et0H/E、t0Ac,接箸是 100% MeOH ,以2步驟進行)層析以提供9-0-(卜四氫峨喃基)史賓諾辛 -243 - ' 本紙伕尺度適用中國國家標準(CNS ) A4規格(2i〇x 297公瘦) ----:--·--着II (請先閱讀背面之注意事項再填寫本頁)Example F7: H7-H-desmethylspinoxine D. Spinoxin D (5 · 10 gms, 6.8% mm ο 1) and sodium acetate (10.3 gm, 125 mmol) in 80% methanol / water ( 500 ml) suspension was heated to 50 ° C while blowing nitrogen through the liquid for 15 minutes (pH = 8.96). When a part of the iodine (3.15 gms, 12.4 mmol) was added in a solid form, the pH was reduced to pH 8 to obtain a brown color. The pH was maintained at 8-9 by adding IN sodium hydroxide over time. The reaction was heated for 1.5 hours (during which time the color faded to pale yellow) and then cooled to room temperature. Add 10% sodium bisulfite (100 mL) to neutralize unreacted iodine. The reaction was concentrated on a rotary evaporator to a total volume of 150 mL and the solution was extracted with 3 x 100 mL of ethyl acetate. The ethyl acetate extracts were combined and washed with saline solution (100 mL). The ethyl acetate solution was dried over potassium carbonate and concentrated in a rotary evaporator. 5.0 gm yellow oil was obtained. The crude product was purified by flash chromatography (500 mL SiO2, CH2Cl2: CH3OH, 95:05) to obtain N-desmethylspinoxin D (3.79 g ms, 75.8%): part 1H- KMR (CDC 1 3, 300Mz) 6.68 (1H, bs), 5.50 (1H, bs), 4.86. (1R, s), 4.67 (1H, m), 4.46 (1H, bd -240-unit Paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) ----: --------- 丨 (Please read the precautions on the back before filling this page) Order 487559 Employees of the Central Standards Bureau of the Ministry of Economic Affairs Printed by the consumer cooperative A7 B7 V. Description of the invention (238) ·), 4 · 30 (1H, bd), 2 · 43 (6H, s), 1 · 72 (3Η, s ”啻 旆 Example 8-Ν, Ν -Didemethylspinoxine! (The reaction was performed as described in Example HI, starting with desmethylspinoxine K (891 mg, 1.27 mmol); however, the extraction was performed with ethyl acetate It was not carried out with diethyl ether. The obtained N, N-didemethylspinoxin K (463.6mg) was a colorless glass. Fenxiong H9-zhongkepinxin F 17-Psa espinoxin E 17- The compound was prepared from 35 mg (0.049 mmol) of Spinoxin F as described in Psa (Example H10). The obtained Spinoxin F 17-Psa 24 mg (88%) was obtained as none. Foam · HMR (CDCls) δ 6.75 (br s, 1H, H-13), 5.83 (d, 1H, H-5), 5.75 (dt, 1H, H-6), 4.82 (s, 1H, H -lf) 4.65 (m, 1H, H-21), 4.28 fm, 1H, H-9), 4.15 (m, 1H, H-17), 3.52 (s, 3H, 4, -0CH3), 3.46 (s, 6H, 2,-, 3'-0CH3), 1.25 (d, 3H, H-6 '); MS m / z 576 (2). Examination example H1 0 -Zhongxinxin R 1 7- A pseudoglycoside compound was added to a 35 mg solution of spinosinol E in water (0.7 mL) with appropriate stirring, and a portion of IN H2SO4 (0.1 mL) solution was added. The resulting solution was heated to 90-100 ° C and then The temperature was maintained for 24 hours. The resulting pseudoglycoside compound was isolated during this time. The mixture was then cooled to room temperature and the crude product was extracted into methylene chloride. The organic extract was then washed with saturated NaC U and dried ( MgS04 :). After evaporation, the crude 17-pseudoglycoside compound was purified by chromatography on silica gel using CH 2 C 12 solution of methanol as the eluent to obtain 26 mg (92¾) Spinoxin E. 17-Pseudoglycoside compound, -241-This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) ---- Γ --.---- (Please read the precautions on the back before (Fill in this page) D, Yan 487559 A7 _ B7 _ V. Description of the invention (239) · 1 Colorless foam: 4_〇 !? (00 (: 13) 0'6.74 (1 ^ 3,11), [1- 13), 5.83 (d, 1H, H-5), 5.75, (dt, lH, H-6), 4.81 (s, 1H, H-1 ') 4,72 (m, 1H, H-21), 4.28 H-9), 3.52 (s, 3H, 4, -0CH3), 3.46 (s, 6H, 2,-, 3, -0CH3), 1 · 13 (d, 3H, H-22) ; MS m / z 576 (2). Part I Deargon Demonstration and Enlightenment of Beef Demonstration Example T1 Demethylphenidate-2 Deuterium and Demonstration No. 1 Printed by the Consumers' Cooperative of the Central Economic Standards Bureau (Please read the precautions on the back before filling out this page) Compound 2'-deoxyspinoxin Q (940 mg, 1.31 mmol) was dissolved in hot 70% Me0H / 30% pH 9 buffer (40 ml). Add sodium acetate trihydrate (1.3 gms, 9.6 mmo 1) and heat the suspension to 47 ° C. Then add iodine (438 mg, 17 mmol) as a solid. After stirring for 4 hours at 47 ° C, additional iodine (150 · 8 mg, 0.59 mmo 1) was added. The mixture was stirred for an additional 4 hours at 47 ° C, then cooled to room temperature and stirred for another 12 hours. The solution was poured into 5% sodium thiosulfate and extracted with Et20. The Et20 portion was washed with brine, dried (K2CO3), and evaporated at room temperature. The residue was chromatographed on a silica gel column (5% MeOH / CH2Cl 2) and provided N-desmethyl-2 ^ -deoxyspinoxin QU62.7 mg; yield 56% to recover the starting material As a reference), a light pink solid; FDMS, m / z (relative intensity) 702 (100), 159 (10). Example I2-N-Normo-3'-demethyl-based Shimou sheep, f reacted as described in Example II to 3'-deoxy. Spinozin J (1.51 gms, 2.16 mmol ) Is the starting material. The obtained N-desmethyl-3'-deoxyspinoxin J (937.6 mg; yield 63%) was a white solid; FDMS, m / e (relative strength) 687 (100) 159 (10).- 242-This paper size is in accordance with Chinese National Standard (CNS) A4 (2 丨 0X297 mm) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 __B7___ 5. Description of the Invention (24〇) Example 13-3, Deargonization Very Medium Inoxanosin J 17-Psa 3'-Deoxyspinoxin J (25,7.2 mg, 0.37 mmol) was suspended in an IN H2SO4 (5 ml) solution and heated to reflux temperature for 2.25 hours. The mixture was then cooled to room temperature, diluted with CH2C12 and washed with water. The CH2C12 portion was washed with brine, dried (K2CO3) and evaporated at room temperature. The residue was chromatographed on a silica gel column (50% EtOAc / hexane) to provide 3 deoxyspinoxin J 17-Psa (112 rag; yield 54%); FDMS. M / e, (relative strength) 560 (100), 159/16). Fushi Example T4-9-0- (1-tetrakis-amino group) Spinozin A 9-Psa (a mixture of α and / ¾ oligomeric compounds) The compound Spinozin A 9-Psa (106.6 mg , 0.20 mmol) was dissolved in benzene (10 ml) and added with diqirmaine (21 ml, 0.23 mraol) and then a catalytic amount of p-toluenesulfonic acid was added. The mixture was heated to reflux temperature for 16 hours. Since no reaction was observed, more dihydropiran (200 ml) was added. The mixture was refluxed in a Dean / Stark trap for 6 hours and then cooled to room temperature. The mixture was released with CH2Cld # and washed with IN NaOH. The CH2C12 portion was washed with brine, dried (K2C03) and concentrated at room temperature. Dissolve the residue (105 mg, mostly spinoxin A 9-Psa) in benzene (10 ml), add dihydropiperan (200 ml, 2.2 mmol), and then add p-toluenesulfonic acid (42.9 mg, 0.23 mmol). The mixture was stirred at room temperature for 1 hour and then diluted with Et20. The Et20 portion was washed with saturated NaHC03, brine, dried (U2CO3) and evaporated at room temperature. The residue was chromatographed on a silica gel plate (100% EtOAc, then 10% Et0H / E, t0Ac, then 100% MeOH, performed in 2 steps) to provide 9-0- (tetrahydroeranyl) spine Northing-243-'This paper's standard is applicable to China National Standard (CNS) A4 specification (2i0x 297 male thin) ----: ----- II (Please read the precautions on the back before filling this page )

、1T 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(241 ) A 9-Psa (α及/3異構物之混合物:)(116.8 mg;産率93¾) ;FDMS m/e (相對強度)628 (1〇9),142(5)。Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, 1T 487559 A7 B7 V. Description of the invention (241) A 9-Psa (a mixture of α and / 3 isomers :) (116.8 mg; yield 93¾); FDMS m / e (relative intensity) 628 (109), 142 (5).

窖施例T.H ’ -Π-乙醗某中客謀李J 將化合物史賓諾辛J (207.9 mg, 0.29 mmol)溶於Ott 啶(2 ml)並加入乙酸酐(140 ml, 1.5 mmol)。將混合物在 室溫下攪拌24小時,並接著在室溫下蒸發。將殘餘物在矽 膠管柱上(7¾ MeOH/CH2Cl2)層析以提供3夂0-乙醯基史賓 諾辛J(148.8 mg,産率68%),為無色玻璃狀物。FDMS, ro/e (相對強度)759 (100:), 283 (4), 142 (7)。 ψ 窨旆例’ -0-乙醅基中窨諾辛Η 依實施例15所述進行反應,以史賓諾辛Η (211.9 mg, 0.29 mmol)為起始物質。所得2T-0-乙醯基史賓諾辛H( 175.2 mg,産率801),為無色玻璃狀物。FDMS, m/e ( 相對強度)759 (100), 142 (6)。Example T.H ′ -Π-Ethyl Acetate Li J. The compound Spinoxin J (207.9 mg, 0.29 mmol) was dissolved in Ottidine (2 ml) and acetic anhydride (140 ml, 1.5 mmol) was added. The mixture was stirred at room temperature for 24 hours, and then evaporated at room temperature. The residue was chromatographed on a silica gel column (7¾ MeOH / CH2Cl2) to provide 3 夂 -ethylstilpinoxine J (148.8 mg, yield 68%) as a colorless glass. FDMS, ro / e (relative strength) 759 (100 :), 283 (4), 142 (7). ψ Example 窨 旆 -0-Ethylpyridinium oxoxine The reaction was carried out as described in Example 15, starting with spinosynoxine (211.9 mg, 0.29 mmol). The obtained 2T-0-acetylspinoxin H (175.2 mg, yield 801) was a colorless glass. FDMS, m / e (relative intensity) 759 (100), 142 (6).

富施例17-4 ’ 乙醯基中窨諶辛K 依實施例15所述進行反應,以史賓諾辛K(207.0 mg, 0.29 mmol)為起始物質。所得4’-0-乙醯基史賓諾辛K( 204.9 mg,産率93%),為白色玻璃狀物。FDMS, m/e (相 對強度)759 (100)。Fu Shi Example 17-4 'Acetyl mesitycin K was reacted as described in Example 15 with Spinoxin K (207.0 mg, 0.29 mmol) as the starting material. The obtained 4'-0-acetylspinoxin K (204.9 mg, yield 93%) was obtained as a white glass. FDMS, m / e (relative strength) 759 (100).

審旆例T8-4 Γ (S-甲某)二硫羰甚1中窨諶辛K 將史賓諾辛K(201.0 mg, (L28 mmol)及眯唑(催化量) 溶於無水THF (2 m 1 ),並在室溫及氮氣下攪拌。將氫化鈉 (50¾之礦物油溶液;25 mg, 0.52、mmol)加入溶液中,接 著加入二硫化磺(90 ml, 1.5 mmol)及接箸加入碘甲烷(90 本紙張尺度適用中國國家標準(CNS ) A4規格( 210X297公釐) ----:--.---- (請先閱讀背面之注意事項再填寫本頁) 訂 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(242 ) ml , 1.44 mmol)。在室溫下攪拌1小時後,加入乙酸(90 ml),並將混合物倒入飽和NaHC0,3中。接著以(:[12(:12萃取 水層。以鹽水清洗CH2C12部分,乾燥(MgS〇4)及在室溫下 蒸發以提供4’-0-[(S-甲基)二硫羰基]史賓諾辛K(218.1 mg,産率97% ),為黃色玻璃狀物。FDMS, m/e (相對強 度)808(100)。Examination example T8-4 Γ (S-methyl) dithiocarbonyl 1 in spinoxin K (201.0 mg, (L28 mmol) and oxazole (catalytic amount) was dissolved in anhydrous THF (2 m 1), and stirred at room temperature under nitrogen. Sodium hydride (50¾ in mineral oil solution; 25 mg, 0.52, mmol) was added to the solution, followed by sulfur disulfide (90 ml, 1.5 mmol) and then added Methyl iodide (90 paper sizes applicable to Chinese National Standard (CNS) A4 specifications (210X297 mm) ----: --.---- (Please read the precautions on the back before filling this page)) Order 487559 Ministry of Economic Affairs A7 B7 printed by the Consumer Standards Cooperative of the Central Bureau of Standards 5. Description of the invention (242) ml, 1.44 mmol). After stirring at room temperature for 1 hour, add acetic acid (90 ml) and pour the mixture into saturated NaHC0,3. The aqueous layer was then extracted with (: [12 (: 12. The CH2C12 portion was washed with brine, dried (MgS04) and evaporated at room temperature to provide a 4'-0-[(S-methyl) dithiocarbonyl] history. Binoxin K (218.1 mg, yield 97%) is a yellow glass. FDMS, m / e (relative strength) 808 (100).

窖旆例Tfl -.v-n-r(s-甲甚)二硫羰某)1中窨諾辛J 依實施例18所述進行反應,以史賓諾辛J(207.1 mg, 0 · 2 9 in m ο 1)為起始物質。所得3夂0 - [ (S -甲基)二硫激基)] 史賓諾辛J(224.0 mg,産率96¾),為黃色玻璃狀物。FDMS ,m/z (相對強度)808 (100)。 實施例110 - 2’-0-[(S._甲基)二硫镚某1中客謀辛Η 依實施例18所述進行反應,以史賓諾辛H(204.0 mg, 0·2δ mmol)為起始物質。所得2^0-[(S-甲基)二硫羰基] 史賓諾辛Η(218·8 mg,産率97¾)為黃色玻璃狀物。FDMS, m/z (相對強度)808 (100)。Example Tfl -.vnr (s-methyl) dithiocarbonyl 1) Noxin J was reacted as described in Example 18 with Spinoxin J (207.1 mg, 0 · 2 9 in m ο 1) is the starting material. The obtained 3 夂 0-[(S -methyl) dithiol)] Spinoxin J (224.0 mg, yield 96¾) was a yellow glass. FDMS, m / z (relative intensity) 808 (100). Example 110-2'-0-[(S._Methyl) dithiocarbamate, 1 in the case of Kouxin Xin, the reaction was performed as described in Example 18, with Spinoxin H (204.0 mg, 0.2δ mmol ) Is the starting material. The resulting 2 ^ 0-[(S-methyl) dithiocarbonyl] spinosinol (218 · 8 mg, yield 97¾) was a yellow glass. FDMS, m / z (relative intensity) 808 (100).

實施例11 1 -2 ’ -Q - [(S -甲甚)二醅羰甚1中客柒辛Q 依實施例18所述進行反應,以史賓諾辛Q (1.00 gms, 1·4 nunol)為起始物質。所得2’-0-[(S-甲基)二醯羰基]史 賓諾辛Q(1.13 gras,産率98%),為黃色玻璃狀物。FDMS, ηι/ζ,(相對強度)822 (100)。Example 11 1 -2 '-Q-[(S -methyl) dioxocarboxan 1 in ketoxin Q The reaction was carried out as described in Example 18, with Spinoxin Q (1.00 gms, 1.4 nunol ) Is the starting material. The obtained 2'-0-[(S-methyl) difluorenylcarbonyl] spinoxin Q (1.13 gras, yield 98%) was yellow glass. FDMS, η / ζ, (relative intensity) 822 (100).

奮施例II2-3’-0-(S-甲某)二硫羰甚)中客錤辛L 將史貧諾半 L(1.65 gms, 2.2、mmo 1 )溶於無水THF1 (50 m 1)並於氮氣下及冰浴中冷卻。加入眯唑(21 . 2 mg , 〇 · 3 -245 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) _' ----:--·--Φ衣-- (請先閱讀背面之注意事項再填寫本頁)Fenshi Example II2-3'-0- (S-A) dithiocarbonyl and even ketoxin L dissolved Stronoline L (1.65 gms, 2.2, mmo 1) in anhydrous THF1 (50 m 1) And cooled under nitrogen and in an ice bath. Add oxazole (21.2 mg, 0.3-245-this paper size applies to Chinese National Standard (CNS) A4 specification (210X 297 mm) _ '----: ----- Φ clothing-( (Please read the notes on the back before filling out this page)

、1T 487559 經濟部中央標準局員工消費合作社印f- A7 B7 五、發明説明(243 ) mmo Γ)至溶液中,接著加入氫化鈉(60¾之礦物油溶液; 105.0 mg, 2.6 mmol)及接著加入二硫化碳(700 ml, 11.64 mmol)及碘甲院(700 ml, 11·1 mmol)。將混合物在 室溫下攪拌1小時,接箸加入少量之NaH並持續攪拌1小時 。將混合物倒入飽和氯化銨溶液並以CH 2 C 12萃取。乾燥 CH2C12部分(K2C〇3)並在室溫下蒸發以提供3’-0-(S-甲基) 二硫羰基)史賓諾辛L(l.86 mg,産率100%),為黃色固體 ◦FDMS, m/e (相對強度)821 (100), 160 (4)。1T 487559 F-A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (243) mmo Γ) into the solution, followed by sodium hydride (60¾ mineral oil solution; 105.0 mg, 2.6 mmol) and then added Carbon disulfide (700 ml, 11.64 mmol) and iodotin (700 ml, 11.1 mmol). The mixture was stirred at room temperature for 1 hour, then a small amount of NaH was added and stirring was continued for 1 hour. The mixture was poured into a saturated ammonium chloride solution and extracted with CH 2 C 12. The CH2C12 portion (K2C03) was dried and evaporated at room temperature to provide 3'-0- (S-methyl) dithiocarbonyl) Spinoxin L (1.86 mg, yield 100%) as yellow Solids FDMS, m / e (relative strength) 821 (100), 160 (4).

窨施例Π3-4’-去氫甚-中窨諾辛K 將化合物4’-0-[(S-甲基)二硫羰基]史賓諾辛K( 182.5 rag, 0.23 mmol)溶於甲苯(10 ml)。加入氫化三丁 錫(93 ml, 0.35 mmol)及AIBN(催化量)並使溶液迴流。再 2小時後,加入更多的氫化三丁錫(100 ml)。使混合物再 迴流12小時,並在室溫下攪拌5小時。接箸將溶劑蒸發至 小體積並接著在矽膠管柱(80¾ EtOAc/己烷)上層析以提供 4’-去氧基史賓諾辛K(59.9 mg,産率37%),為無色玻璃狀 物。FDMS, m/e(相對強度)702 (100)。Example Example 3-4'-Dehydrogeno-Mesanosine K Dissolve the compound 4'-0-[(S-methyl) dithiocarbonyl] Spinosin K (182.5 rag, 0.23 mmol) in toluene (10 ml). Add tributyltin hydride (93 ml, 0.35 mmol) and AIBN (catalytic amount) and reflux the solution. After another 2 hours, more tributyltin hydride (100 ml) was added. The mixture was refluxed for another 12 hours and stirred at room temperature for 5 hours. The solvent was then evaporated to a small volume and then chromatographed on a silica gel column (80¾ EtOAc / hexane) to provide 4'-deoxyspinoxin K (59.9 mg, yield 37%) as a colorless glass Thing. FDMS, m / e (relative intensity) 702 (100).

奮施例Π 4-3’ -去氬基Φ窨柒辛J 將化合物3 ’ -0- [ (S -甲基)二硫羰基]史賓諾辛J (849 · 1 m g , 1.0 5 m m ο 1)溶於無水甲苯(5 0 m 1)。加入新鮮氫化三 丁基錫(500 ml, 1.6 mmol)及 AIBN (10.2 mg)並使混合物 迴流。於8小時後,再加入A IBN (32.8 mg),及持續迴流2 小時。在5°C放置48小時後,將溶翔蒸發至小體積。殘餘 物在矽膠管柱上層析(3 . 5% Me0H/CH2C 12)以提供3 ’ -去氧 本紙張尺度適用中國國家標準(CNS〉A4規格(210X 297公釐) ----,—·—— (請先閱讀背面之注意事項再填寫本頁) 、-口 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(244 ) , 基史賓諾辛J (557.0 mg,産率76t),為無色玻璃狀物。 FDMS, m/z (相對強度)701 (100),。 奮旆例T1 5-2’-关g甚中客諶辛Η 將化合物2 ’ -0- [ (S_甲基)二硫羰基]史賓諾辛Η (1 · 15 gms, 1.4 mmol)溶於無水甲苯(50 ml)。加入新鮮氫化三 丁基錫(750 ml, 2.8 mmol)及AIBM30 mg)並使混合物迴 流。於2. 5小時後,再加入AIBN (20.5 mg)並持續迴流5 小時。於室溫下攪拌11.5小時後,蒸發溶劑至小體積並將 殘餘物在矽膠管柱上層析(3.5% MeOH/CH 2 C 12)以提供2 ’ -去氧基史賓諾辛H (821.5.mg,産率84:ϊ),為無色玻璃狀 物。FDMS, m/z (相對強度)701 (100)。Fenshi Example Π 4-3'-Dearginyl Pyridoxine J Compound 3 '-0- [(S -methyl) dithiocarbonyl] Spinoxin J (849 · 1 mg, 1.0 5 mm ο 1) Dissolved in anhydrous toluene (50 m 1). Fresh tributyltin hydride (500 ml, 1.6 mmol) and AIBN (10.2 mg) were added and the mixture was refluxed. After 8 hours, add A IBN (32.8 mg) and continue refluxing for 2 hours. After standing at 5 ° C for 48 hours, the lysate was evaporated to a small volume. The residue was chromatographed on a silica gel column (3.5% Me0H / CH2C 12) to provide 3'-deoxygenation. This paper is sized to the Chinese national standard (CNS> A4 specification (210X 297 mm)). · —— (Please read the precautions on the back before filling this page),-Printed by the Consumers Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs, printed by 487559 A7 B7 V. Invention Description (244) The rate is 76t), which is a colorless glass. FDMS, m / z (relative strength) 701 (100) ,. Fen example T1 5-2'-guan g is very Chinese guest 谌 Xin Η will compound 2 '-0- [ (S_methyl) dithiocarbonyl] Spinoxine (1 · 15 gms, 1.4 mmol) was dissolved in anhydrous toluene (50 ml). Fresh tributyltin hydride (750 ml, 2.8 mmol) and AIBM 30 mg) were added and The mixture was refluxed. After 2.5 hours, add AIBN (20.5 mg) again and keep refluxing for 5 hours. After stirring at room temperature for 11.5 hours, the solvent was evaporated to a small volume and the residue was chromatographed on a silica gel column (3.5% MeOH / CH 2 C 12) to provide 2′-deoxyspinoxin H (821.5. mg, yield 84: i)) as a colorless glass. FDMS, m / z (relative intensity) 701 (100).

富渝例T16-2’-去舊,某Φ窨柒辛Q 將化合物2 ’ -0- [ (S -甲基)二硫羰基]史賓諾辛Q (1 · 08 gms, 1.3 mmol)溶於無水甲苯(50 ml)。加入新鮮氫化三 丁基錫(750 ml, 2.8 mmol)及 AIBNC47.5 mg)並使混合物 迴流2.5小時及接著冷卻至室溫。於20小時後,蒸發溶劑 並將殘餘物在矽膠管柱(3.54 MeOH/CH 2C 12)上層析以提供 2’-去氧基史賓諾辛Q (912.9 mg,産率98¾),為無色玻璃 狀物。FDMS, m/Z (相對強度)716(100)。Fuyu Example T16-2'-Old, a certain 窨 柒 窨 柒 octyl Q dissolves the compound 2 '-0- [(S -methyl) dithiocarbonyl] spinoxin Q (1.08 gms, 1.3 mmol) In anhydrous toluene (50 ml). Fresh tributyltin hydride (750 ml, 2.8 mmol) and AIBNC 47.5 mg) were added and the mixture was refluxed for 2.5 hours and then cooled to room temperature. After 20 hours, the solvent was evaporated and the residue was chromatographed on a silica gel column (3.54 MeOH / CH 2C 12) to provide 2'-deoxyspinoxin Q (912.9 mg, yield 98¾) as a colorless glass Thing. FDMS, m / Z (relative intensity) 716 (100).

奮施例Π7-:Γ-去《甚中客柒辛L 依實施例116所述進行反應,以3^0-(3-甲基硫羰基) 史賓諾辛L(1.85 gms, 2.25 mmol)。3’-去氧基史賓諾辛L (1.16 gms,産率7«),為無色玻.璃狀物。FDMS, m/e (相 對強度)716(100)。 -247 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公慶1 I------:---- (請先閱讀背面之注意事項再填寫本頁) 訂 487559 A7 B7 五、發明説明(245 ) 富施例Ι18-9-Π-(ητ -L-3,4 -二乙酿暮鼠李糖某)中賓謀 辛 A 9'Psa , 將史賓諾辛 A 9-Psa(1.56 gms, 2·9 mmol)及卜溴-2, 3,4-tri-O-乙醯基鼠李糖 41.52 gms, 4.3 mmol)溶於 CH2C12 (75 ml ;無水)。加入四甲脲(1·〇 ml, 8.4 mmol) ,接著加入三氣甲磺酸銀(823.8 mg, 3.2 mmol),並將反 應燒瓶覆蓋铝箔。於攪拌24小時後,在室溫及暗室中使反 應混合物經矽藻土過濾,並以CH2C12清洗矽藻土。收集濾 液並以飽和NaHC〇3清洗,乾燥(MgS〇4)及在室溫下蒸發。 殘餘物置於高度真空下以産生黏稠黃色油3.29 gins。將該 物質在矽膠管柱(5%E tOH/CH 2C 12,接箸以ΙΟΟίϊΕ tOH清洗管 柱)上層析以提供産物9-0- U -L-3,4-二-0-乙醯基鼠李糖 基)史賓諾辛A 9-Psa(259,6 mg,以回收之史賓諾辛A 9-Psa為基準為15¾,為無色玻璃狀物)。IR (KBr, cm-1) 3480.99 (OH), 2938.92, 1747.73, 1661.89, 1457.41, 1373.49, 1232.67, 1164.19, 1125.61, 1042.66, 988.64, 902·80· FDMS (m/z,相對強度)774 (100)‘: (C42H63N〇12)之分析:估計值·· C: 65.18, Η: 8.20, 經濟部中央標準局員工消費合作社印策 ι_ϋ ml II ml n_·^ I m mu · ϋϋ —Hi ml ml ·11_1 TJ 、\'彡 (請先閲讀背面之注意事項再填寫本頁) Ν: 1.81;實際值·· C: 64.94, Η: 8·28, Ν: 1·97。 甯旆例Π9-3.4-二甚-6-去氬甚-1-¾萄烯搪Fenshi Example Π7-: Γ-Qiqinqinqinxin L was reacted as described in Example 116, with 3 ^ 0- (3-methylthiocarbonyl) spinoxin L (1.85 gms, 2.25 mmol) . 3'-Deoxyspinoxin L (1.16 gms, yield 7 «) is a colorless glass. FDMS, m / e (relative intensity) 716 (100). -247-This paper size applies to Chinese National Standard (CNS) A4 specification (210X 297 Public Holiday 1 I ------: ---- (Please read the precautions on the back before filling this page) Order 487559 A7 B7 V. Description of the Invention (245) Rich Example I18-9-Π- (ητ-L-3,4-Diethyl Twisted Rhamnoside) Zhongbin Mooxin A 9'Psa, Spinozin A 9 -Psa (1.56 gms, 2.9 mmol) and bromo-2, 3,4-tri-O-ethynyl rhamnoside 41.52 gms, 4.3 mmol) were dissolved in CH2C12 (75 ml; anhydrous). Tetramethylurea (1.0 ml, 8.4 mmol) was added, followed by silver trigas methanesulfonate (823.8 mg, 3.2 mmol), and the reaction flask was covered with aluminum foil. After stirring for 24 hours, the reaction mixture was filtered through celite at room temperature and in a dark room, and the celite was washed with CH2C12. The filtrate was collected and washed with saturated NaHC03, dried (MgS04) and evaporated at room temperature. The residue was placed under high vacuum to produce a viscous yellow oil 3.29 gins. This material was chromatographed on a silica gel column (5% E tOH / CH 2C 12, followed by washing the column with 10 ΟίϊΕ tOH) to provide the product 9-0- U -L-3,4-di-0-acetamidine Base rhamnosyl) Spinozin A 9-Psa (259,6 mg, 15¾ based on recovered Spinozin A 9-Psa, a colorless glass). IR (KBr, cm-1) 3480.99 (OH), 2938.92, 1747.73, 1661.89, 1457.41, 1373.49, 1232.67, 1164.19, 1125.61, 1042.66, 988.64, 902 · 80 · FDMS (m / z, relative strength) 774 (100) ': Analysis of (C42H63N〇12): Estimated value · C: 65.18, Η: 8.20, the policy of employee consumer cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs ι_ϋ ml II ml n_ · ^ I m mu · ϋϋ —Hi ml ml · 11_1 TJ, \ '彡 (Please read the notes on the back before filling this page) Ν: 1.81; actual value ·· C: 64.94, Η: 8 · 28, Ν: 1.97. Example of Ning 9-3.4-Di-6-6

將碘乙烷(32 mL, 0.40 mol), 3,4-二-0-乙醯基-6 -去氧基-L-葡萄烯糖(4.28 g, 0.20 mol), 50%Na0H水溶液 (43 mL, 0·81 mol)及 DMS0 (11.4-mL, 0.16 mol)依序添 加至配備有頂部M器之300-mL圓底之三頸燒瓶中:開始M -248 - 本紙張尺度適用中國國家標皁(CNS ) Λ4規格(210X297公釐) 經濟、那中央標準局員工消費合作社印製 487559 A7 ________ B7_ 五、發明説明( 246 ) 拌並以單一部分方式加入四丁基鞍氫硫酸鹽(2.04 g, 0.006 mol)。持續Μ拌66小時。混合物在水及Et2〇間平衡 。以Et2〇(20 mL)萃取水層2次並最後一^Wl:lEt2〇-CH2C12(20 mL)萃取。合併有機層,連續以水、稀釋〖之硫 代硫酸鈉水溶液、水及鹽水清洗,並以硫酸鈉及碳酸鉀乾 燥,及在減壓下濃縮。在蒸發期間沈澱白色固體。以戊烷 稀釋混合物並藉由過濾去除固體。在減壓下自濾液去除溶 劑以産生淺黃色油(3.2 g, 87%),其傺充分均質以用於後 續反應而無需額外純化。1H-NMR d 6.32 (dd, J = 6.1, 0.6, 1H), 4.78 (dd, J = 6.1 , 1.2 , 1H), 1.36 (d, J= 6·4 , 3H), 1,22 (t, J = 7.0, 6H)。 富旆例120 - 3,4-二-il-n-丙某-fi-去氬某-L-gi菊烯耱 將碘 n-丙烷(39 mL, 0.40 mol), 3,4-二-0-乙醯基-6 -去氣基-L-S 萄烯糖(4.28g, 0.20 mol), 50%Na0H 水溶液 (43 mL, 0.81 mol)及 DMS0(11.4 mL, 0·16 mol)i次序添加 至配備有頂部攪器之300-mL圓底之三頸燒瓶中。開始攪拌 並單一部分方式加入四丁基銨氫硫酸鹽(2.04 g, 0.006 mo 1)。在室溫下攪拌混合物17小時。混合物在水及戊烷間 平衡。以額外之戊烷萃取水層。合併有機層並以水連續以 水(3次),稀釋之硫代硫酸鈉,稀釋之磺酸氫鈉及鹽水清 洗。在減壓(先20托再0 · 1托)下去除溶劑以獲得淺黃色油( 4.0g, 94:¾),其可供使用而無需進一步純化。HMR d 6.31 (dd, J = 6.1, 1.4, 1H), 4.78 (dd, J = 6.1, 2.4, 1H), 1.60 (m, 4H), 1.37 (d, J = 6.4 , 3H), -249 - 本紙張尺度適用中國國家標準(CNS ) A4規格(2iox公釐) (請先閱讀背面之注意事項再填寫本頁)Add iodoethane (32 mL, 0.40 mol), 3,4-di-0-acetamido-6-deoxy-L-glucoside (4.28 g, 0.20 mol), 50% Na0H aqueous solution (43 mL , 0 · 81 mol) and DMS0 (11.4-mL, 0.16 mol) were sequentially added to a 300-mL round bottom three-necked flask equipped with a top M device: Start M-248-This paper is scaled to Chinese National Standard Soap (CNS) Λ4 specification (210X297 mm) economic, printed by the Central Standards Bureau ’s consumer cooperative 487559 A7 ________ B7_ V. Description of the invention (246) Mix and add tetrabutylanhydrosulfate (2.04 g, 0.006 mol). Continue mixing for 66 hours. The mixture was equilibrated between water and Et20. The aqueous layer was extracted twice with Et20 (20 mL) and the last one was extracted with Et20-CH2C12 (20 mL). The organic layers were combined, washed successively with water, a dilute aqueous solution of sodium thiosulfate, water and brine, dried over sodium sulfate and potassium carbonate, and concentrated under reduced pressure. A white solid precipitated during evaporation. The mixture was diluted with pentane and the solids were removed by filtration. The solvent was removed from the filtrate under reduced pressure to give a pale yellow oil (3.2 g, 87%), which was sufficiently homogeneous for subsequent reactions without additional purification. 1H-NMR d 6.32 (dd, J = 6.1, 0.6, 1H), 4.78 (dd, J = 6.1, 1.2, 1H), 1.36 (d, J = 6.4, 3H), 1,22 (t, J = 7.0, 6H). Enriched Example 120-3,4-Di-il-n-propan-fi-deargon-L-gi-permethenol Iodine n-propane (39 mL, 0.40 mol), 3,4-di-0 -Acetyl-6-Degassed-LS glucose (4.28g, 0.20 mol), 50% Na0H aqueous solution (43 mL, 0.81 mol) and DMS0 (11.4 mL, 0 · 16 mol) are added to the equipment in order A 300-mL round bottom three-necked flask with a top stirrer. Start stirring and add tetrabutylammonium hydrogen sulfate (2.04 g, 0.006 mo 1) in a single portion. The mixture was stirred at room temperature for 17 hours. The mixture was equilibrated between water and pentane. The aqueous layer was extracted with additional pentane. The organic layers were combined and washed successively with water (three times), diluted sodium thiosulfate, diluted sodium hydrogen sulfonate and brine. The solvent was removed under reduced pressure (20 Torr then 0 · 1 Torr) to obtain a pale yellow oil (4.0g, 94: ¾), which was used without further purification. HMR d 6.31 (dd, J = 6.1, 1.4, 1H), 4.78 (dd, J = 6.1, 2.4, 1H), 1.60 (m, 4H), 1.37 (d, J = 6.4, 3H), -249-this Paper size applies Chinese National Standard (CNS) A4 (2iox mm) (Please read the precautions on the back before filling this page)

五、發明説明( 247 ) , 經濟、那中央標準局員工消費合作社印製 0.93 (t, J = 6·3 , 3H), 0·94 (t, J=6.3 , 3H)。 窨旆例12卜3,4-二-0-i-丙基-fi-尖舊,甚- L-S萄烯糖 將碘 i -丙院(40 mL, 0.40 mol), 3,4 -二-〇 -乙醯基&quot;*6 -去氧基-L - ® 萄嫌糖(4 · 2 8 g,〇 . 2 0 m ο 1.) , 5 0 % N a 0 Η 水溶妝 (43 juL, 0·81 mol)及 DMS0 (11·4 mL, 0.16 mol)依予添 加至配備有頂部攪器之300-mL圓底之三頸燒瓶中。開始攪 拌並以一單一部分添加四丁基銨氫硫酸鹽(2.04 g, 0.006 mol)。在室溫下攪拌混合物67小時且在迴流溫度下攪拌24 小時。將混合物冷卻至室溫並於水及戊烷間平衡。再以戊 烷萃取水層。合併有機層並以水(4次)、稀釋之硫代硫酸 鈉、水及飽和磺酸氫鈉清洗。在減壓(先20托接箸為0 . 1托 下去除溶劑以産生淺黃色油(1.2 g, 28% ),其可供使用而 無需進一步純化。1H-NMR d 6.29 (dd, J= 6.1, 1.4, 1H ),4.70 (dd, j= 6.1, 2.4, 1H), 1.35 (d, J = 6.4, 3H), 1.21(d, J = 6.4 , 3H), 1.18 (d, J = 6.4, 6H), 1·17 (d, J = 6·4 , 3H)。 實施例Τ22·9_(2 -去氨某-3_0,4 - 0-二-n-丙基-鼠李I庚 甚卜中窨諶辛A 9-假搪茌BR某化会物及9-(2-去氣基- 3- 〇·4-〇-二- η-丙某-卜;3 -鼠李糖某)-中窨諶辛A 9-假耱轩Κ某化会物 使用與實施例129所述相同之步驟及反應物,其使用 量如下:史賓諾辛A 9-假糖苷配基化合物(544 mg, 1.00 mmol), CH2C12 配基化合物(4 mlj, 3,4-二-0-n-丙基-6-去氧基-L-葡萄烯搪(429 mg, 2.00 mmol)及樟腦磺酸( -250 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) I---.--^--螻II (請先閱讀背面之注意事項再填寫本頁) 、11 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明( 248 )V. Description of the invention (247), Economy, that printed by the Consumer Standards Cooperative of the Central Bureau of Standards 0.93 (t, J = 6.3, 3H), 0.94 (t, J = 6.3, 3H). Example 12: 3,4-di-0-i-propyl-fi-dioxane, even-LS glucose and iodine i-propion (40 mL, 0.40 mol), 3,4-di-〇 -Ethyl &quot; * 6 -Deoxy-L-® Glucose (4 · 28 g, 0.20 m ο 1.), 50% N a 0 Η Water soluble makeup (43 juL, 0 · 81 mol) and DMS0 (11 · 4 mL, 0.16 mol) were added to a 300-mL round bottom three-necked flask equipped with a top stirrer. Start stirring and add tetrabutylammonium hydrogen sulfate (2.04 g, 0.006 mol) in a single portion. The mixture was stirred at room temperature for 67 hours and at reflux temperature for 24 hours. The mixture was cooled to room temperature and equilibrated between water and pentane. The aqueous layer was extracted with pentane. The organic layers were combined and washed with water (4 times), diluted sodium thiosulfate, water, and saturated sodium bisulfate. The solvent was removed under reduced pressure (first 20 Torr to 0.1 Torr to give a pale yellow oil (1.2 g, 28%)) which was used without further purification. 1H-NMR d 6.29 (dd, J = 6.1 , 1.4, 1H), 4.70 (dd, j = 6.1, 2.4, 1H), 1.35 (d, J = 6.4, 3H), 1.21 (d, J = 6.4, 3H), 1.18 (d, J = 6.4, 6H ), 1 · 17 (d, J = 6.4, 3H). Example T22 · 9_ (2 -Deammine-3_0,4-0-di-n-propyl-rhamn I. Gengshibuzhongzhong谌 辛 A 9-False 茌 BR, a certain chemical compound, and 9- (2-degassing group-3- 〇 · 4-〇- 二-η- 丙 某-Bu; 3 -rhamnose) -Zhong Phenocin A 9-Pseudoxanthine K uses a chemical compound with the same procedures and reactants as described in Example 129, and the amount used is as follows: Spinoxin A 9-pseudoglycoside (544 mg, 1.00 mmol ), CH2C12 ligand compound (4 mlj, 3,4-di-0-n-propyl-6-deoxy-L-grapeline (429 mg, 2.00 mmol) and camphorsulfonic acid (-250-present Paper size applies Chinese National Standard (CNS) A4 specification (210X297mm) I ---.-- ^-蝼 II (Please read the notes on the back before filling this page), 11 487559 Central Bureau of Standards, Ministry of Economic Affairs Printed by employee consumer cooperatives A7 B7 , Described the invention (248)

279 mg, 1.20 mmol)。粗産物在矽膠(80 g)上層析,以 3% MeOH之CHC13溶液溶析及在逆,相管柱(Kroroasil’ C18, 氣化矽 ODS, 100A, 10 m,球形,25 cm X 20 mm),以 90%Me0H及10¾水(含有〇·Π v/v濃NH4〇H水溶液)以提供 皆為白色泡沫體之變旋異構物;α -變旋異構物(307 mg, 41%) 4-NMR d 4.85 (br d, J = 2·9, 1H), 0.94 (t, J =7.5, 3Η), (Κ92 (t, J = 7.5, 3Η)及 /3-變旋異構物( 80 mg, 1(U) LR d 4·42 (m, 2H), 0·93 (t, J 二 7.3, 3H), 0·92 (t, J = 7.3, 3H)。 窨旆例 123-9-( 去《基-3-0.4-0-二-i-丙某-1-a -鼠李 煻某)-中窨諶辛A 9 -假搪茌配某仆会物 使用與實施例129相同之步驟及反應物,其使用量如 下:史賓諾辛A 9-假糖苷配基化合物(543 mg, 1.00 mmol), CH2Cl2(4 mL), 3,4 -二- -丙基-6 -去氧基 -L· 葡萄烯糖(428 mg, 2.00 mmol)及樟腦磺酸(279 mg, 1.20 mmol)。粗産物在矽膠(100 g)上以Eto Ac層析及在逆相管 柱(Kromasil’ C18,氧化矽 0DS, 100A, 10 m,球形,25 cmX20 mm)上以 90% MeOH 及 10¾ 水(含有 0.1¾ v/v 濃 NH4〇H 水 溶液)以産生白色粉末(306 mg, 40¾)。UMR d 4· 84 ( br d, J =2.9, 1H), 1.40 - 1.13 (m, 25 Η;) 〇 窨旆例T2H -(0·(!-二乙基二硫礤醣甚)去氬甚二 -0 ~•乙酿甚-鼠李糖 將3,4 -二-0 -乙醯基-6 -去氧基- L- 葡萄烯糖(2.14 g, 10.0 mmo 1)溶於苯(20 mL) 在5分鐘内,添加〇 , 〇-二乙基 / - 251 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) I -—I- - - - . -I —-1- I I- - · - _ ..... (請先閱讀背面之注意事項#填寫本貫) 訂 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(249 ) 硫磷酸(1.96g, 10.5 mmol)之苯(10 mL)溶液並將所得之 混合物在室溫下擬拌18小時。再,加入二硫磷酸(〇.1〇 g, 0· 54 mmol)且再將混合物攪拌20小時。以稀釋之磺酸氫鈉 水溶液(2次),水及鹽水萃取混合物。將混合物Na2S〇4及 MgS〇4乾燥。在減壓下去除溶劑以産生黃色油(4.03 g, 101%)。 奮旆例T25-9- (2-去氫基- 3-0 · 4-0-二乙醅某α -鼠李搪 甚)-中窨誤辛 A 9-假糖甚仆t合物 將經4A分子篩之粉狀物(500 mg)及AgF(685 ms, 5.40 mmol)懸浮於乙腈(2 inL)中。添加單一部分之1-(0,0-二乙 基二硫磷醯基)-2-去氧基-3,4-二-0-乙醯基-鼠李糖(400 mg , 1.00 miiio 1)之乙睛溶液。將所得之暗綠棕色混合物在 室溫下攪拌6天。將混合物經過矽藻土過濾以去除黑色沈 澱,蒸發溶劑並將殘餘物溶於EtOAc-Et2〇之1:1混合物(20 fflL)中。將混合物連續以NaOH(2次)、水(2次)及鹽水清洗 。蒸發溶劑並使殘餘物在逆相管柱(KromasiT C18,氧化 矽 0DS,100A, 10 m,球形,25 cmX20 mm)上,利用 90% MeoH及水(含有0. 1% v/v濃NH4〇H水溶液)層析以産生非晶 形白色固體(36 mg, 9¾)。tH-NMR d 4·85 (br d, J 二 2·9, 1 Η), 2·08 (s, 3 Η), 2·01 (s, 3H)。 奮旆例 126-9- (2H-5-R-Z,醅氬某-5.6-二氯-β-S-甲基-__2jia -P济喃某)-中客柒辛A卜假搪茌BP基化合物 將史賓諾辛A 9-假糖苷配基化合物(272 mg, 0.500 mmol)及3,4-二-0-乙醯基-6-去氣基-L—®萄烯糖(214 mg, / - 252 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ----;—,—— (請先閲讀背面之注意事項再填寫本頁) 、^τ 經濟部中央標準局員工消費合作社印製 487559 A7 B7 _ 五、發明説明(250 ) 1 · 00 mmo 1)溶於CH2C 12 (3 mL)中ϋ添加通過分子篩之物 質(4 A,4 0 m g)及樟腦磺酸(12 8 /n g , 〇 · 5 5 0 m m ο 1)。於 18 小時後,再加入樟腦磺酸(20 mg, 0.086 mmol)。將混合 物攪拌3天。以CH2Cl2(l〇 mL)稀釋混合物並以水-飽和碳 酸氫鈉水溶液-1.0N NaOH之1:1:1混合物稀釋。以CH2C12 (2次)萃取水層及以水清洗合併之有機層,以無水硫酸鈉 乾燥並蒸發以獲得深色油。將殘餘物在逆相管柱( Kromasil’ C18,氧化矽 〇DS,100A, 10 m,球形,25 cmX 20 mm)上,利用 90%MeoH 及 10% 水(含有 〇·1% v/v 濃 NH4〇H 水 溶液)層析以産生白色泡沫體(44 mg, 11%)。HMR d 5.92 - 5·73 (m, 4H), 5.01 (br s, 1H), 2.09 (s, 3H)279 mg, 1.20 mmol). The crude product was chromatographed on silica gel (80 g), eluted with 3% MeOH in CHC13, and reversed phase (Kroroasil 'C18, siliconized silicon ODS, 100A, 10 m, spherical, 25 cm X 20 mm ), With 90% Me0H and 10¾ water (containing 0.2 · v / v concentrated NH4 0H aqueous solution) to provide alloisomers which are all white foams; α-alloisomers (307 mg, 41% ) 4-NMR d 4.85 (br d, J = 2.9, 1H), 0.94 (t, J = 7.5, 3Η), (K92 (t, J = 7.5, 3Η), and / 3- allomers (80 mg, 1 (U) LR d 4 · 42 (m, 2H), 0 · 93 (t, J 2 7.3, 3H), 0 · 92 (t, J = 7.3, 3H). Example 123- 9- (To "Mizyl-3-0.4-0-Di-i-Bingmou-1a-Rhamnine")-Zhongxinxin A 9-Puppet with a servant and use Example 129 The same steps and reactants were used as follows: Spinoxin A 9-pseudoglycoside (543 mg, 1.00 mmol), CH2Cl2 (4 mL), 3,4-di-propyl-6- Deoxy-L. Glucosulose (428 mg, 2.00 mmol) and camphorsulfonic acid (279 mg, 1.20 mmol). The crude product was chromatographed on silica gel (100 g) using Eto Ac chromatography and on a reverse-phase column (Kromasil '' C18, Silicon Oxide 0DS, 100A, 10 m, spherical, 25 cm X20 mm) with 90% MeOH and 10¾ water (containing 0.1¾ v / v concentrated NH4〇H in water) to produce a white powder (306 mg, 40¾). UMR d 4.84 (br d, J = 2.9, 1H) , 1.40-1.13 (m, 25 Η;) 〇 Example T2H-(0 · (!-Diethyldithiogalanose) deargonate-2 ~~ • Ethanol-rhamnose will be 3, 4-Di-0-Ethyl-6-deoxy-L-glucoside (2.14 g, 10.0 mmo 1) dissolved in benzene (20 mL) Within 5 minutes, 〇-〇- diethyl / -251-This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297mm) I -—I-----. -I —-1- I I--·-_ ..... (Please First read the notes on the back #Fill in this order) Order 487559 A7 B7 printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (249) A solution of thiophosphoric acid (1.96g, 10.5 mmol) in benzene (10 mL) and The resulting mixture was stirred at room temperature for 18 hours. Further, dithiophosphoric acid (0.10 g, 0.54 mmol) was added and the mixture was stirred for another 20 hours. The mixture was extracted with dilute aqueous sodium hydrogen sulfonate (twice), water and brine. The mixture Na2S04 and MgS04 was dried. The solvent was removed under reduced pressure to give a yellow oil (4.03 g, 101%). Example F25-9- (2-Dehydro- 3-0 · 4-0-Diethyl a certain α-rhamnolide) -Zhongxuan Mixin A 9-Pseudosugar The powder of 4A molecular sieve (500 mg) and AgF (685 ms, 5.40 mmol) were suspended in acetonitrile (2 inL). Add a single portion of 1- (0,0-diethyldithiophosphoranyl) -2-deoxy-3,4-di-0-ethenyl-rhamnose (400 mg, 1.00 miiio 1) Acetonitrile solution. The resulting dark green-brown mixture was stirred at room temperature for 6 days. The mixture was filtered through celite to remove black precipitate, the solvent was evaporated and the residue was dissolved in a 1: 1 mixture of EtOAc-Et20 (20 fflL). The mixture was washed successively with NaOH (2 times), water (2 times) and brine. The solvent was evaporated and the residue was placed on a reverse-phase column (KromasiT C18, silica 0DS, 100A, 10 m, spherical, 25 cm × 20 mm) using 90% MeoH and water (containing 0.1% v / v concentrated NH4. H solution) was chromatographed to give an amorphous white solid (36 mg, 9¾). tH-NMR d 4 · 85 (br d, J 2 2 · 9, 1 Η), 2 · 08 (s, 3 Η), 2 · 01 (s, 3H). Example 126-9- (2H-5-RZ, argon-5.6-dichloro-β-S-methyl -__ 2jia-P-Jinan) -Zhongkexin Abu pseudo-BP-based compound Spinoloxin A 9-pseudoglycoside compound (272 mg, 0.500 mmol) and 3,4-di-0-acetamido-6-deairyl-L-®glucone (214 mg, / -252-This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X 297mm) ----;-,-(Please read the precautions on the back before filling this page), ^ τ Central Standard of the Ministry of Economic Affairs Printed by the Bureau's Consumer Cooperatives 487559 A7 B7 _ V. Description of the invention (250) 1 · 00 mmo 1) Dissolved in CH2C 12 (3 mL), adding substances that passed through molecular sieves (4 A, 40 mg) and camphorsulfonic acid (12 8 / ng, 0.55 0 mm ο 1). After 18 hours, add camphorsulfonic acid (20 mg, 0.086 mmol). The mixture was stirred for 3 days. The mixture was diluted with CH2Cl2 (10 mL) and diluted with a 1: 1: 1 mixture of water-saturated aqueous sodium hydrogen carbonate solution-1.0N NaOH. The aqueous layer was extracted with CH2C12 (twice) and the combined organic layers were washed with water, dried over anhydrous sodium sulfate and evaporated to obtain a dark oil. The residue was placed on a reverse-phase column (Kromasil 'C18, silica ODS, 100A, 10 m, spherical, 25 cmX 20 mm) using 90% MeoH and 10% water (containing 0.1% v / v concentration NH4OH solution) was chromatographed to give a white foam (44 mg, 11%). HMR d 5.92-5.73 (m, 4H), 5.01 (br s, 1H), 2.09 (s, 3H)

O 奮施例T27-5』-二氣-9-(2-关氬某-3-0.4-0-二乙基-1-a -鼠李糖某中客諶李 A 9 -假糖茌BR某彳h会物 將9-(2-去氧基-3-0,4-0-二乙基-1-a-鼠李糖基)-史 賓諾辛A 9-假糖苷配基化合物(200 mg, 273 mmol)及環己 烷(0.40 inL, 3.95 mmol)溶於純乙醇(4 mL)。小心地添加 把/木炭(10%, 20 mg/ 19 mmol)及將所得混合物在迴流溫 度下加熱3小時。將混合物在室溫下再攪拌17小時。使混 合物經由矽藻土過濾及在氮氣流下蒸發。將殘餘物在逆相 管柱(Kromasil’ C18,氧化矽 0DS,100A, 10 m,球形, 25 cmX20 mm)上,利用 90%MeoH 及 10¾ 水(含有 0.1¾ v/v 濃 NH4〇H水溶液)層析以産生玻璃狀固體(45 mg, 22%)。4-NMR d 6.83 (br s, 1 H),在 5.9-5.7 問缺乏 2H-多重譜線 ^ - 253 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210 X297公釐) -----,--,----- (請先閲讀背面之注意事項再填寫本頁) 訂 487559 A7 B7____ 五、發明説明(251 ) , 0 富旆例 T28U-二氯关氬基- 3:ι0·4-0-二- η-丙基,1 -α -鼠李糖甚卜中客銮辛A 9 -假糖轩BR基化合 物 將環己烷(3·0 mL, 28.6 mmel)及耙/木炭(10%, 43 mg)添加至純乙醇(3 mL)。添加9-(2-去氧基-3-0,4-0-二 -η-丙基-Ι-a-鼠李糖基)-史賓諾辛A 9-假糖苷配基化合物 (188 mg, 0.248 mmol)之乙醇(2 niL)溶液及將混合物在迴 流溫度下加熱5小時。在1小時及4.5小時之際,於反應混 合物中分別再加入耙/木炭38 mg及67 mg。冷卻混合物, 經由矽藻土過濾及濃縮成濃稠油。將殘餘物溶於Et20及以 濃縮之碩酸氫鈉及鹽水清洗,以無水磺酸鉀乾燥並蒸發以 産生淺灰色泡沫體。將該物質在逆相管柱(Kromasil’ C18 ,氧化矽 0DS,100A, 10 m,球形,25 cmX20 mm)上,利用 92%MeoH及8%水(含有0. 1¾ v/v濃NH4〇H水溶液)層析以産生 非晶形粉末(80 mg, 42¾).1^)^ d 6.73 (br s, 1H), 在5.9-5.7間缺乏2H-多重譜線。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 窨旆例T29-9- (2_去g某-3-Π . 4-Π-二7.甚-1 - α -鼠李糖某 )-中客諶辛A 9 -假I唐茌配某(h合物 將史賓諾辛A 9-假糖苷配基化合物(136 mg, 0.250 mmol)溶於CH2C12(1 mL)。依序加入單一部分之3,4-二-0-乙基-6-去氧基-L-»萄烯糖(93 mg, 0.50 mmol)及樟腦磺 酸(70 mg, 0.30 roraol)。將反應混合物在室溫下攪拌1小 時。添加飽和碳酸氫鈉水溶液及以E t0 Ac ( 5 mL )稀釋混合 , -254 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(252 ) · 物·。混合物在飽和磺酸氫銷(10 mL)及l.ON MaOH (2 mL) 及EtOAcUO mL)之混合物間平衡,。以額外之EtOAc萃取水 層。將合併之有機層連續以飽和磺酸氫鈉及鹽水清洗並以 無水Na2S〇4乾燥。在減壓下去除溶劑及將殘餘物在逆相 管柱(Kroroasir C18,氧化矽 0DS,100A, 10 m,球形, 25 cmX20 mm)上,利用 90%MeoH 及 10¾ 水(含有 0.1% v/v 濃 N H4〇H水溶液)層析以産生非晶形白色固體(74 mg, 40¾)。 'H-NMR d 4.84 (br d, J = 2.9, 1H), 1.21 (t, J = 7·1, 3H), 1.20 (t, J = 7·2, 3H)。 J部分蕻由鼠李糖;&gt; 取代修飾假搪茌BF甚彳卜.合物A2 富旆例.11-9-0-『(1’5,2^1)-2-甲某-4-(】’.2夂等-乙 醱氬基-3 ’ _锊甚丁某)-5-锊某-K卩-二氬戊環-2 -甚1 Φ窨諶辛A Q-Psa#二氬戍璟:&gt; 位詈2及5的 混合物 於史賓諾辛 A 9-Psa (100.8 mg, 0.19 mmol)之二氯 甲烷溶液中,添加1-溴-2, 3,4-三-0_乙醯基-鼠李糖1 ( 67.9 mg, 0.19 mmol),接著添加三氣甲基磺酸銀(52.3 mg, 0.2 mmol)並接著加入二異丙基乙胺(35 mg, 0.2 mmo 1)。在室溫及暗室中攪拌混合物3 . 5小時。接箸以二氯 甲烷稀釋混合物及以水清洗。接著以鹽水清洗二氯甲烷部 分,以MgS〇4乾燥及在室溫及減壓下濃縮。藉由在氧化矽 上層析使産物與未反應之起始物質分離,以5%甲醇之二氛 甲烷溶液溶析。所得之9-0- [ (1 f S: 2 ’ S , 3 ’ S) -2-甲基-4-( 1,,2,-雙-乙醯氧基-3 ’ -羥基丁基卜5 -羥基-1, 3 -二氯戊環 ' -255 - 本紙張尺度適用中國國家標準(CNS ) Α4規格( 210X297公釐) ϋϋ· ϋϋ ϋϋ· ί m »ϋϋ I— ϋϋ —I- (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印袋 487559 A7 B7 五、發明説明( 253 ) -2-基]史賓諾辛A 9-Psa在二氧戊環之位置2及5的混合物 (75·2 mg;産率 49%), FDMS, m/,e (相對強度)816 (M、 70), 815 (100), 585 (10)。 實施例 J_._2 二2.-0 - [ (1 ’?;· 2 ’S.iVS)-?-田某-4 - Π ’,2,'V -三 涇^丁基卜5-涇基二気ft璟-2-甚1中客謀 圭i^9-Psa在二氣戊ig 位詈2及5的混合物 於 9-0-[(l’s, 2’S, 3’S)-2-甲基-4-(1’,2’-雙-乙醯氧 基-3 羥基丁基)-5-羥基-1 , 3-二氧戊環-2-基]史賓諾辛A 9-Psa在二氧戊環之位置2及5的混合物(104.2 mg, 0.12 mmol)之甲醇(4 ml)溶液,加入微量之氫化M (60¾之礦物 油分散液)並産生氣體。在室溫下攪拌反應混合物15分鐘 。接著以二氯甲烷稀釋混合物並以飽和氯化銨水溶液清洗 。以鹽水清洗二氯甲烷部分,以MgS〇4乾燥及在室溫及減 壓下濃縮。所得9-0-[(11,2’5,31)_2-甲基-4-(1’,2’, 3 三羥基丁基卜5-羥基-1,3-二氧戊環-2-基]史賓諾辛A 9-Psa在二氧戊環之位置2及5的混合物(44.2 mg;産率50¾ ),為米黃色固體,FDMS, m/e (相對強度)733 (95), 732 (M+, 100), 543 (10)。 窨旆例甲氬基乙氫甚甲基)中窨諾辛A fl-Psa 於史賓諾辛 A 9-Psa (474.3rag, 0.87 mmol)之二氯 甲烷(20 ml)溶液中,添加二異丙基乙胺(225 /i 1 , 1 · 3 mmol)及2-甲氧基乙氧基甲基氯化物(1〇〇 ul, 0·87 mmol) 。將反應混合物加熱至迴流溫度2'4小時並接箸在室溫下攪 拌2天。接箸以二氯甲烷稀釋混合物,及以飽和NaHCO 3水 ; -256 - 本紙張尺度適用中國國家標窣(CNS ) A4規格(210X 297公釐) I . .--II (請先閱讀背面之注意事項再填寫本貢) 、1Τ 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(254) · 溶液清洗。以K2C〇3乾燥二氯甲烷部分,及在室溫及減壓 下濃縮。藉由在氧化矽上之層析,使産物與未反應物質分離 ,以4%甲醇之二氯甲烷溶液,接箸以10¾甲醇之二氯甲烷 溶液溶析。所得之9-0- (2-甲氧基乙氧基甲基)史賓諾辛A 9-Psa(226.5 mg;産率56%,以回收之起始物質為基準), 為無色玻璃狀物,FDMS, ra/e (相對強度:)632 (M、40), 631 (100)。 窨施例J4-9_0-甲基史g柒幸A Q-Pu 於史賓諾牛 A 9-Psa (200.1 mg, 0.37 mmol)之 THF(2 m 1)溶液中,添加氫化鈉(50%之礦物油分散液;34.6 mg, 0.72 mmol),接著添加碘甲烷(90 ul, 1.4 mmol)。將反 應混合物在室溫攪拌3.5小時,同時進行緩慢的蒸發作用 。以乙醚稀釋混合物及以水清洗。接著以鹽水清洗乙醚部 分,以K2C〇3乾燥及在室溫及減壓下濃縮。藉由在氧化矽 上之層析使産物與未反應物質分離,以7%甲醇之二氯甲烷 溶液溶析。所得之9-0-甲基史賓諾辛A 9-Psa(75.6ing; 産率37%),為白色玻璃狀物,FDMS, m/e (相對強度) 558 (M+,60), 557 (100)- 窨旆例 J5-9-0- f (2R · 3S . 4S. 5R . 9R &gt; - 2-甲莘 SS 氬基 j -二甲某胺甚-7-甲某-1,6.8-三氧代L01二一 環千烷-7-甚1中窨柒辛A 9-Psa_- 於史賓諾辛 A 9-Psa(564.5 mg, 1·〇4 mmol)及 1-溴-2,4-二-0-乙醯基磺黴糖氫溴酸酯2(487.4 mg, 1·15 mmol )之無水二氯甲烷(30 ml)溶液中,加入四甲基脲(358 ml, ' -257 - 本紙張尺度適用中國國家標準·( CMS〉A4規格(2丨〇X297公釐) (請先閱讀背面之注意事項再填寫本頁)O Fenshi Example T27-5 "-Diqi-9- (2-guan argan-3-0.4-0-diethyl-1 -a-rhamnoside, a Chinese guest Li A 9-pseudosugar BR A certain compound will be 9- (2-deoxy-3-0,4-0-diethyl-1-a-rhamnosyl) -spinoxin A 9-pseudoglycoside compound ( 200 mg, 273 mmol) and cyclohexane (0.40 inL, 3.95 mmol) were dissolved in pure ethanol (4 mL). Carefully add charcoal / charcoal (10%, 20 mg / 19 mmol) and the resulting mixture at reflux temperature Heat for 3 hours. Stir the mixture for another 17 hours at room temperature. Filter the mixture through diatomaceous earth and evaporate under a stream of nitrogen. The residue is placed in a reverse-phase column (Kromasil 'C18, silica 0DS, 100A, 10 m, Sphere, 25 cm × 20 mm), chromatographed with 90% MeoH and 10¾ water (containing 0.1¾ v / v concentrated NH4OH solution) to give a glassy solid (45 mg, 22%). 4-NMR d 6.83 (br s, 1 H), the lack of 2H-multiple spectral lines in 5.9-5.7 asks ^-253-This paper size applies the Chinese National Standard (CNS) A4 specification (210 X297 mm) -----,-,- ---- (Please read the notes on the back before filling this page) Order 487559 A7 B7____ V. Description of the invention (251), 0 Example T28U-Dichloroguanyl-3: ι0 · 4-0-bis-η-propyl, 1-α-rhamnose, Kekexin A 9-pseudosugar BR-based compound will be cyclohexane (3 0 mL, 28.6 mmel) and rake / charcoal (10%, 43 mg) were added to pure ethanol (3 mL). 9- (2-deoxy-3-0,4-0-di-η-propyl was added -I-a-rhamnosyl) -Spinoxin A 9-pseudoglycoside compound (188 mg, 0.248 mmol) in ethanol (2 niL) and the mixture was heated at reflux temperature for 5 hours. At 1 At the hour and 4.5 hours, 38 mg and 67 mg of rake / charcoal were added to the reaction mixture. The mixture was cooled, filtered through diatomaceous earth and concentrated to a thick oil. The residue was dissolved in Et20 and concentrated concentrated acid. Wash with sodium bicarbonate and brine, dry with anhydrous potassium sulfonate and evaporate to produce a light gray foam. The material was placed on a reverse-phase column (Kromasil 'C18, silica 0DS, 100A, 10 m, spherical, 25 cmX20 mm) , Using 92% MeoH and 8% water (containing 0.1 2 v / v concentrated NH 4 0 H aqueous solution) chromatography to produce an amorphous powder (80 mg, 42¾). 1 ^) ^ d 6.73 (br s, 1H), The lack of 2H-multiline between 5.9-5.7. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) 窨 旆 例 T29-9- (2_ 去 g 某 -3-Π. 4-Π- 二 7. Even- 1-α -Rhamnosyl) -Chokepin A 9 -PseudoI Tang Zhi with a (h-complex dissolved Spinoxin A 9-pseudoglycoside compound (136 mg, 0.250 mmol) in CH2C12 (1 mL). A single portion of 3,4-di-0-ethyl-6-deoxy-L- »glucose (93 mg, 0.50 mmol) and camphorsulfonic acid (70 mg, 0.30) were added sequentially. roraol). Stir the reaction mixture at room temperature for 1 hour. Add a saturated aqueous sodium bicarbonate solution and dilute with E t0 Ac (5 mL), -254-This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 (Mm) 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (252) · Things · The mixture was sold in saturated hydrogen sulfonate (10 mL) and l. ON MaOH (2 mL) and EtOAcUO mL ) Between the mixture ,. The aqueous layer was extracted with additional EtOAc. The combined organic layers were successively washed with saturated sodium bisulfate and brine and dried over anhydrous Na 2 SO 4. Remove the solvent under reduced pressure and place the residue on a reverse-phase column (Kroroasir C18, silica 0DS, 100A, 10 m, spherical, 25 cmX20 mm) using 90% MeoH and 10¾ water (containing 0.1% v / v Concentrated aqueous N H 4 0 H) was chromatographed to give an amorphous white solid (74 mg, 40¾). 'H-NMR d 4.84 (br d, J = 2.9, 1H), 1.21 (t, J = 7.1, 3H), 1.20 (t, J = 7.2, 3H). Part J is modified by rhamnose; &gt; Substitute modification of pseudofluorene, BF, and compound A2. Example of enrichment. 11-9-0- "(1'5,2 ^ 1) -2- 甲某 -4 -(] '. 2 夂 Etc.-Ethyl argonyl-3' _ 锊 锊 丁丁) -5- 锊 --K 二 -Diargon ring-2-11 Φ 窨 谌 辛 A Q-Psa # 二Argon Krypton: &gt; A mixture of krypton 2 and 5 in a solution of Spinozin A 9-Psa (100.8 mg, 0.19 mmol) in dichloromethane, 1-bromo-2, 3,4-tri-0 was added _Ethyl-rhamnose 1 (67.9 mg, 0.19 mmol), followed by trigas silver methanesulfonate (52.3 mg, 0.2 mmol) and then diisopropylethylamine (35 mg, 0.2 mmo 1) . The mixture was stirred at room temperature and in a dark room for 3.5 hours. Then the mixture was diluted with dichloromethane and washed with water. The methylene chloride portion was then washed with brine, dried over MgS04 and concentrated at room temperature under reduced pressure. The product was separated from unreacted starting materials by chromatography on silica, and eluted with 5% methanol in dichloromethane. The obtained 9-0- [(1 f S: 2 'S, 3' S) -2-methyl-4- (1,2, -2, -bis-acetoxy-3'-hydroxybutylbenzene 5 -Hydroxy-1, 3 -dichloropentane '-255-This paper size applies to China National Standard (CNS) A4 (210X297 mm)) · ϋϋ ϋϋ · ί m »ϋϋ I— ϋϋ —I- (please Read the notes on the back and fill in this page) Order the printed bag 487559 A7 B7 of the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the Invention (253) 2-based] Spinoxin A 9-Psa Mixture of positions 2 and 5 (75 · 2 mg; yield 49%), FDMS, m /, e (relative strength) 816 (M, 70), 815 (100), 585 (10). Example J _._ 2 2. 2.-0-[(1 '?; · 2' S.iVS)-?-Tianmou-4-Π ', 2,' V -tris (^ butylbutyl 5-fluorenyldi) ft 璟- The 2- and 1-membered mixture of ^ 9-Psa in the digastric position 詈 2 and 5 is 9-0-[(l's, 2'S, 3'S) -2-methyl-4- (1 ', 2'-Bis-Ethoxy-3-hydroxybutyl) -5-hydroxy-1,3-dioxolane-2-yl] Spinoxin A 9-Psa at position 2 and 5 (104.2 mg, 0.12 mmol) in methanol (4 ml) A small amount of hydrogenated M (a mineral oil dispersion of 60¾) was added and gas was generated. The reaction mixture was stirred at room temperature for 15 minutes. The mixture was then diluted with dichloromethane and washed with a saturated aqueous ammonium chloride solution. The dichloromethane portion was washed with brine. , Dried over MgS04 and concentrated under reduced pressure at room temperature. The obtained 9-0-[(11,2'5,31) _2-methyl-4- (1 ', 2', 3 trihydroxybutyl [5-Hydroxy-1,3-dioxolane-2-yl] Spinoxin A 9-Psa A mixture of positions 2 and 5 of dioxolane (44.2 mg; yield 50¾), beige Solid, FDMS, m / e (relative strength) 733 (95), 732 (M +, 100), 543 (10). Example of arsenoxine A fl-Psa in history To a solution of Pinoxin A 9-Psa (474.3rag, 0.87 mmol) in dichloromethane (20 ml) was added diisopropylethylamine (225 / i 1, 1.3 mmol) and 2-methoxyethyl Oxymethyl chloride (100 ul, 0.87 mmol). The reaction mixture was heated to reflux temperature for 2'4 hours and then stirred at room temperature for 2 days. Then dilute the mixture with dichloromethane and saturated NaHCO 3 water; -256-This paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) I.. --II (Please read the back Note for re-filling this tribute), 1TT printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 V. Description of the invention (254) · Solution cleaning. The dichloromethane portion was dried with K2CO3 and concentrated under reduced pressure at room temperature. The product was separated from the unreacted material by chromatography on silica, and then eluted with 4% methanol in dichloromethane followed by 10¾ methanol in dichloromethane. The obtained 9-0- (2-methoxyethoxymethyl) spinoxin A 9-Psa (226.5 mg; yield 56%, based on the recovered starting material) was a colorless glass , FDMS, ra / e (relative intensity :) 632 (M, 40), 631 (100).例 Example J4-9_0-Methyl Shig Xing A A-Pu To a solution of Spinola A 9-Psa (200.1 mg, 0.37 mmol) in THF (2 m 1), add sodium hydride (50% of Mineral oil dispersion; 34.6 mg, 0.72 mmol), followed by methyl iodide (90 ul, 1.4 mmol). The reaction mixture was stirred at room temperature for 3.5 hours while performing a slow evaporation. The mixture was diluted with ether and washed with water. The ether portion was then washed with brine, dried over K2CO3 and concentrated at room temperature under reduced pressure. The product was separated from unreacted material by chromatography on silica and eluted with 7% methanol in dichloromethane. The obtained 9-0-methyl spinosin A 9-Psa (75.6ing; yield 37%) was a white glass, FDMS, m / e (relative strength) 558 (M +, 60), 557 ( 100)-窨 旆 例 J5-9-0- f (2R · 3S. 4S. 5R. 9R &gt;-2-formamidine SS argon j-dimethylamine and even -7-methyl-1, 6.8- Trioxo L01, dicyclocycloalkane-7-even1, mesooctane A 9-Psa_- Yuspinoxin A 9-Psa (564.5 mg, 1.04 mmol) and 1-bromo-2,4 -Di-0-acetamidosulfonyl hydrobromide 2 (487.4 mg, 1.15 mmol) in anhydrous dichloromethane (30 ml), and tetramethylurea (358 ml, '-257- This paper size applies to Chinese national standards · (CMS> A4 specification (2 丨 〇X297mm) (Please read the precautions on the back before filling in this page)

經濟部中央標準局員工消費合作社印裝 487559 A7 __· B7__ 五、發明説明(255 ) 3.0 mmol)及三氟甲基磺酸銀(298.4 mg, 1.18 mmol)。在 室溫及暗室中攪拌反應混合物20小時。接著將反應混合物 以二氯甲烷稀釋及以IN NaOH清洗。接著以鹽水清洗二氯 甲烷部分並以K2C〇3乾燥及在室溫及減壓下蒸發。藉由在 氧化矽上之層析使産物與未反應物質分離,以5%甲醇之二 氯甲烷溶液溶析。所得之9-0-[(21?,35,43,51?,91〇-2-甲基 -3-乙醯氧基-4-二甲基胺基-7-甲基-1,6,8-三氧代[4.3. 〇]二環壬烷-7-基]史賓諾辛A 9-Psa(101.9 mg;産率13¾ ,以回收之起始物質為基準),為異構物之混合物。FDMS , m/e(相對強度)828 (20:), 800 (M+-H,100), 759 (20), 543 (30)。Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 __ · B7__ V. Description of the invention (255) 3.0 mmol) and silver trifluoromethanesulfonate (298.4 mg, 1.18 mmol). The reaction mixture was stirred at room temperature and in a dark room for 20 hours. The reaction mixture was then diluted with dichloromethane and washed with IN NaOH. The dichloromethane portion was then washed with brine and dried over K2CO3 and evaporated at room temperature under reduced pressure. The product was separated from unreacted material by chromatography on silica and eluted with a 5% methanol in dichloromethane solution. The obtained 9-0-[(21?, 35,43,51?, 91〇-2-methyl-3-ethoxy-4-dimethylamino-7-methyl-1,6, 8-trioxo [4.3.〇] bicyclononane-7-yl] Spinoxin A 9-Psa (101.9 mg; yield 13¾, based on the recovered starting material), which is the Mixture. FDMS, m / e (relative strength) 828 (20 :), 800 (M + -H, 100), 759 (20), 543 (30).

富旆例J6-9-0-乙醯基中窨諶辛A 於史賓諾辛 A 9-Psa (167.3 mg, 0.31 mmol)之氯仿(5 ml)溶液中,加入二異丙基乙基胺(220 til, 1.26 mmol)並 接著加入乙_氯(220 ml, 3.1 mmol)。將反應混合物在室 溫下攪拌2小時。接著以乙醚稀釋混合物並以IN NaOH清冼 ,以K2C〇3乾燥及在室溫及減壓下蒸發。藉由在氧化矽上 之層析純化産物,以50%乙酸乙酯之己烷溶液溶析。所得 之9-0-乙醯基史賓諾辛A 9-Psa(110.6 mg ;産率61%), 為白色偏離玻璃物,FDMS, m/e (相對強度)586 (50), 585 (M、100)。 實施例J7-9-0-碳7:氬某乙醯某中客钨幸A q-Pu 依實施例J6所述進行反應,以史賓諾辛A 9-Psa(177 mg , 0 · 33 mino 1 )及乙基丙二醯基氯化物為起始物質‘:·所得 ' -258 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)Enriched Example J6-9-0-Ethylpyridinium A in a solution of Spinoxin A 9-Psa (167.3 mg, 0.31 mmol) in chloroform (5 ml) and diisopropylethylamine (220 til, 1.26 mmol) and then ethyl chloride (220 ml, 3.1 mmol). The reaction mixture was stirred at room temperature for 2 hours. The mixture was then diluted with ether and decanted with 1N NaOH, dried over K2CO3 and evaporated at room temperature under reduced pressure. The product was purified by chromatography on silica and eluted with 50% ethyl acetate in hexane. The obtained 9-0-acetylspinoxin A 9-Psa (110.6 mg; yield 61%) was a white off-glass object, FDMS, m / e (relative strength) 586 (50), 585 (M, 100). Example J7-9-0-carbon 7: argon, acetone, selenium, tungsten, etc. A q-Pu The reaction was carried out as described in Example J6, with Spinoxin A 9-Psa (177 mg, 0.333 mino 1) and Ethylmalonyl Chloride as starting materials ': · Earned' -258-This paper size applies to China National Standard (CNS) A4 (210X 297 mm) (Please read the precautions on the back before (Fill in this page)

經濟部中央標準局員工消費合作社印製 487559 A7 __B7_ 五、發明説明(256 ) 之9-0-碳乙氧基乙醯基史賓諾辛A 9-Psa(124.4 mg;産率 57%),為白色偏離玻璃狀物,FD,MS, m/e (相對強度)658 (MH+, 100)。 奮旆例J8-9-0. N-二田甚中賓諶辛A 9-Psa碘化物 於史賓諾辛 A 9-Psa (101.1 mg, 0·19 mmol)之 DMF (0.5 ml)溶液中,加入氧化銀(11)(81.9 mg, 0·35 mmol) 及碘甲烷(35 ul, 0.56 mmol)。在室溫下及暗室中攪拌反 應混合物7天。接著以乙醚稀釋混合物並過濾。使沈澱溶 於水並以新鮮乙醚清洗。將水層部分冷凍乾燥及以乙醚研 製殘餘物,並在氮氣流下乾燥。所得9-0, N-二甲基史賓諾 辛A 9-Psa碘化物(13.5 mg;産率10¾),為黃褐色固體, FDMS, m/e (相對強度:)761 (10), 573 (30), 572 (M' 100), 188 (25)。 窨旆例JQ-9-0-「(S-甲某)二硫羰某)中窨諶辛A 9-Psa 於史賓諾辛A 9-Psa (205.5 mg, 0.38 mmol)及眯唑 結晶之無水THF(2 ml)溶液,加入氫化鈉(50%之礦物油分 散液;33.8 mg, 0.7 mmol),接著加入二硫化碳(90 til, 1.5 mmol)及接著加入碘甲烷(90 ul, 1.4 mmol)。在室溫 下攪拌反應混合物並接著加入,冰醋酸(90 u 1)。接箸將反 應物倒入飽和NaHCO 3水溶液並以二氯甲烷萃取。以鹽水清 洗二氯甲烷部分,以MgSO 4乾燥及在室溫及減壓下蒸發。 所得9-0-US-甲基)二硫羰基)史賓諾辛A 9-Psa(230 mg; 産率95%),為黃色玻璃物,FDMS,m/e (相對強度)634 ( 60) , 633 (100) , 142 (50)。 , -259 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ^ (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 __B7_ V. Invention Note (256) of 9-0-Carbonethoxyacetamido Spinoxin A 9-Psa (124.4 mg; Yield 57%), as White deviates from glass, FD, MS, m / e (relative intensity) 658 (MH +, 100). Fenxiong J8-9-0. N-Nitaji Binbinxin A 9-Psa iodide in DMF (0.5 ml) solution of Spinoxin A 9-Psa (101.1 mg, 0.19 mmol) Add silver oxide (11) (81.9 mg, 0.35 mmol) and methyl iodide (35 ul, 0.56 mmol). The reaction mixture was stirred at room temperature in a dark room for 7 days. The mixture was then diluted with ether and filtered. The precipitate was dissolved in water and washed with fresh ether. The aqueous layer was partially lyophilized and the residue was triturated with ether and dried under a stream of nitrogen. The obtained 9-0, N-dimethylspinoxin A 9-Psa iodide (13.5 mg; yield 10¾) was a tan solid, FDMS, m / e (relative strength :) 761 (10), 573 (30), 572 (M '100), 188 (25). Example of JQ-9-0-"(S-methyl) dithiocarbonyl" in the crystals of acetoxine A 9-Psa in spinoxin A 9-Psa (205.5 mg, 0.38 mmol) and oxazole Anhydrous THF (2 ml) was added with sodium hydride (50% mineral oil dispersion; 33.8 mg, 0.7 mmol), followed by carbon disulfide (90 til, 1.5 mmol) and then methyl iodide (90 ul, 1.4 mmol). The reaction mixture was stirred at room temperature and then added, glacial acetic acid (90 u 1). The reaction was then poured into saturated aqueous NaHCO 3 solution and extracted with dichloromethane. The dichloromethane portion was washed with brine, dried over MgSO 4 and Evaporate at room temperature under reduced pressure. 9-0-US-methyl) dithiocarbonyl) Spinoxin A 9-Psa (230 mg; yield 95%) was obtained as a yellow glass, FDMS, m / e (relative strength) 634 (60), 633 (100), 142 (50)., -259-This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) ^ (Please read the precautions on the back first (Fill in this page again)

經濟部中央標準局員工消費合作社印製 487559 A7 _____ B7 五、發明説明(257 ) , 1施例 &lt;110-9-0-「(21^,35,45.51^训卜?-田某-:^锊某-^:1:2 里基胺基-7-甲基-1, 6.1二気代U· 3-01二tg 壬_烷-7-基1史審謠辛Α Ώ-Ρμ 依實施例J2所述進行反應,以9-0-[(2R,3S,4S,5R,9R )-2-甲基-3-乙醯氧基-4-二甲基胺基-7-甲基-1,6,8-三氧 代[4.3.0]二環壬烷-7-基]史賓諾辛A 9-Psa (40 mg, 0·05 mmol)為起始物質。所得之 9-0-[(2R,3S,4S,5R,9R)-2-甲基-3-羥基-4-二甲基胺基-7-甲基-1,6,8-三氧代[4.3 - 0]二環壬烷-7-基]史賓諾辛A 9-Psa(15.2 mg;産率40¾ ),FDMS, ni/e (相對強度)759 (M+, 100), 543 (35)。 富施例J1 1 -9-Πι-甲氬甚苄気甚ΊΦ窨柒辛A 9-假糖茌 配甚化合物 ’_;_ 如實施例J18所述之相同步驟,但是立刻添加吡咯烷 并毗啶以及在反應物中以Et2〇取代EtOAc。使用相同之層 析條件以産生非晶形白色固體(110 mg, 54%),M-NMR d 7.61 (dd, J 二 7·7 , 0·9 , 1 Η), 7·54 (4,J=2 1Η) 7·34 (t, J=7.8 1Η), 7.10 (dd, J=8.2, 2.0), 3·86 ( s, 3 Η) 〇 2Tatsuka, Κ.; Tanaka, A.; Fujimoto, K.; Kinoshita ,M.; Umezainwa, S. J. Am. Chein. Soc. 1977, 99 (17), 5826 〇 富施例J1 2-9-(1-對-甲氬甚苄g基_中賓諾辛A 9-假糖佳_ffi 甚化合物_二___ 依實施例J 18所述之步驟,但是立刻添加吡咯烷并11比 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) I---.--1---- (請£閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製_ 487559 A7 B7____ 五、發明説明(258 ) 啶以及在反應物中以Et2〇取代EtOAc。使用相同之層析條 件以産生非晶形白色固體(1〇〇 M,49%), iH-NMR d 7·98 (d, J = 8·9 , 2Η), 6·92 (d, J = 8·9 , 2Η), 3.87 (s ,3H” 審偷例,Π 3-9-表-9-(1-茉氬乙SI基-史賓諾辛A 9-假:擴苷配 某化会物 _-__ 將史賓諾辛A 9-假糖苷配碁化合物(544 mg, 1·〇〇 mmol)及三苯基膦(525 mg, 2.00 mmol)溶於苯(5 mL)並將 溶液冷卻至4°C。以使溫度維持低於5°C之速率逐滴加入二 乙基偶氮羧酸鹽(0.31 mL, 2· 00 mmol)且試劑之顔色在各 滴間消失。當雒持5 C -11°C時,將混合物再攪拌20分鐘, 且於無冷卻下攪拌60分鐘。以水驟冷反應物並以碳酸氫鈉 水溶液稀釋並於EtOAC及稀釋之磺酸氫鈉水溶液間分配。 以Et0Ac溶液萃取水層(2次)。連續以稀釋之磺酸氫鈉(2次 )及鹽水清洗合併之有機層。以無水硫酸鈉乾燥混合物並 蒸發以産生油狀固體。將該固體溶於Et 2 0並以稀釋之HC 1 萃取(3次)。合併呈乳狀之水層並以Et2〇萃取。以1.0N NaOH調整水層之pH至接近10。以鹽水(2次)清洗合併之 EtOAc部分並以無水硫酸鈉乾燥。蒸發溶劑並使殘餘物在 逆相管柱(KromasiT C18,氧化矽 0DS, 100A, 10m,球 形,25 cm X 20 nun)上層析,以90%Me0H及10¾水(含有 0.1% v/v濃NH4〇H水溶液)以産生白色非晶形固體(0.54 g ,79%) lH-NMR d 7.26 (t, J = ^.4, 2 H), 6.95 (t, J =8·4, 1H), 6·87 (d, J = 8·4, 2H), 5.35 (br q, J= : -261 - 本紙張尺度適用中國國家標準(CNS ) A4規格(2l〇&gt;&lt;297公釐) ~ ----·--^----- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(259 ) 6·〇, 1H), 4.58(s, 2H卜 實施例J14-9-0- (2 · 3,5-三-Π-甲某)-a -L-D妄喃核糖基中 1諾辛 A 9-Psa 及 9-0-(2,15-三-0-甲基-召4 二P夫喃核糖基中窨諾辛A 9-Pm 所獲得之産率84%的α :卢9_0- (2, 3, 5-三-0-甲基)-α -L-呋喃核糖基)史賓諾辛A 9-Psa之9 :1混合物俗得自史賓 Μ 半 A 9-psa(0.33 g, 0.63 mmol)、Dtl:旋鏺對甲苯鑛酸 鹽(0·2 g, 0·8 mmol)及 0-(2,3,5-二-〇-甲基-1/3-匕_映喃 核糖基)三氯乙醯亞胺鹽(1.6 g, 4.75 mmol)之反應,該 反應偽以實施例J1 8相同之步驟進行。α及;3異構物傺藉 由 HPLC 以 41·4 mm (i.d·) X 25 cm (1)之逆相 C18 管柱分 離。α -變旋異構物首先析出。α -變旋異構物:10 0 m g ; 無色泡沫體;UMR (丙酮-d6, 400 MHz) δ 7.06 (s, 1H, H-13), 5·10 (d, J = 4.1, 1H, H-l’),4·66 (in, 1H, H-21), 4.47 (dd, J = 10, 2, 1H, H-l”),4·32(ιη, 1H, H-9) ; MS m/z 719 (100)。/3 -變旋異搆物:Π mg;無色 泡沫體;1H-NMR (丙酮-d6, 400 MHZ) δ 7.05 (s,lH, Η -13), 4.99 (d, J =1.2, 1H, 4.66 (m, 1H, H- 21), 4.47 (dd, J =10, 2, 1H, H-l”), 4.32 (m, 1H, H-9); MS m/z 719 (100)。 富旆例J15-9-0-(2,3,k6-四-0-甲某卜a -卜甘霖p报喃糖 某中窨諾辛_A 9-Psa及Q-n-(2.3.4.R-四-0-甲 某-/3 -L-甘露瞰喃糖甚)中客諶幸A 9-Psa 〇及&gt;99-0-(2,3,4,6-四-0-甲基卜《-1-甘露峨喃搪 : -262 , 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ----.--Ί,---- (請先閱讀背面之注意事項再填寫本頁) -一α 經濟部中央標準局員工消費合作社印製 487559 A7 ___ B7 ___ 五、發明説明(260 ) · 基)史賓諾辛A 9-Psa之1.9:1變旋異構物混合物(0·4 g, 産率71Γ)係獲自於史賓諾辛A ,9-psa (0.4 g, 〇·74 mmol), nth 症鐵對甲苯磺酸鹽(0.25 g, 1.0 mmol)及 0-(2, 3,4,6-四-0-甲基-a -L-甘露哌喃糖基)三-氯乙醯亞胺鹽 (1.7 g, 4.49 mmol)之反應,該反應偽藉由與實施例J18 所述相同之步驟進行。變旋異構物傺以藉由逆相HPLC分離 ,利用2部分之C18結合的氧化矽(8邱I)管柱(41· 4 mm (i.d ·) x 25 cm (1)),以 10%H2〇(含有 0·1%ΝΗ40Η)之 MeOH 溶液 為溶析液。變旋異構物先析出。/3變旋異構物:18 mg •,無色泡沫體;1H-MMR (CDC13) δ6·74 (s, 1H, H-13), 4.63 (m, 1H, H-21), 4.42 (m, 2H, H-9, H- lft), 4.38 (s, 1H, H-l’); MS m/z 762 (100)。α 變旋異搆物·· 95 mg;無色泡沫體;UMR (CDC13)S6.75 (s, 1H, M-13) ,4.93(d, J=1.2, 1H, H-lf), 4.63 (m, 1H, H-21), 4·42 (d, J=7.5, 1H, H-l”), 4·34 (ra, 1H, H-9); MS m /z 762 (100)。 富施例J1 - (N_去甲甚-N- (2.2, 2-三氯乙氬基羰基)- γυ -D-胺糖基)中窨諶辛 A Q-Pm及9-0-(N-去 甲基-N-2.2,2-三氛乙氬基羰某)-D-胺擴某 )中窨諾辛A 9-PsaPrinted by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 _____ B7 V. Description of Invention (257), 1 Example &lt; 110-9-0- "(21 ^, 35,45.51 ^ Training Proposal?-田某-: ^ 锊-^: 1: 2 Rylamino-7-methyl-1, 6.1 dihydrazyl U · 3-01 ditg nonyl_7-7-yl 1 historical trial rumor Α Ώ-Ρμ according to implementation The reaction was performed as described in Example J2, with 9-0-[(2R, 3S, 4S, 5R, 9R) -2-methyl-3-ethoxy-4-dimethylamino-7-methyl- 1,6,8-trioxo [4.3.0] bicyclononane-7-yl] spinoxin A 9-Psa (40 mg, 0.05 mmol) was used as the starting material. The obtained 9-0 -[(2R, 3S, 4S, 5R, 9R) -2-methyl-3-hydroxy-4-dimethylamino-7-methyl-1,6,8-trioxo [4.3-0] Bicyclononane-7-yl] Spinoxin A 9-Psa (15.2 mg; yield 40¾), FDMS, ni / e (relative strength) 759 (M +, 100), 543 (35). Rich examples J1 1 -9-Πι-methyl argon benzyl hydrazine Ί 窨 柒 窨 柒 窨 柒 窨 柒 窨 柒 窨 柒 假 A 9-pseudoglycoside complex compound '_; _ same steps as described in Example J18, but immediately add pyrrolidine and pyridine and in The reaction was replaced by EtOAc with Et20. The same chromatographic conditions were used to give an amorphous white solid (110 mg, 54%), M-NMR d 7.61 (dd, J 7 · 7, 0 · 9, 1 Η), 7.54 (4, J = 2 1Η) 7.34 (t, J = 7.8 1Η), 7.10 (dd, J = 8.2, 2.0), 3.86 ( s, 3 Η) 〇 2 Tatsuka, KK .; Tanaka, A .; Fujimoto, K .; Kinoshita, M .; Umezainwa, SJ Am. Chein. Soc. 1977, 99 (17), 5826 〇 富 例 例 J1 2- 9- (1-p-Methyl argon benzyl gyl group_Zinobinoxine A 9-Pseudosaccharide_ffi compound_Di___ Follow the procedure described in Example J 18, but immediately add pyrrolidine and 11 ratio This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) I ---.-- 1 ---- (Please read the notes on the back and fill in this page) Staff of the Central Bureau of Standards of the Ministry of Economic Affairs Printed by the Consumer Cooperative _ 487559 A7 B7____ 5. Description of the Invention (258) Pyridine and Et2O instead of EtOAc in the reaction. The same chromatographic conditions were used to produce an amorphous white solid (100M, 49%), iH -NMR d 7 · 98 (d, J = 8.9, 2Η), 6.92 (d, J = 8.9, 2Η), 3.87 (s, 3H ”stealing case, Π 3-9-Table- 9- (1-Pyridoxine SI group-Spinoxin A 9-False: Expanding glycoside with a chemical compound _-__ Spinoxin A 9- pseudoglycoside with fluorene compound (544 mg, 1.0 〇mmol) and three Phenylphosphine (525 mg, 2.00 mmol) was dissolved in benzene (5 mL) and the solution was cooled to 4 ° C. Diethyl azocarboxylate (0.31 mL, 2.00 mmol) was added dropwise at a rate such that the temperature was maintained below 5 ° C and the color of the reagent disappeared between drops. While holding at 5 C to 11 ° C, the mixture was stirred for an additional 20 minutes and stirred for 60 minutes without cooling. The reaction was quenched with water and diluted with aqueous sodium bicarbonate solution and partitioned between EtOAC and the diluted aqueous sodium bisulfate solution. The aqueous layer was extracted with Et0Ac solution (twice). The combined organic layers were washed successively with diluted sodium bisulfate (2 times) and brine. The mixture was dried over anhydrous sodium sulfate and evaporated to give an oily solid. This solid was dissolved in Et 2 0 and extracted with diluted HC 1 (3 times). The milky aqueous layers were combined and extracted with Et20. The pH of the aqueous layer was adjusted to approximately 10 with 1.0 N NaOH. The combined EtOAc portions were washed with brine (2 times) and dried over anhydrous sodium sulfate. The solvent was evaporated and the residue was chromatographed on a reverse-phase column (KromasiT C18, silica 0DS, 100A, 10m, spherical, 25 cm X 20 nun) with 90% Me0H and 10¾ water (containing 0.1% v / v concentration NH4〇H aqueous solution) to give a white amorphous solid (0.54 g, 79%) lH-NMR d 7.26 (t, J = ^ .4, 2 H), 6.95 (t, J = 8.4, 1H), 6 · 87 (d, J = 8.4, 2H), 5.35 (br q, J =: -261-This paper size applies to China National Standard (CNS) A4 specifications (2l0 &gt; &lt; 297mm) ~- --- ·-^ ----- (Please read the notes on the back before filling out this page) Order printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 V. Invention Description (259) 6 · 〇, 1H), 4.58 (s, 2H) Example J14-9-0- (2,3,5-tri-II-A) -a -LD 1-Nucin A 9-Psa and 9- 0- (2,15-tri-0-methyl-zhao 4 dinopyranosine A 9-Pm in di-P-ribofuranosyl yield of 84% α: Lu 9_0- (2, 3, 5- Tri-O-methyl) -α-L-ribofuranosyl) Spinoxin A 9-Psa 9: 1 mixture is commonly obtained from Spinn M Semi-A 9-psa (0.33 g, 0.63 mmol), Dtl: Rotary p-toluene mineral salt (0.2 g, 0.8 mmol) and 0- (2,3,5 -Di-O-methyl-1 / 3-D-enantiribosyl) trichloroacetimide salt (1.6 g, 4.75 mmol), the reaction was performed in the same manner as in Example J18. Α And 3 isomers 傺 separated by HPLC on a reverse phase C18 column of 41.4 mm (id ·) X 25 cm (1). Α-Aromeric isomers first precipitated. Α-Aromeric isomers : 100 mg; colorless foam; UMR (acetone-d6, 400 MHz) δ 7.06 (s, 1H, H-13), 5 · 10 (d, J = 4.1, 1H, H-1 '), 4. · 66 (in, 1H, H-21), 4.47 (dd, J = 10, 2, 1H, Hl ”), 4.32 (ιη, 1H, H-9); MS m / z 719 (100) ./ 3-rotomers: Π mg; colorless foam; 1H-NMR (acetone-d6, 400 MHZ) δ 7.05 (s, 1H, Η -13), 4.99 (d, J = 1.2, 1H, 4.66 ( m, 1H, H-21), 4.47 (dd, J = 10, 2, 1H, Hl ”), 4.32 (m, 1H, H-9); MS m / z 719 (100). Enriched cases J15-9-0- (2,3, k6-tetra-0-a certain bua-bu Ganlin p reported ranose nosin_A 9-Psa and Qn- (2.3.4.R -Tetra-0-A-Mou- / 3-L-mannose and glucomannan)) Chinese passenger luck A 9-Psa 〇 &gt; 99-0- (2,3,4,6-tetra-0-methyl Bu "-1- Ganlu Anan: -262, this paper size applies to the Chinese National Standard (CNS) A4 specification (210X 297 mm) ----.-- Ί, ---- (Please read the back Please fill in this page for further information)-1 Printed by the Consumers Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A7 ___ B7 ___ V. Invention Description (260) · Basic) Spinozin A 9-Psa 1.9: 1 changes The structure mixture (0.4 g, yield 71Γ) was obtained from Spinoxin A, 9-psa (0.4 g, 0.74 mmol), nth iron p-toluenesulfonate (0.25 g, 1.0 mmol ) And 0- (2, 3,4,6-tetra-0-methyl-a-L-mannanuranosyl) tri-chloroacetimide salt (1.7 g, 4.49 mmol), the reaction Pseudo-preparation was performed by the same procedure as described in Example J18. The isomers were converted by reverse-phase HPLC using 2 parts of C18-bound silica (8Que I) column (41.4 mm ( id)) x 25 cm (1)), with 10% H2〇 (containing 0.1% ΝΗ40Η) in MeOH solution is the eluent. The metameric isomers are first precipitated./3 metameric isomers: 18 mg •, colorless foam; 1H, H-13), 4.63 (m, 1H, H-21), 4.42 (m, 2H, H-9, H- lft), 4.38 (s, 1H, H-l '); MS m / z 762 (100). Alpha isomers · 95 mg; colorless foam; UMR (CDC13) S6.75 (s, 1H, M-13), 4.93 (d, J = 1.2, 1H, H-lf) , 4.63 (m, 1H, H-21), 4.42 (d, J = 7.5, 1H, Hl ”), 4.34 (ra, 1H, H-9); MS m / z 762 (100). Rich Example J1-(N_Norso-N- (2.2, 2-trichloroethylargonylcarbonyl)-γυ -D-aminoglycosyl) octyl A Q-Pm and 9-0- (N -Demethyl-N-2.2,2-trifluoroethane (1) -D-Amine) (2) -Nanoxin A 9-Psa

將一部分三甲基矽烷基三氣甲烷磺酸酯(0.7 mL, 3.6 nunol)添加至冷(_40°C )、經適當攪拌之N-去甲基-N-(2,2, 2-三氯乙氧基)羰基-1-0 - (4-硝基彳氧基)胺糖(為約 6 a ·· 1 /3之變旋異構物混合物)(0 · 7 g , 1 . 49 mmo 1 )及4A ; -263 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公廣^ 一 I. ί ϋ^ϋ ϋϋ ϋϋ ϋϋ ι_ι— m ^—ϋ ι_1 (請先閱讀背面之注意事項再填寫本頁) 、11 經濟部中央標隼局員工消費合作社印製 487559 A7 • B7__ 五、發明説明(261 ) , 分子篩分物(珠粒,8-12篩目,2.0 g)之CH2C12(30 mL) 及Et20(30 mL)混合物之懸浮液中。將混合物加熱至-10°C 20分鐘,接箸同時維持反應物之溫度為-l〇°C,在20分鐘 内逐滴加入史賓諾辛A 9-Psa (0·5 g, 0·92 mmol)之 CH2C12 (30 mL)溶液。在10°C攪拌4小時後,將整個混合物 倒入經適當攪拌之飽和NaHC03 (240 mL)及冰(約100 g)的 混合物中。分離有機層並以CH2C12 (2 X 75 mL)萃取水層 。以飽和之NaHC〇3(75 roL)清洗合併之有機層,接箸以鹽 水(7 5 mL)清洗並乾燥(MgS〇4)。濃縮物餘留1.1 g殘餘物, 將該殘餘物以氧化矽(175 mL)進行閃蒸層析,利用3%MeOH 之CH2Cl2g溶析液,以獲得0.6 g (77¾)乾淨的糖基化9-0 -(N-去甲基-H-(2,2,2-三氯乙氧基羰基- a -D-胺搪基)史賓 諾辛A 9-Psa, α至/3之3:1變旋異構物的混合物,為無色 泡沫體。藉由逆相HPLC分離混合物,以C18結合之氧化矽 管柱[41·4 fflmU.d.) X 25 cro(l)),利用 5%Η2〇(含有 0.15 % ΝΗ 4OH)之MeOH之溶液為溶析液以獲得個別之純變旋異物 。/?-變旋異搆物首先析出。/3 -變旋異構物:140 mg ;無 色泡沫體;1H-NMR (CDC13) δ 6.77 (s, 1H, H-13),Add a portion of trimethylsilyl trigas methanesulfonate (0.7 mL, 3.6 nunol) to cold (_40 ° C), properly stirred N-desmethyl-N- (2,2, 2-trichloro Ethoxy) carbonyl-1-0-(4-nitroamidooxy) amine sugar (a mixture of allomeric isomers of about 6 a ·· 1/3) (0 · 7 g, 1. 49 mmo 1 ) And 4A; -263-This paper size applies to the Chinese National Standard (CNS) A4 specification (210X 297 Gong ^^ I. ί ϋ ^ ϋ ϋϋ ϋϋ ι_ι— m ^ —ϋ ι_1 (Please read the notes on the back first Fill out this page again), 11 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A7 • B7__ V. Description of the Invention (261), Molecular Sieves (Beads, 8-12 Mesh, 2.0 g) CH2C12 (30 mL) and Et20 (30 mL) mixture. Heat the mixture to -10 ° C for 20 minutes, then maintain the temperature of the reactant at -10 ° C, and add the dropwise Spinol over 20 minutes. A solution of octane 9-Psa (0.5 g, 0.92 mmol) in CH2C12 (30 mL). After stirring at 10 ° C for 4 hours, the entire mixture was poured into saturated agitated NaHC03 (240 mL) and ice. (About 100 g) in a mixture. The organic layer and the aqueous layer were extracted with CH2C12 (2 X 75 mL). The combined organic layers were washed with saturated NaHC03 (75 roL), then washed with brine (75 mL) and dried (MgS04). Concentrated 1.1 g of the residue remained, and the residue was subjected to flash chromatography with silica (175 mL), and the eluate with 3% MeOH in CH2Cl2g was used to obtain 0.6 g (77¾) of clean glycosylation 9-0 -(N-desmethyl-H- (2,2,2-trichloroethoxycarbonyl-a-D-aminobenzyl) Spinoxin A 9-Psa, α to / 3 3: 1 change The mixture of the isomers was a colorless foam. The mixture was separated by reverse-phase HPLC, and a C18-bound silica column [41 · 4 fflmU.d.) X 25 cro (l)) was used at 5% Η20. A solution of MeOH (containing 0.15% NH 4OH) was used as the eluent to obtain individual pure metamorphic foreign matter. /?-Anomer is first precipitated. / 3-arachimer: 140 mg; colorless foam; 1H-NMR (CDC13) δ 6.77 (s, 1H, H-13),

4.74 (m, 3H, H-21, CC13CH20), 4.40 (m, 3H, M-9, H-I’,H-I”),2.87 及 2.83 (s,總共 3H, 4’-N(CH3))。oc-變旋異構物:285 mg;無色泡沫K; HMR (CDCl3)S 6.75 (s, 1H, H-13), 4·75 (m, 4H, H-l’, H-21, CCl3CH2〇), 4.43 (d,lH, H-1”),·4·30 (m, 1H, H-9), 2·87及 2.85(s,總共 3H, 4’-N(CH3) ) :| : -264 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐Ί —------&gt;---- (請先閲讀背面之注意事項再填寫本頁) 訂 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(262 ) 實_施例J17H- (N-去甲某-D-臉糖甚)中y諶辛a Q-Psa i 藉由實施例J20所使用之步驟製備化合物。由100 mg of9 0 [H-去甲基- N- 2,2,2-二氯乙氧基鑛基-胺糖 基)史負諾牛A 9-Psa獲得37 mg之9 - 0-(M -去甲基- yS-D-胺糖基)史賓諾辛A 9-Psa,為白色泡沫體:ih-NMR ( CDC13)0' 6.78 (s, 1H, H-13), 4.66 (m, 1M, H-21), 4.42 (m, 2H, H-1’,H-1”),3.62 (m, 1H, H-9), 2.42 (s, 3H, NH(CH3)), 2·23 (s, 6H, N(CH3)2); MS m/z 671 (1ΓΗ, 10), 377 (100), 3S7 (95), 336 (24)。 實施例J18m-甲氢基苄氬某中窨柒芏A Q-假耱苷Bff甚 化合物__ 將史賓諾辛A 9-假糖苷配基化合物(163 mg, 0.300 mmol)溶於CH2C1 2 (0.6 inL)中。加入0-甲氧基苄氧基氯化 物(56 ul, 0.38 mmol)及三乙胺(53 ul, 0.38 mmol)。於 3小時後,加入4-吡咯烷并吡啶(3 mg, 0.02 mmol)並攪拌 15小時。反應物在EtOAc(5 mL)及0.5N NaOH水溶液(5 mL) 間分配。連續以0.5H NaOH水溶液及鹽水清洗有機層,以 無水M g S 0 4乾燥及在減壓下濃縮ϋ殘餘物在逆相管柱 (KromasiT C18,氧代矽 0DS, 100 Α, 10 m,球形,25 cm X 20 nun)上層析,利用 90%Me0H 及 10%H2〇(含有 0.14 v / v濃N Η 4 0 Η水溶妝)以産生非晶形白色固體(11 〇 m s,5 4 % ) ,'H-NMR d 7.76 (dd, J=8.0 Γ.8 , 1H), 7.47 (t, J =8·0 1 H), 3.90 (s, 3 H)。 : -265 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) I---:--.--·衣—丨 (請先閱讀背面之注意事項再填寫本頁) 、11 經濟部中央標準局員工消費合作社印製 487559 A7 _ B7 _^ 五、發明説明(263 ) , 奮施例J19-Q_n- (2.4-三-Π-甲某-I.•艰蘇_喃耱甚)史 客諾辛A 9-Pm _ 於適當漫拌之史賓諾辛A 9-Psa (0.4 g, 0.74 mmol )及吡啶鎌對甲苯磺酸鹽(0.25 g, 1.0 之含有粉狀4 A分子篩分物(0.8g)之乾CH2C12(50 mL)溶液中,在20分鐘 内逐滴加入0-(2,3,4-三-0-甲基-a-L-來蘇哌喃基)三-氯 乙醯亞胺鹽(2.3 g, 6.8 mmol)之CH2C12(10 mL)溶液。攪 拌反應混合物72小時,接箸經由矽藻土過濾,以CH 2 Cl2( 25 mL)清洗所收集之固體及合併濾液並以飽和Na2C〇3 (2x 20 ml)及鹽水(20 mL)清洗,及乾燥(MgSO 4)。濃縮後留下 2.8 g殘餘物,將該殘餘物以氧化矽(240 mL)進行閃蒸層 析,利用3¾ MeOH之(:112(:12溶液溶析,以産生0.45 g (85% )之乾淨偶合産物,為/3 : a 9-0-(2, 3,4-三-0-甲基-L-來 蘇哌喃糖基)史賓諾辛A 9-Psa之1. 5 :1變旋異構物的混合 物。混合物藉HPLC分離,以3個約150 rag之部分用於41.4 m m (i · d · ) X 2 5 c m (1)逆相 C18 管柱,利用 10 % Η 2 0 (含有 0.15¾ ΗΗ40Η)之MeOΗ溶液為溶析液。-變旋異構物首先 析出。&gt;9 -變旋異構物:102 mg;無色泡沫體;HMR (CDCla) d^.78 (s, 1H, H-13), 4.68 (m, 1H, H-21), 4.55 (d, J = 1.4, 1H, Η-Γ), 4.44 (d,J = 7.7, 1M, E-l,f ),4.38 (ία, 1H, H-9); MS m/s 435 (2), 175 (10), 142 (30), 71 (100)。a-變旋異構物·· 60mg;無色泡沫 體;1H-NMR (CDC13) d 6·79 (sr 1M, H-13), 4·84 (d, J =2.9, 1H, H-l,), 4.67 (m, 1H, M-21), 4.41 (d, J- , -266 -本紙浪尺度適用中國國家標準(CNS ) A4規格(210x297公釐) -—--1 - - I I 1 - —II I ί -- - :-- I (請先閲讀背面之注意事項再填寫本頁) 、11 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(264 ) -7.3, 1H, Η-Γ?), 4.31 (m, 1H, H-9); MS m/z 435 (2), 175 (10), 142 (50) , 71 (100) 〇 ; 實施例J20-9-0- (N-去甲基-a-D-胺糖某)中窨諾辛A 9-Pm 將活化之Zri粉末(0.4g)加入已適當攪拌之9-0-(N-去 甲基(2 , 2,2-三氛乙氧基羰基)-a-D-胺搪基)史賓諾辛A 9 - Psa 0·1 g, 0·12 mmol)之 THF(3 mL)溶液,加入 MeOH ( 0.5mL)及1M NH40Ac並將混合物在室溫下攪拌3天。藉由過 濾去除固體並以THF (5 mL)清洗。合併濾液及洗液並蒸發 至乾並以CH2C12 (30 inL)收集殘餘物。將此CH2C12溶液以 飽和Na2C〇3(5 mL)及鹽水清洗及乾燥(MgS〇4)。濃縮後留 下66 mg殘餘物,將該殘餘物以氧化矽(20 mL)層析,利用 MMeOH之CH2C12溶液,以獲得42邮之9-0-(N-去甲基-a-D -胺糖基)史賓諾辛A9-Psa,為白色泡沫體,UMR (CDC13)5 6.76 (s, 1H, M-13), 4.78 (d, J=1.9, 1H, H-l’:),4.66 (m, 1H, H-21), 4.41 (d, J = 8.1, 1M, H -1”), 4·28 (m, 1H, H-9); MS m/z 671 (M+H, 12), 544 (20) , 377 (44) , 357 (100) , 336 (40)。 K部分 Α8ΜΜ:&gt;三璟部分的假搪茌甚化合物I C9上 h ^修飾 蓠旆例K1-9-表史賓諾辛A 9-Psa 於 9-酮基史賓諾辛 A 9-Psa(207.9 mg, 0.38 mmol) 之無水甲醇(10 ml)溶液中,添加硼氫化鈉(23 mg, 0·61 ππηο 1)。將反應混合物在室溫下攪拌40分鐘,接箸以二氛 甲烷稀釋及以水清洗。以鹽水清洗二氯甲烷部分,以 本纸張尺度適用中國國家標準(CNS ) A4規格(.21〇 X 297公釐) mai «ιϋ_1 ml 111 mu ϋ—ϋ l^n ίϋ Λιβββ tt 1 (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 487559 A7 B7___ 五、發明説明(265 ) K2C〇3乾燥,及在室溫及減壓下乾燥。藉由製備型HPLC在 C18管柱上分離産物,以乙睛:甲p享:0.1¾ NfU0Ac(35··35 :30至40 :40: 20, 60分鐘内之線性梯度.)溶析。所得之9-表史賓諾辛 A 9-Pea (57 mg;産率 28%), FDMS, m/e ( 相對強度)1084 Λ15), 544 (Μ、45),543 (100)及史 賓諾辛 A 9-Psa (42 mg ;産率20¾)。 審旆例K2-(9S &gt;及(9R )甲某史賓諾辛A 9-Psa_ 於 9 -酮基史賓諾辛 A 9-Psa (336.8 mg, 0.62 mmol) 之無水THF (7 ml)溶液中,添加氯化甲基鎂(3.0 Μ; 250 ul, 0.75 ππηοΐ)。於格利雅試劑添加期間,將反應混合物 加熱至迴流溫度,接箸在室溫下攪拌1小時。再加入氯化 甲基鎂(500 ul, 1.5 mmol)並將混合物在室溫下再攪拌1 小時。以乙醚稀釋混合物並以水清洗。將乙醚部分經由矽 藻土過濾以去除鎂鹽,以鹽水清洗,以K2C〇3乾燥,及在 室溫及減壓下濃縮。藉由製備型HPLC在C18管柱上分離産 物,以乙睛:甲醇:0.1% NH40Ac(30:30:40至 45:45:10, 60 分鐘之線性梯度)溶析。所得之(9S)-9-甲基史賓諾辛A 9_ Psa(93 mg;産率 27%), FDMS, m/e (相對強度)558 (M+, 30), 557 (100)及(9R) - 9-甲基史賓諾辛 A9-Psa(55、g; 産率 16%), FDMS, m/e (相對強度)558 (M+, 40),557 (100)。 靈施例1(3-9-去氯基-$賓諸辛儿9-?53及9-去氛基-8.9-夫 氣史窨謀辛 A · 於9-0-[(S-甲基.)二硫羰基]史賓諾辛A 9-Psa (219.7 / - 268 -本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)4.74 (m, 3H, H-21, CC13CH20), 4.40 (m, 3H, M-9, H-I ', HI "), 2.87 and 2.83 (s, total 3H, 4'-N (CH3)). oc-rotomers: 285 mg; colorless foam K; HMR (CDCl3) S 6.75 (s, 1H, H-13), 4.75 (m, 4H, H-1 ', H-21, CCl3CH2. ), 4.43 (d, lH, H-1 ”), 4.30 (m, 1H, H-9), 2.87 and 2.85 (s, total 3H, 4'-N (CH3)): |: -264-This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mmΊ ------- &gt; ---- (Please read the precautions on the back before filling this page) Order 487559 Economy Printed by the Consumer Standards Cooperative of the Ministry of Standards of the People's Republic of China A7 B7 V. Description of the invention (262) Implementation _ Example J17H- (N-Deryl-D-Face Sugar) y 谌 xina Q-Psa i By way of example The compound was prepared using the procedure used in J20. 100 mg of 9 0 [H-desmethyl-N- 2,2,2-dichloroethoxymine-aminoglycosyl) Schinoparox A 9-Psa obtained 37 mg of 9-0- (M-desmethyl-yS-D-aminoglycosyl) Spinoxin A 9-Psa, as a white foam: ih-NMR (CDC13) 0 '6.78 (s, 1H, H -13), 4.66 (m, 1M, H-21), 4.42 (m, 2H, H-1 ', H-1 ”), 3.62 (m, 1H, H-9), 2.42 (s, 3H, NH (CH3)), 2.23 (s, 6H, N (CH3) 2); MS m / z 671 (1ΓΗ, 10), 377 (100), 3S7 (95), 336 (24). Example J18m -Methylbenzyl argon in a certain compound A Q-Pseudoglycoside Bff compound__ Spinoloxin A 9-pseudoglycoside compound (163 mg, 0.300 mmol) was dissolved in CH2C1 2 (0.6 inL) Medium. Add 0-methoxybenzyloxy chloride (56 ul, 0.38 mmol) and triethylamine (53 ul, 0.38 mmol). After 3 hours, add 4-pyrrolidinopyridine (3 mg, 0.02 mmol) ) And stirred for 15 hours. The reaction was partitioned between EtOAc (5 mL) and 0.5 N NaOH aqueous solution (5 mL). The organic layer was washed successively with 0.5 H NaOH aqueous solution and brine, dried over anhydrous M g S 0 4 and under reduced pressure. The concentrated radon residue was chromatographed on a reversed-phase column (KromasiT C18, oxo-DS 0DS, 100 A, 10 m, spherical, 25 cm X 20 nun) using 90% Me0H and 10% H2O (containing 0.14 v / v concentrated N Η 4 0 Η water soluble makeup) to produce an amorphous white solid (110 ms, 54%), 'H-NMR d 7.76 (dd, J = 8.0 Γ.8, 1H), 7.47 (t, J = 8. 0 1 H), 3.90 (s, 3 H). : -265-This paper size applies to Chinese National Standard (CNS) A4 specification (210X297mm) I ---: --.-- · yi — (Please read the precautions on the back before filling this page), 11 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 _ B7 _ ^ V. Description of the Invention (263), Fen Shi J19-Q_n- (2.4-Three-Π- 甲某 -I. • 难 苏 _ 兰 耱 很) Spinoxin A 9-Pm _ Spinoxin A 9-Psa (0.4 g, 0.74 mmol) and pyridinium p-toluenesulfonate (0.25 g, 1.0 containing powdered 4 A molecular sieves) To a solution of the fraction (0.8 g) in dry CH2C12 (50 mL), 0- (2,3,4-tri-0-methyl-aL-lysupranyl) tri-chloro was added dropwise over 20 minutes. A solution of acetamidine salt (2.3 g, 6.8 mmol) in CH2C12 (10 mL). The reaction mixture was stirred for 72 hours, then filtered through celite, the collected solids were washed with CH 2 Cl2 (25 mL), and the combined filtrates were combined. It was washed with saturated Na2CO3 (2x 20 ml) and brine (20 mL), and dried (MgSO 4). After concentration, 2.8 g of the residue was left, and the residue was flashed with silica (240 mL). Analysis, using 3¾ MeOH (: 112 (: 12 solution, To produce 0.45 g (85%) of a clean coupling product as / 3: a 9-0- (2, 3,4-tri-0-methyl-L-lysupranosyl) Spinoxin A 9-Psa 1.5: 1 mixture of allomeric isomers. The mixture was separated by HPLC and 3 parts of about 150 rag were used for 41.4 mm (i · d ·) X 2 5 cm (1) reverse phase C18 Column, using 10% Η 2 0 (containing 0.15¾ ΗΗ 40Η) of MeOΗ solution as the eluent.-Metamer isomers first precipitate. &Gt; 9-metamers: 102 mg; colorless foam; HMR (CDCla) d ^ .78 (s, 1H, H-13), 4.68 (m, 1H, H-21), 4.55 (d, J = 1.4, 1H, Η-Γ), 4.44 (d, J = 7.7 , 1M, El, f), 4.38 (ία, 1H, H-9); MS m / s 435 (2), 175 (10), 142 (30), 71 (100). A-aramer 60mg; colorless foam; 1H-NMR (CDC13) d 6.79 (sr 1M, H-13), 4.84 (d, J = 2.9, 1H, Hl,), 4.67 (m, 1H, M -21), 4.41 (d, J-, -266-The paper scale is applicable to China National Standard (CNS) A4 (210x297 mm)---1--II 1--II I ί--:- -I (Please read the notes on the back before filling out this page), 11 487559 Employee Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs System A7 B7 V. Description of the invention (264) -7.3, 1H, Η-Γ?), 4.31 (m, 1H, H-9); MS m / z 435 (2), 175 (10), 142 (50) 71 (100) 〇; Example J20-9-0- (N-desmethyl-aD-amine sugar) in the noroxin A 9-Pm activated Zri powder (0.4g) was added to the appropriate stirring 9-0- (N-desmethyl (2, 2,2-trifluoroethoxycarbonyl) -aD-aminobenzyl) Spinoxin A 9-Psa 0.1 g, 0.12 mmol) THF (3 mL) solution, MeOH (0.5 mL) and 1M NH40Ac were added and the mixture was stirred at room temperature for 3 days. The solid was removed by filtration and washed with THF (5 mL). The filtrate and washings were combined and evaporated to dryness and the residue was collected in CH2C12 (30 inL). This CH2C12 solution was washed with saturated Na2CO3 (5 mL) and brine and dried (MgS04). After concentrating, 66 mg of residue was left. The residue was chromatographed on silica (20 mL) using CH2C12 solution of MMeOH to obtain 9-0- (N-desmethyl-aD-aminoglycosyl) ) Spinozin A9-Psa, white foam, UMR (CDC13) 5 6.76 (s, 1H, M-13), 4.78 (d, J = 1.9, 1H, H-l ':), 4.66 (m , 1H, H-21), 4.41 (d, J = 8.1, 1M, H -1 ”), 4 · 28 (m, 1H, H-9); MS m / z 671 (M + H, 12), 544 (20), 377 (44), 357 (100), 336 (40). K-part A8MM: &gt; Tri-part pseudo-molecular compound I C9 h ^ modification Example K1-9-Table history Binoxin A 9-Psa To a solution of 9-ketospinoxin A 9-Psa (207.9 mg, 0.38 mmol) in anhydrous methanol (10 ml) was added sodium borohydride (23 mg, 0.61 ππηο 1) The reaction mixture was stirred at room temperature for 40 minutes, then diluted with dichloromethane and washed with water. The methylene chloride portion was washed with brine, and the Chinese National Standard (CNS) A4 specification (.21) was applied to this paper scale. X 297 mm) mai «ιϋ_1 ml 111 mu ϋ—ϋ l ^ n ίϋ Λιβββ tt 1 (Please read the precautions on the back before filling this page) Order Central Printed by the Standards Bureau Consumer Cooperative 487559 A7 B7___ V. Description of the invention (265) K2C03 is dried and dried at room temperature and under reduced pressure. The product is separated on a C18 column by preparative HPLC with acetonitrile: A pH: 0.1¾ NfU0Ac (35 ·· 35: 30 to 40:40: 20, linear gradient within 60 minutes.) Dissolution. The obtained 9-epi-spinoxin A 9-Pea (57 mg; yield 28%), FDMS, m / e (relative strength) 1084 Λ15), 544 (M, 45), 543 (100) and spinosyn A 9-Psa (42 mg; yield 20¾). Example K2 -(9S &gt; and (9R) a Spinozin A 9-Psa_ in a solution of 9-keto Spinosin A 9-Psa (336.8 mg, 0.62 mmol) in anhydrous THF (7 ml), add chlorine Methyl magnesium (3.0 M; 250 ul, 0.75 ππηοΐ). During the Grignard reagent addition, the reaction mixture was heated to reflux temperature, followed by stirring at room temperature for 1 hour. Methyl magnesium chloride (500 ul, 1.5 mmol) was added and the mixture was stirred at room temperature for another hour. The mixture was diluted with ether and washed with water. The ether portion was filtered through celite to remove magnesium salts, washed with brine, dried over K2CO3, and concentrated at room temperature under reduced pressure. The product was separated on a C18 column by preparative HPLC and eluted with acetonitrile: methanol: 0.1% NH40Ac (30:30:40 to 45:45:10, linear gradient for 60 minutes). The obtained (9S) -9-methylspinoxin A 9_ Psa (93 mg; yield 27%), FDMS, m / e (relative strength) 558 (M +, 30), 557 (100) and (9R )-9-methyl spinosinol A9-Psa (55, g; yield 16%), FDMS, m / e (relative strength) 558 (M +, 40), 557 (100). Example 1 (3-9-Dechloroyl-Benzoxin 9-? 53 and 9-Desmoyl-8.9-Fu Shi Shi Mou Xin A · in 9-0-[(S-methyl .) Dithiocarbonyl] Spinoxin A 9-Psa (219.7 /-268-This paper size is applicable to China National Standard (CNS) A4 specifications (210X 297 mm) (Please read the precautions on the back before filling out this page )

487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(266 ) m g ; 0.3 5 m m ο 1)之甲本(1 〇 m 1)浴妝中,添加氫化二丁錫( 2 5 0 m 1 , 1.0 m m ο 1)及微量A IB N。,將反應混合加熱至迴流 溫度20小時,未有明顯反應。再加入A IBN (微量)並持續加 熱28小時。接著將混合物在室溫下攪拌4天及在室溫及減 壓下去除溶劑。産物最初藉由氧化矽上之層析純化,以5 % 甲醇之二氯甲烷溶液溶析,接著藉由Π8管柱上之製備型 HPLC與未反應之起始物質分離,以乙睛:甲醇:0.14% NH4〇Ac(40:40:20至45:45:10, 90分鐘之線性梯度)。所得 9-去氧基-8,9-去氫史賓諾辛&amp;9-卩33(8 11^;産率《), FDMS, m/e (相對強度)526 (M+, 65), 525 (100)及 9-去 氧基-史賓諾辛 A 9-Psa(34 mg ; 18¾ yield), FDMS, m/e (相對強度)528 (MS 55), 527 (100),皆為白色固體。 奮旃例IU-Q-Π-甲某中賓諾辛Α Ακ 依實施例2所述進行反應,以9-0-甲基史賓諾辛A 9-Psa(188.8 mg, 0.34 mmol)為起始物質。所得之9-0-甲基 史賓諾辛A Ag(126.9 mg;産率90¾)為白色固體,FDMS, m/e (相對強度)417 (M + , 40), 416 (100)。 窨施例去氬甚- Q-N-d馬P林甚)Φ窨諾辛A 9-Pm 於 9 -酮基史賓諾辛 A 9-Psa (154.4 mg, 0·28 mmol) 之無水甲醇(7 ml)溶液中,添加嗎啉(244 ul, 2.8 mmol) 。在室溫下攪拌反應混合物45分鐘,接著加入氰硼氫化鈉 (84.5 mg, 1.3 mrool) 在室溫下持續攪拌7小時,及接著 以乙睡稀釋。以水清冼乙醚部分,·接箸以鹽水清洗,以 MgS〇4乾燥,及在室溫及減壓下濃縮。藉由在氧化矽上層 ' -269 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(.210 X 297公釐) (請先閲讀背面之注意事項再填寫本頁) ,ιτ A7 487559 B7 五、發明説明(267 ) (請先閱讀背面之注意事項再填寫本頁) 析使産物與未知之雜質分離,以51甲醇之二氯甲烷溶液溶 析。所得之9-去氧基-9HS啉_ )史賓諾辛A 9-Psa (48.5 mg;産率28%),為異構物之混合物,FDMS, m/e (相對強 度:)614 (30), 613 (M+, 50), 612 (100)。 審旃例Κβ-9-去氛甚中客謀辛A Ag 依實施例2所述進行反應,以9-去氧基史賓諾辛々9-P s a (3 3 5 m g , 0.6 3 m m ο 1)為起始物質。所得之9 -去氧基史 賓諾辛A Ag(129.5 mg;産率53%)為白色固體,FDMS, m/e (相對強度)(M+, 45) , 386 (100)。 奮施例K7-9-_甚中窨柒辛A 9-Psa 將 N-氯丁二醯亞胺(1.4 g, 10.5 mmol)懸浮於 CH2C12 (35 ml )中並在氮氣下冷卻至-70 °C。添加乙硫醚(825 ul , 11· 2 mmol)並於-70 1C下Μ拌30分鐘後,缓慢地加入史賓 諾辛 A 9_Psa(2.0 g, 3·7 mmol)之 CH2C12(13 ml)溶液。 於-70°C下攪拌2小時後,加入三乙胺(1.4 ml, 10 mmol) 並使反應物加熱至室溫。於在室溫下Μ拌20小時後,並在 〇°C下靜置24小時,以CH2C12稀釋溶液並以Η2〇清洗。接著 以鹽水清洗CH2C12部分,乾燥(MgS〇4),並在室溫及減壓 下濃縮。殘餘物在矽膠管柱(7%MeOH/CH2Cl2)上層析以提 供9 -酮基史賓諾辛A 9-Psa(1.83 g, 91%),為白色玻璃狀 物。FDMS, m/e (相對強度)541 (100) : 竄施例K8-K- αΖ^-9-Ο-茉氣醯甚-中窨柒辛A 假糖 登15基化合种f . -270 - ^張尺度適用中國國家標準(〇奶)八4規格(21〇&gt;&lt; 297公麓) 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(268 ) 將史賓諾辛A 9-假糖苷配基化合物(163 mg, 0.300 mmol)及 4-吡咯烷并吡啶(6 mg, ,0.04 mmol)溶於CH2C12( 1 mL)中。以單一部分方式加入苯氣乙醯氯(55 mL, 0.40 1)。在室溫下攪拌混合物18小時。以固態碳酸氫鈉驟 冷混合物並使其在EtOAc及碳酸氫鈉水溶液間分配。以水 及鹽水清洗有機層及以無水硫酸鎂乾燥。蒸發溶劑並在逆 相管柱上(Kromasir C18,氧化矽 ODS, 100A, 10m,球 形,25 cm X 20 mm)使殘餘物層析,以90% MeOH及水(含 肴0.1% v/v濃NH4〇H水溶液)以獲得白色固體(108 mg, 53%)。UMR d (t, J = 8·4, 2 Η), 6.95 (E, J = 8.4 ,1 Η), 6.87 (d, J = 8.4, 2 Η), 4.85, (br s, 0.5 Η ),4.61 (s, 2 Η), 4.42 (br d, J=7.8, 0·5 Η)。 奮施例Κ9_9-耒-中窨諾辛A 9-假搪轩BR甚化合物 將9-表-9-0-苯氧乙醯基-史賓諾辛A 9-假糖苷配基化 合物(0.44§,0.65 1«〇1)懸浮於1^(^(9 11^)及水(11^.) 之混合物中。將碳酸鉀加入(135 mg , 0.97 mmo 1)所得漿 液中。沿燒杯壁添加3毫升9 :1 MeOH-水。於4小時後,均 質溶液在EtOAc及1 :1水-飽和碩酸氫鈉水溶液間平衡。以 EtOAc萃取水相及連續以稀釋之碩酸氫鈉(2次)及鹽水清冼 合併之有機相。以無水硫酸鈉乾燥並在減壓下去除溶劑以 産生玻璃狀固體(366 mg, 104%) M-NMR d 4·50 (br q, J = 6 · 0 , 1 Η) 0 實施例KlO-fl-衷U2-0 . 3-0.4-Ch~三乙某-1 - a -鼠李糖基 )-中g諶辛 A 假搪茌BP甚ih合物及9-表-9- ' -271 -. 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ----ΊΙ1ΙΦ! (請先閱讀背面之注意事項再填寫本頁) 訂 五 經濟部中央標準局員工消費合作社印製 A7 B7 發明説明(269 ) β-η. X). 4-0-三π基- l-/?-鼠李耱基)-史賓 毕芏A Q…假搪茌甚化合物 將9-表-史賓諾辛A 9-假糖苷配基化合物(340 mg, 〇·625 mmol)溶於CH2C12(6 mL)。於此溶液中添加分子篩 分物(4A; 420 mg)及吡啶鐵甲苯磺酸鹽(210 mg, 0· 837 mmo 1)。將此混合物冷卻至0 °C並維持在該溫度下,同時在 10分鐘内,逐滴加入l-(a / /3 )-2-0,3-0,4-0 -三乙基-鼠 李糖基-三氯乙醯亞胺鹽(1.23 g, 3·13 mmol)之CH2C12(5 mL)溶液。將混合物在0°C下攪拌40分鐘及在室溫下攪拌 1δ小時。反應混合物在CH2C12及磺酸氫鈉水溶液間分配。 以稀釋之硕酸氫鈉水溶液、水(2次)及鹽水清洗有機層。 在減壓下去除溶劑並將殘餘物在矽膠(60 g)上,以3¾487559 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (266) mg; 0.3 5 mm ο 1) In the original (10m 1) bath makeup, dibutyltin hydride (2 5 0 m 1, 1.0 mm ο 1) and trace A IB N. The reaction was heated to reflux temperature for 20 hours without significant reaction. Add A IBN (trace) and continue heating for 28 hours. The mixture was then stirred at room temperature for 4 days and the solvent was removed at room temperature under reduced pressure. The product was initially purified by chromatography on silica, eluted with 5% methanol in dichloromethane, and then separated from unreacted starting material by preparative HPLC on a Π8 column with acetonitrile: methanol: 0.14% NH4〇Ac (40:40:20 to 45:45:10, linear gradient of 90 minutes). The obtained 9-deoxy-8,9-dehydrospinoxin &amp; 9- 卩 33 (8 11 ^; yield "), FDMS, m / e (relative intensity) 526 (M +, 65), 525 (100) and 9-deoxy-spinoxin A 9-Psa (34 mg; 18¾ yield), FDMS, m / e (relative strength) 528 (MS 55), 527 (100), all are white solids . Fenxiong IU-Q-Π-A, a certain Pinoxin A Ακ was reacted as described in Example 2, starting from 9-0-methyl Spinoxin A 9-Psa (188.8 mg, 0.34 mmol)始 物。 Starting material. The obtained 9-0-methyl spinosyn A Ag (126.9 mg; yield 90¾) was a white solid, FDMS, m / e (relative strength) 417 (M +, 40), 416 (100).例 Examples of deargonization-QNd, Ma Plinci) Φ 窨 Norsin A 9-Pm in 9-ketospinoxin A 9-Psa (154.4 mg, 0 · 28 mmol) solution in anhydrous methanol (7 ml) , Add morpholine (244 ul, 2.8 mmol). The reaction mixture was stirred at room temperature for 45 minutes, then sodium cyanoborohydride (84.5 mg, 1.3 mrool) was added, and stirring was continued at room temperature for 7 hours, followed by diluting with ethyl acetate. The ether portion was washed with water, washed with brine, dried over MgS04, and concentrated at room temperature under reduced pressure. With the upper layer of silicon oxide '-269-This paper size applies Chinese National Standard (CNS) A4 specification (.210 X 297 mm) (Please read the precautions on the back before filling this page), ιτ A7 487559 B7 V. Description of the invention (267) (Please read the precautions on the back before filling in this page) The product is separated from unknown impurities, and the product is eluted with 51 methanol in dichloromethane. The obtained 9-deoxy-9HS phthaloline _) Spinoxin A 9-Psa (48.5 mg; yield 28%), a mixture of isomers, FDMS, m / e (relative strength :) 614 (30 ), 613 (M +, 50), 612 (100). Examination Example κβ-9-Dehydroxanthylmoxixin A Ag The reaction was performed as described in Example 2 with 9-deoxyspinoxin 9-P sa (3 3 5 mg, 0.6 3 mm ο 1) Is the starting material. The obtained 9-deoxybinninoxin A Ag (129.5 mg; yield 53%) was a white solid, FDMS, m / e (relative strength) (M +, 45), 386 (100). Fen Example K7-9-_Vidinoxanthine A 9-Psa Suspend N-chlorobutanediimide (1.4 g, 10.5 mmol) in CH2C12 (35 ml) and cool to -70 ° under nitrogen C. After adding ethyl sulfide (825 ul, 11.2 mmol) and stirring at -70 1C for 30 minutes, slowly add Spinoxin A 9_Psa (2.0 g, 3.7 mmol) in CH2C12 (13 ml). . After stirring at -70 ° C for 2 hours, triethylamine (1.4 ml, 10 mmol) was added and the reaction was warmed to room temperature. After stirring at room temperature for 20 hours, it was left at 0 ° C for 24 hours. The solution was diluted with CH2C12 and washed with Η20. The CH2C12 portion was then washed with brine, dried (MgS04), and concentrated at room temperature under reduced pressure. The residue was chromatographed on a silica gel column (7% MeOH / CH2Cl2) to provide 9-ketospinoxin A 9-Psa (1.83 g, 91%) as a white glass. FDMS, m / e (relative strength) 541 (100): Channeling example K8-K- αZ ^ -9-〇-Moqi qi-Zhongxinxin A false sugar 15-base compound f. -270- ^ Zhang scale is applicable to Chinese National Standard (〇 奶) 8 4 specifications (21〇 &lt; 297 km) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (268) Will Spinozin A 9-Pseudoglycoside (163 mg, 0.300 mmol) and 4-pyrrolidinopyridine (6 mg, 0.04 mmol) were dissolved in CH2C12 (1 mL). Add benzylacetamidine (55 mL, 0.40 1) in a single portion. The mixture was stirred at room temperature for 18 hours. The mixture was quenched with solid sodium bicarbonate and partitioned between EtOAc and aqueous sodium bicarbonate. The organic layer was washed with water and brine and dried over anhydrous magnesium sulfate. The solvent was evaporated and the residue was chromatographed on a reverse-phase column (Kromasir C18, silica ODS, 100A, 10m, spherical, 25 cm X 20 mm), and 90% MeOH and water (containing 0.1% v / v concentrated solution) NH4OH solution) to obtain a white solid (108 mg, 53%). UMR d (t, J = 8.4, 2 Η), 6.95 (E, J = 8.4, 1 Η), 6.87 (d, J = 8.4, 2 Η), 4.85, (br s, 0.5 Η), 4.61 (s, 2 Η), 4.42 (br d, J = 7.8, 0 · 5 Η). Fen example Κ9_9- 耒-中 窨 诺辛 A A 9-False 搪 Hin BR BR compound will be 9- Table-9-0-phenoxyethenyl-spinoxin A 9-pseudoglycoside compound (0.44§ , 0.65 1 «〇1) suspended in a mixture of 1 ^ (^ (9 11 ^) and water (11 ^.). Potassium carbonate was added to the slurry obtained (135 mg, 0.97 mmo 1). 3 was added along the beaker wall Ml 9: 1 MeOH-water. After 4 hours, the homogeneous solution was equilibrated between EtOAc and 1: 1 water-saturated sodium bisulfate aqueous solution. The aqueous phase was extracted with EtOAc and successively dilute sodium bisulfate (2 times) The combined organic phases were washed with brine and dried. The organic phase was dried over anhydrous sodium sulfate and the solvent was removed under reduced pressure to give a glassy solid (366 mg, 104%). M-NMR d 4 · 50 (br q, J = 6 · 0, 1 Η) 0 Example KlO-fl-Zhong U2-0. 3-0.4-Ch ~ Triethyl-1-a -rhamnosyl) -Medium glyoxin A False BP and ih complex and 9 -Table-9- '-271-. This paper size applies to China National Standard (CNS) A4 (210X297mm) ---- ΊΙ1ΙΦ! (Please read the notes on the back before filling this page) Order 5 Ministry of Economy A7 B7 printed by the Consumer Standards of the Central Bureau of Standards (269) β-η. X). 4-0-III π-l-/?-rhamnolide) -Spimidine AQ ... Pseudo-Ethanol Compound 9-Epi-Spinoxin A 9-Pseudoglycoside (340 mg, 0.625 mmol) In CH2C12 (6 mL). To this solution was added molecular sieves (4A; 420 mg) and pyridinium iron tosylate (210 mg, 0.837 mmo 1). This mixture was cooled to 0 ° C and maintained at this temperature, while l- (a / / 3) -2-0,3-0,4-0 -triethyl-rat was added dropwise over 10 minutes. A solution of glycosyl-trichloroacetimide salt (1.23 g, 3.13 mmol) in CH2C12 (5 mL). The mixture was stirred at 0 ° C for 40 minutes and at room temperature for 1 δ hours. The reaction mixture was partitioned between CH2C12 and aqueous sodium hydrogen sulfonate. Wash the organic layer with dilute sodium bisulfate aqueous solution, water (twice) and brine. Remove the solvent under reduced pressure and place the residue on silica gel (60 g) with 3¾

MeOH之CHaCldS液層析。收集含有産物之溶析份並在減壓 下去除溶劑。將殘餘物在逆相管柱(Kromasir C18,氧化 矽 0DS, 100A, 10m,球形,25 cm X 20 mm)上層析,以 92¾ MeOH及8¾水(含有0.1¾ v/v濃NH4〇H水溶液:)溶析以分 別獲得非晶形白色固體之二種變旋異構物,α - (142 mg, 29¾) LR d 4·75 (d, J = 1.4, 1 Η), 1·32 - 1·15 (m, 22 H); /3- (70 mg, 14%) ^-NMR d 4.31 (br s, 1 H) , 1.35 - 1·13 (m, 22 H) ·:' ϊ,部分 蕻由形成中窨錤李二聚物准行修飾 . 富渝例1」-雙Π中客謀甚卜田烷f田萜孽(中賓 諾-辛 J - 3 , 1编膝 、 依照化合物3 ’ -0 , N -雙(三氘甲基)史賓諾辛Μ所述步驟 , -272 - 本紙張尺度適用中國國家標準(CNS ) Α4規格( noX 297公釐) (請先閱讀背面之注意事項再填寫本頁)CHaCldS liquid chromatography with MeOH. The eluate containing the product was collected and the solvent was removed under reduced pressure. The residue was chromatographed on a reverse-phase column (Kromasir C18, silica ODS, 100A, 10m, spherical, 25 cm X 20 mm) with 92¾ MeOH and 8¾ water (containing 0.1¾ v / v concentrated NH4〇H aqueous solution). :) Dissolved to obtain two isomers of amorphous white solid, α-(142 mg, 29¾) LR d 4.75 (d, J = 1.4, 1 Η), 1.32-1 · 15 (m, 22 H); / 3- (70 mg, 14%) ^ -NMR d 4.31 (br s, 1 H), 1.35-1.13 (m, 22 H) ·: 'ϊ, part of 蕻The quaternary plum dimer was formed to be quasi-modified. Fuyu Example 1 "-Double Π Zhongkemou Shibantetan f Tianterin (Zhongbinnuo-Xin J-3, 1 Knee, according to compound 3 '-0, N-Bis (tris-deuterated methyl) spinosinoxin M, -272-This paper size applies Chinese National Standard (CNS) A4 specification (noX 297 mm) (Please read the precautions on the back before filling in this page)

487559 A7 B7 ____ 五、發明説明(27〇) . ,利用磺酸鉀(3·0 g),四丁基銨氫硫酸鹽(1.80 g),15% MaOH 水溶液(50 mL)及 CH2Br&gt;2 (4,5 roL&gt; 使史賓諾辛 J(〇·93 g, 1.29 mmol)與CH2B「2反應。於逐漸反應完成後,藉由 矽膠上之層析純化粗産物並接著藉由HPLC (88:12,MeOH/ H2〇)分離,以提供甲醛雙(史賓諾辛縮醛(47 mg, 54),為白色固體:ESI MS m/z 1448 (M + 1)。 啻旆例L2_「SI R/S-雙ΠΦ窨謀辛J-3 ’ 基1硫醚— 將史賓諾辛J (2.70 g, 3·76 mmol)溶於乾吡啶(1〇 mL)中。加入乾二氯甲烷(4 mL)。在氮氣下攪拌混合物並 冷卻- 78°C。緩緩加入亞硫醯氯(〇 . 90 raL, 12· 3 mmo 1) ° 將混合物加熱至室溫並攪拌20小時。一般逐漸反應完成並 在矽膠上層析(乙酸乙酯,接著為10%Et0H之EtOAc溶液)以 提供[S]R/S-雙[(史賓諾辛J-3f-0-)基]硫醚(1180 mg, 42¾),為白色固體:ESI MS m/Z 1482 (Μ + 1)。 富_例五亞甲某橋榕中窨謠辛Β二聚物孖4”-Ν, 4二 -Ν-(pent-l · k二某)中審柒辛Β淳_ 經濟部中央標準局員工消費合作社印製 - I ...... ——I— I— I 1&quot;ί:· In nn I (請先閱讀背面之注意事項再填寫本頁) 依據實施例C24之方法,由1,5-二溴戊烷(38 mL, 64 mg, 0·28 mmol), (i-pr)2NEt(0.30 mL, 0.22 g, 1·7 mmol),史賓諾辛 B (0.40 g, 0·56 mmol),及 DMF (1·5 mL)製備化合物。MPLC (0:100 至 20:80 Me0H/CH2Cl2)可 得0.07 g (17¾)之4”-N-五亞甲基橋接史賓諾辛B二聚物, 為白色粉末(亦可回收史賓諾辛B, 0.16 g (40%))·· MS (πΤΗ+ &amp; m*2H + /2)預期值·· 1504.D &amp; 752.5。實際值·· :1504.1 &amp; 753.1 及 4”-N, 4”-N-(Pei)t-l,5-二基)史 Λ - 273 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(2!0Χ297公慶) _ 487559 經濟部中央標準局員工消費合作社印裝 A7 B7 五、發明説明(271 ) 賓諾辛B溴鹽,〇·17 g (35%): MS U-Br-)預期值: 786.5.實際值:786.7。 ’ Μ部分 化學式;I ^大璟部分上位詈2 ^修飾487559 A7 B7 ____ V. Description of the invention (27〇). Using potassium sulfonate (3.0 g), tetrabutylammonium hydrogen sulfate (1.80 g), 15% MaOH aqueous solution (50 mL) and CH2Br &gt; 2 ( 4,5 roL> Spinolsin J (0.93 g, 1.29 mmol) was reacted with CH 2 B 2. After the gradual reaction was completed, the crude product was purified by chromatography on silica gel and then by HPLC (88: 12, MeOH / H20) was isolated to provide formaldehyde bis (spinoxin acetal (47 mg, 54) as a white solid: ESI MS m / z 1448 (M + 1). Example L2_ "SI R / S-Bi-Phi 窨 Mouxin J-3 'yl 1 sulfide — Spinozin J (2.70 g, 3.76 mmol) was dissolved in dry pyridine (10 mL). Dry dichloromethane (4 mL). Stir the mixture under nitrogen and cool-78 ° C. Slowly add thionyl chloride (0.90 raL, 12.3 mmo 1) ° Warm the mixture to room temperature and stir for 20 hours. Generally the reaction is gradually completed And chromatographed on silica gel (ethyl acetate, followed by 10% Et0H in EtOAc) to provide [S] R / S-bis [(Spinoxin J-3f-0-) yl] sulfide (1180 mg , 42¾), as a white solid: ESI MS m / Z 1482 (Μ + 1).窨 rumin B dimer 孖 4 ″ -Ν, 4 di-N- (pent-l · k Ermou) Intermediate review 柒 Bin Chun _ Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs-I .... .. ——I— I— I 1 &quot; ί: · In nn I (Please read the precautions on the back before filling this page) According to the method of Example C24, 1,5-dibromopentane (38 mL, 64 mg, 0.28 mmol), (i-pr) 2NEt (0.30 mL, 0.22 g, 1.7 mmol), spinosyn B (0.40 g, 0.56 mmol), and DMF (1.5 mL ) To prepare the compound. MPLC (0: 100 to 20:80 Me0H / CH2Cl2) can obtain 0.07 g (17¾) of 4 ”-N-pentamethylene bridged spinoxin B dimer as a white powder (also Recovery of Spinozin B, 0.16 g (40%)). MS (πΤΗ + &amp; m * 2H + / 2) Expected value 1504.D &amp; 752.5. Actual value: 1504.1 &amp; 753.1 and 4 ”-N, 4” -N- (Pei) tl, 5-Secondary) History Λ-273-This paper size applies to China National Standard (CNS) Α4 specification (2! 0 × 297 public celebration) _ 487559 Central Standard of the Ministry of Economic Affairs A7 B7 printed by the Bureau's Consumer Cooperatives V. Description of the Invention (271) Binoxin B bromide, 1.7 g (35%): MS U-Br-) Expected value: 786.5. Actual value: 786.7. ′ M 部 Chemical formula; I ^ 大 璟 部 上 詈 2 ^ Modification

窨旆例Μ1 乙基中窨諶辛 A . 按照如實施例M23所述之史賓諾辛A的2-甲基類 似物之製程,以碘化乙烷(1·〇 g, 6.4 mmol)取代碘甲烷 。因此,1克的史賓諾辛A以製備型的逆相層析可産生〇 . 3 5克純的同質異構地之2-乙基史賓諾辛A〇C43He3N〇10 的分析估算值為:C, 67·96; Μ, 9.15; Ν, 1·84·實際值 為C, 67·65; Η, 9,01; Ν, 1·96。Example M1 Ethyloctyl A in ethyl. According to the process of 2-methyl analog of Spinoxin A as described in Example M23, replace with ethane iodide (1.0 g, 6.4 mmol) Methyl iodide. Therefore, 1 gram of Spinoloxin A in preparative reverse phase chromatography can produce 0.35 grams of pure isomeric 2-ethyl Spinoloxin A〇C43He3N〇10. The analytical evaluation value is: C, 67 · 96; M, 9.15; Ν, 1.84. Actual value is C, 67 · 65; Η, 9,01; Ν, 1.96.

審旆例Μ2-2-Ζ氬羰某中蒈錤辛A 按照如實施例M23所述之史賓諾辛A的2-甲基類 似物之製程,以氰基甲酸酯(0.69 g, 6.98 mmol)取代為親 電子試劑。以製備型的逆相層析(C-18,以85-98%的甲醇 :0.1¾的NH40H/水之悌度沖洗)可産生0.14克的2-乙氧 羰基史賓諾辛A〇C44H^N〇2的分析估計值為:C, 65.72 ;M, 8.65; N,1.74.實際值為·· C, 65·77;Η, 8·38; N, 1·79 〇Examination Example M2-2-Z-Hydroxycarbamidine A. According to the process of 2-methyl analogue of Spinoxin A as described in Example M23, cyanoformate (0.69 g, 6.98 mmol) was substituted for electrophile. Preparative reversed-phase chromatography (C-18, flushing with 85-98% methanol: 0.1¾ of NH40H / water) to produce 0.14 g of 2-ethoxycarbonyl Spinoxin AOC44H ^ Analyzed and estimated values for No. 2 are: C, 65.72; M, 8.65; N, 1.74. Actual values are ···, 65 · 77; Η, 8.38; N, 1.79.

審朐例H2-甲某硫Φ客柒某A 按照如實施例M23所述之史賓諾辛A的2-甲基類似 物之製程,以二甲基硫化物(0.66 g, 6.98 mmol)取代為親 電子試劑。以製備型的逆相層析(018,以85-98¾的甲醇 :0,1%的HH40H/水之梯度沖洗Γ可産生0.20克的2-甲基 硫史賓諾辛 A。1 H-NMR (300 MHz, CDC U ) d 2.2 (s, -274 - 本紙張尺度適用中國國家標準(CNS ) Λ4規格(ZlOX 297公釐) —ml ·ϋϋ ϋϋ I ϋϋ - - Μ^ϋϋ n·^ n (請先閱讀背面之注意事項再填寫本頁) 、11 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(印) 3H,順式CH3),C44H63N〇2的分析估計值為:C, 65.72; Μ,8.65; N, 1.74。實際值為:C, 65.77 ;H, 8.38; N, 1.79 cC42HG7N0it)S 的分析估計值為·· C, 64.83; Η, 8.68; Ν, 1.80; S, 4.1。實際值為:C, 65.18; Η, 10.43; Μ, 1.76; S, 3.66 〇 審偷例M4-2-溴代史審諾辛J\ 按照如實施例M23所述之史賓諾辛A的2-甲基類似物 之製程,在-70°C下以1,2-二溴四氣乙烷(0.9 g, 3.47 mmol)取代為親電子試劑。以製備型的逆相層析斤-18,以 85-98¾的甲醇:〇.1%ΝΗ4〇Η/水之梯度沖洗:)可産生0.5克 的2-溴代史賓諾辛^\。〇41[^4卩〇11^「的分析估計值為:(:, 60.73; Η, 7.95; Ν, 1.72。實際值為 C, 62.14; Η, 7.93 ;Ν, 1·79。 審渝例Μ5-2- (2 锊某)乙基中客諾辛Α的R和S累構物 按照如實施例M23所述之史賓諾辛A的2-甲基類似物 之製程,在-70°C下以1,2-二溴四~氟乙烷(0.9 g, 3.47 mmol)取代為親電子試劑。以製備型的逆相層析(C-18,以 85-98%的甲醇:0.1¾的NfUOH/水之悌度沖洗)可産生産 生二種2- (2 羥基)乙基史賓諾辛A的R和S異構物(每膣 0.25克)異構物分析估計值為:C, 66.55 ;H, 8.96; N, 1.80。實際值為:C, 66·48; Η,10·6; N, 1.84 ,同分異構物2 : C 4 3 H s 3 MO : i的分析估計值為:C , 66.55; Η, 8·96; N, 1.80。實際值為:C, 65·82; H, 10.07; Ν, 1,72 〇 ; -275 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) —t-IL—m_| (請先閲讀背面之注意事項再填寫本頁) 、?! 經濟部中央標準局員工消費合作社印製 487559 A7 ____ B7 _ 五、發明説明(仍)Examination Example H2-Methyl sulphur Φ guest A certain A According to the process of 2-methyl analog of Spinoxin A as described in Example M23, it was replaced with dimethyl sulfide (0.66 g, 6.98 mmol) It is an electrophilic reagent. Preparative reversed-phase chromatography (018, 85-98¾ methanol: 0,1% HH40H / water gradient rinse) Γ can produce 0.20 g 2-methylthiospinoxin A. 1 H-NMR (300 MHz, CDC U) d 2.2 (s, -274-This paper size applies Chinese National Standard (CNS) Λ4 specification (ZlOX 297 mm) —ml · ϋϋ ϋϋ I ϋϋ--Μ ^ ϋϋ n · ^ n ( Please read the notes on the back before filling this page), 11 Printed by the Consumers Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs, printed 487559 A7 B7 V. Description of the invention (printed) 3H, cis CH3), C44H63N02 The estimated analytical value is C, 65.72; M, 8.65; N, 1.74. Actual values: C, 65.77; H, 8.38; N, 1.79. The estimated analytical value of S is C, 64.83; Η, 8.68; Ν, 1.80; S , 4.1. Actual values are: C, 65.18; Η, 10.43; M, 1.76; S, 3.66 〇 Trial example M4-2-bromohistohistory Nosin J J According to Spinoxin A 2 as described in Example M23 -Methyl analogue production process, substituted with 1,2-dibromotetrakiethane (0.9 g, 3.47 mmol) as electrophilic reagent at -70 ° C. Rinse with preparative reverse phase chromatography -18, with 85-98¾ methanol: 0.1% NH4Η / water gradient :) can produce 0.5 g of 2-bromospinoxin ^. 〇41 [^ 4 卩 〇11 ^ "The estimated analytical value is: (:, 60.73; Η, 7.95; Ν, 1.72. Actual value is C, 62.14; Η, 7.93; Ν, 1.79. Examination example M5 -2- (2): The R and S complexes of methanosin A in ethyl are prepared according to the 2-methyl analogue of spinosin A as described in Example M23, at -70 ° C. In the following, 1,2-dibromotetrafluoroethane (0.9 g, 3.47 mmol) was used as the electrophilic reagent. Preparative reverse phase chromatography (C-18, 85-98% methanol: 0.1¾ NfUOH / water rinsing) can produce R and S isomers (0.25 g per 克) that produce two 2- (2-hydroxy) ethyl spinosyn A. The estimated value of the analysis of isomers is C, 66.55 ; H, 8.96; N, 1.80. Actual value: C, 66 · 48;;, 10 · 6; N, 1.84, isomer 2: C 4 3 H s 3 MO: i : C, 66.55; Η, 8.96; N, 1.80. Actual values: C, 65 · 82; H, 10.07; Ν, 1,72 〇; -275-This paper size applies to Chinese National Standard (CNS) Α4 Specifications (210 × 297 mm) —t-IL—m_ | (Please read the precautions on the back before filling out this page),?! Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 48 7559 A7 ____ B7 _ 5. Description of the invention (still)

置荥甚硫中窨諾辛A 按照如實施例M23所述之末賓.諾辛A的2-甲基類似物 之製程,以二甲基硫化物(1 · 5 2 g , 6 · 9 8 m m ο 1 )取代為親 電子試劑。以製備型逆相層析(018,以85-98¾的甲醇: 〇· 1¾ NfUOH/水之悌度沖洗)可産生〇. 71克的2-苯基硫史 賓諾辛A 。C4 7H6 sNOi 〇S的分析估計值為:C, 67.19; Η, 8·28; Ν,1·67; S, 3.81。實際值為:C, 67.12; Η, 8·51; Ν, 1.65; S, 3·34。Place oxosulfan in noroxin A according to the process described for the 2-methyl analogue of oxin. Noroxin A as described in Example M23, using dimethyl sulfide (1.52 g, 6.98 8 mm ο 1) instead of electrophilic reagents. Preparative reverse phase chromatography (018, flushing with 85-98¾ of methanol: 0.125 NfUOH / water at 0.5 °) yielded 0.71 g of 2-phenylthiospininoxin A. Analytical estimates for C4 7H6 sNOi 0S are: C, 67.19; H, 8.28; N, 1.67; S, 3.81. Actual values: C, 67.12; Η, 8.51; Ν, 1.65; S, 3.34.

窨施例Μ7-2-田醅甚Φ窨謀辛A 此化合物以類似實施例M23製備得,除了在-70°C 下以甲酸乙酯(0.56毫升,6.98 mmol)取代為親電子試劑 。以製備型的逆相層析(C-18,以85-98%的甲醇·· 0.1% 的NH4〇H/水之梯度沖洗)可産生0· 1克的2-甲醯基史賓諾 辛 AqCuHwNOh分析估計值為··'(:,66.37; H, 8.75; N, 1.84.7; S, 3.81。實際值為·· C, 63.77; Η, 8.46; N, 1.88。 窨旆例Μ8-?-兩巧碏醯基史賓諾辛A. Ν-気仆,物 攪拌好的2-甲基硫史賓諾辛Α溶液(1.0 g, 1.3 mmol )在10毫升的無水甲醇裡被冷卻到0°C和分批添加間-氯過苯甲酸酸(50¾,0.67 g, 1·9 。觀察其放熱到 10°C 。在攪拌1個小時之後將反應混合物倒入10% HC1 之内並以乙醚洗2次‘:水層以NaHC03鹼化並以減壓濃縮至 固體,再以25毫升的乙醚三次,和25毫升的EtoAc二次 一起研製成粉。聯合有機層物質並予濃縮。以製備型的逆 • - 276 - 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇&gt;&lt;297公釐) -----.----#! (請先閲讀背面之注意事項再填寫本頁)Example M7-2-Tianxixi Mouxin A This compound was prepared similarly to Example M23, except that ethyl formate (0.56 ml, 6.98 mmol) was substituted as the electrophilic reagent at -70 ° C. Preparative reverse-phase chromatography (C-18, 85-98% methanol · 0.1% NH4OH / water gradient washing) can produce 0.1 g of 2-formamyl spinosin AqCuHwNOh The estimated value of the analysis is · '(:, 66.37; H, 8.75; N, 1.84.7; S, 3.81. The actual value is ·· C, 63.77; Η, 8.46; N, 1.88. Example M8-?- The 2-methylthiospinoxin A. Ν-α-bismuth solution, the well-stirred 2-methylthiospinoxin A solution (1.0 g, 1.3 mmol) was cooled to 0 ° C in 10 ml of anhydrous methanol. And add m-chloroperbenzoic acid (50¾, 0.67 g, 1 · 9 in portions. Observe it exotherm to 10 ° C. After stirring for 1 hour, pour the reaction mixture into 10% HC1 and wash with ether 2 Times': The aqueous layer was basified with NaHC03 and concentrated to a solid under reduced pressure, and then triturated with 25 ml of ether three times and 25 ml of EtoAc to form a powder. The organic layer materials were combined and concentrated. •-276-This paper size applies Chinese National Standard (CNS) A4 specification (21〇 &gt; &lt; 297mm) -----.---- #! (Please read the notes on the back before filling in this page)

、tT 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(辦) 相層析(〇18,以85-98%的甲醇:0.1¾的ΝΗ4〇Η/水之梯 度沖洗)可産生〇 . 36克淡黃色的,2-甲亞磺醯基史賓諾辛ή ,-氧化物固體泡沫。〇42[^7卩〇12$的分析估計值為:C, 62·27; Η, 8.34; 1.73; S, 3·95:實際值為:C, 58.63; Η, 8·07; Ν, 1.64; S, 4‘12。, TT 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, A7 B7 V. Description of the invention (office) Phase chromatography (〇18, gradient washing with 85-98% methanol: 0.1¾ NΗ4〇Η / water) This gave 0.36 g of pale yellow, 2-methanesulfenylspinoxinol, an oxide solid foam. 〇42 [^ 7 卩 〇12 $ Analyzed estimated value: C, 62 · 27; Η, 8.34; 1.73; S, 3.95: actual value: C, 58.63; Η, 8.07; Ν, 1.64 ; S, 4'12.

MLMJL9-2-田亞碏㈣甚中客柒辛A 攛拌好的2-甲基硫史賓諾辛A溶液(〇·5 g, 0· 65 mino 1)之1 〇毫升無水甲醇溶液被冷卻到-30 °C並經由針筒 加入5·5 Μ在甲醇中的間-氯過苯甲酸酸(50%,0.67 g, 1 · 9 mmo 1)。經由旋轉式蒸發器濃縮,然後殘餘物溶於10 毫升的10!KHC1中,再用30毫升的Et20洗過2次。水層以 NaHC〇3鹼化並且用乙醚/EtOAc萃取3次,乾燥,在旋轉式蒸 發器上濃縮産生0.45克的油狀物。以製備型的逆相層析(C -18,以85-98¾的甲醇:0.1%的NIU0H/水之梯度沖洗)可 産生0.36克的2-甲亞磺醯基史賓諾辛A。〇421^7關113的 分析估計值是:C, 63.53; H, 8.50; N, 1.76; S, 4.02。 實際值是:C, 63.17; Η, 9.50; 1.77; S, 4.02。MLMJL9-2-Tian Yajiu Zhongzhong Kexin A A 10-mL anhydrous methanol solution of 2-methylthiospinoxin A solution (0.5 g, 0.6 65 mino 1) was cooled To -30 ° C and add 5 · 5 M of m-chloroperbenzoic acid (50%, 0.67 g, 1 · 9 mmo 1) in methanol via syringe. Concentrate via a rotary evaporator, then the residue is dissolved in 10 ml of 10! KHC1 and washed twice with 30 ml of Et20. The aqueous layer was basified with NaHC03 and extracted 3 times with ether / EtOAc, dried, and concentrated on a rotary evaporator to give 0.45 g of an oil. Preparative reverse-phase chromatography (C-18, flushing with 85-98¾ methanol: 0.1% NIUOH / water gradient) yielded 0.36 g of 2-methylsulfinylspinoxin A. 〇421 ^ 7guan 113 analysis and estimated values are: C, 63.53; H, 8.50; N, 1.76; S, 4.02. Actual values are: C, 63.17; Η, 9.50; 1.77; S, 4.02.

實施例Μ10-2-羥甚甲甚中窨謠辛Α和?-Ν-Ρ飛啶甚申甚中 窨諶辛A 在20 °C下將哌啶(0.06 g, 0.7 mmol)加入到在MeOH 25毫升裡的2-甲醯基甲基史賓諾辛A(0.44 g, 0.6 mmol) 溶液。1 5分鐘後,溶液被冷卻到〇 °(〕並分批加入氰硼化 鈉(0 · 5 g,0 · 9 mmo 1)以錐持其在1 〇 °C以下的溫度。20分 鐘之後,加入10¾ HC1到此反應物之内並以Et2〇洗過2次 : .-277 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) HI. - - n ml nn -J- - n ϋϋ I (請先閲讀背面之注意事項再填寫本頁)Example M10-2-Hydroxymethyl Amino Acid A and A? -N-P Pyridine Chisinocin Acetoxin A Piperidine (0.06 g, 0.7 mmol) was added to 2-methylamidomethylspinoxin A (25 mL) 0.44 g, 0.6 mmol). After 15 minutes, the solution was cooled to 0 ° () and sodium cyanoboride (0.5 g, 0.9 mmo 1) was added in portions to maintain its temperature below 10 ° C. After 20 minutes, Add 10¾ HC1 to this reactant and wash twice with Et20: .-277-This paper size applies Chinese National Standard (CNS) A4 specification (210 × 297 mm) HI.--N ml nn -J-- n ϋϋ I (Please read the notes on the back before filling out this page)

、1T 487559 A7 ____ B7_______ 五、發明説明(沉) 。水層以HaHCCh鹼化再用EtOAc萃取3次。乾燥聯合的有 機層,經由旋轉式蒸發器濃縮成神狀物。以製備型的逆相 層析(C-18,以85-98%的甲醇:0.1%的NH40H之梯度沖洗 )可産生0·1克的2-羥基甲基史賓諾辛A和2-正-哌啶基甲 基史賓諾辛A對2-羥基甲基史賓諾辛A。Η 的分析1T 487559 A7 ____ B7_______ 5. Description of the invention (Shen). The aqueous layer was basified with HaHCCh and extracted three times with EtOAc. The combined organic layers were dried and concentrated to a godlike appearance via a rotary evaporator. Preparative reverse-phase chromatography (C-18, washed with a gradient of 85-98% methanol: 0.1% NH40H) can produce 0.1 g of 2-hydroxymethyl spinosin A and 2-n -Piperidinylmethyl spinoxin A vs. 2-hydroxymethyl spinoxin A. Η Analysis

估計值是:C, 66.19; Η, 8.86; N, 1.84。實際值為:C,6 4·95;Η, 8·65; N, 1.83.對2-正-哌啶基甲基史賓諾辛A。 〇47^2〇1〇的分析估計值是:(:,68.08;19.24;只, 3.38。·實際值為:C, 67.89; H, 9.31; N, 3.13。 實施例Μ1Ϊ-2- (1 -田氯甚-1 -镡申某)中客諶辛 A 經濟部中央標準局員工消費合作社印製 I---^--J---0II (請先閲讀背面之注意事項再填寫本頁) 史賓諾辛A的烯醇物(4.1 mmol)可依照在實施例M23 中所描述的一般程序備製得到。逐滴加入甲酸乙酯(1. 5g , 20 mmol)超過10分鐘,於此冷卻(-70°C)的溶液中,然 後容許其慢慢地加溫到-30¾。再將此溶液倒在一已攪和, 冷卻(〇°C)過之飽和NH4C1(75毫升)和乙_ (75毫升)的水 溶液中。將有機層分離並以與鹽水清洗,乾燥、濃縮到油 狀物。以HPLC逆相層析(35-98%的甲醇:0.1%的NH4〇H)可 産生1.5克的純半縮醛。(:4 3 H s 3 N0 ί 2的分析估計值是:C , 65.12; Η, 8·78; Ν, 1.77。實際值為:C, 65.16; Η, 8·65; Ν,1.83 〇Estimates are: C, 66.19; Η, 8.86; N, 1.84. Actual values are: C, 6 4.95; H, 8.65; N, 1.83. For p-n-piperidinylmethyl spinosin A. The estimated analytical value of 〇47 ^ 2〇1〇 is: (:, 68.08; 19.24; only, 3.38. · Actual value: C, 67.89; H, 9.31; N, 3.13. Example M1Ϊ-2- (1- Tian Clousi-1-Mr. Shen Shen) Printed by I --- ^-J --- 0II of the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (Please read the precautions on the back before filling out this page) Spinoloxin enol (4.1 mmol) can be prepared according to the general procedure described in Example M23. Ethyl formate (1.5 g, 20 mmol) is added dropwise for more than 10 minutes, and cooled down here. (-70 ° C) solution, and then allow it to slowly warm to -30¾. Then pour this solution into a stirred, cooled (0 ° C) saturated NH4C1 (75 ml) and B_ ( 75 ml) aqueous solution. The organic layer was separated and washed with brine, dried and concentrated to an oil. Reverse phase chromatography (35-98% methanol: 0.1% NH4OH) by HPLC yielded 1.5 g Of pure hemiacetal. (: The analytical estimate of 4 3 H s 3 N0 ί 2 is: C, 65.12; Η, 8.78; Ν, 1.77. Actual value: C, 65.16; Η, 8.65; Ν, 1.83 〇

奮旆例ΜΪ2-2-荣某?W甚中客諶辛 A 按照如實施例M23所述之史賓諾辛A的2-甲基類似物之 製程,以甲基硒基氯化物(0.26 g·,1.37 mmol)取代碘甲 烷。如此藉由製備型的逆相層析(〇18,以85-98%的-甲醇 ' -278 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X:297公釐) 經濟、那中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明( :0.1%的NFUOH之梯度沖洗)1克的史賓諾辛A可産生二 種2-苯基硒基史賓諾辛A的異構,物(R和S)(0.19 g和 0.06 g)主要的異構物 ^H-NMR (300 MHz, CDC13) d 7.7( m,2H); 7.25 (ra, 3H); 4.05 (br s, 1H) ^ C47 Ηb9N0 i 〇Se 的分析估計值為:C, 63·64; Η, 7·84; N, 1·58·實際值為 :C, 63.57; Η, 7.85; Μ, 1.53。微量異搆物:ΐΗ-ΝΜΜ300 MHz, CDC13) d 7.6 (m, 2H) ; 7.25 (m, 3H) ; 6.82(brs, 1H) ; 4..55(d, J = 4.2 Hz, 1H)。Fen Ϊ 例 MΪ2-2-Rong? In addition, according to the procedure of 2-methyl analogue of spinosin A as described in Example M23, methylocenyl chloride was replaced with methylselenyl chloride (0.26 g ·, 1.37 mmol). In this way, by preparative reverse phase chromatography (〇18, 85-98% -methanol '-278-this paper size applies the Chinese National Standard (CNS) A4 specification (210X: 297 mm) economic, that central standard Printed by the Bureau ’s Consumer Cooperatives 487559 A7 B7 V. Description of the Invention (: 0.1% NFUOH gradient washing) 1 gram of Spinoxin A can produce two isomers of 2-phenylselenyl Spinoxin A (R and S) (0.19 g and 0.06 g) main isomers ^ H-NMR (300 MHz, CDC13) d 7.7 (m, 2H); 7.25 (ra, 3H); 4.05 (br s, 1H) ^ The analytical estimated value of C47 Ηb9N0 i 〇Se is: C, 63 · 64; Η, 7.84; N, 1.58 · actual value: C, 63.57; Η, 7.85; M, 1.53. Trace isomers: ΐΗ-NMM300 MHz, CDC13) d 7.6 (m, 2H); 7.25 (m, 3H); 6.82 (brs, 1H); 4..55 (d, J = 4.2 Hz, 1H).

富施例MU-(R和S )2-乙氯羰基甲基史賓詻辛A 史賓諾辛A烯醇(1.37 mmol)可依照在實施例M23中所 描述的一般程序備製得到。在-60°C下加入溴醋酸乙酯( 0.76 g, 4.5 mmol),然後容許其慢慢地加溫到0°C。再將 此溶液倒在飽和的NH4C 1的水溶液中。並以Et2〇 50毫升 萃取兩次,合併之有機物又以50毫升的0.1N HC1萃取 ,然後産生酸的水層用飽和的NaHC〇3鹼化,再用EU0 50 毫升萃取兩次。再將聯合的有機層物乾燥、濃縮産生一 克的油狀物後,藉由逆相層析。以沖提悌度85-98%的甲醇 :0.1UH4〇H可産生二種2-乙氧鑛基甲基史賓諾辛A異構物 (0.17 g,17%和0. 13g, 131)。也可以回收史賓諾辛A ( 0.2g)。 窨旆例-M1 4-2-荥甚硒氬某中窨諶辛A和? 二氣中客謅辛 6 在10毫升無水MeOH裡的2-苯基硒氧基史賓諾辛A (主異 構物;0·20 g, 0.22minol)溶液,在N2及磁石ift伴下冷卻到 / - 279 -, 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 、11 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(&gt;,7) -60°C,同時加入三份 MCPBA (0.06 g, t 約是 0·25 mmol 的57-35%純MCPB A)超過15分鐘。,溶液可加熱到室溫超過 1小時,然後以50毫升的Et2〇稀釋、飽和的NaHC〇3溶液清 洗。有機層以30毫升的1N HC 1萃取。酸的水層以飽和的 NaHC〇3溶液將其鹼化(pH 9)並再以25毫升的Et2〇萃取兩次 。有機層以MgS〇4乾燥,濃縮的成油狀物。藉由層析(C-18,使用沖提悌度85-90¾甲醇:O.UNH4〇H)産生兩種物質 。第一種(0.06 g)就是2-苯基硒氧基史賓諾辛A。第二種 産物(0.02 g)為2,3-去氫史賓諾辛A。加入硒氧化物(0.4 g, 0·44ηπα〇1)到10毫升的甲苯並且迴流加熱30分鐘,冷 卻後,以乙»稀釋、25毫升的1H HC1清洗。分離水層,ρΗ 值以NaHC〇3水溶液調節到9 ,再以50毫升的Et2〇萃取 兩次將聯合的有機的層乾燥、濃縮和層析(018 ,使用沖提 梯度85-90¾:甲醇:0. 1¾ 帅4〇1〇産生0.1〇8的2,3-去氫 史賓諾辛 Α·ΐΗ-ΝΜ!ϊ (300MHz, CDCM δ7·9- 8.0(m, 2H );7.45(m, 3H); 6.77(br s, 1H) ; (br d, J = 11Hz, 1H );5.05 (br d, 5.05(br d, J = 11 Hz, 1H) ; 4.87(m, 1H); 4.75(s, 1H); 4.4(d,J = 7Hz, 1H); 4·18 (m,lH)。 對於2,3-去氫史賓諾辛&amp;:111-_1?(300〖丨[^,00(:13)5 6.85(br s, 1H); 5.97 (br d, J = 10 Hz, 1H); 5.82( br d, J = 10 Hz, 1H); 5·65 (s, 1M); 4.82 (s, 1H); 4.65 (d, J = 7Hz, 1H); 4.25 - 4.4 (m, 2M); 4.1 (m, 1H); 4.87 (in, 1H; 4.75 (s, 1M) ; 4.4 (d, J = 7Hz, 1H); 4·18 (m, 1M).M.S. M+H 730*9 。 ’ ' -280 -本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公釐) I---·------- (請先閲讀背面之注意事項再填寫本頁) 、?! 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(辦) 實Ml例-M15-2-苯基硒氯基中窨諶辛A和?. h去氣中客譯李 ή , 在10毫升無水MeOH裡的2-苯基硒氧基史賓諾辛Α (次異 構物;0·20 g, 0.25mmol)溶液,在N2及磁石攪伴下冷卻到 -60¾ ,同時加入三份MCPBA (0.065 g,大約是0.25 mmol的57 - 85¾純MCPBA )超過15分鐘。溶液可加 熱到室溫超過1小時,然後以50毫升的Et2〇稀釋、鉋 和的NaHC03溶液清洗。有機層以30毫升的IN HC1萃 取。酸的水層以鉋和的NaHC〇3溶液將其鹼化(酸鹼值9 )並再以25毫升的Et2〇萃取兩次。有機層以MgS04乾燥 ,濃縮的成油狀物。藉由層析(018,使用冲提梯度85-9 8¾甲醇:0.1% NH4〇H)純化此硒化物(0.2 g)的一部份。 CarHi^NOnSe 的分析估計值:C, 62.51; Η, 7·70;·Ν, 1.55。實際值是:C, 62.13; Η, 1.64; Ν, 7.73。此剩餘 的粗硒化物(0.2克)在10毫升的苯中加熱45分鐘,冷卻後, 再濃縮、層析(C-18,使用沖提梯度85-98¾甲醇:0.1¾ 1^4〇[〇。産生0.078的2,3-去氫史賓諾辛&amp;黃色泡沫 。此物質靜置於室溫下分解。1H-NMR (300 MHz, CDC13) d6.85(br s, 1H); 5·97 (br d, J =10 Hz, 1Η);5·82 (b rd,J= 10 Hz, 1H); 5.65 (s, 1H); 4.82 (s,lH);4.65 ( d,J= 7Hz, 1H);4.25 - 4.4(ιη, 2H) ; 4.l(m, 1H) . ; 4.87 (in, 1H;4.75 (s, 1H); 4.4 (d, J = 7Hz, 1H); 4.18 (m ,1H) 。 · 奮施例M 1 Γ)-中客諶辛A . t - 丁甚二甲基矽烷基縮_ / - 281 -本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX297公釐) ·--^---- (請先閱讀背面之注意事項再填寫本頁) 、11 487559 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(州) 加入2毫升的HMP A及1克的t-丁基二甲基矽烷基氯化 物(6.9 mmol)到一有磁性攪拌並,冷卻卜40 °C )之20毫升 THP裡的LDA(6.8 mmol)溶液中。然後加入在2毫升THF裡 的史賓諾辛Α(1·〇 g,1.36 mmol)超過2min,並容允溶液 慢慢地加溫到〇 °C。産生的溶液再倒入50毫升的水和50毫 升的乙醚。分層後,有機相用鹽水清洗,乾燥及濃縮。層 析(85-98% MeOH/H2〇的冲提梯度)産生0.55g純的史賓 諾辛A,t-丁基二甲基矽烷基縮酮。1H-NMR (300 MHz, CDCla): d 6.78 (br s, 1H); 8.83(m, 2H); 4,82 (s, 1H); 4.15 - 4.32 (m, 2H); 4.05 (d, J = 6Hz, 1H); 3.83 (m, 1H); 0.9 (s, 9H); 0.2 (d,J = 11Hz, 6H) 〇 CrHuNUi 的分析估計值:C, 66.71; H, 9.41; N, 1.66。實際值為:C, 66.54; H, 9.50; N, 1· 64。 審渝例M1 7-2-氯Ψ窨諾辛 k 賓諾辛A之TBS縮嗣(O.lg, 0.12mm〇n之5毫升無水 THF溶液被以磁石攪拌並被冷卻到_78°C後,加入一部份 的N-氯代丁二醯亞胺(15 mg, 0.125 mmol 。允許溶液慢 慢地加溫到室溫後,使其區分在30毫升的乙醚和30毫升 的鹽水溶液之間。乾燥有機層並濃縮成油狀物,再以層析( 逆相,85-98% Me0H/H2之沖提梯度)得到40毫克的2_(R 卜氯史賓諾辛 tH-NMR (300 MHz, CDC13) d 4.68 (S,1H; C2-H). M.S. M+H 766: 審旆例M1 8-?-氩中窨諶辛A · 史賓諾辛A之TBS縮酮(0.05g, 0·06 mmol)之5毫升無 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) I---.--;----- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 487559 * A7 B7 五、發明説明(撕) 水THF溶液被磁石攪拌並被冷卻到-78°C後,加入一部份 的XeF2 (15 mg, 0.09 mm〇l)。允許溶液慢慢地加溫到室 溫後,使其區分在30毫升的乙醚和30毫升的鹽水溶液 之間。乾燥有機層並濃縮成油狀物,再以層析(逆相,85-98% MeOH/H2之沖提梯度)得到18毫克的2-氣史賓諾辛A。 ^H-NMRCSOO MHz, CDCla) d 5.12 (d, J=50Hz, 1H;C2-H) 〇 M.S. M + H 750。Rich Example MU- (R and S) 2-Ethylchlorocarbonylmethylspinoxine A Spinoxin Aenol (1.37 mmol) can be prepared according to the general procedure described in Example M23. Add ethyl bromoacetate (0.76 g, 4.5 mmol) at -60 ° C, then allow it to slowly warm to 0 ° C. This solution was poured into a saturated aqueous solution of NH4C1. It was extracted twice with 50 ml of Et20, and the combined organics were extracted again with 50 ml of 0.1N HC1. The aqueous layer that produced the acid was then basified with saturated NaHC03, and extracted twice with 50 ml of EU0. The combined organic layers were dried and concentrated to give one gram of oil, which was then subjected to reverse phase chromatography. With the extraction degree of 85-98% methanol: 0.1UH4OH, two 2-ethoxymine-methyl spinosin A isomers (0.17 g, 17% and 0.13 g, 131) can be produced. Spinozin A (0.2g) can also be recovered.窨 旆 例 -M1 4-2- 荥 selenium argon in a certain amount of A and A? 2-Phenylselenospinoxin A (main isomer; 0.20 g, 0.22 minol) in 10 ml of anhydrous MeOH, and cooled to N2 and magnet ift /-279-, This paper size is applicable to Chinese National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling out this page), 11 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 V. Explanation of the invention (&gt;, 7) -60 ° C, and simultaneously add three portions of MCPBA (0.06 g, 57-35% pure MCPB A at about 0.25 mmol) for more than 15 minutes. The solution can be heated to room temperature for more than 1 hour, and then washed with 50 ml of Et20 diluted, saturated NaHC0 solution. The organic layer was extracted with 30 ml of 1N HC1. The acidic aqueous layer was basified (pH 9) with a saturated NaHC03 solution and extracted twice with 25 ml of Et20. The organic layer was dried over MgS04 and concentrated to an oil. Two substances were produced by chromatography (C-18, using an extraction degree of 85-90¾ methanol: O.UNH4OH). The first (0.06 g) was 2-phenylselenoxy spinosinoxin A. The second product (0.02 g) was 2,3-dehydrospinoxin A. Add selenium oxide (0.4 g, 0.44 ηπα〇1) to 10 ml of toluene and heat at reflux for 30 minutes. After cooling, wash with ethyl dilute, 25 ml of 1H HC1. The aqueous layer was separated, and the pH was adjusted to 9 with an aqueous solution of NaHC0, and then extracted twice with 50 ml of Et20. The combined organic layers were dried, concentrated, and chromatographed (018, using an extraction gradient of 85-90¾: methanol: 0.12 Shuai 4〇10 produces 0.1〇2 of 2,3-dehydrospinoxin A · ΐΗ-NM! Ϊ (300MHz, CDCM δ 7.9- 8.0 (m, 2H); 7.45 (m, 3H ); 6.77 (br s, 1H); (br d, J = 11Hz, 1H); 5.05 (br d, 5.05 (br d, J = 11 Hz, 1H); 4.87 (m, 1H); 4.75 (s, 1H); 4.4 (d, J = 7Hz, 1H); 4 · 18 (m, lH). For 2,3-dehydrospinoxin &amp;: 111-_1? (300 〖丨 [^, 00 ( : 13) 5 6.85 (br s, 1H); 5.97 (br d, J = 10 Hz, 1H); 5.82 (br d, J = 10 Hz, 1H); 5.65 (s, 1M); 4.82 (s , 1H); 4.65 (d, J = 7Hz, 1H); 4.25-4.4 (m, 2M); 4.1 (m, 1H); 4.87 (in, 1H; 4.75 (s, 1M); 4.4 (d, J = 7Hz, 1H); 4 · 18 (m, 1M) .MS M + H 730 * 9. '' -280-This paper size is applicable to China National Standard (CNS) A4 (210x297 mm) I --- ·- ------ (Please read the precautions on the back before filling out this page),?! 487559 Printed by the Consumer Cooperative of the Central Standards Bureau, Ministry of Economic Affairs, A7 B 7 V. Description of the invention (office) Examples of Ml-M15-2-phenylselenium chloride in the p-octyl A and? .H degassing guest translation Li price, 2-phenylselenium in 10 ml of anhydrous MeOH Solution of oxyspinoxin A (sub-isomer; 0.20 g, 0.25 mmol), cooled to -60¾ with N2 and magnetic stirring, and added three portions of MCPBA (0.065 g, approximately 0.25 mmol of 57- 85¾ pure MCPBA) for more than 15 minutes. The solution can be heated to room temperature for more than 1 hour, and then washed with 50 ml of Et20 diluted, planed and NaHC03 solution. The organic layer is extracted with 30 ml of IN HC1. The acidic aqueous layer is planed It was basified with a solution of NaHC03 (pH 9) and extracted twice with 25 ml of Et20. The organic layer was dried over MgS04 and concentrated to an oil. A portion of this selenide (0.2 g) was purified by chromatography (018, using an elution gradient of 85-9 8¾ methanol: 0.1% NH4OH). CarHi ^ NOnSe analytical estimates: C, 62.51;;, 7.70; · N, 1.55. Actual values are: C, 62.13; Η, 1.64; Ν, 7.73. This remaining crude selenide (0.2 g) was heated in 10 ml of benzene for 45 minutes, and after cooling, it was concentrated and chromatographed (C-18, using an extraction gradient of 85-98 ¾ methanol: 0.1 ¾ 1 ^ 40). . Generates 0.078 of 2,3-dehydrospinoxin &amp; yellow foam. This material decomposes at room temperature. 1H-NMR (300 MHz, CDC13) d6.85 (br s, 1H); 5. · 97 (br d, J = 10 Hz, 1Η); 5.82 (brd, J = 10 Hz, 1H); 5.65 (s, 1H); 4.82 (s, lH); 4.65 (d, J = 7Hz, 1H); 4.25-4.4 (ιη, 2H); 4.l (m, 1H) .; 4.87 (in, 1H; 4.75 (s, 1H); 4.4 (d, J = 7Hz, 1H); 4.18 (m, 1H). · Fen Example M 1 Γ) -China Kexin A. T-Butyl Dimethyl Silane Condensation _ /-281-This paper size applies Chinese National Standard (CNS) A4 specification (21 OX297 mm ) --- ^ ---- (Please read the notes on the back before filling out this page), 11 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (state) Add 2 ml of HMP A And 1 g of t-butyldimethylsilyl chloride (6.9 mmol) into a magnetic stirrer and cooled at 40 ° C (20 ° C) in LDA (6.8 mmol) to dissolve In. Then spinoxin A (1.0 g, 1.36 mmol) in 2 ml of THF was added for more than 2 min, and the solution was allowed to slowly warm to 0 ° C. The resulting solution was poured into 50 ml of water and 50 ml of ether. After the layers were separated, the organic phase was washed with brine, dried and concentrated. Lamination (85-98% MeOH / H2O extraction gradient) yielded 0.55 g of pure spinoxin A, t-butyldimethylsilyl ketal. 1H-NMR (300 MHz, CDCla): d 6.78 (br s, 1H); 8.83 (m, 2H); 4,82 (s, 1H); 4.15-4.32 (m, 2H); 4.05 (d, J = 6Hz, 1H); 3.83 (m, 1H); 0.9 (s, 9H); 0.2 (d, J = 11Hz, 6H) 〇 Analytical estimates of CrHuNUi: C, 66.71; H, 9.41; N, 1.66. Actual values: C, 66.54; H, 9.50; N, 1.64. Examination example M1 7-2-Chloroxanthinol and TBS shrinking of binoxin A (O.lg, 0.12mmon 5 ml anhydrous THF solution was stirred with magnet and cooled to _78 ° C Add a portion of N-chlorobutanediimide (15 mg, 0.125 mmol.) Allow the solution to slowly warm to room temperature, and allow it to distinguish between 30 ml of diethyl ether and 30 ml of saline solution The organic layer was dried and concentrated to an oil, and then chromatographed (reverse phase, gradient of 85-98% Me0H / H2) to obtain 40 mg of 2_ (R buclispinoxin tH-NMR (300 MHz , CDC13) d 4.68 (S, 1H; C2-H). MS M + H 766: Examination case M1 8-?-Arsenine A in Spinium · Spinosin A TBS ketal (0.05g, 0 · 06 mmol) of 5 ml paper without this standard is applicable to China National Standard (CNS) A4 specification (210X297 mm) I ---.--; ----- (Please read the precautions on the back before filling this page ) Order printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs, printed 487559 * A7 B7 V. Description of the Invention (Tear) After the water THF solution was stirred with a magnet and cooled to -78 ° C, a portion of XeF2 (15 mg, 0.09 mm〇l). Allow the solution to slowly warm to room temperature It was separated between 30 ml of diethyl ether and 30 ml of saline solution. The organic layer was dried and concentrated to an oil, and then chromatographed (reverse phase, 85-98% MeOH / H2 gradient of extraction) to obtain 18 mg 2-Gas Spinoxin A. ^ H-NMR CSOO MHz, CDCla) d 5.12 (d, J = 50Hz, 1H; C2-H) OM M + H 750.

啻旆例Ml 9-2-(二甲某氬某)亞胺田甚中客謀辛A 2-史賓諾辛(1-甲氧基-卜羥基甲基)(0.1 g, 0.13 m m ο 1)的3毫升M e 0 Η溶液中,加入11 m g (0 · 18 m m ο 1)的N ,N-二甲基聯氨。然後以蒸氣浴加熱2小時,再冷卻、 濃縮。殘餘物以層析(逆相,85-98% MeOH/H2〇的沖提梯度 )産生 3 毫克的腙。1H-NMR (300 MHz,CDC13) d 6.65 (d, J = 7 Hz, 1H; C2-CH = NNMe2) ;4. 1 (dd, J=7,4 Mz, 1H; C2-CH); 2.78 (s, 6H). M,S· M+H 802·8。Example Ml 9-2- (Dimethyl, argon, argon) imine Tianzhong Kemouxin A 2-Spinoxin (1-methoxy-buhydroxymethyl) (0.1 g, 0.13 mm ο 1 ) In 3 ml of Me 0 Η solution, 11 mg (0 · 18 mm ο 1) of N, N-dimethylhydrazine was added. It was then heated in a steam bath for 2 hours, then cooled and concentrated. The residue was chromatographed (reverse phase, eluent gradient of 85-98% MeOH / H20) to produce 3 mg of rhenium. 1H-NMR (300 MHz, CDC13) d 6.65 (d, J = 7 Hz, 1H; C2-CH = NNMe2); 4. 1 (dd, J = 7, 4 Mz, 1H; C2-CH); 2.78 ( s, 6H). M, S · M + H 802 · 8.

奮施例M20-2-揮某亞胺甲某中窨諶辛 A 2 -史賓諾辛(1 -甲氧基-1-羥基甲基)(0.06 g, 0.08 mmol)的 3 毫升 MeOH 溶液中,加入 10mg(〇.14 nunol)的 羥胺鹽酸鹽。然後以蒸氣浴加熱2小時,再冷卻、濃縮 。殘餘物以Et2〇佔滿並以NaHC03溶液清洗。乾燥、濃縮 有機眉後,産生0.05 g之肟的順式和反式異構物。Fenshi Example M20-2-Hydroxyiminomethoxine A 2-Spinoxin (1-methoxy-1-hydroxymethyl) (0.06 g, 0.08 mmol) in 3 ml of MeOH 10 mg (0.14 nunol) of hydroxylamine hydrochloride was added. It was then heated in a steam bath for 2 hours, then cooled and concentrated. The residue was filled up with Et20 and washed with NaHC03 solution. After drying and concentrating the organic eyebrows, 0.05 g of the cis and trans isomers of the oxime were produced.

M-NMR (300 MHz, CDC13) d 7.55 and 6.95(雙鋒J 二6 Ηζ,ΙΗ; C2-CH = N0H); 4.15 及 4.72Ί:二 dd, J = 6,4.5 Hz, IN ;CS-CHhCnHesNsOH 的分析估計值:C, 65·09; Η,8·58 ' -283 - · 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -----;—J—------—訂------—: (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 B7_ 五、發明説明(卻) · ,· N, 3,61。實際值·· C, 65.10 ;H, 8.86; Ν,1· 57。 實施例M2 1-2-氣基中窨柒辛A , 2 - (1-甲氧基卜羥基methyl)史賓諾辛A (0.4 g, 0.5 mmol)之5毫升MeOH溶液中,加入Μ, N_二甲基聯胺( 0 · 05 g , 0 · 8 mmo 1),並以迴流加熱1小時,然後冷卻、 真空濃縮。殘餘物覆入於1毫升的MeOH中並加以攪拌, 冷卻(-4 0 °C )裡單過苯二甲酸 ij| ( m ο η 〇 p e r p h t h a 1 a t e)( MMPP, 85%; 0.5 g , 0.8 mmol)之 3 毫升MeOH溶篏。溶液 可以室溫加溫並整夜攪拌,之後將其到入鉋和的10毫升 NaHC〇3水溶液中,再以Et2〇 25毫升萃取兩次。乾燥此有 機溶液並濃縮後,經層析(逆相,85-98% MeOH/H2〇沖提梯度 )産生85毫克的2-氰基史賓諾辛AM + H 757.5. ^-NMR (300 MHz, CDC13)〜4·43 (d, J= 4.7 Hz,lH;C2-CH)。 C42HB4N2〇lfl 的分析估計值:C, 67.81; Η, 8·81;Ν, 1.88 。實際值:C, 67·68;Η, 9·05; N, 1.73。M-NMR (300 MHz, CDC13) d 7.55 and 6.95 (double front J 2 6 Ηζ, 1Η; C2-CH = N0H); 4.15 and 4.72Ί: two dd, J = 6, 4.5 Hz, IN; CS-CHhCnHesNsOH Analytical estimated value: C, 65 · 09; Η, 8.58 '-283-· This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) -----; —J —-- ----— Order ------—: (Please read the notes on the back before filling this page) Printed by the Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7_ V. Description of the invention (but) N, 3, 61. Actual values C, 65.10; H, 8.86; N, 1.57. Example M2 In a solution of 1-amino radical acetoxin A, 2- (1-methoxybutyromethyl) spinoxin A (0.4 g, 0.5 mmol) in 5 ml of MeOH, M, N was added. Dimethyl hydrazine (0. 05 g, 0. 8 mmo 1), heated at reflux for 1 hour, then cooled and concentrated in vacuo. The residue was covered with 1 ml of MeOH and stirred, and cooled (-4 0 ° C) to monoperphthalic acid ij | (m ο η 〇perphtha 1 ate) (MMPP, 85%; 0.5 g, 0.8 mmol ) Of 3 ml of MeOH. The solution can be warmed at room temperature and stirred overnight, after which it is poured into 10 ml of NaHC03 aqueous solution, and extracted twice with 25 ml of Et20. After drying the organic solution and concentrating, chromatography (reverse phase, 85-98% MeOH / H20 stripping gradient) yielded 85 mg of 2-cyano Spinosin AM + H 757.5. ^ -NMR (300 MHz, CDC13) to 4.43 (d, J = 4.7 Hz, 1H; C2-CH). Analytical estimates for C42HB4N2Olfl: C, 67.81; H, 8.81; N, 1.88. Actual values: C, 67 · 68; Η, 9.05; N, 1.73.

甯旆例M22-2-氡-2-氩中客諶辛 A 在N2下,25毫升的燒瓶裡的已冷卻(_40°C)、攪過 之無水THF溶液4毫升中,加入丁基鋰(1·6 M, 0.1毫升, 0.16 mmol)和二異两基氛(30 ul, 0.2 mmol)。在 30 分鐘 之後,加入2-氰史賓諾辛A (0.105 g, 0.14 mmol)之0.5 毫升無水THF溶液。此溶液可再攪拌0· 5小時,然後加 入 N-氟苯磺亞胺(NFSi; 50 mg, 0.16 mmol),於-40°C 下 攪拌0.5小時,然後容許其慢慢她加溫到0¾,然後倒入 Et2〇内,並以鹽水溶液清洗。之後再乾燥、濃度而得到一 ; -284 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公董) _ I---:--^---Φ-- (請先閱讀背面之注意事項再填寫本頁) 、?τ 487559 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(2纟i ) 淺黃色油狀物,經層析(逆相,85-98¾ MeOH/H2〇沖提梯度 )産生35毫克的2-氰-2-氟史賓諾辛A «:M.S· M + H 775.6。 實旆例MM?-甲甚中窨柒辛 A累構物Ning Yiming M22-2- 氡 -2-Arsenoxine A in argon Under N2, 4 ml of a cooled (_40 ° C), stirred anhydrous THF solution in a 25 ml flask was added with butyl lithium (1 · 6 M, 0.1 ml, 0.16 mmol) and diisoxyl (30 ul, 0.2 mmol). After 30 minutes, add 0.5 ml of a solution of 2-cyano Spinosin A (0.105 g, 0.14 mmol) in anhydrous THF. This solution can be stirred for another 0.5 hours, then N-fluorobenzenesulfenimide (NFSi; 50 mg, 0.16 mmol) is added, stirred at -40 ° C for 0.5 hours, and then allowed to slowly warm to 0¾, It was then poured into Et20 and washed with saline solution. After drying and concentration, one is obtained; -284-This paper size applies the Chinese National Standard (CNS) A4 specification (210x297). _ I --- ::-^ --- Φ-- (Please read the Note for refilling this page),? Τ 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Α7 Β7 V. Description of the invention (2 纟 i) Light yellow oil, chromatographed (reverse phase, 85-98¾ MeOH / H20 stripping gradient) yielded 35 mg of 2-cyano-2-fluorospinoxin A «: MS · M + H 775.6. Example MM? -A very structure

將N2入口裝置在50毫升的3-頸口圓底燒瓶,並加上漏 斗和溫度計,及倒入15毫升的無水THF 。磁性地攪拌此 溶液,並且冷卻到-40°C。再加入丁基鋰(在己烷裡1.6 M, 4.5毫升,7.2 mmol),接著逐滴加入二異丙基氧(1.0 毫升,7.2 romo 1),超過2分鐘。添加完成之後,溶液冷 卻到-70°C ,加入HMPA(1.2毫升)及在3毫升之無水THF 裡的史賓諾辛A (1 . 0 g , 1 . 37 mmo 1)。可將溶液慢慢地加 溫到-40°C超過1小時,然後再冷到_70°C,並逐滴加入2 毫升THF裡的碘甲烷(1 g, 7 mmol),在添加期間維持溫度 在-60°C以下。移去冷浴並可使溶液慢慢地加溫到-10°C ( 預估45分鐘)。將溶液倒入冰水之中,以兩次50毫升的二 乙醚萃取得有機産物。聯合有機層並以鹽水溶液清洗, MgS04乾燥後再濃縮成淺黃色的膠狀物。藉由備製的逆相 層析(C18,沖提梯度以85-98%甲醇:0.1¾ NfUOH)得到二 個2-甲基史賓諾辛A類似物(162.9 mg和69.8 mg)異構物 。分離剩下的物質是不反應的史賓諾辛A。 主異構物: 'H-NMR (300 MHz, CDCla) d 6.79 (br s, 1H), 1*4 (d, J = 10 Hz, 3H)。C42Hs7N〇1Q 的分析估計值是:C, 67.62; Η, 9.05; N, 1.88。實際、值為:(:,67.49; Η, 3.50; Ν, 1·86。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) I———If II----、玎—----- (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(Mi) 次異構物: 'H-NMR (300 MHz, CDCls) d 6.71 (br s, 1H), 1.25 (d ,3H)。CuHszNOiQ的分析估計值是:實際值是:C, 67.20; Η, 9.31; Ν, 2.12. Ι\ί邬份化擧式I仆,合物的三璟部分:&gt; 修飾 富妳例Ν1-5-羥某中g諾辛D. 7-甲醅《甚中客柒幸D. 7.8 -去氣中客諶辛D和7, ΐ卜去氬中客钹李[) 史賓諾辛D(7· 5 g, 10 mmol)溶於20毫升的二噁烷 (dioxane)及40毫升的甲酸(90%),冷卻到-l〇°C並磁性 地攪拌,同時加入一部份的二氧化硒(2.3 g, 2.1 mmol) 將此溶液維持在這個溫度4小時,然後在真空下濃縮,此 時溫度維持在0°C或以下。之後此微紅的殘餘物以乙醚( 250毫升)覆入並且加入飽和的NaHC〇3 100毫升。那些集 層液小心地搖動直到氣體之産生終了,然後以矽藻土過濾 並分層。有機層以鹽水清洗,乾燥、濃縮後成為半固體物 質。以MeOH再結晶産生4·5克5-及7-羥基史賓諾辛D之甲 酸鹽酯的混合物。以MeOH再結晶産生純的7-甲醯基史賓諾 辛D,rap· 184°C。M.S. M + H 790.8。殘餘物(預估 2.5g) 以30毫升的THF覆入並且加入在10毫升水裡之LiOOH 0.5g溶液。可許可此溶液在室溫下有磁性地攪拌3小時, 然後區分在EtOAc和水之間。有機層予以乾燥(MgS04)和 濃縮,殘餘物藉由層析(逆相,80-98% MeOH/H2〇的沖提梯 度)所得之第一個主要的坡峰是由'5-及7」經基史賓諾辛 D組成之混合物。以MeOH再結晶移去(少量的)7-異構物 -286 - * 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) I---;I—.-I豐------1T------0 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(泌〇 並産生純的1.4克純的5-羥基史賓諾辛D,mp .115¾。M. SM + Η 762· 4.第二個主要的坡峰是7,,8-dehydro史賓諾辛D, mp · 150°C M. S . M + H 744.4。C4 2Hg sNOi 〇的分析估計值是:C ,67.81; H, 8.81; N, 1.88、實際值為:C,67.60; H, 8· 81; N, 1.88。緊先前於7,8-二氫異構物被沖提分離出 的一値小坡峰,確定是7,11-二氫史賓諾辛D, mp· 160°C 0M.S. 744.7 :C42HssM0ifl 的分析估計值是:C,67.81; Η ,8·81;Ν,1·88。實際值為:C, 67·68; Η,9·05; Ν, 1.73 ΟPlace the N2 inlet in a 50 ml 3-neck round bottom flask, add a funnel and thermometer, and pour 15 ml of anhydrous THF. The solution was stirred magnetically and cooled to -40 ° C. Additional butyllithium (1.6 M in hexane, 4.5 mL, 7.2 mmol) was added followed by diisopropyloxy (1.0 mL, 7.2 romo 1) dropwise over 2 minutes. After the addition was complete, the solution was cooled to -70 ° C, and HMPA (1.2 mL) and Spinoxin A (1.0 g, 1.37 mmo 1) in 3 mL of anhydrous THF were added. The solution can be slowly warmed to -40 ° C for more than 1 hour, then cooled to _70 ° C, and the methyl iodide (1 g, 7 mmol) in 2 ml of THF is added dropwise to maintain the temperature during the addition Below -60 ° C. Remove the cold bath and allow the solution to slowly warm to -10 ° C (estimated 45 minutes). The solution was poured into ice water and extracted twice with 50 ml of diethyl ether to obtain an organic product. Combine the organic layers and wash with saline solution. MgS04 was dried and concentrated to a light yellow gum. Two prepared 2-methylspinoxin A analogs (162.9 mg and 69.8 mg) isomers were prepared by reversed-phase chromatography (C18, extraction gradient with 85-98% methanol: 0.1¾ NfUOH). . The remaining material was isolated Spinozin A. Major isomers: 'H-NMR (300 MHz, CDCla) d 6.79 (br s, 1H), 1 * 4 (d, J = 10 Hz, 3H). The analytical estimates for C42Hs7N01Q are: C, 67.62; Η, 9.05; N, 1.88. Actual, values are: (:, 67.49; Η, 3.50; Ν, 1.86. This paper size applies to China National Standard (CNS) A4 specification (210X 297 mm) I ——— If II ----, 玎—----- (Please read the notes on the back before filling out this page) Printed by the Consumers 'Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 487559 A7 B7 V. Description of the invention (Mi) Sub-isomers:' H-NMR (300 MHz, CDCls) d 6.71 (br s, 1H), 1.25 (d, 3H). The analytical estimate of CuHszNOiQ is: the actual value is: C, 67.20; Η, 9.31; Ν, 2.12. Ι \ ί 邬Formula I, the three tri-parts of the compound: &gt; Modification of the enriched example N1-5-Hydroxyglycinoloxine D. 7-formylol, "Very Influential D. 7.8-Degassed Influent D" And 7, dioxin in argon [] Spinoxin D (7.5 g, 10 mmol) dissolved in 20 ml of dioxane and 40 ml of formic acid (90%), cooled to -10 ° C and magnetically stir while adding a part of selenium dioxide (2.3 g, 2.1 mmol) to maintain the solution at this temperature for 4 hours, and then concentrate under vacuum, at this time the temperature is maintained at 0 ° C Or below. This reddish residue was then covered with ether (250 ml) and saturated NaHC03 100 ml was added. Those accumulating fluids were carefully shaken until the end of the gas generation, then filtered through diatomaceous earth and separated into layers. The organic layer was washed with brine, dried, and concentrated to a semi-solid substance. Recrystallization from MeOH yielded 4.5 g of a mixture of 5- and 7-hydroxyspinoxin D formate esters. Recrystallization from MeOH yielded pure 7-formamyl Spinozin D, rap. 184 ° C. M.S. M + H 790.8. The residue (estimated 2.5 g) was covered with 30 ml of THF and a 0.5 g solution of LiOOH in 10 ml of water was added. This solution may be allowed to stir magnetically at room temperature for 3 hours, then distinguish between EtOAc and water. The organic layer was dried (MgS04) and concentrated. The first major slope of the residue obtained by chromatography (reverse phase, 80-98% MeOH / H20 gradient) was from '5- and 7' Mixture consisting of Kirspinoxin D. Removal of (a small amount) of 7-isomers with MeOH -286-* This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) I ---; I -.- I 丰 --- --- 1T ------ 0 (Please read the precautions on the back before filling out this page) Printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 V. Description of the invention (Break 0 and produce pure 1.4 grams Pure 5-hydroxyspinoxin D, mp. 115¾. M. SM + Η 762 · 4. The second major slope is 7,8-dehydro Spinoxin D, mp · 150 ° C M S. M + H 744.4. Analytical estimates for C4 2Hg sNOi 〇 are: C, 67.81; H, 8.81; N, 1.88, actual values: C, 67.60; H, 8.81; N, 1.88. A small slope peak separated by the 7,8-dihydro isomer was extracted and determined to be 7,11-dihydrospinoxin D, mp · 160 ° C 0M.S. 744.7: C42HssM0ifl The estimated value is: C, 67.81; Η, 8.81; N, 1.88. The actual value is: C, 67 · 68; Η, 9.05; Ν, 1.73 Ο

審施例NS7. 1 1 · 1 2· 雙-关氫(Χ543351 )中窨謠辛D 史賓諾辛D(3. 5 g, 9 mmol)溶於10毫升的二噁烷及20 毫升的甲酸(905Π,冷卻到_l〇°C並磁性地攪拌,同時加 入一部份的Se02(2.3 g, 2.1 mmol)將此溶液雒持在這個 溫度4小時,然後可允許其加溫到室溫。連續攪拌一整夜, 之後此微紅的殘餘物以乙醚(250毫升)覆入並且加入 飽和的NaHCCh 100毫升。那些集層液小心地搖動直到氣 體之産生終了,然後以矽藻土過濾並分層。有機層以鹽水 清洗,乾燥、濃縮。殘餘物藉由層析(逆相,沖提梯度由 85到98¾在0.1¾ NH4〇H水溶液裡的MeOH)可收集到7 ,11,12,5-雙-去氫史賓諾辛〇(3〇11^)在32〇11111下之1«^)&lt; 的微量溶析份。M.S_ M + H 742.7.Examination Example NS7. 1 1 · 1 2 · Bis-Hydrogen (X543351) in the ballad D D. Spinoxin D (3.5 g, 9 mmol) dissolved in 10 ml of dioxane and 20 ml of formic acid (905Π, cooled to -10 ° C and magnetically stirred, while adding a part of Se02 (2.3 g, 2.1 mmol) to hold the solution at this temperature for 4 hours, then allowed to warm to room temperature. Stir continuously overnight, after which the reddish residue was covered with diethyl ether (250 ml) and 100 ml of saturated NaHCCh was added. The layers were carefully shaken until the end of gas generation, then filtered through celite and separated. The organic layer was washed with brine, dried, and concentrated. The residue was collected by chromatography (reverse phase, stripping gradient from 85 to 98¾ MeOH in 0.1¾ NH4OH aqueous solution), 7, 11, 12, 5 -Micro-dissolution fractions of bis-dehydrospinoxin 0 (3010 ^) at 320.111). M.S_ M + H 742.7.

窨旆例N3-5-酾甚7-去氫史審諾辛D 在室溫下,磁性地攪拌於5毫升CH2C12中的5-和7 -羥基史賓諾辛D異構物(0.60 g, 0.79 mmol)之混合物,並 ’ -287 - 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇&gt;&lt;297公釐) -----.--.--19^------1T------0 (請先閱讀背面之注意事項再填寫本頁) 487559 Α7 Β7 五、發明説明(2汀) 加入PDC(1.6 ίπιαοί)。在1小時之後,將溶液區分在水和Et OAc之間,分離得有機層並以鹽#清洗,再乾燥、濃縮。沖 提殘餘物,首先以Et2〇經由矽膠管柱可移去鉻鹽,然後經 由逆相管柱,(80-98% MeOH/H2〇沖提梯度)可得到60毫 克的標題化合物,mpl48°C。.M.S.M + H 760.7。 奮渝例H4-5-氩某-ft. 7-去氫中窨諶辛[)和7-氩甚中窨諶辛 D. 磁石攪拌5-和7-羥基史賓諾辛D異構物(1.0 g, 1. 34 mmol)之8毫升CH2C12混合物,並在氮氣下冷卻到0°C。 的然後逐滴加入DAST (0.32 g, 1.5 eq)超過5分鐘。30 分鐘之後,將其倒入25毫升的磺酸氫鹽水溶液中,再以 30毫升CH 2 C 12萃取,將有機層乾燥、濃縮後,以逆相管柱 (80-98% MeOH/H2〇之沖提悌度)産生4脑餾出物。分離出 的第一個産物,以MeOH再結晶得到0.16克的5-氣基-6, 7-去氫史賓諾辛D, mp. 165°C。M.S. M + H高峰在764.7 。沖提得之第二部份餾出物是7-氟基史賓諾辛D, M.S. M + H高峰在760.8 .其餘的餾出物主要是不飽和的(7,8-及7 ,11 -去氫)物質ϋ I---Ίί .---0—I (請先閱讀背面之注意事項再填寫本頁)Example N3-5- 酾 7-dehydrohistoroxine D magnetically stir the 5- and 7-hydroxyspinoxin D isomers (0.60 g, 0.79 mmol), and '-287-This paper size applies Chinese National Standard (CNS) A4 specification (21〇 &gt; &lt; 297mm) -----.--.-- 19 ^ --- --- 1T ------ 0 (Please read the notes on the back before filling this page) 487559 Α7 Β7 V. Description of the Invention (2 Ting) Join PDC (1.6 ίπιαοί). After 1 hour, the solution was separated between water and Et OAc, the organic layer was separated and washed with salt #, dried, and concentrated. The residue was stripped. First, the chromium salt was removed through a silica gel column with Et2O, and then through a reverse phase column (80-98% MeOH / H2O stripping gradient) to obtain 60 mg of the title compound, mpl 48 ° C. . .M.S.M + H 760.7. Fenyu example H4-5-argon-ft. 7-dehydromidazoxin [) and 7-argon very midazoxin D. Magnetic stirring of 5- and 7-hydroxyspinoxin D isomers ( 1.0 g, 1.34 mmol) in a mixture of 8 ml of CH2C12 and cooled to 0 ° C under nitrogen. Then add DAST (0.32 g, 1.5 eq) dropwise over 5 minutes. After 30 minutes, it was poured into 25 ml of a hydrogen sulfonate aqueous solution and extracted with 30 ml of CH 2 C 12. The organic layer was dried and concentrated, and then passed through a reverse-phase column (80-98% MeOH / H2. The degree of extraction) produces 4 brain distillates. The first product isolated was recrystallized from MeOH to give 0.16 g of 5-amino-6,7-dehydrospinoxin D, mp. 165 ° C. M.S. M + H peaked at 764.7. The second part of the distillate was 7-fluorospinostinosin D, with MS M + H peaking at 760.8. The remaining distillates were mainly unsaturated (7, 8- and 7, 11-go Hydrogen) Substance ϋ I --- Ίί .--- 0—I (Please read the precautions on the back before filling this page)

、1T 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 經濟部中央標準局員工消費合作社印製 487559 A7 B7___ 五、發明説明(说) 宵带例Μ- 5 · 6 -二氣-β · 7 -去氫史賓—諾辛D及5,一6 -二氫-.711 -去氤中審諾辛[) , 於0.2 g(〇.27 mmol)7,8-二氫史賓諾辛D之5 ml乙醇 溶液中添加0 · 5 m 1環己院及5 0 m g (c a t)濕潤之P d (0 Η) 2 / C 。將溶液在迴流溫度下加熱2小時,接著將其冷卻、過擴 及濃縮成油狀物。層析(逆相管柱,80-98%甲醇/水梯度溶 液)提供二種新産物。第一種(40 mg)為5,6-二氫_7, 11-去 氫史賓諾辛 D, rap· 166°C。UMRUOO MHz, CDC13)5 1.0(d, J = 7 Hz, 3H; C-6 甲基)。C42HuN(h〇 之分析: 所需值:C, 67.62; Η, 9 · 05; N, 1· 88。實際值:C, 66.65; Η, 9.07; N, 1.73。第二種(60 mg)為 5,6-二氫-6 ,7-去氫史賓諾辛 DUp· HSChUMRUOOMHz, CDC13 )56.73(br s, 1H); 4.9(s, 1H); 4.63(m, 1H) ; .4.42( d, J=6 Hz, 1H); 4.15(m, 1H); 1.67(d, J = 2Hz, 3H); t-6丙烯基甲基)。 窨施例1 8 -殺昆蟲劑及殺蟎劑之利用桦 本發明之化合物顯示抗多種毘蟲及蟎的活性。更恃別 別地,本發明之化合物顯示抗西瓜蚜蟲之活性,該蚜蟲為 同翅目毘蟲之一員。其他同翅目之成員包含葉蟬、飛虱、 梨黃大虱、蘋果吸盤蟲、蚧、粉虱、沫蟬及許多其他持定 寄主之蚜蟲類。亦可觀察到對溫氏薊馬的活性,其為缓翅 目之成員。本發明之化合物亦可抗亞熱帶黏蟲,其為鳞翅 目之一員。其他典型之此目成員每含蘋果蠹蛾.、地老虎、 衣蛾、印度谷螟、捲葉蟲、美洲棉鈐蟲、歐洲玉米_、菜 -289 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -----:--^---ΜΨ-- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 487559 A7 __B7_ 五、發明説明(必) 螟、甘籃尺蠖、美洲棉鈐蟲、袋蛾、洲天幕毛蟲、sod w e b w 〇 r m、草地黏蟲ϋ ; 本發明之化合物可用於降低昆蟲及蟎的族群,及可用 於抑制毘蟲或蟎之族群,其包含將如上述實施例所述之本 發明的化合物以有效之毘蟲或蟎之去活性量施用在毘蟲或 蟎出沒的地點。結果報告如下表,其中下述為表中所用之 縮寫: ALH 意指紫莞葉蟬 BAW 意指甜菜葉蛾 CA 意指棉蚜 MEM 意指花生根節線結蟲類 SCRW意指十一星瓜葉甲 TBW 意指美洲菸葉蛾 TSSM意指棉葉織 GECR意指德國蟑螂 在進行殺害蟲活性評估時,每個試驗化合物係調製成 400 ppm溶液,及該溶液接著以水稀釋成較低之濃度。400 PPm溶液之製備像藉由將19 · 2 ml之0 · 05%吐溫(Tween) 20 ( 聚氯乙烯(20)去水山梨醇單月桂酸酯)之水溶液與8 mg本 發明之化合物之8m 1丙酮/乙醇(9/1)的溶液。抗紫莞葉蟬 之活性的測定如下。此測試偽利用400 ppm及50 ppm之濃 度進行。1盅司之塑膠杯中含有利用扇形霧錐噴嘴噴覆有 0.4 ml配製物質之棉芯。容許過量的水份蒸發。將5至10 二氧化碳麻醉的成蟬放入每個杯子中。將杯子加蓋並在室 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) -----Ί — ^---MW-- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 487559 A7 B7 五、發明説明(成) 溫下保持24小時。可計算死亡率。 抗甜菜葉蛾之活性係如下述評估。此測試偽利用400 ppm及50 PPIU之濃度進行。一般目的之鳞翅目人工食料以5 ίϋ非營養性洋菜膠稀釋成一半強度°取8 m 1食料物質分佈 於1盎司之餵食杯内。在處理前1小時,將35-40蛋分佈在 食料表面。接著將杯子經由扇形霧錐噴嘴噴覆經調配之物 質。使經處理之杯子在以塑膠蓋密封前風乾,杯子在室溫 下放置6天。活性傺依活存及死亡之幼蟲總量及依活存之 幼蟲的大小決定。 抗棉蚜及棉葉蛾之活性偽如下述評估° G ο 1 d e n c r ο 〇 k neck南瓜植物像生長以延伸子葉階段(約6至8天)。在施 用測試物質前使植物藉由自保存菌種切下害蟲群之轉移薄 片以感染棉蚜及棉葉蛾16-24小時。在噴覆測試物質之前 ,很快地將轉移薄片自南瓜植物移開。測試傺採用400 PPm及50 ppm之濃度進行。利用在17 psi之霧化噴霧器使 植物噴覆測試物質。葉面及葉背的表面都要塗覆直至呈可 流動,及接著使其乾燥。每種化合物之活性皆在處理後3 天測定。活性係以蟎或蟬在僅以溶劑噴覆之植物上出現數 目為基準。 抗花生根節線結蟲類之活性係如下述評估。5個未處 理之黃瓜種子放在乾淨之1盎司之杯子的底部,加入20 g 乾淨的白沙,及當噴霧杯子時同時旋轉底部以使1. 〇 m 1之 400 ppm的溶液可位於沙上。於每1固杯子中加入2 · 5-3 · 0 ml含有300至500線蟲之去離子水。將杯子置於環境生長室 -291 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) I---^-------0-- (請先閲讀背面之注意事項再填寫本頁), 1T Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs This paper is printed in accordance with the Chinese National Standard (CNS) A4 specification (210 × 297 mm) Printed by the Employees Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7___ 5. Description of the invention (say) Xiao Example M- 5 · 6-Digas-β · 7-Dehydrospin-Nosin D and 5, 6-Dihydro-.711-Desmodium Nosing [], at 0.2 g (0. 27 mmol) of 7,8-dihydrospinoxin D in 5 ml of ethanol solution was added with 0.5 m 1 of cyclohexane and 50 mg (cat) of moist Pd (0 Η) 2 / C. The solution was heated at reflux temperature for 2 hours, then it was cooled, over-expanded and concentrated to an oil. Chromatography (reverse phase column, 80-98% methanol / water gradient solution) provided two new products. The first (40 mg) was 5,6-dihydro-7, 11-dehydrospinoxin D, rap · 166 ° C. UMRUOO MHz, CDC13) 5 1.0 (d, J = 7 Hz, 3H; C-6 methyl). Analysis of C42HuN (h〇: required value: C, 67.62; Η, 9 · 05; N, 1. 88. Actual value: C, 66.65; Η, 9.07; N, 1.73. The second (60 mg) is 5,6-dihydro-6,7-dehydrospinnoxin DUp · HSChUMRUOOMHz, CDC13) 56.73 (br s, 1H); 4.9 (s, 1H); 4.63 (m, 1H); .4.42 (d, J = 6 Hz, 1H); 4.15 (m, 1H); 1.67 (d, J = 2Hz, 3H); t-6 propenylmethyl). Example 18-Utilization of Insecticides and Acaricides The compounds of the present invention show activity against various migratory insects and mites. More particularly, the compound of the present invention exhibits an activity against watermelon aphids, which is a member of Homoptera. Other members of the order Homoptera include leafhoppers, planthoppers, pear yellow planthoppers, apple worms, pupae, whiteflies, mochi, and many other host aphids. Activity on thrips Wynn was also observed, which is a member of the order Homoptera. The compounds of the present invention are also resistant to subtropical armyworms, which are members of the order Lepidoptera. Other typical members of this order each contain Apple maggot moth, ground tiger, clothes moth, Indian valley maggot, leaf curler, cotton bollworm, European corn _, vegetable -289-This paper size applies Chinese National Standard (CNS) A4 specifications (210X297 mm) -----:-^ --- ΜΨ-- (Please read the notes on the back before filling out this page) Ordered by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs to print 487559 A7 __B7_ 5 2. Description of the invention (must) maggots, crickets, cotton woolworms, bag moths, canopy caterpillars, sod webw omm, grasshopper worms; the compounds of the present invention can be used to reduce insects and mites, and can be used for A mime or mite-inhibiting population comprises applying a compound of the present invention as described in the above examples in an effective deactivating amount of a mime or mite to a place where the mime or mite is infested. The results are reported in the following table, where the following are the abbreviations used in the table: ALH means purple cicada leafhopper BAW means beet leaf moth CA means cotton aphid MEM means peanut root knot nematodes SCRW means eleven star melon Leaf beetle TBW means Tobacco leaf moth TSSM means cotton leaf weave GECR means German cockroach In the evaluation of insecticidal activity, each test compound was prepared into a 400 ppm solution, and the solution was then diluted to a lower concentration with water . The 400 PPm solution was prepared by mixing an aqueous solution of 19.2 ml of 0. 05% Tween 20 (polyvinyl chloride (20) sorbitan monolaurate) with 8 mg of a compound of the invention 8 ml of a solution of acetone / ethanol (9/1). The activity against the purple leafhopper was determined as follows. This test was performed using 400 ppm and 50 ppm concentrations. The plastic cup of 1 cup Division contains a cotton core coated with 0.4 ml of formulated substance using a fan-shaped mist cone nozzle. Allow excess water to evaporate. Put 5 to 10 carbon dioxide anesthetized adults into each cup. Cover the cup and apply the Chinese National Standard (CNS) A4 specification (210 X 297 mm) in the paper size of the room. ----- Ί — ^ --- MW-- (Please read the notes on the back before filling This page) Order printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 B7 V. Description of the invention (into) Keep at temperature for 24 hours. Calculate mortality. The activity against beet leaf moth was evaluated as follows. This test was performed at a concentration of 400 ppm and 50 PPIU. General purpose Lepidoptera artificial food is diluted with 5 liters of non-nutritive agar gelatin to half strength. 8 m 1 of food material is distributed in a 1-ounce feeding cup. One hour before treatment, 35-40 eggs were distributed on the surface of the food. The cup is then sprayed with the formulated substance through a fan-shaped mist cone nozzle. The treated cups were allowed to air dry before being sealed with a plastic lid, and the cups were left at room temperature for 6 days. Active 傺 depends on the total number of live and dead larvae and the size of live larvae. The activity against cotton aphids and cotton leaf moths was evaluated as follows: ° G ο 1 d e n c r ο k neck Pumpkin plants grew to extend the cotyledon stage (about 6 to 8 days). Before applying the test substance, the plants were infected with cotton aphids and cotton leaf moths by cutting off a transfer sheet of the pest swarm by preserving the strains for 16-24 hours. Before spraying the test substance, the transfer flakes were quickly removed from the pumpkin plant. The test was performed at 400 PPm and 50 ppm. Plants were sprayed with the test substance using a spray atomizer at 17 psi. Both the leaf surface and the back of the leaf are coated until they are flowable and then allowed to dry. The activity of each compound was measured 3 days after treatment. Activity is based on the number of mites or cicadas appearing on plants sprayed with solvents only. The activity against peanut root-knot nematodes was evaluated as follows. Five untreated cucumber seeds were placed on the bottom of a clean 1 ounce cup, 20 g of clean white sand was added, and the bottom was rotated while spraying the cup so that a solution of 1.0 ppm of 400 ppm could be placed on the sand. Add 2 · 5-3 · 0 ml deionized water containing 300 to 500 nematodes per 1 cup. Place the cup in the environmental growth room -291-This paper size applies to Chinese National Standard (CNS) Α4 size (210X297mm) I --- ^ ------- 0-- (Please read the precautions on the back first (Fill in this page again)

、1T 經濟部中央標準局員工消費合作社印製 487559 A7 B7_ 五、發明説明(翊) 内10至12天,在溫度76至856T及大氣濕度為50至60%。 於10至12天後’藉由倒轉杯子及,觀察線蟲之死亡率及對黃 瓜植物危害程度來評估° 抗十一星瓜葉甲之活性偽藉由將1 in 1含有預決定濃度 之測試溶液添加至含有玉米粒之16g貧土中以評估。由此 産生之土壤内濃度為24 ppm。於乾燥1.5至2小時後,將5 個四齡幼蟲之十一星瓜葉甲置入每個杯子中。於3至4天後 ,藉由將杯子倒空於一盤子上並檢查土壤中之活蟲數。 抗美洲菸葉蛾之活性係評估如下。將一般目的之鱗翅 目人工食料以5¾非營養性洋菜膠稀釋成一半強度。取8 m 1 食料物質分佈於1盎司之餵食杯内。在處理前1小時,將35 -40蛋分佈在食料表面。接著將杯子經由扇形霧錐噴嘴噴 覆經調配之物質。測試係利用400 ppm及50 ppm進行。使 經處理之杯子在以塑膠蓋密封前風乾,杯子在室溫下放置 6天。活性偽依活存及死亡之幼蟲總量及依活存之幼蟲的 大小決定。 抗德國蟑螂之活性係評估如下。將8ιη 1以綠色害蟲食 物為主的苜蓿放入1盎司之餓.食杯中。接箸經由扇形霧錐 噴嘴使杯子噴覆經調製之物質。測試偽利用400 ppm及50 P P in之濃度進行。使測試杯風乾2 4小時並感染比第三齡晚 五及第四龄之德國蟑螂。使杯子上蓋及在環境生長室中保 持10天,溫度為76-85°C。活性偽依存活及死亡蟲數之總 量來評估。 殺蟎劑^利用桦 -292 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -----^-IJ---ΦII (請先閱讀背面之注意事項再填寫本頁) 、tr 經濟部中央標準局員工消費合作社印製 487559 A7 __B7_ 五、發明説明(do) , 本發明之方法根據殺蟎劑應用之標準技術實行。一般 而言,良好的殺織活性可被預期在1 _ 10 1 b s / a c r e之等级 。化合物可配製成本文中所描述的形式。當配製成分散液 時,殺蟎劑一般偽以浸液形式施用在生長植物的周圍或經 由刺激条統增進使用。當以顆粒形式使用時,殺蟎劑可在 耕種前與土壤混合,或以帶狀形式施用在種子列的表面、 播種區及接著與土壤混合,或可以側塗之方式施用於已長 成之作物。 下述活性係由下述化合物發現: 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, 1T 487559 A7 B7_ V. Description of the invention (翊) Within 10 to 12 days, at a temperature of 76 to 856T and an atmospheric humidity of 50 to 60%. After 10 to 12 days, 'evaluate by inverting the cup and observing the nematode mortality rate and the degree of damage to cucumber plants ° The activity against the eleven star melon leaf beetle is by 1 in 1 containing a predetermined concentration of the test solution Added to 16g of lean soil containing corn kernels for evaluation. The resulting soil concentration was 24 ppm. After drying for 1.5 to 2 hours, the eleven star melon leaves of five fourth instar larvae were placed in each cup. After 3 to 4 days, check the number of live insects in the soil by emptying the cup on a plate. The activity system against American tobacco leaf moth was evaluated as follows. The general purpose Lepidoptera artificial food was diluted to half strength with 5¾ non-nutritive agar gum. Take 8 m 1 of food material and distribute it in a 1 ounce feeding cup. One hour before the treatment, 35-40 eggs were distributed on the surface of the food. The cup is then sprayed with the formulated substance via a fan-shaped mist cone nozzle. The tests were performed using 400 ppm and 50 ppm. The treated cups were air-dried before being sealed with a plastic lid, and the cups were left at room temperature for 6 days. The active pseudonym depends on the total number of live and dead larvae and the size of the live larvae. The activity against German cockroaches was evaluated as follows. Place 8 alfalfa, which is dominated by green pest food, into a 1-ounce cup of hungry food. The cup is then sprayed with the prepared substance via a fan-shaped mist cone nozzle. The test was performed using 400 ppm and 50 P in concentrations. The test cup was air-dried for 24 hours and infected with German cockroaches that were five and four years later than the third age. The cup was kept on top and kept in an environmental growth chamber for 10 days at a temperature of 76-85 ° C. The activity was evaluated in terms of the total number of surviving and dead insects. Acaricide ^ Using birch-292-This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297mm) ----- ^-IJ --- ΦII (Please read the precautions on the back before filling in this Page), tr Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 487559 A7 __B7_ 5. Description of the Invention (do), The method of the present invention is implemented according to the standard technology of acaricide application. In general, good weaving activity can be expected on the order of 1 _ 10 1 b s / a c r e. The compounds may be formulated in the forms described herein. When formulated as a dispersion, the acaricide is generally applied in the form of an infusion in the vicinity of the growing plant or is enhanced by stimulating the system. When used in granular form, the acaricide can be mixed with the soil before cultivation, or applied in bands on the surface of the seed row, the sowing area and then mixed with the soil, or it can be applied sideways to the grown crop. The following activities were discovered by the following compounds: This paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page)

487559 A7 B7 五、發明説明⑺丨) 經濟部中央標準局員工消費合作社印製 % 樣品編號 曰虫 t匕虫Λ 速率 死亡率 A1 T3W 400 , 100 A1 TSSM 400 100 A2 TBW 400 100 A3 T3W 400 100 A4 TBW 400 100 A5 T3W 400 100 A6 TBW 400 100 A7 TBW 400 100 A9 TBW 400 100 A10 TBW 400 100 All TBW 400 100 A12 TBW 400 100 A13a TBW 400 100 A13b TBW 400 100 A14 T3W 400 100 A15 TBW 400 100 A16 TBW 400 100 All TBW 400 100 A18 TBW 400 100 A13 TSSM 400 100 A19 TBW 400 100 A20 TBW 400 100 A21 TBW 400 100 A22 TBW 400 100 A22 TSSM 400 100 A23 TBW 400 100 A23 TSSM 400 100 A24 TBW 400 100 A24 TSSM 400 100 A25 TBW 400 100 A25 TSSM 400 100 A26 TBW 400 100 A26 TSSM 400 100 A27 TBW 400 100 Λ23 TBW 400 ' 100 -294 - (請先閱讀背面之注意事項再填寫本頁)487559 A7 B7 V. Description of the invention)) Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs% Sample No. Worm t Dagger Λ Rate Mortality A1 T3W 400, 100 A1 TSSM 400 100 A2 TBW 400 100 A3 T3W 400 100 A4 TBW 400 100 A5 T3W 400 100 A6 TBW 400 100 A7 TBW 400 100 A9 TBW 400 100 A10 TBW 400 100 All TBW 400 100 A12 TBW 400 100 A13a TBW 400 100 A13b TBW 400 100 A14 T3W 400 100 A15 TBW 400 100 A16 TBW 400 100 All TBW 400 100 A18 TBW 400 100 A13 TSSM 400 100 A19 TBW 400 100 A20 TBW 400 100 A21 TBW 400 100 A22 TBW 400 100 A22 TSSM 400 100 A23 TBW 400 100 A23 TSSM 400 100 A24 TBW 400 100 A24 TSSM 400 100 A25 TBW 400 100 A25 TSSM 400 100 A26 TBW 400 100 A26 TSSM 400 100 A27 TBW 400 100 Λ23 TBW 400 '100 -294-(Please read the precautions on the back before filling this page)

本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 487559 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(印) A29 Λ29 A3 0 A31 A3 2 A3 3 Λ3 4 Λ3 5 A3 6 A3 7 A3 3 A3 3 A3 9 A3 9 A40 1 A41 A42 A43 A44 A45a A4 5c A45c A45b A4 6 A43 A49a A49b ASO A51 A52 A53 A53 A54 A54 A55 A5 5 Λ5 6 Λ5 5 T3W 400 100 T3SM 400 100 T3W 400, 100 TBW 400 100 TBW 400 90 T3W 400 100 T3W 400 10C TBW 400 100 TBV/ 400 100 T3W 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TSSM 400 100 T3W 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TBW 30 100 TBW 400 100 TBW 400 30 TBW 64 25 TBW 400 100 Intiermed TBW 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TSSM 400 100 TBW 400 ' 100 TSSM 400 100 295 - —^ϋ· im §§1 ϋ_ι ml —ϋ Βϋ—i -ϋ^ I (請先閱讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 487559 A7 B7 五、發明説明(M3) Λ57 A53a A53b A59 AoOa A50b Λ 51 A62 A53 A53 A64a A〇4b A65 Αββ Αβ β Α67 Α67 Α63 Λ69 Α7 0 Α71 Α72 Α7 3 Α7 4 Α7 5 Α7 6 Α77 A73a A7 3b A7 3c A79 A80a A8 0b A31 A31 AS 5 A3S Λ37 TSSM 400 100 T3W 400 100 TEW 400 100 T3W 400 100 TBW 400 100 TBW 4〇p 100 TBW 400 1G0 TBW 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 T3W 400 100 T3W 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 T3W 400 100 TBW 400 100 TBW 64 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 丄00 TBW 400 100 GECR 400 20 TBW 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TBW _ 100 T3W 400 100 296 - —---,--1---- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 487559 A7 B7 五、發明説明(2料) 經濟部中央標準局員工消費合作社印製 A3 3 CLH 400 20 A3 9 T3W 400 100 A91 Incarmed i B1 TSSM 400 90 B2 T3W 100 100 B3 TSSM 200 40 B4 TSSM 100 50 35 TSSM 100 65 B6 TBW · 30 100 B7 CA 200 60 B8 TBW 400 100 B9 TBW 400 100 B10 .TBW 400 100 B11 TBW 400 60 B12 TSSM 400 90 B12 TBW 400 100 B13 TBW 400 100 B14 TBW 400 100 B15 TBW 400 ' 100 B16 TSSM 400 100 B16 TBW 400 100 B17 TBW 400 100 B19 Incermed C1 TBW 80 100 C1 TSSM 400 100 C3 TBW 400 100 C3 TSSM 400 100 C4 TBW 80 100 C5 TBW 400 100 C6 TBW 80 60 C7 TBW 80 100 C7 TSSM 40 97 C3 TSSM 200 50 C9 TBW 400 100 C10 TBW 400 100 C11 TBW 400 * 100 C12 TBW *400 100 C12 TSSM 400 100 297 - (請先閱讀背面之注意事項再填寫本頁)This paper size applies to China National Standard (CNS) A4 (210X 297 mm) 487559 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (printed) A29 Λ29 A3 0 A31 A3 2 A3 3 Λ3 4 Λ3 5 A3 6 A3 7 A3 3 A3 3 A3 9 A3 9 A40 1 A41 A42 A43 A44 A45a A4 5c A45c A45b A4 6 A43 A49a A49b ASO A51 A52 A53 A53 A54 A54 A55 A5 5 Λ5 6 Λ5 5 T3W 400 100 T3SM 400 100 T3W 400, 100 TBW 400 100 TBW 400 90 T3W 400 100 T3W 400 10C TBW 400 100 TBV / 400 100 T3W 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TSSM 400 100 T3W 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TBW 30 100 TBW 400 100 TBW 400 30 TBW 64 25 TBW 400 100 Intiermed TBW 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TSSM 400 100 TBW 400 '100 TSSM 400 100 295-— ^ ϋ · im §§1 ϋ_ι ml —ϋ Βϋ—i -ϋ ^ I (Please read the notes on the back before filling this page) The paper size of the paper is applicable to the Chinese national standard (CNS) A4 specifications (210X297 mm) 487559 A7 B7 V. Description of the invention (M3) Λ57 A53a A53b A59 AoOa A50b Λ 51 A62 A53 A53 A64a A〇4b A65 Αββ Αβ β Α67 Α67 Α63 Λ69 Α7 0 Α71 Α72 4 Α7 5 Α7 6 Α77 A73a A7 3b A7 3c A79 A80a A8 0b A31 A31 AS 5 A3S Λ37 TSSM 400 100 T3W 400 100 TEW 400 100 T3W 400 100 TBW 400 100 TBW 4〇p 100 TBW 400 1G0 TBW 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 T3W 400 100 T3W 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 T3W 400 100 TBW 400 100 TBW 64 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 丄 00 TBW 400 100 GECR 400 20 TBW 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TBW _ 100 T3W 400 100 296------, --1-- -(Please read the precautions on the back before filling out this page) Order the paper printed by the Central Consumers Bureau of the Ministry of Economic Affairs. The paper size is applicable to the Chinese National Standard (CNS) A4 (210X 297 mm) 487559 A7 B7 5 Description of the invention (2 materials) Printed by A3 3 CLH 400 20 A3 9 T3W 400 100 A91 Incarmed i B1 TSSM 400 90 B2 T3W 100 100 B3 TSSM 200 40 B4 TSSM 100 50 35 TSSM 100 65 B6 TBW30 100 B7 CA 200 60 B8 TBW 400 100 B9 TBW 400 100 B10 .TBW 400 100 B11 TBW 400 60 B12 TSSM 400 90 B12 TBW 400 100 B13 TBW 400 100 B14 TBW 400 100 B15 TBW 400 '100 B16 TSSM 400 100 B16 TBW 400 100 B17 TBW 400 100 B19 Incermed C1 TBW 80 100 C1 TSSM 400 100 C3 TBW 400 100 C3 TSSM 400 100 C4 TBW 80 100 C5 TBW 400 100 C6 TBW 80 60 C7 TBW 80 100 C7 TSSM 40 97 C3 TSSM 200 50 C9 TBW 400 100 C10 TBW 400 100 C11 TBW 400 * 100 C12 TBW * 400 100 C12 TSSM 400 100 297-(Please read the precautions on the back before filling this page)

本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐) 487559 A7 B7 五、發明説明(灼r) 、 C13a C14 C15 CIS CIS C17 C13 C13 C19 C19 C20 C21a C21b C22 C22 C23 C23 C24 C25 C26 C27 C23 C29 C3 0 C31 D1 D2 D4 D4 D5 D6 D7 D8 D9 DIO Dll Dll DI2 TBW 64 100 T3W 21 42 TBW 400 100 TSSM 400 100 TBW 64 54 TBW 400 70 T3W 400 100 TSSM 400 100 T3W 400 100 TSSM 400 100 GECR 400 20 TBW 400 100 TSSM 400 100 TBW 400 · 100 TSSM 400 100 T3W 400 100 TSSM 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 64 100 TBW 400 30 TBW 64 • 22 TBW 400 100 TBW 30 33 TBW 80 90 TBW 400 100 TSSM 400 100 TBW 64 95 TBW 400 100 TBW 64 58 TBW 400 100 TBW 400 100 TBW 400 80 TBW · 400 100 TSSM 400 90 TBW 400 100 (請先閱讀背面之注意事項再填寫本頁)This paper size applies to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 487559 A7 B7 V. Description of the invention (Chao), C13a C14 C15 CIS CIS C17 C13 C13 C19 C19 C20 C21a C21b C22 C22 C23 C23 C24 C25 C26 C27 C23 C29 C3 0 C31 D1 D2 D4 D4 D5 D6 D7 D8 D9 DIO Dll Dll DI2 TBW 64 100 T3W 21 42 TBW 400 100 TSSM 400 100 TBW 64 54 TBW 400 70 T3W 400 100 TSSM 400 100 T3W 400 100 TSSM 400 100 GECR 400 20 TBW 400 100 TSSM 400 100 TBW 400100 TSSM 400 100 T3W 400 100 TSSM 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 64 100 TBW 400 30 TBW 64 • 22 TBW 400 100 TBW 30 33 TBW 80 90 TBW 400 100 TSSM 400 100 TBW 64 95 TBW 400 100 TBW 64 58 TBW 400 100 TBW 400 100 TBW 400 80 TBW400 100 TSSM 400 90 TBW 400 100 (Please read the notes on the back before filling this page)

、1T 4 經濟部中央標準局員工消費合作社印製 -208 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 487559 A7 B7 五、發明説明(州 經濟部中央標準局員工消費合作社印製 D13 _ GECR 400 40 D14 TBW 400 100 D15 TBW 400 100 DI5 TSSM 400 100 D16 Incermed D17 3AW 400 60 D18 TBW 400 100 D19 TBW 400 30 D20 TBW 400 100 D21a GECR 400 2G D21b TBW 400 100 ΞΙ ALH 400 100 Ε2 GECR 400 20 E4b TBW 400 100 E4b TSSM 400 60 E5 TBW 30 35 Eo NEHA 400 100 E7 TSSM 200 100 E3 BAW 400 30 FI TBW 400 100 F2 TBW 400 · 100 F3 TBW 400 100 F3 TSSM 64 24 F4 TBW 64 24 F5a TBW 400 100 F5b TBW 400 100 F7 TBW 64 100 F7 TSSM 400 100 FBa TBW 400 100 F3a TSSM 400 90 F8b TBW 400 100 F9a TBW 400 100 •F9a TSSM 400 90 F9b TBW 400 100 F9b TSSM 400 90 F10 Incermed Fll Incermed F12a BAW 56 SO 299 - I---:-I^—MmII (請先閱讀背面之注意事項再填寫本頁)1T 4 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs -208-This paper size applies to the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 487559 A7 B7 V. Description of the invention (Employment Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Printed D13 _ GECR 400 40 D14 TBW 400 100 D15 TBW 400 100 DI5 TSSM 400 100 D16 Incermed D17 3AW 400 60 D18 TBW 400 100 D19 TBW 400 30 D20 TBW 400 100 D21a GECR 400 2G D21b TBW 400 100 ALΙ ALH 400 100 Ε2 GECR 400 20 E4b TBW 400 100 E4b TSSM 400 60 E5 TBW 30 35 Eo NEHA 400 100 E7 TSSM 200 100 E3 BAW 400 30 FI TBW 400 100 F2 TBW 400 100 F3 TBW 400 100 F3 TSSM 64 24 F4 TBW 64 24 F5a TBW 400 100 F5b TBW 400 100 F7 TBW 64 100 F7 TSSM 400 100 FBa TBW 400 100 F3a TSSM 400 90 F8b TBW 400 100 F9a TBW 400 100 F9a TSSM 400 90 F9b TBW 400 100 F9b TSSM 400 90 F10 Incermed Fll Incermed F12a BAW 56 SO 299-I ---:-I ^ —MmII (Please read the notes on the back before filling this page)

、1T 本紙張尺度適用中國國家標準(CNS ) Α4規格(210 X 297公釐) 487559 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(d?) F12b F13a F13a F13b F14 F15a Fl5b Flo F17 F18 F19 F20 F21a F22 F23 F24 F25 F26 F27 F23 F29 F29 F30 F3 0 F31 G1 G2 G4 G5 G6 HI HI H2 H3 H3 H4 H5 TBW 400 100 TBW 400 100 TSSM * 400 100 T3W 400 LOG T3W 400 100 T3W 400 10C T3W 400 o 0 TBW 400 100 T3W 400 60 T3W 400 10C T3W 400 100 T3W 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 T3W 400 100 BAW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TSSM. 400 100 TBW 400 100 Intermed TSSM 200 20 Incermed TBW 400 100 Incermed TBW 400 100 TSSM 400 100 Incermed TBW 400 100 TSSM 400 100 TBW 400 100 TSW 400 100 TBW 400 100 300 - -----;--^--ΑΨ —— (請先閱讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 487559 A7 B7 五、發明説明(2郎) 經濟部中央標準局員工消費合作社印製 H6 TSSM 400 100 H7 TBW 400 100 H3 T3W 400 , 100 H3 TSSM 400 100 11 TBW 400 100 11 TSSM 400 100 12 T3W 400 100 12 TSSM 400 100 13 TBW 400 100 13 TSSM 400 90 14 TBW 400 100 14 TSSM 400 30 15 TBW 400 100 15 TSSM 400 100 工6 TBW 400 100 16 TSSM 400 30 17 TBW 400 100 17 TSSM 400 100 13 TBW 400 100 13 TSSM 400 100 19 TBW 400 100 110 TBW 400 100 111 Incermed 112 Incermed 113 TBW 400 100 113 TSSM 400 100 114 TBW 400 100 114 TSSM 400 100 115 TBW 400 100 116 TBW 400 100 117 T5W 400 100 113 BAW 400 30 J1 BAW 400 30 J2 TBW 400 40 J3 TBW 400 100 J4 TBW 400 100 J6 GECR 200 20 301 — I---‘--?----(請先閱讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 487559 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(介Ο J7 GECR 200 20 K1 TSSM 400 100 K2a CA 400 50 K2b TBW 64 15 K5 CPH 400 100 實施例19實施例17之史賓諾辛衍生物 廯螫欞及顥«夕捽制 測試步驟如下: 將欲評估之化合物溶解於1份丙酮及1份乙醇中以提供 濃度為5000ppm之化合物原液。將溶液在超音波振盪中振 盪15分鐘。把原液部分置於15 ml試管及加入部分牛血清 以提供所欲之化合物稀釋度。把牙線芯置於每根試管中使 血清可鉋和該芯。 就麗蠅之測試而言,將約20麗蠅幼蟲置於飽和牙線芯 之頂部中心,及以棉花塞緊試管並培養於27 °C及70%濕度 下24至48小時。計數所造成之幼蟲死亡率及以控制媒介物 調整死亡率以決定抗麗蠅之效率百分比。 就廄螫蠅之成蟲測試而言,飽和芯係放置於培養皿之 濾紙上,將約10隻冷卻存活之飢蛾廄螫蠅放在皿底中央。 蓋上培養皿並培養在27°C及60%相對濕度下48小時。各自 在24及48小時記錄死亡率讀數及以控制媒介物調整任何死 亡率以決定抗廄螫蠅蓋_成蟲的有效性。 結果報告如下: 、 -302 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) ' — ------I^-IdwII (請先閲讀背面之注意事項再填寫本頁) 訂 487559 A7 B7 五、發明説明(3的) 中客諾宰頷化合物之動物科擧齡摅 本發明 實施例 編號 在 lOOppm 時,ASF 被殺死的 百分比 在 10 P P m 時,縦 被殺死的 百分比 在 10 0 p p m 時,LBF 被殺死的 百分比 在lOppm 時,LBF 被殺死的 百分比 Λ2 A3 100% Α5 100% Α6 100% Α7 100% Λ9 100% Λ10 100% All 100% A12 100% -- (請先閲讀背面之注意事項再填寫本頁) 1.、 1T This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) 487559 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of invention (d?) F12b F13a F13a F13b F14 F15a Fl5b Flo F17 F18 F19 F20 F21a F22 F23 F24 F25 F26 F27 F23 F29 F29 F30 F3 0 F31 G1 G2 G4 G5 G6 HI HI H2 H3 H3 H4 H5 TBW 400 100 TBW 400 100 TSSM * 400 100 T3W 400 LOG T3W 400 100 T3W 400 10C T3W 400 o 0 TBW 400 100 T3W 400 60 T3W 400 10C T3W 400 100 T3W 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 T3W 400 100 BAW 400 100 TBW 400 100 TBW 400 100 TBW 400 100 TSSM 400 100 TBW 400 100 TSSM. 400 100 TBW 400 100 Intermed TSSM 200 20 Incermed TBW 400 100 Incermed TBW 400 100 TSSM 400 100 Incermed TBW 400 100 TSSM 400 100 TBW 400 100 TSW 400 100 TBW 400 100 300------;-^ --ΑΨ —— (Please read the notes on the back before filling out this page) The size of the paper is applicable to the Chinese National Standard (CNS) A4 (210X 297 mm) 487559 A7 B7 Ming (2 Lang) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs H6 TSSM 400 100 H7 TBW 400 100 H3 T3W 400, 100 H3 TSSM 400 100 11 TBW 400 100 11 TSSM 400 100 12 T3W 400 100 12 TSSM 400 100 13 TBW 400 100 13 TSSM 400 90 14 TBW 400 100 14 TSSM 400 30 15 TBW 400 100 15 TSSM 400 100 TBW 400 100 16 TSSM 400 30 17 TBW 400 100 17 TSSM 400 100 13 TBW 400 100 13 TSSM 400 100 19 TBW 400 100 110 TBW 400 100 111 Incermed 112 Incermed 113 TBW 400 100 113 TSSM 400 100 114 TBW 400 100 114 TSSM 400 100 115 TBW 400 100 116 TBW 400 100 117 T5W 400 100 113 BAW 400 30 J1 BAW 400 30 J2 TBW 400 40 J3 TBW 400 100 J4 TBW 400 100 J6 GECR 200 20 301 — I ---'--? ---- (Please read the precautions on the back before filling out this page) The paper size for this edition applies the Chinese National Standard (CNS) A4 Specifications (210X297 mm) 487559 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (introduction J7 GECR 200 20 K1 TSSM 400 100 K2a CA 400 50 K2b TBW 64 15 K5 CPH 400 10 0 Example 19 The Spinoxin derivative of Example 19 and the preparation method of Example 17 are as follows: The compound to be evaluated is dissolved in 1 part of acetone and 1 part of ethanol to provide a stock solution of the compound at a concentration of 5000 ppm. . The solution was shaken for 15 minutes in an ultrasonic wave. Place a portion of the stock solution in a 15 ml tube and add a portion of bovine serum to provide the desired compound dilution. Place the dental floss core in each tube to allow the serum to shave the core. For the test of the fly, about 20 fly larvae are placed in the center of the top of the saturated dental floss core, and the test tube is stuffed with cotton and cultured at 27 ° C and 70% humidity for 24 to 48 hours. Count the larval mortality and adjust the mortality with the control medium to determine the percentage efficiency against Lividae. For the test of adult flies, a saturated core was placed on a filter paper in a petri dish, and about 10 chilled and live flies were placed in the center of the bottom of the dish. Cover the petri dish and incubate at 27 ° C and 60% relative humidity for 48 hours. Mortality readings were recorded at 24 and 48 hours, respectively, and any mortality rate was adjusted with the control vehicle to determine the effectiveness against the flyfly cover adult. The result report is as follows: 、 -302-This paper size applies to Chinese National Standard (CNS) A4 specification (210X 297mm) '— ------ I ^ -IdwII (Please read the precautions on the back before filling this page ) Order 487559 A7 B7 V. Description of the invention (3) The animal family age of the cockroach 颔 compound in the present invention Example No. When the number of the present invention is 100 ppm, the percentage of ASF killed is 10 PP m. When the percentage is at 100 ppm, the percentage of LBF killed is at 10 ppm. The percentage of LBF killed is Λ2 A3 100% Α5 100% Α6 100% Α7 100% Λ9 100% Λ10 100% All 100% A12 100%- (Please read the notes on the back before filling this page) 1.

、1T 經濟部中央標準局員工消費合作社印製 -303 - 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 487559 A7 B7 五、發明説明(別) 經濟部中央標準局員工消費合作社印製 A13a 100% A13d 100% Λ14 100% ) ΛΙ5 100% A17 100% A13 100% Λ19 100% Λ2 0 100% Λ22 100% A23 100% Λ2 5 100% A27 100% A23 100% A29 100% A3 0 100% A3 1,117 100% A3 2 丄00% A3 3 100% A3 4 100% A3 6 100% A3 7 100% A4 0 100% A4 6 100% 100% A47 &lt;:50% A43 100% &lt;5G% A49b &lt;:50% A50 100% A52 100% A53 100% A54 100% A55 100% A56 100% A57 100% A53a 100% AS 3 b 100% A59 100% Ao 0&lt;a 100% A60b 100% A6丄 30% Λ62 100% Λ63 100% Ao4a 100% (請先閲讀背面之注意事項再填寫本頁) • ϋ n m m m m. ·、 1T Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs -303-This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 487559 A7 B7 V. Description of the invention (others) Employee Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs Printed A13a 100% A13d 100% Λ14 100%) ΛΙ5 100% A17 100% A13 100% Λ19 100% Λ2 0 100% Λ22 100% A23 100% Λ2 5 100% A27 100% A23 100% A29 100% A3 0 100 % A3 1,117 100% A3 2 丄 00% A3 3 100% A3 4 100% A3 6 100% A3 7 100% A4 0 100% A4 6 100% 100% A47 &lt;: 50% A43 100% &lt; 5G% A49b &lt;: 50% A50 100% A52 100% A53 100% A54 100% A55 100% A56 100% A57 100% A53a 100% AS 3 b 100% A59 100% Ao 0 &lt; a 100% A60b 100% A6 丄 30% Λ62 100% Λ63 100% Ao4a 100% (Please read the notes on the back before filling this page) • ϋ nmmm m. ·

,1T -304 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 487559 A7 B7 五、發明説明(3〇2) 經濟部中央標準局員工消費合作社印製 A6 4b 100% A5 6 100% Λ67 100% ; Λ63 100% A59 100% Λ7 0 100% A71 100% Λ72 100% A7 3 &lt;50% A7 4 &lt; 50% Λ7 6 100% Λ77 100% A7 8a 100% A7 3b 100% A7 3c 100% A7 9 100% Λ3 0&lt;a 100% A3 Ob &lt;50% A31 100% Λ36,Λ90 &lt;50% A3 7 100% A3 3 &lt;50% A3 9 100% Λ9 I &lt;50% B1 90% &lt;50% 100% 32 60% &lt;50% 53 &lt;50% &lt;:50% B4 &lt;50% &lt;50% B5 &lt;50% &lt;50% Bo &lt;50% 75% 37 &lt;50% •:.50% 33 100% 30% 39 30% 100% 310 &lt; 50% •:50% 3丄丄 &lt;50% &lt;50% 312 &lt;50% BI3 30% S丄4 、50% &lt; 50% 315 100% 、 50% 〇16 90% 50% BIT 100% BI3 90¾ -305 - I---1--^---0^-- (請先閱讀背面之注意事項再填寫本頁) 訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 487559 A7 B7, 1T -304-This paper size is applicable to Chinese National Standard (CNS) A4 (210X297mm) 487559 A7 B7 V. Description of Invention (302) Printed by A6 4b 100% A5 6 100% Λ67 100%; Λ63 100% A59 100% Λ7 0 100% A71 100% Λ72 100% A7 3 &lt; 50% A7 4 &lt; 50% Λ7 6 100% Λ77 100% A7 8a 100% A7 3b 100% A7 3c 100% A7 9 100% Λ3 0 &lt; a 100% A3 Ob &lt; 50% A31 100% Λ36, Λ90 &lt; 50% A3 7 100% A3 3 &lt; 50% A3 9 100% Λ9 I &lt; 50% B1 90% &lt; 50% 100% 32 60% &lt; 50% 53 &lt; 50% &lt;: 50% B4 &lt; 50% &lt; 50% B5 &lt; 50% &lt; 50% Bo &lt; 50% 75% 37 &lt; 50% •: .50% 33 100% 30% 39 30% 100% 310 &lt; 50% •: 50% 3 丄 丄 &lt; 50% &lt; 50% 312 &lt; 50% BI3 30% S 丄4, 50% &lt; 50% 315 100%, 50% 〇16 90% 50% BIT 100% BI3 90¾ -305-I --- 1-^ --- 0 ^-(Please read the note on the back first Please fill in this page for the matters) Chinese National Standard (CNS) A4 size (210X297 mm) 487559 A7 B7

(奶) 經濟部中央標準局員工消費合作社印製(Milk) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

319 &lt; 50% Cl#C13b 100% 80% 100% &lt;50% C2 60% &lt;50% &lt; 50% v50% C3 100% 100% 100% 100% C4 100% 100% &lt;50% &lt;50% C5 100% &lt; 50% 100% &lt; 50% C5 90% 100% C9 90% CIO 100% C1I 100% 9 0% C16 &lt;50% C17 70% C19 100% C20 &lt; 50% C21a 100% C21b 90% C22 &lt; 50% C23 100% C24 100% C25 100% C26 100% C27 100% C28 60% C29 100% C3G &lt;50% C3i 100% D1 &lt;50% &lt;.50% D2 100% &lt;.50% D3 100% &lt;50% D4 100% D5 100% D6 100% D7 100% DB 100% D9a &lt;50% D9b 100% DIO &lt;50% D12 100% 100% D13 .50% D17 70% D丄3 100¾ £1 90°ό SO'% , - 306 - 隼(CNS ) A4規格(210X297公釐)319 &lt; 50% Cl # C13b 100% 80% 100% &lt; 50% C2 60% &lt; 50% &lt; 50% v50% C3 100% 100% 100% 100% C4 100% 100% &lt; 50% &lt; 50% C5 100% &lt; 50% 100% &lt; 50% C5 90% 100% C9 90% CIO 100% C1I 100% 9 0% C16 &lt; 50% C17 70% C19 100% C20 &lt; 50% C21a 100% C21b 90% C22 &lt; 50% C23 100% C24 100% C25 100% C26 100% C27 100% C28 60% C29 100% C3G &lt; 50% C3i 100% D1 &lt; 50% &lt; .50% D2 100% &lt; .50% D3 100% &lt; 50% D4 100% D5 100% D6 100% D7 100% DB 100% D9a &lt; 50% D9b 100% DIO &lt; 50% D12 100% 100% D13 .50 % D17 70% D 丄 3 100¾ £ 1 90 ° ό SO '%,-306-隼 (CNS) A4 size (210X297 mm)

---^----! (請先閱讀背面之注意事項再填寫本頁) 、11 487559 經濟部中央標準局員工消費合作社印製--- ^ ----! (Please read the notes on the back before filling this page), 11 487559 Printed by the Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs

-——ΊΊ鑀! (請先閱讀背面之注意事項再填寫本頁) ΜΨ 訂------ 487559 B7 五 發明説明(3β) 經濟部中央標準局員工消費合作社印製 H5 100% 100% } H6 100% 100% H7 100% 100% 100% 100% H8 100% 11 100% 工2 100% 工3 &lt;50% 15 100% 工6 100% 17 100% 19 100% 工11 100% 114 100% 115 100% 100% 116 100% J1 90% 100% J2 &lt;50% J3 &lt;:5Ό% J4 100% J5 &lt;:50% J6 &lt;:50% &lt;50% J7 &lt;:50% &lt;:50% J10 &lt;50% K1 &lt;:50% K2a &lt;50% K2b &lt;50% K3b &lt;50% K4 90% Κ5 &lt;50% Κβ &lt;50% Κ7 &lt;50% &lt;50% (請先閲讀背面之注意事項再填寫本頁) 訂 # 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐)-—— Oh! (Please read the precautions on the back before filling out this page) ΜΨ Order ------ 487559 B7 Five Invention Instructions (3β) Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economy H5 100% 100%} H6 100% 100% H7 100% 100% 100% 100% H8 100% 11 100% Job 2 100% Job 3 &lt; 50% 15 100% Job 6 100% 17 100% 19 100% Job 11 100% 114 100% 115 100% 100% 116 100% J1 90% 100% J2 &lt; 50% J3 &lt;: 5Ό% J4 100% J5 &lt;: 50% J6 &lt;: 50% &lt; 50% J7 &lt;: 50% &lt;: 50% J10 &lt; 50% K1 &lt;: 50% K2a &lt; 50% K2b &lt; 50% K3b &lt; 50% K4 90% Κ5 &lt; 50% Κβ &lt; 50% Κ7 &lt; 50% &lt; 50% (please first Read the notes on the reverse side and fill out this page) Order # This paper size applies to China National Standard (CNS) Α4 size (210X297 mm)

Claims (1)

487559 C8 , ,, 1 :… D8 Γ ^ _ -- t、申請專利範圍 第083102553A01號專利再審查案申請專利範圍修正本 修正曰期:90年6月 1. 一種化合物,其係擇自下列群組: 3’-〇-11-丙基史賓諾辛(3口丨11〇5;711)】; 3’-〇-乙基史賓諾辛J ; 3’-0-乙基史賓諾辛K ; 3’-〇-乙基史賓諾辛L ; 3’-0-n-丁基史賓諾辛J ; 3、〇-異丁醯基史賓諾辛J; 5.6- 二氫-3’-0-乙基史賓諾辛J; 5.6- 二氫-3’-0-n-丙基史賓諾辛J; 5.6- 二氫-3’-0-n-丁基史賓諾辛J; 3’-〇-乙基史賓諾辛J半戊二酸鹽; 3’-0-五氘乙基史賓諾辛J半戊二酸鹽; 5.6- 二氫-3’-0-n-丙基史賓諾辛J半戊二酸鹽; 3’-0-乙基史賓諾辛L半戊二酸鹽; 3’-0-五氘乙基史賓諾辛J; 3’-0-異丙基史賓諾辛J ; 3 ’ -O-n -丙基史負諾辛J, 3’-0-n-丙基史賓諾辛L ; 5.6- 二氫-3’-0-n-丙基史賓諾辛J; 3’-0-丙基史賓諾辛J檸檬酸鹽; 3’-0-丙基史賓諾辛L檸檬酸鹽; 5.6- 二氫-3’-0-n-丙基史賓諾辛J檸檬酸鹽; 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) ------------------訂--------- (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印利衣 487559 A8 B8 C8487559 C8, ,, 1:… D8 Γ ^ _-t. Application for Patent Reexamination No. 083102553A01 Application for Revision of Patent Scope Amendment Date: June 1990 1. A compound selected from the following group Group: 3'-〇-11-propyl spinosinoxine (3 mouth 丨 1105; 711)]; 3'-〇-ethyl spinosinin J; 3'-0-ethyl spinosinin K; 3'-〇-Ethyl Spinoxin L; 3'-0-n-Butyl Spinozin J; 3, 0-isobutyridinyl Spinozin J; 5.6-Dihydro-3'-0-B Base Spinoxin J; 5.6-Dihydro-3'-0-n-propyl Spinoxin J; 5.6-Dihydro-3'-0-n-butyl Spinoxin J; 3'-〇-B Spinylspinoxin J hemiglutarate; 3'-0-pentadeuteryl ethylspinoxin J hemiglutarate; 5.6-dihydro-3'-0-n-propyl spinoxin J semipenta Diacid salt; 3'-0-ethylspinoxin L hemiglutarate; 3'-0-penta-deuterated ethylspinoxin J; 3'-0-isopropylspinoxin J; 3 ' -On-propyl-spinoxin J, 3'-0-n-propylspinoxin L; 5.6-dihydro-3'-0-n-propyl-spinoxin J; 3'-0-propyl Binoxin J citrate; 3'-0-propyl spine Nosin L citrate; 5.6-dihydro-3'-0-n-propyl Spinozin J citrate; This paper size applies to China National Standard (CNS) A4 (210 X 297 mm)- ---------------- Order --------- (Please read the precautions on the back before filling out this page) Intellectual Property Cooperative of Intellectual Property of the Intellectual Property Bureau of the Ministry of Economic Affairs 487559 A8 B8 C8 六、申請專利範圍 5.6- 二氫-3’-〇-異丙基史賓諾辛j; 3’-0.-乙基曱醯基史賓諾辛μ ; (請先閱讀背面之注意事項再填寫本頁} 3’-0-乙基史賓諾辛μ ; 5.6- 一氫-3-表-Ν- 3’ -甲醯基_丙基史賓諾辛 5.6- 二氫-3-表-3’-丙基史賓諾辛j ; (14S)-13,14-二氫乙基史賓諾辛μ ; (14S)-13,14-二氫-3’-〇-η-丙基史賓諾辛 j ; (1R/S,15R,21S)-15-去氧-1,15-氧-3’-0-η-丙基-ΐ,2ΐ-斷 史負諾辛J1-半縮酸; (1511)-15-去氧-15-羥基-3’-0-11-丙基史賓諾辛了; (143)-5,6,13,!4-四羥基-3’-〇-11-丙基史賓諾辛1; 3’-0-丙基史賓諾辛L ; 3’-0 -丙基史賓諸辛J; 3’-0-乙基史賓諾辛L ; 3’-0-η-丙基史賓諾辛Q; 4”-羥基史賓諾辛A ; (4 S)-4 -去曱基-(二曱基胺基)_4,’_經基史賓諾辛α· 4’’-去氨基-5, 6-二氫-4”(S)-經基史賓諸辛c ; 經濟部智慧財產局員工消費合作社印剩衣 9-0- (2,3,4-三乙基-L-鼠李糖基之5,6-二氫基衍 生物)史賓諾辛A Psa ; (5S,6R)-環氧-2’-0-(p-三氟曱基)苯甲酿基史賓諾辛^ 5.6- 二氫-3’-0-乙基史賓諾辛j; 5.6- 二氫-3’-0-n-丙基史賓諾辛j ; 5.6- 二氫-3’-0-n-丁基史賓諾辛j; 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) 經濟部智慧財產局員工消費合作社印製 487559 A8 B8 C8 D8 六、申請專利範圍 5.6- 二氫-3’-0-n-丙基史賓諾辛J半戊二酸鹽; 5.6- 二氫-2’-0-乙基史賓諾辛H; 5.6- 二氫-2’-0-n-丙基史賓諾辛H; (5R,6S)-5,6-環氧-3’-0-n-丙基史賓諾辛L; (5S,6R)-5,6-環氧丙基史賓諾辛L; (511,63)-3’-去氧-5,6-環氧-3’-亞甲基史賓諾辛了; (5S,6R)- 3、去氧-5,6-環氧-3’-亞曱基史賓諾辛J ; 5.6- 二氫-3’-0-n-丙基史賓諾辛J; 5.6- 二氫-3’-0-n-異丙基史賓諾辛J; 5,6·二氫-3’-表-N-曱醯基-3’-丙基史賓諾辛J; 5.6- 二氫-3’-表-3’-丙基史賓諾辛J; 5.6- 二氫-3’-0-乙烯基史賓諾辛J; (143)-5,6,13,14-四氫-3’-0-11-丙基史賓諾辛1; 5.6- 二氫-3’-曱氧曱基-史賓諾辛J ; 4”-N-去曱基-4”-N-(2-氟乙基)-5,6-二氫-3’-0-丙基史賓 諾辛J ; 4”-N-去甲基-5,6-二氫-3’-0-丙基史賓諾辛J; 5.6- 二氫-N-曱醯史賓諾辛B; 4”-去氨基-5,6-二氫-4”-酮基史賓諾辛C; 4”-去氨基-5,6-二氫-4”(S)-氫氧基史賓諾辛C ; 4”-去氨基-5,6-二氫-4”(S)-甲氧基史賓諾辛C; (143)-5,6,13,14-四氫史賓諾辛八; (14R)-5,6,13,14-四氫史賓諾辛A; (143)-5,6,13,14-四氫-3’-去氧史賓諾辛1; 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 裝 · 487559 §Sixth, the scope of application for patents is 5.6-dihydro-3'-〇-isopropylspinoxin j; 3'-0.-ethylspinylspinoxin μ; (Please read the precautions on the back before filling in this Page} 3'-0-Ethyl Spinoxin μ; 5.6-monohydro-3-epi-N- 3'-methylamido-propyl Spinoxin 5.6-dihydro-3-epi-3'-propyl Base Spinoxin j; (14S) -13,14-dihydroethyl Spinoxin μ; (14S) -13,14-dihydro-3'-〇-η-propyl Spinoxin j; (1R / S, 15R, 21S) -15-deoxy-1,15-oxy-3'-0-η-propyl-fluorene, 2 hydrazine-Nosin J1-hemiacetic acid; (1511) -15- Deoxy-15-hydroxy-3'-0-11-propyl spinosynoxine; (143) -5,6,13 ,! 4-tetrahydroxy-3'-〇-11-propyl spinosynoxine 1 ; 3'-0-propyl Spinoxin L; 3'-0 -propyl Spinoxin J; 3'-0-ethyl Spinoxin L; 3'-0-η-propyl Spinoxin Q 4 ”-Hydroxy Spinoxin A; (4 S) -4 -Defluorenyl- (difluorenylamino) _4, '_ Chenyl Spinoxin α · 4" -Deamino-5, 6 -Dihydro-4 "(S) -Jing Shi Bin Zhu Xin c; Employees' Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs, Yin Yuyi 9-0- (2,3,4-triethyl-L-rhamnose 5,6-dihydrogen derivative) Spinozin A Psa; (5S, 6R) -epoxy-2'-0- (p-trifluorofluorenyl) benzyl spinosin ^^ 5.6 -Dihydro-3'-0-ethyl Spinozin j; 5.6- dihydro-3'-0-n-propyl Spinozin j; 5.6- dihydro-3'-0-n-butyl Spinn Northyn j; This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) Printed by the Employees 'Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs 487559 A8 B8 C8 D8 VI. Application for patent scope 5.6- Dihydro-3' -0-n-propyl Spinocinol J hemiglutarate; 5.6-dihydro-2'-0-ethylspinoxin H; 5.6-dihydro-2'-0-n-propylspinodin Octane H; (5R, 6S) -5,6-epoxy-3'-0-n-propyl Spinolsin L; (5S, 6R) -5,6-epoxypropyl Spinolsin L; ( 511,63) -3'-deoxy-5,6-epoxy-3'-methylene spinosinol; (5S, 6R) -3, deoxy-5,6-epoxy-3 ' -Arylene Spinnockin J; 5.6-dihydro-3'-0-n-propyl Spinnockin J; 5.6-dihydro-3'-0-n-isopropyl Spinnockin J; 5, 6 · Dihydro-3'-epi-N-fluorenyl-3'-propyl spinosinoxin J; 5.6- Dihydro-3'-epi-3'-propyl spinosinol J; 5.6- two Hydrogen-3'-0-vinyl Spinozin J; (143) -5,6,13,14-tetrahydro-3'-0-11-propyl Spinozin 1; 5.6-dihydro-3 ' -Phenoxyfluorenyl-Spinoxin J; 4 "-N-Defluorenyl-4" -N- (2-fluoroethyl) -5,6-dihydro-3'-0-propyl Spino Sin J; 4 "-N-desmethyl-5,6-dihydro-3'-0-propyl Spinozin J; 5.6-dihydro-N-Spinnoxin B; 4" -Go Amino-5,6-dihydro-4 "-ketospinoxin C; 4" -deamino-5,6-dihydro-4 "(S) -hydroxyoxyspinoxin C; 4" -to Amino-5,6-dihydro-4 "(S) -methoxyspinoxin C; (143) -5,6,13,14-tetrahydrospinoxin VIII; (14R) -5,6 , 13,14-tetrahydrospinoxin A; (143) -5,6,13,14-tetrahydro-3'-deoxyspinoxin 1; This paper size applies Chinese National Standard (CNS) A4 Specifications (210 X 297 mm) (Please read the notes on the back before filling out this page) Packing · 487559 § ^、申請專利範圍 經濟部智慧財產局員工消費合作社印製 (5R,6R)-5-(2,基乙氧基)冬漠史賓料a 17_Psa ; (5S,6R)-5,6-乙氧基_17_〇-三甲基甲矽烷基史賓諾辛a 17-Psa ; (5S,6R)-5-環氧基史賓諾辛Al7-Psa; (5S,6R)_5-(2-羥基乙氧基)_6_溴史賓諾辛a; (5S,6R)-5,6-二羥基 _5,6_二氫基史賓諾辛 a 17_psa ; (5S,6R)-史賓諾辛a碳酸鹽; (5S,6S)-乙酸基-6-溴-史賓諾辛a ; (5R,6R)-乙酸基-6-、;臭-史賓諸辛a ; 5.6- 二氫史賓諾辛a ; 5.6- 二溴史賓諾辛A17Psa; 5.6- 二氫史賓諾辛a ; (5S,6R)-5,6-環氧基史賓諾辛a ; (5R,6S)-環氧基史賓諾辛a ; (5R,6S)-i^氧基史賓諾辛d; (5S,6R)-環氧基史賓諾辛a、N氧化物; (5R,6S)-環氧基史賓諸辛a、N氧化物; (53,611)-環氧基史賓諾辛〇、&gt;1氧化物; (5S,6R)-環氧基史賓諾辛d、N氧化物; (5R,6S)-5,6-二溴-4”-酮基史賓諾辛a; (5匕61^)-5,6-二&gt;臭-6-經基史賓諾辛3; 5.6- 順式-二羥基-5,6-二氫史賓諾辛b; (5S,6R)-5,6-二羥基史負諾辛A之二氯乙烯酮縮醛; (5S,6R)-5,6-雙(三氯-乙醯氧基)史賓諾辛a; 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) AWI ^--------^--------- (請先閱讀背面之注意事項再填寫本頁) -4- 487559 A8 B8 C8 D8 經濟部智慧財產局員工消費合作社印製 申請專利範圍 (5R,6R)-5,6-二溴史賓.諾辛 A; (5S)-5,6-二氫-5-羥基史賓諾辛A; (6S)-5,6 -二氮-6-經基史負語辛A, (6R)-5,6-二氫-6-羥基史賓諾辛A; (5R:6R)-5-乙醯氧基-6-硫代曱氧基史賓諾辛A; (5R,6R)-5-乙醯氧基-6-甲基磺醯基史賓諾辛A ; (5R,6R)-6-溴-5-羥基史賓諾辛J; 5.6- 二氫史賓諾辛A 9-Psa ; 5.6- 二氫史賓諾辛A 17-Psa ; 5.6- 二氫史賓諾辛J ; 5.6- 二氫史賓諾辛Η ; 5.6- 二氫史賓諾辛Α半戊二酸鹽; 5.6- 二氫史賓諾辛B ; (5S,6R)-環氧基史賓諾辛Q ; (5S,6R)-5,6-二氫-5,6-二羥基史賓諾辛A; (5R,6S)-5,6-二氫-5,6-二羥基史賓諾辛A; 5.6- 二氫史賓諾辛D ; 9-(2H-5-R-乙醯氧基-5,6-二氫-6-S-甲基-2-A-哌喃基)-史賓諾辛A 9-假糖苔配基化合物;以及 5.6- 二氫-9-(2-去氧基-3-0,4-0-二乙基-l-α -鼠李糖基) 史賓諾辛A 9-假糖苔配基化合物。 本紙張尺度適用中國國家標準(CNS)A4規格(210 X 297公釐) -------------------訂-------- (請先閱讀背面之注意事項再填寫本頁)^ Application for patents printed by (5R, 6R) -5- (2, ethoxy) Dongmo Shibin materials a 17_Psa; (5S, 6R) -5,6-B Oxy_17_〇-trimethylsilyl spinoxin a 17-Psa; (5S, 6R) -5-epoxy spinoxin Al7-Psa; (5S, 6R) _5- (2-hydroxy (Ethoxy) _6_bromo-spinoxin a; (5S, 6R) -5,6-dihydroxy_5,6_dihydro-spinoxin a 17_psa; (5S, 6R) -spinoxin a Carbonate; (5S, 6S) -acetoxy-6-bromo-spinoxin a; (5R, 6R) -acetoxy-6- ,; odorant-spinozin a; 5.6-dihydrospino Octyl a; 5.6-dibromospinoxin A17Psa; 5.6-dihydrospinoxin a; (5S, 6R) -5,6-epoxyspinoxin a; (5R, 6S) -epoxy (5R, 6S) -i-Spinoxin d; (5S, 6R) -epoxy-Spinoxin a, N oxide; (5R, 6S) -epoxy-Spinozin a, N oxide; (53,611) -epoxy spinosinoxin, &gt; 1 oxide; (5S, 6R) -epoxy spinosinoxin d, N oxide; (5R, 6S) -5, 6-dibromo-4 "-ketospinoxin a; (5D61 ^)-5,6-di &gt; stinky-6-jingspinoxin 3; 5. 6-cis-dihydroxy-5,6-dihydrospirinoloxin b; (5S, 6R) -5,6-dihydroxyspirinoloxacin dichloroketal acetal; (5S, 6R) -5,6-Bis (trichloro-ethoxyl) Spinoloxine a; This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) AWI ^ -------- ^ --------- (Please read the notes on the back before filling in this page) -4- 487559 A8 B8 C8 D8 The scope of patent application (5R, 6R) printed by the Consumer Consumption Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs- 5,6-Dibromosphinx. Nosin A; (5S) -5,6-dihydro-5-hydroxyspinoxin A; (6S) -5,6-Diaza-6-jingshi negative Octyl A, (6R) -5,6-dihydro-6-hydroxyspinoxin A; (5R: 6R) -5-ethoxyl-6-thioxanthyl spinoxin A; (5R , 6R) -5-Ethyloxy-6-methylsulfonylspinoxin A; (5R, 6R) -6-bromo-5-hydroxyspinoxin J; 5.6-dihydrospinoxin A 9-Psa; 5.6-dihydrospirinoxin A 17-Psa; 5.6- dihydrospirinoxin J; 5.6- dihydrospirinoxin Η; 5.6- dihydrospirinoxin A hemipentane Acid salt; 5.6-dihydrospinoxin B; (5S, 6R) -epoxy-spinoxin Q; (5S, 6R) -5,6-dihydro-5,6-dihydroxy Kirspinoxin A; (5R, 6S) -5,6-dihydro-5,6-dihydroxyspinoxin A; 5.6-dihydrospinoxin D; 9- (2H-5-R- Acetyloxy-5,6-dihydro-6-S-methyl-2-A-piperanyl) -Spinoxin A 9-pseudoglucosyl compound; and 5.6-dihydro-9- (2-Deoxy-3-0,4-0-diethyl-l-α-rhamnosyl) Spinoxin A 9-pseudoglucosyl compound. This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) ------------------- Order -------- (please first (Read the notes on the back and fill out this page)
TW83102553A01 1995-06-14 1996-12-13 A83543 compounds, their preparation process and their uses TW487559B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20195P 1995-06-14 1995-06-14
US143595P 1995-07-14 1995-07-14
US900695P 1995-12-21 1995-12-21
US66254996A 1996-06-13 1996-06-13

Publications (1)

Publication Number Publication Date
TW487559B true TW487559B (en) 2002-05-21

Family

ID=27484980

Family Applications (1)

Application Number Title Priority Date Filing Date
TW83102553A01 TW487559B (en) 1995-06-14 1996-12-13 A83543 compounds, their preparation process and their uses

Country Status (1)

Country Link
TW (1) TW487559B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI513407B (en) * 2010-02-19 2015-12-21 Sumitomo Chemical Co Pest control composition
CN106188184A (en) * 2015-06-01 2016-12-07 中南大学 Pleocidin derivative application in terms of preparing antitumor drug and anti-KSHV virus drugs
CN115010778A (en) * 2022-06-10 2022-09-06 康纳新型材料(杭州)有限公司 Preparation method of spinetoram
CN115785180A (en) * 2022-12-19 2023-03-14 利民化学有限责任公司 Spinosad derivative as pesticide and preparation method and application thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI513407B (en) * 2010-02-19 2015-12-21 Sumitomo Chemical Co Pest control composition
CN106188184A (en) * 2015-06-01 2016-12-07 中南大学 Pleocidin derivative application in terms of preparing antitumor drug and anti-KSHV virus drugs
CN106188184B (en) * 2015-06-01 2021-01-05 中南大学 Application of spinosyn derivative in preparation of anti-tumor drugs and anti-KSHV virus drugs
CN115010778A (en) * 2022-06-10 2022-09-06 康纳新型材料(杭州)有限公司 Preparation method of spinetoram
CN115010778B (en) * 2022-06-10 2024-07-02 康纳新型材料(杭州)有限公司 Preparation method of spinetoram
CN115785180A (en) * 2022-12-19 2023-03-14 利民化学有限责任公司 Spinosad derivative as pesticide and preparation method and application thereof

Similar Documents

Publication Publication Date Title
JP4717163B2 (en) Synthetic modification of spinosyn compounds
JP5046116B2 (en) Avermectin substituted at the 4 &#34;position and avermectin monosaccharide substituted at the 4 &#39;position
AU618446B2 (en) Avermectin derivatives
DE69224234T2 (en) 4-a-Substituted avermectin derivatives
JPH10504041A (en) Nodulisporic acid derivative
AU609399B2 (en) Macrolide compounds
KR960013079B1 (en) Macrolide compounds, their preparation and their use
CA2130664C (en) Antiparasitic agents
JPH0759584B2 (en) 13.BETA.-Alkylmylbemycin, process for its production, and pest control composition
TW487559B (en) A83543 compounds, their preparation process and their uses
JPS62265289A (en) Macrolide antibiotic
AU603956B2 (en) Avermectin and milbemycin derivatives from streptomyces avermitiosis ATCC 31267, 31271 and 31272
EP0710242B1 (en) Antiparasitic agents
KR960007867B1 (en) 23-oxo(keto)and 23-imino derivatives of mono and diepoxy ll-f28249 compounds
PT90507B (en) PROCESS FOR THE PREPARATION OF MACROLIDATE COMPOUNDS
PT95241B (en) 13-ALKYL-23-IMINO AND 13-HALO-23-IMINO COMPOUND LL-F28249 DERIVATIVES, UTEIS AS ENDO-E ECTOPARIASITICID AGENTS
RU2099334C1 (en) Macrolide compounds, composition showing antibiotic activity, veterinary composition, insecticide-acaricide-nematocide composition and a method of insect and/or tick and nematode killing
AP38A (en) Macrolide Compounds.
PT86900B (en) PROCESS FOR THE PREPARATION OF MONO- AND DIEPOXIDE DERIVATIVES OF 23-DESOXY-LL-F28249 COMPOUNDS
CS262673B2 (en) Process for preparing new derivatives of avermectine
SI8712186A (en) Process for obtaining new macrolide compounds